concept_id	concept_synonym_name	language_concept_id
36032387	1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; QNT; Quan; Quant; Quantitative; Standard score; THC; THF; UA; UR; Urn; Z score; Z value; Z-score	4180186
36032387	THF 24h Z-score Ur	4180186
36032387	四氢皮质醇:Z评分:24小时:尿液:定量型	4182948
36032390	HEDIS 评测年度 2020 取值集合 - 粪便潜血试验:-:时间点:^患者:-	4182948
36032390	HEDIS MY 2020 FOBT; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
36032390	HEDIS MY 2020 FOBT	4180186
36032391	除肾上腺皮质癌之外（外、以外）的肾上腺恶性肿瘤的概率:似然性:时间点:^患者:定量型:基于临床数据和实验室数据	4182948
36032391	ACC Prob; Adrnl; CLIN.RISK; from clin+lab data; Malig; Oncology; Other adrenal malig Prob; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
36032391	Other adrenal malig Prob clin+lab data	4180186
36032392	NEONAT; Pain/agitat; Pain/agitat pnl; Pan; PANEL.NEONAT; Panl; Pnl; Point in time; Random	4180186
36032392	Pain/agitat pnl NPASS	4180186
36032394	表面诱导型凝血过程.因子替换^在添加1:1正常血浆后孵育之后2小时:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
36032394	120 min; 120 minutes; 120min; 2 hours; 2h p 1:1 NP; 2h p Inc; Activated partial thromboplastin time; After; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; i; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
36032394	aPTT 2h p 1:1 NP PPP	4180186
36032395	甘蔗花粉 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36032395	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f021; f21; G900; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sugar cane; Sugar cane pollen; Sugarcane	4180186
36032395	Sugar cane pollen IgE Qn	4180186
36032396	Squamous # Bronch Manual	4180186
36032396	#; ABS; absolute; absolutes; Bro; Cell; Cellularity; Cnt; Count; Count/volume; CT; Epi; Epi Cells; Epith; Epithelia; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; SEC; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells	4180186
36032396	上皮细胞.鳞状上皮细胞型:计数型浓度:时间点:支气管来源的标本:定量型:手工计数方法	4182948
36032399	纤维蛋白形成速率.玻璃珠诱导型^在肝素中和之后:任意型速率:时间点:全血:定量型:微黏度测定法	4182948
36032399	After; Arbitrary rate; Blood; Clot Rate Glass Bead Ind; Clot Rt Gls Bd Ind HepNtr; COAGULATION; Hematology; Heme; Hep; Hepar; Heparin Nt; Heparn; MicrVisc; Neut; Neutr; p hep neut; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36032399	Clot Rate GlsBead HepNtr Bld MicrVisc	4180186
36032400	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36032401	胆固醇与甘油三酯与乳糜微粒组套:-:时间点:尿液:-	4182948
36032401	Cholest+triglyceride+chylomicrons Pnl Ur	4180186
36032401	Chemistry; Chol; Choles; Cholest; Cholest+triglyceride+chylomicrons Pnl; Cholesterol total; Cholesterols; Chylomicron; Chyluria Screen; Galacturia; Lipid; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Tg; Trig; Trigly; Triglycerides; Triglycrides; UA; ULDL; Ultra low density lipoproteins; UR; Urn	4180186
36032404	一氧化碳/气体.总计^呼气末^经过针对环境一氧化碳而校正的:体积分数:时间点:呼出的气体:定量型	4182948
36032404	ambient CO cor; Breath; ETCOc; ExG; Exhaled gas; Exhaled gas (=breath); Exp; Gases; Lung; Percent; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Tot; Totl; Volfr; Volume fraction	4180186
36032404	ETCOc	4180186
36032413	肾上腺皮质癌的概率:似然性:时间点:^患者:定量型:基于临床数据和实验室数据	4182948
36032413	ACC Prob; Adrnl; CLIN.RISK; from clin+lab data; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
36032413	ACC Prob from clin+lab data	4180186
36032415	弹性纤维:计数型浓度:时间点:呼吸道.下:定量型:手工计数方法	4182948
36032415	Elastic fibers # Lower resp Manual	4180186
36032415	#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Fiber; Low; Lower resp; Manl; Number concentration; Number Concentration (count/vol); PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36032418	微生物学 - 分枝杆菌学检查:发现:时间点:^患者:文档型	4182948
36032418	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36032418	Mycobacteriology studies Doc	4180186
36032421	HLA-DP 与 DQ 与 DR (II 类) 分型组套:-:时间点:全血/组织:-:高分辨率方法	4182948
36032421	2; Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class II; HLA Cls II Typ Pnl; HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Inherited; Pan; PANEL.HLA; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36032421	HLA Cls II Typ Pnl Bld/T High Res	4180186
36032422	长轴:百分位数:时间点:股骨.骨干^胎儿:定量型:按所估计的孕龄	4182948
36032422	Comp of est fetal wgt W std pop dist at same; Est; estimation; Femoral; Fetal; Gest; Gestation; Gyn; Gynecology; Length; Lower extremity; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Per est GA; Percentile; Point in time; Prenatal; QNT; Quan; Quant; Quantitative; Random; Upper leg	4180186
36032422	Fet FDL Prctl per est GA	4180186
36032423	Finding; Findings; Mental health; MentalHealth; Ordinal; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Rel; Screen; Survey; SURVEY.NIDA	4180186
36032424	Assessment; clinical genomics; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Genetic; Genetics; Genomic; H&P; Heredity; Heritable; History and physical; Inherited; Medical Genetics; medical genomics; notes; Point in time; Random; Visit note	4180186
36032424	Clinical genetics Eval note	4180186
36032424	评价记录:发现:时间点:{环境}:文档型:临床遗传学	4182948
36032426	血管紧张素 (1-7):质量浓度:时间点:血浆:定量型	4182948
36032426	Ang-(1-7) Plas-mCnc	4180186
36032426	AGT; Ang-(1-7); Chemistry; i; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36032427	伤口等级:发现:时间点:足部:序数型:UT-DWCS	4182948
36032427	CLIN; Finding; Findings; Ft; Lower extremity; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36032427	Wound grade Ft UT-DWCS	4180186
36032428	HBG1 基因与 HBG2 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36032428	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; gamma Globin; Genetics; HBG; HBG1 + HBG2; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36032428	HBG1 + HBG2 Full Mut Anl Bld/T Seq	4180186
36032670	IO_IN.SUMMARY	4180186
36032801	ABL1 gene.c.944C>T	4180186
36032899	PUBLICHEALTH	4180186
36032933	IO_IN_SALTS+CALS	4180186
36032997	H&P.PX	4180186
36033084	IO_IN.INFUS	4180186
36033122	PANEL.H&P	4180186
36033132	EYE.ERG	4180186
36033207	IO_OUT.TIMED.MOLE	4180186
36033265	IO_OUT.MOLEC	4180186
36033605	IO_IN.ATOM	4180186
36033639	SARS 冠状病毒 2 免疫接种状态:历史记录:时间点:^患者:名义型	4182948
36033639	SARS-CoV-2 immunization status	4180186
36033639	2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; History; ID; II; Immunization status; Infectious Disease; InfectiousDisease; Nominal; PH; Point in time; Public Health; PublicHealth; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 immunization status; Severe Acute Respiratory Syndrome; Vaccination; Vaccinations; Vaccine; Viral Pneumonias; Wuhan coronavirus	4180186
36033640	SARS 冠状病毒 2 ORF1ab 区域:任意型浓度:时间点:呼吸道.上:定量型:探针法.基因扩增.靶向	4182948
36033640	SARS-CoV-2 ORF1ab U resp NAA+probe-aCnc	4180186
36033640	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; PH; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 ORF1ab; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp; Viral load; Viral Pneumonias; Wuhan coronavirus	4180186
36033642	SARS 冠状病毒 2 Nsp2 基因:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36033642	SARS-CoV-2 Nsp2 Upper resp Ql NAA+probe	4180186
36033642	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 Nsp2; Screen; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp; Viral Pneumonias; Wuhan coronavirus	4180186
36033645	SARS 冠状病毒 2 M 基因:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36033645	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; SARS; SARS Coronavirus; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 M gene; SARS-CoV-2 strain; Screen; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp; Viral Pneumonias; Wuhan coronavirus	4180186
36033645	SARS-CoV-2 M gene Upper resp Ql NAA+prb	4180186
36033646	SARS 冠状病毒 2 N 基因:存在情况或阈值:时间点:唾液:序数型:探针法.基因扩增.靶向.CDC 引物-探针组 N2	4182948
36033646	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Centers for Disease Control and Prevention; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA N2; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Oral fluid; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Sal; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 N gene; Screen; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36033646	SARS-CoV-2 N gene Sal Ql NAA N2	4180186
36033649	SARS 冠状病毒 2 ORF1ab 区域:阈值循环圈数:时间点:口咽洗液:定量型:探针法.基因扩增.靶向	4182948
36033649	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mouthwash; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OPA wash; Oph; Oral cavity wash; Oropharyngeal; Oropharynx; PCR; Pharynx gargle; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Saline gargle; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 ORF1ab; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; Throat rinse; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36033649	SARS-CoV-2 ORF1ab Ct OPA wash Qn NAA+prb	4180186
36033650	SARS 冠状病毒 2 S 基因:阈值循环圈数:时间点:口咽洗液:定量型:探针法.基因扩增.靶向	4182948
36033650	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mouthwash; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OPA wash; Oph; Oral cavity wash; Oropharyngeal; Oropharynx; PCR; Pharynx gargle; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S prime; Saline gargle; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S gene; SARS-Related Coronavirus; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; Throat rinse; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36033650	SARS-CoV-2 S gene Ct OPA wash Qn NAA+prb	4180186
36033652	SARS 冠状病毒 2 谱系:存在与否或特征标识:时间点:XXX:名义型:分子遗传学类实验室方法	4182948
36033652	2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; ID; Identity or presence; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 lineage; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Unspecified; Viral Pneumonias; Wuhan coronavirus	4180186
36033652	SARS-CoV-2 lineage Spec	4180186
36033659	SARS 冠状病毒 2 E 基因:阈值循环圈数:时间点:呼吸道:定量型:探针法.基因扩增.靶向	4182948
36033659	SARS-CoV-2 E gene Ct Resp Qn NAA+probe	4180186
36033659	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 E gene; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36033661	SARS 冠状病毒 2 变异解释:印象:时间点:XXX:叙述型	4182948
36033661	SARS-CoV-2 variant Imp Spec	4180186
36033661	2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; II; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Microbiology; Misc; Miscellaneous; Narrative; Other; Point in time; Random; Report; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 strain; SARS-CoV-2 variant; SARS-CoV-2 variant Imp; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Unspecified; Viral Pneumonias; VOC 202012/01; Wuhan coronavirus	4180186
36033662	SARS 冠状病毒 2 S 基因密码子 N501=:存在情况或阈值:时间点:XXX:序数型:分子遗传学类实验室方法	4182948
36033662	SARS-CoV-2 S gene N501= Spec Ql	4180186
36033662	2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; PH; Point in time; PR; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; S prime; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S gene; SARS-CoV-2 S gene N501=; SARS-Related Coronavirus; Screen; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Unspecified; Viral Pneumonias; Wuhan coronavirus	4180186
36033663	SARS 冠状病毒 2 S 基因密码子 N501Y:存在情况或阈值:时间点:XXX:序数型:分子遗传学类实验室方法	4182948
36033663	SARS-CoV-2 S gene N501Y Spec Ql	4180186
36033663	2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; PH; Point in time; PR; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; S prime; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S gene; SARS-CoV-2 S gene N501Y; SARS-Related Coronavirus; Screen; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Unspecified; Viral Pneumonias; Wuhan coronavirus	4180186
36033664	所检出的 SARS 冠状病毒 2 S 基因突变:存在与否或特征标识:时间点:XXX:名义型:分子遗传学类实验室方法	4182948
36033664	SARS-CoV-2 S gene mut Spec	4180186
36033664	2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; ID; Identity or presence; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Mut; Mutations; Nominal; Other; PCR; Point in time; Random; S prime; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S gene; SARS-CoV-2 S gene mut; SARS-Related Coronavirus; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Unspecified; Viral Pneumonias; Wuhan coronavirus	4180186
36033666	SARS 冠状病毒 2 抗体.IgG:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36033666	2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SR; SUDS; Viral Pneumonias; Wuhan coronavirus	4180186
36033666	SARS-CoV-2 IgG SerPl IA-mCnc	4180186
36033667	SARS 冠状病毒 2 变异:类型:时间点:XXX:名义型:序列测定	4182948
36033667	2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; high-throughput sequencing; HTS; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Next generation sequencing; NGS; Nominal; Other; Point in time; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 strain; SARS-CoV-2 variant; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Typ; Unspecified; Viral Pneumonias; VOC 202012/01; Wuhan coronavirus	4180186
36033667	SARS-CoV-2 variant Spec Seq	4180186
36033669	COVID-19+会诊记录:发现:时间点:{环境}:文档型:{角色}	4182948
36033669	COVID-19 Consult note	4180186
36033669	2019 Novel Coronavirus; 2019-nCoV; Consult note; Coronavirus disease 2019; COVID19; COVID-19 Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Visit note	4180186
36033673	人群分组:类型:时间点:^患者:名义型	4182948
36033673	Nominal; PH; Point in time; Public Health; PUBLICHEALTH; Random; Typ	4180186
36033681	Pinus pinea Ab.IgE	4180186
36033686	During the past 1W, how often have you been bothered by your skin condition being irritated	4180186
36033699	Ganglion cells.left	4180186
36033707	Aspalathus linearis Ab.IgE	4180186
36033710	Influenza virus A & Influenza virus B & SARS coronavirus 2 identified	4180186
36033719	Clot formation & Platelet function.glass bead induced post heparin neutralization panel	4180186
36033724	Electroretinogram.pattern	4180186
36033727	Tetrachlorophthalic anhydride Ab.IgE	4180186
36033732	During the past 3Mo, how often have you used sedatives or sleeping pills	4180186
36033735	Indomethacin Ab.IgE	4180186
36033736	During the last Mo did you have to eat less because your family didn't have enough money to buy food	4180186
36033742	During the past 3Mo, how often have you used street opioids	4180186
36033745	During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of sedatives or sleeping pills	4180186
36033747	During the past 1W, how often have you been bothered by being annoyed about your skin condition	4180186
36033750	HEDIS Measurement Year 2020 Value Set - CT Colonography	4180186
36033753	Based on clinical+lab data	4180186
36033755	During the last Mo did your meals only include a few kinds of cheap foods because your family was running out of money to buy food	4180186
36033764	(Gentamycin+Lincomycin+Neomycin+Streptomycin+Tobramycin) Ab.IgE	4180186
36033768	During the past 1W, how often have you been bothered by your skin condition burning or stinging	4180186
36033774	Hay dust Ab.IgE	4180186
36033775	Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel	4180186
36033780	Immunoglobulin light chains.free & immunofixation panel	4180186
36033783	During the past 4W, I worry about getting scars from my skin condition	4180186
36033784	During the past 3Mo, how often has your use of methamphetamine led to health, social, legal or financial problems	4180186
36033787	During the past 3Mo, how often have you had a strong desire or urge to use inhalants	4180186
36033792	During the past 4W, I am annoyed by my skin condition	4180186
36033797	Substances you have had a strong desire or urge to use during the past 3Mo	4180186
36033799	Admitted to intensive care unit for condition of interest	4180186
36033800	During the past 4W, my skin condition affects how well I sleep	4180186
36033802	During the past 4W, I am embarrassed by my skin condition	4180186
36033808	Pattern electroretinography measurements panel	4180186
36033809	Cymbopogon citratus	4180186
36033810	During the past 4W, my skin is sensitive	4180186
36033818	During the past 4W, my skin condition burns or stings	4180186
36033824	During the past 4W, my skin is irritated	4180186
36033827	HLA-DP & DQ & DR (class II) typing panel	4180186
36033835	Abies alba wood dust	4180186
36033836	Curschmann's spirals & crystals	4180186
36033853	UT-DWCS	4180186
36033856	SARS coronavirus 2 spike protein RBD	4180186
36033858	SARS coronavirus 2 spike protein RBD Ab.neut	4180186
36033866	During the past 3Mo, how often has your use of other substances led to health, social, legal or financial problems	4180186
36033867	During the past 3Mo, how often have you had a strong desire or urge to use street opioids	4180186
36033874	Abies alba wood dust Ab.IgE	4180186
36033875	Treated sheep wool Ab.IgE	4180186
36033888	Employed in a healthcare setting	4180186
36033894	Intensive care unit beds	4180186
36033896	SARS coronavirus 2 stimulated gamma interferon release by T-cells	4180186
36033904	Coagulation factor II activity & inhibitor panel	4180186
36033913	HEDIS Measurement Year 2020 Value Set - Quantitative Urine Albumin Lab Test	4180186
36033918	HEDIS Measurement Year 2020 Value Set - Group A Strep Tests	4180186
36033934	During the past 1W, how often have you been bothered by symptoms of your skin problem	4180186
36033935	Rods.right	4180186
36033943	Ethylparaben Ab.IgE	4180186
36033947	Cones.left	4180186
36033949	IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - discharge performance	4180186
36033961	Copper.free	4180186
36033984	During the past 3Mo, how often has your use of cocaine led to health, social, legal or financial problems	4180186
36033986	Argas reflexus	4180186
36033987	IDH1 gene & IDH2 gene	4180186
36033993	Ammonium persulfate Ab.IgE	4180186
36033999	During the past 4W, my skin condition makes showing affection difficult	4180186
36034022	ABL1 & ABL2 & PDGFRB gene rearrangements	4180186
36034027	During the past 3Mo, how often have you had a strong desire or urge to use hallucinogens	4180186
36034028	Pain &or agitation total score	4180186
36034037	During the past 1W, how often have you been bothered by your skin condition making it hard to work or do what you enjoy	4180186
36034042	Saccharum officinarum pollen Ab.IgE	4180186
36034058	Neonatal pain, agitation, & sedation scale panel	4180186
36034060	During the past 4W, I worry about side-effects from skin medications or treatments	4180186
36034076	Alpha-internexin Ab.IgG	4180186
36034083	NumDiff	4180186
36034086	During the past 1W, how often have you been bothered by the persistence or reoccurrence of your skin condition	4180186
36034091	HEDIS Measurement Year 2020 Value Set - HbA1C Tests	4180186
36034113	Fraxinus excelsior wood dust	4180186
36034118	Cydonia oblonga	4180186
36034123	Sodium nitrite Ab.IgE	4180186
36034130	Chromium & cobalt panel	4180186
36034131	During the past 3Mo, how often have you had a strong desire or urge to use other substances	4180186
36034132	Cobalamins Ab.IgE	4180186
36034133	During the past 1W, how often have you been bothered by your skin condition hurting	4180186
36034136	During the past 3Mo, how often have you used cannabis	4180186
36034137	Extracorporeal membrane oxygenation for condition of interest	4180186
36034143	Other substances that have led to health, social, legal or financial problems in the past 3Mo	4180186
36034145	Scorzonera hispanica Ab.IgE	4180186
36034152	HBG1 gene & HBG2 gene	4180186
36034166	Azorubine Ab.IgE	4180186
36034168	Substances that have led to health, social, legal or financial problems during the past 3Mo	4180186
36034178	Tobacco use in the past 1Y	4180186
36034191	During the last Mo how often were you not able to eat a balanced meal because your family didn't have enough money	4180186
36034200	HEDIS Measurement Year 2020 Value Sets	4180186
36034207	Pinus pinea	4180186
36034219	HIV 1 & 2 RNA	4180186
36034226	Gerbera spp Ab.IgE	4180186
36034228	During the past 1W, how often have you been bothered by frustration about your skin condition	4180186
36034237	During the past 4W, I tend to do things by myself because of my skin condition	4180186
36034246	Coagulation factor IX activity & inhibitor panel	4180186
36034251	First test for condition of interest	4180186
36034252	B & T cell crossmatch panel	4180186
36034255	SARS coronavirus 2+SARS-related coronavirus RNA	4180186
36034262	Methadone & 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine panel	4180186
36034264	During the past 3Mo, how often has your use of street opioids led to health, social, legal or financial problems	4180186
36034265	Adrenal malignancy other than adrenal cortical carcinoma probability	4180186
36034273	Pain &or agitation	4180186
36034274	Cichorium intybus var foliosum	4180186
36034277	(Quercus alba+Quercus rubra+Quercus velutina) Ab.IgE	4180186
36034279	During the past 4W, water bothers my skin condition (bathing, washing hands)	4180186
36034282	During the past 4W, my skin condition bleeds	4180186
36034286	During the past 4W, my skin condition interferes with my sex life	4180186
36034293	HEDIS Measurement Year 2020 Value Set - Pregnancy Test Exclusion	4180186
36034298	Elastic fibers.calcified	4180186
36034302	Number of D hospitalized	4180186
36034309	Cydonia oblonga Ab.IgE	4180186
36034324	HEDIS Measurement Year 2020 Value Set - BMI percentile	4180186
36034328	During the past 3Mo, how often have you used inhalants	4180186
36034332	HEDIS Measurement Year 2020 Value Set - Chlamydia Tests	4180186
36034342	HEDIS Measurement Year 2020 Value Set - Systolic Blood Pressure	4180186
36034343	During the past 1W, how often have you been emotionally bothered by your skin problem	4180186
36034360	Mechanical ventilation for condition of interest	4180186
36034365	Alpha-1-Fetoprotein & Alpha-1-Fetoprotein.L3 panel	4180186
36034366	HEDIS Measurement Year 2020 Value Set - PSA Tests	4180186
36034371	SARS coronavirus 2 stimulated gamma interferon panel	4180186
36034376	During the last Mo did you worry that food at home would run out before your family got money to buy more	4180186
36034392	During the past 3Mo, how often have you had a strong desire or urge to use prescription opioids	4180186
36034397	Influenza virus A & Influenza virus B & SARS coronavirus 2	4180186
36034398	Fagus grandifolia wood dust Ab.IgE	4180186
36034412	Treponema pallidum & Haemophilus ducreyi & Herpes simplex virus DNA panel	4180186
36034416	Butylparaben Ab.IgE	4180186
36034423	Ketoprofen Ab.IgE	4180186
36034426	During the past 4W, I am frustrated by my skin condition	4180186
36034437	During the past 3Mo, how often have you used other substances	4180186
36034456	During the past 4W, my skin hurts	4180186
36034460	LCDS v4.00 - Swallowing &or nutritional status	4180186
36034464	U.S. Food Security Survey.Child	4180186
36034479	During the past 4W, I am ashamed of my skin condition	4180186
36034481	During the past 1W, how often have you been bothered by the effects of your skin condition on your interactions with others	4180186
36034488	(Quercus alba+Quercus rubra+Quercus velutina)	4180186
36034492	Aspalathus linearis	4180186
36034494	During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of inhalants	4180186
36034499	Multifocal electroretinography panel	4180186
36034500	During the past 4W, my skin condition affects my social life	4180186
36034503	During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of cannabis	4180186
36034508	Substances used during the past 3Mo	4180186
36034509	Coagulation factor V activity & inhibitor panel	4180186
36034512	Arnica montana Ab.IgE	4180186
36034525	During the past 4W, I worry that my skin condition may be serious	4180186
36034528	HEDIS Measurement Year 2020 Value Set - PSA Test Exclusion	4180186
36034532	Optic disc+retinal nerve fiber layer.right	4180186
36034533	During the past 1W, how often have you been bothered by your skin condition making it hard to show affection	4180186
36034534	carBAMazepine Ab.IgE	4180186
36034544	Other substances that have caused you to fail to do what was normally expected of you in the past 3Mo	4180186
36034547	Adrenal cancer risk assessment & urine steroid fractions panel	4180186
36034550	During the past 4W, I tend to stay at home because of my skin condition	4180186
36034555	Rho GTPase-activating protein 26 Ab.IgG	4180186
36034556	During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of hallucinogens	4180186
36034557	IRF-PAI v2.0 - Swallowing &or nutritional status - admission	4180186
36034560	IgLON family member 5 Ab.IgG	4180186
36034561	HEDIS Measurement Year 2020 Value Set - Cholesterol Tests Other Than LDL	4180186
36203099	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36203101	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36203102	1 day; 24 hours; 24H; 24HR; Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey	4180186
36203104	1 day; 24 hours; 24H; 24HR; Activity; Count/time; Dextro; Exercise; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey	4180186
36203110	Activ; Activity; Actvty; Exercise; Movements; Ordinal; Ql; Qual; Qualitative; Scale; Screen; Survey; Tot; Total phys activity score; Totl	4180186
36203111	Sup marg Ca extent Br ca spec Ql Micro	4180186
36203111	Br ca spec; Brst; CA; Ca spec; Finding; Findings; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; Sup marg Ca extent	4180186
36203111	上缘癌累及范围:发现:时间点:乳腺癌标本:序数型:显微镜检查.光学	4182948
36203112	Br ca spec; Brst; CA; Ca spec; Ductal carcinoma in situ; Largest; Length; LM; Maximal; Maximum; Micro; Micros; Microscopic; Pathology; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203112	DCIS.max dim Br ca spec Micro	4180186
36203112	DCIS.最大尺寸:长度:时间点:乳腺癌标本:定量型:显微镜检查.光学	4182948
36203114	Br ca spec; Brst; CA; Ca spec; C-ERBB-2; erb; ERB2; ERB-2; erbB2; HER-2; HER-2/neu; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Oncology; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; St; Stains; Stn	4180186
36203114	Her2 Br ca spec Ql ImStn	4180186
36203114	Her2:存在情况或阈值:时间点:乳腺癌标本:序数型:免疫染色法	4182948
36203115	FDA insert REMS conversion to shared sys	4180186
36203115	DOCUMENT.REF; FDA insert; SPL; Structured Product Labelling	4180186
36203115	针对共享系统的 REMS 转换:-:-:^FDA 包装说明书:-	4182948
36203117	Adj struct invaded; Anatomy; CA; Ca spec; CRC spec; LM; Micro; Micros; Microscopic; Nominal; PATH.HISTO; PATHOLOGY; Point in time; Random; Spec	4180186
36203117	Adj struct invaded CRC spec Micro	4180186
36203117	肿瘤所侵犯的邻近结构:解剖学:时间点:结直肠癌标本:名义型:显微镜检查.光学	4182948
36203119	Ca dist closest uninv muc marg CRC Micro	4180186
36203119	CA; Ca dist closest uninv muc marg; Ca spec; CRC spec; Length; LM; Micro; Micros; Microscopic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203119	当并未累及所有黏膜边缘时癌相距最近黏膜边缘的距离:长度:时间点:结直肠癌标本:定量型:显微镜检查.光学	4182948
36203125	Peritum lymph resp Ca spec Ql Micro	4180186
36203125	CA; Ca spec; Finding; Findings; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Peritum lymph resp; Point in time; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36203125	肿瘤周围淋巴细胞反应:发现:时间点:癌标本:序数型:显微镜检查.光学	4182948
36203126	CA; Ca spec; CRC spec; LM; Micro; Micros; Microscopic; Nominal; Pathology; Point in time; Polyp in which inv carc arose; Random; Spec; Typ	4180186
36203126	Polyp type in which inv carc arose Micro	4180186
36203126	其中发生浸润性癌的息肉:类型:时间点:结直肠癌标本:名义型:显微镜检查.光学	4182948
36203127	CA; Ca spec; Meth; Method of; Nominal; Pathology; Point in time; Prom methyl method; Random; Spec; Typ	4180186
36203127	Prom methyl method Ca spec	4180186
36203127	启动子甲基化检测方法:类型:时间点:癌标本:名义型:*	4182948
36203130	Signet ring cells NFr CRC spec Micro	4180186
36203130	CA; Ca spec; Cell; Cellularity; CRC spec; Gated cells; LM; Micro; Micros; Microscopic; Number fraction; PATHOLOGY; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203130	印戒细胞/100 个细胞:计数型分数:时间点:结直肠癌标本:定量型:显微镜检查.光学	4182948
36203132	CA; Ca spec; CRC spec; LM; Marg tumor invol.deep; Marg tumor involve; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Surg	4180186
36203132	Marg tumor invol.deep CRC spec Ql Micro	4180186
36203132	外科手术边界肿瘤累及.深部:存在情况或阈值:时间点:结直肠癌标本:序数型:显微镜检查.光学	4182948
36203133	CA; Ca spec; CRC spec; LM; Marg tumor invol.dist; Marg tumor involve; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Surg	4180186
36203133	Marg tumor invol.dist CRC spec Ql Micro	4180186
36203133	外科手术边界肿瘤累及.远处:存在情况或阈值:时间点:结直肠癌标本:序数型:显微镜检查.光学	4182948
36203135	CA; Ca spec; CRC spec; Identity or presence; LM; Marg tumor invol.muc; Marg tumor involve; Micro; Micros; Microscopic; Nominal; Pathology; Point in time; Random; Spec; Surg	4180186
36203135	Marg tumor invol.muc CRC spec Micro	4180186
36203135	外科手术边界肿瘤累及.粘膜:存在与否或特征标识:时间点:结直肠癌标本:名义型:显微镜检查.光学	4182948
36203140	Br ca spec; Brst; CA; Ca spec; Dist Ca ant marg; Length; LM; Micro; Micros; Microscopic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203140	Dist Ca ant marg Br ca spec Micro	4180186
36203140	癌相距未累及前缘的距离:长度:时间点:乳腺癌标本:定量型:显微镜检查.光学	4182948
36203141	Br ca spec; Brst; CA; Ca spec; Dist Ca infer marg; Inf; Length; LM; Micro; Micros; Microscopic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203141	Dist Ca infer marg Br ca spec Micro	4180186
36203141	癌相距未累及下缘的距离:长度:时间点:乳腺癌标本:定量型:显微镜检查.光学	4182948
36203144	Br ca spec; Brst; CA; Ca spec; Dist Ca post marg; Length; LM; Micro; Micros; Microscopic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203144	Dist Ca post marg Br ca spec Micro	4180186
36203144	癌相距未累及后缘的距离:长度:时间点:乳腺癌标本:定量型:显微镜检查.光学	4182948
36203147	Ant marg Ca extent Br ca spec Ql Micro	4180186
36203147	Ant marg Ca extent; Br ca spec; Brst; CA; Ca spec; Finding; Findings; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36203147	前缘癌累及范围:发现:时间点:乳腺癌标本:序数型:显微镜检查.光学	4182948
36203151	Post marg Ca extent Br ca spec Ql Micro	4180186
36203151	Br ca spec; Brst; CA; Ca spec; Finding; Findings; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; Post marg Ca extent; Ql; Qual; Qualitative; Random; Screen; Spec	4180186
36203151	后缘癌累及范围:发现:时间点:乳腺癌标本:序数型:显微镜检查.光学	4182948
36203153	腺体分化:评分:时间点:乳腺癌标本:序数型:诺丁汉法	4182948
36203153	Br ca spec; Brst; CA; Ca spec; Gland diff; Pathology; Point in time; Random; Scale; SmQn; Spec	4180186
36203153	Gland diff Score Br ca spec Nottingham	4180186
36203156	Br ca spec; Brst; CA; Ca spec; Cell; Cellularity; Gated cells; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Number fraction; Oncology; P4; Pathology; Percent; Point in time; PR; PR+ cells; Prog; Proges; Progest; Progestin; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Spec; St; Stains; Stn	4180186
36203156	PR+ cells NFr Br ca spec ImStn	4180186
36203156	细胞.孕酮受体/100 个细胞:计数型分数:时间点:乳腺癌标本:定量型:免疫染色法	4182948
36203158	Foci Br ca spec Micro	4180186
36203158	Br ca spec; Brst; CA; Ca spec; Cnt; Count; LM; Micro; Micros; Microscopic; Number; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203158	病灶:数量(计数):时间点:乳腺癌标本:定量型:显微镜检查.光学	4182948
36203162	Br ca spec; Brst; CA; Ca spec; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Oncology; Ordinal; P4; Pathology; Point in time; PR; PR fluor intensity; Prog; Proges; Progest; Progestin; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Spec; St; Stains; Stn; Typ	4180186
36203162	PR fluor intensity Br ca spec Ql ImStn	4180186
36203162	孕酮受体荧光强度:类型:时间点:乳腺癌标本:序数型:免疫染色法	4182948
36203164	Add; Br ca spec; Brst; CA; Ca spec; DCIS.addl dim 1; Ductal carcinoma in situ; i; Length; LM; Micro; Micros; Microscopic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203164	DCIS.addl dim 1 Br ca spec Micro	4180186
36203164	DCIS.附加尺寸 1:长度:时间点:乳腺癌标本:定量型:显微镜检查.光学	4182948
36203165	Br ca spec; Brst; CA; Ca spec; Ductal carcinoma in situ; LM; Marg DCIS involve; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Surg	4180186
36203165	Marg DCIS involve Br ca spec Ql Micro	4180186
36203165	手术边缘 DCIS 累及:存在情况或阈值:时间点:乳腺癌标本:序数型:显微镜检查.光学	4182948
36203171	Br ca spec; Brst; CA; Ca spec; Ductal carcinoma in situ; LM; Micro; Micros; Microscopic; Nominal; Pathology; Point in time; Random; Spec; Typ	4180186
36203171	DCIS necrosis Br ca spec Micro	4180186
36203171	DCIS 坏死:类型:时间点:乳腺癌标本:名义型:显微镜检查.光学	4182948
36203173	Anatomy; CA; Ca spec; LN; LN origin; Nominal; Pathology; Point in time; Random; Spec	4180186
36203173	LN origin Ca spec	4180186
36203173	原始淋巴结部位:解剖学:时间点:癌标本:名义型	4182948
36203175	CA; Ca spec; Cnt; Count; LM; LN micromets; Micro; Micros; Microscopic; Number; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203175	LN micromets Ca spec Micro	4180186
36203175	存在微转移的淋巴结:数量(计数):时间点:癌标本:定量型:显微镜检查.光学	4182948
36203176	Dermal LVI Ca spec Ql Micro	4180186
36203176	CA; Ca spec; Dermal LVI; Finding; Findings; LM; Micro; Micros; Microscopic; Ordinal; PATH.HISTO; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36203176	皮肤淋巴-血管浸润:发现:时间点:癌标本:序数型:显微镜检查.光学	4182948
36203177	Cnt; Count; Number; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203177	Blocks examined Spec	4180186
36203177	已检查的组织块:数量(计数):时间点:标本:定量型	4182948
36203178	CA; Ca spec; Cnt; Count; LM; LN exam; Micro; Micros; Microscopic; Number; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Sent LN exam; Spec	4180186
36203178	Sent LN exam Ca spec Micro	4180186
36203178	已检查的前哨淋巴结:数量(计数):时间点:癌标本:定量型:显微镜检查.光学	4182948
36203179	Nominal; Pathology; Point in time; Proc to obtain tumor spec; Random; Spec; Typ	4180186
36203179	Proc to obtain tumor spec Spec	4180186
36203179	用于获取肿瘤标本的操作项目:类型:时间点:标本:名义型	4182948
36203182	CA; Ca spec; Largest; Length; LM; LN; LN metastasis.max dim; Maximal; Maximum; Micro; Micros; Microscopic; Pathology; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203182	LN metastasis.max dim Ca spec Micro	4180186
36203182	淋巴结转移沉积.最大尺寸:长度:时间点:癌标本:定量型:显微镜检查.光学	4182948
36203184	Vitals+wt+ht+hc+SaO2+BMI Pnl	4180186
36203184	Girth; HC; O2; Pan; PANEL.VITAL SIGNS; Panl; Pnl; Point in time; Random; SaO2; SAT; Satn; SO2; tO2; Vitals+wt+ht+hc+SaO2+BMI Pnl; Wt	4180186
36203184	生命体征、体重、身高、头围、氧饱和度及体质指数组套:-:时间点:^患者:-	4182948
36203185	BP pnl w all optional	4180186
36203185	Art sys; BP; BP Pnl; BP pnl w all optional; Pan; PANEL.VITAL SIGNS; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203185	所有儿童均可选的血压组套:-:时间点:动脉系统:定量型	4182948
36203187	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PEDv; PEDV proto S; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S prime; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203187	PEDV proto S Ct Spec Qn NAA+probe	4180186
36203187	猪流行性腹泻病毒原始毒株 S 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203188	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; PEDv; PEDV Pro+S INDEL S gene Pnl; Pnl; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; S prime; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203188	PEDV Pro+S INDEL S gene Pnl Spec NAA+pr	4180186
36203188	猪流行性腹泻病毒原始毒株与 S INDEL 毒株 S 基因组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
36203191	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pert; B pert+bron+holm IS481; B pertussis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Pertussis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Whooping cough	4180186
36203191	B pert+bron+holm IS481 Nph NAA+non-Probe	4180186
36203191	百日咳博德特菌+支气管败血性百日咳博德特菌+霍氏博德特菌 IS481 DNA:存在情况或阈值:时间点:鼻咽:序数型:非探针法.基因扩增.靶向	4182948
36203193	3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Bro; Compx; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lower respiratory; Lung; M tb; M TB Cmplx; M tuberculosis; Microbiology; Mtb; MTBC; Myco; Mycobact; Mycobacterium tuberculosum; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Spt; Spt/Bro; Sputum; Sputum or bronchial; Strand Displacement Amplification; TB; TMA; Transcription mediated amplification; Tuberculosis	4180186
36203193	M TB Cmplx DNA Spt/Bro Ql NAA+probe	4180186
36203193	结核分枝杆菌复合菌群 DNA:存在情况或阈值:时间点:痰液/支气管来源的标本:序数型:探针法.基因扩增.靶向	4182948
36203196	Neutrophil membrane Ab Ser Ql IF	4180186
36203196	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neut; Neutr; Neutrophils; Ordinal; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
36203196	嗜中性粒细胞膜 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
36203198	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neut; Neutr; Neutrophil membrane.IgG; Neutrophils; Ordinal; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
36203198	Neutrophil membrane IgG Ser Ql IF	4180186
36203198	嗜中性粒细胞膜 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
36203200	#; ABS; absolute; absolutes; Blood; Cnt; Contrl; Count; Count/volume; CT; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Neut; Neutr; Neutrophil; Normal; Number concentration; Number Concentration (count/vol); PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36203200	Neutrophils # Cont Bld FC	4180186
36203200	嗜中性粒细胞:计数型浓度:时间点:全血^对照:定量型:流式细胞测量术	4182948
36203205	Arbitrary; Average; Avg; Blood; Dynamic; FC; HEMATOLOGY/CELL COUNTS; MFI; Neut; Neut PMA DHR; Neut.PMA stim.DHR MFI; Neutr; Neutrophil oxidative bursts; Neutrophils; Phorbol myristate acetate stimulated; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36203205	Neut.PMA stim.DHR MFI Bld FC	4180186
36203205	嗜中性粒细胞.经 PMA 刺激.DHR 平均荧光强度:任意型:时间点:全血:定量型:流式细胞测量术	4182948
36203206	Neut.PMA stim.DHR MFI Cont Bld FC	4180186
36203206	Arbitrary; Average; Avg; Blood; Contrl; Dynamic; FC; HEMATOLOGY/CELL COUNTS; MFI; Neut; Neut PMA DHR; Neut.PMA stim.DHR MFI; Neutr; Neutrophil oxidative bursts; Neutrophils; Normal; Phorbol myristate acetate stimulated; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36203206	嗜中性粒细胞.经 PMA 刺激.DHR 平均荧光强度:任意型:时间点:全血^对照:定量型:流式细胞测量术	4182948
36203207	Neut PMA DHR/Neut PMA NFr Bld FC	4180186
36203207	Blood; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Neut; Neut PMA; Neut PMA DHR; Neutr; Neutrophil oxidative bursts; Neutrophils; Number fraction; Percent; Phorbol myristate acetate stimulated; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
36203207	嗜中性粒细胞.经 PMA 刺激.DHR/嗜中性粒细胞.经 PMA 刺激.总计:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
36203209	RBC.EMA MFI Act/Nor Bld FC	4180186
36203209	Act/Nor; Average; Avg; Blood; Control; Discocytes; Dynamic; Erthrocyte; Erythrocyte; FC; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBC.EMA MFI; RBC.EMA MFI actual; RBC.EMA MFI actual/normal; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Relative ratio; WB; Whole blood	4180186
36203209	红细胞.EMA 平均荧光强度 实际的/正常的:相对比率:时间点:全血:定量型:流式细胞测量术	4182948
36203212	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203213	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203215	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203217	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203219	Assessment; Centers for Medicare and Medicaid Assessment; Disch; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203220	Centers for Medicare and Medicaid Assessment; Cnt; Count; No; Num; Number; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203221	Centers for Medicare and Medicaid Assessment; Disch; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203223	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203224	Admin info; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203225	Date serology test pre pregnancy Mother	4180186
36203225	Before; Date serology test; Gestation; Gestations; Gravida; H+P; H+P.HX; Mat; Maternal; Matnl; P prime; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random	4180186
36203225	血清学检验项目日期^在妊娠之前:日期:时间点:^母亲:定量型	4182948
36203228	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; C albicans; C albicans DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Monilia; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203228	C albicans DNA Bld Pos Ql NAA+non-probe	4180186
36203228	白色假丝酵母 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203230	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da 12F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 12	4180186
36203230	S pneum Da 12F IgG Ser IA-aCnc	4180186
36203230	肺炎链球菌丹麦血清型 12F 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36203231	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da 12F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203231	S pneum Da 12F IgG Ser-mCnc	4180186
36203231	肺炎链球菌丹麦血清型 12F 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36203232	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da 12F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203232	S pneum Da 12F IgG sp1 Ser-mCnc	4180186
36203232	肺炎链球菌丹麦血清型 12F 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36203235	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36203235	S pn Da sero 19F Ab sp1 Ser-aCnc	4180186
36203235	肺炎链球菌丹麦血清型 19F 抗体^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36203236	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36203236	S pn Da sero 19F Ab sp1 Ser-mCnc	4180186
36203236	肺炎链球菌丹麦血清型 19F 抗体^第1个标本:质量浓度:时间点:血清:定量型	4182948
36203240	Act/Nor; Control; EGFR c.2369C&gt;T; epidermal growth factor receptor; Epidermal growth factor receptor gene; ERBB; ERBB1; Genetics; HER1; Heredity; Heritable; Inherited; mENA; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NISBD2; Oncogene ERBB; PCR; PIG61; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; rs121434569; T prime; T790M; Thr790Met; V-ERB-B avian erythroblastic leukemia viral oncogene homolog	4180186
36203240	EGFR c.2369C>T Act/Nor Plas.cfDNA	4180186
36203240	EGFR 基因.c.2369C>T 实际的/正常的:相对比率:时间点:血浆.cfDNA:定量型:分子遗传学类实验室方法	4182948
36203241	Amisulpride SerPl-mCnc	4180186
36203241	Amival; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Solian; Soltus; SR; Sulpitac; Sulprix	4180186
36203241	氨磺必利:质量浓度:时间点:血清/血浆:定量型	4182948
36203243	Arm; BMD; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; EXT; Extr-L; Films; Humerus-L; Imaging; L; LT; LUE; MAric; Point in time; QNT; Quan; Quant; Quantitative; Rad; RADIOLOGY; Random; UE; UE-L; Up; Upper extremity; View; Views for BMD; VWS	4180186
36203243	DXA Humerus-L ArMass BMD	4180186
36203243	针对骨密度的多重视图:质量/面积:时间点:上肢.左侧>肱骨:定量型:双能X线吸收法	4182948
36203250	Admin; Nominal; Point in time; Random; Survey; Transferred; Typ	4180186
36203251	Housing; Living Arrangement; Living Arrangements; Nominal; Point in time; Random; Survey; Typ	4180186
36203256	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203257	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203259	Arth; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36203260	Centers for Medicare and Medicaid Assessment; Deglutition; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203261	Centers for Medicare and Medicaid Assessment; Deglutition; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203263	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36203267	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36203269	Centers for Medicare and Medicaid Assessment; Disch; Finding; Findings; Housing; Living Arrangements; Nominal; Point in time; Random; Residence; Survey	4180186
36203270	Centers for Medicare and Medicaid Assessment; Dx; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
36203271	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
36203272	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36203275	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36203275	Eravacycline Islt MIC	4180186
36203275	厄伐环素:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36203276	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Imi+Rel; Imipeneum; Imp; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Primaxin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36203276	Imi+Rel Islt MIC	4180186
36203276	亚胺培南+瑞雷巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36203278	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Islt.mening; Isol; Mening; Meronem; Merrem; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36203278	Meropenem Islt.mening MIC	4180186
36203278	美罗培南:抗生素敏感性:时间点:分离株.脑膜炎:定量型或序数型:最小抑菌浓度法	4182948
36203279	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klebsiella pneumonia carbapenemase; KPC; Mero+Vab; Meronem; Merrem; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vabomere	4180186
36203279	Mero+Vab Islt MIC	4180186
36203279	美罗培南+伐波巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36203280	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Islt.mening; Isol; Mening; Minimum inhibitory concentration; PCN; Pen; Penicilloyl; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Wycillin	4180186
36203280	Penicillin Islt.mening MIC	4180186
36203280	青霉素:抗生素敏感性:时间点:分离株.脑膜炎:定量型或序数型:最小抑菌浓度法	4182948
36203282	DIR - example sections+entries; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
36203282	DIR - example sections+entries	4180186
36203282	影像学诊断报告 - 示例小节与条目:-:时间点:{环境}:-	4182948
36203284	ADMIN; Nominal; Point in time; Random; Relationship to pt; Typ	4180186
36203284	Relationship to pt Contact	4180186
36203284	相对于患者的关系:类型:时间点:^联系人:名义型	4182948
36203285	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Lung; notes; Point in time; Pulmonary; Pulmonology; Random; Resp therapy; Respiratory; Visit note	4180186
36203285	Resp therapy D/C sum	4180186
36203285	出院摘要记录:发现:时间点:{环境}:文档型:呼吸疗法	4182948
36203287	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203287	记录:发现:时间点:{环境}:文档型:缓和照顾	4182948
36203288	Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Visit note	4180186
36203288	Cardiothor surg Note	4180186
36203288	记录:发现:时间点:{环境}:文档型:胸心外科学	4182948
36203289	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Fam Med; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203289	Fam Med Note	4180186
36203289	记录:发现:时间点:{环境}:文档型:家庭医学	4182948
36203292	Vascular surgery D/C sum	4180186
36203292	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
36203292	出院摘要记录:发现:时间点:{环境}:文档型:血管外科学	4182948
36203295	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Heme; notes; Point in time; Random; Visit note	4180186
36203295	记录:发现:时间点:{环境}:文档型:血液学	4182948
36203297	Geri med Note	4180186
36203297	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Geri med; Gerontology; notes; Point in time; Random; Visit note	4180186
36203297	记录:发现:时间点:{环境}:文档型:老年医学	4182948
36203298	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36203301	electronic Patient Centered Assessment Method; Levels; Levl; LV; LVL; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
36203303	electronic Patient Centered Assessment Method; Levels; Levl; LV; LVL; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SDOH; Survey; SURVEY.GNHLTH	4180186
36203305	electronic Patient Centered Assessment Method; Levels; Levl; LV; LVL; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
36203308	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
36203313	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SDOH; Survey; SURVEY.GNHLTH	4180186
36203314	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
36203315	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SDOH; Survey; SURVEY.GNHLTH	4180186
36203317	Ordinal; Past; Point in time; PR; Public Health; Public Health Documents; PUBLICHEALTH; Ql; Qual; Qualitative; Random; Screen	4180186
36203317	Male sexual partner in last 12Mo	4180186
36203317	过去12个月当中的男性性伴侣:存在情况或阈值:时间点:^患者:序数型	4182948
36203318	植入式心电循环监测仪检查:发现:检查过程持续时间:心脏:文档型	4182948
36203318	Card implant loop study	4180186
36203318	Card implant loop study; CARD.PROC; Cardiac; Cardio; Cardiology; Document; Finding; Findings; Heart Disease; Hrt; ILR; monitor; recorder; Studies; Study; Study report; Sutdies	4180186
36203320	3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; FLUAV+FLUBV+RSV RNA pnl; FLUV; Fowl plague; HRSV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Respiratory; Ribonucleic acid; RSV; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
36203320	FLUAV+FLUBV+RSV RNA pnl Up resp NAA+pr	4180186
36203320	流感病毒 A 与 B 型与呼吸道合胞病毒 RNA 组套:-:时间点:呼吸道.上:-:探针法.基因扩增.靶向	4182948
36203321	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
36203321	FLUAV RNA Upper resp Ql NAA+probe	4180186
36203321	流感病毒 A 型 RNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36203322	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
36203322	FLUBV RNA Upper resp Ql NAA+probe	4180186
36203322	流感病毒 B 型 RNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36203325	Bld estabt reg + prod listing; DOCUMENT.REGULATORY; FDA label; Narrative; Report	4180186
36203325	FDA label Bld estabt reg + prod listing	4180186
36203325	血液制品企业注册与产品列名:-:-:^FDA 产品标签:叙述型	4182948
36203329	Antigen; Antigens; Bennett-Goodspeed Antigen; Bg sup(b); BLOOD BANK; Erythrocytes; Hematology; Heme; HLA-B17; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36203329	Bg sup(b) Ag RBC Ql	4180186
36203329	Bg^b 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
36203333	Centers for Medicare and Medicaid Assessment; i; Path; QNT; Quan; Quant; Quantitative; Report period; Survey; Tx	4180186
36203335	Centers for Medicare and Medicaid Assessment; i; Path; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203336	Centers for Medicare and Medicaid Assessment; i; Path; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203338	Centers for Medicare and Medicaid Assessment; i; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36203339	Centers for Medicare and Medicaid Assessment; II; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36203340	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; S pneum serotype; S pneumo; S pneumoniae; SDA; Sertyp; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203340	S pneum Sertyp Spec NAA+probe	4180186
36203340	肺炎链球菌 血清型:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
36203341	Clozaril; CNO; DRUG/TOXICOLOGY; Drugs; FazaClo; Leponex; Level; Mass concentration; Metabolite; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36203341	CNO SerPl-mCnc	4180186
36203341	氯氮平 N-氧化物:质量浓度:时间点:血清/血浆:定量型	4182948
36203342	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203342	blaIMP Islt/Spm Ql	4180186
36203342	细菌碳青霉烯类耐药 blaIMP 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203344	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anorectl; AnorectlIslt; ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rectum; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36203344	blaNDM AnorectlIslt Ql NAA+probe	4180186
36203344	细菌碳青霉烯类耐药 blaNDM 基因:存在情况或阈值:时间点:肛门直肠/分离株:序数型:探针法.基因扩增.靶向	4182948
36203345	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203345	blaVIM Islt/Spm Ql	4180186
36203345	细菌碳青霉烯类耐药 blaVIM 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203346	ANTIBIOTIC SUSCEPTIBILITIES; Bact; BCR gene pnl; Carbapenemase; CPR; CPR genes; Islt; Islt/Spm; Isol; Molecular genetics; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; PCR; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
36203346	BCR gene pnl Islt/Spm	4180186
36203346	细菌碳青霉烯类耐药基因组套:-:时间点:分离株/标本:-:分子遗传学类实验室方法	4182948
36203349	BLOOD BANK; D phenotyping; D typing; Molecular genetics; Nominal; Oral fluid; PCR; Point in time; Random; Rh phenotyping; Rh typing; Sal; Typ	4180186
36203349	Rh.presumptive Sal by Molgen	4180186
36203349	Rh.推断的:类型:时间点:唾液:名义型:分子遗传学类实验室方法	4182948
36203350	10q23del; Bannayan-Zonana syndrome; BZS; CA; Ca spec; CRC spec; CWS1; DEC; Genetics; GLM2; Heredity; Heritable; Human mutated in multiple advanced cancers protein (MMAC1) mRNA, complete cds; Identity or presence; Inherited; MGC11227; MHAM; MMAC1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutated in multiple advanced cancers 1; Mutations; Nominal; PCR; Phosphatase and tensin homolog; Point in time; PTEN1; Random; Spec; TEP1	4180186
36203350	PTEN gene Mut Anl CRC spec	4180186
36203350	PTEN 基因 突变分析:存在与否或特征标识:时间点:结直肠癌标本:名义型:分子遗传学类实验室方法	4182948
36203351	CA; Ca spec; CLOVE; CRC spec; CWS5; E542K; E545D; E545K; Genetics; H1047R; Heredity; Heritable; Identity or presence; Inherited; MCAP; MCM; MCMTC; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; p110-alpha; P13K; PCR; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; PI3K; PIK3CA Oncogene; Point in time; Random; Spec	4180186
36203351	PIK3CA gene Mut Anl CRC spec	4180186
36203351	PIK3CA 基因 突变分析:存在与否或特征标识:时间点:结直肠癌标本:名义型:分子遗传学类实验室方法	4182948
36203352	Satellite nodules CRC spec Micro	4180186
36203352	CA; Ca spec; Cnt; Count; CRC spec; ETD; Extramural tumor deposits; LM; Micro; Micros; Microscopic; Number; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Tumor deposits	4180186
36203352	卫星结节:数量(计数):时间点:结直肠癌标本:定量型:显微镜检查.光学	4182948
36203353	CA; Ca spec; CFC2; C-K-RAS; CRC spec; Genetics; Heredity; Heritable; Identity or presence; Inherited; KI-RAS; Kirsten ras 1; Kirsten rat sarcoma viral oncogene homolog; Kirsten rat sarcoma virus 2; KRAS1; KRAS1P; KRAS2; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; NS; NS3; Oncogene KRAS1; Oncogene KRAS2; PCR; Point in time; Random; RASK1; RASK2; Spec; V-KI-RAS1 pseudogene; v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog	4180186
36203353	KRAS gene Mut Anl CRC spec	4180186
36203353	KRAS2 基因 突变分析:存在与否或特征标识:时间点:结直肠癌标本:名义型:分子遗传学类实验室方法	4182948
36203356	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Delta hepatitis; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; HDV; Hep; Hep D; Hep Delta; Hepatis; Hepatit; Hepatitis delta virus; Hepatology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36203356	HDV RNA Ser NAA+probe-aCnc	4180186
36203356	丁型肝炎病毒 RNA:任意型浓度:时间点:血清:定量型:探针法.基因扩增.靶向	4182948
36203357	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Delta hepatitis; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; HDV; Hep; Hep D; Hep Delta; Hepatis; Hepatit; Hepatitis delta virus; Hepatology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Log ACNC; Log IU; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36203357	HDV RNA Ser NAA+probe-Log IU	4180186
36203357	丁型肝炎病毒 RNA:对数型任意浓度:时间点:血清:定量型:探针法.基因扩增.靶向	4182948
36203360	Bariatric surg Note	4180186
36203360	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Metabolic and bariatric surgery; notes; Point in time; Random; Surg; Visit note	4180186
36203360	记录:发现:时间点:{环境}:文档型:减肥外科手术	4182948
36203362	Child Adolsnt Psych Initial eval note	4180186
36203362	Assessment; Child Adolsnt Psych; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
36203362	初步评价记录:发现:时间点:{环境}:文档型:儿童与青少年心理学	4182948
36203363	Child Adolsnt Psych; Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203363	Child Adolsnt Psych Consult note	4180186
36203363	会诊记录:发现:时间点:{环境}:文档型:儿童与青少年心理学	4182948
36203365	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Undersea+hyperbar; Visit note	4180186
36203365	Undersea+hyperbar Note	4180186
36203365	记录:发现:时间点:{环境}:文档型:水下与高气压医学	4182948
36203366	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; Metabolic and bariatric surgery; notes; Point in time; Random; Surg; Visit note	4180186
36203366	Bariatric surg Initial eval note	4180186
36203366	初步评价记录:发现:时间点:{环境}:文档型:减肥外科手术	4182948
36203367	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
36203369	PRRSV NA strain IgG Titr Ser IF	4180186
36203369	猪生殖与呼吸综合征病毒北美株 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36203369	Abortus blauw; ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Blue-eared pig disease; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Lelystad virus; Microbiology; Mystery swine disease; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PRRS; PRRSV; PRRSV NA strain; Random; Serum; Seuchenhafter spatabort der schweine; SIRSV; SmQn; SR; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Vet; Veterinary	4180186
36203370	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; FLUDV; FLUDV PB2 gene; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203370	FLUDV PB2 gene Ct Spec Qn NAA+probe	4180186
36203370	流感病毒 D 型 PB2 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203373	Abortus blauw; ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Blue-eared pig disease; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lelystad virus; Microbiology; Mystery swine disease; Ordinal; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PR; PRRS; PRRSV; PRRSV NA strain; Ql; Qual; Qualitative; Random; Screen; Serum; Seuchenhafter spatabort der schweine; SIRSV; SR; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Time Resolved Fluorescence; TRF; Vet; Veterinary	4180186
36203373	PRRSV NA strain IgG Ser Ql IF	4180186
36203373	猪生殖与呼吸综合征病毒北美株 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
36203375	Abortus blauw; Blue-eared pig disease; high-throughput sequencing; HTS; Islt; Isol; Lelystad virus; Microbiology; Mystery swine disease; Next generation sequencing; NGS; Nominal; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PRRS; PRRSV; PRRSV whole genome; Random; Seuchenhafter spatabort der schweine; SIRSV; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Vet; Veterinary	4180186
36203375	PRRSV whole genome Islt-Seq	4180186
36203375	猪生殖与呼吸综合征病毒全基因组:序列:时间点:分离株:名义型:序列测定	4182948
36203376	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV whole genome; FLUV; Fowl plague; high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Vet; Veterinary	4180186
36203376	FLUAV whole genome Islt-Seq	4180186
36203376	流感病毒 A 型全基因组:序列:时间点:分离株:名义型:序列测定	4182948
36203377	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUAV porcine NUC; FLUAV porcine NUC Ab; FLUAV porcine NUC Ab IgG; FLUV; Fowl plague; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Misc; Miscellaneous; Other; Point in time; Pork; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Spec; SUDS; Swine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36203377	FLUAV porcine NUC IgG/Pos cntrl Spec IA	4180186
36203377	流感病毒 A 型猪起源核蛋白 抗体.IgG/阳性对照:相对比率:时间点:XXX:定量型:免疫测定法	4182948
36203378	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUAV avian NP Ab; FLUAV avian NUC; FLUV; Fowl; Fowl plague; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; NEG; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36203378	FLUAV avian NUC Ab Ser IA	4180186
36203378	流感病毒 A 型禽类起源核蛋白 抗体/阴性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36203379	#; ABS; absolute; absolutes; Avian influenza; Bird flu; Cnt; Count; Count/volume; CT; FLUA; FLUAV; FLUAV RNA TCID50; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Misc; Miscellaneous; Number concentration; Number Concentration (count/vol); Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36203379	FLUAV RNA TCID50 # Spec	4180186
36203379	流感病毒 A 型 RNA 组织培养感染剂量 50:计数型浓度:时间点:XXX:定量型	4182948
36203381	3 Self-Sustaining Sequence Replication; 3SR SR; Abortus blauw; Amplif; Amplification; Amplified; Blue-eared pig disease; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Lelystad virus; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Mystery swine disease; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; Probe amp; Probe with ampification; Probe with target amplification; PRRS; PRRSV; PRRSV Ingel ATP ORF5; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Seuchenhafter spatabort der schweine; SIRSV; Spec; Strand Displacement Amplification; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203381	PRRSV Ingel ATP ORF5 Ct Spec Qn NAA+prb	4180186
36203381	猪生殖与呼吸综合征病毒 Ingelvac ATP 株 ORF5 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203382	Abortus blauw; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue-eared pig disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; Lelystad virus; MEIA; Microbiology; Mystery swine disease; Oral fluid; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; Pos; Pos cntrl; PRRS; PRRSV; PRRSV Ab; PRRSV IgG; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Sal; Seuchenhafter spatabort der schweine; SIRSV; SUDS; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Vet; Veterinary	4180186
36203382	PRRSV IgG/Pos cntrl Sal IA	4180186
36203382	猪繁殖与呼吸综合征病毒 抗体.IgG/阳性对照:相对比率:时间点:唾液:定量型:免疫测定法	4182948
36203383	Abortus blauw; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue-eared pig disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lelystad virus; MEIA; Microbiology; Mystery swine disease; Pl; Plasma; Plsm; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; Pos; Pos cntrl; PRRS; PRRSV; PRRSV Ab; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SerP; SerPl; SerPlas; Serum; Serum or plasma; Seuchenhafter spatabort der schweine; SIRSV; SR; SUDS; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Vet; Veterinary	4180186
36203383	PRRSV Ab/Pos cntrl SerPl IA	4180186
36203383	猪繁殖与呼吸综合征病毒 抗体/阳性对照:相对比率:时间点:血清/血浆:定量型:免疫测定法	4182948
36203387	PRRSV European NAb Titr Ser Nt	4180186
36203387	猪生殖与呼吸综合征病毒欧洲株 抗体.中和:滴定度:时间点:血清:定量型:中和试验	4182948
36203387	Abortus blauw; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue-eared pig disease; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Lelystad virus; Microbiology; Mystery swine disease; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PRRS; PRRSV; PRRSV European; Random; Serum; Serum virus neutralization; Seuchenhafter spatabort der schweine; SIRSV; SmQn; SR; SVN; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Titer; Titered; Titre; Ttr; Vet; Veterinary; Virus neutralization test; VNT	4180186
36203389	Abortus blauw; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue-eared pig disease; Conventional virus neutralization test; cVNT; ID; Infectious Disease; InfectiousDisease; Lelystad virus; Microbiology; Mystery swine disease; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PR; PRRS; PRRSV; PRRSV NA strain; Ql; Qual; Qualitative; Random; Screen; Serum; Serum virus neutralization; Seuchenhafter spatabort der schweine; SIRSV; SR; SVN; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Vet; Veterinary; Virus neutralization test; VNT	4180186
36203389	PRRSV NA strain NAb Ser Ql Nt	4180186
36203389	猪生殖与呼吸综合征病毒北美株 抗体.中和:存在情况或阈值:时间点:血清:序数型:中和试验	4182948
36203391	FLUAV porcine NUC IgA/Pos cntrl Spec IA	4180186
36203391	流感病毒 A 型猪起源核蛋白 抗体.IgA/阳性对照:相对比率:时间点:XXX:定量型:免疫测定法	4182948
36203391	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUAV porcine NUC; FLUAV porcine NUC Ab; FLUAV porcine NUC Ab IgA; FLUV; Fowl plague; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Misc; Miscellaneous; Other; Point in time; Pork; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Spec; SUDS; Swine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36203392	M flocc 16S rRNA Spec Ql NAA+probe	4180186
36203392	絮状支原体 16S rRNA 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203392	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M flocc 16S rRNA; M flocculare; M flocculare 16S; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203393	Meth; Method of; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36203396	Centers for Medicare and Medicaid Assessment; i; PT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203402	Centers for Medicare and Medicaid Assessment; i; OT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203404	Centers for Medicare and Medicaid Assessment; i; OT; QNT; Quan; Quant; Quantitative; Report period; Survey; Tx	4180186
36203405	Centers for Medicare and Medicaid Assessment; i; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; PT; Report period; Survey	4180186
36203409	Centers for Medicare and Medicaid Assessment; II; PT; QNT; Quan; Quant; Quantitative; Report period; Survey; Tx	4180186
36203410	Centers for Medicare and Medicaid Assessment; II; OT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203413	Centers for Medicare and Medicaid Assessment; II; OT; QNT; Quan; Quant; Quantitative; Report period; Survey; Tx	4180186
36203414	Centers for Medicare and Medicaid Assessment; II; Path; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203417	Centers for Medicare and Medicaid Assessment; II; Path; QNT; Quan; Quant; Quantitative; Report period; Survey; Tx	4180186
36203419	Birth defects Hosp Registry rpt	4180186
36203419	DOC.ONT; Document; Finding; Findings; Hosp; Inpatient; Point in time; Random; Registry rpt	4180186
36203419	登记报告:发现:时间点:医院:文档型:出生缺陷	4182948
36203420	3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Bro; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lower respiratory; Lung; M avium; M avium+M intracel; M avium+M intracellulare DNA; M intracellulare; Microbiology; Myco; Mycobact; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Respiratory; SDA; Spt; Spt/Bro; Sputum; Sputum or bronchial; Strand Displacement Amplification; TMA; Transcription mediated amplification; Tuberculosis	4180186
36203420	M avium+M intracel DNA Spt/Bro NAA+probe	4180186
36203420	鸟型分枝杆菌与胞内分枝杆菌 DNA:存在与否或特征标识:时间点:痰液/支气管来源的标本:名义型:探针法.基因扩增.靶向	4182948
36203430	Centers for Medicare and Medicaid Assessment; II; Pan; Panel; PANEL.SURVEY.CMS; Panl; Path; Pnl; Report period; Survey	4180186
36203431	Planned HD loc	4180186
36203431	CLIN; Nominal; Planned HD loc; Point in time; Random; Typ	4180186
36203431	已计划的血液透析地点:类型:时间点:^患者:名义型	4182948
36203432	Donor kidney type	4180186
36203432	CLIN; Donor kidney type; Nominal; Point in time; Random; Typ	4180186
36203432	供体肾脏类型:类型:时间点:^患者:名义型	4182948
36203433	Pref dial type if req before trans	4180186
36203433	CLIN; Dialy; Nominal; Point in time; Pref dial type if req before trans; Random; Typ	4180186
36203433	移植之前必要时的透析类型:类型:时间点:^患者:名义型	4182948
36203434	Will hospice be provided	4180186
36203434	CLIN; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Will hospice be provided	4180186
36203434	是否将提供临终关怀服务:发现:时间点:^患者:序数型	4182948
36203437	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203438	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203439	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203440	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203441	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203442	Emot score; Minnesota Living with Heart Failure Questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey	4180186
36203443	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Hosp; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203444	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203445	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Cnc; Conc; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203447	Minnesota Living with Heart Failure Questionnaire; Phys score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey	4180186
36203450	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; ZIKV; ZIKV RNA	4180186
36203450	ZIKV RNA Amn Ql NAA+probe	4180186
36203450	寨卡病毒 RNA:存在情况或阈值:时间点:羊水:序数型:探针法.基因扩增.靶向	4182948
36203451	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; ZIKV; ZIKV RNA	4180186
36203451	ZIKV RNA SerPl Ql NAA+probe	4180186
36203451	寨卡病毒 RNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
36203452	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn; ZIKV; ZIKV RNA	4180186
36203452	ZIKV RNA Ur Ql NAA+probe	4180186
36203452	寨卡病毒 RNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
36203454	Kidney fail 5Y risk KFRE.dynamic	4180186
36203454	Chemistry; Kidney fail 5Y risk; Kidney Failure Risk Equation - dynamic; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
36203454	肾功能衰竭 5 年风险:似然性:时间点:^患者:定量型:肾功能衰竭风险公式	4182948
36203455	Kidney fail 2Y + 5Y risk KFRE.dyn Pnl	4180186
36203455	Chemistry; Kidney fail 2Y + 5Y risk Pnl; Kidney Failure Risk Equation - dynamic; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203455	肾功能衰竭 2 年与 5 年风险组套:-:时间点:^患者:定量型:肾功能衰竭风险公式	4182948
36203461	Admin; Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
36203462	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; S prime; Survey	4180186
36203463	3 days; Exchange; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Replace; S prime; Screen; Survey	4180186
36203464	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203466	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203467	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203470	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203473	3 days; Centers for Medicare and Medicaid Assessment; Deglutition; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey; Swallowing/nutritional status	4180186
36203474	Assessment; Centers for Medicare and Medicaid Assessment; Eval; H&P; History and physical; Hosp; LTPAC; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203477	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203480	3 days; Arterial Stenosis; Dynamic; Finding; Findings; Ordinal; Ql; Qual; Qualitative; S prime; Screen; Survey	4180186
36203482	3 days; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Up	4180186
36203483	Assessment; Centers for Medicare and Medicaid Assessment; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203484	3 days; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203489	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203491	Assessment; Centers for Medicare and Medicaid Assessment; Disch; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203493	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203494	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203496	Finding; Findings; H+P; H+P.HX; Mat; Maternal; Matnl; Nominal; P prime; Point in time; Prev; Prev illness dx by; Random	4180186
36203496	Moth Prev illness dx by	4180186
36203496	既往疾病诊断人员:发现:时间点:^母亲:名义型	4182948
36203498	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influen acs; H influenza; H influenzae; Haem influ; Haemoph; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203498	H influen acs Ct Spec Qn NAA+probe	4180186
36203498	流感嗜血杆菌 acs 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203499	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influen bex; H influenza; H influenzae; Haem influ; Haemoph; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203499	H influen bex Ct Spec Qn NAA+probe	4180186
36203499	流感嗜血杆菌 bex 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203500	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influen ecs; H influenza; H influenzae; Haem influ; Haemoph; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203500	H influen ecs Ct Spec Qn NAA+probe	4180186
36203500	流感嗜血杆菌 ecs 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203502	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influen ccs; H influenza; H influenzae; Haem influ; Haemoph; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203502	H influen ccs Ct Spec Qn NAA+probe	4180186
36203502	流感嗜血杆菌 ccs 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203505	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; M hyopneumo; M hyopneumo P146; M hyopneumoniae; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Next generation sequencing; NGS; Nominal; Other; Point in time; Porcine respiratory mycoplasmosis; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36203505	M hyopneumo P146 Spec-Seq	4180186
36203505	猪肺炎支原体 P146 基因:序列:时间点:XXX:名义型:序列测定	4182948
36203506	ABS; Aby; ACIF; AIDS; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Blood; FA; Fluorescent antibody; Fluoresent; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Time Resolved Fluorescence; TRF; WB; Whole blood	4180186
36203506	HIV1 Ab SerPlBld Ql IF	4180186
36203506	HIV 1 型 抗体:存在情况或阈值:时间点:血清/血浆/全血:序数型:免疫荧光法	4182948
36203507	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum lytA; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203507	S pneum lytA Ct Spec Qn NAA+probe	4180186
36203507	肺炎链球菌 lytA 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203510	Finding; Findings; H+P; H+P.HX; Narrative; P prime; Point in time; Random; Report	4180186
36203510	Autopsy result	4180186
36203510	尸体解剖结果:发现:时间点:^患者:叙述型	4182948
36203512	Prev rubella virus tx result	4180186
36203512	Congenital rubella syndrome; Finding; Findings; German measles; Nominal; Point in time; Prev; Prev rubella virus tx result; Random; RUBV; VACCINE	4180186
36203512	既往风疹病毒检验结果:发现:时间点:^患者:名义型	4182948
36203514	H+P; H+P.HX; P prime; Point in time; Prior cond onset Y; QNT; Quan; Quant; Quantitative; Random	4180186
36203514	Prior cond onset Y	4180186
36203514	既往疾病初次发作年份:日期:时间点:^患者:定量型	4182948
36203517	Age at immunity testing; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203517	Age at immunity testing	4180186
36203517	免疫力检测时的年龄:时间:时间点:^患者:定量型	4182948
36203520	Date exposure to illness; Exp; H+P; H+P.HX; Mat; Maternal; Matnl; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203520	Mother Date exposure to illness	4180186
36203520	暴露于患有确诊疾病个人的日期:日期:时间点:^母亲:定量型	4182948
36203521	H+P; H+P.HX; Mat; Maternal; Matnl; Nominal; P prime; Point in time; Random; Rel to indiv w conf illness; Typ	4180186
36203521	Mother Rel to indiv w conf illness	4180186
36203521	与患有确诊疾病个人的关系:类型:时间点:^母亲:名义型	4182948
36203525	Prenatal care location Mother	4180186
36203525	H+P; H+P.HX; Mat; Maternal; Matnl; Nominal; P prime; Point in time; Random; Typ	4180186
36203525	产前照护地点:类型:时间点:^母亲:名义型	4182948
36203527	Cnt; Count; Gestation; Gestations; Gravida; Mat; Maternal; Matnl; No; Num; Num in house under 18 dur preg; Num in house under 18 rubella vac; Number; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random; World Heatlth Organization	4180186
36203527	Num in house under 18 rubella vac	4180186
36203527	在此次妊娠期间生活在家中的不满18岁且接受过风疹疫苗接种的儿童的人数:数量(计数):时间点:^母亲:定量型	4182948
36203528	Finding; Findings; Gestation; Gestations; Gravida; Mat; Maternal; Matnl; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Rubella vac rcvd by under 18; Screen	4180186
36203528	Rubella vac rcvd by under 18	4180186
36203528	在此次妊娠期间生活在家中的不满18岁的儿童接受过风疹疫苗接种:发现:时间点:^母亲:序数型	4182948
36203529	Num in house under 18 dur preg	4180186
36203529	Cnt; Count; Gestation; Gestations; Gravida; H+P; H+P.HX; Mat; Maternal; Matnl; No; Num; Num in house under 18 dur preg; Number; P prime; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random	4180186
36203529	在此次妊娠期间生活在家中的不满18岁的儿童的人数:数量(计数):时间点:^母亲:定量型	4182948
36203530	Attend fam plan prior conception; Finding; Findings; H+P; H+P.HX; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36203530	Attend fam plan prior conception Mother	4180186
36203530	在受孕之前曾经到计划生育门诊就诊:发现:时间点:^母亲:序数型	4182948
36203533	Finding; Findings; H+P; H+P.HX; Mat; Maternal; Matnl; Nominal; Other symp of illness; Othr; P prime; Point in time; Random; Sx	4180186
36203533	Other maternal symp of illness	4180186
36203533	疾病的其他症状:发现:时间点:^母亲:名义型	4182948
36203534	Lymphadenopathy Mother	4180186
36203534	Finding; Findings; H+P; H+P.HX; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36203534	淋巴结病:发现:时间点:^母亲:序数型	4182948
36203536	Date of fever onset Mother	4180186
36203536	H+P; H+P.HX; Mat; Maternal; Matnl; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203536	发热起始日期:日期:时间点:^母亲:定量型	4182948
36203540	Maculopapular rash Mother	4180186
36203540	Finding; Findings; H+P; H+P.HX; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36203540	斑丘疹:发现:时间点:^母亲:序数型	4182948
36203544	BLOOD BANK; Erythrocytes; Hematology; Heme; O sub h phenotype; O(null) phenotype; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36203544	Bombay phenotype RBC Ql	4180186
36203544	孟买表型:存在情况或阈值:时间点:红细胞:序数型	4182948
36203546	BLOOD BANK; Donr; Erythrocytes; Hematology; Heme; O sub h phenotype; O(null) phenotype; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36203546	Bombay phenotype RBC Donr Ql	4180186
36203546	孟买表型:存在情况或阈值:时间点:红细胞^供体:序数型	4182948
36203548	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PPSV23; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 DNA; S pneum Da type; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; U.S. serotype 4; Unspecified	4180186
36203548	S pneum Da 4 DNA Ct Spec Qn NAA+probe	4180186
36203548	肺炎链球菌丹麦血清型 4 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203549	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PPSV23; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 DNA; S pneum Da type; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; U.S. serotype 3; Unspecified	4180186
36203549	S pneum Da 3 DNA Ct Spec Qn NAA+probe	4180186
36203549	肺炎链球菌丹麦血清型 3 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203550	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PPSV23; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F DNA; S pneum Da type; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; U.S. serotype 23; Unspecified	4180186
36203550	S pneum Da 23F DNA Ct Spec Qn NAA+probe	4180186
36203550	肺炎链球菌丹麦血清型 23F DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203551	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PPSV23; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 2; S pneum Da 2 DNA; S pneum Da type; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; U.S. serotype 2; Unspecified	4180186
36203551	S pneum Da 2 DNA Ct Spec Qn NAA+probe	4180186
36203551	肺炎链球菌丹麦血清型 2 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203552	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PPSV23; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F DNA; S pneum Da type; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; U.S. serotype 19; Unspecified	4180186
36203552	S pn Da sero 19F DNA Ct Spec Qn NAA+prb	4180186
36203552	肺炎链球菌丹麦血清型 19F DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203554	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PPSV23; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 DNA; S pneum Da type; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; U.S. serotype 1; Unspecified	4180186
36203554	S pneum Da 1 DNA Ct Spec Qn NAA+probe	4180186
36203554	肺炎链球菌丹麦血清型 1 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203556	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pn Da 22A+22F; S pneum Da 22A+22F DNA; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203556	S pn Da 22A+22F DNA Ct Spec Qn NAA+probe	4180186
36203556	肺炎链球菌丹麦血清型 22A+22F DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203560	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6C+6D; S pneum Da 6C+6D DNA; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203560	S pneum Da 6C+6D DNA Ct Spec Qn NAA+prb	4180186
36203560	肺炎链球菌丹麦血清型 6C+6D DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203562	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pn Da 33A+33F+37; S pneum Da 33A+33F+37 DNA; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203562	S pn Da 33A+33F+37 DNA Ct Spec Qn NAA+pr	4180186
36203562	肺炎链球菌丹麦血清型 33A+33F+37 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203563	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneumo; S pneumoniae; SDA; Spec; Spn; Spn Da 18A+B+C+F; Spneu Da 18A+B+C+F DNA; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203563	Spn Da 18A+B+C+F DNA Ct Spec Qn NAA+prb	4180186
36203563	肺炎链球菌丹麦血清型 18A+18B+18C+18F DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203564	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneumo; S pneumoniae; SDA; Spec; Spn; Spneu Da 15A+15F; Spneu Da 15A+15F DNA; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203564	Spneu Da 15A+15F DNA Ct Spec Qn NAA+prb	4180186
36203564	肺炎链球菌丹麦血清型 15A+15F DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203565	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneumo; S pneumoniae; SDA; Spec; Spn; Spneu Da 12A+12F+44+46; Spneu Da 12A+12F+44+46 DNA; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203565	Spn Da 12A+12F+44+46 DNA Ct Spec NAA+pr	4180186
36203565	肺炎链球菌丹麦血清型 12A+12F+44+46 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203569	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; Strep; Strept; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203569	Streptococcus DNA Bld Pos NAA+non-probe	4180186
36203569	链球菌属单个未知种 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203572	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pyogenes; Screen; SDA; Steptococcus Group A; Strand Displacement Amplification; Strep; Strept; Streptococci group A; Streptococcus group A; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203572	S pyo DNA Bld Pos Ql NAA+non-probe	4180186
36203572	化脓性链球菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203573	3 Self-Sustaining Sequence Replication; 3SR SR; A baumannii; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203573	A baumannii DNA Bld Pos Ql NAA+non-probe	4180186
36203573	鲍曼不动杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203574	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203574	Enterobact DNA Bld Pos Ql NAA+non-probe	4180186
36203574	肠内菌科 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203575	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Compx; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E cloac comp; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203575	E cloac comp DNA Bld Pos NAA+non-probe	4180186
36203575	阴沟肠杆菌复合菌群 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203576	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203576	E coli DNA Bld Pos Ql NAA+non-probe	4180186
36203576	大肠埃希菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203577	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K oxytoca; K oxytoca DNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203577	K oxytoca DNA Bld Pos Ql NAA+non-probe	4180186
36203577	产酸克雷伯菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203579	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203579	Proteus sp DNA Bld Pos Ql NAA+non-probe	4180186
36203579	变形杆菌属单个未知种 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203581	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influenza; H influenzae; Haem influ; Haemoph; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203581	Haem influ DNA Bld Pos Ql NAA+non-probe	4180186
36203581	流感嗜血杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203583	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; C krusei; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203583	C krusei DNA Bld Pos Ql NAA+non-probe	4180186
36203583	克鲁斯假丝酵母 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203584	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; C parap; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203584	C parap DNA Bld Pos Ql NAA+non-probe	4180186
36203584	近平滑假丝酵母 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203585	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; C tropicls; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203585	C tropicls DNA Bld Pos Ql NAA+non-probe	4180186
36203585	热带假丝酵母 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203586	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; Celbenin; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Metacillin; Methicillin resistance gene; Metin; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Staficyn; Staphicillin; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203586	mecA Bld Pos Ql NAA+non-probe	4180186
36203586	细菌甲氧西林耐药 mecA 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203587	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; c162; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; VANC; Vancocin; Vancomycin resistance gene; Vancor; WB; Whole blood	4180186
36203587	vanA+vanB Bld Pos Ql NAA+non-probe	4180186
36203587	细菌万古霉素耐药 vanA+vanB 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203591	CD3+CD4+CD45RO+/100 CD3 NFr Bld	4180186
36203591	100 CD3; Blood; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; T4; T-4; T4 helper/inducer cells; UCHL-1; W3/25; WB; Whole blood	4180186
36203591	细胞.CD3+CD4+CD45RO+/100 个细胞.CD3:计数型分数:时间点:全血:定量型	4182948
36203592	CD3+CD4+CD45RO+ # Bld	4180186
36203592	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T3; T4; T-4; T4 helper/inducer cells; UCHL-1; W3/25; WB; Whole blood	4180186
36203592	细胞.CD3+CD4+CD45RO+:计数型浓度:时间点:全血:定量型	4182948
36203594	Arthralgia AndOr arthritis Mother	4180186
36203594	Arth; Arthralgia AndOr arthritis; Finding; Findings; H+P; H+P.HX; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36203594	关节痛和/或关节炎:发现:时间点:^母亲:序数型	4182948
36203595	Congenital rubella syndrome; German measles; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RUBV; RUBV E1; RUBV E1 + genotype Pnl; Spec; To be specified in another part of the message; Unspecified	4180186
36203595	RUBV E1 + genotype Pnl Spec	4180186
36203595	风疹病毒 E1 基因与基因型组套:-:时间点:XXX:-	4182948
36203597	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg DNA; N men sg DNA Pnl; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203597	N men sg DNA Pnl Spec NAA+probe	4180186
36203597	脑膜炎奈瑟菌血清群 DNA 组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
36203600	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; MuV; MuV SH gene; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203600	MuV SH gene Ct Spec Qn NAA+probe	4180186
36203600	流行性腮腺炎病毒 SH 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203602	FLUAV H1 Ag Titr Islt HAI	4180186
36203602	流感病毒 A 型血凝素 H1 型 抗原:滴定度:时间点:分离株:定量型:红细胞凝集抑制试验法	4182948
36203602	Antigen; Antigens; Avian influenza; Bird flu; Dilution factor; Dilution Factor (Titer); FLUA; FLUAV; FLUAV H1; FLUV; Fowl plague; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Point in time; Random; SmQn; Titer; Titered; Titre; Ttr	4180186
36203603	FLUAV H3 Ag Titr Islt HAI	4180186
36203603	流感病毒 A 型血凝素 H3 型 抗原:滴定度:时间点:分离株:定量型:红细胞凝集抑制试验法	4182948
36203603	Antigen; Antigens; Avian influenza; Bird flu; Dilution factor; Dilution Factor (Titer); FLUA; FLUAV; FLUAV H3; FLUV; Fowl plague; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Point in time; Random; SmQn; Titer; Titered; Titre; Ttr	4180186
36203606	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MeV; MeV RNA and N gene Pnl; Microbiology; Misc; Miscellaneous; Msls; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; Rubeola; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203606	MeV RNA and N gene Pnl Spec NAA+probe	4180186
36203606	麻疹病毒 RNA 与 N 基因组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
36203608	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; MuV; MuV RNA and SH gene Pnl; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203608	MuV RNA and SH gene Pnl Spec NAA+probe	4180186
36203608	流行性腮腺炎病毒 RNA 与 SH 基因组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
36203609	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B per + parap + holm DNA Pnl; B pert; B pertussis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pertussis; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Whooping cough	4180186
36203609	B per + parap + holm DNA Pnl Spec NAA+pr	4180186
36203609	百日咳博德特菌与副百日咳博德特菌与霍氏博德特菌 DNA 组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
36203613	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Srce; Survey	4180186
36203615	Before; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203619	CF reduc 60M p MA p hepase LenFr Bld TEG	4180186
36203619	凝块稳固性降低^在添加肝素酶及最大凝固幅度之后60分钟:长度分数:时间点:全血:定量型:血栓弹力描记术	4182948
36203619	60M p MA p hepase; add heparinase; Blood; CF; CF reduc; COAGULATION; Hematology; Heme; Length Fraction; P Hpase; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood	4180186
36203622	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203622	AmpC blaCMY+blaMOX genes Islt/Spm Ql	4180186
36203622	细菌 beta-内酰胺耐药 AmpC blaCMY+blaMOX 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203623	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203623	blaGES Islt/Spm Ql	4180186
36203623	细菌碳青霉烯类耐药 blaGES 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203627	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203627	blaOXA-48-like Islt/Spm Ql	4180186
36203627	细菌碳青霉烯类耐药 blaOXA-48-样基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203629	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PEDv; PEDV Ab; Point in time; Pork; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Swine; Vet; Veterinary	4180186
36203629	PEDv Ab/Pos cntrl Ser IA	4180186
36203629	猪流行性腹泻病毒 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36203631	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVA	4180186
36203631	RVA RNA Islt-Seq	4180186
36203631	轮状病毒 A 组 RNA:序列:时间点:分离株:名义型:序列测定	4182948
36203632	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; PEDv; PEDv RNA; Point in time; Pork; Random; Ribonucleic acid; Swine; Vet; Veterinary	4180186
36203632	PEDv RNA Islt-Seq	4180186
36203632	猪流行性腹泻病毒 RNA:序列:时间点:分离株:名义型:序列测定	4182948
36203634	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVC; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203634	RVC RNA Ct Spec Qn NAA+probe	4180186
36203634	轮状病毒 C RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203635	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVA; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203635	RVA RNA Ct Spec Qn NAA+probe	4180186
36203635	轮状病毒 A 组 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203636	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVB; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203636	RVB RNA Ct Spec Qn NAA+probe	4180186
36203636	轮状病毒 B RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203638	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; L intracell; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203638	L intracell RNA Ct Spec Qn NAA+probe	4180186
36203638	胞内劳森菌 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203641	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; PEDv; PEDv RNA; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
36203641	PEDv RNA # Spec NAA+probe	4180186
36203641	猪流行性腹泻病毒 RNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203642	Antigen; Antigens; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; PDCoV; PDCoV Ag; Point in time; Pork; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Swine; Tissue; Tissue, unspecified; Vet; Veterinary	4180186
36203642	PDCoV Ag Tiss Ql ImStn	4180186
36203642	猪 Delta 冠状病毒 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
36203643	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203643	blaOXA Islt/Spm Ql	4180186
36203643	细菌碳青霉烯类耐药 blaOXA 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203645	3 Self-Sustaining Sequence Replication; 3SR SR; A pleuropn; A pleuropn ser ident; A pleuropn Sertyp; A pleuropneumoniae; Actino; Amplif; Amplification; Amplified; Contagious swine pleuropneumonia; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vet; Veterinary	4180186
36203645	A pleuropn Sertyp Islt NAA+probe	4180186
36203645	胸膜肺炎放线杆菌血清型 已鉴定的:存在与否或特征标识:时间点:分离株:名义型:探针法.基因扩增.靶向	4182948
36203646	3 Self-Sustaining Sequence Replication; 3SR SR; A suis; Actino; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203646	A suis DNA Spec Ql NAA+probe	4180186
36203646	猪放线杆菌 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203647	3 Self-Sustaining Sequence Replication; 3SR SR; A suis; Actino; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203647	A suis DNA Ct Spec Qn NAA+probe	4180186
36203647	猪放线杆菌 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203649	Antigen; Antigens; E rhusiopathiae; E rhusiopathiae Ag; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; Vet; Veterinary	4180186
36203649	E rhusiopathiae Ag Tiss Ql ImStn	4180186
36203649	猪红斑丹毒丝菌 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
36203652	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E tonsillarum; E tonsillarum DNA; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203652	E tonsillarum DNA Ct Spec Qn NAA+probe	4180186
36203652	扁桃体丹毒丝菌 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203653	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H parasuis; H parasuis DNA; Haemoph; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203653	H parasuis DNA Ct Spec Qn NAA+probe	4180186
36203653	副猪嗜血杆菌 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203654	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; L borg Har-bovis; L borgp; L borgp Hardjo-bovis DNA; L borgpetersenii; LAT; LCR; Leptospirosis; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203654	L borg Har-bovis DNA Ct Spec Qn NAA+prb	4180186
36203654	鲍格彼得森钩端螺旋体 Hardjo-bovis 血清型变种 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203657	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Parvo; Parvo virus; Parvov; Point in time; Porcine reproductive parvovirus; Pork; PPV; PR; QL; Qual; Qualitative; Random; Screen; Spec; Swine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36203657	PPV Spec Ql Cult	4180186
36203657	猪细小病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36203662	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; T gondii; To be specified in another part of the message; Toxo; Toxoplasmosis; Unspecified	4180186
36203662	T gondii IgG Spec Ql IA	4180186
36203662	刚地弓形虫 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36203663	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S suis; SDA; Spec; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203663	S suis DNA Ct Spec Qn NAA+probe	4180186
36203663	猪链球菌 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203664	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203664	blaSPM Islt/Spm Ql	4180186
36203664	细菌碳青霉烯类耐药 blaSPM 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203666	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203666	ESBL blaBEL gene Islt/Spm Ql	4180186
36203666	细菌 beta-内酰胺耐药 ESBL blaBEL 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203668	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203668	blaGIM Islt/Spm Ql	4180186
36203668	细菌碳青霉烯类耐药 blaGIM 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203670	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; blaCTX-M-8+blaCTX-M-25 Grp; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203670	blaCTX-M-8+blaCTX-M-25 Gr Islt/Spm Ql	4180186
36203670	细菌 beta-内酰胺耐药 ESBL blaCTX-M-8+blaCTX-M-25 组基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203671	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203671	ESBL blaGES gene Islt/Spm Ql	4180186
36203671	细菌 beta-内酰胺耐药 ESBL blaGES 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203675	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203675	ESBL blaVEB gene Islt/Spm Ql	4180186
36203675	细菌 beta-内酰胺耐药 ESBL blaVEB 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203676	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203676	AmpC blaACC gene Islt/Spm Ql	4180186
36203676	细菌 beta-内酰胺耐药 AmpC blaACC 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203681	Wmns hlth OP Letter	4180186
36203681	DOC.ONT; Document; Finding; Findings; OP; Point in time; Random; Wmns hlth	4180186
36203681	信函:发现:时间点:门诊病人:文档型:女性健康	4182948
36203682	Wmns hlth OP H&P note	4180186
36203682	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; OP; Point in time; Random; Visit note; Wmns hlth	4180186
36203682	病史与体格检查记录:发现:时间点:门诊病人:文档型:女性健康	4182948
36203688	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203688	Sleep med Consult note	4180186
36203688	会诊记录:发现:时间点:{环境}:文档型:睡眠医学	4182948
36203689	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note; Wmns hlth	4180186
36203689	Wmns hlth H&P note	4180186
36203689	病史与体格检查记录:发现:时间点:{环境}:文档型:女性健康	4182948
36203693	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; Wmns hlth	4180186
36203693	Wmns hlth Consult note	4180186
36203693	会诊记录:发现:时间点:{环境}:文档型:女性健康	4182948
36203695	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; M.D.; MD; notes; Point in time; Random; Visit note	4180186
36203695	MD Restraint note	4180186
36203695	约束记录:发现:时间点:{环境}:文档型:医师	4182948
36203699	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
36203699	Neuropsych Initial eval note	4180186
36203699	初步评价记录:发现:时间点:{环境}:文档型:神经心理学	4182948
36203700	Neuropsych D/C sum	4180186
36203700	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203700	出院摘要记录:发现:时间点:{环境}:文档型:神经心理学	4182948
36203703	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Eye care; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Visit note	4180186
36203703	Ophthalmol Teleimaging Note	4180186
36203703	记录:发现:时间点:远程影像学:文档型:眼科学	4182948
36203707	Dermatology Post-op E/M note	4180186
36203707	Assessment; Clinical encounter note; Derm; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Post-op E/M note; Post-operative; Random; Visit note	4180186
36203707	术后评价与管理记录:发现:时间点:{环境}:文档型:皮肤病学	4182948
36203719	Addiction; Alfa; alpha-PVP; a-PVP; Cathinone; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyl Pyrovalerone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; O-2387; Point in time; PotentialForAbuse; Prolintanone; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; β-keto-prolintane	4180186
36203719	a-PVP Ur Cfm-mCnc	4180186
36203719	Alpha 吡咯啉苯戊酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
36203721	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg Y; N men sg Y synF; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group Y; Neisseria meningitidis type Y; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203721	N men sg Y synF Ct Spec Qn NAA+probe	4180186
36203721	脑膜炎奈瑟菌血清群 Y synF 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203722	Antigen; Antigens; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVA; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; Vet; Veterinary	4180186
36203722	RVA Ag Tiss Ql ImStn	4180186
36203722	轮状病毒 A 组 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
36203724	Document; Finding; Findings; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Other; PEDv; PEDV gene; PEDV seq + phylo XXX Doc; Point in time; Pork; Random; Spec; Swine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36203724	PEDV seq + phylo XXX Doc Spec Doc	4180186
36203724	猪流行性腹泻病毒基因序列与系统发育分析:发现:时间点:XXX:文档型	4182948
36203726	Antigen; Antigens; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; L intracell; L intracellularis Ag; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; Vet; Veterinary	4180186
36203726	L intracell Ag Tiss Ql ImStn	4180186
36203726	胞内劳森菌 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
36203727	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; PDCoV; Point in time; Pork; PR; QL; Qual; Qualitative; Random; Screen; Spec; Swine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36203727	PDCoV Spec Ql Cult	4180186
36203727	猪 Delta 冠状病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36203732	CHC Case mgr; Comm hlth care; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203732	CHC Case mgr Note	4180186
36203732	记录:发现:时间点:{环境}:文档型:社区医疗保健服务.病例管理人员	4182948
36203734	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL nasal sup thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203734	R ret RNFL nasal sup thickness OCT	4180186
36203734	视网膜神经纤维层.鼻上厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203738	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL nasal thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203738	R ret RNFL nasal thickness OCT	4180186
36203738	视网膜神经纤维层.鼻侧厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203739	Brst; Brst + Brst specimen-L; Brst spec; Brst spec-L; Brst-L; CorePlaybook; Document; Films; Finding; Findings; Guid; Guide; Guided; Imaging; L; Local; LT; NDL; Needle loc + Views; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; View; VWS	4180186
36203739	MG Brst-L Needle loc + Brst spec View	4180186
36203739	旨在针定位的引导 && 多重视图:发现:时间点:乳腺.左侧 &&^乳腺标本.左侧:文档型:乳房X线摄影术	4182948
36203741	1V; 1V for clip place; Brst; Brst-Ul; CorePlaybook; Document; Film; Finding; Findings; Imaging; Playbook; Point in time; Rad; Radiology; Random; Single View; VW	4180186
36203741	MG Brst-Ul 1V for clip place	4180186
36203741	针对夹放置的视图:发现:时间点:乳腺.单侧:文档型:乳房X线摄影术	4182948
36203742	Add; Asp; Brst; Brst-L; CorePlaybook; Cyst asp addl; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36203742	MG Guided Brst-L Cyst asp addl	4180186
36203742	旨在额外囊肿抽吸的引导:发现:时间点:乳腺.左侧:文档型:乳房X线摄影术	4182948
36203743	Add; Asp; Brst; Brst-R; CorePlaybook; Cyst asp addl; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; R; Rad; RADIOLOGY; Random; RT	4180186
36203743	MG Guided Brst-R Cyst asp addl	4180186
36203743	旨在额外囊肿抽吸的引导:发现:时间点:乳腺.右侧:文档型:乳房X线摄影术	4182948
36203747	Add; Brst; Brst-R; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Local; NDL; Needle loc addl; Playbook; Point in time; R; Rad; RADIOLOGY; Random; RT	4180186
36203747	MG Guided Brst-R Needle loc addl	4180186
36203747	旨在额外针定位的引导:发现:时间点:乳腺.右侧:文档型:乳房X线摄影术	4182948
36203748	Brst; Brst-L; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L; Local; LT; NDL; Playbook; Point in time; Rad; Radiology; Random	4180186
36203748	MG Guided Brst-L Needle loc	4180186
36203748	旨在针定位的引导:发现:时间点:乳腺.左侧:文档型:乳房X线摄影术	4182948
36203755	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203755	HAdV DNA Bld Ql NAA+probe	4180186
36203755	腺病毒 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36203757	ABS; Aby; Adeno virus; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HAdV; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
36203757	HAdV IgM Ser Ql IA	4180186
36203757	腺病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36203760	Contraception; Contraceptive Method; H+P; H+P.HX; Meth; Method of; Nominal; P prime; Point in time; Random; Typ	4180186
36203760	节育方法^接诊时:类型:时间点:^患者:名义型:报告法	4182948
36203761	Reason no birth control at intake	4180186
36203761	Contraception; Contraceptive Method; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Reason no birth control	4180186
36203761	关于未使用任何节育措施的原因^接诊时:发现:时间点:^患者:名义型:报告法	4182948
36203764	Addiction med Attend; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36203764	Addiction med Attend Note	4180186
36203764	记录:发现:时间点:{环境}:文档型:成瘾医学.主治	4182948
36203765	Vocational rehab Med clearance note	4180186
36203765	Cl; Clear; Clearanc; Clearances; Clr; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Med clearance note; notes; Point in time; Random; Visit note	4180186
36203765	体检合格记录:发现:时间点:{环境}:文档型:职业康复	4182948
36203766	Wmns hlth Annual eval note	4180186
36203766	Annual eval note; Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note; Wmns hlth	4180186
36203766	年度评价记录:发现:时间点:{环境}:文档型:女性健康	4182948
36203767	Cancer; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Hematology and Oncology; Hematology+Oncology; Heme; HemOnc; notes; Oncology; Point in time; Random; Visit note	4180186
36203767	HemOnc Disease staging	4180186
36203767	疾病分期记录:发现:时间点:{环境}:文档型:血液学+内科肿瘤学	4182948
36203768	PEDv NAb Titr Ser Nt	4180186
36203768	猪流行性腹泻病毒 抗体.中和:滴定度:时间点:血清:定量型:中和试验	4182948
36203768	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; PEDv; PEDV Ab; PEDV Nab; Point in time; Pork; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Swine; Titer; Titered; Titre; Ttr; Vet; Veterinary; Virus neutralization test; VNT	4180186
36203770	Antigen; Antigens; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; S suis; Screen; Spec; St; Stains; Stn; Strep; Strept; To be specified in another part of the message; Unspecified	4180186
36203770	S suis Ag Spec Ql ImStn	4180186
36203770	猪链球菌 抗原:存在情况或阈值:时间点:XXX:序数型:免疫染色法	4182948
36203771	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Parvo; Parvo virus; Parvov; PCR; Point in time; Polymerase chain reaction; Porcine reproductive parvovirus; Pork; PPV; PPV 2; PPV 2 DNA; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203771	PPV 2 DNA Ct Spec Qn NAA+probe	4180186
36203771	猪细小病毒 2 型 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203773	Dermatologic; Epidermis; Integument; LM; Marg tumor invol.deep; Marg tumor involve; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Skn; Surg	4180186
36203773	Marg tumor invol.deep Mel Ql Micro	4180186
36203773	外科手术边界肿瘤累及.深部:存在情况或阈值:时间点:皮肤黑色素瘤:序数型:显微镜检查.光学	4182948
36203774	CLIN; Nominal; Point in time; Random; Typ	4180186
36203774	照护服务团队:类型:时间点:^患者:名义型	4182948
36203775	Coded cause death CDA R1 Sec; Congenital dyserythropoietic anaemia; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
36203775	Coded cause death CDA R1 Sec	4180186
36203775	编码型死亡原因 - 推荐 CDA R1 小节:-:时间点:{环境}:-	4182948
36203777	Jurisdiction death info CDA R2.1 Sec	4180186
36203777	Congenital dyserythropoietic anaemia; Jurisdiction death info CDA R2.1 Sec; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
36203777	管辖区域死亡信息 - 推荐 CDA R1 小节:-:时间点:{环境}:-	4182948
36203779	Congenital dyserythropoietic anaemia; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Provider death reg CDA R2.1 Sec; Random	4180186
36203779	Provider death reg CDA R2.1 Sec	4180186
36203779	服务提供方死亡登记 - 推荐 CDA R1 小节:-:时间点:{环境}:-	4182948
36203781	DOC.MISC; Document; Ethnicity; Finding; Findings; MISC; Point in time; Random	4180186
36203781	Race and ethnicity info Doc	4180186
36203781	种族与族群信息:发现:时间点:^患者:文档型	4182948
36203782	Jurisdiction death reg Doc	4180186
36203782	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36203782	管辖区域死亡登记:发现:时间点:^患者:文档型	4182948
36203783	Death admin info Doc	4180186
36203783	Admin info; Death admin info; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36203783	死亡管理类信息:发现:时间点:^患者:文档型	4182948
36203784	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36203784	Provider death registration Doc	4180186
36203784	服务提供方死亡登记:发现:时间点:^患者:文档型	4182948
36203785	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Flav Ab; Flavi virus; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum virus neutralization; Spec; SVN; To be specified in another part of the message; Unspecified; Virus neutralization test; VNT	4180186
36203785	Flavivirus NAb Spec Ql Nt	4180186
36203785	黄病毒 抗体.中和:存在情况或阈值:时间点:XXX:序数型:中和试验	4182948
36203786	DENV2 NAb Titr Spec Nt	4180186
36203786	登革热病毒 2 型 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36203786	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Conventional virus neutralization test; cVNT; Dengue type II; Denv; DENV2; Dilution factor; Dilution Factor (Titer); Flavivirus; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36203787	DENV3 NAb Titr Spec Nt	4180186
36203787	登革热病毒 3 型 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36203787	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Conventional virus neutralization test; cVNT; Dengue type III; Denv; DENV3; Dilution factor; Dilution Factor (Titer); Flavivirus; ID; III; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36203788	DENV1 NAb Titr Spec Nt	4180186
36203788	登革热病毒 1 型 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36203788	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Conventional virus neutralization test; cVNT; Dengue type I; Denv; DENV1; Dilution factor; Dilution Factor (Titer); Flavivirus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36203790	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Conventional virus neutralization test; cVNT; Dengue type IV; Denv; DENV4; Flavivirus; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum virus neutralization; Spec; SVN; To be specified in another part of the message; Unspecified; Virus neutralization test; VNT	4180186
36203790	DENV4 NAb Spec Ql Nt	4180186
36203790	登革热病毒 4 型 抗体.中和:存在情况或阈值:时间点:XXX:序数型:中和试验	4182948
36203793	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Conventional virus neutralization test; cVNT; Dengue type I; Denv; DENV1; Flavivirus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum virus neutralization; Spec; SVN; To be specified in another part of the message; Unspecified; Virus neutralization test; VNT	4180186
36203793	DENV1 NAb Spec Ql Nt	4180186
36203793	登革热病毒 1 型 抗体.中和:存在情况或阈值:时间点:XXX:序数型:中和试验	4182948
36203795	Cancer Path Pnl Br ca spec CAP prot	4180186
36203795	Br ca spec; Brst; CA; Ca spec; Cancer Path Pnl; CAP prot; Pan; PANEL.PATH; Panl; Path; Pathology; Pnl; Point in time; Random; Spec	4180186
36203795	癌症病理学组套:-:时间点:乳腺癌标本:-:美国病理学家协会癌症方案	4182948
36203796	Cancer Path Pnl CRC spec CAP prot	4180186
36203796	CA; Ca spec; Cancer Path Pnl; CAP prot; CRC spec; Pan; PANEL.PATH; Panl; Path; Pathology; Pnl; Point in time; Random; Spec	4180186
36203796	癌症病理学组套:-:时间点:结直肠癌标本:-:美国病理学家协会癌症方案	4182948
36203797	Phys find Teeth+gum	4180186
36203797	Exam; Examination; Finding; Findings; H+P; H+P.HX; Narrative; P prime; Phys find; Point in time; Random; Report; Teeth+gum	4180186
36203797	体格检查发现:发现:时间点:牙齿与牙龈:叙述型:观察法	4182948
36203799	Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Spec sent to CDC	4180186
36203799	标本送往CDC的日期:日期:时间点:^患者:定量型	4182948
36203800	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203800	唾液腺肿胀初次发作日期:日期:时间点:^患者:定量型	4182948
36203801	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203801	咳嗽初次发作日期:日期:时间点:^患者:定量型	4182948
36203806	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36203806	记录:发现:时间点:{环境}:文档型:妇科学	4182948
36203808	Electrophysiology Pre-op note	4180186
36203808	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Visit note	4180186
36203808	术前评价与管理记录:发现:时间点:{环境}:文档型:临床心脏电生理学	4182948
36203809	Electrophysiology Post-op E/M note	4180186
36203809	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Post-op E/M note; Post-operative; Random; Visit note	4180186
36203809	术后评价与管理记录:发现:时间点:{环境}:文档型:临床心脏电生理学	4182948
36203810	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; Gastro; Gastroenterology; GI; H&P; History and physical; notes; Point in time; Post-op E/M note; Post-operative; Random; Visit note	4180186
36203810	Gastroenterology Post-op E/M note	4180186
36203810	术后评价与管理记录:发现:时间点:{环境}:文档型:胃肠病学	4182948
36203811	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; Gastro; Gastroenterology; GI; H&P; History and physical; notes; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Visit note	4180186
36203811	Gastroenterology Pre-op note	4180186
36203811	术前评价与管理记录:发现:时间点:{环境}:文档型:胃肠病学	4182948
36203812	Orthopaedic surgery Post-op E/M note	4180186
36203812	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Orthopedic; Orthopedic surgery; Point in time; Post-op E/M note; Post-operative; Random; Surg; Visit note	4180186
36203812	术后评价与管理记录:发现:时间点:{环境}:文档型:矫形外科学	4182948
36203813	Assessment; Clinical encounter note; Dis; Diseases; DOC.ONT; Document; Dz; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Lung; notes; Point in time; Pre-Op; Pre-op note; Pre-Operative; Pulmonary; Pulmonology; Random; Respiratory; Respirology; Visit note	4180186
36203813	Pulmonary disease Pre-op note	4180186
36203813	术前评价与管理记录:发现:时间点:{环境}:文档型:肺病	4182948
36203816	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Nurse.surgery; nursing; OP; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Surg; Surgery Nurse; Visit note	4180186
36203816	Surgery Nurse OP Pre-op note	4180186
36203816	术前评价与管理记录:发现:时间点:门诊病人:文档型:外科学.护士	4182948
36203818	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203818	皮疹初次发作年龄:时间:时间点:^患者:定量型	4182948
36203819	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; i; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203819	S pneum Da 1 Ab Ser-mCnc	4180186
36203819	肺炎链球菌丹麦血清型 1 抗体:质量浓度:时间点:血清:定量型	4182948
36203820	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; i; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203820	S pneum Da 1 Ab Ser-aCnc	4180186
36203820	肺炎链球菌丹麦血清型 1 抗体:任意型浓度:时间点:血清:定量型	4182948
36203822	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 1	4180186
36203822	S pneum Da 1 IgG Ser IA-mCnc	4180186
36203822	肺炎链球菌丹麦血清型 1 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203829	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 10 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203829	R ret RNFL 10 o'clock thickness OCT	4180186
36203829	视网膜神经纤维层.10点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203830	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 11 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203830	R ret RNFL 11 o'clock thickness OCT	4180186
36203830	视网膜神经纤维层.11点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203831	Abd; Abd+Pelvis; Abdo; Abdominal; Bil; Bilat; Both; c; Contr; Contra; Contrst; CorePlaybook; Cystogram; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kdny-Bl; Kid-Bl+Uret; Kid-Bl+Uret-Bl+Blad; Kidney; Kidneys; Nephric; Nephrology; Pelvic; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Retro; Ureter-Bl; View; VWS; W contr Retro; WC	4180186
36203831	RF Kid-Bl+Uret-Bl+Blad Vs W contr Retr	4180186
36203831	多重视图^采用逆行性对比剂:发现:时间点:腹部>肾脏.双侧 & 腹部+盆腔>输尿管.双侧 & 盆腔>膀胱:文档型:放射荧光透视法	4182948
36203832	AO; Aortagram; Aortic; Aortogm; Aortogram; Aortography; Arteriogram; c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; RFA; Thorax; View; VWS; W contr IA; WC	4180186
36203832	RFA TA Views W contr IA	4180186
36203832	多重视图^采用动脉注射对比剂:发现:时间点:胸部>主动脉.胸腔段:文档型:放射荧光透视法.血管造影术	4182948
36203833	Ba; Barium Swallow; c; Contr; Contra; Contrst; CorePlaybook; Deglutition; Document; Esophageal; Esophagram; FCN; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Func; Funct; Hypoph+Esophagus; Imaging; Playbook; Point in time; Rad; Radiology; Random; RF video; Thorax; View; Views for swallow func; VWS; W Ba PO; W speech+W Ba PO	4180186
36203833	RF vid Hypoph+Eso swallow fn W Speech+Ba	4180186
36203833	针对吞咽功能的多重视图^采用说话+采用口服钡对比剂:发现:时间点:颈部>下咽部 & 胸部>食管:文档型:放射荧光透视法.摄像术	4182948
36203834	c; Cardio; Cardiology; Contr; Contra; Contrst; CorePlaybook; Document; EXT; Extr vv-Ul; Extr-Ul; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Heart Disease; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; RFA; Venogram; Venography; View; VWS; W contr IV; WC	4180186
36203834	RFA Extr vv-Ul Views W contr IV	4180186
36203834	多重视图^采用静脉注射对比剂:发现:时间点:肢体.单侧>肢体静脉类:文档型:放射荧光透视法.血管造影术	4182948
36203836	14 days; 2 weeks; dressing yourself HF limited past 2W; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36203837	14 days; 2 weeks; Finding; Findings; i; Kansas City Cardiomyopathy Questionnaire; Last; Levels; Levl; LMTED; LTD; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; walk 1 block HF limited past 2W	4180186
36203838	14 days; 2 weeks; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; yard, house, carry HF limited past 2W	4180186
36203839	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Bact; Celbenin; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Metacillin; Metin; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Smell; Staficyn; Staphicillin; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36203839	mecA+mecC Nose Ql NAA+probe	4180186
36203839	细菌甲氧西林耐药 mecA+mecC 基因:存在情况或阈值:时间点:鼻:序数型:探针法.基因扩增.靶向	4182948
36203841	ANTIBIOTIC SUSCEPTIBILITIES; Celbenin; Dimethoxypenicillin; Metacillin; Metin; Nasal; Nos; Nose (nasal passage); o71; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent; S aureus; SCCmec + mecA+mecC; SCCmec + mecA+mecC pnl; Smell; Staficyn; Staph; Staphicillin; Staphylococcus cassette chromosome (SCCmec)	4180186
36203841	SCCmec + mecA+mecC pnl Nose	4180186
36203841	金黄色葡萄球菌甲氧西林耐药 SCCmec 与 mecA+mecC 基因组套:-:时间点:鼻:-	4182948
36203842	ATTACH; ATTACH.MODIFIER; Emergency Medical Service(s); III; Levels; Levl; LV; LVL; Point in time; Random; Scope.mod.doc temp; Send Doc Conforms L3 EMS R2	4180186
36203842	发送符合第 3 级 EMS R2 模板的文档:范围.修饰成分.文档模板:时间点:X12^277:-	4182948
36203843	ATTACH; ATTACH.MODIFIER; Cancer; Point in time; Random; Scope.mod.doc temp; Send Doc Conforms Onc Plan R1.3; Tx	4180186
36203843	发送符合肿瘤学治疗计划摘要 R1.3 模板的文档:范围.修饰成分.文档模板:时间点:X12^277:-	4182948
36203845	PEDv IgG Titr Ser IF	4180186
36203845	猪流行性腹泻病毒 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36203845	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PEDv; PEDV Ab; PEDv IgG; Point in time; Pork; Random; Serum; SmQn; SR; Swine; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Vet; Veterinary	4180186
36203847	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Colistin res mcr-1; Colmycin; Colymycin; i; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203847	Colistin res mcr-1 Islt/Spm Ql	4180186
36203847	细菌粘菌素耐药 mcr-1 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203848	Addiction; Anexsia; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Vicodin; WB; Whole blood	4180186
36203848	HYDROcodone SerPlBld Cfm-mCnc	4180186
36203848	氢可酮:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
36203849	Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydromorphinone; Illicit; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
36203849	HYDROmorphone SerPlBld Cfm-mCnc	4180186
36203849	二氢吗啡酮:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
36203852	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; Blt; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; WBLOT; West blot; West blt; Western blot; Whole blood	4180186
36203852	HIV1 Ab SerPlBld Ql IB	4180186
36203852	HIV 1 型 抗体:存在情况或阈值:时间点:血清/血浆/全血:序数型:免疫印迹法	4182948
36203853	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg A; N men sg A sacB; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group A; Neisseria meningitidis type A; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203853	N men sg A sacB Ct Spec Qn NAA+probe	4180186
36203853	脑膜炎奈瑟菌血清群 A sacB 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203855	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg C; N men sg C synE; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group C; Neisseria meningitidis type C; Neissieria mengitidis serogroup C; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203855	N men sg C synE Ct Spec Qn NAA+probe	4180186
36203855	脑膜炎奈瑟菌血清群 C synE 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203858	CA; Ca spec; Cell; Cells.chr 3 mono; Cellularity; Chromosom; Chromosomes; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; III; Inherited; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203858	Cells.chr 3 mono/Cells NFr Ca spec FISH	4180186
36203858	细胞.染色体 3 单体性/已计数的细胞:计数型分数:时间点:癌标本:定量型:FISH	4182948
36203859	AQP4 H2O channel IgG Titr CSF FC	4180186
36203859	水通道蛋白 4 受体 抗体.IgG:滴定度:时间点:脑脊液:定量型:流式细胞测量术	4182948
36203859	ABS; Aby; Antby; Anti; Antibodies; Antibody; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Devic's disease; Dilution factor; Dilution Factor (Titer); Dynamic; FC; Immune globulin G; Immunoglobulin G; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr; Water channel aquaporin-4	4180186
36203860	AQP4 H2O channel IgG Titr SerPl FC	4180186
36203860	水通道蛋白 4 受体 抗体.IgG:滴定度:时间点:血清/血浆:定量型:流式细胞测量术	4182948
36203860	ABS; Aby; Antby; Anti; Antibodies; Antibody; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Devic's disease; Dilution factor; Dilution Factor (Titer); Dynamic; FC; Immune globulin G; Immunoglobulin G; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Pl; Plasma; Plsm; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr; Water channel aquaporin-4	4180186
36203865	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL temp thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203865	R ret RNFL temp thickness OCT	4180186
36203865	视网膜神经纤维层.颞侧厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203866	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL temp sup thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203866	R ret RNFL temp sup thickness OCT	4180186
36203866	视网膜神经纤维层.颞上厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203867	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL temp sup thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203867	L ret RNFL temp sup thickness OCT	4180186
36203867	视网膜神经纤维层.颞上厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203868	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL sup thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203868	R ret RNFL sup thickness OCT	4180186
36203868	视网膜神经纤维层.上方厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203869	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL sup thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203869	L ret RNFL sup thickness OCT	4180186
36203869	视网膜神经纤维层.上方厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203870	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL temp thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203870	L ret RNFL temp thickness OCT	4180186
36203870	视网膜神经纤维层.颞侧厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203871	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL nasal thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203871	L ret RNFL nasal thickness OCT	4180186
36203871	视网膜神经纤维层.鼻侧厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203872	Discocyte; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Report	4180186
36203872	Erythrocyte deformability RBC-Imp	4180186
36203872	红细胞变形性:印象:时间点:红细胞:叙述型	4182948
36203873	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 9 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203873	L ret RNFL 9 o'clock thickness OCT	4180186
36203873	视网膜神经纤维层.9点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203875	EYE; EYE.OCT; Fibers; Inf; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL inf thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203875	L ret RNFL inf thickness OCT	4180186
36203875	视网膜神经纤维层.下方厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203876	EYE; EYE.OCT; Fibers; Inf; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL inf temp thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203876	L ret RNFL inf temp thickness OCT	4180186
36203876	视网膜神经纤维层.颞下厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203877	Average; Avg; EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL mean thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203877	L ret RNFL mean thickness OCT	4180186
36203877	视网膜神经纤维层.平均厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203878	EYE; Fibers; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Pan; PANEL.EYE; Panl; Pnl; Point in time; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL Pnl; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203878	Retina RNFL Pnl OCT	4180186
36203878	视网膜神经纤维层组套:-:时间点:视网膜:-:光学相干断层扫描术	4182948
36203879	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 12 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203879	L ret RNFL 12 o'clock thickness OCT	4180186
36203879	视网膜神经纤维层.12点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203882	EYE; EYE.OCT; Fibers; III; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 3 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203882	L ret RNFL 3 o'clock thickness OCT	4180186
36203882	视网膜神经纤维层.3点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203886	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 7 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203886	L ret RNFL 7 o'clock thickness OCT	4180186
36203886	视网膜神经纤维层.7点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203888	Average; Avg; EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL mean thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203888	R ret RNFL mean thickness OCT	4180186
36203888	视网膜神经纤维层.平均厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203889	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 10 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203889	L ret RNFL 10 o'clock thickness OCT	4180186
36203889	视网膜神经纤维层.10点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203890	ATTACH; ATTACH.MODIFIER; Cancer; Point in time; Random; Scope.mod.doc temp; Send Doc Conforms Onc Plan R1.2.1; Tx	4180186
36203890	发送符合肿瘤学治疗计划摘要 R1.2.1 模板的文档:范围.修饰成分.文档模板:时间点:X12^277:-	4182948
36203891	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; i; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203891	S pneum Da 1 IgG Ser-aCnc	4180186
36203891	肺炎链球菌丹麦血清型 1 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
36203892	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 1	4180186
36203892	S pneum Da 1 IgG Ser IA-aCnc	4180186
36203892	肺炎链球菌丹麦血清型 1 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36203893	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; i; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 1	4180186
36203893	S pneum Da 1 IgG sp1 Ser IA-mCnc	4180186
36203893	肺炎链球菌丹麦血清型 1 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203894	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; i; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203894	S pneum Da 1 IgG sp1 Ser-mCnc	4180186
36203894	肺炎链球菌丹麦血清型 1 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36203895	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; i; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203895	S pneum Da 1 IgG sp1 Ser-aCnc	4180186
36203895	肺炎链球菌丹麦血清型 1 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36203899	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; i; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203899	S pneum Da 1 IgG 2:1 Ser-Rto	4180186
36203899	肺炎链球菌丹麦血清型 1 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36203901	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; i; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 1	4180186
36203901	S pneum Da 1 Ab sp1 Ser IA-aCnc	4180186
36203901	肺炎链球菌丹麦血清型 1 抗体^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36203903	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; i; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203903	S pneum Da 1 Ab sp2 Ser-mCnc	4180186
36203903	肺炎链球菌丹麦血清型 1 抗体^第2个标本:质量浓度:时间点:血清:定量型	4182948
36203907	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203907	S pneum Da 12F Ab Ser-aCnc	4180186
36203907	肺炎链球菌丹麦血清型 12F 抗体:任意型浓度:时间点:血清:定量型	4182948
36203911	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da 12F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 12	4180186
36203911	S pneum Da 12F IgG sp1 Ser IA-mCnc	4180186
36203911	肺炎链球菌丹麦血清型 12F 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203913	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da 12F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203913	S pneum Da 12F IgG sp2 Ser-aCnc	4180186
36203913	肺炎链球菌丹麦血清型 12F 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36203915	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203915	S pneum Da 12F Ab sp1 Ser-aCnc	4180186
36203915	肺炎链球菌丹麦血清型 12F 抗体^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36203916	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203916	S pneum Da 12F Ab sp1 Ser-mCnc	4180186
36203916	肺炎链球菌丹麦血清型 12F 抗体^第1个标本:质量浓度:时间点:血清:定量型	4182948
36203918	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203918	S pneum Da 12F Ab sp2 Ser-mCnc	4180186
36203918	肺炎链球菌丹麦血清型 12F 抗体^第2个标本:质量浓度:时间点:血清:定量型	4182948
36203921	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203921	S pneum Da 14 Ab Ser-aCnc	4180186
36203921	肺炎链球菌丹麦血清型 14 抗体:任意型浓度:时间点:血清:定量型	4182948
36203922	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da 14 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203922	S pneum Da 14 IgG Ser-mCnc	4180186
36203922	肺炎链球菌丹麦血清型 14 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36203923	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da 14 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 14	4180186
36203923	S pneum Da 14 IgG Ser IA-mCnc	4180186
36203923	肺炎链球菌丹麦血清型 14 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203925	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da 14 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 14	4180186
36203925	S pneum Da 14 IgG Ser IA-aCnc	4180186
36203925	肺炎链球菌丹麦血清型 14 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36203928	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da 14 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203928	S pneum Da 14 IgG sp1 Ser-aCnc	4180186
36203928	肺炎链球菌丹麦血清型 14 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36203932	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203932	S pneum Da 14 Ab sp1 Ser-mCnc	4180186
36203932	肺炎链球菌丹麦血清型 14 抗体^第1个标本:质量浓度:时间点:血清:定量型	4182948
36203937	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 12 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203937	R ret RNFL 12 o'clock thickness OCT	4180186
36203937	视网膜神经纤维层.12点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203938	EYE; EYE.OCT; Fibers; i; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 1 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203938	R ret RNFL 1 o'clock thickness OCT	4180186
36203938	视网膜神经纤维层.1点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203939	EYE; EYE.OCT; Fibers; II; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 2 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203939	R ret RNFL 2 o'clock thickness OCT	4180186
36203939	视网膜神经纤维层.2点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203942	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUAV H1 2009 pand; FLUV; Fowl plague; H1N1; H1N1v; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza virus A hemagglutinin H1 swine origin; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; S-OIV; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203942	FLUAV H1 2009 pand RNA Ct Spec Qn NAA+pr	4180186
36203942	流感病毒 A 型血凝素 H1 型 2009 大流行 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203943	Antigen; Antigens; FLUB; FLUBV; FLUBV Yam; FLUV; HEMAGGLUTINATION INHIBITION; HI; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36203943	FLUBV Yam Ag Islt Ql HAI	4180186
36203943	流感病毒 B 型 Yamagata 谱系 抗原:存在情况或阈值:时间点:分离株:序数型:红细胞凝集抑制试验法	4182948
36203945	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum virus neutralization; Spec; SVN; To be specified in another part of the message; Unspecified; Virus neutralization test; VNT; Zika virus Nab; ZIKV	4180186
36203945	ZIKV NAb Spec Ql Nt	4180186
36203945	寨卡病毒 抗体.中和:存在情况或阈值:时间点:XXX:序数型:中和试验	4182948
36203946	ZIKV NAb Titr Spec Nt	4180186
36203946	寨卡病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36203946	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT; Zika virus Nab; ZIKV	4180186
36203949	Bact; Count/mass; Food sample; Foods; ID; Infectious Disease; InfectiousDisease; Microbiology; Number content; Point in time; QNT; Quan; Quant; Quantitative; Random; Viab Cnt	4180186
36203949	Coliform in Food Viab Cnt	4180186
36203949	大肠菌群:计数型含量:时间点:食物:定量型:活菌计数法	4182948
36203951	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B holm hIS1001; B holmseii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203951	B holm hIS1001 DNA Ct Spec Qn NAA+probe	4180186
36203951	霍氏博德特菌 hIS1001 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203952	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B parap IS1001; B parapert; B parapertussis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Whooping cough	4180186
36203952	B parap IS1001 DNA Ct Spec Qn NAA+probe	4180186
36203952	副百日咳博德特菌 IS1001 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203953	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; AdV 21 DNA; AdV B(21); Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203953	AdV B(21) DNA Spec Ql NAA+probe	4180186
36203953	腺病毒 21 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203956	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; AdV 14 DNA; AdV B(14); Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203956	AdV B(14) DNA Spec Ql NAA+probe	4180186
36203956	腺病毒 14 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203963	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6A; S pneum Da 6A+6B; S pneum Da 6A+6B Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 6	4180186
36203963	S pneum Da 6A+6B Ab Ser-aCnc	4180186
36203963	肺炎链球菌丹麦血清型 6A+6B 抗体:任意型浓度:时间点:血清:定量型	4182948
36203964	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6A; S pneum Da 6A+6B; S pneum Da 6A+6B IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 6	4180186
36203964	S pneum Da 6A+6B IgG Ab Ser-aCnc	4180186
36203964	肺炎链球菌丹麦血清型 6A+6B IgG 抗体:任意型浓度:时间点:血清:定量型	4182948
36203966	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6A; S pneum Da 6A+6B; S pneum Da 6A+6B Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 6	4180186
36203966	S pneum Da 6A+6B Ab sp1 Ser-aCnc	4180186
36203966	肺炎链球菌丹麦血清型 6A+6B 抗体^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36203971	U.S. Birth cert 2003 set	4180186
36203971	Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random; S prime; U.S. Birth cert 2003 set	4180186
36203971	美国标准出生证明 - 推荐 2003 年修订版集合:-:时间点:{环境}:-	4182948
36203972	Add; Brst; Brst-R; Bx; Bx addl; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; R; Rad; Radiology; Random; RT; Stereo	4180186
36203972	MG.stereo Guided Brst-R Bx addl	4180186
36203972	旨在额外活组织检查的引导:发现:时间点:乳腺.右侧:文档型:乳房X线摄影术.立体定位	4182948
36203973	Add; Brst; Brst-L; Bx; Bx addl; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Playbook; Point in time; Rad; Radiology; Random; Vac Bx addl	4180186
36203973	MG Guided Brst-L Vac Bx addl	4180186
36203973	旨在额外真空活组织检查的引导:发现:时间点:乳腺.左侧:文档型:乳房X线摄影术	4182948
36203974	Add; Brst; Brst-R; Bx; Bx addl; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; R; Rad; Radiology; Random; RT; Vac Bx addl	4180186
36203974	MG Guided Brst-R Vac Bx addl	4180186
36203974	旨在额外真空活组织检查的引导:发现:时间点:乳腺.右侧:文档型:乳房X线摄影术	4182948
36203975	Brst; Brst-L; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Playbook; Point in time; Rad; Radiology; Random; Vac Bx	4180186
36203975	MG Guided Brst-L Vac Bx	4180186
36203975	旨在真空活组织检查的引导:发现:时间点:乳腺.左侧:文档型:乳房X线摄影术	4182948
36203977	Brst; CorePlaybook; Document; Dx; Dx for clin call back; Films; Finding; Findings; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Symptomatic; View; VWS	4180186
36203977	MG Brst Dx for clin call back	4180186
36203977	针对临床性唤回的诊断性多重视图:发现:时间点:乳腺:文档型:乳房X线摄影术	4182948
36203979	c; Contr; Contra; Contrst; CorePlaybook; Document; EXT; Extr-Ul; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; INTRALYMPHATIC; LE; Leg; Low; Ped lymph ves-Ul; Playbook; Point in time; Rad; RADIOLOGY; Random; RFA; Vesl; Vessels.XXX; View; VWS; W contr IL; WC	4180186
36203979	RFA Ped lymph ves-Ul Views W contr IL	4180186
36203979	多重视图^采用淋巴管内对比剂:发现:时间点:下肢.单侧>足背淋巴管类:文档型:放射荧光透视法.血管造影术	4182948
36203980	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; c; CAG; Cath; CHGM; Cholangiogram; Cholangiography; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Playbook; Point in time; Rad; Radiology; Random; View; VWS; W contr via exist cath; WC	4180186
36203980	RF BDs Views W contr via exist cath	4180186
36203980	多重视图^采用经已有导管的对比剂:发现:时间点:腹部>胆管类:文档型:放射荧光透视法	4182948
36203981	Abd; Abd+Pelvis; Abdo; Abdominal; Adv feed tube; CorePlaybook; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; GI tract; Guid; Guide; Guided; Imaging; Pelvic; Playbook; Point in time; Rad; Radiology; Random	4180186
36203981	RF Guided GI tract Adv feed tube	4180186
36203981	旨在推进饲管的引导:发现:时间点:腹部+盆腔>胃肠道:文档型:放射荧光透视法	4182948
36203982	Abd; Abd+Pelvis; Abdo; Abdominal; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; GI tract; Imaging; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; View; VWS	4180186
36203982	RF GI tract Views for fistula	4180186
36203982	针对瘘管的多重视图:发现:时间点:腹部+盆腔>胃肠道:文档型:放射荧光透视法	4182948
36203983	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Ileal Conduits; Imaging; Loopogram; Playbook; Point in time; Rad; Radiology; Random; SB; Small Intestine; View; VWS	4180186
36203983	RF SB Views for loop diversion	4180186
36203983	针对肠袢改道的多重视图:发现:时间点:腹部>小肠:文档型:放射荧光透视法	4182948
36203988	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 14; S pneum Da 14 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 14	4180186
36203988	S pneum Da 14 Ab 2:1 Ser IA-Rto	4180186
36203988	肺炎链球菌丹麦血清型 14 抗体^第2个标本/第1个标本:比率:时间点:血清:定量型:免疫测定法	4182948
36203989	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 14; S pneum Da 14 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203989	S pneum Da 14 Ab 2:1 Ser-Rto	4180186
36203989	肺炎链球菌丹麦血清型 14 抗体^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36203990	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 17F; S pneum Da 17F Ab; S pneum Da 17F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 17	4180186
36203990	S pneum Da 17F IgG Ser-mCnc	4180186
36203990	肺炎链球菌丹麦血清型 17F 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36203991	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 17F; S pneum Da 17F Ab; S pneum Da 17F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 17	4180186
36203991	S pneum Da 17F IgG Ser IA-mCnc	4180186
36203991	肺炎链球菌丹麦血清型 17F 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203992	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 17F; S pneum Da 17F Ab; S pneum Da 17F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 17	4180186
36203992	S pneum Da 17F IgG sp1 Ser-mCnc	4180186
36203992	肺炎链球菌丹麦血清型 17F 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36203993	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 17F; S pneum Da 17F Ab; S pneum Da 17F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 17	4180186
36203993	S pneum Da 17F IgG sp1 Ser IA-mCnc	4180186
36203993	肺炎链球菌丹麦血清型 17F 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203996	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 17F; S pneum Da 17F Ab; S pneum Da 17F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 17	4180186
36203996	S pneum Da 17F IgG 2:1 Ser-Rto	4180186
36203996	肺炎链球菌丹麦血清型 17F 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36203997	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 18F; S pneum Da 18F Ab; S pneum Da 18F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 18	4180186
36203997	S pneum Da 18F IgG Ser-mCnc	4180186
36203997	肺炎链球菌丹麦血清型 18F 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36203998	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 18F; S pneum Da 18F Ab; S pneum Da 18F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 18	4180186
36203998	S pneum Da 18F IgG Ser IA-mCnc	4180186
36203998	肺炎链球菌丹麦血清型 18F 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204006	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36204006	S pn Da sero 19F IgG sp1 Ser-mCnc	4180186
36204006	肺炎链球菌丹麦血清型 19F 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204009	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36204009	S pn Da sero 19F IgG sp2 Ser-mCnc	4180186
36204009	肺炎链球菌丹麦血清型 19F 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204011	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 19	4180186
36204011	S pn Da sero 19F IgG sp2 Ser IA-mCnc	4180186
36204011	肺炎链球菌丹麦血清型 19F 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204012	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 19	4180186
36204012	S pn Da sero 19F Ab sp2 Ser IA-aCnc	4180186
36204012	肺炎链球菌丹麦血清型 19F 抗体^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204016	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da 2; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 2	4180186
36204016	S pneum Da 2 IgG Ser-mCnc	4180186
36204016	肺炎链球菌丹麦血清型 2 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204017	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da 2; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 2	4180186
36204017	S pneum Da 2 IgG sp1 Ser IA-mCnc	4180186
36204017	肺炎链球菌丹麦血清型 2 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204018	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da 2; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 2	4180186
36204018	S pneum Da 2 IgG sp1 Ser-mCnc	4180186
36204018	肺炎链球菌丹麦血清型 2 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204019	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da 2; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 2	4180186
36204019	S pneum Da 2 IgG sp2 Ser IA-mCnc	4180186
36204019	肺炎链球菌丹麦血清型 2 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204020	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da 2; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 2	4180186
36204020	S pneum Da 2 IgG sp2 Ser-mCnc	4180186
36204020	肺炎链球菌丹麦血清型 2 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204021	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da 2; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 2	4180186
36204021	S pneum Da 2 IgG 2:1 Ser-Rto	4180186
36204021	肺炎链球菌丹麦血清型 2 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204022	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 20A; S pneum Da 20A Ab; S pneum Da 20A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 20	4180186
36204022	S pneum Da 20A IgG Ser-mCnc	4180186
36204022	肺炎链球菌丹麦血清型 20A 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204023	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 20A; S pneum Da 20A Ab; S pneum Da 20A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 20	4180186
36204023	S pneum Da 20A IgG Ser IA-mCnc	4180186
36204023	肺炎链球菌丹麦血清型 20A 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204024	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 20A; S pneum Da 20A Ab; S pneum Da 20A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 20	4180186
36204024	S pneum Da 20A IgG sp1 Ser-mCnc	4180186
36204024	肺炎链球菌丹麦血清型 20A 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204029	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 22F; S pneum Da 22F Ab; S pneum Da 22F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 22	4180186
36204029	S pneum Da 22F IgG Ser-mCnc	4180186
36204029	肺炎链球菌丹麦血清型 22F 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204033	Abd; Abdo; Abdomen+; Abdominal; After; c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Gall bladder; GB; Imaging; Playbook; Point in time; PST; Rad; Radiology; Random; View; VWS; W contr PO; W contr+Fatty Meal PO; WC	4180186
36204033	RF GB Views W contr+Fatty Meal PO	4180186
36204033	多重视图^采用口服对比剂+脂肪餐:发现:时间点:腹部>胆囊:文档型:放射荧光透视法	4182948
36204034	Abd; Abdo; Abdomen+; Abdominal; c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Gall bladder; GB; Imaging; Playbook; Point in time; Rad; Radiology; Random; View; VWS; W contr PO; WC	4180186
36204034	RF GB Views W contr PO	4180186
36204034	多重视图^采用口服对比剂:发现:时间点:腹部>胆囊:文档型:放射荧光透视法	4182948
36204036	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; CorePlaybook; Cystogram; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrology; Pelvic; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Ureter+Blad; View; VWS; W contr Ante; WC	4180186
36204036	RF Kid+Uret+Blad Views W contr Ante	4180186
36204036	多重视图^采用顺行性对比剂:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:放射荧光透视法	4182948
36204037	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; CorePlaybook; Cystogram; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrology; Pelvic; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Retro; Ureter+Blad; View; VWS; W contr Retro; WC	4180186
36204037	RF Kid+Uret+Blad Views W contr Retro	4180186
36204037	多重视图^采用逆行性对比剂:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:放射荧光透视法	4182948
36204039	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; CorePlaybook; Cystogram; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrology; Nephrostogram; NT; Pelvic; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Ureter+Blad; View; VWS; W contr via NT; WC	4180186
36204039	RF Kid+Uret+Blad Views W contr via NT	4180186
36204039	多重视图^采用经肾脏造瘘管给予对比剂:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:放射荧光透视法	4182948
36204044	CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Inj; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Shuntogm; Shuntogram; Spec; To be specified in another part of the message; Unspecified; View; Views+Non-vasc shunt inject guid; VWS	4180186
36204044	RF Views+Guided Non-vasc shunt inject	4180186
36204044	旨在注射非血管性分流的多重视图 & 引导:发现:时间点:XXX:文档型:放射荧光透视法	4182948
36204045	CorePlaybook; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; NDL; Needle place; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36204045	RF Guided Needle place	4180186
36204045	旨在置入针的引导:发现:时间点:XXX:文档型:放射荧光透视法	4182948
36204048	Cath; Cath place; CorePlaybook; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Gyn; Gynecology; Imaging; OB; ObGyn; Obstetrics; Pelvic; Plac of cath; Playbook; Point in time; Rad; Radiology; Random; Tub; Tube, unspecified	4180186
36204048	RF Guided Fallopian tube Cath place	4180186
36204048	旨在置入导管的引导:发现:时间点:盆腔>输卵管:文档型:放射荧光透视法	4182948
36204049	Asp; CorePlaybook; Document; Finding; Findings; Fld; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; PC fluid asp; Pelvic; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36204049	RF Guided Bladder PC fluid asp	4180186
36204049	旨在经皮穿刺抽吸的引导:发现:时间点:盆腔>膀胱:文档型:放射荧光透视法	4182948
36204052	CorePlaybook; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36204052	RF Guided Guide	4180186
36204052	引导:发现:时间点:XXX:文档型:放射荧光透视法	4182948
36204054	Ba; c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; Rectal; View; Views for rect dysf; VWS; W Ba PR	4180186
36204054	RF Rectum Views for rect dysf W Ba PR	4180186
36204054	针对直肠功能障碍的多重视图^采用经直肠给予钡对比剂:发现:时间点:盆腔>直肠:文档型:放射荧光透视法	4182948
36204057	c; Contr; Contra; Contrst; Document; EXT; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; INTRALYMPHATIC; LE; Leg; Low; Ped lymph ves; Point in time; Rad; Radiology; Random; RFA; Vesl; Vessels.XXX; View; VWS; W contr IL; WC	4180186
36204057	RFA Ped lymph ves Views W contr IL	4180186
36204057	多重视图^采用淋巴管内对比剂:发现:时间点:下肢>足背淋巴管类:文档型:放射荧光透视法.血管造影术	4182948
36204061	Bil; Bilat; Both; Breast-Bl; Breast-Bl and Breast specimen-Bl; Breasts; Brst; Brst spec; Brst spec-Bl; Brst-Bl; CorePlaybook; Document; Films; Finding; Findings; Guid; Guide; Guided; Imaging; Local; NDL; Needle loc + Views; Playbook; Point in time; Rad; Radiology; Random; Spec; View; VWS	4180186
36204061	MG Brst-Bl Needle loc + Brst spec View	4180186
36204061	旨在针定位的引导 && 多重视图:发现:时间点:乳腺.双侧 &&^乳腺标本.双侧:文档型:乳房X线摄影术	4182948
36204062	Arteriogram; Bil; Bilat; Both; Brain; c; Cereb; Cerebral aa; Cerebral aa-Bl; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Intracranial; Playbook; Point in time; Rad; Radiology; Random; RFA; Skull; View; VWS; W contr IA; WC	4180186
36204062	RFA Cerebral aa-Bl Views W contr IA	4180186
36204062	多重视图^采用动脉注射对比剂:发现:时间点:头部>脑动脉类.双侧:文档型:放射荧光透视法.血管造影术	4182948
36204064	Abd; Abdo; Abdomen+; Abdominal; Arteriogram; c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Playbook; Point in time; Rad; Radiology; Random; RFA; View; Visc aa; VWS; W contr IA; WC	4180186
36204064	RFA Visc aa Views W contr IA	4180186
36204064	多重视图^采用动脉注射对比剂:发现:时间点:腹部>内脏动脉类:文档型:放射荧光透视法.血管造影术	4182948
36204065	Abd; Abdo; Abdomen+; Abdominal; Ba; c; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; Imaging; Point in time; Rad; RADIOLOGY; Random; UGI; Up; View; VWS; W Air contr PO; W air PO+W Ba PO; W Ba PO	4180186
36204065	RF UGI Views W air PO+W Ba PO	4180186
36204065	多重视图^采用口服空气对比剂+采用口服钡对比剂:发现:时间点:腹部>胃肠道.上段:文档型:放射荧光透视法	4182948
36204066	1V; Abd; Abdo; Abdomen+; Abdominal; Ba; c; Contr; Contra; Contrst; CorePlaybook; Document; Film; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; Imaging; Plain Films; Playbook; Point in time; Rad; Radiology; Random; Single View; UGI; Up; View; View + Views; VW; VWS; W Air contr PO; W air PO+W Ba PO; W Ba PO; XR and Flr; Xray; X-ray	4180186
36204066	AXR and Flr UGI W air PO+W Ba PO	4180186
36204066	视图 && 多重视图^采用口服空气对比剂+采用口服钡对比剂:发现:时间点:腹部>胃肠道.上段:文档型:X射线摄影术 && 放射荧光透视法	4182948
36204067	1V; Abd; Abdo; Abdomen+; Abdominal; c; Contr; Contra; Contrst; CorePlaybook; Document; Film; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; Imaging; Plain Films; Playbook; Point in time; Rad; RADIOLOGY; Random; Single View; UGI; Up; View; View + Views; VW; VWS; W H2O soluble contr PO; XR and Flr; Xray; X-ray	4180186
36204067	AXR and Flr UGI W H2O soluble contr PO	4180186
36204067	视图 && 多重视图^采用口服水溶性对比剂:发现:时间点:腹部>胃肠道.上段:文档型:X射线摄影术 && 放射荧光透视法	4182948
36204068	1V; Abd; Abdo; Abdomen+; Abdominal; c; Contr; Contra; Contrst; Document; Film; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; Imaging; Plain Films; Point in time; Rad; RADIOLOGY; Random; Single View; UGI; Up; View; View + Views; VW; VWS; W contr PO; WC; XR and Flr; Xray; X-ray	4180186
36204068	AXR and Flr UGI W contr PO	4180186
36204068	视图 && 多重视图^采用口服对比剂:发现:时间点:腹部>胃肠道.上段:文档型:X射线摄影术 && 放射荧光透视法	4182948
36204071	Brain; c; Cardio; Cardiology; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Heart Disease; Imaging; Intracranial; Jugular v-Ul; Playbook; Point in time; Rad; RADIOLOGY; Random; RFA; Skull; Ven; Venogram; Venography; Venous; View; VWS; W contr IV; WC	4180186
36204071	RFA Jugular v-Ul Views W contr IV	4180186
36204071	多重视图^采用静脉注射对比剂:发现:时间点:头部+颈部>颈内静脉.单侧:文档型:放射荧光透视法.血管造影术	4182948
36204080	Bil; Bilat; Both; Brain; c; Cardio; Cardiology; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Heart Disease; Imaging; Intracranial; Jugular v-Bl; Playbook; Point in time; Rad; RADIOLOGY; Random; RFA; Skull; Vein-Bl; Ven; Venogram; Venography; Venous; View; VWS; W contr IV; WC	4180186
36204080	RFA Jugular v-Bl Views W contr IV	4180186
36204080	多重视图^采用静脉注射对比剂:发现:时间点:头部+颈部>颈内静脉.双侧:文档型:放射荧光透视法.血管造影术	4182948
36204081	c; Contr; Contra; Contrst; CorePlaybook; Document; Finding; Findings; Fistulogram; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Tx; Unspecified; W contr intra fist; WC	4180186
36204081	RF Guided Fistula Tx W contr int fist	4180186
36204081	旨在治疗的引导^采用瘘管内对比剂:发现:时间点:XXX>瘘管:文档型:放射荧光透视法	4182948
36204084	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 22F; S pneum Da 22F Ab; S pneum Da 22F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 22	4180186
36204084	S pneum Da 22F IgG sp1 Ser-mCnc	4180186
36204084	肺炎链球菌丹麦血清型 22F 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204085	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 22F; S pneum Da 22F Ab; S pneum Da 22F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 22	4180186
36204085	S pneum Da 22F IgG sp1 Ser IA-mCnc	4180186
36204085	肺炎链球菌丹麦血清型 22F 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204086	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 22F; S pneum Da 22F Ab; S pneum Da 22F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 22	4180186
36204086	S pneum Da 22F IgG sp2 Ser-mCnc	4180186
36204086	肺炎链球菌丹麦血清型 22F 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204091	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 23	4180186
36204091	S pneum Da 23F IgG Ser IA-mCnc	4180186
36204091	肺炎链球菌丹麦血清型 23F 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204093	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 23	4180186
36204093	S pneum Da 23F IgG Ser IA-aCnc	4180186
36204093	肺炎链球菌丹麦血清型 23F 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204099	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204099	S pneum Da 23F IgG sp2 Ser-aCnc	4180186
36204099	肺炎链球菌丹麦血清型 23F 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204100	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 23	4180186
36204100	S pneum Da 23F IgG sp2 Ser IA-mCnc	4180186
36204100	肺炎链球菌丹麦血清型 23F 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204102	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 23	4180186
36204102	S pneum Da 23F Ab sp1 Ser IA-aCnc	4180186
36204102	肺炎链球菌丹麦血清型 23F 抗体^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204103	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204103	S pneum Da 23F Ab sp1 Ser-aCnc	4180186
36204103	肺炎链球菌丹麦血清型 23F 抗体^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204104	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204104	S pneum Da 23F Ab sp1 Ser-mCnc	4180186
36204104	肺炎链球菌丹麦血清型 23F 抗体^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204106	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204106	S pneum Da 23F Ab sp2 Ser-aCnc	4180186
36204106	肺炎链球菌丹麦血清型 23F 抗体^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204107	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204107	S pneum Da 23F Ab sp2 Ser-mCnc	4180186
36204107	肺炎链球菌丹麦血清型 23F 抗体^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204108	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; III; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204108	S pneum Da 3 Ab Ser-mCnc	4180186
36204108	肺炎链球菌丹麦血清型 3 抗体:质量浓度:时间点:血清:定量型	4182948
36204109	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; III; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204109	S pneum Da 3 Ab Ser-aCnc	4180186
36204109	肺炎链球菌丹麦血清型 3 抗体:任意型浓度:时间点:血清:定量型	4182948
36204111	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da 3 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 3	4180186
36204111	S pneum Da 3 IgG Ser IA-mCnc	4180186
36204111	肺炎链球菌丹麦血清型 3 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204112	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da 3 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204112	S pneum Da 3 IgG Ser-aCnc	4180186
36204112	肺炎链球菌丹麦血清型 3 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
36204114	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da 3 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 3	4180186
36204114	S pneum Da 3 IgG sp1 Ser IA-mCnc	4180186
36204114	肺炎链球菌丹麦血清型 3 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204119	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da 3 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204119	S pneum Da 3 IgG sp2 Ser-aCnc	4180186
36204119	肺炎链球菌丹麦血清型 3 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204121	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; III; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204121	S pneum Da 3 Ab sp1 Ser-mCnc	4180186
36204121	肺炎链球菌丹麦血清型 3 抗体^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204122	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; III; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 3	4180186
36204122	S pneum Da 3 Ab sp1 Ser IA-aCnc	4180186
36204122	肺炎链球菌丹麦血清型 3 抗体^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204127	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; III; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 3; S pneum Da 3 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204127	S pneum Da 3 Ab 2:1 Ser-Rto	4180186
36204127	肺炎链球菌丹麦血清型 3 抗体^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204129	c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Pelvic; Playbook; Point in time; Rad; Radiology; Random; Sem vesicle; View; VWS; W contr intra sem ves; WC	4180186
36204129	RF Sem vesicle Vs W contr intra sem ves	4180186
36204129	多重视图^采用精囊内对比剂:发现:时间点:盆腔>精囊:文档型:放射荧光透视法	4182948
36204130	Abd; Abd+Pelvis; Abdo; Abdominal; CorePlaybook; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrology; Pelvic; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Ureter+Blad; Whitaker	4180186
36204130	RF Guided Kid+Uret+Blad Manometry	4180186
36204130	旨在压力测量的引导:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:放射荧光透视法	4182948
36204131	Art; Arteriogram; Brain; c; Cardio; Cardiology; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Heart Disease; Imaging; Intracranial; Playbook; Point in time; Rad; RADIOLOGY; Random; RFA; Skull; VA; Vertebral a-Ul; View; VWS; W contr IA; WC	4180186
36204131	RFA Vertebral a-Ul Views W contr IA	4180186
36204131	多重视图^采用动脉注射对比剂:发现:时间点:头部+颈部>椎动脉.单侧:文档型:放射荧光透视法.血管造影术	4182948
36204132	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; View; VWS; W contr intra ureter; WC	4180186
36204132	RF Ureter Views W contr intra ureter	4180186
36204132	多重视图^采用输尿管内对比剂:发现:时间点:腹部+盆腔>输尿管:文档型:放射荧光透视法	4182948
36204133	DOCUMENT.REGULATORY; FDA label; Manufacturing estab infor; Narrative; Report	4180186
36204133	FDA label Manufacturing estab infor	4180186
36204133	制造企业信息:-:-:^FDA 产品标签:叙述型	4182948
36204136	Cell Tiss Est Reg; Cell Tiss Est Reg info change; DOCUMENT.REGULATORY; Exchange; FDA label; Narrative; Replace; Report	4180186
36204136	FDA label Cell Tiss Est Reg info change	4180186
36204136	人类细胞与组织制品企业注册与产品列名信息变更:-:-:^FDA 产品标签:叙述型	4182948
36204141	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36204141	记录:发现:时间点:{环境}:文档型:伦理学	4182948
36204147	Brucella Ab Titr Ser Rivanol aggl	4180186
36204147	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bruc; Brucellosis; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Rivanol aggl; Serum; SmQn; species; spp; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36204147	布鲁氏菌属单个未知种 抗体:滴定度:时间点:血清:定量型:凝集试验法.Rivanol	4182948
36204153	Ab Ao; Abd; Abd Aorta; Abdo; Abdomen; Abdomen+; Abdominal; Aneur or diss repair; Aneurysm repair; AO; Aortic; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Infrarenal aorta; Point in time; Rad; Radiology; Random; RFA; TEVAR; Thoracic endovascular aortic repair	4180186
36204153	RFA Guided Infrarenal AA or dissect rep	4180186
36204153	旨在修复动脉瘤或夹层的引导:发现:时间点:腹部>主动脉.腹腔段.肾下:文档型:放射荧光透视法.血管造影术	4182948
36204154	APRI Ser+Bld Calc-Rto	4180186
36204154	APRI; Blood; Both serum and blood; Calc; Calculation; Chemistry; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SerBld; Serum; Serum or whole blood; SR; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
36204154	天冬氨酸氨基转移酶与血小板比值指数:比率:时间点:血清+全血:定量型:计算法	4182948
36204158	14 days; 2 weeks; climb wo stop HF limited past 2W; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204163	14 days; 2 weeks; Fatigue limited ability past 2W; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204166	14 days; 2 weeks; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; SOB past 2W; Survey; SURVEY.GNHLTH	4180186
36204168	Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Know what to do or who to call if HF gets worse; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36204169	Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Sx; Understand how to keep HF symptoms from get worse	4180186
36204173	14 days; 2 weeks; Finding; Findings; HF limited hobbies rec past 2W; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204174	14 days; 2 weeks; Finding; Findings; HF limited work chores past 2W; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204175	14 days; 2 weeks; Finding; Findings; HF limited visiting past 2W; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204179	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 10A; S pneum Da 10A Ab; S pneum Da 10A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 34	4180186
36204179	S pneum Da 10A IgG Ser IA-mCnc	4180186
36204179	肺炎链球菌丹麦血清型 10A 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204180	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 10A; S pneum Da 10A Ab; S pneum Da 10A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 34	4180186
36204180	S pneum Da 10A IgG sp1 Ser-mCnc	4180186
36204180	肺炎链球菌丹麦血清型 10A 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204181	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 10A; S pneum Da 10A Ab; S pneum Da 10A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 34	4180186
36204181	S pneum Da 10A IgG sp1 Ser IA-mCnc	4180186
36204181	肺炎链球菌丹麦血清型 10A 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204182	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 10A; S pneum Da 10A Ab; S pneum Da 10A IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 34	4180186
36204182	S pneum Da 10A IgG sp2 Ser-mCnc	4180186
36204182	肺炎链球菌丹麦血清型 10A 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204183	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 10A; S pneum Da 10A Ab; S pneum Da 10A IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 34	4180186
36204183	S pneum Da 10A IgG sp2 Ser IA-mCnc	4180186
36204183	肺炎链球菌丹麦血清型 10A 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204184	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 10A; S pneum Da 10A Ab; S pneum Da 10A IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 34	4180186
36204184	S pneum Da 10A IgG 2:1 Ser-Rto	4180186
36204184	肺炎链球菌丹麦血清型 10A 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204187	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da 4 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204187	S pneum Da 4 IgG Ser-mCnc	4180186
36204187	肺炎链球菌丹麦血清型 4 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204188	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da 4 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 4	4180186
36204188	S pneum Da 4 IgG Ser IA-mCnc	4180186
36204188	肺炎链球菌丹麦血清型 4 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204190	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da 4 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 4	4180186
36204190	S pneum Da 4 IgG Ser IA-aCnc	4180186
36204190	肺炎链球菌丹麦血清型 4 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204191	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da 4 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 4	4180186
36204191	S pneum Da 4 IgG sp1 Ser IA-mCnc	4180186
36204191	肺炎链球菌丹麦血清型 4 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204192	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da 4 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204192	S pneum Da 4 IgG sp1 Ser-mCnc	4180186
36204192	肺炎链球菌丹麦血清型 4 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204194	Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; GCMS; Illicit; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Synthetic opioid; WB; Whole blood	4180186
36204194	Acetyl norfentanyl SerPlBld Cfm-mCnc	4180186
36204194	乙酰基去甲基芬太尼:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
36204195	Alpraz/Creat Ur Cfm	4180186
36204195	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Niravam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Xanax	4180186
36204195	阿普唑仑/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36204197	Addiction; Blood; c260; C300; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Methylmorphine; Morphine methyl ether; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
36204197	Codeine SerPlBld Cfm-mCnc	4180186
36204197	可待因:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
36204198	Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DF-118; DHC; DHCPlus; Drocode; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
36204198	DHC SerPlBld Cfm-mCnc	4180186
36204198	二氢可待因:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
36204199	Ethyl sulfate Sal Ql	4180186
36204199	DRUG/TOXICOLOGY; Drugs; Ethanol metabolite; ethyl hydrogen sulfate; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Screen; SO4; SO4-2; Sulf; Sulfovinate; Sulfovinic acid	4180186
36204199	硫酸乙酯:存在情况或阈值:时间点:唾液:序数型	4182948
36204200	Brst; Brst-R; CorePlaybook; Document; Dx; Dx for clin call back; Films; Finding; Findings; Imaging; Playbook; Point in time; R; Rad; RADIOLOGY; Random; RT; Symptomatic; View; VWS	4180186
36204200	MG Brst-R Dx for clin call back	4180186
36204200	针对临床性唤回的诊断性多重视图:发现:时间点:乳腺.右侧:文档型:乳房X线摄影术	4182948
36204201	Brst; CorePlaybook; Document; Dx; Dx for tech call back; Films; Finding; Findings; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Symptomatic; View; VWS	4180186
36204201	MG Brst Dx for tech call back	4180186
36204201	针对技术性唤回的诊断性多重视图:发现:时间点:乳腺:文档型:乳房X线摄影术	4182948
36204205	Bil; Bilat; Both; c; Contr; Contra; Contrst; CorePlaybook; Document; EXT; Extr-Bl; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; INTRALYMPHATIC; LE; LE-Bl; Leg; Low; Ped lymph ves-Bl; Playbook; Point in time; Rad; RADIOLOGY; Random; RFA; Vesl; Vessels.XXX; View; VWS; W contr IL; WC	4180186
36204205	RFA Ped lymph ves-Bl Views W contr IL	4180186
36204205	多重视图^采用淋巴管内对比剂:发现:时间点:下肢.双侧>足背淋巴管类:文档型:放射荧光透视法.血管造影术	4182948
36204206	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Shingles; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Typ; Unspecified; VZ; VZV; VZV strain; VZV strain DNA; Zoster	4180186
36204206	VZV strain DNA Spec NAA+probe	4180186
36204206	水痘带状疱疹病毒毒株 DNA:类型:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
36204207	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; S pneum serotype; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36204207	Deprecated S pneum serotype DNA XXX NAA+probe	4180186
36204210	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; CMV; Cytomegalo virus; Cytomgal; DFA; FA; Fluorescent antibody; Fluoresent; HHV-5; Human Herpesvirus-5; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF	4180186
36204210	CMV Ag Tiss Ql IF	4180186
36204210	巨细胞病毒 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫荧光法	4182948
36204211	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; EBO; EBOV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204211	EBOV RNA Bld Ql NAA+probe	4180186
36204211	埃博拉病毒 RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36204212	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Enc; Enceph; Encephalomyelitis; FSME; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Serum; SR; Strand Displacement Amplification; TBEV; TBEV RNA; TMA; Transcription mediated amplification	4180186
36204212	TBEV RNA Ser Ql NAA+probe	4180186
36204212	欧洲蜱传脑炎病毒 RNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
36204214	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36204214	blaOXA-51-like Islt/Spm Ql	4180186
36204214	细菌碳青霉烯类耐药 blaOXA-51-样基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36204215	A pleuropn Ab Titr Ser CF	4180186
36204215	胸膜肺炎放线杆菌 抗体:滴定度:时间点:血清:定量型:补体结合试验	4182948
36204215	A pleuropn; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Contagious swine pleuropneumonia; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36204216	3 Self-Sustaining Sequence Replication; 3SR SR; A pleuropn; A pleuropneumoniae; Actino; Amplif; Amplification; Amplified; Contagious swine pleuropneumonia; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vet; Veterinary	4180186
36204216	A pleuropn DNA Ct Islt Qn NAA+probe	4180186
36204216	胸膜肺炎放线杆菌 DNA:阈值循环圈数:时间点:分离株:定量型:探针法.基因扩增.靶向	4182948
36204217	A pleuropn 1 Ab Titr Ser CF	4180186
36204217	胸膜肺炎放线杆菌血清型 1 抗体:滴定度:时间点:血清:定量型:补体结合试验	4182948
36204217	A pleuropn; A pleuropn 1; A pleuropn Sertyp; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Contagious swine pleuropneumonia; Dilution factor; Dilution Factor (Titer); i; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36204218	A pleuropn 3 Ab Titr Ser CF	4180186
36204218	胸膜肺炎放线杆菌血清型 3 抗体:滴定度:时间点:血清:定量型:补体结合试验	4182948
36204218	A pleuropn; A pleuropn 3; A pleuropn Sertyp; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Contagious swine pleuropneumonia; Dilution factor; Dilution Factor (Titer); ID; III; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36204222	Admission notifctn note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36204222	入院通知记录:发现:时间点:{环境}:文档型:{角色}	4182948
36204223	DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
36204223	生前意愿:发现:时间点:{环境}:文档型:患者	4182948
36204224	Disease staging	4180186
36204224	Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36204224	疾病分期记录:发现:时间点:{环境}:文档型:{角色}	4182948
36204225	Assoc; Congenital dyserythropoietic anaemia; HAI; HAI report; HAI report CDA R3 set; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
36204225	HAI report CDA R3 set	4180186
36204225	医疗保健相关感染报告 - 推荐 CDA R3 集合:-:时间点:{环境}:-	4182948
36204226	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; Orthohantavirus; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SNV; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36204226	Hantavirus RNA CSF Ql NAA+probe	4180186
36204226	汉坦病毒 RNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36204227	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Orthohantavirus; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SNV; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204227	Hantavirus RNA Tiss Ql NAA+probe	4180186
36204227	汉坦病毒 RNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204228	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Orthohantavirus; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SNV; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
36204228	Hantavirus RNA Ur Ql NAA+probe	4180186
36204228	汉坦病毒 RNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
36204229	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204229	HSV1 DNA Tiss Ql NAA+probe	4180186
36204229	单纯疱疹病毒 1 型 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204230	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF	4180186
36204230	HSV2 Ag Tiss Ql IF	4180186
36204230	单纯疱疹病毒 2 型 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫荧光法	4182948
36204232	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204232	HSV DNA Tiss Ql NAA+probe	4180186
36204232	单纯疱疹病毒 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204233	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BM; BON; Bone marrow; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV6; HHV-6; Human herpes virus; Human herpes virus type 6; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36204233	HHV6 DNA Mar Ql NAA+probe	4180186
36204233	疱疹病毒 6 型 DNA:存在情况或阈值:时间点:骨髓:序数型:探针法.基因扩增.靶向	4182948
36204237	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; AIDS; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 2; HIV type II; Human immunodeficiency virus; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36204237	HIV 2 RNA # CSF NAA+probe	4180186
36204237	HIV 2 RNA:计数型浓度:时间点:脑脊液:定量型:探针法.基因扩增.靶向	4182948
36204239	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 2; HIV type II; Human immunodeficiency virus; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36204239	HIV 2 RNA CSF NAA+probe-Log#	4180186
36204239	HIV 2 RNA:对数型数量或计数浓度:时间点:脑脊液:定量型:探针法.基因扩增.靶向	4182948
36204241	Nominal; Point in time; Random; Typ	4180186
36204241	流行性感冒疫苗周期:类型:时间点:疫苗:名义型	4182948
36204245	Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Report period; Staff med contraindication to flu vacc; Survey; SURVEY.CDC; World Heatlth Organization	4180186
36204248	DOC.MISC; Document; Finding; Findings; HC-FLU summary; HP-FLU summary report; Immunizations; MISC; NHCS; Report period; Vaccine	4180186
36204248	HCP flu vaccine report Doc	4180186
36204248	医疗保健服务人员流行性感冒疫苗接种摘要报告:发现:报告期:{环境}^人群:文档型	4182948
36204249	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HBoV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204249	HBoV DNA Tiss Ql NAA+probe	4180186
36204249	人博卡病毒 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204252	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV18; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204252	HPV18 DNA Tiss Ql NAA+probe	4180186
36204252	人乳头瘤病毒 18 型 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204253	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV H Risk 12 DNA; HPV HR 12; HPV31; HPV31+33; HPV31+33+35; Human papilloma virus; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Papilloma virus high risk; Papilloma virus intermediate/high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204253	HPV HR 12 DNA Tiss Ql NAA+probe	4180186
36204253	人乳头瘤病毒 31+33+35+39+45+51+52+56+58+59+66+68 型 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204256	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
36204256	FLUAV IgG Ser Ql IA	4180186
36204256	流感病毒 A 型 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36204258	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36204258	FLUAV RNA CSF Ql NAA+probe	4180186
36204258	流感病毒 A 型 RNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36204262	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204262	FLUBV RNA Tiss Ql NAA+probe	4180186
36204262	流感病毒 B 型 RNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204265	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MeV; Microbiology; Msls; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Rubeola; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36204265	MeV RNA CSF Ql NAA+probe	4180186
36204265	麻疹病毒 RNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36204267	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MeV; Microbiology; Msls; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Rubeola; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
36204267	MeV RNA Ur Ql NAA+probe	4180186
36204267	麻疹病毒 RNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
36204268	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Camel flu; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV-EMC/2012; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MERS-CoV; MERS-CoV RNA; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204268	MERS-CoV RNA Bld Ql NAA+probe	4180186
36204268	中东呼吸综合征冠状病毒 RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36204270	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da 4 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 4	4180186
36204270	S pneum Da 4 IgG sp2 Ser IA-mCnc	4180186
36204270	肺炎链球菌丹麦血清型 4 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204272	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da 4 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204272	S pneum Da 4 IgG sp2 Ser-aCnc	4180186
36204272	肺炎链球菌丹麦血清型 4 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204276	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204276	S pneum Da 4 Ab sp2 Ser-mCnc	4180186
36204276	肺炎链球菌丹麦血清型 4 抗体^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204277	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204277	S pneum Da 4 Ab sp2 Ser-aCnc	4180186
36204277	肺炎链球菌丹麦血清型 4 抗体^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204282	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 11A; S pneum Da 11A Ab; S pneum Da 11A IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 43	4180186
36204282	S pneum Da 11A IgG sp2 Ser-mCnc	4180186
36204282	肺炎链球菌丹麦血清型 11A 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204283	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 11A; S pneum Da 11A Ab; S pneum Da 11A IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 43	4180186
36204283	S pneum Da 11A IgG sp2 Ser IA-mCnc	4180186
36204283	肺炎链球菌丹麦血清型 11A 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204284	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 11A; S pneum Da 11A Ab; S pneum Da 11A IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 43	4180186
36204284	S pneum Da 11A IgG 2:1 Ser-Rto	4180186
36204284	肺炎链球菌丹麦血清型 11A 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204285	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 5; S pneum Da 5 Ab; S pneum Da 5 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 5	4180186
36204285	S pneum Da 5 IgG Ser IA-mCnc	4180186
36204285	肺炎链球菌丹麦血清型 5 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204287	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 5; S pneum Da 5 Ab; S pneum Da 5 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 5	4180186
36204287	S pneum Da 5 IgG sp1 Ser IA-mCnc	4180186
36204287	肺炎链球菌丹麦血清型 5 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204289	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 5; S pneum Da 5 Ab; S pneum Da 5 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 5	4180186
36204289	S pneum Da 5 IgG sp2 Ser IA-mCnc	4180186
36204289	肺炎链球菌丹麦血清型 5 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204291	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 5; S pneum Da 5 Ab; S pneum Da 5 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 5	4180186
36204291	S pneum Da 5 IgG 2:1 Ser-Rto	4180186
36204291	肺炎链球菌丹麦血清型 5 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204292	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6A; S pneum Da 6A Ab; S pneum Da 6A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 6	4180186
36204292	S pneum Da 6A IgG Ser-mCnc	4180186
36204292	肺炎链球菌丹麦血清型 6A 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204293	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6A; S pneum Da 6A Ab; S pneum Da 6A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 6	4180186
36204293	S pneum Da 6A IgG Ser-aCnc	4180186
36204293	肺炎链球菌丹麦血清型 6A 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
36204295	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6A; S pneum Da 6A Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 6	4180186
36204295	S pneum Da 6A Ab sp2 Ser-aCnc	4180186
36204295	肺炎链球菌丹麦血清型 6A 抗体^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204296	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6A; S pneum Da 6A Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 6	4180186
36204296	S pneum Da 6A Ab sp2 Ser-mCnc	4180186
36204296	肺炎链球菌丹麦血清型 6A 抗体^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204297	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 7A; S pneum Da 7A Ab; S pneum Da 7A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 7	4180186
36204297	S pneum Da 7A IgG Ser-aCnc	4180186
36204297	肺炎链球菌丹麦血清型 7A 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
36204299	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; PR; QL; Qual; Qualitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da type; S pneumo; S pneumoniae; Screen; Serum; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204299	S pneum Da 8 Ab Ser Ql	4180186
36204299	肺炎链球菌丹麦血清型 8 抗体:存在情况或阈值:时间点:血清:序数型	4182948
36204300	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; PR; QL; Qual; Qualitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da type; S pneumo; S pneumoniae; Screen; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 8	4180186
36204300	S pneum Da 8 Ab Ser Ql IA	4180186
36204300	肺炎链球菌丹麦血清型 8 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36204305	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; HPeV A RNA; Human Parecho virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Ljungan virus; LV; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; PeV; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36204305	Parechovirus A RNA CSF Ql NAA+probe	4180186
36204305	副肠孤病毒 A RNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36204306	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyssavirus; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Screen; Serum; SR; SUDS	4180186
36204306	RABV IgG Ser Ql IA	4180186
36204306	狂犬病病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36204308	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Congenital rubella syndrome; DNA NUCLEIC ACID PROBE; DNA probe; German measles; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; RUBV; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
36204308	RUBV RNA Ur Ql NAA+probe	4180186
36204308	风疹病毒 RNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
36204309	Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Spn; Strep; Strept; SUDS	4180186
36204309	S pneum Ag CSF Ql IA.rapid	4180186
36204309	肺炎链球菌 抗原:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法.快速	4182948
36204313	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; ZIKV; ZIKV RNA	4180186
36204313	ZIKV RNA CSF Ql NAA+probe	4180186
36204313	寨卡病毒 RNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36204315	Perio attach CDA R1 set	4180186
36204315	Congenital dyserythropoietic anaemia; Pan; Panel; PANEL.DOC; Panl; Perio attach CDA R1 set; Pnl; Point in time; Random	4180186
36204315	牙周病学附件 - 推荐 CDA R1 集合:-:时间点:{环境}:-	4182948
36204317	1-hydroxytriazolam; Addiction; Alfa; Alpha hydroxy triazolam; A-OH-triazolam; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydroxy triazolam; Illicit; Mass concentration ratio; Mass ratio; MCRto; OH-Triazolam; OHTRZ; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Triazolam metabolite; UA; UCr; UR; Urn	4180186
36204317	A-OH-triazolam/Creat Ur Cfm	4180186
36204317	Alpha 羟基三唑仑/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36204318	Addiction; Cfm; CNFR; CNFRM; Cocaine/Ethanol By-Product; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Mass concentration ratio; Mass ratio; MCRto; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36204318	Cocaethylene/Creat Ur Cfm	4180186
36204318	古柯乙烯/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36204319	Addiction; Benzoylmethylecgonine; Cfm; CNFR; CNFRM; Coke; Conf; Confirmation; Confirmatory; CR; Crack; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; GCMS; Illicit; Mass concentration ratio; Mass ratio; MCRto; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Snow; UA; UCr; UR; Urn	4180186
36204319	Cocaine/Creat Ur Cfm	4180186
36204319	可卡因/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36204320	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Mass concentration ratio; Mass ratio; MCRto; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36204320	Norcodeine/Creat Ur Cfm	4180186
36204320	去甲可待因/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36204321	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Mass concentration ratio; Mass ratio; MCRto; Oxycodone metabolite; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36204321	Noroxymorphone/Creat Ur Cfm	4180186
36204321	去甲基羟吗啡酮/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36204327	1 week; FCN; Func; Funct; Knee injury and Osteoarthritis Outcome Score for Joint Replacement; KOOS JR; KOOS, JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
36204328	1 week; HOOS JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
36204330	Family planning report Doc	4180186
36204330	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36204330	计划生育报告:发现:时间点:{环境}:文档型:{角色}	4182948
36204331	Pan; Panel; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS	4180186
36204332	ADMIN; Nominal; Point in time; Random; Typ	4180186
36204332	医疗服务人员角色:类型:时间点:服务提供者:名义型	4182948
36204334	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Cnt; Count; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36204334	Household size	4180186
36204334	家庭人数:数量(计数):时间点:^患者:定量型	4182948
36204335	Finding; Findings; H+P; H+P.HX; LMTED; LTD; Ltd Eng prof; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36204335	Ltd Eng prof	4180186
36204335	英语熟练程度有限:发现:时间点:^患者:序数型	4182948
36204336	BP; BP Pnl; Family Planning Annual Report; Hgt, Wgt + BP Pnl; Pan; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS; Wt	4180186
36204341	Ever had sex Lifetime Ql Reported	4180186
36204341	Finding; Findings; Gender; H+P; H+P.HX; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
36204341	是否曾经发生过性行为:发现:一生:^患者:序数型:报告法	4182948
36204345	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36204345	Contraceptive counseling	4180186
36204345	当时提供了避孕建议:发现:时间点:^患者:序数型	4182948
36204346	Counseling achieve pregnancy	4180186
36204346	Counseling achieve pregnancy; Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Ordinal; P prime; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen	4180186
36204346	当时提供了旨在实现妊娠的建议:发现:时间点:^患者:序数型	4182948
36204348	AIDS; HIV 1 and 2 FPAR 2.0 set; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; II; Pan; Panel; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS	4180186
36204349	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204349	S pneum Da 8 Ab Ser-aCnc	4180186
36204349	肺炎链球菌丹麦血清型 8 抗体:任意型浓度:时间点:血清:定量型	4182948
36204351	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da 8 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204351	S pneum Da 8 IgG Ser-mCnc	4180186
36204351	肺炎链球菌丹麦血清型 8 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204353	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da 8 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204353	S pneum Da 8 IgG Ser-aCnc	4180186
36204353	肺炎链球菌丹麦血清型 8 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
36204355	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da 8 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 8	4180186
36204355	S pneum Da 8 IgG sp1 Ser IA-mCnc	4180186
36204355	肺炎链球菌丹麦血清型 8 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204356	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da 8 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204356	S pneum Da 8 IgG sp1 Ser-mCnc	4180186
36204356	肺炎链球菌丹麦血清型 8 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204357	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da 8 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204357	S pneum Da 8 IgG sp1 Ser-aCnc	4180186
36204357	肺炎链球菌丹麦血清型 8 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204361	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 8; S pneum Da 8 Ab; S pneum Da 8 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204361	S pneum Da 8 IgG 2:1 Ser-Rto	4180186
36204361	肺炎链球菌丹麦血清型 8 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204362	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204362	S pneum Da 8 Ab sp1 Ser-mCnc	4180186
36204362	肺炎链球菌丹麦血清型 8 抗体^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204363	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204363	S pneum Da 8 Ab sp1 Ser-aCnc	4180186
36204363	肺炎链球菌丹麦血清型 8 抗体^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204365	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204365	S pneum Da 8 Ab sp2 Ser-aCnc	4180186
36204365	肺炎链球菌丹麦血清型 8 抗体^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204366	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; PR; QL; Qual; Qualitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Screen; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 9	4180186
36204366	S pneum Da 9N Ab Ser Ql IA	4180186
36204366	肺炎链球菌丹麦血清型 9N 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36204370	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da 9N IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 9	4180186
36204370	S pneum Da 9N IgG Ser IA-mCnc	4180186
36204370	肺炎链球菌丹麦血清型 9N 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204371	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da 9N IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204371	S pneum Da 9N IgG Ser-aCnc	4180186
36204371	肺炎链球菌丹麦血清型 9N 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
36204373	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da 9N IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204373	S pneum Da 9N IgG Ser-mCnc	4180186
36204373	肺炎链球菌丹麦血清型 9N 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204374	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da 9N IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204374	S pneum Da 9N IgG sp1 Ser-mCnc	4180186
36204374	肺炎链球菌丹麦血清型 9N 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204375	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da 9N IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204375	S pneum Da 9N IgG sp1 Ser-aCnc	4180186
36204375	肺炎链球菌丹麦血清型 9N 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204378	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da 9N IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204378	S pneum Da 9N IgG sp2 Ser-aCnc	4180186
36204378	肺炎链球菌丹麦血清型 9N 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204379	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da 9N IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 9	4180186
36204379	S pneum Da 9N IgG sp2 Ser IA-mCnc	4180186
36204379	肺炎链球菌丹麦血清型 9N 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204380	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da 9N IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204380	S pneum Da 9N IgG 2:1 Ser-Rto	4180186
36204380	肺炎链球菌丹麦血清型 9N 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204382	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204382	S pneum Da 9N Ab sp1 Ser-aCnc	4180186
36204382	肺炎链球菌丹麦血清型 9N 抗体^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204383	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204383	S pneum Da 9N Ab sp1 Ser-mCnc	4180186
36204383	肺炎链球菌丹麦血清型 9N 抗体^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204386	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 9	4180186
36204386	S pneum Da 9N Ab sp2 Ser IA-aCnc	4180186
36204386	肺炎链球菌丹麦血清型 9N 抗体^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204387	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204387	S pneum Da 9N Ab sp2 Ser-aCnc	4180186
36204387	肺炎链球菌丹麦血清型 9N 抗体^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204389	H+P; H+P.HX; History; Job; Nominal; P prime; Point in time; Random; Work	4180186
36204389	Hx of Occupation industry	4180186
36204389	就职行业:历史记录:时间点:^患者:名义型	4182948
36204392	4-MEC; Addiction; Cathinone; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36204392	4-MEC Ur Cfm-mCnc	4180186
36204392	4-甲基乙卡西酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
36204394	3,4-DMMC; Addiction; Cathinone; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dimethylmethcathinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; III; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36204394	3,4-DMMC Ur Cfm-mCnc	4180186
36204394	3,4-二甲基甲卡西酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
36204397	Chlam; Chlamid; Chlamydia sp FPAR 2.0 set; Pan; Panel; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; species; spp; Survey; SURVEY.HHS	4180186
36204399	C trac; C trach; C trach+GC; C trach+GC FPAR 2.0 set; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT/GC; GC; Gono; Gonorrhea; Gonorrhea FPAR 2.0 set; LGV; Lymphogranuloma venereum; N gonorrhoea; N gonorrhoeae; Pan; Panel; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS; Trachoma	4180186
36204400	Pan; Panel; PANEL.SURVEY.HHS; Panl; Pap smear tests FPAR 2.0; Pnl; Point in time; Random; smears; Survey; SURVEY.HHS	4180186
36204401	AIDS; Family Planning Annual Report; HIV referral Pnl; Human immunodeficiency virus; Pan; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS	4180186
36204402	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36204402	转诊记录:发现:时间点:{环境}:文档型:HIV 医疗服务	4182948
36204404	Tumor invasion level Mel Ql Clark	4180186
36204404	Dermatologic; Epidermis; Finding; Findings; Integument; Levels; Levl; LV; LVL; Ordinal; PATH.HISTO; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Screen; Skn; Tumor invasion level	4180186
36204404	肿瘤侵袭程度:发现:时间点:皮肤黑色素瘤:序数型:Clark 分级法	4182948
36204405	Depth deep marg inv IM Mel Micro	4180186
36204405	Depth deep marg inv IM; Dermatologic; Dpth; Epidermis; Integument; Length; LM; Micro; Micros; Microscopic; PATH.HISTO; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Skn	4180186
36204405	侵袭性黑素瘤所累及深部边缘的深度:长度:时间点:皮肤黑色素瘤:定量型:显微镜检查.光学	4182948
36204406	#/area; CA; Ca spec; LM; Micro; Micros; Microscopic; Mitoses; Number areic; PATH.HISTO; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36204406	Mitotic figures #/area Ca spec Micro	4180186
36204406	有丝分裂象:单位面积数量或计数:时间点:癌标本:定量型:显微镜检查.光学	4182948
36204407	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVC; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
36204407	RVC Spec Ql Cult	4180186
36204407	轮状病毒 C:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36204408	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVA; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
36204408	RVA Spec Ql Cult	4180186
36204408	轮状病毒 A 组:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36204414	Arm; BMD; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; EXT; Films; Imaging; Point in time; QNT; Quan; Quant; Quantitative; Rad; RADIOLOGY; Random; Standard score; UE; Up; Upper arm; Upper extremity; View; Views for BMD; VWS; Z score; Z value; Z-score	4180186
36204414	DXA Humerus Z-score BMD	4180186
36204414	针对骨密度的多重视图:Z评分:时间点:上肢>肱骨:定量型:双能X线吸收法	4182948
36204415	Arm; BMD; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; EXT; Extr-R; Films; Humerus-R; Imaging; Point in time; QNT; Quan; Quant; Quantitative; R; Rad; RADIOLOGY; Random; RT; RUE; Standard score; UE; UE-R; Up; Upper extremity; View; Views for BMD; VWS; Z score; Z value; Z-score	4180186
36204415	DXA Humerus-R Z-score BMD	4180186
36204415	针对骨密度的多重视图:Z评分:时间点:上肢.右侧>肱骨:定量型:双能X线吸收法	4182948
36204417	Abd; Abdo; Abdomen+; Abdominal; BMD; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; Films; Imaging; L/sp; L-spine; Lumbar; Lumbo; Point in time; QNT; Quan; Quant; Quantitative; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Standard score; View; Views for BMD; VWS; Z score; Z value; Z-score	4180186
36204417	DXA L-spine Z-score BMD	4180186
36204417	针对骨密度的多重视图:Z评分:时间点:腹部>脊椎.腰段:定量型:双能X线吸收法	4182948
36204418	Age and setting verified; Exp; Exposure; Exposure setting; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
36204421	Cnt; Count; Deliveries in US; Mat; Maternal; Matnl; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Survey; SURVEY.CDC	4180186
36204422	H+P; H+P.HX; Mat; Maternal; Matnl; P prime; Point in time; Prev; QNT; Quan; Quant; Quantitative; Random; S prime; Year of prev delivery in U.S.	4180186
36204422	Year of prev delivery in U.S. Mother	4180186
36204422	上次在美国国内分娩时的年份:日期:时间点:^母亲:定量型	4182948
36204424	血液病原体类组套:-:时间点:血液.生长阳性:-:非探针法.基因扩增.靶向	4182948
36204424	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Blood path Pnl; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204424	Blood path Pnl Bld Pos NAA+non-probe	4180186
36204425	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; L monocytog; L monocytogenes; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Listeriosis; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204425	L monocytog DNA Bld Pos Ql NAA+non-probe	4180186
36204425	单核细胞增生李斯特菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36204426	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Staph; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204426	S aureus+CoNS DNA Bld Pos NAA+non-probe	4180186
36204426	葡萄球菌单个未知种 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36204429	Wmns hlth Phone Note	4180186
36204429	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; Wmns hlth	4180186
36204429	记录:发现:时间点:电话就医:文档型:女性健康	4182948
36204431	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; Wmns hlth	4180186
36204431	Wmns hlth Procedure note	4180186
36204431	操作记录:发现:时间点:{环境}:文档型:女性健康	4182948
36204432	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Visit note; Wmns hlth	4180186
36204432	Wmns hlth OP Note	4180186
36204432	记录:发现:时间点:门诊病人:文档型:女性健康	4182948
36204433	CA; Ca spec; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36204433	Tumor budding Ca spec Ql Micro	4180186
36204433	肿瘤出芽:存在情况或阈值:时间点:癌标本:序数型:显微镜检查.光学	4182948
36204435	Struct incl in spec Spec	4180186
36204435	Anatomy; bod; Bodies; Nominal; Pathology; Point in time; Random; Spec; Struct incl in spec	4180186
36204435	包括在标本之中的身体结构:解剖学:时间点:标本:名义型	4182948
36204436	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36204439	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Self-care; Survey	4180186
36204440	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36204446	electronic Patient Centered Assessment Method; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; SDOH; Survey; SURVEY.GNHLTH	4180186
36204447	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SDOH; Survey; SURVEY.GNHLTH	4180186
36204451	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M hyopneumo; M hyopneumo DNA; M hyopneumoniae; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Porcine respiratory mycoplasmosis; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
36204451	M hyopneumo DNA # Spec NAA+probe	4180186
36204451	猪肺炎支原体 DNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36204452	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M hyosyn 16S rRNA; M hyosynov 16S; M hyosynoviae; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; rDNA; ribosomal RNA; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36204452	M hyosyn 16S rRNA Ct Spec Qn NAA+probe	4180186
36204452	猪滑液支原体 16S rRNA 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36204453	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M hyorhinis; M hyorhinis 16S; M hyorhinis 16S rRNA; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; rDNA; ribosomal RNA; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36204453	M hyorhinis 16S rRNA Ct Spec Qn NAA+prb	4180186
36204453	猪鼻支原体 16S rRNA 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36204456	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204463	Reason vacc not recvd	4180186
36204463	Finding; Findings; Nominal; Point in time; Random; Reason vacc not recvd	4180186
36204463	关于未接受疫苗接种的原因:发现:时间点:^患者:名义型	4182948
36204465	Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Rubella-like illness dur preg; Screen	4180186
36204465	Rubella-like illness dur preg Mother	4180186
36204465	妊娠期间的风疹样疾病:发现:时间点:^母亲:序数型	4182948
36204468	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36204468	AmpC blaFOX gene Islt/Spm Ql	4180186
36204468	细菌 beta-内酰胺耐药 AmpC blaFOX 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36204469	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ESBL blaCTX-M2 Grp gene; ID; II; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36204469	ESBL blaCTX-M2 Grp gene Islt/Spm Ql	4180186
36204469	细菌 beta-内酰胺耐药 ESBL blaCTX-M-2 组基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36204470	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
36204471	Centers for Medicare and Medicaid Assessment; Deglutition; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36204472	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36204472	Pt Care team info	4180186
36204472	照护服务团队信息:发现:时间点:^患者:文档型	4182948
36204475	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204477	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204478	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204480	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204483	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204485	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204488	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204491	CD8+CD45RA+ Cells # Bld	4180186
36204491	#; 2H4; ABS; absolute; absolutes; Blood; CD8 Cells; CD8+CD45RA+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Leu18; Leu-18; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36204491	细胞.CD8+CD45RA+:计数型浓度:时间点:全血:定量型	4182948
36204492	100 CD8; 2H4; Blood; CD8 Cells; CD8+CD45RA+ Cells; Cell; CELL MARKERS; Cellularity; Leu18; Leu-18; Leu2; Leu-2; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36204492	CD8+CD45RA+ Cells/100 CD8 NFr Bld	4180186
36204492	细胞.CD8+CD45RA+/100 个细胞.CD8:计数型分数:时间点:全血:定量型	4182948
36204493	2; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Wheel 50ft 2 turns goal	4180186
36204498	12 steps ability; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204499	3 days; 4 steps goal; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204500	3 days; 4 steps ability; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204501	1 step curb goal; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; i; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204502	1 step curb ability; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; i; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204504	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Walk 10 ft uneven ability	4180186
36204509	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Walk 10 ft goal	4180186
36204511	3 days; Car transfer goal; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204513	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Toilet transfer goal	4180186
36204515	3 days; Bed to chair goal; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204516	3 days; Bed to chair ability; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204517	3 days; 30s CST; 30-Second Chair Stand; 30sSTS; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Sit to stand goal; Stands; Survey	4180186
36204518	3 days; 30s CST; 30-Second Chair Stand; 30sSTS; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Sit to stand ability; Stands; Survey	4180186
36204519	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Lie to sit goal; Ordinal; QL; Qual; Qualitative; Screen; Survey	4180186
36204521	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Sit to lie goal; Survey	4180186
36204523	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; L; LT; Ordinal; Ql; Qual; Qualitative; R; Roll goal; RT; Screen; Survey	4180186
36204526	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Footwear ability; Ordinal; QL; Qual; Qualitative; Screen; Survey	4180186
36204527	3 days; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; Low; Lower dress goal; Ordinal; QL; Qual; Qualitative; Screen; Survey	4180186
36204529	3 days; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Up; Upper dressing goal	4180186
36204530	3 days; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Up; Upper dressing ability	4180186
36204531	3 days; Bathe goal; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204536	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Oral hygiene ability; Ordinal; QL; Qual; Qualitative; Screen; Survey	4180186
36204537	3 days; Centers for Medicare and Medicaid Assessment; Eating goal; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204538	3 days; Centers for Medicare and Medicaid Assessment; Eating ability; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204539	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36204540	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
36204543	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36204544	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204545	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204546	Centers for Medicare and Medicaid Assessment; Finding; Findings; Memory/recall ability; Nominal; Point in time; Random; Survey	4180186
36204549	Comorbid coexisting; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
36204550	3 days; Centers for Medicare and Medicaid Assessment; Deglutition; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey; Swallow nutrional; Swallowing/nutritional status	4180186
36204551	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Survey; Swallow nutrional ability	4180186
36204552	Centers for Medicare and Medicaid Assessment; No; Num; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey	4180186
36204554	3 days; BIMS; BIMS conducted; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204555	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Understand verbal	4180186
36204556	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204558	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Report period; Special Txs, procedures and programs; Survey; Tx; Tx, px, programs admission; Txs	4180186
36204560	Centers for Medicare and Medicaid Assessment; Disch; No; Num; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey	4180186
36204561	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey	4180186
36204562	Centers for Medicare and Medicaid Assessment; Cnt; Count; i; No; Num; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
36204563	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Tx, px, programs admit; Txs	4180186
36204564	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204567	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204569	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36204570	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204571	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204572	3 days; Centers for Medicare and Medicaid Assessment; Nominal; Survey; Typ	4180186
36204573	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204574	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Surg; Survey	4180186
36204579	Centers for Medicare and Medicaid Assessment; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204582	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; Random; Survey; Ulcer	4180186
36204584	Centers for Medicare and Medicaid Assessment; Cnt; Count; III; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
36204586	Centers for Medicare and Medicaid Assessment; Cnt; Count; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
36204588	Centers for Medicare and Medicaid Assessment; Cnt; Count; Number; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; Ulcer	4180186
36204796	HNA 4a-4a	4180186
36204999	Staphylococcus aureus.methicillin resistant	4180186
36205278	Abdomen>Splenic vein	4180186
36205497	Dopamine receptor D2 long	4180186
36205870	L little e	4180186
36205875	L little e super little x	4180186
36205884	Purkinje cell cytoplasmic type 1	4180186
36206022	Pelvis>Urethra	4180186
36206049	Head+Neck>Carotid artery & Head>Cerebral artery	4180186
36206050	Head+Neck>Jugular vein	4180186
36206072	HNA 1a-1a	4180186
36206109	Staphylococcus aureus.methicillin susceptible	4180186
36206281	Diphtheria sp	4180186
36206496	Radial position of closest mucosal margin when mucosal margin uninvolved by invasive carcinoma	4180186
36206506	Lower extremity>Pedal lymphatic vessels	4180186
36206672	N-methyl-D-aspartate receptor	4180186
36206805	Head>Cerebral arteries	4180186
36206826	Abdomen>gastric artery	4180186
36207010	CD34 & Coagulation factor XIII	4180186
36207273	HNA 4a-4b	4180186
36207462	Head+Neck>Carotid artery.external	4180186
36207464	Head+Neck>Carotid artery & Head>Cerebral artery.right	4180186
36207481	Chest>Internal thoracic artery.left	4180186
36207520	XXX>Lymphatic vessels	4180186
36207608	Mycoplasma sp.respiratory	4180186
36207712	Middle East respiratory syndrome coronavirus	4180186
36208006	NOS	4180186
36208828	L little u super little a super little b	4180186
36208863	S little c 2	4180186
36209465	Extremity.unilateral>Extremity veins	4180186
36210056	Porcine reproductive and respiratory syndrome virus European strain	4180186
36210655	Date ultrasound	4180186
36303235	Centers for Medicare and Medicaid Assessment; III; Len; Length; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; Ulcer	4180186
36303236	Centers for Medicare and Medicaid Assessment; OT; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303238	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36303238	Preventive med Group counseling note	4180186
36303238	团体咨询记录:发现:时间点:{环境}:文档型:预防医学	4182948
36303239	BON; Chemistry; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; Vet; Veterinary	4180186
36303239	Bone ash MFr Bone	4180186
36303239	骨灰/骨.总计:质量分数:时间点:骨:定量型	4182948
36303241	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303241	Chlorophacinone Spec-mCnt	4180186
36303241	氯鼠酮:质量含量:时间点:XXX:定量型	4182948
36303243	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36303247	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Sx	4180186
36303248	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Othr; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36303249	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303250	Abd; Abdo; Abdomen+; Abdominal; Assessment; CorePlaybook; Document; Eval; Finding; Findings; Guid; Guide; Guided; H&P; Hepar; Hepatic; History and physical; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36303250	Guided Liver Hemodynamic eval	4180186
36303250	旨在血液动力学评价的引导:发现:时间点:腹部>肝脏:文档型:{成像方式}	4182948
36303252	lamoTRIgine/Creat Ur Cfm	4180186
36303252	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Lamictal; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36303252	拉莫三嗪/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36303253	Centers for Medicare and Medicaid Assessment; Dextro; Disch; Inpatient admission agency discharge items - d/c from agency; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303255	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breakbone fever; Dengue fever; Dengue type I; Dengue type I+II+III+IV; Denv; DENV 1+2+3+4; DENV 1+2+3+4 RNA; DENV1; DENV1+2+3+4; DNA NUCLEIC ACID PROBE; DNA probe; Flavivirus; i; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
36303255	DENV1+2+3+4 RNA Ur Ql NAA+probe	4180186
36303255	登革热病毒 1+2+3+4 型 RNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
36303256	Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Hip-Bl; Hips; Imaging; LE; LE-Bl; Leg; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Pelvic; Pelvis + Hip-Bl; Pelvis and Hip-Bl; Pelvis+LE; Pelvis+LE-Bl; Point in time; Rad; Radiology; Random; without contrast	4180186
36303256	CT Pelvis and Hip-Bl WO contr	4180186
36303256	多层^不采用对比剂:发现:时间点:盆腔 & 下肢.双侧>髋关节:文档型:CT	4182948
36303257	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303260	Bro; Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random	4180186
36303260	Micro CNAMTS panel Bronch	4180186
36303260	微生物学 CNAMTS 组套:-:时间点:支气管来源的标本:-	4182948
36303261	Cerebral spinal fluid; Cerebrospinal Fl; Gram Stn; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; St; Stains; Stn; WBC; WBCs; White blood cell; White blood cells	4180186
36303261	WBC CSF Ql Gram Stn	4180186
36303261	白细胞:存在情况或阈值:时间点:脑脊液:序数型:革兰氏染色法	4182948
36303263	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Arbitrary concentration; Autoantibodies; Autoantibody; DNA-Topoisomerase I; ENA; ENA Scl70; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Scleroderma; Scleroderma ab; Serology; Serum; SR; Topo I; Topoisomerase I	4180186
36303263	ENA Scl70 Ab Ser Line blot-aCnc	4180186
36303263	SCL-70 可提取性核 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36303265	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C perfringens; C perfringens cpb2; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303265	C perfringens cpb2 Islt Ql NAA+probe	4180186
36303265	产气荚膜梭菌 cpb2 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36303266	ANTIBIOTIC SUSCEPTIBILITIES; AST; Bovine Respiratory Disease; BRD; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary; Zactran	4180186
36303266	Gamithromycin Islt KB	4180186
36303266	加米霉素:抗生素敏感性:时间点:分离株:定量型或序数型:琼脂扩散法	4182948
36303272	Primary Dx ICD code	4180186
36303272	CLIN; Dx; Dx ICD code; International Classification of Diseases; Nominal; Point in time; Primary Dx ICD code; Random; Typ	4180186
36303272	主要诊断 ICD 代码:类型:时间点:^患者:名义型	4182948
36303273	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Substance abuse; Visit note	4180186
36303273	Addiction med H&P note	4180186
36303273	病史与体格检查记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36303277	Centers for Medicare and Medicaid Assessment; EOC; Finding; Findings; Immunizations; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Vaccine	4180186
36303279	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36303279	OB Discharge teach note	4180186
36303279	出院宣教记录:发现:时间点:{环境}:文档型:产科学	4182948
36303280	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36303286	3; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ordinal; Point in time; Pol III; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; RNAp III; Screen; Serology; Serum; SR	4180186
36303286	RNAp III Ab Ser Ql Line blot	4180186
36303286	RNA 聚合酶 III 抗体:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36303288	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; insertions; Playbook; Point in time; Rad; RADIOLOGY; Random; Thoracentesis+tube insert; Thorax	4180186
36303288	Guided Chest Thoracentesis+tube insert	4180186
36303288	旨在胸腔穿刺术+插入管道的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36303289	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Parecho virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; LV; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; PeV; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
36303289	PeV RNA Upper resp Ql NAA+probe	4180186
36303289	副肠孤病毒 RNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36303290	4-Hydroxycoumarin; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Rodenticide; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303290	Bromadiolone Spec-mCnt	4180186
36303290	溴敌隆:质量含量:时间点:XXX:定量型	4182948
36303292	Chest Pleura; Chest.pleura; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiofreq abl; RADIOLOGY; Random; Thorax	4180186
36303292	Guided Chest Pleura Radiofreq abl	4180186
36303292	旨在射频消融术的引导:发现:时间点:胸部>胸膜:文档型:{成像方式}	4182948
36303298	1,3-Beta-D-Glucan; B; Beta glucan; i; ID; III; Infectious Disease; InfectiousDisease; Level; Low; Lower resp; Lung; Mass concentration; Microbiology; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36303298	1,3 beta glucan Lower resp-mCnc	4180186
36303298	1,3 Beta 葡聚糖:质量浓度:时间点:呼吸道.下:定量型	4182948
36303299	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303300	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; III; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; QUPIC; Random; Screen; Synthetic cannabinoid; UA; UR; Urn	4180186
36303300	PB-22 3-carboxyindole Ur Ql Cfm	4180186
36303300	PB-22 3-吲哚甲酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36303301	ADMIN; Fetal; Fetal death registration date; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36303301	Fetal death registration date	4180186
36303301	胎儿死亡登记日期:日期:时间点:^胎儿:定量型	4182948
36303302	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Eye socket; Finding; Findings; Imaging; Intracranial; Orbital; Point in time; Rad; RADIOLOGY; Random; Skull; without contrast	4180186
36303302	CT Orbit+Face WO contr	4180186
36303302	多层^不采用对比剂:发现:时间点:头部>眼眶+面部:文档型:CT	4182948
36303305	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303306	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Tx, px, programs discharge; Txs	4180186
36303307	Centers for Disease Control and Prevention; Ethnicity; Nominal; Point in time; Random; Survey; SURVEY.CDC; Typ	4180186
36303311	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); P carinii; P jiroveci; PCP; PCR; Pneumocystis carinii; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QNT; Quan; Quant; Quantitative; Random; Respiratory; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36303311	P jiroveci DNA # Lower resp NAA+probe	4180186
36303311	耶氏肺孢子菌 DNA:计数型浓度:时间点:呼吸道.下:定量型:探针法.基因扩增.靶向	4182948
36303314	Glial nuc type 1 Ab Ser Line blot-aCnc	4180186
36303314	ABS; Aby; AGNA; AGNA-1; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Glial nuc type 1; i; Lambert-Eaton myasthenic syndrome; Nuc; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; Sox1; Sox1 nuclear antigen; SR	4180186
36303314	神经胶质细胞核 1 型 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36303318	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36303318	OB Administrative note	4180186
36303318	行政管理记录:发现:时间点:{环境}:文档型:产科学	4182948
36303319	Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Transcath Bx; Unspecified	4180186
36303319	Guided Unsp region Transcath Bx	4180186
36303319	旨在经导管活组织检查的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36303320	# days of training & skill practice in communication; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36303321	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P; History and physical; notes; OB; ObGyn; Obstetrics; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Visit note	4180186
36303321	Gynecology Pre-op note	4180186
36303321	术前评价与管理记录:发现:时间点:{环境}:文档型:妇科学	4182948
36303323	Centers for Medicare and Medicaid Assessment; Oral/dent status; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36303326	ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn	4180186
36303326	Yeast Ur Ql	4180186
36303326	酵母:存在情况或阈值:时间点:尿液:序数型	4182948
36303328	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Port place; Rad; RADIOLOGY; Random	4180186
36303328	Guided Peritoneum Port place	4180186
36303328	旨在置入输液港的引导:发现:时间点:腹部>腹膜:文档型:{成像方式}	4182948
36303332	Activ; Activity; Actvty; Arbitrary rate; Exercise; Job; Moderate PA.yard work; Moderate phys activity; Movements; Occupation; QNT; Quan; Quant; Quantitative; Survey	4180186
36303337	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.GNHLTH	4180186
36303339	Ang; Angio; Angiography; Angm; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; Finding; Findings; Heart Disease; Imaging; Point in time; Pulm vv; Rad; Radiology; Random; Thorax; Venogram; Venography; W contr IV; WC	4180186
36303339	CTA Pulm vv W contr IV	4180186
36303339	多层^采用静脉注射对比剂:发现:时间点:胸部>肺静脉类:文档型:CT.血管造影术	4182948
36303340	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; LAT; LCR; Legion; Legionela; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumophilia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303340	L pneumo DNA Lower resp Ql NAA+probe	4180186
36303340	嗜肺军团菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36303341	Mycoph + Mycoph-G Pnl SerPl	4180186
36303341	Cellcept; DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; MMF; MPA; MPAG; MPA-G; Mycoph + Mycoph-G Pnl; Mycophenolate mofetil; Mycophenolate-G; Mycophenolic acid; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36303341	吗替麦考酚酯与葡糖苷酸吗替麦考酚酯组套:-:时间点:血清/血浆:定量型	4182948
36303347	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36303347	GBU4-5 Ab SerPl IA-aCnc	4180186
36303347	GBU4-5 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36303350	Abd; Abdo; Abdomen+; Abdominal; Change; CorePlaybook; Document; Feeding tube; Finding; Findings; G tube; G-tube exch; Guid; Guidance for exchange; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Replace	4180186
36303350	Guided Stom G-tube exch	4180186
36303350	旨在更换胃造瘘管的引导:发现:时间点:腹部>胃:文档型:{成像方式}	4182948
36303351	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; OP; Point in time; Random; Visit note	4180186
36303351	Gynecology OP Note	4180186
36303351	记录:发现:时间点:门诊病人:文档型:妇科学	4182948
36303354	CLIN; Identity or presence; Nominal; Point in time; Random	4180186
36303354	Instructions provided	4180186
36303354	所提供的指导:存在与否或特征标识:时间点:^患者:名义型	4182948
36303356	ANTIBIOTIC SUSCEPTIBILITIES; AST; Bovine Respiratory Disease; BRD; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary; Zactran	4180186
36303356	Gamithromycin Islt MIC	4180186
36303356	加米霉素:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36303357	A pleuropn; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Oral fluid; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Sal; SUDS	4180186
36303357	A pleuropn IgG/Pos cntrl Sal IA	4180186
36303357	胸膜肺炎放线杆菌 抗体.IgG/阳性对照:相对比率:时间点:唾液:定量型:免疫测定法	4182948
36303358	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gastro; Gastroenterology; GI; GI pathogens; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36303358	GI pathogens Spec NAA+probe	4180186
36303358	胃肠道病原体类 已鉴定的:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
36303363	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Ganglioside monosialo; GM1 Gangl; Immune globulin G; Immunoglobulin G; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36303363	GM1 Gangl IgG CSF Ql Line blot	4180186
36303363	神经节苷脂 GM1 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36303364	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; c; Contr; Contra; Contrast inject; Contrst; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Playbook; Point in time; Rad; Radiology; Random	4180186
36303364	Guided BDs Contrast inject	4180186
36303364	旨在注射对比剂的引导:发现:时间点:腹部>胆管类:文档型:{成像方式}	4182948
36303365	DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; Humira; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36303365	Adalimumab SerPl IA-mCnc	4180186
36303365	阿达木单抗:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36303366	Centers for Medicare and Medicaid Assessment; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36303367	Health stat prior emerg incident	4180186
36303367	Finding; Findings; Health stat prior emerg incident; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36303367	突发事件之前的健康状况:发现:时间点:^患者:序数型	4182948
36303369	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH	4180186
36303370	Noroxymorphone Ur Ql Scn	4180186
36303370	DRUG/TOXICOLOGY; Drugs; Ordinal; Oxycodone metabolite; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
36303370	去甲基羟吗啡酮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36303371	A pleuropn; A pleuropn 4+7; A pleuropn 4+7 Ab; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36303371	A pleuropn 4+7 Ab/Pos cntrl Ser IA	4180186
36303371	胸膜肺炎放线杆菌血清型 4+7 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36303375	Centers for Medicare and Medicaid Assessment; IRF-PAI v1.5; LTPAC; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303376	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Random; Substance abuse; Visit note	4180186
36303376	Addiction med Hosp Note	4180186
36303376	记录:发现:时间点:医院:文档型:成瘾医学	4182948
36303379	Activ; Activity; Actvty; Arbitrary rate; Exercise; Moderate PA.leisure-time; Moderate phys activity; Movements; QNT; Quan; Quant; Quantitative; Survey	4180186
36303380	Assoc; CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; Down syndrome; Edward syndrome; Fetal; Gestation; Gestations; Gravida; Gyn; Gynecology; HCG; Human chorionic gonadotropin; OB; ObGyn; Obstetrics; PAPPA; PAPP-A; Pappalysin-1; Point in time; PR; Pregnancies; Prot; QNT; Quan; Quant; Quantitative; Random; Risk; T18 risk; trisomy 21; Ts; Ts 18 risk; Ts 18 risk-Age; Ts 18 risk-age+PAPPA+HCG+NT	4180186
36303380	Ts 18 risk-age+PAPPA+HCG+NT Fetus	4180186
36303380	基于母亲年龄+妊娠相关血浆蛋白 A +绒毛膜促性腺激素+颈项透明层的三体型 18 风险:似然性:时间点:^胎儿:定量型	4182948
36303381	BEC; BEG; Benz; Benzoylec; BZE; Cfm; CNFR; CNFRM; Cocaine degradation production; Cocaine metabolite; Conf; Confirmation; Confirmatory; Crack metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
36303381	BZE Sal Cfm-mCnc	4180186
36303381	苯甲酰芽子碱:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36303387	Before; Blood; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36303387	Glucose pre-meal Bld-mCnc	4180186
36303387	葡萄糖^在进餐之前:质量浓度:时间点:全血:定量型	4182948
36303389	Glutarylcarn/C3 DBS-sRto	4180186
36303389	Blood; C3; C3-carntitine; C5DC; C5-DC; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
36303389	戊二酰肉碱 (C5-DC)/丙酰肉碱 (C3):物质的量比率:时间点:全血.斑点:定量型	4182948
36303391	Proc+Serv+Supp code	4180186
36303391	ADMIN; Nominal; Point in time; Proc+Serv+Supp code; Random; Typ	4180186
36303391	操作项目、服务项目或供应品代码:类型:时间点:^患者:名义型	4182948
36303392	DOC.ONT; Document; Finding; Findings; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; Random	4180186
36303392	流程记录单:发现:时间点:{环境}:文档型:妇科学	4182948
36303393	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Eye fluid; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Occular fluid; Ocflu; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303393	CMV DNA Ocflu Ql NAA+probe	4180186
36303393	巨细胞病毒 DNA:存在情况或阈值:时间点:眼液:序数型:探针法.基因扩增.靶向	4182948
36303394	Macroscopic obs Stl-Imp	4180186
36303394	Bowel movement; Faecal; Faeces; Fecal; Feces; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Microbiology; Narrative; Point in time; Random; Report; Stl; Stool = Fecal	4180186
36303394	大体观察:印象:时间点:大便:叙述型	4182948
36303395	GD1b Gangl IgG+IgM Ser IA-aCnc	4180186
36303395	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Disialolganglioside; Disialylganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1b; GD1b Gangl; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
36303395	神经节苷脂 GD1b 抗体.IgG+IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36303396	Abcid; Agribon; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Primor; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36303396	Sulfadimethoxine Susc Islt	4180186
36303396	磺胺二甲氧嘧啶:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36303397	Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Regurgitation; St; Stains; Stn; Vom; Vomitus	4180186
36303397	Gram Stn Vom	4180186
36303397	显微镜观察:存在与否或特征标识:时间点:呕吐物:名义型:革兰氏染色法	4182948
36303399	Durat; infl phase dur; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36303399	Infl phase dur vent timed infl	4180186
36303399	充气阶段持续时间:时间:时间点:呼吸机:定量型	4182948
36303401	Abd; Abd+Pelvis; Abdo; Abdominal; CorePlaybook; Document; Extraction; Finding; Findings; Guid; Guide; Guided; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrology; Pelvic; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Remove; Renal; Transurethral nephrouret stent removal; Ureter+Blad	4180186
36303401	Guided Nephrouret stent rem via urethra	4180186
36303401	旨在经尿道去除肾输尿管支架的引导:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:{成像方式}	4182948
36303403	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Seneca Valley Virus; SVA; SVA whole genome; Vet; Veterinary	4180186
36303403	SVA whole genome Islt-Seq	4180186
36303403	塞内卡病毒 A 全基因组:序列:时间点:分离株:名义型:序列测定	4182948
36303404	Centers for Medicare and Medicaid Assessment; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303406	Chemistry; Fine needle; Intact Parathormone; intact parathyroid hormone; iPTH; Level; Mass concentration; Parathormone; Parathyroid hormone; Point in time; PTH; PTH-Intact; QNT; Quan; Quant; Quantitative; Random; Tiss FNA; Tissue; Tissue fine needle aspirate; Tissue, unspecified; Tumor marker	4180186
36303406	PTH-Intact Tiss FNA-mCnc	4180186
36303406	甲状旁腺素.完整型:质量浓度:时间点:组织.细针吸出物:定量型	4182948
36303407	PTH-Intact goal mCnc SerPl	4180186
36303407	CLIN; Intact Parathormone; intact parathyroid hormone; iPTH; Level; Mass concentration; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; PTH-Intact; PTH-Intact goal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
36303407	甲状旁腺素.完整型 目标:质量浓度:时间点:血清/血浆:定量型	4182948
36303409	Abd; Abdo; Abdomen+; Abdominal; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; Perc; Playbook; Point in time; Rad; Radiology; Random; Renal	4180186
36303409	Guided Kidney Bx	4180186
36303409	旨在经皮活组织检查的引导:发现:时间点:腹部>肾脏:文档型:{成像方式}	4182948
36303410	Methcathinone/Creat Ur Cfm	4180186
36303410	Bath salts; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; ephedrone; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36303410	甲卡西酮/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36303413	c215; c281; C52; Cambia; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Voltaren optha; Voltaren opthalmic	4180186
36303413	Diclofenac/Creat Ur Cfm	4180186
36303413	环氟拉嗪/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36303416	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36303416	CT Parathyroid gland WO+W contr IV	4180186
36303416	多层^不采用 & 采用静脉注射对比剂:发现:时间点:颈部>甲状旁腺:文档型:CT	4182948
36303417	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36303418	Cath; CorePlaybook; CVC w port repair; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
36303418	Guided Chest CVC w port repair	4180186
36303418	旨在修复带有输液港的中心静脉导管的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36303421	Assessment; Centers for Medicare and Medicaid Assessment; Disch; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303422	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; Throm; Thromb inject for pseudoaneurysm; To be specified in another part of the message; Unspecified	4180186
36303422	Thromb inj for pseudoaneurysm	4180186
36303422	旨在假动脉瘤注射凝血酶的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36303423	1 week; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH; Sx	4180186
36303424	Centers for Medicare and Medicaid Assessment; Hx; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Patient Hx; Pnl; Point in time; Random; Started; Survey	4180186
36303426	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyssavirus; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Rabies; RABV; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36303426	RABV RNA Tiss Ql NAA+probe	4180186
36303426	狂犬病病毒 RNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36303429	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; CPR; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; WB; Whole blood	4180186
36303429	blaNDM Bld Pos Ql Probe	4180186
36303429	细菌碳青霉烯类耐药 blaNDM 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36303430	Admit H&P note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P note; Hx; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36303430	OB Admit H&P note	4180186
36303430	入院史与体格检查记录:发现:时间点:{环境}:文档型:产科学	4182948
36303436	Centers for Medicare and Medicaid Assessment; Othr; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303438	Eastern Cooperative Oncology Group; Everyday Cognition; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36303439	Arm; Arthrogram; Arthrography; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Imaging; intraarticular; intrasynovial; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; Shoulder-Bl; UE; UE-Bl; Up; Upper extremity joint; W contr IS; WC	4180186
36303439	CT Shoulder-Bl W contr IS	4180186
36303439	多层^采用关节内对比剂:发现:时间点:上肢.双侧>肩部:文档型:CT	4182948
36303440	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303442	Epi Cells # Ur Auto	4180186
36303442	#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Epi; Epi Cells; Epith; Epithelia; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn	4180186
36303442	上皮细胞:计数型浓度:时间点:尿液:定量型:自动化法	4182948
36303445	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Extraction; Filter removal; Finding; Findings; Guid; Guide; Guided; Heart; Imaging; Inf; IVC; Playbook; Point in time; Rad; Radiology; Random; Remove; VC	4180186
36303445	Guided IVC Filter removal	4180186
36303445	旨在去除静脉滤器的引导:发现:时间点:腹部>腔静脉.下:文档型:{成像方式}	4182948
36303446	Finding; Findings; MISC; Nominal; Point in time; Random; Survey; Survey.Misc	4180186
36303447	Asp; CorePlaybook; Document; Finding; Findings; FNA; Guid; Guide; Guided; Imaging; NDL; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Thy	4180186
36303447	Guided Thyroid FNA	4180186
36303447	旨在经皮细针抽吸的引导:发现:时间点:颈部>甲状腺:文档型:{成像方式}	4182948
36303449	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Ulcer; Visit note	4180186
36303449	会诊记录:发现:时间点:{环境}:文档型:脑损伤	4182948
36303450	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Shingles; Strand Displacement Amplification; TMA; Transcription mediated amplification; VZ; VZV; Zoster	4180186
36303450	VZV DNA Lower resp Ql NAA+probe	4180186
36303450	水痘带状疱疹病毒 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36303452	Cath; CorePlaybook; Deep drain+cath place; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; Removal of fluid	4180186
36303452	Guided Pelvis Deep drain+cath place	4180186
36303452	旨在深部引流+引流导管置入的引导:发现:时间点:盆腔:文档型:{成像方式}	4182948
36303453	Omega-3 index SFr SerPl	4180186
36303453	Acd; Acid; C20:5w3; C22:6w3; Cervonate; Cervonic acid; Chemistry; DHA; Docosahexaenoic acid; Eicosapentaenoic acid; EPA; EPA+DHA; Fatty acid; Icosapentaenoate; Lipid; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Timnodonate; Timnodonic Acid	4180186
36303453	二十碳五烯酸+二十二碳六烯酸/脂肪酸类.C14-C24:物质的量分数:时间点:血清/血浆:定量型	4182948
36303457	Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36303458	Meth; Method of; Nominal; Point in time; Random; TRAUMA; Typ	4180186
36303458	加温方法:类型:时间点:^患者:名义型:*	4182948
36303459	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36303461	Len; Pan; Panel; Panl; Pnl; Point in time; Pos; Random	4180186
36303462	Count/time; Dextro; Last; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey; SURVEY.GNHLTH	4180186
36303463	C&S; Chicken pox; Chicken pox virus; Chickenpox; Corn/Cnjt; Corneal; Cult; Cultures; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Shingles; Spec; VZ; VZV; Zoster	4180186
36303463	VZV Corn/Cnjt Ql Cult	4180186
36303463	水痘带状疱疹病毒:存在情况或阈值:时间点:角膜/结膜:序数型:微生物特异性培养	4182948
36303464	1 day; 24 hours; 24HR; CR; Crea; Creat; Creat Pnl; DRUG/TOXICOLOGY; Drugs; Metaneph; Metaneph+Normetaneph; Metanephrine fractionated; Metanephrines panel; Metanephrne; Metanephs+Creat pnl; Metenephrine; Normeta; Normetaneph; Normetanephrn; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; UA; UCr; UR; Urn	4180186
36303464	Metanephs+Creat pnl 24h Ur	4180186
36303464	间甲肾上腺素与去甲间肾上腺素与肌酐组套:-:24小时:尿液:-	4182948
36303465	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Legion; Legionela; Microbiology; Nominal; Point in time; Random; Spec; species; spp; Tissue; Tissue, unspecified	4180186
36303465	Legionella Tiss Cult	4180186
36303465	军团菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:组织与涂片:名义型:微生物特异性培养	4182948
36303467	Centers for Medicare and Medicaid Assessment; Dextro; Disch; No; Num; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey	4180186
36303472	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303473	Feline; Felis domesticus; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
36303474	Addiction med Therapist; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36303474	Addiction med Therapist Note	4180186
36303474	记录:发现:时间点:{环境}:文档型:成瘾医学.治疗师	4182948
36303476	Ciodrin; Cypona E.C.; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303476	Crotoxyphos Spec-mCnt	4180186
36303476	赛吸磷:质量含量:时间点:XXX:定量型	4182948
36303477	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genitourinary; GU; notes; Point in time; Random; Telemedicine; URO; Urology; Visit note	4180186
36303477	会诊记录:发现:时间点:远程医疗:文档型:泌尿外科学	4182948
36303478	Abd; Abd and Chest+Abd; Abdo; Abdomen+; Abdominal; c; CAT scan; Chest + Abd; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax; without contrast	4180186
36303478	CT Abd WO + CT Abd+Chest W contr IV	4180186
36303478	多层^WO contrast && Multisection^W contrast IV:发现:时间点:腹部 && 胸部+腹部:文档型:CT	4182948
36303479	Activities of Daily Living; Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36303482	Breath H2 10M p fruct PO	4180186
36303482	10M p fruct PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Levulose; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Revulose; Volfr; Volume fraction	4180186
36303482	氢/已呼出的气体^在口服剂量果糖之后10分钟:体积分数:时间点:呼出的气体:定量型	4182948
36303484	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-G; EV-G RNA; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; PEV; Point in time; Polymerase chain reaction; Porcine enterovirus B; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36303484	EV-G RNA Spec Ql NAA+probe	4180186
36303484	肠道病毒 G RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36303485	Finding; Findings; Nominal; Point in time; Random; TRAUMA	4180186
36303485	伤口覆盖状态:发现:时间点:^患者:名义型	4182948
36303486	Predominant leukocyte Ear Micro	4180186
36303486	Hearing; HEMATOLOGY/CELL COUNTS; Isolated; Leuc; Leuk; Leukocytes; Lkcs; LM; Micro; Micros; Microscopic; Nominal; Otologic; Point in time; Random; Typ; WBC; WBCs; White blood cell; White blood cells	4180186
36303486	占优势的白细胞 已鉴定的:类型:时间点:耳:名义型:显微镜检查.光学	4182948
36303489	Insp pause time; Insp pause time set; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36303489	Insp pause time set Vent	4180186
36303489	吸气停顿时间设置:时间:时间点:呼吸机:定量型	4182948
36303490	粗球孢子菌抗体.IgG 与 IgM 组套:-:时间点:血清/血浆:-	4182948
36303490	B immitis; Blastomycoides immitis; C esteriformis; C immitis; C immitis IgG + IgM Pnl; Coccidioides esteriformis; Coccidiomycosis; Coccio; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; P esteriformis; P mazzai; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Posadasia esteriformis; Pseudococcidioides mazzai; Random; San Joaquin Valley fever; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T proteolyticum; Trichosporon proteolyticum; Valley fever	4180186
36303490	C immitis IgG + IgM Pnl SerPl	4180186
36303491	CLIN; Finding; Findings; Nominal; Point in time; Prov percept pt comprehension; Random; S prime	4180186
36303491	Prov percept pt comprehension	4180186
36303491	医疗服务人员关于患者对讨论内容理解情况的感觉:发现:时间点:^患者:名义型	4182948
36303493	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pilosicoli; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36303493	B pilosicoli DNA Spec Ql NAA+probe	4180186
36303493	毛肠短螺旋体 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36303495	Difonate; Difonatul; DRUG/TOXICOLOGY; Drugs; Dyfonate; Dyphonate; Fonophos; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303495	Fonofos Spec-mCnt	4180186
36303495	地虫磷:质量含量:时间点:XXX:定量型	4182948
36303496	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303497	Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Musc; Muscl; Other; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36303497	Guided Muscle Bx	4180186
36303497	旨在经皮活组织检查的引导:发现:时间点:XXX>肌肉:文档型:{成像方式}	4182948
36303498	Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36303500	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Filter reposition; Finding; Findings; Guid; Guide; Guided; Heart; Imaging; Inf; IVC; Playbook; Point in time; Rad; RADIOLOGY; Random; VC	4180186
36303500	Guided IVC Filter reposition	4180186
36303500	旨在静脉滤器复位的引导:发现:时间点:腹部>腔静脉.下:文档型:{成像方式}	4182948
36303504	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C burnet; C burnetii; Coxiella burnettii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36303504	C burnet DNA Tiss Ql NAA+probe	4180186
36303504	贝氏柯克斯体 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36303505	Nurse LTC fac Transfer sum note	4180186
36303505	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; LTC fac; LTCF; notes; nursing; Point in time; Random; Transfer sum note; Visit note	4180186
36303505	移交摘要记录:发现:时间点:长期医疗服务设施:文档型:护士	4182948
36303506	Activity; Count/time; Dextro; Exercise; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36303507	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303509	Assoc; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36303511	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Vent alarm	4180186
36303511	Vent alarm settings Doc	4180186
36303511	设置:发现:时间点:呼吸机.警报:文档型	4182948
36303512	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303514	Centers for Medicare and Medicaid Assessment; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303515	#/area; Cast; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Renal failure casts; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36303515	Broad Casts #/area UrnS	4180186
36303515	宽大管型:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36303516	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Assoc; Autoantibodies; Autoantibody; CAGE; CAGE Ab; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36303516	CAGE Ab SerPl IA-aCnc	4180186
36303516	癌症相关基因 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36303520	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Filarial; Filariasis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Microfilaria; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36303520	Filaria DNA Bld Ql NAA+probe	4180186
36303520	丝虫属 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36303523	KCCQ; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36303524	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303526	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B afz+burg+gari; B afzelii; Bands; bnd; ID; IgM Patrn; Immune globulin M; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Nominal; Patrn; Point in time; Random; Serum; SR	4180186
36303526	B afz+burg+gari IgM Ptrn Ser Line blot	4180186
36303526	阿夫塞疏螺旋体+伯氏疏螺旋体+加里疏螺旋体 抗体.IgM 区带模式:印象:时间点:血清:名义型:线点印迹法	4182948
36303527	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36303529	Bact; Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GN bact; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Isolated; Microbiology; NEG; Nominal; Point in time; Random; WB; Whole blood	4180186
36303529	GN bact Bld Pos Probe-Imp	4180186
36303529	革兰氏阴性细菌 已鉴定的:印象:时间点:血液.生长阳性:名义型:DNA探针	4182948
36303530	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36303532	Acd; Acid; C20:5w3; Chemistry; Eicosapentaenoic acid; EPA; Fatty acid; Icosapentaenoate; Lipid; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Timnodonate; Timnodonic Acid	4180186
36303532	EPA/Fatty acids.C14-C24 SFr SerPl	4180186
36303532	二十碳五烯酸/脂肪酸类.C14-C24:物质的量分数:时间点:血清/血浆:定量型	4182948
36303535	Centers for Medicare and Medicaid Assessment; Finding; Findings; L; LT; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey	4180186
36303536	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Lyme disease; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Relapsing fever; SDA; species; spp; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36303536	Borrelia DNA Tiss NAA+probe	4180186
36303536	疏螺旋体属单个未知种 DNA:存在与否或特征标识:时间点:组织与涂片:名义型:探针法.基因扩增.靶向	4182948
36303539	CD3+CD4+CD27-CD45RO+CD62L- cells # Bld	4180186
36303539	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD4+ Cells; CD3+CD4+CD27+CD45RO+CD62L+ cells; CD3+CD4+CD27-CD45RO+CD62L- cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; Inducer T cells; L3T4; LAM-1; LECAM-1; Leu3; Leu-3; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; T3; T4; T-4; T4 helper/inducer cells; TQ-1; UCHL-1; W3/25; WB; Whole blood	4180186
36303539	细胞.CD3+CD4+CD27-CD45RO+CD62L-:计数型浓度:时间点:全血:定量型	4182948
36303542	Calcium goal mCnc SerPl	4180186
36303542	Ca; Cal; CLIN; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36303542	钙目标:质量浓度:时间点:血清/血浆:定量型	4182948
36303546	Activity; Count/time; Dextro; Exercise; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36303547	ID; Identity or presence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Potassium hydroxide preparation; Prep; Pulmonary; Pulmonology; Random; Respiratory	4180186
36303547	KOH Prep Lower resp	4180186
36303547	显微镜观察:存在与否或特征标识:时间点:呼吸道.下:名义型:氢氧化钾制片法	4182948
36303551	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303553	Dyspnoea questionnaire; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; RDS; Survey; SURVEY.GNHLTH	4180186
36303555	Dynamic; Flow; Insp flow set; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume Rate; vRate	4180186
36303555	Insp flow set Vent	4180186
36303555	吸气流量设置:体积速率:时间点:呼吸机:定量型	4182948
36303556	EMS MD qualification	4180186
36303556	Emergency Medical Service(s); EMS MD qualification; Nominal; Point in time; Random; TRAUMA; Typ	4180186
36303556	急救医疗服务医师资格:类型:时间点:服务提供者:名义型	4182948
36303557	Ezogabine/Creat Ur Cfm	4180186
36303557	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Retigabine; UA; UCr; UR; Urn	4180186
36303557	瑞替加滨/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36303558	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Finding; Findings; Nominal; Point in time; Random	4180186
36303558	移民身份:发现:时间点:^患者:名义型	4182948
36303562	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Crimean-Congo virus; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303562	Crimean-Congo virus RNA Ser Ql NAA+probe	4180186
36303562	克里米亚-刚果出血热病毒 RNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
36303563	1,2,3,4,5,6-Hexachlorocyclohexane; Benhexachlor; BHC; c621; C6H6Cl6; DRUG/TOXICOLOGY; Drugs; Gamma benzene hexachloride; Gamma hexachlorocyclohexane; HCH; Lindatox; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; t-HCH; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303563	Lindane Spec-mCnt	4180186
36303563	六氯化苯:质量含量:时间点:XXX:定量型	4182948
36303567	CT C+T+L-spine WO contr	4180186
36303567	多层^不采用对比剂:发现:时间点:颈部>脊椎.颈段 & 胸部>脊椎.胸段 & 腹部>脊椎.腰段:文档型:CT	4182948
36303567	Abd; Abdo; Abdomen+; Abdominal; c; C/sp; C+T+L-spine; C+T-spine; CAT scan; Cerv; Computed tomography; Computerized tomography; Contr; Contra; Contrst; C-spine; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord; T Spine+Ab; T+L-Spine; Th/sp; Thorax; T-spine; without contrast	4180186
36303568	Care plan; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Treatment plan; Visit note	4180186
36303568	OB Plan of care note	4180186
36303568	医疗服务计划记录:发现:时间点:{环境}:文档型:产科学	4182948
36303569	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36303569	CT Head+Neck WO+W contr IV	4180186
36303569	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部+颈部:文档型:CT	4182948
36303571	Cath; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Swan-Ganz cath place; Thorax	4180186
36303571	Guided Chest Swan-Ganz cath place	4180186
36303571	旨在置入 Swan-Ganz 导管的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36303572	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; NO2; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303572	Nitrite Spec-mCnc	4180186
36303572	亚硝酸盐:质量浓度:时间点:XXX:定量型	4182948
36303573	TUG + Phys findings of gait Pnl CDC	4180186
36303573	Centers for Disease Control and Prevention; Exam; Examination; H+P; P prime; Pan; PANEL.H&P; Panl; Phys find; Pnl; Point in time; Random; TUG + Phys findings of gait Pnl	4180186
36303573	起立-行走计时测试与步态体格检查发现组套:-:时间点:^患者:-:CDC	4182948
36303577	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
36303578	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Circo virus; FA; Fluorescent antibody; Fluoresent; ID; IFA; II; Immune fluorescence; Immune globulin G; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; PCV; PCV2; PCV2 Ab; PCV2 IgG; Point in time; Pork; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Swine; Time Resolved Fluorescence; TRF; Vet; Veterinary	4180186
36303578	PCV2 IgG+IgM Ser Ql IF	4180186
36303578	猪圆环病毒 2 型 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
36303579	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36303580	Abcid; Agribon; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Primor; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36303580	Sulfadimethoxine Islt MIC	4180186
36303580	磺胺二甲氧嘧啶:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36303581	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Sx	4180186
36303582	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; FLUB; FLUBV; Fluorescent antibody; Fluoresent; FLUV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Low; Lower resp; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF	4180186
36303582	FLUBV Ag Lower resp Ql IF	4180186
36303582	流感病毒 B 型 抗原:存在情况或阈值:时间点:呼吸道.下:序数型:免疫荧光法	4182948
36303583	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36303584	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Wnd	4180186
36303584	伤口床组套:-:时间点:伤口:-	4182948
36303585	Abd; Abdo; Abdomen+; Abdominal; Add; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L/sp; L-spine; Lumbar; Lumbo; Playbook; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord; Vertebroplasty addl	4180186
36303585	Guided L-spine Vertebroplasty addl	4180186
36303585	旨在额外椎体成形术的引导:发现:时间点:腹部>脊椎.腰段:文档型:{成像方式}	4182948
36303587	# days of training & skill practice in amputation or prosthesis care; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36303589	50M p fruct PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; Levulose; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Revulose; Volfr; Volume fraction	4180186
36303589	Breath H2 50M p fruct PO	4180186
36303589	氢/已呼出的气体^在口服剂量果糖之后50分钟:体积分数:时间点:呼出的气体:定量型	4182948
36303590	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Corn/Cnjt; Corneal; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Myco; Mycobact; Nominal; Point in time; Random; Spec; species; spp; Tuberculosis	4180186
36303590	Mycobacterium Corn/Cnjt Cult	4180186
36303590	分枝杆菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:角膜/结膜:名义型:微生物特异性培养	4182948
36303593	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cysticercosis; Cysticercus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T sol; T sol lar; T solium; Tapeworm; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36303593	T sol lar DNA Tiss Ql NAA+probe	4180186
36303593	猪囊尾蚴 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36303595	ADL; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Low; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303597	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; OP; Point in time; Prenatal; Random; Visit note	4180186
36303597	OB OP Note	4180186
36303597	记录:发现:时间点:门诊病人:文档型:产科学	4182948
36303598	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36303599	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; EC aidA-I gene; Escherichia coli adhesion-involved-indiffuse-adherence; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vet; Veterinary	4180186
36303599	EC aidA-I gene Islt Ql NAA+probe	4180186
36303599	大肠埃希菌 aidA-I 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36303602	Count/time; Heart beat; HEART RATE.MOLEC; Misc; Miscellaneous; nRate; Number rate; Number Rate = Count/Time; Other; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36303602	Heart rate during apnea	4180186
36303602	心率^在呼吸暂停过程中:计数型速率:时间点:XXX:定量型	4182948
36303603	Surgery Parentrl thrpy note	4180186
36303603	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Parentrl thrpy note; Point in time; Random; Surg; Visit note	4180186
36303603	肠道外治疗记录:发现:时间点:{环境}:文档型:外科学	4182948
36303607	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV 229E; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303607	HCoV 229E RNA Aspirate Ql NAA+probe	4180186
36303607	人类冠状病毒 229E 型 RNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36303609	A pleuropn; A pleuropn 1+9+11; A pleuropn 1+9+11 Ab; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36303609	A pleuropn 1+9+11 Ab/Pos cntrl Ser IA	4180186
36303609	胸膜肺炎放线杆菌血清型 1+9+11 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36303611	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Coronavirus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NEG; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; TGEV; Transmissible gastroenteritis; Vet; Veterinary	4180186
36303611	TGEV Ab Ser IA	4180186
36303611	传染性胃肠炎病毒 抗体/阴性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36303612	Addiction; Carisoprodol metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn	4180186
36303612	Meprobamate Sal Ql Scn	4180186
36303612	氨甲丙二酯:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
36303617	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303624	#/area; Crys; Cryst; Crystal; Kidney; Leu; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36303624	Leucine Cry #/area UrnS	4180186
36303624	亮氨酸结晶:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36303629	Bact; Bacterial Susc Pnl; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Microbiology; Minimum bactericidal concentration; Minimum lethal concentration; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Sus; Susc; Suscept; Susceptibilities; Susceptibilty	4180186
36303629	Bacterial Susc Pnl Islt MLC	4180186
36303629	细菌抗生素敏感性试验组套:-:时间点:分离株:-:最小致死浓度法	4182948
36303631	Adeno virus; C&S; Cult; Cultures; HAdV; ID; Infectious Disease; InfectiousDisease; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Spec; Up; Upper resp	4180186
36303631	HAdV Upper resp Ql Cult	4180186
36303631	腺病毒:存在情况或阈值:时间点:呼吸道.上:序数型:微生物特异性培养	4182948
36303632	Abd; Abdo; Abdomen+; Abdominal; Art; Cardio; Cardiology; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Point in time; Rad; Radiology; Random; W emb ag IA	4180186
36303632	Guided Splenic a Embol--W emb ag IA	4180186
36303632	旨在栓塞的引导^采用动脉注射栓塞剂:发现:时间点:腹部>脾动脉:文档型:{成像方式}	4182948
36303633	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; G tube; G-tube place; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; UGI; Up	4180186
36303633	Guided UGI G-tube place	4180186
36303633	旨在置入胃造瘘管的引导:发现:时间点:腹部>胃肠道.上段:文档型:{成像方式}	4182948
36303634	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; E chaff groEL; E chaffeensis; HME; Human monocytic ehrlichiosis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36303634	E chaff groEL Bld Ql NAA+non-probe	4180186
36303634	查菲埃立克体 groEL 基因:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36303635	Activ; Actvty; Movements; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH	4180186
36303638	Arm; Cath; Change; CorePlaybook; CVC w port exch; Document; EXT; Finding; Findings; Guid; Guidance for exchange; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Replace; UE; Up	4180186
36303638	Guided UE CVC w port exch	4180186
36303638	旨在更换带有输液港的中心静脉导管的引导:发现:时间点:上肢:文档型:{成像方式}	4182948
36303639	Ang; Angio; Angiography; Angm; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; EXT; Extr ves; Extr-Bl; Finding; Findings; Imaging; LE; LE ves; LE ves-Bl; LE-Bl; Leg; Low; Point in time; Rad; Radiology; Random; Vesl; Vessels.XXX; W contr IV; WC	4180186
36303639	CTA LE ves-Bl W contr IV	4180186
36303639	多层^采用静脉注射对比剂:发现:时间点:下肢.双侧>下肢血管类:文档型:CT.血管造影术	4182948
36303641	Centers for Medicare and Medicaid Assessment; Conditions related to ID/DD status; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
36303642	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD4+ Cells; CD3+CD4+CD27+CD62L+ cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; Inducer T cells; L3T4; LAM-1; LECAM-1; Leu3; Leu-3; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; T3; T4; T-4; T4 helper/inducer cells; TQ-1; W3/25; WB; Whole blood	4180186
36303642	CD3+CD4+CD27+CD62L+ cells # Bld	4180186
36303642	细胞.CD3+CD4+CD27+CD62L+:计数型浓度:时间点:全血:定量型	4182948
36303646	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36303646	Polytrauma Phone Note	4180186
36303646	记录:发现:时间点:电话就医:文档型:多发性创伤	4182948
36303647	CD19+CD27+IgD-IgM- cells # Bld	4180186
36303647	#; ABS; absolute; absolutes; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+CD27+ cells; CD19+CD27+IgD+ Cells; CD19+CD27+IgD+IgM+ cells; CD19+CD27+IgD-IgM- cells; CD19+CD27+IgD-IgM+ cells; Cell; CELL MARKERS; Cellularity; Class-switched memory B cells; Cnt; Count; Count/volume; CT; HD-37; IgM-only memory B cells; Immune globulin D; Immune globulin M; Immunoglobulin D; Immunoglobulin M; Leu12; Leu-12; Marginal zone or nonswitched memory B cells; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; Total memory B cells; WB; Whole blood	4180186
36303647	细胞.CD19+CD27+IgD-IgM-:计数型浓度:时间点:全血:定量型	4182948
36303650	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Congenital rubella syndrome; FA; Fluorescent antibody; Fluoresent; German measles; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RUBV; Screen; Serum; SR; Time Resolved Fluorescence; TRF	4180186
36303650	RUBV Ab Ser Ql IF	4180186
36303650	风疹病毒 抗体:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
36303656	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Report period; Survey	4180186
36303660	Assoc; CLIN; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; Special circ assoc obs pnl	4180186
36303660	Special circ assoc obs pnl	4180186
36303660	特殊情况相关观察组套:-:时间点:^患者:-	4182948
36303661	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Boutonneuse fever; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Mediterranean spotted fever; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; R conorii; Random; Ricket; Rickettsial; Screen; Serum; Spotted fever; SR; SUDS	4180186
36303661	R conorii IgM Ser Ql IA	4180186
36303661	康氏立克次体 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36303665	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303665	ZEA Spec-mCnt	4180186
36303665	玉米赤霉烯酮:质量含量:时间点:XXX:定量型	4182948
36303666	DOC.ONT; Document; Finding; Findings; Gyn; Gynecology; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random	4180186
36303666	OB Checklist	4180186
36303666	检查清单:发现:时间点:{环境}:文档型:产科学	4182948
36303667	ANTIBIOTIC SUSCEPTIBILITIES; AST; Convenia; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36303667	Cefovecin Susc Islt	4180186
36303667	头孢维星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36303669	Centers for Medicare and Medicaid Assessment; Dextro; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303674	Bands; bnd; Chemistry; Hematology; Heme; IFE; Ifix; II; Immunofixation electrophoresis; Kidney; Level; M Protein; M Protein 2; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; Urn	4180186
36303674	M Protein 2 Ur IFE-mCnc	4180186
36303674	蛋白质.单克隆型 区带 2:质量浓度:时间点:尿液:定量型:免疫固定电泳分析法	4182948
36303676	100 CD19 cells; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD27 Cells; CD27- cells; Cell; CELL MARKERS; Cells.CD27+; Cellularity; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; WB; Whole blood	4180186
36303676	CD27 Cells/100 CD19 cells NFr Bld	4180186
36303676	细胞.CD27/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
36303678	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36303679	Centers for Medicare and Medicaid Assessment; LTPAC; MDS; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303680	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303681	#; ABS; absolute; absolutes; Alfa; B; Blood; CD4 Cells; CD4+CD8+ Cells; Cell; CELL MARKERS; Cell.DNT-CD45R+TCRa b; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; FC; Helper T cells; Inducer T cells; L3T4; Leu2; Leu-2; Leu3; Leu-3; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; T4; T-4; T8; T-8; TCR A-B; Tsuppressor; W3/25; WB; Whole blood	4180186
36303681	Cell.DNT-CD45R+TCRa b # Bld FC	4180186
36303681	细胞.CD4-CD8-CD45R+TCR alpha beta+:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36303684	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; S prime; Survey	4180186
36303685	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303686	Pan; Panl; Pnl; Point in time; Random; Survey	4180186
36303687	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Disialolganglioside; EIA; ELFA; ELISA; Enzyme immunoassay; GD1a; GD1a Gangl; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
36303687	GD1a Gangl IgG+IgM Ser IA-aCnc	4180186
36303687	神经节苷脂 GD1a 抗体.IgG+IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36303693	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Breakbone fever; Dengue fever; Dengue type I; Dengue type I+II+III+IV; Denv; DENV 1+2+3+4; DENV 1+2+3+4 RNA; DENV1; DENV1+2+3+4; DNA NUCLEIC ACID PROBE; DNA probe; Flavivirus; i; ID; Identity or presence; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; SerBld; Serum; Serum or whole blood; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36303693	DENV 1+2+3+4 RNA SerBld NAA+probe	4180186
36303693	登革热病毒 1 与 2 与 3 与 4 型 RNA:存在与否或特征标识:时间点:血清/全血:名义型:探针法.基因扩增.靶向	4182948
36303695	CT Neck to Pelvis W contr IV	4180186
36303695	Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Neck to Pelvis; Pelvic; Point in time; Rad; Radiology; Random; Thorax; W contr IV; WC	4180186
36303695	多层^采用静脉注射对比剂:发现:时间点:颈部+胸部+腹部+盆腔:文档型:CT	4182948
36303698	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV1; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; Pork; PPIV1; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36303698	PPIV1 RNA Spec Ql NAA+probe	4180186
36303698	猪副流感病毒 1 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36303699	Adeno virus; C&S; Corn/Cnjt; Corneal; Cult; Cultures; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36303699	HAdV Corn/Cnjt Ql Cult	4180186
36303699	腺病毒:存在情况或阈值:时间点:角膜/结膜:序数型:微生物特异性培养	4182948
36303702	Chlordane metabolite; DRUG/TOXICOLOGY; Drugs; Heptachlorane; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303702	Heptachlor Spec-mCnt	4180186
36303702	七氯:质量含量:时间点:XXX:定量型	4182948
36303703	Arterial Stenosis; CLIN; Dial unit visit part of CKD educ; Dialy; Dis; Diseases; Dz; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36303703	Dial unit visit part of CKD educ	4180186
36303703	作为慢性肾脏疾病教育组成部分的透析单元就诊:发现:时间点:^患者:序数型	4182948
36303709	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303710	Cardio; Cardiology; Gram Stn; Heart Disease; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; PCAR; Pericardial Fluid; Point in time; Random; St; Stains; Stn	4180186
36303710	Gram Stn Pcar	4180186
36303710	显微镜观察:存在与否或特征标识:时间点:心包液:名义型:革兰氏染色法	4182948
36303721	Catalytic Concentration; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; LIPA; Lipase; LPS; Pancreatic lipase; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Steapsin; Tributyrase; Tributyrinase	4180186
36303721	Lipase DiafP-cCnc	4180186
36303721	三酰基甘油脂肪酶:催化浓度:时间点:腹膜透析液:定量型	4182948
36303723	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; CMV; Cytomegalo virus; Cytomgal; DFA; FA; Fluorescent antibody; Fluoresent; HHV-5; Human Herpesvirus-5; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36303723	CMV Ag CSF Ql IF	4180186
36303723	巨细胞病毒 抗原:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36303724	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; Cath; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Plac of cath; Playbook; Point in time; PTBD; Rad; RADIOLOGY; Random; Transhep cath place	4180186
36303724	Guided BDs Transhep cath place	4180186
36303724	旨在经肝置入导管的引导:发现:时间点:腹部>胆管类:文档型:{成像方式}	4182948
36303727	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36303729	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303730	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; PM+R; Point in time; Random; Visit note	4180186
36303730	PM+R Counseling note	4180186
36303730	咨询记录:发现:时间点:{环境}:文档型:物理医学与康复学	4182948
36303732	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36303733	Chemistry; Mass Content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303733	Sulfur Spec-mCnt	4180186
36303733	硫:质量含量:时间点:XXX:定量型	4182948
36303736	Add; Cath; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; Thromb infusion addl day; Thrombolysis; To be specified in another part of the message; Unspecified; Vesl; W thromb via cath	4180186
36303736	Guided Throm inf add day W throm in cath	4180186
36303736	旨在额外输注一天溶栓剂的引导^采用经导管给予的溶栓剂:发现:时间点:XXX>血管:文档型:{成像方式}	4182948
36303737	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Wnd	4180186
36303737	伤口面积:面积:时间点:伤口:定量型	4182948
36303741	4 weeks; Finding; Findings; Last; Levels; Levl; LMTED; LTD; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH	4180186
36303742	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C burnet; C burnetii; Coxiella burnettii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36303742	C burnet DNA Bld Ql NAA+probe	4180186
36303742	贝氏柯克斯体 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36303743	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV 1+2 DNA Pnl; HSV1; HSV1+2; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36303743	HSV 1+2 DNA Pnl Spec NAA+probe	4180186
36303743	单纯疱疹病毒 1 与 2 型组套:-:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36303745	Chemistry; Level; Mass concentration; Misc; Miscellaneous; Na; Na+; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303745	Sodium Spec-mCnc	4180186
36303745	钠:质量浓度:时间点:XXX:定量型	4182948
36303748	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36303749	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seneca Valley Virus; Spec; SVA; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303749	SVA Spec Ql Cult	4180186
36303749	塞内卡病毒 A:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36303753	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36303754	DRUG/TOXICOLOGY; Drugs; Level; OXC; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Trileptal	4180186
36303754	OXcarbazepine Trough SerPl-sCnc	4180186
36303754	奥卡西平^波谷:物质的量浓度:时间点:血清/血浆:定量型	4182948
36303756	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.MTLHLTH	4180186
36303758	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Versed	4180186
36303758	Midazolam Sal Cfm-mCnc	4180186
36303758	咪达唑仑:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36303759	BLOOD BANK; Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36303759	P2 phenotype RBC Ql	4180186
36303759	P2 表型:存在情况或阈值:时间点:红细胞:序数型	4182948
36303761	CT T+L-Spine WO+W contr IV	4180186
36303761	多层^不采用 & 采用静脉注射对比剂:发现:时间点:胸部>脊椎.胸段 & 腹部>脊椎.腰段:文档型:CT	4182948
36303761	Abd; Abdo; Abdomen+; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord; T Spine+Ab; T+L-Spine; Th/sp; Thorax; T-spine; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36303764	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36303765	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; MDMA; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn	4180186
36303765	MDMA Sal Ql Scn	4180186
36303765	亚甲基二氧甲基苯丙胺:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
36303769	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; PT; Random; Survey	4180186
36303770	Disyston; Disystox; Dithiodemeton; Dithiosystox; DRUG/TOXICOLOGY; Drugs; Dy-syston; Frumin AL; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Solvirex; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303770	Disulfoton Spec-mCnt	4180186
36303770	乙拌磷:质量含量:时间点:XXX:定量型	4182948
36303771	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f013; f13; f447; IgE RAST; Immune globulin E; Immunoglobulin E; NR1B1; Ordinal; Peanut; Peanut (rAra h) 6; Point in time; PR; QL; Qual; Qualitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; Screen; Serum; SR	4180186
36303771	落花生 重组 (rAra h) 6 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
36303771	Deprecated Peanut (rAra h) 6 IgE RAST Ql	4180186
36303772	Average; Avg; Breathing; Lung; Lungs; MAP; Mean Pres; Point in time; Pressure; Pressure mean; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
36303772	Mean Pres on vent Airway	4180186
36303772	压力.平均值^采用呼吸机:压力或压强:时间点:呼吸系统.气道:定量型	4182948
36303776	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HBoV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303776	HBoV DNA Lower resp Ql NAA+probe	4180186
36303776	人博卡病毒 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36303779	Care plan; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Treatment plan; Ulcer; Visit note	4180186
36303779	医疗服务计划记录:发现:时间点:{环境}:文档型:脑损伤	4182948
36303784	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV3; Human respirovirus 3; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PCR; PI3; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303784	HPIV3 RNA Lower resp Ql NAA+probe	4180186
36303784	副流感病毒 3 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36303786	Addiction med Administrative note	4180186
36303786	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36303786	行政管理记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36303787	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Me-phenidate; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Ritalin; Sal; Scn; Scr; Screen; Scrn	4180186
36303787	Me-phenidate Sal Ql Scn	4180186
36303787	哌甲酯:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
36303789	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B hyody; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36303789	B hyody DNA Ct Spec Qn NAA+probe	4180186
36303789	猪痢疾短螺旋体 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36303790	Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn	4180186
36303790	Epi Cells Ur Ql	4180186
36303790	上皮细胞:存在情况或阈值:时间点:尿液:序数型	4182948
36303791	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36303791	OB Procedure note	4180186
36303791	操作记录:发现:时间点:{环境}:文档型:产科学	4182948
36303792	1 week; Bitumen; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Road tar; Screen; Surf; Survey; SURVEY.GNHLTH	4180186
36303793	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Lung; Microbiology; Nominal; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; Random; Respiratory; thoracentesis fluid	4180186
36303793	Bacteria Plr Anaerobe Cult	4180186
36303793	细菌 已鉴定的:存在与否或特征标识:时间点:胸膜液:名义型:厌氧微生物培养	4182948
36303794	SVA Ab Titr Ser IF	4180186
36303794	塞内卡病毒 A 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36303794	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Seneca Valley Virus; Serum; SmQn; SR; SVA; SVA Ab; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Vet; Veterinary	4180186
36303795	Advanced; Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303797	Blood; BSA pred.non black; Chemistry; EGFR; Estimated GFR; GFR; GFR/1.73 sq M; Glom; Kidney; Nephrology; Pl; PlasBld; Plasma; Plsm; Point in time; Pred GFR; Pred GFR.non Black; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood	4180186
36303797	GFR/BSA pred.nonblk SerPl CKD-EPI-ArVRat	4180186
36303797	肾小球滤过率/1.73 平方米.预测型.非黑人:单位面积体积速率:时间点:血清/血浆/全血:定量型:基于肌酐的公式 (CKD-EPI)	4182948
36303798	Contract; DOC.ONT; Document; Finding; Findings; LTC fac; LTCF; nursing; Point in time; Random	4180186
36303798	Nurse LTC fac Agreement	4180186
36303798	协议:发现:时间点:长期医疗服务设施:文档型:护士	4182948
36303800	Antipsychotic received in last 7D or since admission/reentry if less than 7D; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36303801	Heart rate p BD	4180186
36303801	After; Count/time; Heart beat; HEART RATE.MOLEC; Misc; Miscellaneous; nRate; Number rate; Number Rate = Count/Time; Other; p BD; Point in time; PST; Pulse; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36303801	心率^在支气管扩张之后:计数型速率:时间点:XXX:定量型	4182948
36303802	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L/sp; L-spine; Lumbar; Lumbo; Playbook; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord	4180186
36303802	Guided L-spine Puncture	4180186
36303802	旨在穿刺的引导:发现:时间点:腹部>脊椎.腰段:文档型:{成像方式}	4182948
36303805	Finding; Findings; Hospitalization hx; Nominal; Report period; Survey; SURVEY.GNHLTH	4180186
36303808	Arbitrary concentration; Bind; Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Fac; Fact; Hematology; Heme; Inhib; Inhibit; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Von will; Vonwillebrand; vWf; vWF CBA inhibitor	4180186
36303808	vWF CBA inhibitor PPP Chro-aCnc	4180186
36303808	von Willebrand 因子胶原结合黏附抑制剂:任意型浓度:时间点:贫血小板血浆:定量型:凝血因子酶学测定法	4182948
36303813	APTA; Identity or presence; Nominal; Physical Therapy; Point in time; PT; Random	4180186
36303813	Manual therapy technique used	4180186
36303813	所采用的手法治疗技法:存在与否或特征标识:时间点:^患者:名义型	4182948
36303814	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCMV; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303814	LCMV RNA CSF Ql NAA+probe	4180186
36303814	淋巴细胞性脉络丛脑膜炎病毒 RNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36303816	Breathing; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; TV; Vol; Volume; VT; VT.inspired	4180186
36303816	VT.inspired	4180186
36303816	潮气量.吸入:体积型属性:时间点:呼吸系统:定量型	4182948
36303817	Acd; Acid fast Stn; Acids; AF; AFB stain; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; St; Stains; Stn	4180186
36303817	Acid fast Stn Amn	4180186
36303817	显微镜观察:存在与否或特征标识:时间点:羊水:名义型:抗酸染色法	4182948
36303818	Nurse pract E+M Radiation exposure note	4180186
36303818	Assessment; DOC.ONT; Document; E+M Radiation exposure; E+M Radiation exposure note; Encounter; Eval; Evaluation and management; Evaluation and management note; Exp; Finding; Findings; H&P; History and physical; notes; nursing; Point in time; Random; Visit note	4180186
36303818	辐射暴露评价与管理记录:发现:时间点:{环境}:文档型:执业护士	4182948
36303820	Plat Gp IV Ab SerPl Ql IA	4180186
36303820	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CD36 Antigen; EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; IAA; MEIA; Ordinal; Pl; Plasma; Plat Gp; Plat Gp IV; Platelets; Platelt; Plsm; Plt; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Thrombocyte; Thrombocytes	4180186
36303820	血小板糖蛋白 IV 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
36303822	4-Hydroxycoumarin; C31H23BrO3; DRUG/TOXICOLOGY; Drugs; HAVOC; Klerat; Mass content; Misc; Miscellaneous; Other; Point in time; PP581; QNT; Quan; Quant; Quantitative; Random; Spec; Talon; To be specified in another part of the message; Unspecified; Vet; Veterinary; Volid; WBA8119	4180186
36303822	Brodifacoum Spec-mCnt	4180186
36303822	溴鼠灵:质量含量:时间点:XXX:定量型	4182948
36303823	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; SB; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303823	Antimony Spec-mCnt	4180186
36303823	锑:质量含量:时间点:XXX:定量型	4182948
36303828	100 CD19 cells; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD27 Cells; CD27- cells; CD27+IgD- cells; CD27+IgD+ cells; CD27+IgD+IgM+ cells; CD27+IgD-IgM- cells; CD27+IgD-IgM+ cells; CD27-IgD+ cells; Cell; CELL MARKERS; Cellularity; HD-37; Immune globulin D; Immune globulin M; Immunoglobulin D; Immunoglobulin M; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; WB; Whole blood	4180186
36303828	CD27+IgD-IgM-/100 CD19 cells NFr Bld	4180186
36303828	细胞.CD27+IgD-IgM-/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
36303829	Cereb; NEURO; Neurology; Nominal; Point in time; Random; Typ	4180186
36303829	脑监测仪:类型:时间点:^患者:名义型	4182948
36303832	AUDIO; Audiology; Ear-R; Hearing; Otologic; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT	4180186
36303832	Hearing threshold 2000 Hz Ear-R	4180186
36303832	听阈^2000 赫兹:相对声强:时间点:耳.右侧:定量型	4182948
36303834	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
36303837	3 Self-Sustaining Sequence Replication; 3SR SR; Amebic keratitis; Amebic meningoencephalitis; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Eye; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ophthalmology; Ophtho; Ophthy; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Soil amoeba; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303837	Acanthamoeba DNA Corn/Cnjt Ql NAA+probe	4180186
36303837	棘阿米巴属单个未知种 DNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36303839	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; OP; Outpt Hosp; Point in time; Random; Visit note	4180186
36303839	Outpt Hosp Note	4180186
36303839	记录:发现:时间点:门诊型医院:文档型:{角色}	4182948
36303840	3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M tb; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TB; TMA; Transcription mediated amplification; Tuberculosis	4180186
36303840	M tb DNA Corn/Cnjt Ql NAA+probe	4180186
36303840	结核分枝杆菌 DNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36303841	BON; Bx; CorePlaybook; Deep Bx; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36303841	Guided Bone Deep Bx	4180186
36303841	旨在深部活组织检查的引导:发现:时间点:XXX>骨:文档型:{成像方式}	4182948
36303842	Blood; Chr X + Y aneup; Chromosom; Chromosomes; Document; Finding; Findings; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36303842	Chr X + Y aneup Bld/T FISH	4180186
36303842	染色体 X 与 Y 非整倍体性:发现:时间点:全血/组织:文档型:FISH	4182948
36303847	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303847	FLUBV RNA Corn/Cnjt Ql NAA+probe	4180186
36303847	流感病毒 B 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36303848	Chemistry; Hematology; Heme; IFE; Ifix; Immunofixation electrophoresis; Kidney; Level; M Protein; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Nephrology; Para protein; Paraprotein; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; Urn	4180186
36303848	M Protein Ur IFE-mCnc	4180186
36303848	蛋白质.单克隆型:质量浓度:时间点:尿液:定量型:免疫固定电泳分析法	4182948
36303849	DRUG/TOXICOLOGY; Drugs; Ergot Poisonings; Ergotisms; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303849	Ergocryptine Spec-mCnt	4180186
36303849	麦角隐亭:质量含量:时间点:XXX:定量型	4182948
36303850	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Throat; TMA; Trachoma; Transcription mediated amplification; Upper respiratory	4180186
36303850	C trach DNA Throat Ql NAA+probe	4180186
36303850	沙眼衣原体 DNA:存在情况或阈值:时间点:咽喉:序数型:探针法.基因扩增.靶向	4182948
36303853	Cardio; Cardiology; CorePlaybook; Document; EXT; Extr v; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Playbook; Point in time; Rad; Radiology; Random; Stab phlebectomy GE21; Ven; Venous	4180186
36303853	Guided Extr v Stab phlebectomy GE21	4180186
36303853	旨在大于等于21次静脉曲张点式抽剥术的引导:发现:时间点:肢体>肢体静脉:文档型:{成像方式}	4182948
36303854	Octanoylcarn/C0 DBS-sRto	4180186
36303854	Blood; C0; C8; Carnitine Free; Carnitine.total; Chemistry; DBS; Dried blood spot; FC; Filter paper; FP; FR; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
36303854	辛酰肉碱 (C8)/肉碱.游离型 (C0):物质的量比率:时间点:全血.斑点:定量型	4182948
36303855	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Lung; Playbook; Point in time; Pulmonary; Pulmonology; Rad; Radiofreq abl; RADIOLOGY; Random; Respiratory; Thorax	4180186
36303855	Guided Lung Radiofreq abl	4180186
36303855	旨在射频消融术的引导:发现:时间点:胸部>肺:文档型:{成像方式}	4182948
36303856	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S apiospermum; S apiospermum DNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303856	S apiospermum DNA Islt Ql NAA+probe	4180186
36303856	尖端赛多孢 DNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36303858	Crystals Ur Ql	4180186
36303858	Crys; Cryst; Crystal; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn	4180186
36303858	结晶:存在情况或阈值:时间点:尿液:序数型	4182948
36303860	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
36303862	Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Trouble leisure activities with others	4180186
36303863	Aflatoxicosis; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Mycotoxin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303863	Aflatoxin G1 Spec-mCnt	4180186
36303863	黄曲霉毒素 G1:质量含量:时间点:XXX:定量型	4182948
36303864	CD3+CD45+ Cells # Bld	4180186
36303864	#; ABS; absolute; absolutes; B220; Blood; CD3 Cells; CD3+CD45+ Cells; CD3-CD45+ cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; LCA; Leu4; Leu-4; Leukocyte common antigen; Ly5; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T200; T3; WB; Whole blood	4180186
36303864	细胞.CD3+CD45+:计数型浓度:时间点:全血:定量型	4182948
36303865	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Corn/Cnjt; Corneal; DFA; FA; Fluorescent antibody; Fluoresent; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; TRF	4180186
36303865	HSV1 Ag Corn/Cnjt Ql IF	4180186
36303865	单纯疱疹病毒 1 型 抗原:存在情况或阈值:时间点:角膜/结膜:序数型:免疫荧光法	4182948
36303868	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GN Bld Culture Pnl; ID; Infectious Disease; InfectiousDisease; Microbiology; NEG; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
36303868	GN Bld Culture Pnl Bld Pos Probe	4180186
36303868	革兰氏阴性细菌血液培养组套:-:时间点:血液.生长阳性:-:DNA探针	4182948
36303871	Cardiac troponin T pnl; Chemistry; cTnT; HS; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T prime; TnT; Troponin	4180186
36303871	Cardiac troponin T pnl SerPl HS	4180186
36303871	肌钙蛋白 T.心脏 组套:-:时间点:血清/血浆:-:高灵敏度方法	4182948
36303872	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303873	ADMIN; Nominal; Person name; Point in time; Random	4180186
36303873	第二联系人姓名:人员姓名:时间点:^联系人:名义型	4182948
36303876	Cath; CorePlaybook; CVC inject; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
36303876	Guided Chest CVC inject	4180186
36303876	旨在中心静脉导管注射的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36303878	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303878	Zearalenol Spec-mCnt	4180186
36303878	玉米赤霉烯醇:质量含量:时间点:XXX:定量型	4182948
36303881	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dextro; ENA; ENA SM; ENA SM-D; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh; Rhesus; Screen; Serology; Serum; SM; SmD; SR	4180186
36303881	ENA SM-D Ab Ser Ql Line blot	4180186
36303881	Smith 可提取性核 D 抗体:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36303882	AL; Aluminium; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303882	Aluminum Spec-mCnc	4180186
36303882	铝:质量浓度:时间点:XXX:定量型	4182948
36303885	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
36303887	99 mTC; 99mTc; Abd; Abdo; Abdomen+; Abdominal; Art; Cardio; Cardiology; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Hep a; Hepar; Imaging; Inj; Liver; Liver artery; Macro aggregate albumin; Microalbumin aggregate albumin; Point in time; Rad; Radiology; Random; Scan; TC-99CM; Tc99m; TC-99M; Technetium 99m	4180186
36303887	Guided Hep a Inj--W Tc-99m MAA IA	4180186
36303887	旨在注射的引导^采用动脉注射 Tc-99m MAA:发现:时间点:腹部>肝动脉:文档型:{成像方式}	4182948
36303890	Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nasopharynx; Nominal; Point in time; Random; St; Stains; Stn	4180186
36303890	Gram Stn Nph	4180186
36303890	显微镜观察:存在与否或特征标识:时间点:鼻咽:名义型:革兰氏染色法	4182948
36303891	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303892	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Parentrl thrpy note; Point in time; Random; Visit note	4180186
36303892	Internal Med Parentrl thrpy note	4180186
36303892	肠道外治疗记录:发现:时间点:{环境}:文档型:内科学	4182948
36303894	PAdV Ab Titr Ser IA	4180186
36303894	猪腺病毒 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36303894	ABS; Aby; Adeno virus; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; HAdV; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PAdV; Point in time; Pork; Random; Serum; SmQn; SR; SUDS; Swine; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36303895	Avatec; Bovatec; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303895	Lasalocid Spec-mCnt	4180186
36303895	拉沙里菌素:质量含量:时间点:XXX:定量型	4182948
36303896	CLIN; CLIN.RISK; HSCT risk score; HSCT risk score interp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36303896	HSCT risk score interp EBMT	4180186
36303896	造血干细胞移植风险评分解释:印象:时间点:^患者:序数型:EBMT	4182948
36303897	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Surf; Survey; SURVEY.GNHLTH	4180186
36303898	Dynamic; Flow; Infl trig.flow; Infl trigger flow; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume Rate; vRate	4180186
36303898	Infl trigger flow Vent	4180186
36303898	充气触发流量:体积速率:时间点:呼吸机:定量型	4182948
36303900	ADMIN; ADMIN.PATIENT; ADMIN.PATIENT.ID; Ident; Identifier; Ins group num; Intradermal; No; Nominal; Num; Point in time; Random	4180186
36303900	Ins group num	4180186
36303900	保险集团编号:标识符:时间点:^患者:名义型	4182948
36303901	H parasuis Ab/Pos cntrl Ser IA	4180186
36303901	副猪嗜血杆菌 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36303901	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; H parasuis; H parasuis Ab; Haemoph; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36303903	Addiction; Buprenorphine metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Gluc; Glucouronide; III; Illicit; N3G; NBU; norBUP; Norbuprenorphine glucuronide; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
36303903	N3G Ur Ql Scn	4180186
36303903	去甲基丁丙诺啡-3-葡糖苷酸:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36303904	Centers for Medicare and Medicaid Assessment; Dextro; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303905	Chloditan; Chlodithane; DRUG/TOXICOLOGY; Drugs; Khloditan; Lysodren; Mass content; Misc; Miscellaneous; Mitotane; Mytotan; o,p'- DDD; o,p'-DDD; ortho,para DDD; Other; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303905	o,p'- DDD Spec-mCnt	4180186
36303905	o,p'- 二氯二苯二氯乙烷:质量含量:时间点:XXX:定量型	4182948
36303908	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303909	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B duncani; B duncani 18S; B duncani 18S rRNA; Babesia WA1; Babesiosis; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Piroplasmosis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36303909	B duncani 18S rRNA Bld Ql NAA+non-probe	4180186
36303909	邓肯巴贝斯虫 18S rRNA 基因:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36303911	ACIF; Anticomplement Immunofluorescence; Bronchial alveolar lavage; Bronchoalveolar lavage; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Pulmonary; Pulmonology; Random; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory path Pnl; Respiratory virus panel; Respiratory viruses panel; RVP; Time Resolved Fluorescence; TRF	4180186
36303911	Respiratory path Pnl BAL IF	4180186
36303911	呼吸道病原体类组套:-:时间点:支气管肺泡灌洗液:-:免疫荧光法	4182948
36303912	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303912	CMV DNA Lower resp Ql NAA+probe	4180186
36303912	巨细胞病毒 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36303913	AUDIO; Audiology; Ear-R; Hearing; Otologic; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT	4180186
36303913	Hearing threshold 1000 Hz Ear-R	4180186
36303913	听阈^1000 赫兹:相对声强:时间点:耳.右侧:定量型	4182948
36303915	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303916	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; RSV; RSV A; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303916	RSV A RNA Corn/Cnjt Ql NAA+probe	4180186
36303916	呼吸道合胞病毒 A 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36303918	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ENA; ENA SS-A; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ro; Ro AB; Screen; Serology; Sjogren; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SS; SSA; SS-A	4180186
36303918	ENA SS-A Ab CSF Ql Line blot	4180186
36303918	Sjogrens 综合征-a 可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36303920	Assessment; Centers for Medicare and Medicaid Assessment; Disch; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303922	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303925	ABS; Aby; ANNA 2; ANNA-2; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Hu; Hu2; II; Neuro; Neurology; Neuronal nuclear type II; Nuc; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RI; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36303925	Hu2 Ab CSF Ql Line blot	4180186
36303925	神经元细胞核 2 型 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36303926	Turbidity Wat	4180186
36303926	Arbitrary; Point in time; QNT; Quan; Quant; Quantitative; Random; SPEC; Wat	4180186
36303926	浊度:任意型:时间点:水:定量型	4182948
36303927	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303927	HSV2 DNA Corn/Cnjt Ql NAA+probe	4180186
36303927	单纯疱疹病毒 2 型 DNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36303929	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Parentrl thrpy note; Point in time; Random; Visit note	4180186
36303929	Parentrl thrpy note	4180186
36303929	肠道外治疗记录:发现:时间点:{环境}:文档型:{角色}	4182948
36303930	AUDIO; Audiology; Ear-L; Hearing; L; LT; Otologic; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36303930	Hearing threshold 4000 Hz Ear-L	4180186
36303930	听阈^4000 赫兹:相对声强:时间点:耳.左侧:定量型	4182948
36303933	Bowel movement; Faecal; Faeces; Fecal; Feces; Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Stl; Stool = Fecal	4180186
36303933	Micro CNAMTS panel Stl	4180186
36303933	微生物学 CNAMTS 组套:-:时间点:大便:-	4182948
36303935	ANTIBIOTIC SUSCEPTIBILITIES; AST; BS Poeder; Coccidiox; Coliprim; Cordixina; Cosumix; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Prinzone; Pyradan; Random; Sulfachlorpyridazine; Sulfaclozine sodium; Sulphachlorpyridazine; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary; Vetisulid	4180186
36303935	Sulfachloropyridazine Susc Islt	4180186
36303935	磺胺氯哒嗪:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36303937	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; L intracell; MEIA; Microbiology; NEG; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36303937	L intracell Ab Ser IA	4180186
36303937	胞内劳森菌 抗体/阴性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36303939	BDI FS; BDI FS total score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Scn; Scr; Scrn; Survey; Tot; Totl	4180186
36303942	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; CoV 229E+HKU1+NL63+OC43; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV 229E; HCoV 229E+HKU1+NL63+OC43; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303942	HCoV 229E+HKU1+NL63+OC43 Nph Ql NAA+Pr	4180186
36303942	人类冠状病毒 229E+HKU1+NL63+OC43 RNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
36303943	Heart rate W exercise	4180186
36303943	Count/time; EXCZ; Heart beat; HRTRATE.PSTN.MOLEC; Misc; Miscellaneous; nRate; Number rate; Number Rate = Count/Time; Other; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36303943	心率^采用运动:计数型速率:时间点:XXX:定量型	4182948
36303944	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36303945	3-(1-methylbutyl)phenyl ester; Bux; DRUG/TOXICOLOGY; Drugs; m-(1-Methylbutyl)phenyl methylcarbamate; Mass content; Metalkamate; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303945	Bufencarb Spec-mCnt	4180186
36303945	合杀威:质量含量:时间点:XXX:定量型	4182948
36303946	Breathing; Lung; Lungs; Point in time; Press.plat; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
36303946	Press.plat on vent Airway	4180186
36303946	压力.平台期^采用呼吸机:压力或压强:时间点:呼吸系统.气道:定量型	4182948
36303947	铬:质量含量:时间点:XXX:定量型	4182948
36303947	c609; Chrome; CR; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303947	Cr Spec-mCnt	4180186
36303949	Wells PE risk pnl	4180186
36303949	CLIN; CLIN.RISK; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Pulm; Random	4180186
36303951	Antigen; Antigens; Aspergillus galactomannan; Bronchial alveolar lavage; Bronchoalveolar lavage; GM; ID; Infectious Disease; InfectiousDisease; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
36303951	Galactomannan Ag BAL Ql	4180186
36303951	半乳甘露聚糖 抗原:存在情况或阈值:时间点:支气管肺泡灌洗液:序数型	4182948
36303955	Acd; Acid fast Stn; Acids; AFB stain; BIFL; Bile fluid; Biliary fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
36303955	Acid fast Stn Bifl	4180186
36303955	显微镜观察:存在与否或特征标识:时间点:胆汁:名义型:抗酸染色法	4182948
36303958	6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; Acetylmorphine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin metabolite; Illicit; MAM; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn	4180186
36303958	6MAM Sal Ql Scn	4180186
36303958	6-单乙酰吗啡:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
36303960	Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36303962	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303966	A pleuropn; A pleuropn 12; A pleuropn 12 Ab; A pleuropn Sertyp; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36303966	A pleuropn 12 Ab/Pos cntrl Ser IA	4180186
36303966	胸膜肺炎放线杆菌血清型 12 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36303968	BM; BON; Bone marrow; Control; Erythrocytosis; Genetics; Heredity; Heritable; Inherited; JAK2 p.V617F; JAK2 p.V617F mut; Janus kinase 2; Janus kinase 2 gene; JTK10; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; P prime; PCR; Point in time; Polycythemia vera; PV; QNT; Quan; Quant; Quantitative; Random; Relative ratio; THCYT3	4180186
36303968	JAK2 p.V617F mut/Nor Mar	4180186
36303968	JAK2 基因.p.V617F 突变体/正常:相对比率:时间点:骨髓:定量型:分子遗传学类实验室方法	4182948
36303969	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Head+Sinuses; Imaging; Intracranial; Paranasal sinuses; Point in time; Rad; RADIOLOGY; Random; Sinus; Skull; without contrast	4180186
36303969	CT Head+Sinuses WO contr	4180186
36303969	多层^不采用对比剂:发现:时间点:头部 & 头部>副鼻窦类:文档型:CT	4182948
36303970	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guidance.stereotactic for localization; Guide; Guided; Imaging; Local; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; Stereo; Str loc; To be specified in another part of the message; Unspecified	4180186
36303970	CT Guided Str loc	4180186
36303970	旨在为立体定位的引导:发现:时间点:XXX:文档型:CT	4182948
36303972	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; MN; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36303972	Manganese Spec-mCnt	4180186
36303972	锰:质量含量:时间点:XXX:定量型	4182948
36303975	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36303975	Nucleosome Ab CSF Ql Line blot	4180186
36303975	核小体 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36303976	3 Self-Sustaining Sequence Replication; 3SR SR; A phag+Ehrl sp DNA Pnl; Amplif; Amplification; Amplified; Anaplasmosis; Blood; DNA NUCLEIC ACID PROBE; DNA probe; E equi; E phagocytophila; Ehrlichia equi; Ehrlichia phagocytophila; Ehrlichiosis; HGE; Human granulocytic ehrlichiosis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36303976	A phag+Ehrl sp DNA Pnl Bld NAA+non-probe	4180186
36303976	嗜吞噬球无形体 & 埃立克体属 groEL 基因组套:-:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36303977	ACIF; Anticomplement Immunofluorescence; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Pulmonary; Pulmonology; Random; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory path Pnl; Respiratory virus panel; Respiratory viruses panel; RVP; Throat; Time Resolved Fluorescence; TRF; Upper respiratory	4180186
36303977	Respiratory path Pnl Throat IF	4180186
36303977	呼吸道病原体类组套:-:时间点:咽喉:-:免疫荧光法	4182948
36303978	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyssavirus; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Oral fluid; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Rabies; RABV; Random; Ribonucleic acid; Sal; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303978	RABV RNA Sal Ql NAA+probe	4180186
36303978	狂犬病病毒 RNA:存在情况或阈值:时间点:唾液:序数型:探针法.基因扩增.靶向	4182948
36303979	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Tum embol; Tum ischem or infarct embol; Unspecified; Vesl	4180186
36303979	Guided Ves Tum ischem or infarct embol	4180186
36303979	旨在肿瘤栓塞或缺血或梗死的引导:发现:时间点:XXX>血管:文档型:{成像方式}	4182948
36303981	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36303982	Arm; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Humerus; Imaging; Point in time; Rad; RADIOLOGY; Random; UE; UE-Bl; Up; Upper arm-Bl; Upper extremity; without contrast	4180186
36303982	CT Upper arm-Bl WO contr	4180186
36303982	多层^不采用对比剂:发现:时间点:上肢.双侧>上臂:文档型:CT	4182948
36303983	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; Implnt dev; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Prostheses; Prosthesis; Prosthetic; Random	4180186
36303983	Bacteria Implnt dev Aerobe Cult	4180186
36303983	细菌 已鉴定的:存在与否或特征标识:时间点:植入装置:名义型:需氧微生物培养	4182948
36303984	Bowel movement; C bot; C botulinum; C&S; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Stl; Stool = Fecal	4180186
36303984	C bot Stl Ql Cult	4180186
36303984	肉毒梭菌:存在情况或阈值:时间点:大便:序数型:微生物特异性培养	4182948
36303985	Cath; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax; Tun CVC place; Tun CVC wo port place	4180186
36303985	Guided Chest Tun CVC wo port place	4180186
36303985	旨在置入不带输液港的隧道式中心静脉导管的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36303986	Immunizations; Point in time; QNT; Quan; Quant; Quantitative; Random; Vaccine	4180186
36303986	疫苗接种指征失效日期:日期:时间点:^患者:定量型	4182948
36303987	MTB and RIF resistance Pnl Islt/Spm	4180186
36303987	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; c301; Compx; Deoxyribonucleic acid; Islt; Islt/Spm; Isol; M tb; M TB Cmplx; M tuberculosis; Mtb; MTB and RIF resistance Pnl; MTBC; Mut; Mutations; Myco; Mycobact; Mycobacterium tuberculosum; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent; RIF; Rifadin; Rifampicin; Rimactane; Spec; TB; Tuberculosis	4180186
36303987	结核分枝杆菌复合菌群 DNA 与 rpoB 基因利福平耐药性突变组套:-:时间点:分离株/标本:-	4182948
36303988	Finding; Findings; Job; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Work	4180186
36303991	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303995	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303998	Amebic keratitis; Amebic meningoencephalitis; C&S; Corn/Cnjt; Corneal; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Soil amoeba; Spec; species; spp	4180186
36303998	Acanthamoeba Corn/Cnjt Cult	4180186
36303998	棘阿米巴属单个未知种 已鉴定的:存在与否或特征标识:时间点:角膜/结膜:名义型:微生物特异性培养	4182948
36303999	Dialysis Interdisp Plan of care note	4180186
36303999	Care plan; Dialy; Dialysis Interdisp; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; multidisciplinary; notes; Point in time; Random; Treatment plan; Visit note	4180186
36303999	医疗服务计划记录:发现:时间点:{环境}:文档型:透析.跨学科	4182948
36304000	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304001	Acd; Acids; Chemistry; DHA; Docosahexaenoate; Docosapentaenic acid; DPA; Eicosapentaenoate; EPA; FA omega-3 + omega-6 panel; III; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36304001	FA omega-3 + omega-6 panel SerPl	4180186
36304001	脂肪酸 omega-3 与 omega-6 组套:-:时间点:血清/血浆:-	4182948
36304004	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304004	Urea Spec-mCnt	4180186
36304004	尿素:质量含量:时间点:XXX:定量型	4182948
36304006	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; EMCV; EMCV RNA; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Vet; Veterinary	4180186
36304006	EMCV RNA Tiss Ql NAA+probe	4180186
36304006	脑心肌炎病毒 RNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36304007	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; Pork; PR; Probe amp; Probe with ampification; Probe with target amplification; PSV; PSV RNA; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36304007	PSV RNA Spec Ql NAA+probe	4180186
36304007	猪萨佩罗病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36304008	Centers for Medicare and Medicaid Assessment; Identity or presence; International Classification of Diseases; Nominal; Point in time; Random; Survey	4180186
36304009	Add; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified; Wire place addl	4180186
36304009	Guided Unsp region Wire place addl	4180186
36304009	旨在额外置入导丝的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36304010	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36304010	Dehydroaripiprazole SerPl Cfm-mCnc	4180186
36304010	脱氢阿立哌唑:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
36304011	Blood; DRUG/TOXICOLOGY; Drugs; Horizant; Neurontin; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
36304011	Gabapentin SerPlBld Ql Scn	4180186
36304011	加巴喷丁:存在情况或阈值:时间点:血清/血浆/全血:序数型:毒理学筛查试验	4182948
36304012	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36304012	转诊记录:发现:时间点:{环境}:文档型:妇科学	4182948
36304013	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304014	1 week; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
36304016	Art sys; Blood pressure; BLOOD PRESSURE MEASUREMENTS.MOLEC; Blood pressure systolic; BP; BP sys; BP systolic; Cardio; Cardiology; Heart Disease; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; SBP; Sys BP	4180186
36304016	BP sys--during anesthesia	4180186
36304016	血管内心脏收缩期^在麻醉过程中:压力或压强:时间点:动脉系统:定量型	4182948
36304018	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Mixed connective tissue disorder; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Raynaud's Disease; Ribonuclear protein; RNP; Serology; Serum; snRNP; snRPA; SR; Systemic lupus erythematosus; U1 RNP; U1 snRNP; U1 snRNP-A; U1RNP	4180186
36304018	U1 snRNP-A Ab Ser Line blot-aCnc	4180186
36304018	U1 小细胞核核糖核蛋白 A 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36304020	Amplification; BAT-26; Blood; COCA1; Colon cancer nonpolyposis type 1; Del; Del+Dup; Deletions; DIAR5; Document; Dp; EGP-2; EGP314; EGP40; EPCAM Exons 8 + 9; epithelial cell adhesion molecule; ESA; FCC1; Finding; Findings; HNPCC; HNPCC1; HNPCC8; KS1/4; KSA; LCFS2; Lynch syndrome; M4S1; MIC18; MK-1; Molecular genetics; Molecular pathology; MOLPATH; MSH2 Del+Dup+Full EPCAM 8+9; MSH2 DelDup+Full + EPCAM Ex8+9 DelDup; Mut; Mutations; mutS homolog 2; PCR; Point in time; Random; TACSTD1; Tissue; Tissue, unspecified; TROP1; WB; Whole blood; Whole blood or Tissue	4180186
36304020	MSH2 DelDup+Full EPCAM 8+9 DelDup Bld/T	4180186
36304020	MSH2 基因缺失+重复与全面突变分析与 EPCAM 基因外显子 8 与 9 缺失+重复:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36304023	Disch; DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
36304023	出院检查清单:发现:时间点:{环境}:文档型:{角色}	4182948
36304025	Bact; Hearing; ID; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; Ordinal; Otologic; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36304025	Coccal bact Ear Ql Micro	4180186
36304025	球状细菌:存在情况或阈值:时间点:耳:序数型:显微镜检查.光学	4182948
36304026	Abd; Abdo; Abdomen+; Abdominal; Cardio; Cardiology; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Point in time; Rad; RADIOLOGY; Random; Suprarenal vein; Ven; Venous	4180186
36304026	Guided Adrenal v Venous sampling	4180186
36304026	旨在静脉采样的引导:发现:时间点:腹部>肾上腺静脉:文档型:{成像方式}	4182948
36304028	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304030	Average; Avg; Eastern Cooperative Oncology Group; Everyday Cognition; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
36304031	Abd; Abdo; Abdomen+; Abdominal; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; Playbook; Point in time; Rad; Radiology; Random; Renal; Transjugular Bx; Transjugular Bx+venography	4180186
36304031	Guided Kidney Transjugular Bx+venography	4180186
36304031	旨在经颈静脉活组织检查+静脉造影术的引导:发现:时间点:腹部>肾脏:文档型:{成像方式}	4182948
36304032	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; Hosp; Inpatient; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36304032	Gynecology Hosp Consult note	4180186
36304032	会诊记录:发现:时间点:医院:文档型:妇科学	4182948
36304034	Blood; CD117; c-KIT; Document; Finding; Findings; KIT Exon 8; mast/stem cell growth factor receptor; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mut Anl; Mutations; PBT; PCR; piebald trait; Point in time; Proto-oncogene tyrosine-protein kinase Kit; Random; SCFR; soluble KIT variant; Tissue; Tissue, unspecified; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
36304034	KIT Exon 8 Mut Anl Bld/T	4180186
36304034	KIT 基因外显子 8 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36304035	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36304035	Gynecology Educ note	4180186
36304035	教育记录:发现:时间点:{环境}:文档型:妇科学	4182948
36304036	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304040	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36304042	ADMIN; Ext ID; Nominal; Point in time; Random	4180186
36304042	Birth certifier Ext ID Provider	4180186
36304042	出生证明人员:扩展型标识符:时间点:服务提供者:名义型	4182948
36304043	Flurazepam Sal Cfm-mCnc	4180186
36304043	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dalmane; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
36304043	氟胺安定:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36304046	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Disialolganglioside; GD3 Gangl; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36304046	GD3 Gangl IgG+IgM Ser Ql Line blot	4180186
36304046	神经节苷脂 GD3 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36304049	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); k; Kell Blood Group System; Ordinal; P prime; P sup(k); Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR	4180186
36304049	P sup(k) Ab SerPl BPU Ql	4180186
36304049	P^k 抗体:存在情况或阈值:时间点:血清/血浆^血液制品单位:序数型	4182948
36304057	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304058	Heart beat; HEART RATE.ATOM; Nominal; Point in time; Pulse; Random; Typ	4180186
36304058	心率特殊情况:类型:时间点:^患者:名义型	4182948
36304060	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304070	Dx; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Placent; Placental; Point in time; Random	4180186
36304070	Placental condition	4180186
36304070	诊断:发现:时间点:胎盘:名义型	4182948
36304071	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary; Zn	4180186
36304071	Zinc Spec-mCnt	4180186
36304071	锌:质量含量:时间点:XXX:定量型	4182948
36304074	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304075	A pleuropn; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Vet; Veterinary	4180186
36304075	A pleuropn Ab/Pos cntrl SerPl IA	4180186
36304075	胸膜肺炎放线杆菌 抗体/阳性对照:相对比率:时间点:血清/血浆:定量型:免疫测定法	4182948
36304076	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304077	Cath; Change; CorePlaybook; CVC w port exch; Document; Finding; Findings; Guid; Guidance for exchange; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Replace; Thorax	4180186
36304077	Guided Chest CVC w port exch	4180186
36304077	旨在更换带有输液港的中心静脉导管的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36304078	NK cytotox.0.9:1 E:T/Pos cntrl Bld MC	4180186
36304078	Blood; HEMATOLOGY/CELL COUNTS; i; NK; NK cytotox.0.9:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
36304078	自然杀伤细胞细胞毒性.效应细胞/靶细胞比 0.9:1/阳性对照:相对任意型浓度:时间点:全血单个核细胞:定量型	4182948
36304079	Kidney; Mucous; Mucous Threads; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36304079	Mucous Threads UrnS Ql	4180186
36304079	粘液:存在情况或阈值:时间点:尿沉渣:序数型	4182948
36304080	Centers for Medicare and Medicaid Assessment; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304084	4th; Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-L; Finding; Findings; Finger.4th-L; Finger-L; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; UE; UE-L; Up; W contr IV; WC	4180186
36304084	CT Finger.4th-L W contr IV	4180186
36304084	多层^采用静脉注射对比剂:发现:时间点:上肢.左侧>手指.第四:文档型:CT	4182948
36304085	Phosphate goal mCnc SerPl	4180186
36304085	CLIN; i Phos; Inorganic phosphate; Level; Mass concentration; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pl; Plasma; Plsm; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36304085	磷酸盐目标:质量浓度:时间点:血清/血浆:定量型	4182948
36304087	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304089	99 mTC; 99mTc; Abd; Abdo; Abdomen+; Abdominal; Document; Films; Finding; Findings; Hepar; Hepatic; Imaging; Inj; Liver; Lung; Lung+Liver; Macro aggregate albumin; Microalbumin aggregate albumin; Point in time; Pulmonary; Pulmonology; Rad; RADIOLOGY; Random; Respiratory; Scan; TC-99CM; Tc99m; TC-99M; Technetium 99m; Thorax; View; VWS; W IA hepatic inj	4180186
36304089	NM Lung+Liver Views for AV shunt	4180186
36304089	针对动静脉分流的多重视图^采用 Tc-99m MAA+采用动脉内肝脏注射:发现:时间点:胸部>肺 & 腹部>肝脏:文档型:NM	4182948
36304092	Abd; Abdo; Abdomen+; Abdominal; Change; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Neph tube exchange; Nephric; Nephrology; NT; Perc; Playbook; Point in time; Rad; Radiology; Random; Renal; Replace	4180186
36304092	Guided Kidney Neph tube exchange	4180186
36304092	旨在经皮更换肾脏造瘘管的引导:发现:时间点:腹部>肾脏:文档型:{成像方式}	4182948
36304096	3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV + FLUBV; FLUAV + FLUBV Pnl; FLUAV+FLUBV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Respiratory; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304096	FLUAV + FLUBV Pnl Lower resp NAA+probe	4180186
36304096	流感病毒 A 与 B 型 RNA 组套:-:时间点:呼吸道.下:-:探针法.基因扩增.靶向	4182948
36304099	Abd; Abdo; Abdomen+; Abdominal; Cath; Cath rem; CorePlaybook; Document; Extraction; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Remove	4180186
36304099	Guided Peritoneum Cath rem	4180186
36304099	旨在去除导管的引导:发现:时间点:腹部>腹膜:文档型:{成像方式}	4182948
36304100	Pain medicine Cntrl Substance Agreement	4180186
36304100	Cntrl Substance Agreement; Contract; DOC.ONT; Document; Finding; Findings; Point in time; Random; Subs	4180186
36304100	管制物质协议:发现:时间点:{环境}:文档型:疼痛医学	4182948
36304102	Baclofen/Creat Ur Cfm	4180186
36304102	Baclosan; Beklo; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Gablofen; GCMS; Kemstro; Liofen; Lioresal; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36304102	巴氯芬/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36304103	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random	4180186
36304103	Bacteria Amn Anaerobe Cult	4180186
36304103	细菌 已鉴定的:存在与否或特征标识:时间点:羊水:名义型:厌氧微生物培养	4182948
36304104	# days of training & skill practice in transfer; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304106	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304107	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304108	DRUG/TOXICOLOGY; Drugs; EPN; EPN 300; Mass content; Misc; Miscellaneous; O-Ethyl O-(4-nitrophenyl) phenylphosphonothioate; Organophosphate pesticide; Other; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304108	EPN Spec-mCnt	4180186
36304108	O-乙基 O-(p-硝基苯基) 苯基膦酰基硫代硫酸酯:质量含量:时间点:XXX:定量型	4182948
36304109	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S agalactiae; Screen; Steptococcus Group B; Strep; Strep B; Strep group B; Strept; Streptococci group B; WB; Whole blood	4180186
36304109	S agalactiae hsp60 Bld Pos Ql Probe	4180186
36304109	无乳链球菌 hsp60 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36304110	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304111	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; PT; Random; Survey	4180186
36304113	14 days; 2 weeks; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Past; Patient Health Questionnaire; PHQ9; Pnl; Survey; Sx	4180186
36304114	Troponin I SerPl HS-Imp	4180186
36304114	Chemistry; cTnI; HS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TnI; TrI; Trop I; Troponin	4180186
36304114	肌钙蛋白 I.心脏:印象:时间点:血清/血浆:序数型:高灵敏度方法	4182948
36304115	Aerobe; Aerobe Cult; Aerobed; Bact; Brn; Burn; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
36304115	Bacteria Burn Aerobe Cult	4180186
36304115	细菌 已鉴定的:存在与否或特征标识:时间点:烧伤:名义型:需氧微生物培养	4182948
36304119	Bil; Bilat; BON; Both; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; Temporal bone-Bl; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36304119	CT Temporal bone-Bl WO+W contr IV	4180186
36304119	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部>颞骨.双侧:文档型:CT	4182948
36304121	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304122	Emergency Medical Service(s); EMS; Ident; Identifier; NEMSIS; Nominal; Point in time; Random; TRAUMA	4180186
36304122	Dispatch center EMS Sys	4180186
36304122	调度中心:标识符:时间点:急救医疗服务系统:名义型	4182948
36304123	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Triazole	4180186
36304123	Isavuconazole Susc Islt	4180186
36304123	艾沙康唑:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36304126	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36304126	OB Summary note	4180186
36304126	摘要:发现:时间点:{环境}:文档型:产科学	4182948
36304128	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Fid marker place; Finding; Findings; Guid; Guide; Guided; Imaging; Mark; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36304128	Guided Abd Fid marker place	4180186
36304128	旨在置入基准标记的引导:发现:时间点:腹部:文档型:{成像方式}	4182948
36304129	Cell; Cellularity; Ejaculate; FERTILITY TESTING; Genitourinary; GU; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rnd Cells; Screen; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
36304129	Rnd Cells Smn Ql Micro	4180186
36304129	圆形细胞:存在情况或阈值:时间点:精液:序数型:显微镜检查.光学	4182948
36304133	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RSV; RSV B; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304133	RSV B RNA Lower resp Ql NAA+probe	4180186
36304133	呼吸道合胞病毒 B 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36304135	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; OTA; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304135	OTA Spec-mCnt	4180186
36304135	赭曲霉毒素 A:质量含量:时间点:XXX:定量型	4182948
36304136	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304136	HAdV DNA Corn/Cnjt Ql NAA+probe	4180186
36304136	腺病毒 DNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36304138	Amm; Ammon; Ammonium nitrogen; Amon; DRUG/TOXICOLOGY; Drugs; Mass content; N; N2; NH3; Nit; Point in time; QNT; Quan; Quant; Quantitative; Random; Vet; Veterinary	4180186
36304138	Ammonia nitrogen Feed-mCnt	4180186
36304138	氨氮:质量含量:时间点:饲料:定量型	4182948
36304142	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Tx	4180186
36304145	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; Spinal; Spinal Cord; Spine.epidural space; To be specified in another part of the message; Unspecified	4180186
36304145	Guided Epidural space Inj	4180186
36304145	旨在注射的引导:发现:时间点:XXX>脊椎硬膜外腔:文档型:{成像方式}	4182948
36304152	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304153	DRUG/TOXICOLOGY; Drugs; Flavomycin; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304153	Bambermycins Spec-mCnt	4180186
36304153	班贝霉素:质量含量:时间点:XXX:定量型	4182948
36304156	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Surf; Survey; SURVEY.GNHLTH	4180186
36304157	Cystatin C + GFR by Cystatin C Pnl SerPl	4180186
36304157	Chemistry; Cystatin C + GFR by Cystatin C Pnl; GFR; Glom; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36304157	半胱氨酸蛋白酶抑制剂 C 与采用基于半胱氨酸蛋白酶抑制剂 C 的公式的肾小球滤过率组套:-:时间点:血清/血浆:-	4182948
36304158	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36304159	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
36304160	Encounter location Type	4180186
36304160	Nominal; Point in time; Random; TRAUMA; Typ	4180186
36304160	就医位置:类型:时间点:^患者:名义型	4182948
36304162	Addiction; Buprenorphine metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Gluc; Glucouronide; III; Illicit; Level; Mass concentration; N3G; NBU; norBUP; Norbuprenorphine glucuronide; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36304162	N3G SerPl Cfm-mCnc	4180186
36304162	去甲基丁丙诺啡-3-葡糖苷酸:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
36304163	.alpha.-Endosulfan; DRUG/TOXICOLOGY; Drugs; Endosulfan A; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304163	Endosulfan I Spec-mCnt	4180186
36304163	硫丹 I:质量含量:时间点:XXX:定量型	4182948
36304164	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tazobac; Zerbaxa	4180186
36304164	Ceftolozane+Tazobactam Islt Grad strip	4180186
36304164	头孢洛林+他唑巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
36304166	Antigen; Antigens; Circo virus; ID; IHC; II; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; PCV; PCV2; PCV2 Ag; Point in time; Pork; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Swine; Tissue; Tissue, unspecified; Vet; Veterinary	4180186
36304166	PCV2 Ag Tiss Ql ImStn	4180186
36304166	猪圆环病毒 2 型 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
36304169	Ob Attend Note	4180186
36304169	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OB; Ob Attend; Obstetric; Point in time; Prenatal; Random; Visit note	4180186
36304169	记录:发现:时间点:{环境}:文档型:产科学.主治	4182948
36304171	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304172	Hearing; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Narrative; Otologic; Point in time; Random; Report	4180186
36304172	Ear-Imp	4180186
36304172	显微镜观察:印象:时间点:耳:叙述型	4182948
36304178	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
36304180	Ethyl glucuronide Hair Cfm-mCnt	4180186
36304180	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; EtG; Ethanol metabolite; GCMS; Gluc; Glucouronide; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304180	乙基葡糖苷酸:质量含量:时间点:毛发:定量型:毒理学确认试验	4182948
36304184	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
36304188	4-Hydroxycoumarin; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Rodenticide; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304188	Difenacoum Spec-mCnt	4180186
36304188	鼠得克:质量含量:时间点:XXX:定量型	4182948
36304189	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304191	Activ; Activity; Actvty; Exercise; Job-related PA pnl; Movements; Occupation; Pan; Panl; Physical activity Pnl; Pnl; Point in time; Random; Survey; Work	4180186
36304192	Abd; Abd+Pelvis; Abdo; Abdominal; Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Pelvic; Pelvic artery; Playbook; Point in time; Rad; RADIOLOGY; Random; Stent place	4180186
36304192	Guided Iliac a Stent place	4180186
36304192	旨在置入支架的引导:发现:时间点:腹部+盆腔>髂动脉:文档型:{成像方式}	4182948
36304195	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S prolificans; S prolificans DNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304195	S prolificans DNA Islt Ql NAA+probe	4180186
36304195	多育赛多孢 DNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36304197	Ejaculate; Genitourinary; Gram Stn; GU; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Sem; Seminal fluid; Smn; SMPLS; St; Stains; Stn; URO; Urology	4180186
36304197	Gram Stn Smn	4180186
36304197	显微镜观察:存在与否或特征标识:时间点:精液:名义型:革兰氏染色法	4182948
36304199	BMI; bod; Bodies; Estimated BMI &gt;40; Finding; Findings; H+P; H+P.PX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Quetelet index; Random; Screen	4180186
36304199	Estimated BMI >40	4180186
36304199	估计体质指数大于40:发现:时间点:^患者:序数型	4182948
36304207	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Wnd	4180186
36304207	伤口隧穿组套:-:时间点:伤口:-	4182948
36304215	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Aspirate; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304215	HAdV DNA Aspirate Ql NAA+probe	4180186
36304215	腺病毒 DNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36304216	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; HPIV; HPIV1; Human respirovirus 1; i; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PI1; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF	4180186
36304216	HPIV1 Ag Lower resp Ql IF	4180186
36304216	副流感病毒 1 型 抗原:存在情况或阈值:时间点:呼吸道.下:序数型:免疫荧光法	4182948
36304217	Centers for Medicare and Medicaid Assessment; Count/time; Dextro; Hypnotic received in last 7D or since admission/reentry if less than 7D; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304218	Bld Pos; Blood; Citrobac sp; Citrobac sp ompA+mrkC; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; WB; Whole blood	4180186
36304218	Citrobac sp ompA+mrkC Bld Pos Ql Probe	4180186
36304218	柠檬酸杆菌属 (ompA+mrkC) 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36304219	Date and time; Extubation time; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Time stamp; Timestamp	4180186
36304219	Extubation time	4180186
36304219	拔管时间:时间戳:时间点:^患者:定量型	4182948
36304220	Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36304229	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36304229	行政管理记录:发现:时间点:{环境}:文档型:妇科学	4182948
36304232	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
36304234	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304236	Circo virus; high-throughput sequencing; HTS; ID; II; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; PCV; PCV 2 ORF2 gene; PCV2; Point in time; Pork; Random; Swine; Vet; Veterinary	4180186
36304236	PCV 2 ORF2 gene Islt-Seq	4180186
36304236	猪圆环病毒 2 型 ORF2 基因:序列:时间点:分离株:名义型:序列测定	4182948
36304237	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enzootic pneumonia; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304237	M pneumo DNA Lower resp Ql NAA+probe	4180186
36304237	肺炎支原体 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36304241	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Wnd	4180186
36304241	伤口潜行组套:-:时间点:伤口:-	4182948
36304242	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vibativ	4180186
36304242	Telavancin Susc Islt	4180186
36304242	特拉万星:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36304244	Dicoumarin; Dicumarol; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304244	Dicoumarol Spec-mCnt	4180186
36304244	双香豆素:质量含量:时间点:XXX:定量型	4182948
36304247	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Gram Stn; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; St; Stains; Stn	4180186
36304247	Gram Stn Amn	4180186
36304247	显微镜观察:存在与否或特征标识:时间点:羊水:名义型:革兰氏染色法	4182948
36304248	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304248	Brachyspira DNA Islt Ql NAA+probe	4180186
36304248	短螺旋体属单个未知种 DNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36304250	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36304252	Dis; Diseases; Dyspnoea questionnaire; Dz; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; RDS; Rose dyspnea score; Screen; Survey; SURVEY.GNHLTH	4180186
36304256	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; NT; NT perc place; Perc; Playbook; PN place; Point in time; Rad; Radiology; Random; Renal	4180186
36304256	Guided Kidney NT perc place	4180186
36304256	旨在经皮置入肾脏造瘘管的引导:发现:时间点:腹部>肾脏:文档型:{成像方式}	4182948
36304257	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E.coli Shiga-like toxin gene; EC stx1 gene; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shiga Like Toxin I; Shiga-Like Toxins; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304257	EC stx1 gene Islt Ql NAA+probe	4180186
36304257	大肠埃希菌 Stx1 毒素 stx1 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36304261	Abd; Abdo; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CorePlaybook; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36304261	CTA Mesenteric ves WO+W contr IV	4180186
36304261	多层^不采用 & 采用静脉注射对比剂:发现:时间点:腹部>肠系膜血管类:文档型:CT.血管造影术	4182948
36304263	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304264	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Therapy need & POC - OASIS-C - follow-up	4180186
36304266	ADMIN; ADMIN.PATIENT; Date birth certified; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304266	Date birth certified	4180186
36304266	出生证明日期:日期:时间点:^患者:定量型	4182948
36304267	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36304267	Guided Peritoneum Paracentesis	4180186
36304267	旨在穿刺术的引导:发现:时间点:腹部>腹膜:文档型:{成像方式}	4182948
36304268	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; NO2; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304268	Nitrite Spec-mCnt	4180186
36304268	亚硝酸盐:质量含量:时间点:XXX:定量型	4182948
36304270	Adeno virus; Bowel movement; C&S; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Stl; Stool = Fecal	4180186
36304270	HAdV Stl Ql Cult	4180186
36304270	腺病毒:存在情况或阈值:时间点:大便:序数型:微生物特异性培养	4182948
36304273	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Nucynta; Oral fluid; Palexia; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Tapal	4180186
36304273	Tapentadol Sal Cfm-mCnc	4180186
36304273	他喷他多:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36304274	PCV2 IgG+IgM Titr Ser IF	4180186
36304274	猪圆环病毒 2 型 抗体.IgG+IgM:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36304274	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Circo virus; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; II; Immune fluorescence; Immune globulin G; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; PCV; PCV2; PCV2 Ab; PCV2 IgG; Point in time; Pork; Random; Serum; SmQn; SR; Swine; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Vet; Veterinary	4180186
36304276	Acd; Acids; Axerol; Axerophthol; Biosterol; Chemistry; Mass Content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary; Vit A; Vit A alcohol; Vit A aldehyde; Vit A1; Vit A1 alcohol; Vit A1 aldehyde; Vitamin A; Vitamin A alcohol; Vitamin A aldehyde; Vitamin A1; Vitamin A1 aldehyde	4180186
36304276	Retinal+retinol+retinoic acid Spec-mCnt	4180186
36304276	视黄醛+视黄醇+维甲酸:质量含量:时间点:XXX:定量型	4182948
36304279	Activ; Activity; Actvty; Exercise; Movements; Pan; Panl; Physical activity Pnl; Pnl; Point in time; Random; Survey	4180186
36304287	*^Patient; Admit eval note; Assessment; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Home health care; notes; Point in time; Pt's home; Random; S prime; Visit note	4180186
36304287	Primary care Pt's home Admit eval note	4180186
36304287	入院评价记录:发现:时间点:患者的家:文档型:初级保健服务	4182948
36304288	Apavinphos; CMDP; DRUG/TOXICOLOGY; Drugs; ENT 22374; Fosdrin; Gesfid; Mass content; Meniphos; Menite; Misc; Miscellaneous; OS-2046; Other; PD5; Phosdrin; Phosfene; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304288	Mevinphos Spec-mCnt	4180186
36304288	速灭磷:质量含量:时间点:XXX:定量型	4182948
36304289	3 Self-Sustaining Sequence Replication; 3SR SR; Amebic keratitis; Amebic meningoencephalitis; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Soil amoeba; species; spp; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36304289	Acanthamoeba DNA Tiss Ql NAA+probe	4180186
36304289	棘阿米巴属单个未知种 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36304290	C&S; CMV; Cult; Cultures; Cytomegalo virus; Cytomgal; Eye fluid; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; Microbiology; Occular Fluid; OcFlu; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SVC	4180186
36304290	CMV Ocflu Ql Shell Vial Cult	4180186
36304290	巨细胞病毒:存在情况或阈值:时间点:眼液:序数型:细胞培养瓶培养法	4182948
36304293	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gentyp; HAV; HAV genotype; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; Hepatology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Typ; Unspecified	4180186
36304293	HAV Gentyp Spec NAA+probe	4180186
36304293	甲型肝炎病毒 基因型:类型:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
36304295	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304296	Activ; Activity; Actvty; Arbitrary rate; Exercise; Movements; QNT; Quan; Quant; Quantitative; Survey; Vigorous PA.leisure-time; Vigorous phys activity	4180186
36304297	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Report period; Survey	4180186
36304298	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV4; Human rubulavirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304298	HPIV4 RNA Lower resp Ql NAA+probe	4180186
36304298	副流感病毒 4 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36304301	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304303	Assessment; Centers for Medicare and Medicaid Assessment; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304305	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LCMV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
36304305	LCMV IgM Ser Ql IA	4180186
36304305	淋巴细胞性脉络丛脑膜炎病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36304306	alpha-2 globin; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; HBA1 + HBA2; HBA-T2; HBH; Hemoglobin, alpha 2; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36304306	HBA1 + HBA2 Full Mut Anl Bld/T Seq	4180186
36304306	HBA1 与 HBA2 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36304307	Abd; Abdo; Abdomen+; Abdominal; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36304307	Guided Abd Bx	4180186
36304307	旨在经皮活组织检查的引导:发现:时间点:腹部:文档型:{成像方式}	4182948
36304308	Cardio; Cardiology; CorePlaybook; Document; Endovasc dev place; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
36304308	Guided Vein Endovasc dev place	4180186
36304308	旨在置入血管内装置的引导:发现:时间点:XXX>静脉:文档型:{成像方式}	4182948
36304309	Drug; H+P; H+P.HX; Nominal; NSAID used several times a week; P prime; Point in time; Random; Typ	4180186
36304309	NSAID used several times a week	4180186
36304309	每星期使用数次的非甾体抗炎药物的类型:类型:时间点:^患者:名义型	4182948
36304313	Abd; Abdo; Abdomen+; Abdominal; Chest + Abd; CorePlaybook; Denver shunt; Document; Extraction; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; PV shunt removal; Rad; RADIOLOGY; Random; Remove; Thorax	4180186
36304313	Guided Chest+Abd PV shunt removal	4180186
36304313	旨在去除腹腔静脉分流装置的引导:发现:时间点:腹部+胸部:文档型:{成像方式}	4182948
36304314	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; III; Imaging; Inj; Misc; Miscellaneous; Musc; Muscl; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Trigger point injection GE3; Unspecified	4180186
36304314	Guided Muscle Trigger point inject GE3	4180186
36304314	旨在大于等于3次触痛点注射的引导:发现:时间点:XXX>肌肉:文档型:{成像方式}	4182948
36304317	Respiratory measurements Doc	4180186
36304317	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36304317	呼吸测量指标:发现:时间点:^患者:文档型	4182948
36304318	Hearing; Ordinal; Otologic; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36304318	Cerumen Ear Ql	4180186
36304318	耵聍:存在情况或阈值:时间点:耳:序数型	4182948
36304319	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV2; Human rubulavirus 2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 2; Parainfluenza type II; PCR; PI2; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304319	HPIV2 RNA Lower resp Ql NAA+probe	4180186
36304319	副流感病毒 2 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36304322	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; high-throughput sequencing; HTS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Myco; Mycobact; Next generation sequencing; NGS; Nominal; Point in time; Random; species; spp; Tuberculosis	4180186
36304322	Mycobacterium Islt Seq	4180186
36304322	分枝杆菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:分离株:名义型:序列测定	4182948
36304324	Oxaprozin/Creat Ur Cfm	4180186
36304324	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36304324	奥沙普秦/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36304328	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Hep; Hep E; Hepatis; Hepatit; HEV; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36304328	HEV IgM SerPl Ql IA	4180186
36304328	戊型肝炎病毒 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
36304329	Location; MISC; Nominal; Point in time; Random; Survey; Survey.Misc	4180186
36304330	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV 229E; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304330	HCoV 229E RNA Lower resp Ql NAA+probe	4180186
36304330	人类冠状病毒 229E 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36304331	CARD.PROC; Cardio; Cardiology; Clock time; Defibrillation time; Heart Disease; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304331	除颤时间:时钟时间:时间点:^患者:定量型	4182948
36304332	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Other Chemical; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304332	Other Chemical Spec-mCnt	4180186
36304332	化学物质 XXX:质量含量:时间点:XXX:定量型	4182948
36304335	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Head+Sinuses; Imaging; Intracranial; Paranasal sinuses; Point in time; Rad; RADIOLOGY; Random; Sinus; Skull; W contr IV; WC	4180186
36304335	CT Head+Sinuses W contr IV	4180186
36304335	多层^采用静脉注射对比剂:发现:时间点:头部 & 头部>副鼻窦类:文档型:CT	4182948
36304336	Arbitrary concentration; Comp; Complement c1q binding; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36304336	C1q.functional SerPl-aCnc	4180186
36304336	补体 C1q.功能性:任意型浓度:时间点:血清/血浆:定量型	4182948
36304340	Ur cell cnt CNAMTS panel Ur	4180186
36304340	180 minutes; 180min; 3 hours; 3.0Hr; 3HR; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; UA; UR; Ur cell cnt CNAMTS panel; Urn	4180186
36304340	尿液细胞计数 CNAMTS 组套:-:3小时:尿液:-	4182948
36304342	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; Pork; PR; Probe amp; Probe with ampification; Probe with target amplification; PTV; PTV RNA; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36304342	PTV RNA Spec Ql NAA+probe	4180186
36304342	猪捷申病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36304345	#; ABS; absolute; absolutes; B cells expressing CD19 as a percent of total lymphocytes; B2; B-2; B4; B-4; Blood; C3d receptor; CD19 Cells; CD19+21- cells; CD21 low (immature) B cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CR2; CT; EBV-R; Epstein Barr virus receptor; HD-37; Leu12; Leu-12; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36304345	CD19+21- cells # Bld	4180186
36304345	细胞.CD19+CD21-:计数型浓度:时间点:全血:定量型	4182948
36304348	Hx of Hyperlipidemia	4180186
36304348	H+P; H+P.HX; History; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36304348	高脂质血症:历史记录:时间点:^患者:序数型	4182948
36304352	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304354	Exp pause time; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36304354	Exp pause time Vent	4180186
36304354	呼气停顿时间:时间:时间点:呼吸机:定量型	4182948
36304358	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; nursing; OB; Ob Nurse; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36304358	Ob Nurse Note	4180186
36304358	记录:发现:时间点:{环境}:文档型:产科学.护士	4182948
36304360	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304365	CARD.PROC; Cardio; Cardiology; Clock time; Heart Disease; Point in time; QNT; Quan; Quant; Quantitative; Random; Return of circulation; Time of ROSC	4180186
36304365	Time of ROSC Clock time	4180186
36304365	自主循环恢复时间:时钟时间:时间点:^患者:定量型	4182948
36304368	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304369	c; Cardiac; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; FCN; Finding; Findings; Func; Funct; Hrt; Imaging; L; LT; LV function; Point in time; Rad; RADIOLOGY; Random; Thorax; W contr IV; WC	4180186
36304369	CT Hrt LV function W contr IV	4180186
36304369	针对左心室功能的多层^采用静脉注射对比剂:发现:时间点:胸部>心脏:文档型:CT	4182948
36304370	BP dias goal	4180186
36304370	Art sys; Blood pressure; Blood pressure diastolic; BP; BP dias; BP dias goal; BP diastolic; CLIN; DBP; Dias; Dias BP; Diast; Diastoli; Intravenous; IV; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
36304370	血管内舒张压目标:压力或压强:时间点:动脉系统:定量型	4182948
36304371	Dialy D/C sum	4180186
36304371	D/C sum; Dialy; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36304371	出院摘要记录:发现:时间点:{环境}:文档型:透析法	4182948
36304372	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; c301; Compx; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; M tb; M TB Cmplx; M tuberculosis; Molecular genetics; Mtb; MTB cmplx rpoB RIF mut; Mut; Mutations; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; RIF; Rifadin; Rifampicin; Rimactane; Screen; Spec; TB; Tuberculosis	4180186
36304372	MTB rpoB RIF resist mut Islt/Spm Ql	4180186
36304372	结核分枝杆菌复合菌群 rpoB 基因利福平耐药性突变:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36304373	Asp; CorePlaybook; Document; Finding; Findings; FNA; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; NDL; Other; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304373	Guided Unsp region FNA	4180186
36304373	旨在经皮细针抽吸的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36304375	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304376	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Facial bones + Maxilla; Facial bones+Maxilla; Finding; Findings; Head+Maxillofacial; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36304376	CT Head+Maxillofacial WO+W contr IV	4180186
36304376	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部 & 头部>颌面区域:文档型:CT	4182948
36304377	ID; Infectious Disease; InfectiousDisease; L intracell; L intracell VNTR patt; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; Spec; To be specified in another part of the message; Typ; Unspecified; Vet; Veterinary	4180186
36304377	L intracell VNTR patt Spec	4180186
36304377	胞内劳森菌 VNTR 模式:类型:时间点:XXX:名义型:分子遗传学类实验室方法	4182948
36304383	APTA; Identity or presence; Nominal; Physical Therapy; Point in time; PT; Random	4180186
36304383	Assistive technology prov	4180186
36304383	所提供的辅助技术:存在与否或特征标识:时间点:^患者:名义型	4182948
36304384	Bx; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304384	CT Guided Spinal cord Bx	4180186
36304384	旨在经皮活组织检查的引导:发现:时间点:XXX>脊髓:文档型:CT	4182948
36304385	Ang; Angio; Angiography; Angm; Arteriogram; Brain; c; CAT scan; Circle of Willis+Carotid aa; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Intracranial; Point in time; Rad; Radiology; Random; Skull; W contr IV; WC	4180186
36304385	CTA Circ of Willis+Carot aa W contr IV	4180186
36304385	多层^采用静脉注射对比剂:发现:时间点:头部+颈部>大脑动脉环+颈动脉类:文档型:CT.血管造影术	4182948
36304390	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36304391	10M p lact PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Gastro; Gastroenterology; GI; H2; Hyd; LTT; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
36304391	Breath H2 10M p lact PO	4180186
36304391	氢/已呼出的气体^在口服剂量乳糖之后10分钟:体积分数:时间点:呼出的气体:定量型	4182948
36304392	Abd; Abd+Pelvis; Abdo; Abdominal; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Stent place	4180186
36304392	Guided Ureter Stent place	4180186
36304392	旨在置入支架的引导:发现:时间点:腹部+盆腔>输尿管:文档型:{成像方式}	4182948
36304394	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304396	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; species; spp; Survey; Tx; Txs	4180186
36304399	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304404	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304408	GM2 Gangl IgG Ser Ql Line blot	4180186
36304408	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GM2 Gangl; Immune globulin G; Immunoglobulin G; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36304408	神经节苷脂 GM2 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36304412	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C perfringens; C perfringens cpa; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304412	C perfringens cpa Islt Ql NAA+probe	4180186
36304412	产气荚膜梭菌 cpa 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36304413	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Path; Pnl; Point in time; Random; Survey	4180186
36304415	Micro CNAMTS panel Vag	4180186
36304415	Genital vaginal; Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
36304415	微生物学 CNAMTS 组套:-:时间点:阴道:-	4182948
36304416	Centers for Medicare and Medicaid Assessment; Cnt; Count; Dextro; No; Num; Number; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304417	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Other Chemical; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304417	Other Chemical Spec-mCnc	4180186
36304417	化学物质 XXX:质量浓度:时间点:XXX:定量型	4182948
36304420	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Synthetic cannabinoid; UA; UR; Urn	4180186
36304420	MAB-CHMINACA butanoate Ur Ql Cfm	4180186
36304420	MAB-CHMINACA 丁酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36304423	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; HRV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rhino virus; RHV; Ribonucleic acid; RV+EV; RV+EV RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304423	RV+EV RNA Nph Ql NAA+probe	4180186
36304423	鼻病毒+肠道病毒 RNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
36304425	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; Strep; Strept; WB; Whole blood	4180186
36304425	Streptococcus sp tuf Bld Pos Ql Probe	4180186
36304425	链球菌属 tuf 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36304426	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304428	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Camel flu; Corn/Cnjt; Corneal; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV-EMC/2012; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MERS-CoV; MERS-CoV RNA; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304428	MERS-CoV RNA Corn/Cnjt Ql NAA+probe	4180186
36304428	中东呼吸综合征冠状病毒 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36304429	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; P aeruginosa; P aeruginosa sodA; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
36304429	P aeruginosa sodA Bld Pos Ql Probe	4180186
36304429	铜绿假单胞菌 (sodA) 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36304430	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36304434	Abd; Abdo; Abdomen+; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36304434	CT L-spine by reconstr WO+W contr IV	4180186
36304434	基于重建的多层^不采用 & 采用静脉注射对比剂:发现:时间点:腹部>脊椎.腰段:文档型:CT	4182948
36304435	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304436	Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304436	Guided Artery Embol	4180186
36304436	旨在栓塞的引导:发现:时间点:XXX>动脉:文档型:{成像方式}	4182948
36304439	Breathing; Lung; Lungs; Point in time; Press.plat; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
36304439	Plateau pressure	4180186
36304439	压力.平台期:压力或压强:时间点:呼吸系统.气道:定量型	4182948
36304440	Amebic keratitis; Amebic meningoencephalitis; C&S; Cont lens; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Soil amoeba; Spec; species; spp	4180186
36304440	Acanthamoeba Cont lens Cult	4180186
36304440	棘阿米巴属单个未知种 已鉴定的:存在与否或特征标识:时间点:隐形眼镜:名义型:微生物特异性培养	4182948
36304441	Abd; Abdo; Abdomen+; Abdominal; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; Playbook; Point in time; Rad; Radiology; Random; Renal; Transjugular Bx	4180186
36304441	Guided Kidney Transjugular Bx	4180186
36304441	旨在经颈静脉活组织检查的引导:发现:时间点:腹部>肾脏:文档型:{成像方式}	4182948
36304445	Finding; Findings; No; Num; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Social Security #; SSN requested; Survey; SURVEY.CDC	4180186
36304447	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Myco; Mycobact; Nominal; Point in time; Random; ribosomal RNA; species; spp; Tuberculosis; WB; Whole blood	4180186
36304447	Mycobacterium rRNA Bld Pos Probe	4180186
36304447	分枝杆菌属单个未知种 rRNA:存在与否或特征标识:时间点:血液.生长阳性:名义型:DNA探针	4182948
36304449	Chemistry; i; IgA + IgA1 + IgA2 Pnl; IgA1; IgA2; II; Immune globulin A; Immunoglobulin A; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Subclasses	4180186
36304449	IgA + IgA1 + IgA2 Pnl SerPl	4180186
36304449	IgA 与 IgA 亚类 1 与 IgA 亚类 2 组套:-:时间点:血清/血浆:定量型	4182948
36304451	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
36304452	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304453	DIVI - recommended MIND set; Pan; Panel; PANEL.TRAUMA; Panl; Pnl; Point in time; Random; TRAUMA	4180186
36304453	DIVI - recommended MIND set	4180186
36304453	德国重症监护与急救医学跨学科协会推荐MIND方案集合:-:时间点:{环境}:-	4182948
36304455	Activ; Activity; Actvty; Exercise; IPAQ Tele Short Form; Movements; Pan; Panel; Panl; Patient Telephone; Pnl; Point in time; Random; Survey	4180186
36304458	Activities of Daily Living; ADL assistance; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36304460	Acinetobacter sp rpsA; Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; WB; Whole blood	4180186
36304460	Acinetobacter sp rpsA Bld Pos Ql Probe	4180186
36304460	不动杆菌属 (rpsA) 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36304461	First and last name	4180186
36304461	ADMIN; First and last name; Pan; Panel; PANEL.ADMIN; Panl; Past; Pnl; Point in time; Random	4180186
36304461	患者合法姓名 -姓氏和名字:-:时间点:^患者:-	4182948
36304464	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV OC43; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
36304464	HCoV OC43 RNA Upper resp Ql NAA+probe	4180186
36304464	人类冠状病毒 OC43 型 RNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36304465	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36304466	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36304467	#/area; Cast; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36304467	Waxy Casts #/area UrnS	4180186
36304467	蜡样管型:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36304468	Cast; Kidney; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urn	4180186
36304468	Casts Ur Ql	4180186
36304468	管型类尿液成分:存在情况或阈值:时间点:尿液:序数型	4182948
36304475	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B microti; B microti Ab.IgG+IgM; Babesiosis; ID; IgG+IgM; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Nominal; Piroplasmosis; Point in time; Random; Serum; SR	4180186
36304475	B microti IgG+IgM Ser-Imp	4180186
36304475	鼠源巴贝斯虫 抗体.IgG 与 IgM:印象:时间点:血清:名义型	4182948
36304476	Eye fluid; Gie Stn; GMS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Occular fluid; Ocflu; Point in time; Random; St; Stains; Stn	4180186
36304476	Gie Stn Ocflu	4180186
36304476	显微镜观察:存在与否或特征标识:时间点:眼液:名义型:姬姆萨染色法	4182948
36304480	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S prolificans; S prolificans DNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36304480	S prolificans DNA Spec Ql NAA+probe	4180186
36304480	多育赛多孢 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36304481	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304484	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Twar agent	4180186
36304484	C pneum DNA Aspirate Ql NAA+probe	4180186
36304484	肺炎嗜性衣原体 DNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36304487	Actiq; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Scn; Scr; Screen; Scrn; Sublimaze	4180186
36304487	fentaNYL Sal Ql Scn	4180186
36304487	芬太尼:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
36304488	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304493	ISS NACA	4180186
36304493	Finding; Findings; ISS; Nominal; Point in time; Random; TRAUMA; Ulcer	4180186
36304493	损伤严重程度评分:发现:时间点:^患者:名义型:NACA	4182948
36304494	Abd; Abdo; Abdomen+; Abdominal; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36304494	Guided Liver Bx	4180186
36304494	旨在经皮活组织检查的引导:发现:时间点:腹部>肝脏:文档型:{成像方式}	4182948
36304495	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Filariasis; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; River blindness; Screen; Serum; species; spp; SR; SUDS	4180186
36304495	Onchocerca IgG4 Ser Ql IA	4180186
36304495	盘尾属单个未知种 抗体.IgG4:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36304497	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH	4180186
36304498	Arm; Art; Brach a; Cardio; Cardiology; CorePlaybook; Document; EXT; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; UE; Up; Upper arm	4180186
36304498	Guided Brach a Embol	4180186
36304498	旨在栓塞的引导:发现:时间点:上肢>肱动脉:文档型:{成像方式}	4182948
36304499	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; Eye fluid; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Myco; Mycobact; Nominal; Occular fluid; Ocflu; Point in time; Random; Spec; species; spp; Tuberculosis	4180186
36304499	Mycobacterium Ocflu Cult	4180186
36304499	分枝杆菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:眼液:名义型:微生物特异性培养	4182948
36304500	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36304502	Micro CNAMTS panel Corn/Cnjt	4180186
36304502	Corn/Cnjt; Corneal; Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random	4180186
36304502	微生物学 CNAMTS 组套:-:时间点:角膜/结膜:-	4182948
36304503	AIDS; Cerebral spinal fluid; Cerebrospinal Fl; HIV type 1; HIV type I; HIV1; HIV1 RNA tropism; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Ribonucleic acid; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36304503	HIV1 RNA tropism CSF	4180186
36304503	HIV 1 型 RNA 嗜性:存在与否或特征标识:时间点:脑脊液:名义型	4182948
36304506	Breathing; Exp pressure; Largest; Lung; Lungs; Max exp press; Maximal; Maximum; Peak; Point in time; Press.max; Pressure; Pressure max; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
36304506	Max exp press Airway	4180186
36304506	呼气压.最大值:压力或压强:时间点:呼吸系统.气道:定量型	4182948
36304508	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304509	B burg; B burgdor; B burgdor IgG+IgM Pnl; B burgdorferi; Bb; Blt; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; ID; IMMUNE BLOT; Immune globulin G; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Neuro; Neurology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RIBA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot	4180186
36304509	B burgdor IgG+IgM Pnl CSF IB	4180186
36304509	伯氏疏螺旋体抗体.IgG 与 IgM 组套:-:时间点:脑脊液:-:免疫印迹法	4182948
36304510	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304512	Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Cystogram; Document; Finding; Findings; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrogram; Nephrography; Nephrology; Pelvic; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Ureter+Blad; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36304512	CT Kid+Uret+Blad WO+W contr IV	4180186
36304512	多层^不采用 & 采用静脉注射对比剂:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:CT	4182948
36304513	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Spec; Sulf; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304513	Sulfate Spec-mCnt	4180186
36304513	硫酸根、硫酸盐或硫酸酯:质量含量:时间点:XXX:定量型	4182948
36304515	Mat; Maternal; Matnl; Nominal; Person name; Point in time; Random; Source of info; Srce; Survey; SURVEY.CDC	4180186
36304516	KIT Exon 13 Mut Anl Bld/T	4180186
36304516	Blood; CD117; c-KIT; Document; Finding; Findings; KIT Exon 13; mast/stem cell growth factor receptor; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mut Anl; Mutations; PBT; PCR; piebald trait; Point in time; Proto-oncogene tyrosine-protein kinase Kit; Random; SCFR; soluble KIT variant; Tissue; Tissue, unspecified; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
36304516	KIT 基因外显子 13 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36304517	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36304517	Addiction med Phone Note	4180186
36304517	记录:发现:时间点:电话就医:文档型:成瘾医学	4182948
36304519	Finding; Findings; H+P; H+P.HX; Intoxication cause; Nominal; P prime; Point in time; Random	4180186
36304519	Intoxication cause	4180186
36304519	中毒原因:发现:时间点:^患者:名义型	4182948
36304520	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B hampsonii; B hampsonii DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36304520	B hampsonii DNA Ct Spec Qn NAA+probe	4180186
36304520	汉普森尼短螺旋体 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36304521	Addiction; Cfm; Cloud 10; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Kush; Ordinal; Point in time; PotentialForAbuse; Potpourri; PR; QL; Qual; Qualitative; Random; Screen; Spice; Synthetic cannabinoid; UA; UR; Urn; Zombie	4180186
36304521	AB-PINACA pentanoate Ur Ql Cfm	4180186
36304521	AB-PINACA 戊酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36304524	Donor type risk score	4180186
36304524	CLIN; CLIN.RISK; Donor type risk score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Scale; Screen	4180186
36304524	针对风险计算的供体类型评分:评分:时间点:^患者:序数型	4182948
36304525	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304526	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36304528	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Mult; Multi; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304529	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; DFA; FA; Fluorescent antibody; Fluoresent; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36304529	HSV2 Ag CSF Ql IF	4180186
36304529	单纯疱疹病毒 2 型 抗原:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36304531	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
36304531	Noroxycodone Ur Ql Scn	4180186
36304531	去甲基羟考酮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36304532	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304533	Cholinesterase Fld-cCnc	4180186
36304533	Acylcholine acylhydrolase; B/F; BChE; Benzoyl cholinesterase; Benzoylcholinesterase; BF; bod; Bodies; Body fluid; Body fluid, unsp; Butyrylcholine esterase; Catalytic Concentration; Che; Chemistry; Choline esterase II; CHS; Fl; Fld; FLU; Fluid; Point in time; Pseudocho; Pseudocholinesterase; QNT; Quan; Quant; Quantitative; Random	4180186
36304533	胆碱酯酶:催化浓度:时间点:体液:定量型	4182948
36304535	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Donr; HBV; HCV; Hep; Hep B; Hep B virus; Hep C; Hepatis; Hepatit; Hepatitis C virus; HepB; HIV; HIV 1 RNA+HCV RNA+HBV; HIV 1+HCV RNA+HBV DNA; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; PlasBld; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36304535	HIV1+HCV+HBV SerPlBld Donr NAA+prb	4180186
36304535	HIV 1 型 RNA+丙型肝炎病毒 RNA+乙型肝炎病毒 DNA:存在情况或阈值:时间点:血清/血浆/全血^供体:序数型:探针法.基因扩增.靶向	4182948
36304536	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mental health; MentalHealth; notes; nursing; Point in time; Psych; Psychiatric; Psychiatry; Psychiatry Nurse; Random; Visit note	4180186
36304536	操作记录:发现:时间点:{环境}:文档型:精神病学.护士	4182948
36304538	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Othr; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304539	TS act interp Bld/T-Imp	4180186
36304539	5-FU sensitivity; Activ; Actvty; Blood; Deoxythymidine; DYPD gene product metabolic activity; Fluoropyrimidine toxicity; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; TS act interp; WB; Whole blood; Whole blood or Tissue	4180186
36304539	胸苷合成酶活性解释:印象:时间点:全血/组织:序数型	4182948
36304540	Centers for Medicare and Medicaid Assessment; Finding; Findings; II; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sequence based typing; Survey	4180186
36304541	C&S; Corn/Cnjt; Corneal; Cult; Cultures; hMPV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Spec	4180186
36304541	hMPV Corn/Cnjt Cult	4180186
36304541	人类偏肺病毒 已鉴定的:存在与否或特征标识:时间点:角膜/结膜:名义型:微生物特异性培养	4182948
36304547	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; III; Ordinal; Point in time; PR; PR3; PR-3; PR3-ANCA; Proteinase3; PRTN3; QL; Qual; Qualitative; Random; Screen; Serine protease 3; Serology; Serum; SR; Vasculitis	4180186
36304547	Proteinase3 Ab Ser Ql Line blot	4180186
36304547	蛋白酶 3 抗体:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36304548	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV NL63; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
36304548	HCoV NL63 RNA Upper resp Ql NAA+probe	4180186
36304548	人类冠状病毒 NL63 型 RNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36304549	6 alpha-hydroxynaltrexone; 6 beta-hydroxynaltrexone; 6 beta-Naltrexol; 6b-Naltrexol; Addiction; B; beta-naltrexol; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Naltrexone metabolite; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
36304549	6-Beta naltrexol Sal Cfm-mCnc	4180186
36304549	6-beta 纳曲醇:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36304551	Lab Device CV at 99% URL	4180186
36304551	CV at 99% URL; Lab Device; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto	4180186
36304551	第99百分位数参考值上限处的变异系数:比率:时间点:实验室仪器设备:定量型	4182948
36304552	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; BM; BON; Bone marrow; CMV; Cytomegalo virus; Cytomgal; DFA; FA; Fluorescent antibody; Fluoresent; HHV-5; Human Herpesvirus-5; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; TRF	4180186
36304552	CMV Ag Mar Ql IF	4180186
36304552	巨细胞病毒 抗原:存在情况或阈值:时间点:骨髓:序数型:免疫荧光法	4182948
36304555	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36304555	HIV1 Ab Spec Ql IA	4180186
36304555	HIV 1 型 抗体:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36304556	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Immunization status; notes; nursing; Point in time; Random; Vaccination; Vaccinations; Vaccine; Visit note	4180186
36304556	疫苗接种记录:发现:时间点:{环境}:文档型:护士	4182948
36304557	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304561	A pleuropn; A pleuropn 4+5+7; A pleuropn 4+5+7 Ab; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36304561	A pleuropn 4+5+7 Ab/Pos cntrl Ser IA	4180186
36304561	胸膜肺炎放线杆菌血清型 4+5+7 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36304563	Blood; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Kala azar; Leishmaniasis; Leishmaniosis; Microbiology; Nominal; Point in time; Random; Spec; species; spp; Visceral leishmaniasis; WB; Whole blood	4180186
36304563	Leishmania Bld Cult	4180186
36304563	利什曼原虫属单个未知种 已鉴定的:存在与否或特征标识:时间点:全血:名义型:微生物特异性培养	4182948
36304566	A pleuropn; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SUDS; Vet; Veterinary	4180186
36304566	Deprecated A pleuropn IgG/Pos cntrl IA	4180186
36304571	DOC.ONT; Document; Finding; Findings; Gyn; Gynecology; Hosp; Inpatient; OB; ObGyn; Obstetrics; Point in time; Random	4180186
36304571	Gynecology Hosp Letter	4180186
36304571	信函:发现:时间点:医院:文档型:妇科学	4182948
36304573	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; CoV 229E+HKU1+NL63+OC43; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV 229E; HCoV 229E+HKU1+NL63+OC43; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304573	HCoV 229E+HKU1+NL63+OC43 Np Ql NAA+nonpr	4180186
36304573	人类冠状病毒 229E+HKU1+NL63+OC43 RNA:存在情况或阈值:时间点:鼻咽:序数型:非探针法.基因扩增.靶向	4182948
36304574	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ganglioside monosialo; GM1 Gangl; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Monosialoganglioside; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36304574	GM1 Gangl IgG+IgM Ser Ql Line blot	4180186
36304574	神经节苷脂 GM1 抗体.IgG+IgM:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36304575	Protein + creat Pnl Ur	4180186
36304575	Chemistry; CR; Crea; Creat; Creat Pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PR; Prot; Protein + creat Pnl; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36304575	蛋白质与肌酐组套:-:时间点:尿液:定量型	4182948
36304579	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV 229E; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304579	HCoV 229E RNA Corn/Cnjt Ql NAA+probe	4180186
36304579	人类冠状病毒 229E 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36304580	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; Staph; Staph sp tuf; WB; Whole blood	4180186
36304580	Staph sp tuf Bld Pos Ql Probe	4180186
36304580	葡萄球菌属 tuf 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36304581	NK cytotox.15:1 E:T/Pos cntrl Bld MC	4180186
36304581	Blood; HEMATOLOGY/CELL COUNTS; i; NK; NK cytotox.15:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
36304581	自然杀伤细胞细胞毒性.效应细胞/靶细胞比 15:1/阳性对照:相对任意型浓度:时间点:全血单个核细胞:定量型	4182948
36304582	1-naphthalenol, methylcarbamate; 1-naphthol n-methylcarbamate; 1-naphthyl methylcarbamate; 1-naphthyl n-methylcarbamate; Alpha-naphthalenyl methylcarbamate; Alpha-naphthyl methylcarbamate; Alpha-naphthyl n-methylcarbamate; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sevin; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304582	Carbaryl Spec-mCnt	4180186
36304582	西维因:质量含量:时间点:XXX:定量型	4182948
36304583	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304587	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B parap IS1001; B parapert; B parapertussis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Whooping cough	4180186
36304587	B parap IS1001 DNA Nph Ql NAA+non-probe	4180186
36304587	副百日咳博德特菌 IS1001 DNA:存在情况或阈值:时间点:鼻咽:序数型:非探针法.基因扩增.靶向	4182948
36304588	ADMIN; ADMIN.PATIENT; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; WIC recipient	4180186
36304588	WIC recipient	4180186
36304588	WIC服务接受者:发现:时间点:^患者:序数型	4182948
36304589	AOEObservation; Ordinal; Point in time; PR; Public Health; Public Health Documents; PUBLICHEALTH; Ql; Qual; Qualitative; Random; Screen; Spec	4180186
36304589	Preliminary testing done Spec	4180186
36304589	已完成初步检测:存在情况或阈值:时间点:标本:序数型	4182948
36304590	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304590	Monensin Spec-mCnc	4180186
36304590	莫能菌素:质量浓度:时间点:XXX:定量型	4182948
36304592	ENA SS-A + SSB IgG Pnl Ser	4180186
36304592	A,B; ANA; ANA IgG; ANF; Antinuclear antibody; ENA; ENA SS-A + SSB IgG Pnl; Immune globulin G; Immunoglobulin G; NA; Nuc; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SS	4180186
36304592	Sjogrens 综合征-A 与 B 可提取性核抗体.IgG 组套:-:时间点:血清:定量型	4182948
36304593	Acd; Acid fast Stn; Acids; AFB stain; Gen; Genital tract; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn; Urogenit; Urogenital	4180186
36304593	Acid fast Stn Genital	4180186
36304593	显微镜观察:存在与否或特征标识:时间点:生殖器:名义型:抗酸染色法	4182948
36304596	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax; without contrast	4180186
36304596	CT Neck+Chest WO contr	4180186
36304596	多层^不采用对比剂:发现:时间点:颈部+胸部:文档型:CT	4182948
36304597	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; NI; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304597	Nickel Spec-mCnt	4180186
36304597	镍:质量含量:时间点:XXX:定量型	4182948
36304600	Ang; Angio; Angiography; Angm; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT + CTA; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Head+Neck Ves; Imaging; Intracranial; Neck + Head ves+Neck ves; Point in time; Rad; Radiology; Random; Skull; Vesl; Vessels.XXX; W contr IV; WC	4180186
36304600	CT Neck + CTA Head+Neck ves W cont IV	4180186
36304600	多层^采用静脉注射对比剂:发现:时间点:颈部 && 头部>头部血管类 & 颈部>颈部血管类:文档型:CT && CT.血管造影术	4182948
36304602	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; Tot; Totl	4180186
36304603	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304607	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Circo virus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV; PCV2a; PCV2a DNA; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36304607	PCV2a DNA Ct Spec Qn NAA+probe	4180186
36304607	猪圆环病毒 2a 型 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36304611	Centers for Medicare and Medicaid Assessment; Dextro; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Resp status; Survey	4180186
36304615	Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Resp status; Started; Survey	4180186
36304616	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cardio; Cardiology; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; Heart Disease; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Pcar; PCR; Pericardial fluid; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304616	EV RNA Pcar Ql NAA+probe	4180186
36304616	肠道病毒 RNA:存在情况或阈值:时间点:心包液:序数型:探针法.基因扩增.靶向	4182948
36304617	Golimumab SerPl IA-mCnc	4180186
36304617	DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Simponi; SR; SUDS	4180186
36304617	戈利木单抗:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36304622	Abcid; Agribon; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Primor; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36304622	Ormetoprim+Sulfadimethoxine Susc Islt	4180186
36304622	奥美普林+磺胺二甲氧嘧啶:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36304624	C diphtheriae; C&S; Cult; Cultures; Diphtheria; Diptheria; ID; Infectious Disease; InfectiousDisease; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Spec; Up; Upper resp	4180186
36304624	C diphtheriae Upper resp Ql Cult	4180186
36304624	白喉棒状杆菌:存在情况或阈值:时间点:呼吸道.上:序数型:微生物特异性培养	4182948
36304631	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304632	Molecular resistance method Islt/Spm	4180186
36304632	Identity or presence; Islt; Islt/Spm; Isol; Meth; Method of; MISC; Molecular resistance method; Nominal; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec; Test mthd	4180186
36304632	用于确定耐药性的分子实验室检验方法:存在与否或特征标识:时间点:分离株/标本:名义型:*	4182948
36304633	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304635	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Mycotoxin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304635	Fumonisin B1 Spec-mCnt	4180186
36304635	伏马菌素 B1:质量含量:时间点:XXX:定量型	4182948
36304636	Abd; Abdo; Abdomen+; Abdominal; Chest + Abd; CorePlaybook; Denver shunt; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; PV shunt revision; Rad; RADIOLOGY; Random; Thorax	4180186
36304636	Guided Chest+Abd PV shunt revision	4180186
36304636	旨在修正腹水转流装置的引导:发现:时间点:腹部+胸部:文档型:{成像方式}	4182948
36304637	AUDIO; Audiology; Ear-L; Hearing; L; LT; Otologic; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304637	Hearing threshold 6000 Hz Ear-L	4180186
36304637	听阈^6000 赫兹:相对声强:时间点:耳.左侧:定量型	4182948
36304640	Activity; Arterial Stenosis; Count/time; Dextro; Exercise; Job; nRate; Number rate; Number Rate = Count/Time; Occupation; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304641	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36304643	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304645	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV1; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; Pork; PPIV1; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36304645	PPIV1 RNA Ct Spec Qn NAA+probe	4180186
36304645	猪副流感病毒 1 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36304649	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36304650	SRA 50 IU/mL LMW heparin Ser-aCnc	4180186
36304650	5-HT; 5-hydroxytryptamine; 5-hydroxytryptophane; Arbitrary concentration; C10H12N2O; Clexane; Enoxaparin; Enteramine; Hep; Hepar; Heparin dependent platelet antibody; Heparn; HIT/HITT; LMWH; LMWH-induced thrombocytopenia; Lovenox; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serotonin release assay; Serum; SR; SRA; SRA 50 IU; SRA 50 IU/mL heparin; SRA 50 IU/mL LMW heparin; Thrombocytopenia with thrombosis syndrome; Wt	4180186
36304650	5-羟色胺释放分析 50 IU/mL 肝素.低分子量:任意型浓度:时间点:血清:定量型	4182948
36304651	Document; Finding; Findings; Guid; Guide; Guided; Imaging; in Surg; Intra operative; Intraop; Intraoperative; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; Surg; To be specified in another part of the message; Unspecified	4180186
36304651	Guided Unsp region Guide--in Surg	4180186
36304651	引导^术中:发现:时间点:XXX:文档型:{成像方式}	4182948
36304653	H+P; H+P.HX; History; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36304653	Hx of Severe bleeding due to aspirin use	4180186
36304653	与严重出血相关的阿司匹林使用情况:历史记录:时间点:^患者:序数型	4182948
36304654	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Head+Pit+Sella; Imaging; Intracranial; Pit+Sella turc; Pituitary+ST; Pitutary; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC	4180186
36304654	CT Head+Pit+Sella W contr IV	4180186
36304654	多层^采用静脉注射对比剂:发现:时间点:头部 & 头部>垂体+蝶鞍:文档型:CT	4182948
36304655	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; GJ-tube place; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; UGI; Up	4180186
36304655	Guided UGI GJ-tube place	4180186
36304655	旨在置入胃造瘘-空肠造瘘管的引导:发现:时间点:腹部>胃肠道.上段:文档型:{成像方式}	4182948
36304657	Centers for Medicare and Medicaid Assessment; Dextro; Hx; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Patient Hx; Pnl; Point in time; Random; Survey	4180186
36304658	#; ABS; absolute; absolutes; Blood; CD4 Cells; CD4+CD25+ Cells; CD4+CD25-CD127+ cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; IL-7R; IL-7R alpha; ILR2; Inducer T cells; L3T4; Leu3; Leu-3; Number concentration; Number Concentration (count/vol); p90 Il7 R; Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; Tac antigen; W3/25; WB; Whole blood	4180186
36304658	CD4+CD25-CD127+ cells # Bld	4180186
36304658	细胞.CD4+CD25-CD127+:计数型浓度:时间点:全血:定量型	4182948
36304659	Add; Calf; CorePlaybook; Document; EXT; Fibula; Finding; Findings; Guid; Guide; Guided; Imaging; LE; Leg; Low; Lower extremity; Perc; Playbook; Point in time; PTA; PTA addl; Rad; RADIOLOGY; Random; Tibia	4180186
36304659	Guided Lower leg PTA addl	4180186
36304659	旨在额外经皮腔内血管成形术的引导:发现:时间点:下肢>小腿:文档型:{成像方式}	4182948
36304663	AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Extensively drug resistant tuberculosis; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MDR TB; MDR Tuberculosis; Multi drug resistant tuberculosis; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; Sirturo; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis; XDR TB	4180186
36304663	Bedaquiline Islt SlowMyco	4180186
36304663	贝达喹啉:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
36304671	Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Started; Time stamp; Timestamp; TRAUMA	4180186
36304671	运输开始时间:时间戳:时间点:^患者:定量型	4182948
36304672	Insp time; Insp time set; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36304672	Insp time set Vent	4180186
36304672	吸气时间设置:时间:时间点:呼吸机:定量型	4182948
36304673	Known bact drug resist infect	4180186
36304673	Bact; Drugs; Finding; Findings; Known bact drug resist infect; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36304673	已知的细菌耐药性感染:发现:时间点:^患者:序数型	4182948
36304675	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304676	Counter; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304676	Terbufos Spec-mCnt	4180186
36304676	特丁硫磷:质量含量:时间点:XXX:定量型	4182948
36304677	Ordinal; Point in time; PRO measure score; Ql; Qual; Qualitative; Random; Scale; Screen; Survey; SURVEY.GNHLTH	4180186
36304678	Average; Avg; Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
36304682	#; ABS; absolute; absolutes; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+IgM+ cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; HD-37; IgM B cells; Immune globulin M; Immunoglobulin M; Leu12; Leu-12; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36304682	CD19+IgM+ cells # Bld	4180186
36304682	细胞.CD19+IgM+:计数型浓度:时间点:全血:定量型	4182948
36304683	Associated; bnd; Chemistry; CR; Crea; Creat; LASA; Lipid-associated sialic acid; Lipid-bound sialic acid; LSA; N-Acetylneuraminic Acid; Point in time; QNT; Quan; Quant; Quantitative; Random; SA; Scrto; Sialic acid; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
36304683	LASA/Creat Ur-sRto	4180186
36304683	唾液酸.脂质结合型/肌酐:物质的量比率:时间点:尿液:定量型	4182948
36304684	#/area; Cast; Kidney; Leuc; Leuk; Leukocytes; Lkcs; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; WBC; WBC Casts; WBCs; White blood cell; White blood cells	4180186
36304684	WBC Casts #/area UrnS	4180186
36304684	白细胞管型:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36304685	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304689	CdtB+Vinculin Ab Ser IA-Imp	4180186
36304689	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CdtB; CdtB & Vinculin; CdtB+Vinculin; CdtB+Vinculin Ab; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MEIA; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS; VCL	4180186
36304689	细胞致死膨胀毒素 B+粘着斑蛋白 抗体:印象:时间点:血清:序数型:免疫测定法	4182948
36304691	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Sx	4180186
36304695	Addiction med D/C sum	4180186
36304695	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36304695	出院摘要记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36304697	Activities of Daily Living; Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304698	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B afz+burg+gari; B afzelii; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36304698	B afz+burg+gari IgG Ser Ql Line blot	4180186
36304698	阿夫塞疏螺旋体+伯氏疏螺旋体+加里疏螺旋体 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36304699	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Gyn; Gynecology; Imaging; OB; ObGyn; Obstetrics; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; Tub; Tube, unspecified	4180186
36304699	Guided Fallopian tube Dilation	4180186
36304699	旨在扩张术的引导:发现:时间点:盆腔>输卵管:文档型:{成像方式}	4182948
36304701	Centers for Medicare and Medicaid Assessment; Dextro; Form version; LTPAC; Othr; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304702	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Seattle Angina Questionnaire; Survey; SURVEY.GNHLTH; Sx; Symptom freq score	4180186
36304703	BON; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiofreq abl; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304703	Guided Bone Radiofreq abl	4180186
36304703	旨在射频消融术的引导:发现:时间点:XXX>骨:文档型:{成像方式}	4182948
36304706	BoNT; BTX; C bot; C bot Tox; C botulinum; ID; Identity or presence; Infectious Disease; InfectiousDisease; MA; MA Nt; Microbiology; Neut; Neutr; Nominal; Point in time; Random; Serum; SR	4180186
36304706	C bot Tox Ser MA Nt	4180186
36304706	肉毒梭菌毒素:存在与否或特征标识:时间点:血清:名义型:小鼠生物鉴定.中和作用	4182948
36304710	ACIF; Anticomplement Immunofluorescence; CA; Calif; California encephalitis virus Ab; California Encephalitis Virus AB IGG; California Encephalitis Virus AB IGM; CEV; CEV Ab; CEV Ab.IgG & IgM panel; CEV Ab.IgG+IgM; CEV IgG; CEV IgG & IgM; Enc; Enceph; Encephalomyelitis; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR; Time Resolved Fluorescence; TRF	4180186
36304710	CEV Ab.IgG & IgM panel Ser IF	4180186
36304710	加利福尼亚脑炎病毒抗体.IgG 与 IgM 组套:-:时间点:血清:-:免疫荧光法	4182948
36304711	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Narcan; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
36304711	Naloxone Sal Cfm-mCnc	4180186
36304711	钠洛酮:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36304717	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36304719	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Gall bladder; GB; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random	4180186
36304719	Guided GB Cholecystostomy	4180186
36304719	旨在胆囊造瘘的引导:发现:时间点:腹部>胆囊:文档型:{成像方式}	4182948
36304721	ADMIN; Nominal; Person name; Point in time; Random	4180186
36304721	中间名:人员姓名:时间点:服务提供者:名义型	4182948
36304722	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304724	1 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; MRD; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis; Zyvox	4180186
36304724	Linezolid 1 ug/mL Islt SlowMyco	4180186
36304724	利奈唑胺 1.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
36304725	Document; Dorsal spine; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine	4180186
36304725	Guided T-spine Myelography	4180186
36304725	旨在脊髓造影术的引导:发现:时间点:胸部>脊椎.胸段:文档型:{成像方式}	4182948
36304726	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Compx; Deoxyribonucleic acid; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; M tb; M TB Cmplx; M tuberculosis; Microbiology; Molecular genetics; Mtb; MTBC; Myco; Mycobact; Mycobacterium tuberculosum; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; TB; Tuberculosis	4180186
36304726	M TB Cmplx DNA Islt/Spm Ql	4180186
36304726	结核分枝杆菌复合菌群 DNA:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36304728	CD45RO Cells/100 CD4 cells NFr Bld	4180186
36304728	100 CD4 cells; Blood; CD4 Cells; CD45RO Cells; Cell; CELL MARKERS; Cellularity; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; UCHL-1; W3/25; WB; Whole blood	4180186
36304728	细胞.CD45RO/100 个细胞.CD4:计数型分数:时间点:全血:定量型	4182948
36304731	Brain; CAT scan; Cerebral; Cerebrum; Computed tomography; Computerized tomography; Cranial; Cranium; CT scan; Document; Finding; Findings; Head; Imaging; Intracranial; PET Scan; PET+CT; Point in time; Position Emmision Tomography; Positron Emission Tomography; Rad; RADIOLOGY; Radnuc.PET; Random; RN; RNC; Scan; Skull; W RNC IV	4180186
36304731	PET+CT Brain for amyloidosis W RNC IV	4180186
36304731	针对淀粉样变性的多层^采用静脉注射放射性核素:发现:时间点:头部>脑部:文档型:PT+CT	4182948
36304732	Reportable cond response desc.brief	4180186
36304732	Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report; Reportable cond response desc.brief	4180186
36304732	法定上报情况答复描述.简要:发现:时间点:^患者:叙述型	4182948
36304735	Centers for Medicare and Medicaid Assessment; Dextro; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304739	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304740	3rd; 3rd deg burn area; Bdy surface; bod; Bodies; BSA; Est; estimation; Point in time; QNT; Quan; Quant; Quantitative; Random; Surf; TRAUMA	4180186
36304740	3rd deg burn area/BSA Est	4180186
36304740	三度烧伤面积/体表面积:面积比:时间点:^患者:定量型:估计法	4182948
36304741	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Txs	4180186
36304745	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304745	HAdV DNA Stl Ql NAA+probe	4180186
36304745	腺病毒 DNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
36304746	CLIN; Emotional stability; Finding; Findings; Nominal; Point in time; Random	4180186
36304746	Important mental health issue to address	4180186
36304746	所要处理解决的最重要的心理健康问题:发现:时间点:^患者:名义型	4182948
36304747	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GP Bld Culture Pnl; ID; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Pos; Random; WB; Whole blood	4180186
36304747	GP Bld Culture Pnl Bld Pos Probe	4180186
36304747	革兰氏阳性细菌血液培养组套:-:时间点:血液.生长阳性:-:DNA探针	4182948
36304748	A pleuropn; A pleuropn 3+6+8; A pleuropn 3+6+8 Ab; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; III; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36304748	A pleuropn 3+6+8 Ab/Pos cntrl Ser IA	4180186
36304748	胸膜肺炎放线杆菌血清型 3+6+8 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36304751	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36304752	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304754	Abd; Abdo; Abdomen+; Abdominal; Chest + Abd; CorePlaybook; Denver shunt; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; PV shunt place; Rad; RADIOLOGY; Random; Thorax	4180186
36304754	Guided Chest+Abd PV shunt place	4180186
36304754	旨在置入腹腔静脉分流装置的引导:发现:时间点:腹部+胸部:文档型:{成像方式}	4182948
36304755	14-Hydroxydihydromorphinone; DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; III; Numorphan; Numorphone; O3G; Opana; Ordinal; Oxymorphone-3beta-D-glucuronide; Oxymorphone-3-beta-glucuronide; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
36304755	O3G Ur Ql Scn	4180186
36304755	羟吗啡酮-3-葡糖苷酸:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36304756	PSP SerPlBld IA.rapid-mCnc	4180186
36304756	Blood; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Lithostathine-1-alpha; Mass concentration; MEIA; Pancr; Pancreatc; Pl; PlasBld; Plasma; Plsm; Point in time; PR; Prot; PSP; QNT; Quan; Quant; Quantitative; Random; REG-a1; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; SUDS; WB; Whole blood	4180186
36304756	胰石蛋白:质量浓度:时间点:血清/血浆/全血:定量型:免疫测定法.快速	4182948
36304758	Dialy; Dialysis Nurse; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
36304758	记录:发现:时间点:{环境}:文档型:透析.护士	4182948
36304759	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; HRSV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; RSV; Screen; Time Resolved Fluorescence; TRF	4180186
36304759	RSV Ag Lower resp Ql IF	4180186
36304759	呼吸道合胞病毒 抗原:存在情况或阈值:时间点:呼吸道.下:序数型:免疫荧光法	4182948
36304760	Eastern Cooperative Oncology Group; Everyday Cognition; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304761	Ang; Angio; Angiography; Angm; Arteriogram; Brain; c; CAT scan; Circle of Willis+Carotid aa; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Intracranial; Point in time; Rad; Radiology; Random; Skull; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36304761	CTA Circ of Willis+Carot aa WO+W contr IV	4180186
36304761	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部+颈部>大脑动脉环+颈动脉类:文档型:CT.血管造影术	4182948
36304764	Abd; Abd+Pelvis; Abdo; Abdominal; Change; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrology; Pelvic; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Replace; Transurethral nephrouret stent exchange; Ureter+Blad	4180186
36304764	Guided Nephrouret stent exch via urethra	4180186
36304764	旨在经尿道更换肾输尿管支架的引导:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:{成像方式}	4182948
36304765	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Facial bones + Maxilla; Facial bones+Maxilla; Finding; Findings; Head+Maxillofacial; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC	4180186
36304765	CT Head+Maxillofacial W contr IV	4180186
36304765	多层^采用静脉注射对比剂:发现:时间点:头部 & 头部>颌面区域:文档型:CT	4182948
36304766	Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Typ	4180186
36304766	临床表现状态:类型:时间点:^患者:序数型	4182948
36304769	CD28+HLA DR+ cells/100 CD3+CD8+ NFr Bld	4180186
36304769	100 CD3+CD8+; Blood; CD28 Cells; CD28+HLA DR+ cells; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; HLA-DR; Human Leukocyte Antigen; I3; Leu2; Leu-2; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T44; T8; T-8; T8 suppressor cells; Tp44; Tsuppressor; WB; Whole blood	4180186
36304769	细胞.CD28+HLA DR+/100 个细胞.CD3+CD8+:计数型分数:时间点:全血:定量型	4182948
36304770	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304770	Guided Nerve Sympathectomy	4180186
36304770	旨在经皮交感神经切除术的引导:发现:时间点:XXX>神经:文档型:{成像方式}	4182948
36304771	Asp; BON; CorePlaybook; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304771	Guided Bone Cyst asp	4180186
36304771	旨在经皮囊肿抽吸的引导:发现:时间点:XXX>骨:文档型:{成像方式}	4182948
36304775	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304776	Ba; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304776	Barium Spec-mCnt	4180186
36304776	钡:质量含量:时间点:XXX:定量型	4182948
36304777	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36304777	H capsul DNA Tiss Ql NAA+probe	4180186
36304777	荚膜组织胞浆菌 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36304780	HEDIS 2018 Depression Screen	4180186
36304780	HEDIS 2018 Depression Screen; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn	4180186
36304780	HEDIS 2018 取值集合 - 抑郁筛查:-:时间点:^患者:-	4182948
36304781	Cu; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304781	Copper Spec-mCnt	4180186
36304781	铜:质量含量:时间点:XXX:定量型	4182948
36304783	Centers for Medicare and Medicaid Assessment; Path; QNT; Quan; Quant; Quantitative; Survey; Tx	4180186
36304785	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36304786	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory	4180186
36304786	Virus Lower resp Cult	4180186
36304786	病毒 已鉴定的:存在与否或特征标识:时间点:呼吸道.下:名义型:培养	4182948
36304787	Anatomy; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304788	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36304788	OB Phone Note	4180186
36304788	记录:发现:时间点:电话就医:文档型:产科学	4182948
36304789	Arm; Carpal bone; Carpal bones; Carpal bones and joint; CorePlaybook; Document; EXT; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Playbook; Point in time; Rad; RADIOLOGY; Random; UE; Up; Upper extremity joint	4180186
36304789	Guided Wrist Inj	4180186
36304789	旨在注射的引导:发现:时间点:上肢>腕部:文档型:{成像方式}	4182948
36304790	Arterial Stenosis; Count/time; Dextro; Job; nRate; Number rate; Number Rate = Count/Time; Occupation; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304794	*^Patient; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Home health care; Med mgmt note; notes; Point in time; Pt's home; Random; S prime; Visit note	4180186
36304794	Pt's home Med mgmt note	4180186
36304794	药物管理记录:发现:时间点:患者的家:文档型:{角色}	4182948
36304795	Abd; Abdo; Abdomen+; Abdominal; Change; CorePlaybook; Document; Finding; Findings; Guid; Guidance for exchange; Guide; Guided; Imaging; J-tube exch; Playbook; Point in time; Rad; Radiology; Random; Replace; UGI; Up	4180186
36304795	Guided UGI J-tube exch	4180186
36304795	旨在更换空肠造瘘管的引导:发现:时间点:腹部>胃肠道.上段:文档型:{成像方式}	4182948
36304796	Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Head+Sinuses; Imaging; Intracranial; Paranasal sinuses; Point in time; Rad; RADIOLOGY; Random; Sinus; Skull; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36304796	CT Head+Sinuses WO+W contr IV	4180186
36304796	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部 & 头部>副鼻窦类:文档型:CT	4182948
36304798	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; NDL; Needle place; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304798	Guided Unsp region Needle place	4180186
36304798	旨在置入针的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36304805	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; Humira; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36304805	Adalimumab Ab SerPl IA-mCnc	4180186
36304805	阿达木单抗 抗体:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36304807	C&S; Cerebral spinal fluid; Cerebrospinal Fl; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Lyme; Lyme disease; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Relapsing fever; Spec; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp	4180186
36304807	Borrelia CSF Cult	4180186
36304807	疏螺旋体属单个未知种 已鉴定的:存在与否或特征标识:时间点:脑脊液:名义型:微生物特异性培养	4182948
36304808	Centers for Medicare and Medicaid Assessment; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304814	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gyn Nurse; Gynecology; notes; nursing; OB; ObGyn; Obstetrics; OP; Point in time; Random; Visit note	4180186
36304814	Gyn Nurse OP Note	4180186
36304814	记录:发现:时间点:门诊病人:文档型:妇科学.护士	4182948
36304816	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Implnt dev; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Prostheses; Prosthesis; Prosthetic; Random	4180186
36304816	Bacteria Implnt dev Anaerobe Cult	4180186
36304816	细菌 已鉴定的:存在与否或特征标识:时间点:植入装置:名义型:厌氧微生物培养	4182948
36304817	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304818	呼吸道合胞病毒:存在情况或阈值:时间点:角膜/结膜:序数型:微生物特异性培养	4182948
36304818	C&S; Corn/Cnjt; Corneal; Cult; Cultures; HRSV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RSV; Screen; Spec	4180186
36304818	RSV Corn/Cnjt Ql Cult	4180186
36304821	Cath; CorePlaybook; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Removal of fluid; Spec; To be specified in another part of the message; Unspecified	4180186
36304821	Guided Unsp region Drain+cath place	4180186
36304821	旨在引流+引流导管置入的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36304823	Add; Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Mech thromb addl; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36304823	Guided Artery Mech thromb addl	4180186
36304823	旨在额外经皮机械性血栓切除术的引导:发现:时间点:XXX>动脉:文档型:{成像方式}	4182948
36304825	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; MN; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304825	Manganese Spec-mCnc	4180186
36304825	锰:质量浓度:时间点:XXX:定量型	4182948
36304826	PCV2 Ab Titr Ser IA	4180186
36304826	猪圆环病毒 2 型 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36304826	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circo virus; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV; PCV2; PCV2 Ab; Point in time; Pork; Random; Serum; SmQn; SR; SUDS; Swine; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36304828	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304831	CKD personal health goals pnl; CLIN; Dis; Diseases; Dz; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
36304831	CKD personal health goals pnl	4180186
36304831	慢性肾脏疾病管理个人目标组套:-:时间点:^患者:-	4182948
36304834	EXCZ; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36304837	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P; History and physical; notes; OB; ObGyn; Obstetrics; Point in time; Post-op E/M note; Post-operative; Random; Visit note	4180186
36304837	Gynecology Post-op E/M note	4180186
36304837	术后评价与管理记录:发现:时间点:{环境}:文档型:妇科学	4182948
36304839	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36304840	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304842	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36304843	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; NO3; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304843	Nitrate Spec-mCnc	4180186
36304843	硝酸根:质量浓度:时间点:XXX:定量型	4182948
36304844	ANTIBIOTIC SUSCEPTIBILITIES; AST; Bovine Respiratory Disease; BRD; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary; Zuprevo	4180186
36304844	Tildipirosin Islt MIC	4180186
36304844	泰地罗新:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36304847	Bowel movement; C pylori; C&S; Campylobacter pylori; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; H pyl; H pylori; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Stl; Stool = Fecal	4180186
36304847	H pylori Stl Ql Cult	4180186
36304847	幽门螺杆菌:存在情况或阈值:时间点:大便:序数型:微生物特异性培养	4182948
36304849	#/area; Cast; Discocyte; Erc; Erythrocytes; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBC Casts; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36304849	RBC Casts #/area UrnS	4180186
36304849	红细胞管型:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36304850	Alb; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Protein.albumin; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36304850	Basic metabolic & albumin panel SerPl	4180186
36304850	基础代谢与白蛋白组套:-:时间点:血清/血浆:-	4182948
36304851	PCV2 IgG Titr Ser IA	4180186
36304851	猪圆环病毒 2 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫测定法	4182948
36304851	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circo virus; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV; PCV2; PCV2 Ab; PCV2 IgG; Point in time; Pork; Random; Serum; SmQn; SR; SUDS; Swine; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36304853	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B afz+burg+gari; B afzelii; Bands; bnd; ID; IgG Patrn; Immune globulin G; Immunoglobulin G; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Nominal; Patrn; Point in time; Random; Serum; SR	4180186
36304853	B afz+burg+gari IgG Ptrn Ser Ln blot	4180186
36304853	阿夫塞疏螺旋体+伯氏疏螺旋体+加里疏螺旋体 抗体.IgG 区带模式:印象:时间点:血清:名义型:线点印迹法	4182948
36304854	C trac; C trach; C tracho; C trachomatis; C&S; Chlam; Chlam trac; Chlamid; CT; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Tissue; Tissue, unspecified; Trachoma	4180186
36304854	C trach Tiss Ql Cult	4180186
36304854	沙眼衣原体:存在情况或阈值:时间点:组织与涂片:序数型:微生物特异性培养	4182948
36304856	Cerebral spinal fluid; Cerebrospinal Fl; Gie Stn; GMS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; St; Stains; Stn	4180186
36304856	Gie Stn CSF	4180186
36304856	显微镜观察:存在与否或特征标识:时间点:脑脊液:名义型:姬姆萨染色法	4182948
36304858	Acd; Acid fast Stn; Acids; AFB stain; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn	4180186
36304858	Acid fast Stn Islt Ql	4180186
36304858	显微镜观察:存在情况或阈值:时间点:分离株:序数型:抗酸染色法	4182948
36304859	2; BDI II; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
36304866	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36304866	OB Note	4180186
36304866	记录:发现:时间点:{环境}:文档型:产科学	4182948
36304867	Apnea dur set; Durat; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Vent alarm	4180186
36304867	Apnea dur set Vent alarm	4180186
36304867	呼吸暂停持续时间设置:时间:时间点:呼吸机.警报:定量型	4182948
36304869	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304871	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304876	3; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Point in time; Pol III; POL3RA gene; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; RNAp III; RNAp III RP155; RNAp III RP155 Ab; Serology; Serum; SR	4180186
36304876	RNAp III RP155 Ab Ser Line blot-aCnc	4180186
36304876	RNA 聚合酶 III RP155 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36304879	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Sal; Salmonel; Serum; species; spp; SR; SUDS	4180186
36304879	Salmonella Ab/Pos cntrl Ser IA	4180186
36304879	沙门菌属单个未知种 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36304880	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Sulfadimerazine; Sulfadimezine; Sulfadimidine; Sulphadimethylpyrimidine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304880	Sulfamethazine Spec-mCnt	4180186
36304880	磺胺二甲嘧啶:质量含量:时间点:XXX:定量型	4182948
36304881	Dyspnoea questionnaire; Point in time; QNT; Quan; Quant; Quantitative; Random; RDS; Rose dyspnea score; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36304883	CMV; CMV IgG+IgM Pnl; Cytomegalo virus; Cytomgal; HHV-5; Human Herpesvirus-5; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36304883	CMV IgG+IgM Pnl SerPl	4180186
36304883	巨细胞病毒抗体.IgG 与 IgM 组套:-:时间点:血清/血浆:序数型	4182948
36304884	Chemistry; k; K+; Mass content; Misc; Miscellaneous; Other; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304884	Potassium Spec-mCnt	4180186
36304884	钾:质量含量:时间点:XXX:定量型	4182948
36304885	Ang; Angio; Angiography; Angm; Arteriogram; c; CA; CAT scan; Chest+Coronary aa; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Coronary aa; CT + CTA; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Heart; Imaging; Point in time; Rad; Radiology; Random; Thorax; without contrast	4180186
36304885	CT Chest WO + CTA Coronary aa W contr IV	4180186
36304885	多层^WO contrast && Multisection^W contrast IV:发现:时间点:胸部 & 胸部>冠状动脉类:文档型:CT && CT.血管造影术	4182948
36304889	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304890	CARD.PROC; Cardio; Cardiology; CPR; Heart Disease; Nominal; Point in time; Provider who performed CPR; Random; Typ; World Heatlth Organization	4180186
36304890	Provider who performed CPR	4180186
36304890	执行心肺复苏的医疗服务人员:类型:时间点:^患者:名义型	4182948
36304891	Calf; CorePlaybook; Document; EXT; Fibula; Finding; Findings; Guid; Guide; Guided; Imaging; LE; Leg; Low; Lower extremity; Perc; Playbook; Point in time; PTA; Rad; RADIOLOGY; Random; Tibia	4180186
36304891	Guided Lower leg PTA	4180186
36304891	旨在经皮腔内血管成形术的引导:发现:时间点:下肢>小腿:文档型:{成像方式}	4182948
36304892	BM; BON; Bone marrow; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Kala azar; Leishmaniasis; Leishmaniosis; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; Nominal; Point in time; Random; Spec; species; spp; Visceral leishmaniasis	4180186
36304892	Leishmania Mar Cult	4180186
36304892	利什曼原虫属单个未知种 已鉴定的:存在与否或特征标识:时间点:骨髓:名义型:微生物特异性培养	4182948
36304893	Combat zone hazard duty work; H+P; H+P.HX; Job; Occupation; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304893	Combat zone hazard duty work DateRange	4180186
36304893	战斗活动区域和或危险岗位工作日期范围:日期范围:时间点:^患者:定量型	4182948
36304894	Art; BrachCeph a; Brachiocephalic; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Innominate artery; Perc; Playbook; Point in time; PTA; Rad; RADIOLOGY; Random; Thorax	4180186
36304894	Guided BrachCeph a PTA	4180186
36304894	旨在经皮腔内血管成形术的引导:发现:时间点:胸部>头臂动脉:文档型:{成像方式}	4182948
36304896	DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; Nucynta; Ordinal; Palexia; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tapal; Tapen gluc; Tapentadol; UA; UR; Urn	4180186
36304896	Tapen gluc Ur Ql Scn	4180186
36304896	他喷他多葡萄糖醛酸苷:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36304897	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Cerebral spinal fluid; Cerebrospinal Fl; high-throughput sequencing; HIV 1 RNA IN gene mut det; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Mut; Mut Det; Mutation; Muts; Neuro; Neurology; Next generation sequencing; NGS; Nominal; Point in time; Random; Ribonucleic acid; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36304897	HIV 1 RNA IN Mut Det CSF Seq	4180186
36304897	HIV 1 型 RNA 整合酶基因 已检出的突变:存在与否或特征标识:时间点:脑脊液:名义型:序列测定	4182948
36304898	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B quintana; Cat Scratch Disease; Cat Scratch Fever; CSD; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; R quintana; Random; Rochalimae quintana; Rochalimaea quintana; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Trench fever	4180186
36304898	B quintana DNA Tiss Ql NAA+probe	4180186
36304898	五日热巴通体 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36304900	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; RSV; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304900	RSV RNA Corn/Cnjt Ql NAA+probe	4180186
36304900	呼吸道合胞病毒 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36304901	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304902	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
36304904	Specialty services avail type	4180186
36304904	Nominal; Point in time; Random; TRAUMA; Typ	4180186
36304904	可用的专科服务:类型:时间点:设施:名义型	4182948
36304905	Act/Nor; Activ; Actvty; Antihemophilic factor B; Christmas factor; Chromogenic assay; Coag; Control; ENZY; Enzymatic assay; Fac; Fact; Fact IX; Factor 9; FIX; Hematology; Heme; Movements; Plas; Plasma thromboplastin component; Platelet poor plasma; Point in time; PTC; QNT; Quan; Quant; Quantitative; Random; RlCCnc; Thrombocyte cofactor II	4180186
36304905	Fact IX Act/Nor PPP Chro	4180186
36304905	凝血因子IX活性 实际的/正常的:相对催化浓度:时间点:贫血小板血浆:定量型:凝血因子酶学测定法	4182948
36304906	Addiction med Educ note	4180186
36304906	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36304906	教育记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36304908	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36304909	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Immunization status; notes; Point in time; Random; Vaccination; Vaccinations; Vaccine; Visit note	4180186
36304909	疫苗接种记录:发现:时间点:{环境}:文档型:肝病学	4182948
36304910	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304911	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36304914	Belt; Chlor Kil; Chlordan; Chlortox; Clordano; Corodane; DRUG/TOXICOLOGY; Drugs; Gold Crest C-100; Kilex Lindane; Kypchlor; Mass content; Misc; Miscellaneous; Niran; Octachlor; Octa-Klor; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Synklor; To be specified in another part of the message; Topiclor 20; Toxichlor; Unspecified; Velsicol 1068; Vet; Veterinary	4180186
36304914	Chlordane Spec-mCnt	4180186
36304914	氯丹:质量含量:时间点:XXX:定量型	4182948
36304918	Aldicarb-sulfone; Aldoxycarb; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Standak; Sulfocarb; Temik; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304918	Aldicarb sulfone Spec-mCnt	4180186
36304918	涕灭威砜:质量含量:时间点:XXX:定量型	4182948
36304920	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Joint aspirate; Joint fld; Joint flu; Joint fluid; Microbiology; Nominal; Point in time; Random; Rheum; Rheumatology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
36304920	Bacteria Snv Anaerobe Cult	4180186
36304920	细菌 已鉴定的:存在与否或特征标识:时间点:滑液:名义型:厌氧微生物培养	4182948
36304926	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E.coli Shiga-like toxin gene; EC stx2 gene; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shiga Like Toxin II; Shiga-Like Toxins; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304926	EC stx2 gene Islt Ql NAA+probe	4180186
36304926	大肠埃希菌 Stx2 毒素 stx2 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36304927	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Reportable cond response info+sum	4180186
36304927	Reportable cond response info+sum Doc	4180186
36304927	法定上报情况答复信息与摘要:发现:时间点:^患者:文档型	4182948
36304929	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304930	Feline; Felis domesticus; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
36304931	Acd; Acid fast Kiny Stn; Acid fast Stn; Acids; AFB stain; Cervix; Genital tract; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; St; Stains; Stn	4180186
36304931	Acid fast Kiny Stn Cvx	4180186
36304931	显微镜观察:存在与否或特征标识:时间点:子宫颈:名义型:抗酸染色法.Kinyoun	4182948
36304932	B; B2 Microglob; b2-M; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; II; Kidney; Level; Mass concentration; Microglob; Nephrology; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal	4180186
36304932	B2 Microglob DiafP-mCnc	4180186
36304932	Beta-2-微球蛋白:质量浓度:时间点:腹膜透析液:定量型	4182948
36304933	Contract; DOC.ONT; Document; Finding; Findings; nursing; Point in time; Random	4180186
36304933	协议:发现:时间点:{环境}:文档型:护士	4182948
36304934	Calf; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-L; Fibula; Finding; Findings; Imaging; L; LE; Leg; LE-L; LLE; Low; Lower extremity; Lower leg-L; LT; Point in time; Rad; RADIOLOGY; Random; Tibia	4180186
36304934	CT Lower leg-L	4180186
36304934	多层:发现:时间点:下肢.左侧>小腿:文档型:CT	4182948
36304938	Arthrogram; Arthrography; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Imaging; intraarticular; intrasynovial; Kn; Knee-Bl; Knees; LE; LE-Bl; Leg; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; W contr IS; WC	4180186
36304938	CT Knee-Bl W contr IS	4180186
36304938	多层^采用关节内对比剂:发现:时间点:下肢.双侧>膝关节:文档型:CT	4182948
36304940	ID; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Ordinal; P carinii; P jiroveci; PCP; Pneumocystis carinii; Point in time; PR; Prep; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
36304940	P jiroveci Lower Resp Ql Calco white	4180186
36304940	耶氏肺孢子菌:存在情况或阈值:时间点:呼吸道.下:序数型:荧光增白剂染色法	4182948
36304943	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Filariasis; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; River blindness; Screen; Serum; species; spp; SR; SUDS	4180186
36304943	Onchocerca IgG Ser Ql IA	4180186
36304943	盘尾属单个未知种 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36304944	Gram Stn; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; OB; ObGyn; Obstetrics; Placent; Placental; Point in time; Random; St; Stains; Stn	4180186
36304944	Gram Stn Placenta	4180186
36304944	显微镜观察:存在与否或特征标识:时间点:胎盘:名义型:革兰氏染色法	4182948
36304945	Micro CNAMTS panel Pus	4180186
36304945	Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random	4180186
36304945	微生物学 CNAMTS 组套:-:时间点:脓液:-	4182948
36304946	Abd; Abdo; Abdomen+; Abdominal; Bx; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Kidney-L; L; LT; Nephric; Nephrology; Perc; Point in time; Pyelogram; Rad; RADIOLOGY; Random; Renal	4180186
36304946	CT Guided Kidney-L Bx	4180186
36304946	旨在经皮活组织检查的引导:发现:时间点:腹部>肾脏.左侧:文档型:CT	4182948
36304948	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36304949	Acd; Acid; C20:5w3; C22:6w3; Cervonate; Cervonic acid; Chemistry; DHA; Docosahexaenoic acid; Eicosapentaenoic acid; EPA; EPA+DHA; Fatty acid; Icosapentaenoate; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lipid; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Timnodonate; Timnodonic Acid	4180186
36304949	Omega-3 index risk SFr SerPl	4180186
36304949	二十碳五烯酸+二十二碳六烯酸/脂肪酸类.C14-C24 指数风险:印象:时间点:血清/血浆:序数型	4182948
36304950	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.MTLHLTH	4180186
36304952	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH; World Heatlth Organization	4180186
36304954	BM; BON; Bone marrow; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; Nominal; Point in time; Random; St; Stains; Stn	4180186
36304954	Gram Stn Mar	4180186
36304954	显微镜观察:存在与否或特征标识:时间点:骨髓:名义型:革兰氏染色法	4182948
36304956	DMT; DRUG/TOXICOLOGY; Drugs; Fentanyl metabolite; N-Desmethyltapentadol; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tapentadol metabolite; UA; UR; Urn	4180186
36304956	Nortapentadol Ur Ql Scn	4180186
36304956	去甲基他喷他多:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36304958	Adeno virus; Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; HAdV; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Nasopharynx; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SUDS	4180186
36304958	HAdV Ag Nph Ql IA	4180186
36304958	腺病毒 抗原:存在情况或阈值:时间点:鼻咽:序数型:免疫测定法	4182948
36304960	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M hominis; Metamycoplasma hominis; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304960	M hominis DNA Corn/Cnjt Ql NAA+probe	4180186
36304960	人型支原体 DNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36304961	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV OC43; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304961	HCoV OC43 RNA Lower resp Ql NAA+probe	4180186
36304961	人类冠状病毒 OC43 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36304962	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36304962	FLUAV RNA Corn/Cnjt Ql NAA+probe	4180186
36304962	流感病毒 A 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36304964	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Glyceryl guaincolate; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36304964	guaiFENesin/Creat Ur Cfm	4180186
36304964	愈创木酚甘油醚/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36304965	Cerebral spinal fluid; Cerebrospinal Fl; Discocytes; Erthrocyte; Erythrocyte; Gram Stn; HEMATOLOGY/CELL COUNTS; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; St; Stains; Stn	4180186
36304965	RBC CSF Ql Gram Stn	4180186
36304965	红细胞:存在情况或阈值:时间点:脑脊液:序数型:革兰氏染色法	4182948
36304967	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36304969	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304970	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36304970	病情减轻日期:日期:时间点:^患者:定量型	4182948
36304973	基孔肯亚病毒 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
36304973	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CHIKV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36304973	CHIKV IgM SerPl Ql IA	4180186
36304976	Anaero; Anaerobe; Anaerobe Cult; Bact; Brn; Burn; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
36304976	Bacteria Burn Anaerobe Cult	4180186
36304976	细菌 已鉴定的:存在与否或特征标识:时间点:烧伤:名义型:厌氧微生物培养	4182948
36304977	Add; Augmentation addl; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; Spinal; Spinal Cord; To be specified in another part of the message; Unspecified	4180186
36304977	Guided Vertebra Augmentation addl	4180186
36304977	旨在额外增强的引导:发现:时间点:XXX>脊椎:文档型:{成像方式}	4182948
36304978	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Surf; Survey; SURVEY.GNHLTH	4180186
36304979	ZIKV IgG Titr Ser IF	4180186
36304979	寨卡病毒 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36304979	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; ZIKV	4180186
36304980	EMS MD name	4180186
36304980	Emergency Medical Service(s); EMS MD name; Nominal; Person name; Point in time; Random; TRAUMA	4180186
36304980	急救医疗服务医师姓名:人员姓名:时间点:服务提供者:名义型	4182948
36304982	Add; Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; Stent place addl; To be specified in another part of the message; Unspecified	4180186
36304982	Guided Artery Stent place addl	4180186
36304982	旨在额外置入支架的引导:发现:时间点:XXX>动脉:文档型:{成像方式}	4182948
36304983	QNT; Quan; Quant; Quantitative; Scale; Survey; SURVEY.MTLHLTH	4180186
36304984	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304988	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
36304988	HCoV RNA Upper resp Ql NAA+probe	4180186
36304988	人类冠状病毒 RNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36304989	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36304993	FDA insert REMS admin inform	4180186
36304993	Admin info; DOCUMENT.REF; FDA insert; Narrative; REMS admin inform; Report; SPL; Structured Product Labelling	4180186
36304993	REMS 管理类信息:-:-:^FDA 包装说明书:叙述型	4182948
36304994	Episode Wnd	4180186
36304994	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ; Wnd	4180186
36304994	服务节段:类型:时间点:伤口:名义型	4182948
36304995	Amaze; DRUG/TOXICOLOGY; Drugs; Isophenphos; Mass content; Misc; Miscellaneous; Oftanol; Other; Point in time; Pryfon; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36304995	Isofenphos Spec-mCnt	4180186
36304995	异柳磷:质量含量:时间点:XXX:定量型	4182948
36304998	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sulphathiazole; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36304998	Sulfathiazole Islt MIC	4180186
36304998	磺胺噻唑:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36305000	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Past; Survey	4180186
36305001	c; C/sp; C+T-spine; Cerv; Contr; Contra; Contrst; C-spine; Document; Dorsal spine; Finding; Findings; Imaging; Mitral regurgitation maximum velocity; MRI; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; W contr IV; WC	4180186
36305001	MR C+T-spine W contr IV	4180186
36305001	多层^采用静脉注射对比剂:发现:时间点:颈部>脊椎.颈段 & 胸部>脊椎.胸段:文档型:MR	4182948
36305002	Bact; Hearing; ID; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; Ordinal; Otologic; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36305002	Intracellular bact Ear Ql Micro	4180186
36305002	胞内菌:存在情况或阈值:时间点:耳:序数型:显微镜检查.光学	4182948
36305006	Abd; Abdo; Abdomen+; Abdominal; Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Perc; Playbook; Point in time; PTA; Rad; RADIOLOGY; Random	4180186
36305006	Guided Visceral a PTA	4180186
36305006	旨在经皮腔内血管成形术的引导:发现:时间点:腹部>内脏动脉:文档型:{成像方式}	4182948
36305008	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305009	ANTIBIOTIC SUSCEPTIBILITIES; AST; Carbomethoxyhydrazone; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Mecadox; Minimum inhibitory concentration; Point in time; QdNO; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36305009	Carbadox Islt MIC	4180186
36305009	卡巴氧:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36305012	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV2; Human rubulavirus 2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 2; Parainfluenza type II; PCR; PI2; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305012	HPIV2 RNA Corn/Cnjt Ql NAA+probe	4180186
36305012	副流感病毒 2 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36305014	Important symptom to manage	4180186
36305014	CLIN; Finding; Findings; Nominal; Point in time; Random; Sx	4180186
36305014	所要管理的最重要的症状:发现:时间点:^患者:名义型	4182948
36305015	Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
36305015	Guided Vein Venous sampling	4180186
36305015	旨在静脉采样的引导:发现:时间点:XXX>静脉:文档型:{成像方式}	4182948
36305019	Count/time; Dextro; H+P; H+P.HX; Job; nRate; Number rate; Number Rate = Count/Time; Occupation; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36305019	Work Hs per D nRate	4180186
36305019	每天工作小时数:计数型速率:时间点:^患者:定量型	4182948
36305020	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; c; CAG; CHGM; Cholangiogram; Cholangiography; Contr; Contra; Contrst; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Stricture dilation; Stricture dilation+stent place; W contr IV; WC	4180186
36305020	Guided BD Strict dil+stent plac W con IV	4180186
36305020	旨在狭窄扩张术+置入支架的引导^采用静脉注射对比剂:发现:时间点:腹部>胆管类:文档型:{成像方式}	4182948
36305022	Anaero; Anaerobe; Anaerobe Cult; Bact; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
36305022	Bacteria BPU Anaerobe Cult	4180186
36305022	细菌 已鉴定的:存在与否或特征标识:时间点:^血液制品单位:名义型:厌氧微生物培养	4182948
36305023	Emergency Medical Service(s); EMS destination; EMS destination name; H+P; H+P.HX; Ident; Identifier; Nominal; P prime; Point in time; Random	4180186
36305023	EMS destination name Facility	4180186
36305023	急救医疗服务运输目的地名称:标识符:时间点:设施:名义型	4182948
36305024	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; ENA RNP; ENA SM; ENA SM+RNP; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ribonuclear protein; RNP; Ro; Screen; Serology; Serum; SM; SR	4180186
36305024	ENA SM+RNP Ab Ser Ql Line blot	4180186
36305024	Smith 可提取性核抗体+核糖核蛋白可提取性核 抗体:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36305025	Centers for Medicare and Medicaid Assessment; Hx; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Patient Hx; Pnl; Point in time; Random; Survey	4180186
36305026	Aureomycin; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305026	Chlortetracycline Spec-mCnt	4180186
36305026	氯四环素:质量含量:时间点:XXX:定量型	4182948
36305027	Zopiclone-N-oxide Ur-mCnc	4180186
36305027	DRUG/TOXICOLOGY; Drugs; Eszopiclone metabolite; Imovane; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Zopliclone	4180186
36305027	N-氧化佐匹克隆:质量浓度:时间点:尿液:定量型	4182948
36305028	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305029	Average; Avg; Centers for Medicare and Medicaid Assessment; Fld; Flow; Past; QNT; Quan; Quant; Quantitative; Survey; Volume Rate; vRate	4180186
36305030	Centers for Medicare and Medicaid Assessment; Dx; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305034	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36305035	3; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Point in time; Pol III; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; RNAp III; Serology; Serum; SR	4180186
36305035	RNAp III Ab Ser Line blot-aCnc	4180186
36305035	RNA 聚合酶 III 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36305036	Ustekinumab Ab SerPl IA-aCnc	4180186
36305036	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; STELARA®; SUDS	4180186
36305036	优特克单抗 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36305038	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36305038	Addiction med Referral note	4180186
36305038	转诊记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36305040	Cath; Chest Pleura; Chest.pleura; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; Thorax; Tun cath place	4180186
36305040	Guided Chest Pleura Tun cath place	4180186
36305040	旨在置入隧道式导管的引导:发现:时间点:胸部>胸膜:文档型:{成像方式}	4182948
36305043	C16; C2; Chemistry; Hexadecanoylcarnitine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
36305043	Palmitoylcarn/C2 SerPl-sRto	4180186
36305043	棕榈酰肉碱 (C16)/乙酰肉碱 (C2):物质的量比率:时间点:血清/血浆:定量型	4182948
36305049	Adeno virus; C&S; Cult; Cultures; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; UA; UR; Urn	4180186
36305049	HAdV Ur Ql Cult	4180186
36305049	腺病毒:存在情况或阈值:时间点:尿液:序数型:微生物特异性培养	4182948
36305050	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305051	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305052	C&S; Corn/Cnjt; Corneal; Cult; Cultures; HPIV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Para; Parainflu; Point in time; Random; Spec	4180186
36305052	HPIV Corn/Cnjt Cult	4180186
36305052	副流感病毒 已鉴定的:存在与否或特征标识:时间点:角膜/结膜:名义型:微生物特异性培养	4182948
36305053	Ab Ao; Abd; Abd Aorta; Abdo; Abdomen; Abdomen+; Abdominal; Aneurysm repair; AO; Aortic; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; TEVAR; Thoracic endovascular aortic repair	4180186
36305053	Guided Abd Aorta Aneurysm repair	4180186
36305053	旨在动脉瘤修复术的引导:发现:时间点:腹部>主动脉.腹腔段:文档型:{成像方式}	4182948
36305054	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305055	22q11.2 del risk; Chromosom; Chromosomes; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36305055	Fet 22q11.2 del risk Plas.cfDNA Ql	4180186
36305055	胎儿 22q11.2 染色体缺失风险:印象:时间点:血浆.cfDNA:序数型:染色体特异性 cfDNA 剂量测定	4182948
36305058	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E.coli heat stable gene; ETEC; ETEC stb gene; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305058	ETEC stb gene Islt Ql NAA+probe	4180186
36305058	大肠埃希菌肠产毒素型 stb 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36305060	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305061	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; CMV; Cnt; Count; Count/volume; CT; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Eye fluid; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Occular Fluid; OcFlu; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36305061	CMV DNA # Ocflu NAA+probe	4180186
36305061	巨细胞病毒 DNA:计数型浓度:时间点:眼液:定量型:探针法.基因扩增.靶向	4182948
36305062	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Mo; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305062	Molybdenum Spec-mCnt	4180186
36305062	钼:质量含量:时间点:XXX:定量型	4182948
36305069	Arm; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; UE; UE-Bl; Up; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36305069	CT UE-Bl WO+W contr IV	4180186
36305069	多层^不采用 & 采用静脉注射对比剂:发现:时间点:上肢.双侧:文档型:CT	4182948
36305070	Dialy Note	4180186
36305070	Dialy; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36305070	记录:发现:时间点:{环境}:文档型:透析法	4182948
36305076	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305078	Centers for Medicare and Medicaid Assessment; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
36305082	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305086	AIDS; ANTIBIOTIC SUSCEPTIBILITIES; Cerebral spinal fluid; Cerebrospinal Fl; high-throughput sequencing; HIV 1 RNA PR gene mut; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Identity or presence; Infectious Disease; InfectiousDisease; Mut; Mut Det; Mutation; Muts; Neuro; Neurology; Next generation sequencing; NGS; Nominal; Point in time; PR; Random; Ribonucleic acid; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36305086	HIV 1 RNA PR Mut Det CSF Seq	4180186
36305086	HIV 1 型 RNA 蛋白酶基因 已检出的突变:存在与否或特征标识:时间点:脑脊液:名义型:序列测定	4182948
36305089	Anatomy; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36305090	1 day; 24 hours; 24HR; Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; FR; Hematology; Heme; IFE; Ifix; Immune globulin; Immuno; Immunofixation electrophoresis; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Lambda LC; Lambda LC Free; Non-protein bound; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UR; Urn	4180186
36305090	Lambda LC Free 24h Ur Ql IFE	4180186
36305090	免疫球蛋白轻链.Lambda 型.游离型:存在情况或阈值:24小时:尿液:序数型:免疫固定电泳分析法	4182948
36305092	Addiction med Group counseling note	4180186
36305092	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36305092	团体咨询记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36305094	Abd; Abdo; Abdomen+; Abdominal; Art; Cardio; Cardiology; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Hep a; Hepar; Imaging; Liver; Liver artery; Point in time; Rad; RADIOLOGY; Random; Tum radioemb	4180186
36305094	Guided HA Tum radioemb -W Yttrium-90 IA	4180186
36305094	旨在放射栓塞术的引导^采用动脉注射钇-90:发现:时间点:腹部>肝动脉:文档型:{成像方式}	4182948
36305095	Chemistry; i Phos; Inorganic phosphate; Mass content; Misc; Miscellaneous; Other; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305095	Phosphate Spec-mCnt	4180186
36305095	磷酸盐:质量含量:时间点:XXX:定量型	4182948
36305096	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36305098	Centers for Medicare and Medicaid Assessment; Dx; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305100	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B microti; B microti 18S; B microti 18S rRNA; Babesiosis; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Piroplasmosis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36305100	B microti 18S rRNA Bld Ql NAA+non-probe	4180186
36305100	鼠源巴贝斯虫 18S rRNA 基因:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36305101	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Circo virus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV; PCV1; PCV1 DNA; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36305101	PCV1 DNA Ct Spec Qn NAA+probe	4180186
36305101	猪圆环病毒 1 型 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36305102	Eye fluid; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Occular fluid; Ocflu; Point in time; Random; St; Stains; Stn	4180186
36305102	Gram Stn Ocflu	4180186
36305102	显微镜观察:存在与否或特征标识:时间点:眼液:名义型:革兰氏染色法	4182948
36305104	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305105	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CA; Calif; California encephalitis virus Ab; California Encephalitis Virus AB IGG; California Encephalitis Virus AB IGM; CEV; CEV Ab; CEV Ab.IgG+IgM; CEV IgG; CEV IgG & IgM; Enc; Enceph; Encephalomyelitis; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR; Time Resolved Fluorescence; TRF	4180186
36305105	CEV IgG+IgM Ser IF-Imp	4180186
36305105	加利福尼亚脑炎病毒 抗体.IgG+IgM:印象:时间点:血清:序数型:免疫荧光法	4182948
36305106	CorePlaybook; Document; EXT; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; LE; Leg; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Playbook; Point in time; Rad; Radiology; Random	4180186
36305106	Guided Ankle Inj	4180186
36305106	旨在注射的引导:发现:时间点:下肢>踝关节:文档型:{成像方式}	4182948
36305107	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S epidermidis; Screen; Staph; Staph epi; WB; Whole blood	4180186
36305107	S epidermidis hsp60 Bld Pos Ql Probe	4180186
36305107	表皮葡萄球菌 hsp60 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36305108	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified; ZIKV	4180186
36305108	ZIKV IgM Spec Ql IA	4180186
36305108	寨卡病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36305113	Centers for Medicare and Medicaid Assessment; Disch; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305120	Absc drain+cath place; Absc drainage; Cath; CorePlaybook; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Removal of fluid; Spec; To be specified in another part of the message; Unspecified	4180186
36305120	Guided Unsp region Absc drain+cath place	4180186
36305120	旨在脓肿引流+引流导管置入的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36305121	Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
36305121	HEDIS 2018 取值集合类:-:时间点:^患者:-	4182948
36305122	APTA; Identity or presence; Integ repair protect technique; Nominal; Physical Therapy; Point in time; PT; Random	4180186
36305122	Integ repair protect technique	4180186
36305122	所采用皮肤修复与保护的技法:存在与否或特征标识:时间点:^患者:名义型	4182948
36305124	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36305124	CT Pelvis bones WO+W contr IV	4180186
36305124	多层^不采用 & 采用静脉注射对比剂:发现:时间点:盆腔>盆骨类:文档型:CT	4182948
36305126	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine	4180186
36305126	CT T-spine by reconstr	4180186
36305126	基于重建的多层:发现:时间点:胸部>脊椎.胸段:文档型:CT	4182948
36305127	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36305127	OB Referral note	4180186
36305127	转诊记录:发现:时间点:{环境}:文档型:产科学	4182948
36305128	Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; Survey; SURVEY.MTLHLTH	4180186
36305133	BLOOD BANK; Donr; Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36305133	P2 phenotype RBC Donr Ql	4180186
36305133	P2 表型:存在情况或阈值:时间点:红细胞^供体:序数型	4182948
36305134	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
36305137	Clip place; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Marker placement; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305137	Guided Unsp region Clip place	4180186
36305137	旨在置入夹的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36305138	Cont flow; Cont flow set; Dynamic; Flow; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume Rate; vRate	4180186
36305138	Cont flow set Vent	4180186
36305138	持续气流设置:体积速率:时间点:呼吸机:定量型	4182948
36305140	CorePlaybook; Document; EXT; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Kn; LE; Leg; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Playbook; Point in time; Rad; Radiology; Random	4180186
36305140	Guided Knee Inj	4180186
36305140	旨在注射的引导:发现:时间点:下肢>膝关节:文档型:{成像方式}	4182948
36305143	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305144	CLIN; CLIN.RISK; Ordinal; Point in time; QL; Qual; Qualitative; Random; Scale; Screen	4180186
36305144	针对风险计算的年龄评分:评分:时间点:^患者:序数型	4182948
36305145	*^Patient; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Home health care; notes; Point in time; Pt's home; Random; S prime; Visit note	4180186
36305145	Pt's home D/C sum	4180186
36305145	出院摘要记录:发现:时间点:患者的家:文档型:{角色}	4182948
36305146	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; ETEC; ETEC gene pnl; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36305146	ETEC gene pnl Spec NAA+probe	4180186
36305146	大肠埃希菌肠产毒素型基因组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
36305149	Disch; DOC.ONT; Document; Finding; Findings; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; Random	4180186
36305149	Gynecology Discharge instruct	4180186
36305149	出院指导:发现:时间点:{环境}:文档型:妇科学	4182948
36305151	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Med mgmt note; notes; Point in time; Random; Substance abuse; Visit note	4180186
36305151	Addiction med Med mgmt note	4180186
36305151	药物管理记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36305152	DIR DICOM PS3.20 Sections	4180186
36305152	DIR DICOM PS3.20 Sections; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
36305152	影像学诊断报告 - 推荐 DICOM PS3.20 小节:-:时间点:{环境}:-	4182948
36305153	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S apiospermum; S apiospermum DNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36305153	S apiospermum DNA Spec Ql NAA+probe	4180186
36305153	尖端赛多孢 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36305156	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
36305157	Molindone/Creat Ur Cfm	4180186
36305157	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Moban; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36305157	吗茚酮/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36305158	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36305160	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Misc; Miscellaneous; Other; Pl; Platelets; Platelt; Playbook; Plt; Point in time; PRP inject; Rad; Radiology; Random; Spec; Thrombocyte; Thrombocytes; To be specified in another part of the message; Unspecified	4180186
36305160	Guided Unsp region PRP inject	4180186
36305160	旨在注射富血小板血浆的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36305164	Ob Res Note	4180186
36305164	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OB; Ob Res; Obstetric; Point in time; Prenatal; Random; Visit note	4180186
36305164	记录:发现:时间点:{环境}:文档型:产科学.住院	4182948
36305165	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Sal; Salmonel; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36305165	Salmonella DNA Ct Spec Qn NAA+probe	4180186
36305165	沙门菌属单个未知种 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36305166	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36305168	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
36305168	无烟烟草状况:发现:时间点:^患者:名义型	4182948
36305169	c; C/sp; C+T-spine; CAT scan; Cerv; Computed tomography; Computerized tomography; Contr; Contra; Contrst; C-spine; CT scan; Document; Dorsal spine; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36305169	CT C+T-spine WO+W contr IV	4180186
36305169	多层^不采用 & 采用静脉注射对比剂:发现:时间点:颈部>脊椎.颈段 & 胸部>脊椎.胸段:文档型:CT	4182948
36305170	Assoc; Catalytic Concentration; Chemistry; k203; Lip; Lipoprot; Lipoproteins; LP; Lp-PLA2; nApi m 1 Phospholipase A2, Bee; Pl; Plasma; Platelet-activating factor acetylhydrolase; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rk203; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305170	Lp-PLA2 SerPl-cCnc	4180186
36305170	脂蛋白相关磷脂酶 A2:催化浓度:时间点:血清/血浆:定量型	4182948
36305173	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305174	2; Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305175	Facility county	4180186
36305175	ADMIN; Location; Nominal; Point in time; Random	4180186
36305175	县郡:位置:时间点:设施:名义型	4182948
36305176	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Seneca Valley Virus; Serum; SR; SUDS; SVA; SVA Ab; SVA IgG; Vet; Veterinary	4180186
36305176	SVA IgG/Pos cntrl Ser IA	4180186
36305176	塞内卡病毒 A 抗体.IgG/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36305177	Dyspnoea questionnaire; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; RDS; Rose dyspnea score; Screen; Survey; SURVEY.GNHLTH	4180186
36305179	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corona virus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NEG; Point in time; Pork; PRCoV; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Swine; Vet; Veterinary	4180186
36305179	PRCoV Ab Ser IA	4180186
36305179	猪呼吸道冠状病毒 抗体/阴性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36305180	4th; 4th deg burn area; Bdy surface; bod; Bodies; BSA; Est; estimation; Point in time; QNT; Quan; Quant; Quantitative; Random; Surf; TRAUMA	4180186
36305180	4th deg burn area/BSA Est	4180186
36305180	四度烧伤面积/体表面积:面积比:时间点:^患者:定量型:估计法	4182948
36305186	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; CPR; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; WB; Whole blood	4180186
36305186	blaVIM Bld Pos Ql Probe	4180186
36305186	细菌碳青霉烯类耐药 blaVIM 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36305187	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Playbook; Point in time; Rad; Radiofreq abl; RADIOLOGY; Random	4180186
36305187	Guided Liver Radiofreq abl	4180186
36305187	旨在射频消融术的引导:发现:时间点:腹部>肝脏:文档型:{成像方式}	4182948
36305190	Hex A & Total w Rflx HEXA Pnl WBC-cCnt	4180186
36305190	B; Beta-hexosaminidase subunit alpha; beta-N-acetylhexosaminidase gene; B-NAH; Catalytic Content; Chemistry; GM2 Gangliosidoses; GM2-gangliosidosis; Hex A; Hex A & Total w Rflx HEXA Pnl; Hex B; HEXA; Hexosaminidase; Hexosaminidase A; hexosaminidase A (alpha polypeptide); hexosaminidase A (alpha polypeptide) gene; Leukocytes; N-acetyl-beta-glucosaminidase gene; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Sandhoff disease; Tay Sachs Disease; Tay-Sachs disease; TSD; WBCs; White blood cells	4180186
36305190	Beta-N-乙酰己糖胺酶.A & Beta-N-乙酰己糖胺酶并伺机追加 HEXA 基因组套:催化含量:时间点:白细胞:-	4182948
36305192	FR; Haemoglobin; Haemoglobin oxygenated; Hb; HbO2; HEMATOLOGY/CELL COUNTS; Hemoglobin oxygenated; Hgb; Hgb Free; Hgb Free + OxyHgb Pnl; Non-protein bound; O2Hb; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36305192	Hgb Free + OxyHgb Pnl Plas	4180186
36305192	游离型血红蛋白与氧合血红蛋白组套:-:时间点:血浆:定量型	4182948
36305193	1 day; 24 hours; 24HR; 3Me-tyramine; Chemistry; CR; Crea; Creat; Dopamine metabolite; FR; Free 3-MT; III; Non-protein bound; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
36305193	Free 3-MT/Creat 24h Ur-sRto	4180186
36305193	3-甲氧酪氨酸.游离型/肌酐:物质的量比率:24小时:尿液:定量型	4182948
36305195	A46; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Honey bee; Honeybee; hyaluronidase; Hyaluronidase (rApi m) 2; i001; i1; IgE RAST; II; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36305195	意大利蜜蜂 重组 (rApi m) 2 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
36305195	Deprecated Hyaluronidase (rApi m) 2 IgE RAST Ql	4180186
36305197	Iodide peroxidase; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tg; Thyglobulin; Thyroglbn; Thyroglob; Thyroglob + thyroperox Ab Pnl; Thyroid Microsomal; Thyroid microsomes; Thyroid peroxidase; TPO; Tumor marker	4180186
36305197	Thyroglob + thyroperox Ab Pnl SerPl	4180186
36305197	甲状腺球蛋白与甲状腺过氧化物酶抗体组套:-:时间点:血清/血浆:定量型	4182948
36305198	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305200	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Revia; Sal; Scn; Scr; Screen; Scrn; Vivitrol	4180186
36305200	Naltrexone Sal Ql Scn	4180186
36305200	纳曲酮:存在情况或阈值:时间点:唾液:序数型:毒理学筛查试验	4182948
36305201	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36305201	Carbapenem Susc Islt	4180186
36305201	碳青霉烯:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36305203	Blood; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn; WB; Whole blood	4180186
36305203	Gram Stn Bld	4180186
36305203	显微镜观察:存在与否或特征标识:时间点:全血:名义型:革兰氏染色法	4182948
36305204	Abd; Abd + Abd+Pel; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; without contrast	4180186
36305204	CT Abd WO + CT Abd+Pel W contr IV	4180186
36305204	多层^WO contrast && Multisection^W contrast IV:发现:时间点:腹部 && 腹部+盆腔:文档型:CT	4182948
36305207	Admin info; Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305208	Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36305211	Centers for Medicare and Medicaid Assessment; No; Num; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey	4180186
36305214	Amplification; Blood; BMPR1A+SMAD4; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36305214	BMPR1A+SMAD4 Del+Dup + Full Mut Bld/Tiss	4180186
36305214	BMPR1A 与 SMAD4 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36305218	III; Len; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
36305219	# days of passive range of motion; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; PROM; QNT; Quan; Quant; Quantitative; Rnge; Survey	4180186
36305223	Person completing form title Provider	4180186
36305223	ADMIN; Nominal; Persons; Point in time; Random; Typ	4180186
36305223	表单填写人员职称:类型:时间点:服务提供者:名义型	4182948
36305225	2; Beta endosulfan; DRUG/TOXICOLOGY; Drugs; Endosulfan 2; Endosulfan B; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305225	Endosulfan II Spec-mCnt	4180186
36305225	硫丹 II:质量含量:时间点:XXX:定量型	4182948
36305230	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; Immune globulin M; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; MEIA; Microbiology; Nominal; Point in time; PR; Prot; Random; Serum; SR; SUDS; ZIKV; ZIKV NS1; ZIKV NS1 Ab	4180186
36305230	ZIKV NS1 IgM Ser IA-Imp	4180186
36305230	寨卡病毒非结构蛋白 1 抗体.IgM:印象:时间点:血清:名义型:免疫测定法	4182948
36305232	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305235	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305235	Guided Tendon Inj	4180186
36305235	旨在注射的引导:发现:时间点:XXX>肌腱:文档型:{成像方式}	4182948
36305236	Centers for Medicare and Medicaid Assessment; Finding; Findings; Immunizations; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Vaccine	4180186
36305237	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; EXCZ; Lung; Mass Fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
36305237	SaO2 W exercise % BldA PulseOx	4180186
36305237	氧饱和度^采用运动:质量分数:时间点:动脉全血:定量型:脉搏血氧定量法	4182948
36305238	Potassium goal sCnc SerPl	4180186
36305238	CLIN; k; K+; Level; Pl; Plasma; Plsm; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
36305238	钾目标:物质的量浓度:时间点:血清/血浆:定量型	4182948
36305239	Consult note; DOC.ONT; Document; Encounter; Envir Health; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36305239	Envir Health Consult note	4180186
36305239	会诊记录:发现:时间点:{环境}:文档型:环境卫生学	4182948
36305241	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Sx	4180186
36305243	100 CD19 cells; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD27 Cells; CD27- cells; CD27+IgD- cells; CD27+IgD+ cells; CD27+IgD+IgM+ cells; CD27+IgD-IgM- cells; CD27+IgD-IgM+ cells; CD27-IgD+ cells; Cell; CELL MARKERS; Cellularity; HD-37; Immune globulin D; Immune globulin M; Immunoglobulin D; Immunoglobulin M; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; WB; Whole blood	4180186
36305243	CD27+IgD+IgM+/100 CD19 cells NFr Bld	4180186
36305243	细胞.CD27+IgD+IgM+/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
36305244	Patient Health Questionnaire; Patient Health Questionnaire - 9 Modified for Teens; PHQ; PHQ-9 Teen; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PHQ; Tot; Totl	4180186
36305246	Dyspnoea questionnaire; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; RDS; Rose dyspnea score; Screen; Survey; SURVEY.GNHLTH	4180186
36305252	Melperone SerPl-mCnc	4180186
36305252	Bunil; Buronil; DRUG/TOXICOLOGY; Drugs; Eunerpan; Level; Mass concentration; Melperon; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305252	美哌隆:质量浓度:时间点:血清/血浆:定量型	4182948
36305254	Acd; Acid fast Stn; Acids; AFB stain; Corn/Cnjt; Corneal; Eye; ID; Infectious Disease; InfectiousDisease; Microbiology; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn	4180186
36305254	Acid fast Stn Corn/Cnjt Ql	4180186
36305254	显微镜观察:存在情况或阈值:时间点:角膜/结膜:序数型:抗酸染色法	4182948
36305256	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36305257	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305259	Breathing; IEEE Rosetta; Lungs; Minimal; minimum; Point in time; Press.min; Pressure; QNT; Quan; Quant; Quantitative; Random; RS	4180186
36305259	Press.min Airway	4180186
36305259	压力.最小值:压力或压强:时间点:呼吸系统.气道:定量型	4182948
36305260	BM; BON; Bone marrow; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; T gondii; Toxo; Toxoplasmosis	4180186
36305260	T gondii Mar Ql Cult	4180186
36305260	刚地弓形虫:存在情况或阈值:时间点:骨髓:序数型:微生物特异性培养	4182948
36305261	ANTIBIOTIC SUSCEPTIBILITIES; AST; Carbomethoxyhydrazone; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Mecadox; Point in time; QdNO; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36305261	Carbadox Susc Islt	4180186
36305261	卡巴氧:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36305262	DON; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary; Vomitoxin	4180186
36305262	DON Spec-mCnt	4180186
36305262	脱氧雪腐镰刀菌烯醇:质量含量:时间点:XXX:定量型	4182948
36305263	Art; Cardio; Cardiology; CorePlaybook; Document; EXT; Extr-Ul; Fem a; Fem a+Pop a; Fem a+Popliteal a; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Knee Artery; LE; Leg; Low; Playbook; Point in time; Rad; RADIOLOGY; Random; Stent place; Thigh	4180186
36305263	Guided Fem a+Pop a Stent place	4180186
36305263	旨在置入支架的引导:发现:时间点:下肢.单侧>股动脉+腘动脉:文档型:{成像方式}	4182948
36305265	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.GNHLTH	4180186
36305266	Blood; Cell; Cellularity; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Identity or presence; Leukemia; MGUS; Monoclonal; Monotypic plasma cells; Multiple myeloma; Myeloma cells; Nominal; Plasma cell myeloma; Plasmacyte; Plasmacytes; Point in time; Random; WB; Whole blood	4180186
36305266	Monotypic plasma cells Bld FC	4180186
36305266	浆细胞.单型群:存在与否或特征标识:时间点:全血:名义型:流式细胞测量术	4182948
36305268	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305272	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
36305272	Gynecology Prog note	4180186
36305272	病程记录:发现:时间点:{环境}:文档型:妇科学	4182948
36305273	Alpha+gamma-amanitin SerPl-mCnc	4180186
36305273	Alfa; Alpha+gamma-amanitin; Amanitin phalloides syndrome; Deadly mushroom toxin; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305273	Alpha-鹅膏蕈碱+gamma-鹅膏蕈碱:质量浓度:时间点:血清/血浆:定量型	4182948
36305274	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCMV; PCMV DNA; PCR; Point in time; Polymerase chain reaction; Pork; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36305274	PCMV DNA Spec Ql NAA+probe	4180186
36305274	猪巨细胞病毒 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36305276	Cath; CorePlaybook; CVC rem; CVC w port removal; Document; Extraction; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Remove; Thorax	4180186
36305276	Guided Chest CVC w port removal	4180186
36305276	旨在去除带有输液港的中心静脉导管的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36305278	Audiology; Hearing; ID; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; Mites; Ordinal; Otologic; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36305278	Mite Ear Ql Micro	4180186
36305278	螨:存在情况或阈值:时间点:耳:序数型:显微镜检查.光学	4182948
36305282	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36305283	Bupivacaine/Creat Ur Cfm	4180186
36305283	c285; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Marcain; Marcaine; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Sensorcaine; UA; UCr; UR; Urn; Vivacaine	4180186
36305283	丁哌卡因/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36305284	2,2-Dichlorobinyldimethyl phosphate; C4H7Cl2O4P; DDVP; Dichlorophos; Dichlorovos; DRUG/TOXICOLOGY; Drugs; Equigand; Mass content; Misc; Miscellaneous; Organophosphate pesticide; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; SD1750; Spec; Tetravos; To be specified in another part of the message; Unspecified; Vapona; Vet; Veterinary	4180186
36305284	Dichlorvos Spec-mCnt	4180186
36305284	敌敌畏:质量含量:时间点:XXX:定量型	4182948
36305289	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Crimean-Congo IgG; Crimean-Congo virus; Crimean-Congo virus Ab; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
36305289	Crimean-Congo virus IgG Ser Ql IA	4180186
36305289	克里米亚-刚果出血热病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36305292	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Memory/recall ability; Nominal; Survey	4180186
36305295	Pan; Panl; Pnl; Point in time; Random; Survey	4180186
36305296	C&S; Cerebral spinal fluid; Cerebrospinal Fl; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T gondii; Toxo; Toxoplasmosis	4180186
36305296	T gondii CSF Ql Cult	4180186
36305296	刚地弓形虫:存在情况或阈值:时间点:脑脊液:序数型:微生物特异性培养	4182948
36305297	Ventilator alarm events Doc	4180186
36305297	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36305297	呼吸机警报事件:发现:时间点:^患者:文档型	4182948
36305299	Cancer; CLIN; ECOG; Pan; PANEL.CLINICAL; Panl; Perform status; Perform status Pnl; Pnl; Point in time; Random	4180186
36305299	ECOG Perform Status Pnl	4180186
36305299	日常体能状态组套:-:时间点:^患者:-:美国东部肿瘤协作组	4182948
36305300	c617; CO; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305300	Cobalt Spec-mCnt	4180186
36305300	钴:质量含量:时间点:XXX:定量型	4182948
36305302	DRUG/TOXICOLOGY; Drugs; HCB; Hexa CB; Mass content; Misc; Miscellaneous; Other; Pentachlorophenyl; Perchlorobenzene; Phenyl perchloryl; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305302	HCB Spec-mCnt	4180186
36305302	六氯苯:质量含量:时间点:XXX:定量型	4182948
36305304	CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst inject; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305304	CT Guided Cyst inject	4180186
36305304	旨在囊肿注射的引导:发现:时间点:XXX:文档型:CT	4182948
36305306	Davedax; DRUG/TOXICOLOGY; Drugs; Edronax; Level; Mass concentration; Norebox; Pl; Plasma; Plsm; Point in time; Prolift; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Solvex; SR; Vestra	4180186
36305306	Reboxetine SerPl-mCnc	4180186
36305306	瑞波西汀:质量浓度:时间点:血清/血浆:定量型	4182948
36305307	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305309	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305310	ANTIBIOTIC SUSCEPTIBILITIES; AST; CAPASTAT; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ogostal; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36305310	Capreomycin Islt Genotyp	4180186
36305310	卷曲霉素:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36305312	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36305314	little p phenotype RBC BPU Ql	4180186
36305314	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; Ordinal; p; P prime; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36305314	p 表型:存在情况或阈值:时间点:红细胞^血液制品单位:序数型	4182948
36305316	Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Throat; Upper respiratory	4180186
36305316	Micro CNAMTS panel Throat	4180186
36305316	微生物学 CNAMTS 组套:-:时间点:咽喉:-	4182948
36305317	Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36305319	Addiction; B3G; BU; BUP; Bupe; Buprenex; Buprenorphine glucuronide; buprenorphine HCI; Buprex; Butrans; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Finobrin; GCMS; Gluc; Glucouronide; III; Illicit; Level; Mass concentration; Norspan; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; Prefin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Suboxone; Subutex; Temgesic	4180186
36305319	B3G SerPl Cfm-mCnc	4180186
36305319	丁丙诺啡-3-葡糖苷酸:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
36305320	8-Hydroxy loxapine; 8OH-Loxapine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Hydroxyl; Loxitane metabolite; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36305320	8OH-Loxapine/Creat Ur Cfm	4180186
36305320	8-羟基洛沙平/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36305321	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; RSV; RSV B; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305321	RSV B RNA Corn/Cnjt Ql NAA+probe	4180186
36305321	呼吸道合胞病毒 B 型 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36305322	E granulosus Ab Titr Ser CF	4180186
36305322	细粒棘球绦虫 抗体:滴定度:时间点:血清:定量型:补体结合试验	4182948
36305322	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); E granulosus; Echinococcosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
36305323	Abd; Abdo; Abdomen+; Abdominal; Chest + Abd; CorePlaybook; Denver shunt; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inspection; Playbook; Point in time; PV shunt check; Rad; RADIOLOGY; Random; Thorax	4180186
36305323	Guided Chest+Abd PV shunt check	4180186
36305323	旨在检查腹腔静脉分流装置的引导:发现:时间点:腹部+胸部:文档型:{成像方式}	4182948
36305325	Bil; Bil pupil; Bilat; Both; EYE; EYE.PX; Finding; Findings; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random	4180186
36305325	Bil pupil Pupillary resp	4180186
36305325	瞳孔反应^入院时:发现:时间点:瞳孔.双侧:名义型	4182948
36305327	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36305327	团体咨询记录:发现:时间点:{环境}:文档型:疼痛医学	4182948
36305329	Bdy weight; bod; Bodies; BODY WEIGHT.ATOM; Est; estimation; Fetal; Gyn; Gynecology; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
36305329	Fet Weight Est	4180186
36305329	体重:质量:时间点:^胎儿:定量型:估计法	4182948
36305330	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305330	Difethialone Spec-mCnt	4180186
36305330	噻鼠酮:质量含量:时间点:XXX:定量型	4182948
36305331	100 CD3+CD4+; Blood; CD27 Cells; CD27- cells; CD27+CD45RO+CD62L+CCR7+ cells; CD27-CD45RO+CD62L-CCR7- cells; CD3 Cells; CD3+CD4+ cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Helper T cells; Inducer T cells; L3T4; LAM-1; LECAM-1; Leu3; Leu-3; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; T3; T4; T-4; T4 helper/inducer cells; TQ-1; UCHL-1; W3/25; WB; Whole blood	4180186
36305331	CD27+CD45RO+CD62L+CCR7+/100 CD3+CD4+	4180186
36305331	细胞.CD27+CD45RO+CD62L+CCR7+/100 个细胞.CD3+CD4+:计数型分数:时间点:全血:定量型	4182948
36305332	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305333	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305335	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Arbitrary concentration; bckgrd cor; Blood; Cell; Cellularity; Helper T cells; ID; IFN; IGRA; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu2; Leu-2; Leu3; Leu-3; Lung; M tb; M TB IFN-g; M TBIFN-g CD4+ CD8+T-cells; M tuberculosis; Microbiology; Mtb; Myco; Mycobact; Mycobacterium tuberculosum; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Suppressor T cells; T prime; T4; T-4; T8; T-8; TB; Tsuppressor; Tuberculosis; W3/25; WB; Whole blood	4180186
36305335	M TB IFN-g CD4+CD8+ bckgrnd cor Bld-aCnc	4180186
36305335	CD4+ 和 CD8+ T-细胞所释放的结核分枝杆菌刺激型 gamma 干扰素^^经过针对本底而校正的:任意型浓度:时间点:全血:定量型	4182948
36305336	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305337	Med admin.extended Doc	4180186
36305337	DOC.MISC; Document; Finding; Findings; Med admin.extended; MISC; Point in time; Random	4180186
36305337	药物施用.扩充:发现:时间点:^患者:文档型	4182948
36305338	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305339	CARD.PROC; Cardio; Cardiology; CPR; CPR given on arrival at destination; Finding; Findings; Heart Disease; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36305339	CPR given on arrival at destination	4180186
36305339	当时到达目的地时正在给予心肺复苏:发现:时间点:^患者:序数型	4182948
36305340	PCV2 NAb Titr Ser Nt	4180186
36305340	猪圆环病毒 2 型 抗体.中和:滴定度:时间点:血清:定量型:中和试验	4182948
36305340	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circo virus; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; II; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; PCV; PCV2; PCV2 Ab; PCV2 Nab; Point in time; Pork; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Swine; Titer; Titered; Titre; Ttr; Vet; Veterinary; Virus neutralization test; VNT	4180186
36305341	Ang; Angio; Angiography; Angm; AO; Aortic; Arteriogram; c; CA; CA+TA; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Coronary aa; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Heart; Imaging; Point in time; Rad; Radiology; Random; Thorax; W contr IV; WC	4180186
36305341	CTA CA+TA W contr IV	4180186
36305341	多层^采用静脉注射对比剂:发现:时间点:胸部>冠状动脉类+主动脉.胸腔段:文档型:CT.血管造影术	4182948
36305342	Brain; CorePlaybook; Cranial; Cranium; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Intracranial; Jnt; Playbook; Point in time; Rad; RADIOLOGY; Random; Skull; TMJ	4180186
36305342	Guided TMJ Inj	4180186
36305342	旨在注射的引导:发现:时间点:头部>颞颌关节:文档型:{成像方式}	4182948
36305343	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; Replace; RT; Screen; Survey; SURVEY.GNHLTH	4180186
36305344	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Revia; Sal; Vivitrol	4180186
36305344	Naltrexone Sal Cfm-mCnc	4180186
36305344	纳曲酮:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36305345	Appearance; Colour; Favorite color; MISC; Nominal; Point in time; Random; Survey; Survey.Misc; Typ	4180186
36305348	Appearance; Ar wnd bd; Area wnd bed color; Colour; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Wnd; Wnd base; wound bed	4180186
36305348	Wound bed color % Area of Wnd base	4180186
36305348	所标识伤口床颜色区域的面积/创面面积:面积比:时间点:伤口.基底部:定量型	4182948
36305349	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV HKU1; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305349	HCoV HKU1 RNA Lower resp Ql NAA+probe	4180186
36305349	人类冠状病毒 HKU1 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36305350	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Parent PAM-13; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36305352	Finding; Findings; Gestation; Gestations; Gravida; Married during pregnancy; Mat; Maternal; Matnl; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
36305353	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; L monocytog; L monocytogenes; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Listeriosis; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36305353	L monocytog DNA Bld Ql NAA+probe	4180186
36305353	单核细胞增生李斯特菌 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36305356	GenBank 登录号:标识符:时间点:分离株:名义型	4182948
36305356	GenBank accession ID Islt	4180186
36305356	GenBank accession ID; Ident; Identifier; Islt; Isol; Molecular pathology; MOLPATH; No; Nominal; Num; Point in time; Random	4180186
36305357	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CdtB; CdtB Ab; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
36305357	CdtB Ab Ser IA-aCnc	4180186
36305357	细胞致死膨胀毒素 B 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36305358	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305359	Eastern Cooperative Oncology Group; Everyday Cognition Partner version; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Study report; Survey; SURVEY.GNHLTH	4180186
36305361	ADMIN; Location; Nominal; Point in time; Random; ZIP code	4180186
36305361	邮政编码:位置:时间点:服务提供者:名义型	4182948
36305363	Abd; Abd+Pel + Chest+Abd+Pel; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Thorax; without contrast	4180186
36305363	CT Abd+Pel WO + Chest+Abd+Pel W contr IV	4180186
36305363	多层^WO contrast && Multisection^W contrast IV:发现:时间点:腹部+盆腔 && 胸部+腹部+盆腔:文档型:CT	4182948
36305364	1563-66-2; Curaterr; DRUG/TOXICOLOGY; Drugs; Furadan; Furadan 3G; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary; Yaltox	4180186
36305364	Carbofuran Spec-mCnt	4180186
36305364	虫螨威:质量含量:时间点:XXX:定量型	4182948
36305367	Abd; Abd vv; Abd vv + Pelvis vv; Abd vv+Pelvis vv+LE vv-Bl; Abdo; Abdomen; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; Bil; Bilat; Both; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; EXT; Extr-Bl; Finding; Findings; Heart Disease; Imaging; LE; LE vv; LE vv-Bl; LE-Bl; Leg; Low; Pelvic; Pelvic vv; Pelvis vv; Pelvis vv + LE vv-Bl; Point in time; Rad; Radiology; Random; Venogram; Venography; W contr IV; WC	4180186
36305367	CTA Abd vv+Pelvis vv+LE vv-Bl W contr IV	4180186
36305367	多层^采用静脉注射对比剂:发现:时间点:腹部>腹部静脉类 & 盆腔>盆腔静脉类 & 下肢.双侧>下肢静脉类:文档型:CT.血管造影术	4182948
36305369	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36305370	Dialy; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36305370	Dialy Summary note	4180186
36305370	摘要:发现:时间点:{环境}:文档型:透析法	4182948
36305374	Carbophos; DRUG/TOXICOLOGY; Drugs; Maldison; Mass content; Mercaptothion; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305374	Malathion Spec-mCnt	4180186
36305374	马拉松:质量含量:时间点:XXX:定量型	4182948
36305378	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Perazin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Taxilan	4180186
36305378	Perazine SerPl-mCnc	4180186
36305378	培拉嗪:质量浓度:时间点:血清/血浆:定量型	4182948
36305383	NK cytotox.3.75:1 E:T/Pos cntrl Bld MC	4180186
36305383	Blood; HEMATOLOGY/CELL COUNTS; i; NK; NK cytotox.3.75:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
36305383	自然杀伤细胞细胞毒性.效应细胞/靶细胞比 3.75:1/阳性对照:相对任意型浓度:时间点:全血单个核细胞:定量型	4182948
36305387	ADL; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Up	4180186
36305388	#/area; AM; Amorph; Amorph Cry; Amorphic; Crys; Cryst; Crystal; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36305388	Amorph Cry #/area UrnS	4180186
36305388	结晶.无定形:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36305391	APTA; EXCZ; Identity or presence; Nominal; Physical Therapy; Point in time; PT; Random; Ther; Ther exercise perf	4180186
36305391	Ther exercise perf	4180186
36305391	所进行的治疗性运动:存在与否或特征标识:时间点:^患者:名义型	4182948
36305392	Anaero; Anaerobe; Anaerobe Cult; Bact; Blood - (umbilical) cord; C&S; Cord (umbilical) blood; Cord bld; Cord blood; Cult; Cultures; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random	4180186
36305392	Bacteria BldCo Anaerobe Cult	4180186
36305392	细菌 已鉴定的:存在与否或特征标识:时间点:脐带全血:名义型:厌氧微生物培养	4182948
36305394	inv(2)(EML4,ALK) Tiss Ql	4180186
36305394	Anaplastic lymphoma kinase (Ki-1); DNA; gene fusion; gene translocation; II; inv(2)(EML4,ALK); Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; Tissue; Tissue, unspecified; translocation	4180186
36305394	inv(2)(p21;p23)(EML4,ALK) 融合转录物:存在情况或阈值:时间点:组织与涂片:序数型:分子遗传学类实验室方法	4182948
36305396	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36305398	Asp; Aspartate amino transferase; Aspartate transaminase; Aspartic acid; AST; Catalytic Concentration; Chemistry; Glutamic oxaloacetic transaminase; Hepatology; Liver; P prime; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SGOT; SR; w/o P-5'-P	4180186
36305398	AST SerPl w/o P-5'-P-cCnc	4180186
36305398	天冬氨酸氨基转移酶:催化浓度:时间点:血清/血浆:定量型:不添加 P-5'-P	4182948
36305399	Count/time; Dextro; Mat; Maternal; Matnl; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; Second; Survey; SURVEY.CDC	4180186
36305404	Micro CNAMTS panel; Misc; Miscellaneous; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305404	Micro CNAMTS panel Spec	4180186
36305404	微生物学 CNAMTS 组套:-:时间点:XXX:-	4182948
36305406	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Thorax; TR; Tracheal; without contrast	4180186
36305406	CT Trachea WO contr	4180186
36305406	多层^不采用对比剂:发现:时间点:颈部+胸部>气管:文档型:CT	4182948
36305407	Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36305408	Response cancer treatment	4180186
36305408	Cancer; Finding; Findings; Nominal; ONCOLOGY; Point in time; Random; Response cancer treatment; Tx	4180186
36305408	对癌症治疗的反应:发现:时间点:^患者:名义型	4182948
36305410	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
36305413	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36305414	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; L; LT; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey	4180186
36305416	Activities of Daily Living; ADL assistance; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36305418	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36305418	会诊记录:发现:时间点:{环境}:文档型:妇科学	4182948
36305419	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cerebral spinal fluid; Cerebrospinal Fl; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36305419	Bacteria CSF Aerobe Cult	4180186
36305419	细菌 已鉴定的:存在与否或特征标识:时间点:脑脊液:名义型:需氧微生物培养	4182948
36305420	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305421	Abd; Abdo; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Hep ves; Imaging; Liver; Point in time; Rad; Radiology; Random; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36305421	CTA Hep ves WO+W contr IV	4180186
36305421	多层^不采用 & 采用静脉注射对比剂:发现:时间点:腹部>肝血管类:文档型:CT.血管造影术	4182948
36305422	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36305423	1 day; 24 hours; 24HR; AHF 24 hours prior to proc; H+P; H+P.HX; History; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
36305423	AHF 24 hours prior to proc	4180186
36305423	操作项目之前24小时之内急性心力衰竭:历史记录:24小时:^患者:序数型	4182948
36305428	Chromosom; Chromosomes; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Ms X risk; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; Turner syndrome	4180186
36305428	Fet Ms X risk Plas.cfDNA Ql	4180186
36305428	胎儿单体型 X 风险:印象:时间点:血浆.cfDNA:序数型:染色体特异性 cfDNA 剂量测定	4182948
36305430	Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Galactocerebrosidase; Galactosylceramidase; Krabbe disease; Krabbe Leukodystrophy; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36305430	GALC Del+Dup + Full Mut Anl Bld/T	4180186
36305430	GALC 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36305433	ACIF; ACNA; ACPA; ANCA; ANCA Pnl; Anticomplement Immunofluorescence; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; Granulocyte ab; Granulocyte nucleus ab; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neut; Neutr; Neutrophils; Pan; PANEL.SEROLOGY; Panl; PMN; Pnl; PNM; Point in time; Random; Serology; Serum; SR; Time Resolved Fluorescence; TRF; Vasculitis	4180186
36305433	ANCA Pnl Ser IF	4180186
36305433	嗜中性粒细胞细胞浆抗体组套:-:时间点:血清:-:免疫荧光法	4182948
36305436	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; Herp splx; Herpes simplex virus 1 Ab; Herpes simplex virus 1 antibody; Herpes simplex virus 1 IgM; Herpes simplex virus type 1; Herpes simplex virus type I; HSV; HSV1; i; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36305436	HSV1 IgM CSF Ql IF	4180186
36305436	单纯疱疹病毒 1 型 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36305437	Cnc; Conc; Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; EXT; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305439	Opioid therapy consent	4180186
36305439	DOC.ONT; Document; Finding; Findings; Form; Opioid therapy consent; Point in time; Random	4180186
36305439	长期阿片类药物疼痛治疗同意书:发现:时间点:{环境}:文档型:{角色}	4182948
36305442	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305445	Centers for Medicare and Medicaid Assessment; Disch; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305451	DRUG/TOXICOLOGY; Drugs; Ergot Poisonings; Ergotisms; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305451	Ergocristine Spec-mCnt	4180186
36305451	麦角克碱:质量含量:时间点:XXX:定量型	4182948
36305454	Addiction med Nurse; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Substance abuse; Visit note	4180186
36305454	Addiction med Nurse Note	4180186
36305454	记录:发现:时间点:{环境}:文档型:成瘾医学.护士	4182948
36305458	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36305465	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Immunization status; notes; Point in time; Random; Vaccination; Vaccinations; Vaccine; Visit note	4180186
36305465	疫苗接种记录:发现:时间点:{环境}:文档型:初级保健服务	4182948
36305466	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305467	Acd; Acid fast Stn; Acids; AFB stain; Aspirate; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
36305467	Acid fast Stn Aspirate	4180186
36305467	显微镜观察:存在与否或特征标识:时间点:吸出物:名义型:抗酸染色法	4182948
36305469	Centers for Medicare and Medicaid Assessment; Identity or presence; International Classification of Diseases; Mult; Multi; Nominal; Point in time; Random; Survey	4180186
36305470	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Orthohantavirus; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; PUUV; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SNV; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36305470	PUUV RNA Bld Ql NAA+probe	4180186
36305470	汉坦病毒 普马拉型 RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36305472	MAGE A4 Ab SerPl IA-aCnc	4180186
36305472	ABS; Aby; Ag; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Assoc; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MAGE A4; MAGE A4 Ab; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36305472	黑色素瘤相关抗原 A4 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36305479	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305480	A pleuropn; A pleuropn 1+2+9+11; A pleuropn 1+2+9+11 Ab; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36305480	A pleuropn 1+2+9+11 Ab/Pos cntrl Ser IA	4180186
36305480	胸膜肺炎放线杆菌血清型 1+2+9+11 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36305482	Activ; Activity; Actvty; Count/time; Dextro; Exercise; Movements; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey; SURVEY.GNHLTH	4180186
36305484	CARD.PROC; Cardio; Cardiology; Circ assist devices used; Heart Disease; Identity or presence; Nominal; Point in time; Pre-Op; Random; S prime	4180186
36305484	Circ assist devices used Preop	4180186
36305484	所采用的循环辅助设备^术前:存在与否或特征标识:时间点:^患者:名义型	4182948
36305487	Brivaracetam SerPl-mCnc	4180186
36305487	Anticonvulsant; Antiseizure; Briviact; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305487	布瓦西坦:质量浓度:时间点:血清/血浆:定量型	4182948
36305488	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PHEV; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36305488	PHEV RNA Ct Spec Qn NAA+probe	4180186
36305488	猪血凝性脑脊髓炎病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36305493	2nd; Arm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-R; Finding; Findings; Finger.2nd-R; Finger-R; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; RADIOLOGY; Random; RT; RUE; UE; UE-R; Up; without contrast	4180186
36305493	CT Finger.2nd-R WO contr	4180186
36305493	多层^不采用对比剂:发现:时间点:上肢.右侧>手指.第二:文档型:CT	4182948
36305494	Cogn func; cognition; cognitive status; FCN; Func; Funct; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
36305495	Dialy Consult note	4180186
36305495	Consult note; Dialy; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36305495	会诊记录:发现:时间点:{环境}:文档型:透析法	4182948
36305496	CARD.PROC; Cardio; Cardiology; Cnt; Count; Gvn; Heart Disease; No; Num; Num defib shocks; Num defibrillation shocks given; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36305496	Num defib shocks Gvn	4180186
36305496	除颤电击次数 给予的:数量(计数):时间点:^患者:定量型	4182948
36305497	Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn	4180186
36305497	Micro CNAMTS panel Ur	4180186
36305497	微生物学 CNAMTS 组套:-:时间点:尿液:-	4182948
36305507	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
36305511	Asympt; Asymptomatic; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Scn; Thorax	4180186
36305511	CT Chest Screening	4180186
36305511	针对筛查的多层:发现:时间点:胸部:文档型:CT	4182948
36305512	Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Ln; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305512	Guided LN Bx	4180186
36305512	旨在经皮活组织检查的引导:发现:时间点:XXX>淋巴结:文档型:{成像方式}	4182948
36305514	H+P; H+P.HX; Hospitalization hx; Nominal; P prime; Point in time; Random; Typ	4180186
36305514	关于住院治疗的原因:类型:时间点:^患者:名义型	4182948
36305515	Myeloperoxidase Ab Ser Ql Line blot	4180186
36305515	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; MPO; MPO - ANCA; Myeloperoxidase ANCA; Ordinal; p-ANCA; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Vasculitis	4180186
36305515	髓过氧化物酶 抗体:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36305518	Centers for Medicare and Medicaid Assessment; Exchange; Finding; Findings; Last; Nominal; Point in time; Random; Replace; Survey; Tx	4180186
36305526	Comm hlth care ADCC Consult note	4180186
36305526	ADCC; Comm hlth care; Consult note; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36305526	会诊记录:发现:时间点:成人日间照护中心:文档型:社区医疗保健服务	4182948
36305527	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Tot; Totl	4180186
36305528	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Corn/Cnjt; Corneal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shingles; Strand Displacement Amplification; TMA; Transcription mediated amplification; VZ; VZV; Zoster	4180186
36305528	VZV DNA Corn/Cnjt Ql NAA+probe	4180186
36305528	水痘带状疱疹病毒 DNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
36305529	high-throughput sequencing; HPIV; HPIV1; HTS; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PI1; Point in time; Pork; PPIV1; PPIV1 HN; Random; Swine; Vet; Veterinary	4180186
36305529	PPIV1 HN Islt-Seq	4180186
36305529	猪副流感病毒 1 HN 基因:序列:时间点:分离株:名义型:序列测定	4182948
36305534	ED Parentrl thrpy note	4180186
36305534	DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Parentrl thrpy note; Point in time; Random; Visit note	4180186
36305534	肠道外治疗记录:发现:时间点:急诊科:文档型:{角色}	4182948
36305536	Placenta exam findings	4180186
36305536	DOC.MISC; Document; Exam findings; Finding; Findings; MISC; Placent; Placental; Point in time; Random	4180186
36305536	检查发现:发现:时间点:胎盘:文档型	4182948
36305537	Chemo; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random; Started	4180186
36305537	化疗灌注开始日期:日期:时间点:^患者:定量型	4182948
36305538	100 CD19 cells; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B2; B-2; B4; B-4; Blood; C3d receptor; CD19 Cells; CD21 Cells; CD21- cells; Cell; CELL MARKERS; Cells.CD21+; Cellularity; CR2; EBV-R; Epstein Barr virus receptor; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36305538	CD21 Cells/100 CD19 cells NFr Bld	4180186
36305538	细胞.CD21/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
36305540	Breakbone fever; Denv; DENV IgG+IgM Pnl; Flavivirus; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36305540	DENV IgG+IgM Pnl Ser	4180186
36305540	登革热病毒抗体.IgG 与 IgM 组套:-:时间点:血清:序数型	4182948
36305541	C&S; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Oral; Point in time; Random; Thrush	4180186
36305541	Fungus Mouth Cult	4180186
36305541	真菌 已鉴定的:存在与否或特征标识:时间点:口:名义型:培养	4182948
36305542	CAT scan; Clavicle-R; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Point in time; R; Rad; RADIOLOGY; Random; RT; Thorax; Upper extremity	4180186
36305542	CT Clavicle-R	4180186
36305542	多层:发现:时间点:胸部>锁骨.右侧:文档型:CT	4182948
36305543	Addiction; Cfm; Cloud 10; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; K2; Ordinal; Point in time; PotentialForAbuse; Potpourri; PR; QL; Qual; Qualitative; Random; Screen; Spice; Synthetic cannabinoid; UA; UR; Urn; Zombie	4180186
36305543	AB-CHMINACA butanoate Ur Ql Cfm	4180186
36305543	AB-CHMINACA 丁酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36305544	1 year; 12Mos; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; GC; Gono; Gonorrhea; H+P; H+P.HX; III; LGV; Lymphogranuloma venereum; N gonorrhoea; N gonorrhoeae; Ordinal; P prime; Past; PR; QL; Qual; Qualitative; Screen; Trachoma; Tx for C trachomatis or N gonorrhoeae	4180186
36305544	Tx for C trachomatis or N gonorrhoeae	4180186
36305544	在过去的3至12个月当中接受过针对沙眼衣原体和淋病奈瑟菌的治疗:存在情况或阈值:12个月:^患者:序数型	4182948
36305545	Addiction; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Gluc; Glucouronide; H3G; Hydromorphinone; III; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
36305545	H3G Ur Ql Scn	4180186
36305545	二氢吗啡酮-3-葡糖苷酸:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36305548	Chemistry; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305548	Sulfur Spec-mCnc	4180186
36305548	硫:质量浓度:时间点:XXX:定量型	4182948
36305549	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305550	Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Secondary mech thromb; Spec; To be specified in another part of the message; Unspecified	4180186
36305550	Guided Artery Secondary mech thromb	4180186
36305550	旨在二次经皮机械性血栓切除术的引导:发现:时间点:XXX>动脉:文档型:{成像方式}	4182948
36305551	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Fl; Fld; FLU; Fluid; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PR; Prot; Prot Elph Pnl; Random; Serum electrophoresis	4180186
36305551	Prot Elph Pnl Fld Elph	4180186
36305551	蛋白质类成分组套:-:时间点:体液:-:电泳	4182948
36305552	Calc; Calculation; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SPEC; Wat	4180186
36305552	Hardness Wat Calc-mCnc	4180186
36305552	水质硬度:质量浓度:时间点:水:定量型:计算法	4182948
36305555	Finding; Findings; Mat; Maternal; Matnl; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.CDC; WIC recipient	4180186
36305560	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Mycotoxin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305560	Fumonisin B3 Spec-mCnt	4180186
36305560	伏马菌素 B3:质量含量:时间点:XXX:定量型	4182948
36305562	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L/sp; L-spine; Lumbar; Lumbo; Playbook; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord	4180186
36305562	Guided L-spine Vertebroplasty	4180186
36305562	旨在椎体成形术的引导:发现:时间点:腹部>脊椎.腰段:文档型:{成像方式}	4182948
36305565	FDA insert Immunogenicity	4180186
36305565	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
36305565	免疫原性:-:-:^FDA 包装说明书:叙述型	4182948
36305566	NK cytotox.30:1 E:T/Pos cntrl Bld MC	4180186
36305566	Blood; HEMATOLOGY/CELL COUNTS; i; NK; NK cytotox.30:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
36305566	自然杀伤细胞细胞毒性.效应细胞/靶细胞比 30:1/阳性对照:相对任意型浓度:时间点:全血单个核细胞:定量型	4182948
36305567	# days of splint or brace assistance; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305569	Cardio; Cardiology; Cath; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; Thromb infus D1; Thrombolysis; To be specified in another part of the message; Unspecified; Ven; Venous; W thromb via cath	4180186
36305569	Guided Vein Throm inf D1 W throm in cath	4180186
36305569	旨在最初输注一天溶栓剂的引导^采用经导管给予的溶栓剂:发现:时间点:XXX>静脉:文档型:{成像方式}	4182948
36305571	Albumin goal mCnc SerPl	4180186
36305571	Alb; CLIN; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305571	白蛋白目标:质量浓度:时间点:血清/血浆:定量型	4182948
36305572	Auramine stain; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified	4180186
36305572	Auramine stain Spec Ql	4180186
36305572	显微镜观察:存在情况或阈值:时间点:XXX:序数型:金胺荧光色素染色法	4182948
36305573	CPR guid prior EMS arrival; Emergency Medical Service(s); Guid; Guide; Guided; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36305573	CPR guid prior EMS arrival	4180186
36305573	急救医疗服务方到达之前调度方所提供的心肺复苏指导:存在情况或阈值:时间点:^患者:序数型	4182948
36305574	III; Len; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
36305577	Chemistry; Cl; Cl-; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305577	Chloride Spec-mCnt	4180186
36305577	氯:质量含量:时间点:XXX:定量型	4182948
36305578	CorePlaybook; Document; Dorsal spine; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine	4180186
36305578	Guided T-spine Kyphoplasty	4180186
36305578	旨在椎体后凸成形术的引导:发现:时间点:胸部>脊椎.胸段:文档型:{成像方式}	4182948
36305579	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36305580	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; CPR; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; WB; Whole blood	4180186
36305580	blaIMP Bld Pos Ql Probe	4180186
36305580	细菌碳青霉烯类耐药 blaIMP 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36305581	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305584	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enzootic pneumonia; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305584	M pneumo DNA Nph Ql NAA+probe	4180186
36305584	肺炎支原体 DNA:存在情况或阈值:时间点:鼻咽:序数型:探针法.基因扩增.靶向	4182948
36305585	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305588	333-41-5; Basudin; Diazinone; Dimpylate; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Neocidol; Oleodiazinon; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Spectracide; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305588	Diazinon Spec-mCnt	4180186
36305588	二嗪农:质量含量:时间点:XXX:定量型	4182948
36305589	DRUG/TOXICOLOGY; Drugs; Ergot Poisonings; Ergotisms; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305589	Ergosine Spec-mCnt	4180186
36305589	麦角生碱:质量含量:时间点:XXX:定量型	4182948
36305590	Infl trig press; Lung; Point in time; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
36305590	Infl trig press Vent	4180186
36305590	充气触发压力:压力或压强:时间点:呼吸机:定量型	4182948
36305591	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Crypt; Crypto; Cryptosporidiosis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36305591	Cryptosp DNA Tiss Ql NAA+probe	4180186
36305591	隐孢子虫属单个未知种 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36305595	3 Self-Sustaining Sequence Replication; 3SR SR; A phago groEL; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; E equi; E phagocytophila; Ehrlichia equi; Ehrlichia phagocytophila; HGE; Human granulocytic ehrlichiosis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36305595	A phago groEL Bld Ql NAA+non-probe	4180186
36305595	嗜吞噬球无形体 groEL 基因:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36305598	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; i; Imaging; Kyphoplasty 1 level; Levels; Levl; LV; LVL; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; Spinal; Spinal Cord; To be specified in another part of the message; Unspecified	4180186
36305598	Guided Vertebra Kyphoplasty 1 level	4180186
36305598	旨在1级椎体后凸成形术的引导:发现:时间点:XXX>脊椎:文档型:{成像方式}	4182948
36305600	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E coli K99; E. coli K99 pilus gene; EC K99 DNA; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305600	E coli K99 DNA Islt Ql NAA+probe	4180186
36305600	大肠埃希菌 K99 DNA:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36305602	ACIF; Anticomplement Immunofluorescence; B microti; B microti Ab.IgG+IgM; B microti IgG+IgM Pnl; Babesiosis; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Piroplasmosis; Pnl; Serum; SR; Time Resolved Fluorescence; TRF	4180186
36305602	B microti IgG+IgM Pnl Ser IF	4180186
36305602	鼠源巴贝斯虫抗体.IgG 与 IgM 组套:-:-:血清:-:免疫荧光法	4182948
36305604	Len; Pan; Panel; Panl; Pnl; Point in time; Random	4180186
36305607	Arthrogram; Arthrography; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; intraarticular; Intracranial; intrasynovial; Jnt; Point in time; Rad; RADIOLOGY; Random; Skull; TMJ; W contr IS; WC	4180186
36305607	CT TMJ W contr IS	4180186
36305607	多层^采用关节内对比剂:发现:时间点:头部>颞颌关节:文档型:CT	4182948
36305608	ABS; Aby; Adult- and juvenile-onset dermatomyositis; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; E3 ubiquitin-protein ligase TRIM33; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Transcription intermediary factor 1-gamma Ab.IgG; Transcriptional intermediary factor 1-gamma	4180186
36305608	TIF1-gamma Ab Ser Line blot-aCnc	4180186
36305608	TIF1-gamma 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36305613	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305617	APTA; Dx; Finding; Findings; Movement system dx; Nominal; Physical Therapy; Point in time; PT; Random	4180186
36305617	Movement system dx	4180186
36305617	运动系统诊断:发现:时间点:^患者:名义型	4182948
36305618	Add; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; Spinal; Spinal Cord; To be specified in another part of the message; Unspecified; Vertebroplasty addl	4180186
36305618	Guided Vertebra Vertebroplasty addl	4180186
36305618	旨在额外椎体成形术的引导:发现:时间点:XXX>脊椎:文档型:{成像方式}	4182948
36305620	CLIN; CLIN.RISK; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl	4180186
36305620	Total score Geneva.Revised	4180186
36305622	E rhusiopathiae Ab/Pos cntrl Ser IA	4180186
36305622	猪红斑丹毒丝菌 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36305622	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; E rhusiopathiae; E rhusiopathiae Ab; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36305624	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chagas disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; T cruzi; Trypanosomiasis; Trypanosomosis	4180186
36305624	T cruzi IgG Ser Ql IA	4180186
36305624	克氏锥虫 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36305625	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; Hosp; Inpatient; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36305625	OB Hosp Consult note	4180186
36305625	会诊记录:发现:时间点:医院:文档型:产科学	4182948
36305627	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.GNHLTH	4180186
36305629	Bind; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; LBP; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36305629	LBP SerPl IA-mCnc	4180186
36305629	脂多糖结合蛋白:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36305630	Centers for Medicare and Medicaid Assessment; Dextro; Disch; Inpatient admission agency discharge items - d/c from agency; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305631	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305632	Micro CNAMTS panel Smn	4180186
36305632	Ejaculate; Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Sem; Seminal fluid; Smn; SMPLS	4180186
36305632	微生物学 CNAMTS 组套:-:时间点:精液:-	4182948
36305633	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Source of info; Srce; Survey; Typ	4180186
36305634	Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Oral fluid; Point in time; Random; Sal; St; Stains; Stn	4180186
36305634	Gram Stn Sal	4180186
36305634	显微镜观察:存在与否或特征标识:时间点:唾液:名义型:革兰氏染色法	4182948
36305635	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; OB; Ob NP; Ob Nurse; Obstetric; Point in time; Prenatal; Random; Visit note	4180186
36305635	Ob NP Note	4180186
36305635	记录:发现:时间点:{环境}:文档型:产科学.执业护士	4182948
36305636	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; S apiospermum; S apiospermum DNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305636	S apiospermum DNA Low Resp Ql NAA+probe	4180186
36305636	尖端赛多孢 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36305637	ANTIBIOTIC SUSCEPTIBILITIES; AST; c301; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; RIF; Rifadin; Rifampicin; Rimactane; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36305637	rifAMPin Islt Genotyp	4180186
36305637	利福平:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36305638	AOEObservation; Exp; H+P; H+P.HX; Identity or presence; Nominal; P prime; Point in time; Random	4180186
36305638	Known exposure	4180186
36305638	已知暴露:存在与否或特征标识:时间点:^患者:名义型	4182948
36305642	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36305647	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Extraction; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Port removal; Rad; RADIOLOGY; Random; Remove	4180186
36305647	Guided Peritoneum Port removal	4180186
36305647	旨在去除输液港的引导:发现:时间点:腹部>腹膜:文档型:{成像方式}	4182948
36305649	Chemo; Chemo infusion start time; Clock time; IO_IN.INFUS; IO_INTAKE; Point in time; QNT; Quan; Quant; Quantitative; Random; Started	4180186
36305649	Chemo infusion start time Clock time	4180186
36305649	化疗灌注开始时间:时钟时间:时间点:^患者:定量型	4182948
36305651	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kidney; Kidney-R; Kid-R+Uret; Nephric; Nephrology; Pelvic; Point in time; Pyelogram; Pyelography; R; Rad; RADIOLOGY; Random; Renal; Retro; RT; View; VWS; W contr Retro; W contr retro IU; WC	4180186
36305651	RF Kid-R+Uret Views W contr retro IU	4180186
36305651	多重视图^采用输尿管内逆行性对比剂:发现:时间点:腹部>肾脏.右侧 & 腹部+盆腔>输尿管:文档型:放射荧光透视法	4182948
36305652	Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Femoral; Femur; Finding; Findings; Imaging; LE; LE-Bl; Leg; Low; Lower extremity; Point in time; Rad; RADIOLOGY; Random; Thigh-Bl; W contr IV; WC	4180186
36305652	CT Thigh-Bl W contr IV	4180186
36305652	多层^采用静脉注射对比剂:发现:时间点:下肢.双侧>大腿:文档型:CT	4182948
36305654	#/area; Crys; Cryst; Crystal; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Tyr; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36305654	Tyrosine Cry #/area UrnS	4180186
36305654	酪氨酸结晶:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36305655	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HBoV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
36305655	HBoV DNA Upper resp Ql NAA+probe	4180186
36305655	人博卡病毒 DNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36305659	Centers for Medicare and Medicaid Assessment; Disch; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305665	100 CD3; Alfa; B; Blood; CD3 Cells; CD4 Cells; CD4+CD8+ Cells; Cell; CELL MARKERS; Cell.DNT-CD45R+TCRa b; Cellularity; Dynamic; FC; Helper T cells; Inducer T cells; L3T4; Leu2; Leu-2; Leu3; Leu-3; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; T3; T4; T-4; T8; T-8; TCR A-B; Tsuppressor; W3/25; WB; Whole blood	4180186
36305665	Cells.DNT-CD45R+TCR A-B+/100 CD3 Bld FC	4180186
36305665	细胞.CD4-CD8-CD45R+TCR alpha beta+/100 个细胞.CD3:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
36305667	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36305668	APTA; Intervention or services provided pnl; Pan; PANEL.APTA; Panl; Physical Therapy; Pnl; Point in time; PT; Random	4180186
36305668	Intervention or services provided pnl	4180186
36305668	所提供干预和或服务组套:-:时间点:^患者:-	4182948
36305669	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; i; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305671	# days of training & skill practice in dressing or grooming; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305674	Acd; Acid fast Stn; Acids; AFB stain; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; PR; QL; Qual; Qualitative; Regurgitation; Screen; St; Stains; Stn; Vom; Vomitus	4180186
36305674	Deprecated Acid fast Stn Vom Ql	4180186
36305675	Art; Cardio; Cardiology; Document; Endoleak repair; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305675	Guided Artery Endoleak repair	4180186
36305675	旨在内漏修复术的引导:发现:时间点:XXX>动脉:文档型:{成像方式}	4182948
36305677	Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305677	Guided Unsp region Abscess	4180186
36305677	旨在脓肿的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36305678	Centers for Medicare and Medicaid Assessment; Nominal; Report period; Survey; Typ	4180186
36305679	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; PEDv; PEDV whole genome; Point in time; Pork; Random; Swine; Vet; Veterinary	4180186
36305679	PEDV whole genome Islt-Seq	4180186
36305679	猪流行性腹泻病毒全基因组:序列:时间点:分离株:名义型:序列测定	4182948
36305681	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV1; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305681	HPIV1 RNA Lower resp Ql NAA+probe	4180186
36305681	副流感病毒 1 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36305682	Dynamic; Flow; Lung; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volume Rate; vRate	4180186
36305682	Bias flow set Vent	4180186
36305682	偏流设置:体积速率:时间点:呼吸机:定量型	4182948
36305683	CorePlaybook; Document; Dorsal spine; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine	4180186
36305683	Guided T-spine Vertebroplasty	4180186
36305683	旨在椎体成形术的引导:发现:时间点:胸部>脊椎.胸段:文档型:{成像方式}	4182948
36305684	5-F PB-22 3-carboxyindole; 5F-QUPIC; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; III; Illicit; Kush; Ordinal; Point in time; PotentialForAbuse; Potpourri; PR; QL; Qual; Qualitative; QUPIC; Random; Screen; Smoke; Spice; Synthetic cannabinoid; UA; UR; Urn; Zombie	4180186
36305684	5-F PB-22 3-carboxyindole Ur Ql Cfm	4180186
36305684	5-氟 PB-22 3-吲哚甲酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36305685	Asp; CorePlaybook; Document; Finding; Findings; Gang cyst asp; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305685	Guided Unsp region Gang cyst asp	4180186
36305685	旨在经皮抽吸腱鞘囊肿的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36305687	Antianxiety received in last 7D or since admission/reentry if less than 7D; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305688	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305689	C&S; Cult; Cultures; Diaf; DiafP; Dialysate; Dialysis fluid; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Kidney; Microbiology; Nephrology; Nominal; Peritoneal Dialysis fluid; Point in time; Random; Renal; Thrush	4180186
36305689	Fungus DiafP Cult	4180186
36305689	真菌 已鉴定的:存在与否或特征标识:时间点:腹膜透析液:名义型:培养	4182948
36305690	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Transfer sum note; Visit note	4180186
36305690	OB Transfer sum note	4180186
36305690	移交摘要记录:发现:时间点:{环境}:文档型:产科学	4182948
36305692	A fumigatus; A fumigts+S rectiv+Tvulgaris IgG Pnl; Allergen; Allergens; Allergic Alveolitides, Extrinsic; ALLERGY TESTING; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; F retivirgula; Faenia rectivirgula; Farmers lung; Fum; Gm22; Gm23; Gm3; Hypersensitivity pneumonia; Hypersensitivity Pneumonitides; Immune globulin G; Immunoglobulin G; M faeni; m003; m212; m22; m23; m3; m50; m51; Mcropolyspra; Micropolyspora faeni; Mold Allerg Mix7; Pan; PANEL.ALLERGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; RGm23; RGmx7; Rm212; Rm213; S rectivirgula; S retivirgula; Serum; SR; T vulgaris; Thermoactnom	4180186
36305692	A fumigts+S rectiv+Tvulgaris IgG Pnl Ser	4180186
36305692	烟曲霉 & 直杆糖多孢菌 & 普通高温放线菌 抗体.IgG 组套:-:时间点:血清:定量型	4182948
36305695	Relation to patient's mother	4180186
36305695	ADMIN; Nominal; Point in time; Random; Relation to patient's mother; Relationship to pt; S prime; Typ	4180186
36305695	与患者母亲的关系:类型:时间点:^联系人:名义型	4182948
36305698	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305706	Unsuccessful attempts	4180186
36305706	Cnt; Count; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; TRAUMA	4180186
36305706	失败尝试次数:数量(计数):时间点:^患者:定量型	4182948
36305707	A pleuropn; A pleuropn 10; A pleuropn 10 Ab; A pleuropn Sertyp; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36305707	A pleuropn 10 Ab/Pos cntrl Ser IA	4180186
36305707	胸膜肺炎放线杆菌血清型 10 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36305708	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305710	Abd; Abd+Pelvis; Abdo; Abdominal; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
36305710	CT Chest+Abd+Pelvis	4180186
36305710	多层:发现:时间点:胸部+腹部+盆腔:文档型:CT	4182948
36305714	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305717	粗球孢子菌抗体.IgG 与 IgM 组套:-:时间点:脑脊液:-	4182948
36305717	B immitis; Blastomycoides immitis; C esteriformis; C immitis; C immitis IgG + IgM Pnl; Cerebral spinal fluid; Cerebrospinal Fl; Coccidioides esteriformis; Coccidiomycosis; Coccio; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; P esteriformis; P mazzai; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Posadasia esteriformis; Pseudococcidioides mazzai; Random; San Joaquin Valley fever; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T proteolyticum; Trichosporon proteolyticum; Valley fever	4180186
36305717	C immitis IgG + IgM Pnl CSF	4180186
36305719	C/sp; Cerv; CorePlaybook; C-spine; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random; Removal of fluid; Spinal; Spinal Cord; Ther; Therapeutic punc+drainage	4180186
36305719	Guided C-spine Therapeutic punc+drainage	4180186
36305719	旨在治疗性穿刺+引流术的引导:发现:时间点:颈部>脊椎.颈段:文档型:{成像方式}	4182948
36305720	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E. coli porcine A/E-associated gene; EC paa gene; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vet; Veterinary	4180186
36305720	EC paa gene Islt Ql NAA+probe	4180186
36305720	大肠埃希菌 paa 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36305726	CLIN; Ferr; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305726	Ferritin goal mCnc SerPl	4180186
36305726	铁蛋白目标:质量浓度:时间点:血清/血浆:定量型	4182948
36305727	Breathing; Exp pressure; Lung; Lungs; Min exp press; Minimal; minimum; Point in time; Press.min; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
36305727	Min exp press Airway	4180186
36305727	呼气压力.最小值:压力或压强:时间点:呼吸系统.气道:定量型	4182948
36305728	Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Lyssavirus; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
36305728	RABV Ag CSF Ql IA	4180186
36305728	狂犬病病毒 抗原:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
36305729	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305731	Centers for Medicare and Medicaid Assessment; OT; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305735	Antidepressant received in last 7D or since admission/reentry if less than 7D; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305736	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; Playbook; Point in time; Rad; Radiology; Random; Renal	4180186
36305736	Guided Kidney Cryoablation	4180186
36305736	旨在冷冻消融术的引导:发现:时间点:腹部>肾脏:文档型:{成像方式}	4182948
36305737	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Lyme disease; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Relapsing fever; SDA; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305737	Borrelia DNA CSF NAA+probe	4180186
36305737	疏螺旋体属单个未知种 DNA:存在与否或特征标识:时间点:脑脊液:名义型:探针法.基因扩增.靶向	4182948
36305738	Blood; HEMATOLOGY/CELL COUNTS; i; NK; NK cytotox.1.88:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
36305738	NK cytotox.1.88:1 E:T/Pos cntrl Bld MC	4180186
36305738	自然杀伤细胞细胞毒性.效应细胞/靶细胞比 1.88:1/阳性对照:相对任意型浓度:时间点:全血单个核细胞:定量型	4182948
36305739	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Dombrock Blood Group System; Hy; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305739	Hy Ab SerPl Ql	4180186
36305739	Hy 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
36305741	Trauma Process of care meas Doc	4180186
36305741	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36305741	照护服务过程指标:发现:时间点:{环境}:文档型:创伤专业	4182948
36305745	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; PCN; Pen; Penicilloyl; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary; Wycillin	4180186
36305745	Penicillin Spec-mCnt	4180186
36305745	青霉素:质量含量:时间点:XXX:定量型	4182948
36305751	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVC; RVC VP7; Vet; Veterinary	4180186
36305751	RVC VP7 Islt-Seq	4180186
36305751	轮状病毒 C VP7 基因:序列:时间点:分离株:名义型:序列测定	4182948
36305752	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Phleboviruses; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Sand fly fever; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; TOSV; Transcription mediated amplification	4180186
36305752	TOSV RNA CSF Ql NAA+probe	4180186
36305752	托斯卡纳病毒 RNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36305753	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV Subtyp; FLUV; Fowl plague; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305753	FLUAV Subtyp Corn/Cnjt NAA+probe	4180186
36305753	流感病毒 A 型亚型:存在与否或特征标识:时间点:角膜/结膜:名义型:探针法.基因扩增.靶向	4182948
36305755	Hx of PCI	4180186
36305755	H+P; H+P.HX; History; Ordinal; P prime; PCI; Perc; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36305755	经皮冠状动脉介入治疗:历史记录:时间点:^患者:序数型	4182948
36305757	Glutarylcarn/C2 DBS-sRto	4180186
36305757	Blood; C2; C5DC; C5-DC; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
36305757	戊二酰肉碱 (C5-DC)/乙酰肉碱 (C2):物质的量比率:时间点:全血.斑点:定量型	4182948
36305759	Addiction; c260; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Gluc; Glucouronide; Illicit; M6G; Morphine sulfate; Morphine-6-beta-glucuronide; MS; MSO4; OMPH; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
36305759	Morphine-6-glucuronide Ur Ql Scn	4180186
36305759	吗啡-6-葡糖苷酸:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36305760	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305763	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Filter place; Finding; Findings; Guid; Guide; Guided; Heart; Imaging; Inf; IVC; Playbook; Point in time; Rad; RADIOLOGY; Random; VC	4180186
36305763	Guided IVC Filter place	4180186
36305763	旨在置入下腔静脉滤器的引导:发现:时间点:腹部>腔静脉.下:文档型:{成像方式}	4182948
36305764	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; Othr; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36305765	CARD.PROC; Cardio; Cardiology; Heart Disease; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36305765	心脏功能容量:分类:时间点:^患者:序数型:NYHA	4182948
36305771	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Crypt; Crypto; Cryptosporidiosis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305771	Cryptosp DNA Stl Ql NAA+probe	4180186
36305771	隐孢子虫属单个未知种 DNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
36305772	CLIN; CLIN.RISK; Dis; Disease stg; Diseases; Dz; Ordinal; Point in time; QL; Qual; Qualitative; Random; Scale; Screen	4180186
36305772	针对风险计算的疾病分期评分:评分:时间点:^患者:序数型	4182948
36305773	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; III; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; QUCHIC; Random; Screen; Synthetic cannabinoid; UA; UR; Urn	4180186
36305773	BB-22 3-carboxyindole Ur Ql Cfm	4180186
36305773	BB-22 3-吲哚甲酸:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36305774	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36305776	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; CPR; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; WB; Whole blood	4180186
36305776	blaOXA Bld Pos Ql Probe	4180186
36305776	细菌碳青霉烯类耐药 blaOXA 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:DNA探针	4182948
36305777	Addiction med Initial eval note	4180186
36305777	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Substance abuse; Visit note	4180186
36305777	初步评价记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36305779	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; Othr; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36305782	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF	4180186
36305782	HSV1 Ag Tiss Ql IF	4180186
36305782	单纯疱疹病毒 1 型 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫荧光法	4182948
36305784	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36305786	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
36305787	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36305787	Guided Liver Cryoablation	4180186
36305787	旨在冷冻消融术的引导:发现:时间点:腹部>肝脏:文档型:{成像方式}	4182948
36305789	Free 3-MT Ur-sRto	4180186
36305789	3Me-tyramine; Chemistry; Dopamine metabolite; FR; Free 3-MT; III; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UR; Urn	4180186
36305789	3-甲氧酪氨酸.游离型:物质的量比率:时间点:尿液:定量型	4182948
36305790	DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; STELARA®; SUDS	4180186
36305790	Ustekinumab SerPl IA-mCnc	4180186
36305790	优特克单抗:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36305791	CESD-R; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
36305793	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305794	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Seneca Valley Virus; Spec; Strand Displacement Amplification; SVA; SVA RNA; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
36305794	SVA RNA # Spec NAA+probe	4180186
36305794	塞内卡病毒 A RNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36305796	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Circo virus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV; PCV2; PCV2 Ab; PCV2 IgG; Point in time; Pork; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Swine; Vet; Veterinary	4180186
36305796	PCV2 IgG/Pos cntrl Ser IA	4180186
36305796	猪圆环病毒 2 型 抗体.IgG/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36305800	Centers for Medicare and Medicaid Assessment; Given name; Nominal; Person name; Point in time; Random; Survey	4180186
36305801	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36305801	Histone Ab CSF Ql Line blot	4180186
36305801	组蛋白 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36305802	GM2 Gangl IgG+IgM Ser IA-aCnc	4180186
36305802	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GM2 Gangl; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; MEIA; Monosialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
36305802	神经节苷脂 GM2 抗体.IgG+IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36305803	AUDIO; Audiology; Ear-L; Hearing; L; LT; Otologic; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36305803	Hearing threshold 8000 Hz Ear-L	4180186
36305803	听阈^8000 赫兹:相对声强:时间点:耳.左侧:定量型	4182948
36305804	CorePlaybook; Document; Filter reposition; Finding; Findings; Guid; Guide; Guided; Heart; Imaging; Playbook; Point in time; Rad; Radiology; Random; SVC; Thorax; VC	4180186
36305804	Guided SVC Filter reposition	4180186
36305804	旨在静脉滤器复位的引导:发现:时间点:胸部>腔静脉.上:文档型:{成像方式}	4182948
36305808	CN; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305808	Cyanide Spec-mCnt	4180186
36305808	氰化物:质量含量:时间点:XXX:定量型	4182948
36305809	3 Self-Sustaining Sequence Replication; 3SR SR; Amebic meningoencephalitis; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; N fowleri; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36305809	N fowleri DNA Spec Ql NAA+probe	4180186
36305809	福氏耐格里阿米巴 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36305811	Rescue operation end	4180186
36305811	Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp; TRAUMA	4180186
36305811	救援行动终点:时间戳:时间点:^患者:定量型	4182948
36305812	Genital tract; Micro CNAMTS panel; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Urth	4180186
36305812	Micro CNAMTS panel Urth	4180186
36305812	微生物学 CNAMTS 组套:-:时间点:尿道:-	4182948
36305815	DOC.ONT; Document; Finding; Findings; Gyn; Gynecology; Hosp; Inpatient; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random	4180186
36305815	OB Hosp Letter	4180186
36305815	信函:发现:时间点:医院:文档型:产科学	4182948
36305816	Chlorophenothane; DDT; Dicophane; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305816	DDT Spec-mCnt	4180186
36305816	二氯二苯基三氯乙烷:质量含量:时间点:XXX:定量型	4182948
36305818	Bowel movement; C&S; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Shigellosis; Spec; species; spp; Stl; Stool = Fecal	4180186
36305818	Shigella Stl Cult	4180186
36305818	志贺菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:大便:名义型:微生物特异性培养	4182948
36305819	Aflatoxicosis; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Mycotoxin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305819	Aflatoxin G2 Spec-mCnt	4180186
36305819	黄曲霉毒素 G2:质量含量:时间点:XXX:定量型	4182948
36305820	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; S prolificans; S prolificans DNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305820	S prolificans DNA Low Resp Ql NAA+probe	4180186
36305820	多育赛多孢 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36305823	Cl; Clear; Clearanc; Clearances; Clr; Identity or presence; Lung; Nominal; Point in time; PULMONARY; Pulmonology; Random; Respiratory	4180186
36305823	Airway clearance technique perf	4180186
36305823	所进行的气道清理技术:存在与否或特征标识:时间点:^患者:名义型	4182948
36305824	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36305825	Centers for Medicare and Medicaid Assessment; Othr; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305826	Cnt; Count; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
36305827	CorePlaybook; Dialy; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Misc; Miscellaneous; Nephrology; Other; Perc; Playbook; Point in time; PTA; PTA for dial; Rad; RADIOLOGY; Random; Renal; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
36305827	Guided Vein PTA for dial	4180186
36305827	旨在用于透析的经皮腔内血管成形术的引导:发现:时间点:XXX>静脉:文档型:{成像方式}	4182948
36305828	DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse W Reflex Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
36305828	Drugs of abuse W Reflex Pnl Ur	4180186
36305828	滥用毒品筛查项目与伺机追加型确认项目组套:-:时间点:尿液:-	4182948
36305829	Cath; Change; CorePlaybook; Document; Finding; Findings; Guid; Guidance for exchange; Guide; Guided; Imaging; Non-tun CVC exch; Playbook; Point in time; Rad; RADIOLOGY; Random; Replace; Thorax	4180186
36305829	Guided Chest Non-tun CVC exch	4180186
36305829	旨在更换非隧道式中心静脉导管的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36305830	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Camel flu; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV-EMC/2012; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MERS-CoV; MERS-CoV RNA; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305830	MERS-CoV RNA Aspirate Ql NAA+probe	4180186
36305830	中东呼吸综合征冠状病毒 RNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36305831	Alc; alcoholic; Asympt; Asymptomatic; HEDIS 2018 Alcohol Screen; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Scn	4180186
36305831	HEDIS 2018 Alcohol Screen	4180186
36305831	HEDIS 2018 取值集合 - 酒精筛查:-:时间点:^患者:-	4182948
36305832	DOCUMENT.REF; FDA insert; how suppl + stor + hand sect; Narrative; Report; SPL; Structured Product Labelling	4180186
36305832	FDA insert how suppl + stor + hand sect	4180186
36305832	供应、贮藏及处理方法小节:-:-:^FDA 包装说明书:叙述型	4182948
36305834	Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Suction freq	4180186
36305834	Suction freq	4180186
36305834	吸痰频率:计数型速率:时间点:^患者:定量型	4182948
36305836	Anaero; Anaerobe; Anaerobe Cult; Bact; BIFL; Bile fluid; Biliary fluid; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
36305836	Bacteria Bifl Anaerobe Cult	4180186
36305836	细菌 已鉴定的:存在与否或特征标识:时间点:胆汁:名义型:厌氧微生物培养	4182948
36305837	Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36305841	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cardio; Cardiology; Cult; Cultures; Heart Disease; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; PCAR; Pericardial Fluid; Point in time; Random	4180186
36305841	Bacteria Pcar Anaerobe Cult	4180186
36305841	细菌 已鉴定的:存在与否或特征标识:时间点:心包液:名义型:厌氧微生物培养	4182948
36305844	Acd; Acid fast Stn; Acids; AFB stain; Cervix; Genital tract; Gyn; Gynecology; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; St; Stains; Stn	4180186
36305844	Acid fast Stn Cvx	4180186
36305844	显微镜观察:存在与否或特征标识:时间点:子宫颈:名义型:抗酸染色法	4182948
36305848	#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; E coli; ID; Infectious Disease; InfectiousDisease; Microbiology; Number concentration; Number Concentration (count/vol); o002; Point in time; QNT; Quan; Quant; Quantitative; Random; Viab Cnt; Wat	4180186
36305848	E coli # Wat Viab Cnt	4180186
36305848	大肠埃希菌:计数型浓度:时间点:水:定量型:活菌计数法	4182948
36305850	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305852	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
36305861	DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Organophosphate pnl; Other; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305861	Organophosphate pnl Spec	4180186
36305861	有机磷酸酯组套:-:时间点:XXX:-	4182948
36305862	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified; Vesl; Vessels.XXX	4180186
36305862	Guided Vesl Embol	4180186
36305862	旨在栓塞的引导:发现:时间点:XXX>血管类:文档型:{成像方式}	4182948
36305864	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zithromax	4180186
36305864	Azithromycin Islt Genotyp	4180186
36305864	阿齐霉素:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36305867	#/area; Cast; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36305867	Fatty Casts #/area UrnS	4180186
36305867	脂肪管型:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36305868	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; H&P note; Hx; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36305868	Gynecology H&P note	4180186
36305868	病史与体格检查记录:发现:时间点:{环境}:文档型:妇科学	4182948
36305874	Ang; Angio; Angiography; Angm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; EXT; Extr ves; Extr-R; Finding; Findings; Imaging; LE; LE ves; LE ves-R; Leg; LE-R; Low; Lower extremity vessels.right; Point in time; R; Rad; Radiology; Random; RLE; RT; Vesl; Vessels.XXX; W contr IV; WC	4180186
36305874	CTA LE ves-R W contr IV	4180186
36305874	多层^采用静脉注射对比剂:发现:时间点:下肢.右侧>下肢血管类:文档型:CT.血管造影术	4182948
36305877	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305879	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Job; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305880	AUDIO; Audiology; Ear-R; Hearing; Otologic; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT	4180186
36305880	Hearing threshold 3000 Hz Ear-R	4180186
36305880	听阈^3000 赫兹:相对声强:时间点:耳.右侧:定量型	4182948
36305881	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36305882	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Entyvio; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Vedol; VEMAB	4180186
36305882	Vedolizumab Ab SerPl IA-mCnc	4180186
36305882	维多珠单抗 抗体:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36305883	Centers for Medicare and Medicaid Assessment; Disch; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305885	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; Chicken pox; Chicken pox virus; Chickenpox; DFA; FA; Fluorescent antibody; Fluoresent; Herpes zoster; HHV-3; Human herpesvirus 3; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Shingles; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF; VZ; VZV; Zoster	4180186
36305885	VZV Ag CSF Ql IF	4180186
36305885	水痘带状疱疹病毒 抗原:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36305888	MISC; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Survey.Misc; Velocity	4180186
36305889	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36305892	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Cysticercosis; Cysticercus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T sol; T sol lar; T solium; Tapeworm; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36305892	T sol lar DNA Bld Ql NAA+probe	4180186
36305892	猪囊尾蚴 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36305893	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; HPIV; HPIV3; Human respirovirus 3; ID; IFA; III; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Ordinal; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PI3; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF	4180186
36305893	HPIV3 Ag Lower resp Ql IF	4180186
36305893	副流感病毒 3 型 抗原:存在情况或阈值:时间点:呼吸道.下:序数型:免疫荧光法	4182948
36305894	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36305895	Appls; Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Report period; Survey	4180186
36305898	Cath; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Non-tun CVC wo port repair; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
36305898	Guided Chest Non-tun CVC wo port repair	4180186
36305898	旨在修复不带输液港的非隧道式中心静脉导管的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36305901	Addiction med Alert	4180186
36305901	DOC.ONT; Document; Finding; Findings; Point in time; Random; Substance abuse	4180186
36305901	警示:发现:时间点:{环境}:文档型:成瘾医学	4182948
36305903	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36305904	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; Replace; RT; Screen; Survey; SURVEY.GNHLTH	4180186
36305905	Adeno virus; Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; HAdV; IAA; ID; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; MEIA; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; SUDS	4180186
36305905	HAdV Ag Lower resp Ql IA	4180186
36305905	腺病毒 抗原:存在情况或阈值:时间点:呼吸道.下:序数型:免疫测定法	4182948
36305906	Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
36305906	Guided Mediastinum Bx	4180186
36305906	旨在经皮活组织检查的引导:发现:时间点:胸部>纵隔:文档型:{成像方式}	4182948
36305907	Asp; CorePlaybook; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; Intermediate joint; Jnt; Misc; Miscellaneous; Other; PC fluid asp; Perc; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36305907	Guided Intermediate joint Arthrocentesis	4180186
36305907	旨在经皮穿刺抽吸的引导:发现:时间点:XXX>关节.中:文档型:{成像方式}	4182948
36305909	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; WNV	4180186
36305909	WNV RNA Ct Spec Qn NAA+probe	4180186
36305909	西尼罗河病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36305913	DRUG/TOXICOLOGY; Drugs; Mass content; Mirex; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305913	Dechlorane Spec-mCnt	4180186
36305913	灭蚁灵:质量含量:时间点:XXX:定量型	4182948
36305915	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random	4180186
36305915	CT Pelvis by reconstr	4180186
36305915	基于重建的多层:发现:时间点:盆腔:文档型:CT	4182948
36305916	Centers for Medicare and Medicaid Assessment; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
36305917	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Sx	4180186
36305920	Abd; Abdo; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; Kidney; Point in time; Rad; Radiology; Random; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
36305920	CTA Renal ves WO+W contr IV	4180186
36305920	多层^不采用 & 采用静脉注射对比剂:发现:时间点:腹部>肾血管类:文档型:CT.血管造影术	4182948
36305922	Position &or immobilizer used	4180186
36305922	Emergency Medical Service(s); Finding; Findings; Nominal; Point in time; Random; TRAUMA	4180186
36305922	急救医疗服务运输过程中所使用的体位和或固定器:发现:时间点:^患者:名义型	4182948
36305925	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gyn Res; notes; Point in time; Random; Visit note	4180186
36305925	Gyn Res Note	4180186
36305925	记录:发现:时间点:{环境}:文档型:妇科学.住院	4182948
36305926	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T spiralis; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Tric; Trich; Trichinellosis; Trichinosis	4180186
36305926	T spiralis DNA Tiss Ql NAA+probe	4180186
36305926	旋毛形线虫 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36305929	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305929	HCoV RNA Aspirate Ql NAA+probe	4180186
36305929	人类冠状病毒 RNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36305930	Dev or anatom struc vis wnd; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Typ; Wnd	4180186
36305930	Dev or anatom struc vis wnd	4180186
36305930	伤口内可见的装置或解剖结构:类型:时间点:伤口:名义型	4182948
36305933	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36305934	Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305935	Fetal; ID; Imm; Immune globulin G; Immune globulin M; Immunodiff; Immunodiffusion; Immunoglobulin G; Immunoglobulin M; Imun; Imune; Ordinal; Pleural; Pleural fluid; Point in time; Pork; PR; QL; Qual; Qualitative; Random; Screen; Serology; Swine; thoracentesis fluid; Vet; Veterinary	4180186
36305935	IgG+IgM.porcine Plr Fetus Ql ID	4180186
36305935	IgG+IgM.猪:存在情况或阈值:时间点:胸膜液^胎儿:序数型:免疫扩散法	4182948
36305936	A,B; Chemistry; DIA; Dimeric inhibin A; Inhibin A + B Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305936	Inhibin A + B Pnl SerPl	4180186
36305936	抑制素 A 与 B 组套:-:时间点:血清/血浆:定量型	4182948
36305943	CLIN; Finding; Findings; Nominal; Point in time; Random	4180186
36305943	Important health event to avoid	4180186
36305943	所要避免的最重要的健康事件:发现:时间点:^患者:名义型	4182948
36305944	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Transfer sum note; Visit note	4180186
36305944	Gynecology Transfer sum note	4180186
36305944	移交摘要记录:发现:时间点:{环境}:文档型:妇科学	4182948
36305948	Asp; CorePlaybook; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; Jnt; Misc; Miscellaneous; Other; PC fluid asp; Perc; Playbook; Point in time; Rad; Radiology; Random; Small joint; Spec; To be specified in another part of the message; Unspecified	4180186
36305948	Guided Small joint Arthrocentesis	4180186
36305948	旨在经皮穿刺抽吸的引导:发现:时间点:XXX>关节.小:文档型:{成像方式}	4182948
36305949	Aneurysm repair; AO; Aortic; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; TEVAR; Thoracic endovascular aortic repair; Thorax	4180186
36305949	Guided TA Aneurysm repair	4180186
36305949	旨在动脉瘤修复术的引导:发现:时间点:胸部>主动脉.胸腔段:文档型:{成像方式}	4182948
36305950	p53 Ab SerPl IA-aCnc	4180186
36305950	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36305950	p53 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36305952	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36305954	Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Mech thromb initial; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified; Ven; Venous	4180186
36305954	Guided Vein Mech thromb initial	4180186
36305954	旨在初次经皮机械性血栓切除术的引导:发现:时间点:XXX>静脉:文档型:{成像方式}	4182948
36305956	AUDIO; Audiology; Ear-R; Hearing; Otologic; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT	4180186
36305956	Hearing threshold 6000 Hz Ear-R	4180186
36305956	听阈^6000 赫兹:相对声强:时间点:耳.右侧:定量型	4182948
36305957	3; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Point in time; Pol III; POL3RK; POL3RK gene; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; RNAp III; RNAp III RP11; RNAp III RP11 Ab; Serology; Serum; SR	4180186
36305957	RNAp III RP11 Ab Ser Line blot-aCnc	4180186
36305957	RNA 聚合酶 III RP11 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36305958	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36305964	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36305964	OB Consult note	4180186
36305964	会诊记录:发现:时间点:{环境}:文档型:产科学	4182948
36305967	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Placent; Placental; Point in time; Random	4180186
36305967	Bacteria Placenta Anaerobe Cult	4180186
36305967	细菌 已鉴定的:存在与否或特征标识:时间点:胎盘:名义型:厌氧微生物培养	4182948
36305968	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36305968	OB Educ note	4180186
36305968	教育记录:发现:时间点:{环境}:文档型:产科学	4182948
36305969	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; PEDv; PEDV S1 gene; Point in time; Pork; Random; Swine; Vet; Veterinary	4180186
36305969	PEDV S1 gene Islt-Seq	4180186
36305969	猪流行性腹泻病毒 S1 基因:序列:时间点:分离株:名义型:序列测定	4182948
36305970	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Camel flu; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; HCoV-EMC/2012; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MERS-CoV; MERS-CoV RNA; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36305970	MERS-CoV RNA Stl Ql NAA+probe	4180186
36305970	中东呼吸综合征冠状病毒 RNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
36305971	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36305972	ANTIBIOTIC SUSCEPTIBILITIES; AST; Biaxin; Claripen; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klacid; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36305972	Clarithro Islt Genotyp	4180186
36305972	克拉霉素:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36305973	DRUG/TOXICOLOGY; Drugs; Ergot Poisonings; Ergotisms; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36305973	Ergovaline Spec-mCnt	4180186
36305973	麦角缬碱:质量含量:时间点:XXX:定量型	4182948
36305974	Lung cancer antibody panel SerPl IA	4180186
36305974	肺癌抗体组套:-:时间点:血清/血浆:-:免疫测定法	4182948
36305974	Ab; EarlyCDT; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lung cancer Ab; MEIA; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36305975	CLIN; CLIN.RISK; Point in time; Pulmonary Function Test; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl	4180186
36305977	Finding; Findings; H+P; H+P.PX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Ulcer	4180186
36305977	损伤严重程度:发现:时间点:^患者:序数型	4182948
36305980	Centers for Medicare and Medicaid Assessment; Finding; Findings; II; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Sequence based typing; Survey	4180186
36305984	Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36305987	Brain; c; C/sp; CAT scan; Cerv; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; C-spine; CT scan; Document; Facial bones + Maxilla; Facial bones+Maxilla; Finding; Findings; Head+Maxillofacial; Head+Maxillofacial+C-spine; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; Spinal; Spinal Cord; without contrast	4180186
36305987	CT Head+Maxillofacial+C-spine WO contr	4180186
36305987	多层^不采用对比剂:发现:时间点:头部 & 头部>颌面区域 & 颈部>脊椎.颈段:文档型:CT	4182948
36305994	Cortisol AM + PM Pnl SerPl	4180186
36305994	17-Hydroxycorticosterone; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortisol AM + PM Pnl; Diurnal cortisol; Evening; F; hydrocortisone; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36305994	皮质醇上午与下午组套:-:时间点:血清/血浆:-	4182948
36305995	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Tx; Txs	4180186
36305996	Acute myeloid leukemia; Blood; CD117; C-Kit; D816V; Gastrointestinal Stromal Tumor; Genetics; Germ Cell Tumors; GIST; Heredity; Heritable; Inherited; KIT c.2447A&gt;T; mast/stem cell growth factor receptor; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PBT; PCR; piebald trait; Point in time; PR; Proto-oncogene tyrosine-protein kinase Kit; QL; Qual; Qualitative; Random; SCFR; Screen; soluble KIT variant; Systemic Mastocytosis; T prime; Tissue; Tissue, unspecified; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; WB; Whole blood; Whole blood or Tissue	4180186
36305996	KIT c.2447A>T Bld/T Ql	4180186
36305996	KIT 基因.c.2447A>T:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
36305997	100 CD3+CD4+; Blood; CD27 Cells; CD27- cells; CD27+CD62L+ cells; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4+ T cells; Cell; CELL MARKERS; Cellularity; Helper T cells; Inducer T cells; L3T4; LAM-1; LECAM-1; Leu3; Leu-3; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; S152; T14; T3; T4; T-4; T4 helper/inducer cells; TQ-1; W3/25; WB; Whole blood	4180186
36305997	CD27+CD62L+ cells/100 CD3+CD4+ NFr Bld	4180186
36305997	细胞.CD27+CD62L+/100 个细胞.CD3+CD4+:计数型分数:时间点:全血:定量型	4182948
36305999	CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Transcath stent place; Unspecified	4180186
36305999	Guided Unsp region Transcath stent place	4180186
36305999	旨在经导管置入支架的引导:发现:时间点:XXX:文档型:{成像方式}	4182948
36306000	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Corn/Cnjt; Corneal; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
36306000	Bacteria Corn/Cnjt Aerobe Cult	4180186
36306000	细菌 已鉴定的:存在与否或特征标识:时间点:角膜/结膜:名义型:需氧微生物培养	4182948
36306002	Exp; Gestation; Gestations; Gravida; H+P; H+P.HX; Mat; Maternal; Matnl; Nominal; P prime; Point in time; Pregnancies; Random; Typ	4180186
36306002	Known exposure preg Mother	4180186
36306002	已知暴露^在妊娠过程中:类型:时间点:^母亲:名义型	4182948
36306003	50M p lact PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Gastro; Gastroenterology; GI; H2; Hyd; LTT; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
36306003	Breath H2 50M p lact PO	4180186
36306003	氢/已呼出的气体^在口服剂量乳糖之后50分钟:体积分数:时间点:呼出的气体:定量型	4182948
36306006	Dowco; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Ruelene; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306006	Crufomate Spec-mCnt	4180186
36306006	育畜磷:质量含量:时间点:XXX:定量型	4182948
36306010	Centers for Medicare and Medicaid Assessment; Othr; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306012	Assoc; Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.GNHLTH; Sx	4180186
36306014	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; without contrast	4180186
36306014	CT Pelvis bones WO contr	4180186
36306014	多层^不采用对比剂:发现:时间点:盆腔>盆骨类:文档型:CT	4182948
36306016	#/area; Cast; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36306016	Hyaline Casts #/area UrnS	4180186
36306016	透明管型:单位面积数量或计数:时间点:尿沉渣:定量型	4182948
36306018	Arm; Cath; CorePlaybook; Document; EXT; Finding; Findings; Guid; Guide; Guided; Imaging; Peripherally Inserted Central Venous Catheter; PIC; PICC; PICC place; Playbook; Point in time; Rad; RADIOLOGY; Random; UE; Up	4180186
36306018	Guided UE PICC place	4180186
36306018	旨在置入外周插入型中心静脉导管的引导:发现:时间点:上肢:文档型:{成像方式}	4182948
36306021	1 week; FCN; Func; Funct; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
36306022	CARD.PROC; Cardiac comp start time; Cardio; Cardiology; Clock time; Heart Disease; Point in time; QNT; Quan; Quant; Quantitative; Random; Started	4180186
36306022	Cardiac comp start time Clock time	4180186
36306022	心脏按压开始时间:时钟时间:时间点:^患者:定量型	4182948
36306023	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium DNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
36306023	M genitalium DNA Vag Ql NAA+probe	4180186
36306023	生殖支原体 DNA:存在情况或阈值:时间点:阴道:序数型:探针法.基因扩增.靶向	4182948
36306024	C&S; Chicken pox; Chicken pox virus; Chickenpox; Cult; Cultures; Eye fluid; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; Microbiology; Occular Fluid; OcFlu; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Shingles; Spec; VZ; VZV; Zoster	4180186
36306024	VZV Ocflu Ql Cult	4180186
36306024	水痘带状疱疹病毒:存在情况或阈值:时间点:眼液:序数型:微生物特异性培养	4182948
36306027	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Filarial; Filariasis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Microfilaria; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36306027	Filaria DNA Tiss Ql NAA+probe	4180186
36306027	丝虫属 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36306028	DOCUMENT.REF; FDA insert; Kidney; Narrative; Report; SPL; Structured Product Labelling	4180186
36306028	FDA insert Renal Impairment subsection	4180186
36306028	肾脏损害子节:-:-:^FDA 包装说明书:叙述型	4182948
36306030	Dialy Educ note	4180186
36306030	Dialy; DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36306030	教育记录:发现:时间点:{环境}:文档型:透析法	4182948
36306031	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36306032	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium DNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
36306032	M genitalium DNA Ur Ql NAA+probe	4180186
36306032	生殖支原体 DNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
36306036	E+M consent	4180186
36306036	Assessment; DOC.ONT; Document; E+M consent; Eval; Finding; Findings; Form; H&P; History and physical; Point in time; Random	4180186
36306036	评价与管理同意书:发现:时间点:{环境}:文档型:患者	4182948
36306040	Aflatoxicosis; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Mycotoxin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306040	Aflatoxin M1 Spec-mCnt	4180186
36306040	黄曲霉毒素 M1:质量含量:时间点:XXX:定量型	4182948
36306042	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36306051	A pleuropn; A pleuropn 2; A pleuropn 2 Ab; A pleuropn Sertyp; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious swine pleuropneumonia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36306051	A pleuropn 2 Ab/Pos cntrl Ser IA	4180186
36306051	胸膜肺炎放线杆菌血清型 2 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36306052	Prehosp TH method	4180186
36306052	Meth; Method of; Nominal; Point in time; Prehosp TH method; Random; Ther; TRAUMA; Typ	4180186
36306052	院前低温治疗方法:类型:时间点:^患者:名义型:*	4182948
36306053	Arteriovenous Fistula; AVF; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Hemodialysis access; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Tx; Unspecified	4180186
36306053	Guided AVF Treatment	4180186
36306053	旨在治疗的引导:发现:时间点:XXX>动静脉瘘:文档型:{成像方式}	4182948
36306054	After; Aminoglycosides; c213; DRUG/TOXICOLOGY; Drugs; EID; Garamycin; Genirr; Genj; Gent; Level; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Rand; Rand EID; Rando; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
36306054	Gentamicin Rand EID SerPl-sCnc	4180186
36306054	庆大霉素^在延长时间间隔剂量给药之后随机时间:物质的量浓度:时间点:血清/血浆:定量型	4182948
36306055	Hearing; ID; Infectious Disease; InfectiousDisease; LM; m227; Micro; Microbiology; Micros; Microscopic; Ordinal; Otologic; Pityrosporum; Point in time; PR; QL; Qual; Qualitative; Random; Rm227; Screen; species; spp	4180186
36306055	Malassezia sp Ear Ql Micro	4180186
36306055	马拉色氏霉菌属单个未知种:存在情况或阈值:时间点:耳:序数型:显微镜检查.光学	4182948
36306058	Centers for Medicare and Medicaid Assessment; Nominal; Past; Person name; Point in time; Random; Survey	4180186
36306059	GQ1b Gangl IgG+IgM Ser IA-aCnc	4180186
36306059	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; GQ1b; GQ1b Gangl; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; Tetrasialylganglioside	4180186
36306059	神经节苷脂 GQ1b 抗体.IgG+IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36306062	1 week; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH; Sx	4180186
36306063	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Simponi; SR; SUDS	4180186
36306063	Golimumab Ab SerPl IA-mCnc	4180186
36306063	戈利木单抗 抗体:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36306066	APTA; Identity or presence; Nominal; Physical Therapy; Point in time; PT; Random	4180186
36306066	所采用的生物物理制剂:存在与否或特征标识:时间点:^患者:名义型	4182948
36306068	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306069	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Seneca Valley Virus; Spec; Strand Displacement Amplification; SVA; SVA RNA; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36306069	SVA RNA Ct Spec Qn NAA+probe	4180186
36306069	塞内卡病毒 A RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36306073	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E. coli attaching-effacing gene; EC eaeA gene; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36306073	EC eaeA gene Islt Ql NAA+probe	4180186
36306073	大肠埃希菌 eaeA 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36306075	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; PM+R; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
36306075	PM+R Prog note	4180186
36306075	病程记录:发现:时间点:{环境}:文档型:物理医学与康复学	4182948
36306078	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306079	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Bronchial alveolar lavage; Bronchoalveolar lavage; DFA; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Ordinal; P carinii; P jiroveci; PCP; Pneumocystis carinii; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF	4180186
36306079	P jiroveci Ag BAL Ql IF	4180186
36306079	耶氏肺孢子菌 抗原:存在情况或阈值:时间点:支气管肺泡灌洗液:序数型:免疫荧光法	4182948
36306080	DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
36306080	FDA insert REMS requirements	4180186
36306080	REMS 要求:-:-:^FDA 包装说明书:叙述型	4182948
36306084	After; B; B2 Microglob; b2-M; B2MG^post dialysis; Chemistry; Dialy; II; Kidney; Level; Mass concentration; Microglob; Nephrology; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36306084	B2 Microglob p dialysis SerPl-mCnc	4180186
36306084	Beta-2-微球蛋白^在透析之后:质量浓度:时间点:血清/血浆:定量型	4182948
36306085	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ENA; ENA PCNA; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36306085	ENA PCNA Ab CSF Ql Line blot	4180186
36306085	PCNA 可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36306086	Acecainide; Acetylprocanam; DRUG/TOXICOLOGY; Drugs; NAPA; PA; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Procainamide & NAPA panel; Procainamide+NAPA; Procan; Pronestyl; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36306086	Procainamide & NAPA panel SerPl	4180186
36306086	普鲁卡因胺与N-乙酰普鲁卡因胺组套:-:时间点:血清/血浆:-	4182948
36306089	GT1b Ganlg IgM Ser Ql Line blot	4180186
36306089	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GT1b Ganlg; Immune globulin M; Immunoglobulin M; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Trisialoganglioside	4180186
36306089	神经节苷脂 GT1b 抗体.IgM:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36306092	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36306097	Brn; Burn; C&S; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Thrush	4180186
36306097	Fungus Burn Cult	4180186
36306097	真菌 已鉴定的:存在与否或特征标识:时间点:烧伤:名义型:培养	4182948
36306100	Activ; Activity; Actvty; Arbitrary rate; Exercise; Movements; QNT; Quan; Quant; Quantitative; Survey; Tot; Total PA.domestic+garden; Totl	4180186
36306102	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36306103	Art; Cardio; Cardiology; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Heart Disease; Imaging; Misc; Miscellaneous; Other; Perc; Playbook; Point in time; PTA; PTA of art anast; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36306103	Guided Artery PTA of art anast	4180186
36306103	旨在动脉吻合术经皮腔内血管成形术的引导:发现:时间点:XXX>动脉:文档型:{成像方式}	4182948
36306107	Cardiac; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Hrt; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
36306107	Guided Hrt Pericardiocentesis	4180186
36306107	旨在心包穿刺术的引导:发现:时间点:胸部>心脏:文档型:{成像方式}	4182948
36306110	Average; Avg; Centers for Medicare and Medicaid Assessment; Fld; Flow; Past; QNT; Quan; Quant; Quantitative; Survey; Volume Rate; vRate	4180186
36306111	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306114	ANTIBIOTIC SUSCEPTIBILITIES; Biaxin; C pylori; Campylobacter pylori; Claripen; H pyl; H pylori; H pylori 23S rRNA clarith res; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Klacid; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; ribosomal RNA; Spec	4180186
36306114	H pylori 23S clarithro res mut Islt/Spm	4180186
36306114	幽门螺杆菌 23S rRNA 克拉霉素耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
36306116	Addiction med Consult note	4180186
36306116	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36306116	会诊记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36306117	Centers for Medicare and Medicaid Assessment; Dextro; Form version; LTPAC; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306119	Gyn Attend Note	4180186
36306119	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gyn Attend; notes; Point in time; Random; Visit note	4180186
36306119	记录:发现:时间点:{环境}:文档型:妇科学.主治	4182948
36306122	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Epidemic Parotitis; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Mumps virus antibody; Mumps virus IgG; Mumps virus IgM; MuV; Neuro; Neurology; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36306122	MuV IgG+IgM CSF IF-Imp	4180186
36306122	流行性腮腺炎病毒 抗体.IgG+IgM:印象:时间点:脑脊液:序数型:免疫荧光法	4182948
36306125	BON; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Head+Temp bone; Head+Temporal bone; Imaging; Intracranial; Point in time; Rad; RADIOLOGY; Random; Skull; W contr IV; WC	4180186
36306125	CT Head+Temporal bone W contr IV	4180186
36306125	多层^采用静脉注射对比剂:发现:时间点:头部 & 头部>颞骨:文档型:CT	4182948
36306126	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36306128	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Gall bladder; GB; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; Radiology; Random	4180186
36306128	Guided GB Cholangioscopy	4180186
36306128	旨在胆道镜检查的引导:发现:时间点:腹部>胆囊:文档型:{成像方式}	4182948
36306132	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; Playbook; Point in time; Rad; Radiofreq abl; RADIOLOGY; Random; Renal	4180186
36306132	Guided Kidney Radiofreq abl	4180186
36306132	旨在射频消融术的引导:发现:时间点:腹部>肾脏:文档型:{成像方式}	4182948
36306133	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ENA; ENA SS-B; HA; Ha AB; La AB; NA; Neuro; Neurology; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Sjogren; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SS; SSB; SS-B	4180186
36306133	ENA SS-B Ab CSF Ql Line blot	4180186
36306133	Sjogrens 综合征-b 可提取性核 抗体:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36306134	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; CMV; Cytomegalo virus; Cytomgal; DBS; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Dried blood spot; Filter paper; FP; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36306134	CMV DNA DBS Ql NAA+probe	4180186
36306134	巨细胞病毒 DNA:存在情况或阈值:时间点:全血.斑点:序数型:探针法.基因扩增.靶向	4182948
36306136	CLIN; CLIN.RISK; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl	4180186
36306136	Total score Wells PE risk	4180186
36306137	OB D/C sum	4180186
36306137	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetric; Obstetrics; Point in time; Prenatal; Random; Visit note	4180186
36306137	出院摘要记录:发现:时间点:{环境}:文档型:产科学	4182948
36306139	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36306140	Finding; Findings; Ordinal; Physical abuse reported; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA	4180186
36306140	Physical abuse reported	4180186
36306140	当时报告了身体虐待:发现:时间点:^患者:序数型	4182948
36306143	Finding; Findings; Last; Ordinal; Past; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; SDOH; T prime	4180186
36306144	DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; TL; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306144	Thallium Spec-mCnt	4180186
36306144	铊:质量含量:时间点:XXX:定量型	4182948
36306145	DDE; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; p,p'-DDE; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306145	DDE Spec-mCnt	4180186
36306145	二氯二苯基二氯乙烯:质量含量:时间点:XXX:定量型	4182948
36306148	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36306150	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Lyrica; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36306150	Pregabalin/Creat Ur Cfm	4180186
36306150	普瑞巴林/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36306152	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306154	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asialo Gm1; Asialo GM1 Ab.IgG+IgM; AsialoGM1; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Ganglioside asialo; GM1 Asialo; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; MEIA; Monoasialoganglioside; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
36306154	GM1 Asialo IgG+IgM Ser IA-aCnc	4180186
36306154	无唾液酸基神经节苷脂 Gm1 抗体.IgG+IgM:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36306156	Compound 497; Dieldrite; DRUG/TOXICOLOGY; Drugs; HEOD; Mass content; Misc; Miscellaneous; Octalox; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306156	Dieldrin Spec-mCnt	4180186
36306156	狄氏剂:质量含量:时间点:XXX:定量型	4182948
36306157	Breathing; Largest; Lung; Lungs; Maximal; Maximum; Peak; Point in time; Press.max; Pressure; Pressure max; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
36306157	Press.max on vent Airway	4180186
36306157	压力.最大值^采用呼吸机:压力或压强:时间点:呼吸系统.气道:定量型	4182948
36306161	DRUG/TOXICOLOGY; Drugs; Flytek; Lannate; Lanox; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306161	Methomyl Spec-mCnt	4180186
36306161	灭多威:质量含量:时间点:XXX:定量型	4182948
36306165	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306166	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MeV; MeVA vac str N gene; Misc; Miscellaneous; Molecular pathology; MOLPATH; Msls; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Rubeola; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36306166	MeVA vac str N gene Ct Spec Qn NAA+probe	4180186
36306166	麻疹病毒基因型 A 疫苗株 N 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36306167	Bx; CN; CNB; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Large needle; NDL; PC Bx CN; Perc; Playbook; Point in time; Rad; RADIOLOGY; Random; Thy	4180186
36306167	Guided Thyroid PC Bx CN	4180186
36306167	旨在经皮活组织检查的引导.粗针:发现:时间点:颈部>甲状腺:文档型:{成像方式}	4182948
36306173	Care plan; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Treatment plan; Visit note	4180186
36306173	Addiction med Plan of care note	4180186
36306173	医疗服务计划记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
36306175	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B hyody; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36306175	B hyody DNA Spec Ql NAA+probe	4180186
36306175	猪痢疾短螺旋体 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36306177	C3; C3-carntitine; C5DC; C5-DC; Chemistry; Dicarboxylic carnitine; Pl; Plasma; Plsm; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio	4180186
36306177	Glutarylcarn/C3 SerPl-sRto	4180186
36306177	戊二酰肉碱 (C5-DC)/丙酰肉碱 (C3):物质的量比率:时间点:血清/血浆:定量型	4182948
36306179	Centers for Medicare and Medicaid Assessment; Form version; LTPAC; Othr; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306180	Advanced; Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36306181	Kidney; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
36306181	Fat UrnS Ql	4180186
36306181	脂肪:存在情况或阈值:时间点:尿沉渣:序数型	4182948
36306182	Cust care fac; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Substance abuse; Visit note	4180186
36306182	Addiction med Cust care fac Note	4180186
36306182	记录:发现:时间点:监护设施:文档型:成瘾医学	4182948
36306183	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36306184	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36306187	abn; abnorm; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Treatment abnl Pap test; Tx; Typ	4180186
36306187	Treatment abnl Pap test	4180186
36306187	针对早期子宫颈癌涂片检查异常的处治:类型:时间点:^患者:名义型	4182948
36306192	Chest tube place; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pl space; Playbook; Point in time; Rad; Radiology; Random; Thorax	4180186
36306192	Guided Pl space Chest tube place	4180186
36306192	旨在置入胸腔插管的引导:发现:时间点:胸部>胸膜腔:文档型:{成像方式}	4182948
36306193	AIDS; Blood; EIA; ELFA; ELISA; Enzyme immunoassay; HIV 1 + 2 Ab Pnl; HIV 1 and 2 Ab; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; PlasBld; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; SUDS; WB; Whole blood	4180186
36306193	HIV 1 + 2 Ab Pnl SerPlBld IA.rapid	4180186
36306193	HIV 1 型 与 2 型抗体组套:-:时间点:血清/血浆/全血:-:免疫测定法.快速	4182948
36306194	Coag; Fac; Fact; Hematology; Heme; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Protime; PT; PT PIVKA sensitive; QNT; Quan; Quant; Quantitative; Random	4180186
36306194	PT PIVKA sensitive PPP	4180186
36306194	组织因子诱导型凝血过程.PIVKA 敏感性:时间:时间点:贫血小板血浆:定量型	4182948
36306198	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CMV; Cytomegalo virus; Cytomgal; Donr; EIA; ELFA; ELISA; Enzyme immunoassay; HHV-5; Human Herpesvirus-5; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36306198	CMV IgG SerPl Donr Ql IA	4180186
36306198	巨细胞病毒 抗体.IgG:存在情况或阈值:时间点:血清/血浆^供体:序数型:免疫测定法	4182948
36306199	DRUG/TOXICOLOGY; Drugs; II; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; T prime; T-2 mycotoxin; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306199	T-2 toxin Spec-mCnt	4180186
36306199	T-2 毒素:质量含量:时间点:XXX:定量型	4182948
36306201	Bio-Cox; DRUG/TOXICOLOGY; Drugs; Mass content; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sacox; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306201	Salinomycin Spec-mCnt	4180186
36306201	盐霉素:质量含量:时间点:XXX:定量型	4182948
36306205	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Myasthenia gravis; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Thymoma	4180186
36306205	Titin Ab Ser Line blot-aCnc	4180186
36306205	肌巨蛋白 抗体:任意型浓度:时间点:血清:定量型:线点印迹法	4182948
36306206	AS; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36306206	Arsenic Spec-mCnc	4180186
36306206	砷:质量浓度:时间点:XXX:定量型	4182948
36306210	Vehicle name EMS unit	4180186
36306210	Emergency Medical Service(s); Ident; Identifier; Nominal; Point in time; Random; TRAUMA	4180186
36306210	交通工具名称:标识符:时间点:急救医疗服务单元:名义型	4182948
36306212	ACET; Acetamidophenol; Acetaminoph; Acetominophen; Addiction; APAP; Blood; c209; C55; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hepatology; Hydroxyacetanilide; Illicit; Liver; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; Ordinal; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tylenol; u209; WB; Whole blood	4180186
36306212	APAP Bld Ql Scn	4180186
36306212	对乙酰氨基酚:存在情况或阈值:时间点:全血:序数型:毒理学筛查试验	4182948
36306213	Cath; CorePlaybook; CVC place; CVC w port place; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
36306213	Guided Chest CVC w port place	4180186
36306213	旨在置入带有输液港的中心静脉导管的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36306214	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36306216	Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36306218	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
36306219	Centers for Medicare and Medicaid Assessment; Othr; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36306220	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36306221	C/sp; Cerv; CorePlaybook; C-spine; Diag puncture; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord	4180186
36306221	Guided C-spine Diag puncture	4180186
36306221	旨在诊断性穿刺的引导:发现:时间点:颈部>脊椎.颈段:文档型:{成像方式}	4182948
36306225	III; Len; Pan; Panel; Panl; Pnl; Point in time; Pos; Random	4180186
36306226	Centers for Medicare and Medicaid Assessment; Count/time; nRate; Number rate; Number Rate = Count/Time; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36306260	P super little k	4180186
36306302	Head>Orbit vessels	4180186
36306363	Alpha-amanitin+gamma-amanitin	4180186
36306390	Upper extremity.bilateral>Upper extremity vessels	4180186
36306545	Abdomen+Pelvis>Ureter	4180186
36306560	Lower extremity.bilateral>Thigh	4180186
36306595	Pelvis>Uterine artery	4180186
36306619	Cancer-associated gene	4180186
36306784	Extremity>Extremity lymphatic vessels	4180186
36306803	Borrelia afzelii+burgdorferi+garinii Ab.IgG & IgM panel	4180186
36306883	Pelvis>Fallopian tube	4180186
36307054	Upper extremity.left>Finger.second	4180186
36307097	Dengue virus 1 & 2 & 3 & 4	4180186
36307126	Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM panel	4180186
36307136	Dengue virus 1+2+3+4 & Zika virus	4180186
36307163	XXX>Spinal cord	4180186
36307232	Head+Neck>Vertebral artery	4180186
36307237	Extremity>Extremity vein	4180186
36307386	Upper extremity.left>Thumb	4180186
36307441	Lower extremity.bilateral>Lower leg	4180186
36307460	Head>Brain stem+Nerves.cranial	4180186
36307492	XXX>Spine epidural space	4180186
36307509	Abdomen>Splenic artery	4180186
36659620	Liver diseases autoimmune Ab pnl; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659620	Liver diseases autoimmune Ab pnl SerPl	4180186
36659620	肝脏疾病自身免疫抗体组套:-:时间点:血清/血浆:-	4182948
36659622	西尼罗河病毒 抗体.中和:存在情况或阈值:时间点:XXX:序数型:中和试验	4182948
36659622	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum virus neutralization; Spec; SVN; To be specified in another part of the message; Unspecified; Virus neutralization test; VNT; WNV	4180186
36659622	WNV NAb Spec Ql Nt	4180186
36659626	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey; Tx	4180186
36659628	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36659630	1 month; 1 month (30 days); 30 days; ADL; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; Low; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36659631	2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; Corona virus; COVID19; COVID-19; DBS; Dried blood spot; EIA; ELFA; ELISA; Enzyme immunoassay; Filter paper; FP; IAA; ID; II; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; PH; Point in time; PR; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; Severe Acute Respiratory Syndrome; SUDS; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus	4180186
36659631	SARS-CoV-2 IgM DBS Ql IA	4180186
36659631	SARS 冠状病毒 2 抗体.IgM:存在情况或阈值:时间点:全血.斑点:序数型:免疫测定法	4182948
36659634	#; ABS; absolute; absolutes; Ag; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-A2 CMV CD8 Cells; Human Leukocyte Antigen; IFN; IFN-g HLA-A2 CMV CD8 Cells; IGRA; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36659634	IFN-g HLA-A2 CMV CD8 Cells # Bld FC	4180186
36659634	细胞.CD8.HLA-A2 CMV 特异性.CMV 抗原刺激性 gamma 干扰素产生型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36659639	LSD pnl WBC	4180186
36659639	Chemistry; Leukocytes; LSD; LSD pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
36659639	溶酶体贮积症组套:-:时间点:白细胞:定量型	4182948
36659640	Hu2 IgG Titr CSF IF	4180186
36659640	神经元细胞核 2 型 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
36659640	ABS; Aby; ACIF; ANA IgG; ANNA 2; ANNA-2; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu2; IFA; II; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type II; Nuc; Oncology; Paraneoplastic syndrome; Point in time; Random; RI; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36659641	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36659644	Blood; CHRNA3 c.645C&gt;T; D398N; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; rs1051730; T prime; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659644	CHRNA3 c.645C>T Geno Bld/T	4180186
36659644	CHRNA3 基因.c.645C>T:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36659645	染色体重排:存在与否或特征标识:时间点:全血/组织:名义型:末端配对序列测定法	4182948
36659645	Blood; Chromosom; Chromosomes; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Identity or presence; Inherited; Molecular pathology; MOLPATH; MPSeq; Next generation sequencing; NGS; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659645	AML chromo analys Bld/Mar MPSeq	4180186
36659646	by KM; Corneal; CYL; EYE; EYE.REFRACTION; Inverse Length; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT	4180186
36659646	R cornea Cylinder by KM	4180186
36659646	柱镜:长度倒数:时间点:角膜.右侧:定量型:角膜曲率测量法	4182948
36659647	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36659648	BM Transplant D/C sum	4180186
36659648	BM Transplant; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Heme; notes; Point in time; Random; Visit note	4180186
36659648	出院摘要记录:发现:时间点:{环境}:文档型:骨髓移植	4182948
36659651	14 days; 2 weeks; Finding; Findings; Mental health; MentalHealth; Ordinal; Past; Patient Health Questionnaire; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.PHQ	4180186
36659652	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey; Tx	4180186
36659654	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36659654	单纯疱疹病毒 1 型 DNA:对数型数量或计数浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36659654	HSV1 DNA Amn NAA+probe-Log#	4180186
36659657	3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Compx; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M tb; M TB Cmplx; M tuberculosis; Microbiology; Mtb; MTB complex sp; MTB complex sp id; Myco; Mycobact; Mycobacterium tuberculosum; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TB; TMA; Transcription mediated amplification; Tuberculosis	4180186
36659657	MTB complex sp Islt NAA+probe	4180186
36659657	结核分枝杆菌复合菌群种 已鉴定的:存在与否或特征标识:时间点:分离株:名义型:探针法.基因扩增.靶向	4182948
36659658	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Equin; Equine rhinovirus; Equine Rhinovirus-1; ERAV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36659658	ERAV RNA Ct Spec Qn NAA+probe	4180186
36659658	马甲型鼻炎病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36659659	3 months; Drugs; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Rx; Screen; Survey	4180186
36659660	Disch; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36659660	预计出院日期:日期:时间点:^患者:定量型	4182948
36659661	Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; malonyl-CoA decarboxylase; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659661	MLYCD Del+Dup + Full Mut Anl Bld/T	4180186
36659661	MLYCD 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659667	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV HKU1; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659667	HCoV HKU1 RNA Low resp Ql NAA+non-probe	4180186
36659667	人类冠状病毒 HKU1 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36659668	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36659669	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; EHV; EHV2; Equin; Herpes virus; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36659669	EHV2 RNA Spec Ql NAA+probe	4180186
36659669	马疱疹病毒 2 型 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36659670	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36659671	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B avium; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36659671	禽博德特菌 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36659671	B avium Ab/Pos cntrl Ser IA	4180186
36659672	M avium paraTB Ab Titr Ser CF	4180186
36659672	鸟型分枝杆菌副结核亚种 抗体:滴定度:时间点:血清:定量型:补体结合试验	4182948
36659672	ABS; Aby; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Johnes disease; M avium; M avium paraTB; Microbiology; Myco; Mycobact; Mycobacterium paratuberculosis; Paratuberculosis; Point in time; Random; Serum; SmQn; SR; ssp; Titer; Titered; Titre; Ttr; Tuberculosis; Vet; Veterinary	4180186
36659676	Blood; DRD2 c.-585A&gt;G; g.113475629T&gt;C; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; rs1799978; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659676	DRD2 c.-585A>G Geno Bld/T	4180186
36659676	DRD2 基因.c.-585A>G:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36659677	DULoxetine SerPl Ql Scn	4180186
36659677	Cymbalta; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Yentreve	4180186
36659677	度洛西汀:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
36659681	15M p meal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659681	C peptide 15M p meal SerPl-mCnc	4180186
36659681	C 肽^在进餐之后15分钟:质量浓度:时间点:血清/血浆:定量型	4182948
36659682	D/C sum; Dis; Disch; Discharge summary; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Lung; notes; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Respirology; Visit note	4180186
36659682	Pulmonary disease D/C sum	4180186
36659682	出院摘要记录:发现:时间点:{环境}:文档型:肺病	4182948
36659687	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B mayonii; B mayonii oppA2; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tick-Borne Disease; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36659687	B mayonii oppA2 Bld Ql NAA+non-probe	4180186
36659687	梅奥疏螺旋体 oppA2 基因:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36659688	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S agalactiae; Screen; SDA; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; TMA; Transcription mediated amplification	4180186
36659688	Gp B Strep DNA Lower resp Ql NAA+probe	4180186
36659688	无乳链球菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36659692	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659692	MTMR2 gene Full Mut Anl Bld/T Seq	4180186
36659692	MTMR2 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659693	Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; GLXR; GLYD; glyoxylate reductase/hydroxypyruvate reductase; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; PH2; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659693	GRHPR Del+Dup + Full Mut Anl Bld/T	4180186
36659693	GRHPR 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659694	1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Isohepta-CP; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
36659694	异七羧基卟啉:质量速率:24小时:大便:定量型	4182948
36659694	Isohepta-CP 24h Stl-mRate	4180186
36659696	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Housing; Last; Living Arrangements; Nominal; Residence; Survey	4180186
36659699	FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS; Up	4180186
36659701	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36659707	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659707	HLA-A IgG SerPl FC	4180186
36659707	HLA-A 抗体.IgG:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36659708	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
36659713	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Horizant; Illicit; Level; Mass concentration; Neurontin; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
36659713	Gabapentin Sal Cfm-mCnc	4180186
36659713	加巴喷丁:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36659717	HAV; HAV IgM Pnl; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR	4180186
36659717	HAV IgM Pnl Ser	4180186
36659717	甲型肝炎病毒抗体.IgM组套:-:时间点:血清:-	4182948
36659720	Blood; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Nominal; PCR; Point in time; Random; rs699947; T prime; Tissue; Tissue, unspecified; Vascular endothelial growth factor; VEGF-2578; VEGFA c.-2578A&gt;C + A&gt;T; VEGFA transcript variant; WB; Whole blood; Whole blood or Tissue	4180186
36659720	VEGFA c.-2578A>C + A>T Geno Bld/T	4180186
36659720	VEGFA 基因.c.-2578A>C & c.-2578A>T:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36659721	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36659725	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Desmogelin; Desmoglein 1 IgG; DSG; DSG1; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
36659725	Desmoglein 1 IgG Ser IA-aCnc	4180186
36659725	桥粒芯蛋白 1 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36659728	AR.auto; Eye; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Sph equiv; Vision; Visual	4180186
36659728	R eye Sph equiv AR.auto	4180186
36659728	等效球镜值:长度倒数:时间点:眼睛.右侧:定量型:自动验光仪.自动	4182948
36659730	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36659734	Solid Org Transplant Consult note	4180186
36659734	会诊记录:发现:时间点:{环境}:文档型:实体器官移植	4182948
36659734	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Solid Org Transplant; Visit note	4180186
36659737	Catechols Sup Stand Pnl Plas	4180186
36659737	Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; Catechols Sup Stand Pnl; CHEMISTRY.CHALLENGE TESTING; Epinephrine+norepinephrine+dopamine; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36659737	儿茶酚胺类仰卧位与直立位组套:-:时间点:血浆:定量型	4182948
36659738	Blood; Finding; Findings; Gene fusion details; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Narrative; PCR; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659738	基因融合转录本详情:发现:时间点:全血/组织:叙述型:分子遗传学类实验室方法	4182948
36659738	Gene fusion details Bld/T	4180186
36659739	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M synoviae; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
36659739	M synoviae DNA # Spec NAA+probe	4180186
36659739	鸡滑膜支原体 DNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36659740	Bact; Bronchial alveolar lavage; Bronchoalveolar lavage; ID; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36659740	细菌:存在情况或阈值:时间点:支气管肺泡灌洗液:序数型:显微镜检查.光学	4182948
36659740	Bacteria BAL Ql Micro	4180186
36659741	Amplification; Arc-1; Blood; Cadherin 1; cadherin 1, type 1, E-cadherin (epithelial); Calcium dependent adhesion protein epithelial; CD324; CDHE; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; ECAD; E-cadherin gene; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; LCAM; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; UVO; Uvomorulin; WB; Whole blood; Whole blood or Tissue	4180186
36659741	CDH1 gene Del+Dup + Full Mut Anl Bld/T	4180186
36659741	CDH1 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659742	Blood; carnitine palmitoyltransferase 2; carnitine palmitoyltransferase 2 gene; carnitine palmitoyltransferase II gene; CPT1; CPTASE; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; IIAE4; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659742	CPT2 gene Full Mut Anl Bld/T Seq	4180186
36659742	CPT2 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659747	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; IAA; Insulin-Dependent Diabetes Mellitus; Level; MEIA; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; SUDS	4180186
36659747	GAD65 Ab CSF IA-sCnc	4180186
36659747	谷氨酸脱羧酶-65 抗体:物质的量浓度:时间点:脑脊液:定量型:免疫测定法	4182948
36659748	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Heme; notes; Point in time; Random; Visit note	4180186
36659748	Thromboemb D/C sum	4180186
36659748	出院摘要记录:发现:时间点:{环境}:文档型:血栓栓塞	4182948
36659750	100WBC; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Myel; Myelo; Myelocyte; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36659750	中幼粒细胞/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36659750	Myelocytes/leuk NFr Stem prod Manual	4180186
36659751	24(R),25-dihydroxycholecalciferol; 24,25(OH)2 VitD; 24,25-dihydroxy cholecalciferol; 24,25-dihydroxy vitamin D; 24,25-Dihydroxyvitamin D; 24,25-Dihydroxyvitamin D2 +24,25-Dihydroxyvitamin D3; 24r-Hydroxy calcidiol; 24R-OH-Calcidiol; Chemistry; Esoteric; Hydroxy calcidiol; Level; Mass concentration; OH-Calcidiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659751	24r-羟基钙二醇+24r,25-羟基钙化醇:质量浓度:时间点:血清/血浆:定量型	4182948
36659751	24,25(OH)2 VitD SerPl-mCnc	4180186
36659754	FCN; Func; Funct; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS; Up	4180186
36659756	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Breakbone fever; Dengue fever; Dengue type I; Dengue type I+II+III+IV; Denv; DENV 1+2+3+4; DENV 1+2+3+4 RNA; DENV1; DENV1+2+3+4; DNA NUCLEIC ACID PROBE; DNA probe; Flavivirus; i; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659756	DENV1+2+3+4 RNA Amn Ql NAA+probe	4180186
36659756	登革热病毒 1+2+3+4 型 RNA:存在情况或阈值:时间点:羊水:序数型:探针法.基因扩增.靶向	4182948
36659757	DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659757	Norfluvoxamine SerPl Ql Scn	4180186
36659757	诺氟伏沙明:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
36659758	CCM; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36659758	CCM Telehealth Note	4180186
36659758	记录:发现:时间点:远程医疗:文档型:危重病监护医学	4182948
36659761	#; ABS; absolute; absolutes; Ag; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; CMV CD8 Cells; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; IFN; IFN-g CMV CD8 Cells; IGRA; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36659761	IFN-g CMV CD8 Cells # Bld FC	4180186
36659761	细胞.CD8.CMV 特异性.CMV 抗原刺激性 gamma 干扰素产生型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36659762	Finding; Findings; Mental health; MentalHealth; Ordinal; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Screen; Survey	4180186
36659763	#; ABS; absolute; absolutes; Ag; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-A1 CMV CD8 Cells; Human Leukocyte Antigen; IFN; IFN-g HLA-A1 CMV CD8 Cells; IGRA; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36659763	IFN-g HLA-A1 CMV CD8 Cells # Bld FC	4180186
36659763	细胞.CD8.HLA-A1 CMV 特异性.CMV 抗原刺激性 gamma 干扰素产生型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36659765	鸡毒支原体 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36659765	M gallisep Ab Titr Ser IA	4180186
36659765	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian mycoplasmosis; Chronic respiratory disease; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; M gallisep; M gallisepticum; MEIA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36659767	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pert; B pertussis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pertussis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Whooping cough	4180186
36659767	B pert DNA Lower resp Ql NAA+probe	4180186
36659767	百日咳博德特菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36659768	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
36659770	Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; PK1; PKL; PKR; PKRL; Point in time; Pyruvate kinase 1 gene; Pyruvate kinase isozymes R/L gene; pyruvate kinase, liver and RBC; Pyruvate kinase, liver and RBC gene; Random; Red cell/liver pyruvate kinase gene; RPK; R-type/L-type pyruvate kinase gene; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659770	PKLR gene Del+Dup + Full Mut Anl Bld/T	4180186
36659770	PKLR 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659771	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; c707; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; Glu; Glutamic acid; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; mGluR1; mGluR1 Ab; mGluR1 IgG; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36659771	mGluR1 IgG CSF Ql IF	4180186
36659771	代谢型谷氨酸受体 1 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36659775	Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; Niemann-Pick disease, type C1; NPC; NPC intracellular cholesterol transporter 1; NPC1+NPC2; PCR; POGZ; Point in time; Random; sequencing of entire coding region; SLC65A1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659775	NPC1+NPC2 Del+Dup + Full Mut Anl Bld/T	4180186
36659775	NPC1 基因+NPC2 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659776	Blood; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Nominal; PCR; Point in time; Random; rs2010963; Tissue; Tissue, unspecified; Vascular endothelial growth factor; VEGF-634; VEGFA c.-634C&gt;G; VEGFA transcript variant; WB; Whole blood; Whole blood or Tissue	4180186
36659776	VEGFA c.-634C>G Geno Bld/T	4180186
36659776	VEGFA 基因.c.-634C>G:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36659777	ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Mycobacterial stain + cx Pnl; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified	4180186
36659777	Mycobacterial stain + cx Pnl Spec	4180186
36659777	分枝杆菌染色与培养组套:-:时间点:XXX:-	4182948
36659780	FCN; Func; Funct; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score; Up	4180186
36659784	#; ABS; absolute; absolutes; Ag; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-B35 CMV CD8 Cells; Human Leukocyte Antigen; IFN; IFN-g HLA-B35 CMV CD8 Cells; IGRA; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36659784	IFN-g HLA-B35 CMV CD8 Cells # Bld FC	4180186
36659784	细胞.CD8.HLA-B35 CMV 特异性.CMV 抗原刺激性 gamma 干扰素产生型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36659785	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36659786	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Delta hepatitis; Dextro; HDV; HDVAB; Hep; Hep D; Hep Delta; Hepatis; Hepatit; Hepatitis delta virus; Hepatology; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Liver; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659786	HDV Ab SerPl-Imp	4180186
36659786	丁型肝炎病毒 抗体:印象:时间点:血清/血浆:名义型	4182948
36659789	aIle; alloIle; Allo-isoleucine; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Genetics; Heredity; Heritable; Inherited; Level; MSUD; MSUD (Maple Syrup Urine Disease); Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
36659789	Alloisoleucine DBS-sCnc	4180186
36659789	别异亮氨酸:物质的量浓度:时间点:全血.斑点:定量型	4182948
36659793	A,B; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class I; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659793	HLA-A+B+C (class I) IgG SerPl FC	4180186
36659793	HLA-A 与 B 与 C (I 类) 抗体.IgG:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36659794	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36659795	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; N caninum; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36659795	N caninum DNA Ct Spec Qn NAA+probe	4180186
36659795	犬新孢子虫 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36659797	ADMIN; Ident; Identifier; Nominal; Point in time; Random	4180186
36659797	Personnel	4180186
36659797	组织机构:标识符:时间点:工作人员:名义型	4182948
36659799	Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
36659804	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Contagious agalactia; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M bovis; Microbiology; Misc; Miscellaneous; Mp bovis; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36659804	Mp bovis DNA Ct Spec Qn NAA+probe	4180186
36659804	牛型支原体 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36659809	Blood; BWCR; BWS; cyclin dependent kinase inhibitor 1C; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; KIP2; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; p57; p57Kip2; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; WBS; Whole blood; Whole blood or Tissue	4180186
36659809	CDKN1C Full Mut Anl Bld/T Seq	4180186
36659809	CDKN1C 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659810	ABS; Aby; ANA; ANA IgG; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; NA; Nuc; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36659810	Nuclear IgG SerPl IA-aCnc	4180186
36659810	细胞核 抗体.IgG:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36659811	金黄色葡萄球菌与金黄色葡萄球菌.甲氧西林耐药性 已鉴定的:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
36659811	SA + MRSA Islt/Spm	4180186
36659811	Celbenin; Dimethoxypenicillin; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Isolated; Metacillin; Metin; Microbiology; Molecular genetics; MRSA; Nominal; o71; PCR; Point in time; Random; S aureus; SA + MRSA; SA + MRSA identified; Spec; Staficyn; Staph; Staphicillin	4180186
36659812	1V; Abd; Abdo; Abdomen+; Abdominal; Chest + Abd; Chest+Abd; CXR; Document; Erect; Film; Films; Finding; Findings; Imaging; Lat; Plain Films; Point in time; Rad; RADIOLOGY; Random; Single View; Sup+Upr; Thorax; Upr; Uprt; View; View + Sup+Up; View + Sup+Up+Lat-Decub; View + Views; Views AP (KUB & upright); VW; VWS; Xray; X-ray	4180186
36659812	XR Chest 1V + Abd Sup+Upr+Lat-Decub	4180186
36659812	视图 && 多重视图 仰卧位 + 直立位 + 侧卧位:发现:时间点:头部 && 腹部:文档型:X射线摄影术	4182948
36659813	30M p meal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659813	C peptide 30M p meal SerPl-mCnc	4180186
36659813	C 肽^在进餐之后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
36659815	Chemistry; Dicarboxyl porphyrin; Dicarboxylporphyrin; Erythrocytes; FEP; FR; Free erythrocyte protoporphyrin; Hematology; Heme; Level; Mass concentration; Non-protein bound; Point in time; Protoporph; Protoporphrn; Protoporphyrins; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
36659815	原卟啉.游离型:质量浓度:时间点:红细胞:定量型	4182948
36659815	FEP RBC-mCnc	4180186
36659816	Chemistry; CR; Crea; Creat; Genetics; Heredity; Heritable; HS; Inherited; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SO4; SO4-2; Sulf; UA; UCr; UR; Urn	4180186
36659816	Heparan sulfate/Creat Ur-Rto	4180186
36659816	硫酸类肝素/肌酐:比率:时间点:尿液:定量型	4182948
36659817	Cardio; Cardiology; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Visit note	4180186
36659817	Electrophysiology D/C sum	4180186
36659817	出院摘要记录:发现:时间点:{环境}:文档型:临床心脏电生理学	4182948
36659820	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glucagon p Cfst + meal Pnl; HGF; Hyperglycemic factor; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stim	4180186
36659820	Glucagon p Cfst + meal Pnl SerPl	4180186
36659820	禁食后和进餐刺激胰高血糖素组套:-:时间点:血清/血浆:-	4182948
36659822	Arsenocholine Ur-mCnc	4180186
36659822	Arsenic; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36659822	砷胆碱:质量浓度:时间点:尿液:定量型	4182948
36659823	Arsenic; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36659823	Arsenobetaine Ur-mCnc	4180186
36659823	砷甜菜碱:质量浓度:时间点:尿液:定量型	4182948
36659824	Bact; Bacteria.carbpm resist; C&S; Carbapenemase; carbapenem-resistant Enterobacteriaceae; carbapenem-resistant Klebsiella pneumoniae; CRE; CRKP; Cult; Cultures; Enterobacteriaceae; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36659824	Bacteria.carbpm resist Spec Cult	4180186
36659824	细菌.碳青酶烯类耐药性 已鉴定的:存在与否或特征标识:时间点:XXX:名义型:微生物特异性培养	4182948
36659826	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659826	HLA-DPB1 IgG SerPl FC	4180186
36659826	HLA-DPB1 抗体.IgG:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36659832	by KM; DIA; Diam; EYE; EYE.REFRACTION; Length; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R pupil; Random; RT	4180186
36659832	R pupil Diam by KM	4180186
36659832	直径:长度:时间点:瞳孔.右侧:定量型:角膜曲率测量法	4182948
36659833	Addiction; Celexa; Cipralex; Cipramil; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Lexamil; Lexapro; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Seroplex; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659833	Citalopram+Escitalopram SerPl Ql Scn	4180186
36659833	西酞普兰+右旋西酞普兰:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
36659836	Chemistry; Fetal; Kidney; Nephrology; Osmo; Osmol; Osmolality; osmolarity; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; Urn	4180186
36659836	渗透压:渗透压:时间点:尿液^胎儿:定量型	4182948
36659836	Osmolality Ur Fetus	4180186
36659837	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV 1+2 DNA Pnl; HSV1; HSV1+2; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659837	单纯疱疹病毒 1 与 2 型组套:-:时间点:羊水:-:探针法.基因扩增.靶向	4182948
36659837	HSV 1+2 DNA Pnl Amn NAA+probe	4180186
36659838	Lung; Nominal; Point in time; PULMONARY; Pulmonology; Random; Respiratory; Typ	4180186
36659838	是否有必要插管:类型:时间点:^患者:名义型	4182948
36659839	Document; EXT; Extr-Ul; Films; Finding; Findings; GE 2V; II; Imaging; LE; Leg; Low; Lower extremity joint; Minimum 2 views; Pelvic; Pelvis and Hip-Ul; Pelvis+LE; Plain Films; Point in time; Rad; RADIOLOGY; Random; View; VWS; Xray; X-ray	4180186
36659839	多重视图 GE 双重:发现:时间点:骨盆 & 下肢.单侧>髋关节:文档型:X射线摄影术	4182948
36659839	XR Pelvis and Hip-Ul GE 2V	4180186
36659840	2; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class II; HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659840	HLA-DP+DQ+DR (class II) IgG SerPl FC	4180186
36659840	HLA-DP 与 DQ 与 DR (II 类) 抗体.IgG:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36659842	细胞.CD21lowCD38-:计数型浓度:时间点:全血:定量型	4182948
36659842	#; ABS; absolute; absolutes; Blood; CD21low38- Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36659842	CD21low38- Cells # Bld	4180186
36659844	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36659847	Assisted suicide; Death with dignity; DOC.ONT; Document; End of life option; Finding; Findings; Form; MAiD; MAiD Patient; Medical assistance in dying; Medical assisted death; Physician-assisted death; Point in time; Random	4180186
36659847	MAiD Patient Consent	4180186
36659847	同意:发现:时间点:{环境}:文档型:临终医疗援助.患者	4182948
36659848	100WBC; Discocytes; Erthrocyte; Erythroblasts; Erythrocyte; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Normoblasts; nRBC; nRBCs; Nuc; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36659848	nRBC/100 WBC NFr Stem prod Manual	4180186
36659848	红细胞.有核/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36659849	CLIN; D/T symptom resolution; Date and time; Date+time; Point in time; QNT; Quan; Quant; Quantitative; Random; Sx; Time stamp; Timestamp	4180186
36659849	D/T symptom resolution	4180186
36659849	症状缓解日期和时间:时间戳:时间点:^患者:定量型	4182948
36659851	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36659853	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Viibryd	4180186
36659853	Vilaz SerPl Cfm-mCnc	4180186
36659853	维拉佐酮:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
36659855	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S marcescens; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659855	S marcescens DNA Lower resp Ql NAA+probe	4180186
36659855	粘质沙雷氏菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36659856	Centers for Medicare and Medicaid Assessment; Finding; Findings; Housing; Living Arrangements; Narrative; Point in time; Random; Report; Residence; Survey	4180186
36659858	Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Pulmonary; Random; Respirology; Telemedicine; Visit note	4180186
36659858	Pulmonary disease Telehealth Note	4180186
36659858	记录:发现:时间点:远程医疗:文档型:肺病	4182948
36659859	BM; BON; Bone marrow; Chr 9+11+15 aneu; Chromosom; Chromosomes; Document; Finding; Findings; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; Point in time; Random	4180186
36659859	Chr 9+11+15 aneu Mar FISH	4180186
36659859	染色体 9 与 11 与 15 非整倍体性:发现:时间点:骨髓:文档型:FISH	4182948
36659860	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36659860	巨细胞病毒 DNA:对数型数量或计数浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36659860	CMV DNA Amn NAA+probe-Log#	4180186
36659861	1 hour; 1.0Hr; 1h p meal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659861	C peptide 1h p meal SerPl-mCnc	4180186
36659861	C 肽^在进餐之后1小时:质量浓度:时间点:血清/血浆:定量型	4182948
36659863	瞳距.单眼近用:长度:时间点:眼镜.镜片.左侧:定量型:透镜屈光度计法	4182948
36659863	by LM; EYE; EYE.LENSOMETRY; Focimeter; L; L glasses; Length; Lensometer; LM; LT; Ophthalmology; Ophtho; Ophthy; PD; PD monoc; PD monoc near; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36659863	L glasses PD monoc near by LM	4180186
36659864	Agg; Aggr; COAGULATION; Hematology; Heme; mcg; PA; PA Rist; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; RlACnc; Thrombocyte; Thrombocytes	4180186
36659864	PA Rist 375 ug/mL PRP	4180186
36659864	血小板聚集.瑞斯托菌素诱导型^375 微克/毫升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
36659869	Blood; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; PCR; Point in time; Psychotropic medications panel; Psychotropic pharmacogenomics; Psychotropic Pharmg Analy; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659869	Psychotropic Pharmg Analy Bld/T	4180186
36659869	精神药物药物基因组学分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659870	3 Self-Sustaining Sequence Replication; 3SR SR; A baumannii; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659870	A baumannii DNA Lower resp Ql NAA+probe	4180186
36659870	鲍曼不动杆菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36659871	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36659872	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; C diff; C diff Tox; C diff tox+BI-NAP1-027 DNA Pnl; C difficile; Clostridium difficile; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659872	C diff tox+BI-NAP1-027 Pnl Stl NAA+prb	4180186
36659872	艰难梭菌毒素 & BI-NAP1-027 菌株 DNA 组套:-:时间点:大便:-:探针法.基因扩增.靶向	4182948
36659873	Amphiphysin IgG Titr Ser IF	4180186
36659873	双载蛋白 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36659873	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; breast cancer; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Oncology; Paraneoplastic syndrome; Point in time; Random; Serology; Serum; SmQn; SR; Stiff Man Syndrome; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36659874	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36659875	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Resp therapy; Telemedicine; Visit note	4180186
36659875	记录:发现:时间点:远程医疗:文档型:呼吸疗法	4182948
36659875	Resp therapy Telehealth Note	4180186
36659878	3 months; 4+ drinks 1D past 3Mo; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36659879	Bact; Bact 16S; Bact 16S rRNA; Bact 16S rRNA gene; high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; rDNA; ribosomal RNA; Vet; Veterinary	4180186
36659879	Bact 16S rRNA gene Islt-Seq	4180186
36659879	细菌 16S rRNA 基因:序列:时间点:分离株:名义型:序列测定	4182948
36659880	by KM; Corneal; CYL; EYE; EYE.REFRACTION; Inverse Length; L; L cornea; LT; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36659880	L cornea Cylinder by KM	4180186
36659880	柱镜:长度倒数:时间点:角膜.左侧:定量型:角膜曲率测量法	4182948
36659881	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659881	HLA-B 抗体.IgG:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36659881	HLA-B IgG SerPl FC	4180186
36659888	Antigen; Antigens; Bronchial alveolar lavage; Bronchoalveolar lavage; EIA; ELFA; ELISA; Enzyme immunoassay; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; IAA; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS	4180186
36659888	H capsul Ag BAL IA-mCnc	4180186
36659888	荚膜组织胞浆菌 抗原:质量浓度:时间点:支气管肺泡灌洗液:定量型:免疫测定法	4182948
36659891	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; breast cancer; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Oncology; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stiff Man Syndrome	4180186
36659891	Amphiphysin IgG Ser Ql Line blot	4180186
36659891	双载蛋白 抗体.IgG:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
36659893	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E coli K99; E. coli K99 pilus gene; EC K99 DNA; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36659893	E coli K99 DNA Ct Spec Qn NAA+probe	4180186
36659893	大肠埃希菌 K99 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36659895	Assisted suicide; Death with dignity; DOC.ONT; Document; Encounter; End of life option; Evaluation and management; Evaluation and management note; Finding; Findings; MAiD; Medical assistance in dying; Medical assisted death; notes; Physician-assisted death; Point in time; Random; Visit note	4180186
36659895	MAiD Procedure note	4180186
36659895	操作记录:发现:时间点:{环境}:文档型:临终医疗援助	4182948
36659896	HCV; HCV Ab Pnl; HCVAB; Hep; Hep C; Hepatis; Hepatit; Hepatology; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659896	HCV Ab Pnl SerPl	4180186
36659896	丙型肝炎病毒抗体组套:-:时间点:血清/血浆:-	4182948
36659901	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36659902	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36659905	MMA Ur-mCnc	4180186
36659905	Arsenic; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MMA; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36659905	一甲基砷酸盐:质量浓度:时间点:尿液:定量型	4182948
36659907	Catalytic Content; Cfm; Chemistry; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Galactocerebrosidase; GALC; GCMS; Genetics; Heredity; Heritable; Inherited; Krabbe Leukodystrophy; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
36659907	半乳糖苷神经酰胺酶:催化含量:时间点:白细胞:定量型:毒理学确认试验	4182948
36659907	GALC WBC Cfm-cCnt	4180186
36659909	Blood; DHP; DHPDHase; dihydropyrimidine dehydrogenase; Dihydropyrimidine dehydrogenase gene; Dihydrothymine dehydrogenase gene; Dihydrouracil dehydrogenase gene; Document; DPD; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659909	DPYD gene Full Mut Anl Bld/T Seq	4180186
36659909	DPYD 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659910	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Solid Org Transplant; Visit note	4180186
36659910	Solid Org Transplant D/C sum	4180186
36659910	出院摘要记录:发现:时间点:{环境}:文档型:实体器官移植	4182948
36659913	Anesthesiology D/C sum	4180186
36659913	Anesthesia; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36659913	出院摘要记录:发现:时间点:{环境}:文档型:麻醉学	4182948
36659914	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; E bieneusi; E bieneusi 18S rRNA; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36659914	E bieneusi 18S rRNA Spec Ql NAA+non-prb	4180186
36659914	比氏肠胞微孢子虫 18S rRNA 基因:存在情况或阈值:时间点:XXX:序数型:非探针法.基因扩增.靶向	4182948
36659915	Abd; Abdo; Abdomen+; Abdominal; BDs; BDs+GB; Bile tract; Biliary tract; Document; Films; Finding; Findings; Gall bladder; GB; Hepar; Hepatic; Hepatobiliary; Imaging; Liver+BDs+GB; Point in time; Rad; RADIOLOGY; Random; RN; RNC; Scan; V for pat W radio IV; View; VWS; W RNC IV	4180186
36659915	NM Liver+BDs+GB Views for pat W RNC IV	4180186
36659915	针对通畅性的多重视图^采用静脉注射放射性核素:发现:时间点:腹部>肝+胆管类+胆囊:文档型:NM	4182948
36659921	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M haemolytica; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36659921	溶血性曼氏杆菌 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36659921	M haemolytica DNA Ct Spec Qn NAA+probe	4180186
36659923	Appearance; Colour; H+P; H+P.PX; Har; Nominal; P prime; Point in time; Random; Typ	4180186
36659923	Hair Color	4180186
36659923	天然色:类型:时间点:毛发:名义型	4182948
36659925	100WBC; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Neut; Neutr; Neutrophil; Neuts Seg; N-Seg; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Seg; Segs; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36659925	Neuts Seg/leuk NFr Stem prod Manual	4180186
36659925	嗜中性粒细胞.分叶型/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36659928	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659928	HLA-DPA1 IgG SerPl FC	4180186
36659928	HLA-DPA1 抗体.IgG:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36659929	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; EBV DNA Pnl; Epstn; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36659929	EBV DNA Pnl Amn NAA+probe	4180186
36659929	Epstein Barr 病毒 DNA 组套:-:时间点:羊水:-:探针法.基因扩增.靶向	4182948
36659930	A1A; A1AT; AAT; Alpha-1-antitrypsin deficiency; alpha1AT; Anti-elastase gene; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; PI; PI1; Point in time; PRO2275; Protease inhibitor 1; Random; sequencing of entire coding region; Serine (or cysteine) proteinase inhibitor; serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659930	SERPINA1 gene Full Mut Anl Bld/T Seq	4180186
36659930	SERPINA1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659933	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
36659936	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36659938	Blood; CELL MARKERS; CMV; CMV T-cell panel; Cytomegalo virus; Cytomgal; Dynamic; FC; HHV-5; Human Herpesvirus-5; Immunodeficiency Pnl; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; T cell; T prime; UCHL-1; WB; Whole blood	4180186
36659938	CMV T-cell panel Bld FC	4180186
36659938	巨细胞病毒 T-细胞免疫缺陷组套:-:时间点:全血:定量型:流式细胞测量术	4182948
36659940	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bind; Ca; Cal; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lamblia intestinalis; LEMS; Level; MEIA; Neuro; Neurology; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Substance concentration; SUDS; VDCC; VG; V-G; VGCC; VGCC-P/Q Bind; Voltage-dependent calcium channels	4180186
36659940	VGCC-P/Q Bind Ab Ser IA-sCnc	4180186
36659940	PQ 型电压门控钙离子通道结合 抗体:物质的量浓度:时间点:血清:定量型:免疫测定法	4182948
36659941	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV 1+2 DNA Pnl; HSV1; HSV1+2; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36659941	单纯疱疹病毒 1 与 2 型组套:-:时间点:XXX:-:非探针法.基因扩增.靶向	4182948
36659941	HSV 1+2 DNA Pnl Spec NAA+non-probe	4180186
36659942	#; ABS; absolute; absolutes; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-A2 CMV CD8 Cells; Human Leukocyte Antigen; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36659942	HLA-A2 CMV CD8 Cells # Bld FC	4180186
36659942	细胞.CD8.HLA-A2 CMV 特异性:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36659943	ABS; Aby; AGNA; AGNA-1; ANA IgG; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Glial nuc type 1; i; Immune globulin G; Immunoglobulin G; Lambert-Eaton myasthenic syndrome; Neuro; Neurology; Nuc; Ordinal; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Sox1; Sox1 nuclear antigen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36659943	Glial nuc type 1 IgG CSF Ql Line blot	4180186
36659943	神经胶质细胞核 1 型 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36659947	100WBC; Cell; Cellularity; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Mononuc; Mononuc Cells; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36659947	Mononuc Cells/leuk NFr Stem prod Manual	4180186
36659947	单个核细胞/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36659948	2E-decenedioate; 2E-decenedioic acid; Chemistry; CR; Crea; Creat; Decenedioic acid; Esoteric; II; Medium chain acyl-CoA dehydrogenase deficiency; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
36659948	2-Decenedioate/Creat Ur-sRto	4180186
36659948	2-癸烯二酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
36659951	Amplification; AUTSX3; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; MeCP-2 protein gene; methyl CpG binding protein 2; Methyl CpG binding protein 2 gene; Molecular genetics; Molecular pathology; MOLPATH; MRX16; MRX79; MRXS13; MRXSL; Mut; Mutations; PCR; Point in time; PPMX; Random; Rett syndrome; RS; RTS; RTT; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659951	MECP2 gene Del+Dup + Full Mut Anl Bld/T	4180186
36659951	MECP2 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36659952	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
36659954	3h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659954	葡萄糖^在进餐之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
36659954	Glucose 3h p meal SerPl-mCnc	4180186
36659958	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36659963	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Levels; Levl; LV; LVL; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36659964	Hgb HPLC + electrophoresis Pnl Bld	4180186
36659964	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb HPLC + electrophoresis Pnl; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
36659964	血红蛋白 HPLC 与电泳组套:-:时间点:全血:-	4182948
36659967	Cardio; Cardiology; cards; Consult note; Critical care unit; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; ICU; notes; Point in time; Random; Visit note	4180186
36659967	Cardiology ICU Consult note	4180186
36659967	会诊记录:发现:时间点:重症监护病房:文档型:心血管疾病	4182948
36659969	Glial nuc type 1 IgG Titr Ser IF	4180186
36659969	神经胶质细胞核 1 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36659969	ABS; Aby; ACIF; AGNA; AGNA-1; ANA IgG; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Glial nuc type 1; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Lambert-Eaton myasthenic syndrome; Neuro; Neurology; Nuc; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; Random; Serology; Serum; SmQn; Sox1; Sox1 nuclear antigen; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36659970	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; AVREOV; Bird; EIA; ELFA; ELISA; Enzyme immunoassay; Fowl; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Reo virus; REOV; Serum; SR; SUDS; Vet; Veterinary	4180186
36659970	AVREOV Ab/Pos cntrl Ser IA	4180186
36659970	禽呼肠孤病毒 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36659971	Dementia autoimmune Ab pnl; Neuro; Neurology; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36659971	Dementia autoimmune Ab pnl SerPl	4180186
36659971	痴呆自身免疫抗体组套:-:时间点:血清/血浆:-	4182948
36659973	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gyn Onc; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Telemedicine; Visit note	4180186
36659973	Gyn Onc Telehealth Note	4180186
36659973	记录:发现:时间点:远程医疗:文档型:妇科肿瘤学	4182948
36659974	MAiD Plan of care note	4180186
36659974	医疗服务计划记录:发现:时间点:{环境}:文档型:临终医疗援助	4182948
36659974	Assisted suicide; Care plan; Death with dignity; DOC.ONT; Document; Encounter; End of life option; Evaluation and management; Evaluation and management note; Finding; Findings; MAiD; Medical assistance in dying; Medical assisted death; notes; Physician-assisted death; Point in time; Random; Treatment plan; Visit note	4180186
36659975	Centers for Medicare and Medicaid Assessment; Housing; Living Arrangements; Pan; PANEL.SURVEY.CMS; Panl; Pnl; Residence; Survey	4180186
36659976	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; Pos; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36659977	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
36659980	Blood; CDHF12; CDHR16; C-RET; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HSCR1; HTS; Inherited; MEN2A; MEN2B; Molecular pathology; MOLPATH; MTC1; Multiple endocrine neoplasia type IIa; Multiple endocrine neoplasia type IIb; Mut; Mutations; Next generation sequencing; NGS; Point in time; PTC; Random; ret proto-oncogene; RET51; RET-ELE1; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659980	RET gene Full Mut Anl Bld/T Seq	4180186
36659980	RET 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659982	Antigen; Antigens; Bluetongue; BTV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Microbiology; NEG; Orbivirus; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Reovirus; Serum; SR; SUDS; Vet; Veterinary	4180186
36659982	BTV Ag Ser IA	4180186
36659982	蓝舌病毒 抗原/阴性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36659984	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36659984	记录:发现:时间点:远程医疗:文档型:创伤专业	4182948
36659985	Dental; Dentist; Dentistry; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36659985	记录:发现:时间点:远程医疗:文档型:牙科学	4182948
36659986	AA % inhibition; Blood; Calc; Calculation; Clot strength TXA2-R inhib; COAGULATION; Hematology; Heme; Length Fraction; Percent; Pl; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Thrombocyte; Thrombocytes; Tx; WB; Whole blood	4180186
36659986	Clot strength TXA2-R inhib LenFr Bld	4180186
36659986	凝块强度.血小板血栓烷A2受体抑制型:长度分数:时间点:全血:定量型:计算法	4182948
36659990	Acd; Acid fast Stn; Acids; AFB stain; Convalescent; ID; Infectious Disease; InfectiousDisease; Lower respiratory; Microbiology; Ordinal; Point in time; Post immunization; PR; QL; Qual; Qualitative; Random; Screen; Second; sp2; Spec; Spt; Sputum; St; Stains; Stn	4180186
36659990	Acid fast Stn sp2 Spt Ql	4180186
36659990	显微镜观察^第2个标本:存在情况或阈值:时间点:痰液:序数型:抗酸染色法	4182948
36659992	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; GNPTA; Heredity; Heritable; high-throughput sequencing; HTS; ICD; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; N-acetylglucosamine-1-phosphate transferase subunits alpha and beta; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36659992	GNPTAB Full Mut Anl Bld/T Seq	4180186
36659992	GNPTAB 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36659993	30M p meal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
36659993	胰岛素^在进餐之后30分钟:任意型浓度:时间点:血清/血浆:定量型	4182948
36659993	Insulin 30M p meal SerPl-aCnc	4180186
36659997	ABS; Aby; aMPV; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian pneumovirus; Bird; EIA; ELFA; ELISA; Enzyme immunoassay; Fowl; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Swollen head syndrome; TRTV; Turkey rhinotracheitis; Vet; Veterinary	4180186
36659997	禽肺病毒 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36659997	aMPV Ab/Pos cntrl Ser IA	4180186
36659999	100WBC; Blast; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36659999	Blasts/leuk NFr Stem prod Manual	4180186
36659999	幼稚细胞/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36660000	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Telemedicine; Visit note	4180186
36660000	记录:发现:时间点:远程医疗:文档型:心脏外科学	4182948
36660002	Blood; CMT2V; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MPS3B; MPS-IIIB; Mut; Mutations; N-acetyl-alpha-glucosaminidase; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; UFHSD; WB; Whole blood; Whole blood or Tissue	4180186
36660002	NAGLU Full Mut Anl Bld/T Seq	4180186
36660002	NAGLU 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660005	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pert; B pert.PT; B pert.PT Prmt; B pertussis; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pertussis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Whooping cough	4180186
36660005	百日咳博德特菌百日咳毒素启动子区域:存在情况或阈值:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36660005	B pert.PT Prmt Low resp Ql NAA+non-probe	4180186
36660006	WOC Team Conf eval note	4180186
36660006	Conf eval note; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; WOC; WOC Team	4180186
36660006	会议记录:发现:时间点:{环境}:文档型:伤口、造口和大小便节制照护服务.团队	4182948
36660007	PCA-1 IgG Titr Ser IF	4180186
36660007	浦肯雅细胞胞浆 1 型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36660007	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Oncology; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Yo Ab	4180186
36660008	Centers for Medicare and Medicaid Assessment; Finding; Findings; Housing; Living Arrangements; Nominal; Report period; Residence; Survey	4180186
36660009	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660012	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36660013	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660013	轴:角度:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36660013	Corr lens Axis by LM	4180186
36660016	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; Rh Blood Group System; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660016	HLA-C IgG SerPl FC	4180186
36660016	HLA-C 抗体.IgG:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36660019	Blood; CAC; CACT; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; solute carrier family 25 member 20; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660019	SLC25A20 Full Mut Anl Bld/T Seq	4180186
36660019	SLC25A20 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660020	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Microbiology; N caninum; NEG; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36660020	犬新孢子虫 抗体/阴性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36660020	N caninum Ab Ser IA	4180186
36660021	Blood; Coagulation Factor 2 gene; coagulation factor II (thrombin); Coagulation Factor II gene; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Prothrombin gene; Prothrombin precursor; PT; Random; RPRGL2; sequencing of entire coding region; THPH1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660021	F2 gene Full Mut Anl Bld/T Seq	4180186
36660021	F2 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660022	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660022	记录:发现:时间点:远程医疗:文档型:普通内科学	4182948
36660024	ADMIN; ADMIN.DEMOG; Affiliated with tribe; Finding; Findings; Native American; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36660024	Affiliated with tribe	4180186
36660024	是否隶属于某一部落:发现:时间点:^患者:序数型	4182948
36660029	Addiction; Celexa; Cfm; Cipralex; Cipramil; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Lexamil; Lexapro; Mass concentration; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Seroplex; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660029	Citalopram+Escitalopram SerPl Cfm-mCnc	4180186
36660029	西酞普兰+右旋西酞普兰:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
36660030	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
36660030	所暴露接触的动物类型:类型:时间点:^患者:名义型	4182948
36660031	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; EAdV; EAdV1; Equin; HAdV; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660031	EAdV1 RNA Spec Ql NAA+probe	4180186
36660031	马腺病毒 1 型 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36660032	#; ABS; absolute; absolutes; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; CMV CD8 Cells; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36660032	细胞.CD8.CMV 特异性:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36660032	CMV CD8 Cells # Bld FC	4180186
36660033	1 month; 1 month (30 days); 30 days; 30s CST; 30-Second Chair Stand; 30sSTS; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Stands; Survey	4180186
36660035	Electrophysiology Prog note	4180186
36660035	Cardio; Cardiology; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
36660035	病程记录:发现:时间点:{环境}:文档型:临床心脏电生理学	4182948
36660042	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B gar+afz oppA2; B garinii; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36660042	B gar+afz oppA2 Bld Ql NAA+non-probe	4180186
36660042	加里疏螺旋体抗体+阿夫塞疏螺旋体 oppA2 基因:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36660043	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
36660043	Crit infrastructure workplace type	4180186
36660043	关键基础设施工作场所环境:类型:时间点:^患者:名义型	4182948
36660046	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose p Cfst + meal Pnl; Glucose tolerance; Glucoseur; GTT; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stim	4180186
36660046	Glucose p Cfst + meal Pnl SerPl	4180186
36660046	禁食后和进餐刺激葡萄糖组套:-:时间点:血清/血浆:-	4182948
36660047	Anesthesia; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660047	记录:发现:时间点:远程医疗:文档型:麻醉学	4182948
36660056	Admitted as inpatient; Arterial Stenosis; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Transferred	4180186
36660056	Admitted as inpatient	4180186
36660056	是否收治为住院患者:发现:时间点:^患者:序数型	4182948
36660057	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660057	HSPB1 gene Full Mut Anl Bld/T Seq	4180186
36660057	HSPB1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660058	Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
36660060	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Tx	4180186
36660060	所规定的治疗日期:日期:时间点:^患者:定量型	4182948
36660062	Solid Org Transplant Prog note	4180186
36660062	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; Solid Org Transplant; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
36660062	病程记录:发现:时间点:{环境}:文档型:实体器官移植	4182948
36660063	Chemistry; Chondroitin B sulfate; CR; Crea; Creat; Dermatin; Genetics; Heredity; Heritable; Inherited; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SO4; SO4-2; Sulf; UA; UCr; UR; Urn	4180186
36660063	硫酸皮肤素/肌酐:比率:时间点:尿液:定量型	4182948
36660063	Dermatan Sulfate/Creat Ur-Rto	4180186
36660065	ACRDYS1; ADOHR; Amplification; Blood; CAR; CNC; CNC1; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; PKR1; Point in time; PPNAD1; PRKAR1; protein kinase cAMP-dependent type I regulatory subunit alpha; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; TSE1; WB; Whole blood; Whole blood or Tissue	4180186
36660065	PRKAR1A Del+Dup + Full Mut Anl Bld/T	4180186
36660065	PRKAR1A 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36660066	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Arbitrary concentration; B19 virus; B19V; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fifth Disease; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Parvo; Parvo virus; Parvov; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36660066	B19V DNA Amn NAA+probe-aCnc	4180186
36660066	细小病毒 B19 DNA:任意型浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36660068	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660070	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; G6PD1; Genetics; glucose-6-phosphate dehydrogenase; Glucose-6-phosphate dehydrogenase gene; Glycogen storage disease; Gpd-1; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660070	G6PD gene Full Mut Anl Bld/T Seq	4180186
36660070	G6PD 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660071	Derm; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660071	记录:发现:时间点:远程医疗:文档型:皮肤病学	4182948
36660072	Amphiphysin IgG Titr CSF IF	4180186
36660072	双载蛋白 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
36660072	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; breast cancer; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Oncology; Paraneoplastic syndrome; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stiff Man Syndrome; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660075	Centers for Medicare and Medicaid Assessment; Finding; Findings; Narrative; Point in time; Random; Report; Survey	4180186
36660081	神经胶质纤维酸性蛋白.alpha 亚单位 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36660081	ABS; Aby; ACIF; Alfa; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; GFAP; GFAP alpha; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Ordinal; Pituitary glycoproteins; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stroke; TBI (Traumatic Brain Injury); Time Resolved Fluorescence; Traumatic Brain Injuries; TRF	4180186
36660081	GFAP alpha IgG CSF Ql IF	4180186
36660082	ADMIN; ADMIN.DEMOG; Nominal; Point in time; Random; Typ	4180186
36660082	Workplace	4180186
36660082	工作场所环境:类型:时间点:^患者:名义型	4182948
36660083	Patient Health Questionnaire; PHQ; PHQ-8; PHQ-8 total score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PHQ; Tot; Totl	4180186
36660085	Activ; Actvty; Blood; CP33; CP34; CYP3A; CYP3A3; CYP3A4 gene prod met act; CYPIIIA3; CYPIIIA4; cytochrome P450, family 3, subfamily A, polypeptide 4; Drug metabolism; Gene prod met act imp; Genetics; Heredity; Heritable; HLP; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; NF-25; Ordinal; P450C3; P450PCN1; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660085	CYP3A4 gene prod met act Bld/T-Imp	4180186
36660085	CYP3A4 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
36660087	Spec Collect proc comment	4180186
36660087	cmmt; cmnt; Coll; Collect; Collect procedure comment; Collected; Com; Comm; Comments; Commt; Finding; Findings; Nominal; Point in time; Random; Remarks; Spec	4180186
36660087	采集操作注释:发现:时间点:标本:名义型	4182948
36660088	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; Point in time; Random; Telemedicine; Visit note	4180186
36660088	记录:发现:时间点:远程医疗:文档型:肿瘤学	4182948
36660089	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660093	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660096	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660100	arylsulfatase B; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; G4S; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MPS6; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660100	ARSB Full Mut Anl Bld/T Seq	4180186
36660100	ARSB 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660103	After; aIle; alloIle; Allo-isoleucine; Chemistry; Genetics; Heredity; Heritable; Inherited; Level; Maple syrup urine disease; MSUD; MSUD (Maple Syrup Urine Disease); p diet; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Ther	4180186
36660103	Alloisoleucine p diet SerPl-sCnc	4180186
36660103	别异亮氨酸^在治疗性饮食之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
36660106	Myelopathy Ab pnl; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Serum; SR	4180186
36660106	Myelopathy Ab pnl Ser	4180186
36660106	脊髓病自身免疫抗体组套:-:时间点:血清:-	4182948
36660108	Hu3 IgG Titr CSF IF	4180186
36660108	神经元细胞核 3 型 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
36660108	ABS; Aby; ACIF; ANA IgG; ANNA 3; ANNA-3; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu3; IFA; III; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuronal nuclear type III; Nuc; Oncology; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660110	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660112	钙二醇+羟基钙二醇/24r-羟基钙二醇+24r,25-羟基钙化醇比率组套:-:时间点:血清/血浆:-	4182948
36660112	24(R),25-dihydroxycholecalciferol; 24,25(OH)2 VitD; 24,25(OH)2 VitD Pnl; 24,25-dihydroxy cholecalciferol; 24,25-dihydroxy vitamin D; 24,25-Dihydroxyvitamin D; 24,25-Dihydroxyvitamin D2 +24,25-Dihydroxyvitamin D3; 24r-Hydroxy calcidiol; 24R-OH-Calcidiol; 25 Hydroxyvitamin D 2; 25 Hydroxyvitamin D2; 25(OH)D2; 25(OH)D3; 25(OH)D3+25(OH)D2; 25D3+25D2/24,25D3+24,25D2; 25D3+25D2/24,25D3+24,25D2 Pnl; 25-Hydroxy calciferol; 25-Hydroxy Vit D total; 25-Hydroxycalciferol; 25-hydroxycholecalciferol; 25-Hydroxyergocalciferol; 25-hydroxyvitamin D; 25-Hydroxyvitamin D 2; 25-hydroxyvitamin D 3; 25-Hydroxyvitamin D2; 25-Hydroxyvitamin D2+25-Hydroxyvitamin D3/24,25 Dihydroxyvitamin D; 25-Hydroxyvitamin D2+25-Hydroxyvitamin D3/24,25 Dihydroxyvitamin D2+24,25 Dihydroxyvitamin D3; 25-Hydroxyvitamin D2+25-Hydroxyvitamin D3/24,25-Dihydroxyvitamin D ratio panel; 25-hydroxyvitamin D3; 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol; Calciderol; Calcidiol+Calciferol; Calcidiol+Ercalcidiol; Calcifediol;...	4180186
36660112	25D3+25D2/24,25D3+24,25D2 Pnl SerPl	4180186
36660114	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; Gyn; Gynecology; HPV; HPV E6+E7; HPV E6+E7 mRNA; HPV I/H Risk 4; HPV16; HPV16 and 18; HPV16+18; HPV16+18+H Risk 12; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; Other; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36660114	HPV E6+E7 mRNA Spec Ql NAA+probe	4180186
36660114	人乳头瘤病毒 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 型 mRNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36660115	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36660115	HSV2 DNA Amn NAA+probe-Log#	4180186
36660115	单纯疱疹病毒 2 型 DNA:对数型数量或计数浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36660119	Honey bee (rApi m) 3 IgE Qn	4180186
36660119	ABS; Aby; Ac Phos; Acd; Acid phosphatase.total; Acids; AcP; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Honey bee; Honey bee (rApi m) 3; Honeybee; i001; i1; i215; III; Immune globulin E; Immunoglobulin E; Phos; Phosphtase; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36660119	意大利蜜蜂酸性磷酸酶 重组 (rApi m) 3 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36660120	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Calicivirus; Dis; Diseases; DNA NUCLEIC ACID PROBE; DNA probe; Dz; f213; Hemorrhagic septicemia; Infectious necrotic hepatitis; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Oryctalagus spp; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Rabbit hemorrhagic disease; Random; RHDV; RHDV RNA Pnl; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral hemorrhagic disease	4180186
36660120	RHDV RNA Pnl Spec NAA+probe	4180186
36660120	兔出血症病毒 RNA 组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
36660121	Delta hepatitis; Dextro; HDV; HDV Ab Pnl; HDVAB; Hep; Hep D; Hep Delta; Hepatis; Hepatit; Hepatitis delta virus; Hepatology; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR	4180186
36660121	HDV Ab Pnl Ser	4180186
36660121	丁型肝炎病毒抗体组套:-:时间点:血清:-	4182948
36660124	1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Hexacarbox; Hexacarboxyl porphyrin; Hexacarboxylic acid porphyrin I; Hexacarboxylporphyrins; Hexacarboxyporphy; Hexacarboxyporphyrin; Hexacarboxyporphyrin I; Hexa-CP; Hexa-CP I; Hexaporphyrin; Mass rate; mRate; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
36660124	Hexa-CP I 24h Stl-mRate	4180186
36660124	六羧基卟啉 I:质量速率:24小时:大便:定量型	4182948
36660127	Biliary Neo Chrom-Cyt Analysis; Chromosom; Chromosomes; Document; Finding; Findings; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Oncology; Point in time; Random; Tissue; Tissue, unspecified	4180186
36660127	胆道肿瘤染色体非整倍体性与细胞学分析:发现:时间点:组织与涂片:文档型	4182948
36660127	Biliary Neo Chrom-Cyt Analysis Tiss	4180186
36660128	Blood; Document; EPP; FCE; ferrochelatase; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660128	FECH gene Full Mut Anl Bld/T Seq	4180186
36660128	FECH 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660132	120 min; 120 minutes; 120min; 2 hours; 2h p meal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
36660132	胰岛素^在进餐之后2小时:任意型浓度:时间点:血清/血浆:定量型	4182948
36660132	Insulin 2h p meal SerPl-aCnc	4180186
36660133	Agg; Aggr; COAGULATION; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; PA; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; Random; Thrombocyte; Thrombocytes	4180186
36660133	PA PRP-Imp	4180186
36660133	血小板聚集:印象:时间点:富血小板血浆:名义型	4182948
36660134	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660134	EBV DNA Amn Ql NAA+probe	4180186
36660134	Epstein Barr 病毒 DNA:存在情况或阈值:时间点:羊水:序数型:探针法.基因扩增.靶向	4182948
36660139	1 hour; 1.0Hr; 1h p meal; 60 min; 60 minutes; 60M; 60min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
36660139	Insulin 1h p meal SerPl-aCnc	4180186
36660139	胰岛素^在进餐之后1小时:任意型浓度:时间点:血清/血浆:定量型	4182948
36660142	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Alpha-herpesvirus; Amplif; Amplification; Amplified; Avian infectious laryngotracheitis; Bird; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; Fowl; ID; ILT; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
36660142	禽传染性喉气管炎病毒 RNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660142	ILT RNA # Spec NAA+probe	4180186
36660143	垂直棱镜.下射:长度倒数:时间点:矫正镜片.右侧:定量型:透镜屈光度计法	4182948
36660143	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; RT; V prism-down	4180186
36660143	R corr lens V prism-down by LM	4180186
36660146	3 days; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
36660147	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Ethanol metabolite; ethyl hydrogen sulfate; GCMS; Mass content; Mec; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Sulf; Sulfovinate; Sulfovinic acid	4180186
36660147	硫酸乙酯:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
36660147	Ethyl sulfate Mec Cfm-mCnt	4180186
36660150	120 min; 120 minutes; 120min; 2 hours; 2h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HGF; Hyperglycemic factor; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660150	Glucagon 2h p meal SerPl-mCnc	4180186
36660150	胰高血糖素^在进餐之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660153	Dialy+Ther Apher D/C sum	4180186
36660153	D/C sum; Dialy; Dialy+Ther Apher; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Ther; Visit note	4180186
36660153	出院摘要记录:发现:时间点:{环境}:文档型:透析+治疗性血浆置换	4182948
36660154	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Beef; BRSV; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; RSV; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660154	BRSV RNA Ct Spec Qn NAA+probe	4180186
36660154	牛呼吸道合胞病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660158	Gastroenterology D/C sum	4180186
36660158	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gastro; Gastroenterology; GI; notes; Point in time; Random; Visit note	4180186
36660158	出院摘要记录:发现:时间点:{环境}:文档型:胃肠病学	4182948
36660160	Antigen; Antigens; Beef; BRSV; HRSV; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RSV; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; Vet; Veterinary	4180186
36660160	BRSV Ag Tiss Ql ImStn	4180186
36660160	牛呼吸道合胞病毒 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
36660162	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660163	Blood; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Nominal; PCR; Point in time; Random; SLC25A15 c.562_564delTTC; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660163	SLC25A15 c.562_564delTTC Geno Bld/T	4180186
36660163	SLC25A15 基因.c.562_564delTTC:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36660164	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV1; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660164	HPIV1 RNA Lower resp Ql NAA+non-probe	4180186
36660164	副流感病毒 1 型 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36660165	Axis step; EYE; EYE.LENSOMETRY; Focimeter; Lensometer; LM; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random	4180186
36660165	LM Axis step	4180186
36660165	轴向测量增量:角度:时间点:透镜屈光度计:名义型	4182948
36660167	C&S; Cult; Cultures; EIV; Equin; Equine influenza; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36660167	马流感病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36660167	EIV Spec Ql Cult	4180186
36660171	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Viibryd	4180186
36660171	Vilaz SerPl Ql Scn	4180186
36660171	维拉佐酮:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
36660174	Blood; Chemistry; II; Neuro; Neurology; Point in time; Prealbumin; QNT; Quan; Quant; Quantitative; Random; TTR; TTR - TTR 2; TTR 2; WB; Whole blood	4180186
36660174	甲状腺素视黄质运载蛋白 - 甲状腺素视黄质运载蛋白峰值 2:质量差:时间点:全血:定量型	4182948
36660174	TTR - TTR 2 MDiff Bld	4180186
36660176	Amplification; Blood; Charcot-Marie-Tooth neuropathy, X-linked; CMTX; CMTX1; Connexin 32; CX32; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; gap junction protein, beta 1, 32kDa; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660176	GJB1 gene Del+Dup + Full Mut Anl Bld/T	4180186
36660176	GJB1 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36660177	5h p meal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
36660177	Insulin 5h p meal SerPl-aCnc	4180186
36660177	胰岛素^在进餐之后5小时:任意型浓度:时间点:血清/血浆:定量型	4182948
36660178	by KM; Corneal; EYE; EYE.REFRACTION; Length; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT; Upper extremity	4180186
36660178	R cornea Curvature radius.flat by KM	4180186
36660178	曲率半径.平坦:长度:时间点:角膜.右侧:定量型:角膜曲率测量法	4182948
36660179	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660179	Burn Telehealth Note	4180186
36660179	记录:发现:时间点:远程医疗:文档型:烧伤管理	4182948
36660180	ANTIBIOTIC SUSCEPTIBILITIES; AST; Extensively drug resistant tuberculosis; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MDR TB; MDR Tuberculosis; Multi drug resistant tuberculosis; Point in time; Random; Sirturo; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis; XDR TB	4180186
36660180	Bedaquiline Susc Islt	4180186
36660180	贝达喹啉:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36660181	胚系疾病染色体分析:发现:时间点:羊水/绒毛膜绒毛样本:文档型:末端配对序列测定法	4182948
36660181	AF; Amn; Amn fl; Amn/CVS; Amnio; Amniotic flu; Amniotic fluid; Chorionic villi; Chorionic villus sample; Chrom analy; Chromosom; Chromosomes; Cytogenetics; Document; Finding; Findings; Genetics; Germline disorder chromo analy; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Karyotype; Molecular pathology; MOLPATH; MPSeq; Next generation sequencing; NGS; Point in time; Random	4180186
36660181	Germline chromo analy Amn/CVS MPSeq	4180186
36660182	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; Levels; Levl; LV; LVL; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660185	Vortioxetine SerPl Ql Scn	4180186
36660185	DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660185	沃替西汀:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
36660186	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B per+par+bron gidA; B pert; B pertussis; DNA NUCLEIC ACID PROBE; DNA probe; Glucose-inhibited division protein A; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; mnmG; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pertussis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG; Whooping cough	4180186
36660186	百日咳博德特菌+副百日咳博德特菌+支气管败血性百日咳博德特菌 gidA 基因:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36660186	B per+par+bron gidA Lo Resp Ql NAA+probe	4180186
36660189	ABS; Aby; Acetylch; ACH; AChR; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; MEIA; nAChR; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; SR; Substance concentration; SUDS	4180186
36660189	nAChR Ab Ser IA-sCnc	4180186
36660189	乙酰胆碱受体神经节神经元 抗体:物质的量浓度:时间点:血清:定量型:免疫测定法	4182948
36660190	Dermatologic; Epidermis; H+P; H+P.PX; Integument; Nominal; P prime; Point in time; Random; Skn; Typ	4180186
36660190	皮肤色调:类型:时间点:皮肤:名义型	4182948
36660192	AO; Aortic; Bld flow; CARD.US; Cardio; Cardiology; DOP; DTA; DUPLEX; Dynamic; Echography; Finding; Findings; Heart Disease; Holodias flow reversal; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Thorax; ULS; Ultrasound	4180186
36660192	DTA Holodias flow reversal DOP	4180186
36660192	血流逆转.全舒张期:发现:时间点:主动脉.胸腔段.降支:序数型:超声.多普勒	4182948
36660196	垂直棱镜.上射:长度倒数:时间点:矫正镜片.右侧:定量型:透镜屈光度计法	4182948
36660196	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; RT; V prism-up	4180186
36660196	R corr lens V prism-up by LM	4180186
36660197	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Heme; notes; Point in time; Random; Visit note	4180186
36660197	Thromboemb Consult note	4180186
36660197	会诊记录:发现:时间点:{环境}:文档型:血栓栓塞	4182948
36660198	activated charcoal; After; Clot; Clottable; Coag; Coagulation assay; Coagulation dilute Russell viper venom induced confirmatory test; Dil; Dil Russell Vip Ven; Dilut; Direct oral anticoagulants; DOAC Remove; DOAC-Stop; dRVV; dRVVT; dRVVT cfm; dRVVT confirm; dRVVT confirmation test; dRVVT/dRVVT cfm; EXS; Hematology; Heme; Lipid; Neut; Neutr; p DOAC neut; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
36660198	dRVVT/dRVVT cfm p DOAC neut PPP-Rto	4180186
36660198	稀释蝰蛇毒诱导型凝血过程/稀释蝰蛇毒诱导型凝血过程.过量磷脂^在直接口服抗凝剂中和之后:比率:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
36660200	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUAV H1 2009 pand; FLUV; Fowl plague; H1N1; H1N1v; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza virus A hemagglutinin H1 swine origin; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; S-OIV; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660200	流感病毒 A 型血凝素 H1 型 2009 大流行 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36660200	FLUAV H1 09 pan RNA Lo Rsp Ql NAA+probe	4180186
36660201	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; COVID-19 Progress note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; ID; Infectious Disease; InfectiousDisease; notes; Point in time; Prog note; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
36660201	COVID-19+病程记录:发现:时间点:{环境}:文档型:{角色}	4182948
36660202	Med tech EMS transp	4180186
36660202	Emergency Medical Service(s); Med tech EMS transp; Nominal; Point in time; Random; TRAUMA; Typ	4180186
36660202	急救医疗服务运输过程中所使用的医疗技术:类型:时间点:^患者:名义型	4182948
36660203	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Compx; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E cloac comp; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660203	E cloac comp DNA Lower resp Ql NAA+probe	4180186
36660203	阴沟肠杆菌复合菌群 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36660208	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660209	Delta hepatitis; Dextro; HDV; HDV IgM Pnl; HDVAB; Hep; Hep D; Hep Delta; Hepatis; Hepatit; Hepatitis delta virus; Hepatology; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR	4180186
36660209	HDV IgM Pnl Ser	4180186
36660209	丁型肝炎病毒抗体.IgM组套:-:时间点:血清:-	4182948
36660219	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Insulin-Dependent Diabetes Mellitus; Level; MEIA; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Substance concentration; SUDS	4180186
36660219	GAD65 IgG+IgM Ser IA-sCnc	4180186
36660219	谷氨酸脱羧酶-65 抗体.IgG+IgM:物质的量浓度:时间点:血清:定量型:免疫测定法	4182948
36660221	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary; WNV	4180186
36660221	WNV IgM/Pos cntrl Ser IA	4180186
36660221	西尼罗河病毒 抗体.IgM/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36660222	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log ACNC; Log IU; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Shingles; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; VZ; VZV; Zoster	4180186
36660222	VZV DNA Amn NAA+probe-Log IU	4180186
36660222	水痘带状疱疹病毒 DNA:对数型任意浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36660226	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-DQB1 IgG; Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660226	HLA-DQB1 IgG SerPl FC	4180186
36660226	HLA-DQB1 抗体.IgG:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36660227	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cat (rFel d) 7; Dextro; e231; Feline; Felis domesticus; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36660227	Cat (rFel d) 7 IgE Qn	4180186
36660227	猫 重组 (rFel d) 7 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36660229	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Beef; BHV1; BoHV; BoHV1; BOHV-1; Bovine herpes virus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes virus; i; IBR; ID; Infectious bovine rhinotracheitis; Infectious Disease; Infectious pustular vulvovaginitis; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660229	BoHV1 DNA Ct Spec Qn NAA+probe	4180186
36660229	牛疱疹病毒 1 型 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660230	Cardiology ICU Prog note	4180186
36660230	Cardio; Cardiology; cards; Critical care unit; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; ICU; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
36660230	病程记录:发现:时间点:重症监护病房:文档型:心血管疾病	4182948
36660232	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660232	TRPV4 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660232	TRPV4 gene Full Mut Anl Bld/T Seq	4180186
36660233	Antigen; Antigens; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; L monocytog; L monocytogenes; Listeriosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; Vet; Veterinary	4180186
36660233	L monocytog Ag Tiss Ql ImStn	4180186
36660233	单核细胞增生李斯特菌 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
36660236	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note; WOC	4180186
36660236	WOC Prog note	4180186
36660236	病程记录:发现:时间点:{环境}:文档型:伤口、造口和大小便节制照护服务	4182948
36660237	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breakbone fever; Cerebral spinal fluid; Cerebrospinal Fl; Dengue type I; Dengue type I+II+III+IV; Denv; DENV 1+2+3+4; DENV 1+2+3+4 3' UTR; DENV 1+2+3+4 3' UTR RNA; DENV1; DENV1+2+3+4; DNA NUCLEIC ACID PROBE; DNA probe; Flavivirus; i; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660237	DENV 1+2+3+4 3' UTR RNA CSF Ql NAA+probe	4180186
36660237	登革热病毒 1+2+3+4 3' UTR RNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36660239	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Leu; LGI1; LGI1 Ab; Neuro; Neurology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36660239	LGI1 IgG CSF Ql CBA IFA	4180186
36660239	富亮氨酸胶质瘤失活蛋白 1 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
36660240	A-C shoulder; B bump; B notch; B-B' step; Beta inflection; CARD.US; Cardio; Cardiology; Echography; Finding; Findings; Heart Disease; Interruption of AC slope; MM; mmode; MV; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
36660240	MV B-bump M-mode	4180186
36660240	B-隆起:发现:时间点:二尖瓣:序数型:超声.M 型	4182948
36660242	PhenX - HPV vaccine use protocol	4180186
36660242	Pan; Panel; PANEL.PHENX; Panl; PhenX - HPV vaccine use protocol; Pnl; Point in time; Random	4180186
36660242	PhenX - 人乳头瘤病毒疫苗使用方案 100802:-:时间点:^患者:-:PhenX	4182948
36660247	cmmt; cmnt; Com; Comm; Comments; Commt; Finding; Findings; Nominal; Point in time; Random; Remarks; Spec	4180186
36660247	处理注释:发现:时间点:标本:名义型	4182948
36660250	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; H prism-in; Inverse Length; L; L corr lens; Lensometer; LM; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660250	L corr lens H prism-in by LM	4180186
36660250	水平棱镜.入射:长度倒数:时间点:矫正镜片.左侧:定量型:透镜屈光度计法	4182948
36660251	Ang; Angio; Angiography; Brain; Brain + Head ves; c; Cerebral; Cerebrum; Contr; Contra; Contrst; Cranial; Cranium; Document; Finding; Findings; Head; Imaging; Intracranial; Magnetic Resonance Angiographies; Magnetic resonance imaging; Mitral regurgitation maximum velocity; MR + MRA; MR angiography; MRA; MRI; MRI.angio; Point in time; Rad; Radiology; Random; Skull; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr + WO contr; WO+W contr IV; WWO	4180186
36660251	MR Brain WO+W contr IV+MRA WO contr	4180186
36660251	多层^WO & W contrast IV && Multisection^WO contrast:发现:时间点:头部>脑部 && 头部>头部 血管类:文档型:MR && MR.血管造影术	4182948
36660252	Citalopram metabolite; Desmeth; Desmethylcitalopram; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660252	Norcitalopram SerPl Ql Scn	4180186
36660252	去甲基西酞普兰:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
36660255	Magnesium Sweat-mCnc	4180186
36660255	Chemistry; Level; MAG; Magnes; Mass concentration; Mg; Point in time; QNT; Quan; Quant; Quantitative; Random; SWT	4180186
36660255	镁:质量浓度:时间点:汗液:定量型	4182948
36660260	Amplification; BHD; BHD skin lesion fibrofolliculoma protein; Birt-Hogg-Dube syndrome protein; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; DKFZp547A118; Document; Dp; Finding; Findings; FLCL; FLJ45004; FLJ99377; Folliculin; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; MGC17998; MGC23445; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660260	FLCN gene Del+Dup + Full Mut Anl Bld/T	4180186
36660260	FLCN 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36660261	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660263	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660266	Device mode; Eye; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Typ	4180186
36660266	Device mode	4180186
36660266	设备测量模式:类型:时间点:{装置}:名义型	4182948
36660269	甘油与甘油校正型甘油三酯组套:-:时间点:血清/血浆:-	4182948
36660269	Glycerol + glycerol corr TG Pnl SerPl	4180186
36660269	Chemistry; Glycerol + glycerol corr TG Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tg; Trig; Trigly; Triglycerides; Triglycrides	4180186
36660271	#; ABS; absolute; absolutes; Ag; Blood; CD107ab HLA-A2 CMV CD8 Cells; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-A2 CMV CD8 Cells; Human Leukocyte Antigen; LAMP-1; Leu2; Leu-2; Lysosome-associated membrane-protein 1; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36660271	CD107ab HLA-A2 CMV CD8 Cells # Bld FC	4180186
36660271	细胞.CD8.HLA-A2 CMV 特异性.CMV 抗原刺激性 CD107a+b 表达型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36660272	1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Isohexa-CP; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
36660272	Isohexa-CP 24h Stl-mRate	4180186
36660272	异六羧基卟啉:质量速率:24小时:大便:定量型	4182948
36660273	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bovine venereal trichomonosis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; T foet; T foetus; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660273	T foet DNA Ct Spec Qn NAA+probe	4180186
36660273	胎儿三毛滴虫 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660274	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36660275	硫酸皮肤素 & 硫酸类肝素 & 硫酸角质素组套:-:时间点:全血.斑点:-	4182948
36660275	Blood; Chemistry; Chondroitin B sulfate; Chondroitin sulfate B; DBS; Dermatin; Dried blood spot; Filter paper; FP; HS; keratosulfate; MPS panel; Mucopolysaccharides; Mucopolysaccharidosis; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; SO4; SO4-2; Sulf; WB; Whole blood	4180186
36660275	MPS panel DBS	4180186
36660277	Activated protein C cofactor; APC; Blood; Coagulation Factor 2 gene; coagulation factor II (thrombin); Coagulation Factor II gene; Coagulation Factor V - Leiden gene; coagulation factor V (proaccelerin, labile factor); F2 20210G&gt;A + F5 1691G&gt;A Pnl; F2 c.20210G&gt;A; F5 c.1691G&gt;A; FVL; Genetics; Heredity; Heritable; Inherited; Labile factor; Molecular genetics; Molecular pathology; MOLPATH; Pan; Panel.molpath; Panl; PCCF; PCR; Pnl; Point in time; Proaccelerin gene; Prothrombin gene; Prothrombin precursor; PT; Random; RPRGL1; RPRGL2; THPH1; THPH2; Thrombophilia; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660277	F2 20210G>A + F5 1691G>A Pnl Bld/T	4180186
36660277	F2 基因.c.20210G>A 与 F5 基因.c.1691G>A 组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
36660282	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; Agg; Aggr; ANED; Clopidogrel response assay; COAGULATION; Hematology; Heme; Left; Levo; Medication stress; P2Y12 Assay; P2Y12 inhibition; PA; PA ADP; Pl; Platelet rich plasma; Platelets; Platelt; Plavix response assay; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
36660282	PA ADP 0.6 umol/L PRP	4180186
36660282	血小板聚集.二磷酸腺苷诱导型^0.6 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
36660284	BDV; Beef; Bovine viral diarrhea; BVD; BVDV; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Mucosal disease; Ordinal; Other; Pestivirus; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36660284	BVDV Spec Ql Cult	4180186
36660284	牛病毒性腹泻病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36660288	Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; HEV RNA Pnl; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Ribonucleic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660288	HEV RNA Pnl SerPl	4180186
36660288	戊型肝炎病毒 RNA 组套:-:时间点:血清/血浆:-	4182948
36660291	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36660293	1 year; 12Mos; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; S prime; Screen; SDOH	4180186
36660295	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Beef; BPIV; BPIV3; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV3; Human respirovirus 3; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PCR; PI3; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660295	BPIV3 RNA Ct Spec Qn NAA+probe	4180186
36660295	牛副流感病毒 3 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660296	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log ACNC; Log IU; Microbiology; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36660296	EBV DNA Amn NAA+probe-Log IU	4180186
36660296	Epstein Barr 病毒 DNA:对数型任意浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36660298	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660299	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660301	MAiD Consult note	4180186
36660301	会诊记录:发现:时间点:{环境}:文档型:临终医疗援助	4182948
36660301	Assisted suicide; Consult note; Death with dignity; DOC.ONT; Document; Encounter; End of life option; Evaluation and management; Evaluation and management note; Finding; Findings; MAiD; Medical assistance in dying; Medical assisted death; notes; Physician-assisted death; Point in time; Random; Visit note	4180186
36660302	Cardio; Cardio+Pulm disease; Cardiology; cards; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; OP; Point in time; Pulmonary; Random; Respirology; Visit note	4180186
36660302	Cardio+Pulm disease OP Note	4180186
36660302	记录:发现:时间点:门诊病人:文档型:心血管疾病+肺病	4182948
36660304	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
36660304	是否使用了绷带:发现:时间点:^患者:名义型	4182948
36660309	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; L; LT; Ordinal; Ql; Qual; Qualitative; R; Report period; RT; Screen; Survey	4180186
36660310	稀释倍数:滴定度:时间点:血清/血浆:定量型	4182948
36660310	Dilution factor Titr SerPl	4180186
36660310	Dilution factor; Dilution Factor (Titer); Fac; Fact; MISC; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
36660312	ANCR; Angelman syndrome; AS; Blood; CTCL tumor antigen se37-2; Document; E6AP; E6-AP; EPVE6AP; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HPVE6A; HTS; human papilloma virus E6-associated protein; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; oncogenic protein-associated protein E6-AP; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; ubiquitin protein ligase E3A; Ubiquitin-protein ligase E3A; WB; Whole blood; Whole blood or Tissue	4180186
36660312	UBE3A gene Full Mut Anl Bld/T Seq	4180186
36660312	UBE3A 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660314	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36660315	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660316	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BDV; Beef; Bovine viral diarrhea; BVD; BVDV; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Mucosal disease; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pestivirus; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660316	BVDV RNA Ct Spec Qn NAA+probe	4180186
36660316	牛病毒性腹泻病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660317	2; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class II; HLA class II Ab.IgG med risk; HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660317	HLA-DP 与 DQ 与 DR (II 类) 抗体.IgG 中度风险:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36660317	HLA class II Ab.IgG med risk SerPl FC	4180186
36660319	圣路易型脑炎病毒 抗体.中和:存在情况或阈值:时间点:XXX:序数型:中和试验	4182948
36660319	SLEV NAb Spec Ql Nt	4180186
36660319	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Enc; Enceph; Encephalomyelitis; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum virus neutralization; SLE virus; SLEV; Spec; St Louis; SVN; To be specified in another part of the message; Unspecified; Virus neutralization test; VNT	4180186
36660325	白蛋白/肌酐:存在情况或阈值:时间点:尿液:序数型:检测极限 <= 20 mg/L 试纸条法	4182948
36660325	Microalbumin/Creat Ur Test Str	4180186
36660325	Alb; Chemistry; CR; Crea; Creat; Dip stick; Dipstick; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Micro albumin; Microalbumin; Nephrology; Point in time; PR; Protein.albumin; Random; Renal; SmQn; UA; UCr; UR; Urn	4180186
36660326	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian infectious bronchitis; DNA NUCLEIC ACID PROBE; DNA probe; IBV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660326	IBV RNA Ct Spec Qn NAA+probe	4180186
36660326	传染性支气管炎病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660327	Acd; Acid fast Stn; Acids; AFB stain; Dermatologic; Epidermis; ID; Identity or presence; Infectious Disease; InfectiousDisease; Integument; Microbiology; Nominal; Point in time; Random; Skn; St; Stains; Stn	4180186
36660327	Acid fast Stn Skin	4180186
36660327	显微镜观察:存在与否或特征标识:时间点:皮肤:名义型:抗酸染色法	4182948
36660328	Factors affect result imp; Identity or presence; Interp; Interpret; Interpt; Intrp; Nominal; Point in time; Random	4180186
36660328	Factors affect result imp	4180186
36660328	影响结果解释的临床因素:存在与否或特征标识:时间点:^患者:名义型	4182948
36660332	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; IAA; Insulin-Dependent Diabetes Mellitus; Level; MEIA; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Substance concentration; SUDS	4180186
36660332	谷氨酸脱羧酶-65 抗体:物质的量浓度:时间点:血清:定量型:免疫测定法	4182948
36660332	GAD65 Ab Ser IA-sCnc	4180186
36660333	记录:发现:时间点:远程医疗:文档型:成形外科学	4182948
36660333	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Telemedicine; Visit note	4180186
36660334	B-Globulin 24h Ur Elph-mRate	4180186
36660334	1 day; 24 hours; 24HR; B; B-Globulin; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Mass rate; mRate; Protein beta globulin; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
36660334	Beta 球蛋白:质量速率:24小时:尿液:定量型:电泳	4182948
36660335	EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; Lensometer; LM; Nominal; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Sphere increment	4180186
36660335	LM Sphere increment [InvLen]	4180186
36660335	球镜测量增量:长度倒数:时间点:透镜屈光度计:名义型	4182948
36660341	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Arbitrary concentration; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Shingles; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; VZ; VZV; Zoster	4180186
36660341	水痘带状疱疹病毒 DNA:任意型浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36660341	VZV DNA Amn NAA+probe-aCnc	4180186
36660342	120 min; 120 minutes; 120min; 2 hours; 2h p meal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660342	C 肽^在进餐之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660342	C peptide 2h p meal SerPl-mCnc	4180186
36660349	1 year; 12Mos; Pan; Panel; Panl; Pnl; S prime; SDOH	4180186
36660350	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660357	Assisted suicide; Death with dignity; DOC.ONT; Document; Encounter; End of life option; Evaluation and management; Evaluation and management note; Finding; Findings; MAiD; Medical assistance in dying; Medical assisted death; notes; Physician-assisted death; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
36660357	MAiD Prog note	4180186
36660357	病程记录:发现:时间点:{环境}:文档型:临终医疗援助	4182948
36660361	Anticonvuls; Anticonvulsant; Antiepileptic; Antiseizure; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
36660361	Anticonvulsants Sal Ql Cfm	4180186
36660361	抗惊厥药:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
36660362	Amplification; Ashkenazi jewish workup; Blood; BRCA; BRCC2; Breast cancer 2, early onset; BROVCA2; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; FACD; FAD; FAD1; FANCB; FANCD; FANCD1; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; GLM3; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; PNCA2; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; XRCC11	4180186
36660362	BRCA1+BRCA2 Del+Dup + Full Mut Anl Bld/T	4180186
36660362	BRCA1+BRCA2 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36660363	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
36660365	#; ABS; absolute; absolutes; Ag; Blood; CD107ab HLA-B35 CMV CD8 Cells; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-B35 CMV CD8 Cells; Human Leukocyte Antigen; LAMP-1; Leu2; Leu-2; Lysosome-associated membrane-protein 1; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36660365	CD107ab HLA-B35 CMV CD8 Cells # Bld FC	4180186
36660365	细胞.CD8.HLA-B35 CMV 特异性.CMV 抗原刺激性 CD107a+b 表达型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36660366	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660368	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
36660370	PCA-Tr IgG Titr CSF IF	4180186
36660370	浦肯雅细胞胞浆 Tr 型 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
36660370	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Hodgkin's lymphoma; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Limbic encephalopathy; Neuro; Neurology; Oncology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCA-Tr Ab; PCD; PNS; Point in time; Purkinje Cells Tr Ab; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660371	by KM; Corneal; DIA; Diam; EYE; EYE.REFRACTION; Horiz diam; L; L cornea; Length; LT; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660371	水平直径:长度:时间点:角膜.左侧:定量型:角膜曲率测量法	4182948
36660371	L cornea Horiz diam by KM	4180186
36660372	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
36660373	#; ABS; absolute; absolutes; Ag; Blood; CD107ab HLA-B7 CMV CD8 Cells; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-B7 CMV CD8 Cells; Human Leukocyte Antigen; LAMP-1; Leu2; Leu-2; Lysosome-associated membrane-protein 1; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36660373	CD107ab HLA-B7 CMV CD8 Cells # Bld FC	4180186
36660373	细胞.CD8.HLA-B7 CMV 特异性.CMV 抗原刺激性 CD107a+b 表达型:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36660374	21 Hydroxylase Deficiency; Amplification; Blood; CA21H; CAH1; Congenital adrenal hyperplasia; CPS1; CYP21; CYP21B; cytochrome P450, family 21, subfamily A, polypeptide 2; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; P450c21B; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660374	CYP21A2 Del+Dup + Full Mut Anl Bld/T	4180186
36660374	CYP21A2 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36660377	A,B; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class I; Human Leukocyte Antigen; IAA; Inherited; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36660377	HLA-A+B+C 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
36660377	HLA-A+B+C Ab SerPl Ql IA	4180186
36660379	2; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class II; HLA class II Ab.IgG high risk; HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660379	HLA class II Ab.IgG high risk SerPl FC	4180186
36660379	HLA-DP 与 DQ 与 DR (II 类) 抗体.IgG 高度风险:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36660380	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660382	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36660384	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660384	HLA-DQA1 IgG SerPl FC	4180186
36660384	HLA-DQA1 抗体.IgG:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36660388	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36660390	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660392	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660394	Chemistry; Glu; Gluc; Glucoseur; Lipid & glucose Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660394	脂类与葡萄糖组套:-:时间点:血清/血浆:定量型	4182948
36660394	Lipid & glucose Pnl SerPl	4180186
36660397	100 CD3+CD8+; Blood; CD107ab CD8 Cells; CD3 Cells; CD3+CD8+ Cells; CD8 Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Dynamic; Esoteric; FC; LAMP-1; Leu2; Leu-2; Leu4; Leu-4; Lysosome-associated membrane-protein 1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; Whole blood	4180186
36660397	CD107ab CD8/100 CD3+CD8+ NFr Bld FC	4180186
36660397	细胞.CD8.PMA+离子霉素刺激性 CD107a+b 表达型/100 个细胞.CD3+CD8+:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
36660402	by KM; Corneal; EYE; EYE.REFRACTION; L; L cornea; Length; LT; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Upper extremity	4180186
36660402	L cornea Curvature radius.steep by KM	4180186
36660402	曲率半径.陡峭:长度:时间点:角膜.左侧:定量型:角膜曲率测量法	4182948
36660403	Ab Ao; Abd; Abd Aorta; Abd+Pelvis; Abdo; Abdomen; Abdominal; AO; Aortic; Document; DOP; DUPLEX; Echography; Finding; Findings; Heart; Imaging; Inf; IVC; LMTED; LTD; Pelvic; Point in time; Rad; Radiology; Random; Sonogram; Sonograph; Sonography; T Ao+Abd Ao+IVC+Ves-Il; TA + AA; Thorax; ULS; Ultrasound; VC; Vesl; Vessels.XXX	4180186
36660403	DOP T Ao+Abd Ao+IVC+Ves-Il Ltd	4180186
36660403	局部多层:发现:时间点:胸部>主动脉.胸腔段 & 腹部>主动脉.腹腔段+腔静脉.下 & 腹部+盆腔>髂血管类:文档型:超声.多普勒	4182948
36660411	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H somnus; Haemoph; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660411	H somnus DNA Ct Spec Qn NAA+probe	4180186
36660411	睡眠嗜血杆菌 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660413	Cardio; Cardiology; Chemistry; Genetics; Glycer cor; Heart Disease; Heredity; Heritable; Inherited; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tg; Trig; Trigly; Triglycerides; Triglycrides	4180186
36660413	Trigl Glycer cor Ser-mCnc	4180186
36660413	甘油三酯^^经过针对甘油而校正的:质量浓度:时间点:血清:定量型	4182948
36660416	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-DRB3 + 4 + 5; HLA-DRB3 + 4 + 5 Ab.IgG; HLA-DRB5; Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660416	HLA-DRB3 + 4 + 5 IgG SerPl FC	4180186
36660416	HLA-DRB3 & HLA-DRB4 & HLA DRB5 抗体.IgG:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36660417	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Stand); WB; Weight bearing	4180186
36660417	DOPamine stand Plas-mCnc	4180186
36660417	多巴胺^直立位:质量浓度:时间点:血浆:定量型	4182948
36660418	Bld Bnk+Trans Med; Blood conservation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Tx; Visit note	4180186
36660418	Bld Bnk+Trans Med Telehealth Note	4180186
36660418	记录:发现:时间点:远程医疗:文档型:血库与输血医学	4182948
36660419	ADL; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey; Up	4180186
36660422	Asympt; Asymptomatic; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; New born; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Ther; TYR NBS f/u + monitor Pnl; WB; Whole blood	4180186
36660422	酪氨酸血症新生儿筛查随访和治疗监测组套:-:时间点:全血.斑点:定量型	4182948
36660422	TYR NBS f/u + monitor Pnl DBS	4180186
36660425	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breakbone fever; Dengue type I; Dengue type I+II+III+IV; Denv; DENV 1+2+3+4; DENV 1+2+3+4 3' UTR; DENV 1+2+3+4 3' UTR RNA; DENV1; DENV1+2+3+4; DNA NUCLEIC ACID PROBE; DNA probe; Flavivirus; i; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660425	DENV 1+2+3+4 3' UTR RNA Ser Ql NAA+probe	4180186
36660425	登革热病毒 1+2+3+4 3' UTR RNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
36660427	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Cerebral spinal fluid; Cerebrospinal Fl; Coccidioides esteriformis; Coccidiomycosis; Coccio; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; ID; Imm; Immune globulin M; Immunodiff; Immunodiffusion; Immunoglobulin M; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; PR; Pseudococcidioides mazzai; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T proteolyticum; Trichosporon proteolyticum; Valley fever	4180186
36660427	C immitis IgM CSF Ql ID	4180186
36660427	粗球孢子菌 抗体.IgM:存在情况或阈值:时间点:脑脊液:序数型:免疫扩散法	4182948
36660428	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; L; L corr lens; Lensometer; LM; LT; Number fraction; Ophthalmology; Ophtho; Ophthy; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Ultraviolet Ray; UVT	4180186
36660428	L corr lens UVT by LM	4180186
36660428	紫外线透射率:计数型分数:时间点:矫正镜片.左侧:定量型:透镜屈光度计法	4182948
36660429	PCA-1 IgG Titr CSF IF	4180186
36660429	浦肯雅细胞胞浆 1 型 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
36660429	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Oncology; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Yo Ab	4180186
36660431	ABS; Aby; Antby; Anti; Antibodies; Antibody; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Devic's disease; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuro; Neurology; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Water channel aquaporin-4	4180186
36660431	AQP4 H2O channel IgG Ser Ql CBA IFA	4180186
36660431	水通道蛋白 4 受体 抗体.IgG:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
36660432	ADRA2A c.-1252G&gt;C; Blood; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; NM_000681.3(ADRA2A):c.-1252G&gt;C; Nominal; PCR; Point in time; Random; rs1800544; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660432	ADRA2A c.-1252G>C Geno Bld/T	4180186
36660432	ADRA2A 基因.c.-1252G>C:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36660434	3h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HGF; Hyperglycemic factor; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660434	Glucagon 3h p meal SerPl-mCnc	4180186
36660434	胰高血糖素^在进餐之后3小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660435	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Liver; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660435	HEV Ab SerPl-Imp	4180186
36660435	戊型肝炎病毒 抗体:印象:时间点:血清/血浆:名义型	4182948
36660436	1 day; 24 hours; 24HR; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Mass rate; mRate; Protein gamma globulin; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
36660436	Gamma 球蛋白:质量速率:24小时:尿液:定量型:电泳	4182948
36660436	Gamma glob 24h Ur Elph-mRate	4180186
36660437	PCA-1 Ab Titr Ser IF	4180186
36660437	浦肯雅细胞胞浆 1 型 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36660437	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Oncology; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Yo Ab	4180186
36660440	Dialy+Ther Apher Prog note	4180186
36660440	Dialy; Dialy+Ther Apher; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Ther; Visit note	4180186
36660440	病程记录:发现:时间点:{环境}:文档型:透析+治疗性血浆置换	4182948
36660441	Blood; EIEE6; FEB3; FEB3A; FHM3; GEFSP2; Genetics; HBSCI; Heredity; Heritable; Inherited; IVS5-91G&gt;A; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; NAC1; Nav1.1; Nominal; PCR; Point in time; Random; rs3812718; SCN1; SCN1A c.603-91G&gt;A; SMEI; Sodium channel protein, brain I alpha subunit gene; sodium channel, voltage gated, type I alpha subunit; Sodium channel, voltage-gated, type I, alpha polypeptide gene; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660441	SCN1A c.603-91G>A Geno Bld/T	4180186
36660441	SCN1A 基因.c.603-91G>A:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36660443	Aggr PC risk; Calc; Calc.ExoDx; Calculation; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
36660443	Aggr PC risk Score Patient Calc.ExoDx	4180186
36660443	侵略性前列腺癌风险:评分:时间点:^患者:定量型:计算法.ExoDx	4182948
36660446	Cerebral spinal fluid; Cerebrospinal Fl; Movement autoimmune Ab pnl; Neuro; Neurology; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36660446	Movement autoimmune Ab pnl CSF	4180186
36660446	运动障碍自身免疫抗体组套:-:时间点:脑脊液:-	4182948
36660447	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660449	BM Transplant; Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Heme; notes; Point in time; Random; Visit note	4180186
36660449	BM Transplant Consult note	4180186
36660449	会诊记录:发现:时间点:{环境}:文档型:骨髓移植	4182948
36660452	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; AvORT; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); ORT; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
36660452	ORT RNA # Spec NAA+probe	4180186
36660452	鼻气管炎鸟杆菌 RNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660453	Speech-lang path Telehealth Note	4180186
36660453	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Path; Point in time; Random; Speech pathology; Speech therapy; Speech-lang path; Telemedicine; Visit note	4180186
36660453	记录:发现:时间点:远程医疗:文档型:言语-语言病理学	4182948
36660454	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660455	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660456	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660457	AlphaM integrin chain; AlphaM-beta2; Blood; C3biR; CD11b Cells; Cell; CELL MARKERS; Cellularity; CR3; Leu15; Leu-15; Mac-1; Mo1; Ordinal; Point in time; PR; QL; Qual; Qualitative; R3; Random; Screen; WB; Whole blood	4180186
36660457	CD11b Cells Bld Ql	4180186
36660457	细胞.CD11B:存在情况或阈值:时间点:全血:序数型	4182948
36660458	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
36660459	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; c707; FA; Fluorescent antibody; Fluoresent; Glu; Glutamic acid; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; mGluR1; mGluR1 Ab; mGluR1 IgG; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
36660459	mGluR1 IgG Ser Ql IF	4180186
36660459	代谢型谷氨酸受体 1 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
36660460	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660462	CYL; EYE; EYE.LENSOMETRY; Focimeter; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Typ	4180186
36660462	柱镜模式:类型:时间点:透镜屈光度计:序数型	4182948
36660464	BILIQTL1; Blood; Crigler-Najjar syndrome, type I; Genetics; Gilbert Syndrome; GNT1; Heredity; Heritable; HUG-BR1; Inherited; Ma2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; Repeat; Tissue; Tissue, unspecified; UDP glucuronosyltransferase 1 family, polypeptide A1; UDP glycosyltransferase 1 family, polypeptide A1 gene; UDPGT; UDPGT 1-1; UGT1; UGT1A; UGT1A1 TA; UGT1A5; WB; Whole blood; Whole blood or Tissue	4180186
36660464	UGT1A1 TA Geno Bld/T	4180186
36660464	UGT1A1 基因.TA 重复序列:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36660465	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660466	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influenza; H influenzae; Haem influ; Haemoph; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660466	Haem influ DNA Lower resp Ql NAA+probe	4180186
36660466	流感嗜血杆菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36660467	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pyogenes; Screen; SDA; Steptococcus Group A; Strand Displacement Amplification; Strep; Strept; Streptococci group A; Streptococcus group A; TMA; Transcription mediated amplification	4180186
36660467	S pyo DNA Lower resp Ql NAA+probe	4180186
36660467	化脓性链球菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36660470	Beta glucosidase gene; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Gaucher disease; GBA1; GBA1 (LL); GC (SP); GCB; Genetics; GLUC; GLUC (LL); Glucocerebrosidase gene; glucosidase, beta, acid; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660470	GBA gene Full Mut Anl Bld/T Seq	4180186
36660470	GBA 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660471	Risk calc method	4180186
36660471	CLIN; CLIN.RISK; Meth; Method of; Nominal; Point in time; Random; Risk calc method; Typ	4180186
36660471	所采用的风险计算方法:类型:时间点:^患者:名义型:*	4182948
36660472	AHF; Blood; Classic hemophilia; Coagulation Factor VIII gene; coagulation factor VIII, procoagulant component; Document; DXS1253E; F8B; F8C; Factor 8; Finding; Findings; full gene sequencing; Full Mut Anl; FVIII; FVIII gene; Genetics; Haemophilia; HEMA; Hemophilia A; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Procoagulant component; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660472	F8 gene Full Mut Anl Bld/T Seq	4180186
36660472	F8 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660476	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
36660477	ADMIN; ADMIN.DEMOG; Nominal; Point in time; Random; Typ	4180186
36660477	部落隶属关系:类型:时间点:^患者:名义型	4182948
36660481	Norfluvoxamine SerPl Cfm-mCnc	4180186
36660481	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660481	诺氟伏沙明:质量浓度:时间点:血清/血浆:定量型:毒理学确认试验	4182948
36660483	100WBC; Baso; Basophil; Basos; Bph; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36660483	Basophils/leuk NFr Stem prod Manual	4180186
36660483	嗜碱性粒细胞/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36660484	Ab; Blood; gG; Glycoprot; Glycoproteins; GP; Human Leukocyte Antigen; Pan; PANEL.SEROLOGY; Panl; Pl; Platelet + HLA glycoprotein Ab Pnl; Platelets; Platelt; Plt; Pnl; Point in time; Random; Serology; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
36660484	Platelet + HLA glycoprotein Ab Pnl Bld	4180186
36660484	血小板与 HLA 糖蛋白抗体组套:-:时间点:全血:-	4182948
36660486	#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36660486	WBC # Stem prod	4180186
36660486	白细胞:计数型浓度:时间点:^干细胞产品:定量型	4182948
36660492	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36660492	EBV DNA Amn NAA+probe-Log#	4180186
36660492	Epstein Barr 病毒 DNA:对数型数量或计数浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36660495	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HBV; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Liver; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660495	HBV Ab SerPl-Imp	4180186
36660495	乙型肝炎病毒 抗体:印象:时间点:血清/血浆:名义型	4182948
36660497	Calc; Calculation; Corr lens; EYE; EYE.LENSOMETRY; Inverse Length; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R corr lens; Random; RT; Sph equiv	4180186
36660497	R corr lens Sph equiv Calc	4180186
36660497	等效球镜值:长度倒数:时间点:矫正镜片.右侧:定量型:计算法	4182948
36660498	6-hydroxybupropion; Bupropion metabolite; BW 306U; DRUG/TOXICOLOGY; Drugs; OH-bupropion; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660498	OH-bupropion SerPl Ql Scn	4180186
36660498	羟基丁氨苯丙酮:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
36660499	3 Self-Sustaining Sequence Replication; 3SR SR; Alpha-herpesvirus; Amplif; Amplification; Amplified; Avian infectious laryngotracheitis; Bird; DNA NUCLEIC ACID PROBE; DNA probe; Fowl; ID; ILT; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660499	ILT RNA Ct Spec Qn NAA+probe	4180186
36660499	禽传染性喉气管炎病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660500	ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-CCP; Arbitrary concentration; Autoantibodies; Autoantibody; cCP; CCP3; Cyclic Citrulinated Peptide; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Pept; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatoid arthritis; Rheumatology; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36660500	cCP IgG SerPl IA-aCnc	4180186
36660500	环瓜氨酸肽 抗体.IgG:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36660501	5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HGF; Hyperglycemic factor; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660501	Glucagon 5h p meal SerPl-mCnc	4180186
36660501	胰高血糖素^在进餐之后5小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660502	Audiology D/C sum	4180186
36660502	Audiology; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36660502	出院摘要记录:发现:时间点:{环境}:文档型:听力学	4182948
36660503	5,10-methylenetetrahydrofolate reductase gene; Blood; c.665C&gt;T; C665T; C677T; Genetics; Heredity; Heritable; Inherited; methylenetetrahydrofolate reductase (NAD(P)H); Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; MTHFR c.677C&gt;T; MTHFR c.677C&gt;T + 1298A&gt;C; NADPH; Nominal; p.A222V; p.Ala222Val; PCR; Point in time; Random; T prime; Tissue; Tissue, unspecified; Vascular risk; WB; Whole blood; Whole blood or Tissue	4180186
36660503	MTHFR c.677C>T + 1298A>C Geno Bld/T	4180186
36660503	MTHFR 基因.c.677C>T & c.1298A>C:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36660504	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Genetics; Heredity; Heritable; IAA; Immune globulin G; Immunoglobulin G; Inherited; Level; MEIA; Musc; Muscl; MuSK; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; Spec; SR; Substance concentration; SUDS; Tyr	4180186
36660504	MuSK IgG Ser IA-sCnc	4180186
36660504	肌肉特异性受体酪氨酸激酶 抗体.IgG:物质的量浓度:时间点:血清:定量型:免疫测定法	4182948
36660508	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660509	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36660512	1 month; 1 month (30 days); 2; 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660514	1V; CXR; Document; Film; Films; Finding; Findings; GE 3V; GE 3V + PA; III; Imaging; Minimum 3 views; Plain Films; Point in time; Postero-Anterior; Rad; RADIOLOGY; Random; Ribs-Ul; Ribs-Ul + Chest; Ribs-Ul+chest; Single View; Thorax; View; VW; VWS; Xray; X-ray	4180186
36660514	XR Ribs-Ul GE 3V + Chest PA	4180186
36660514	多重视图 GE 三重 && 视图 后前位:发现:时间点:胸部>肋骨.单侧 && 胸部:文档型:X射线摄影术	4182948
36660516	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C parvum; Crypt; Crypto; Cryptosporidiosis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660516	C parvum DNA Ct Spec Qn NAA+probe	4180186
36660516	小球隐孢子虫 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660518	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Genetics; Heredity; Heritable; IAA; Inherited; k; K+; Level; MEIA; Neuro; Neurology; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Substance concentration; SUDS; VG; V-G; VGKC	4180186
36660518	VGKC Ab Ser IA-sCnc	4180186
36660518	电压门控钾离子通道 抗体:物质的量浓度:时间点:血清:定量型:免疫测定法	4182948
36660521	2.5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HGF; Hyperglycemic factor; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660521	Glucagon 2.5h p meal SerPl-mCnc	4180186
36660521	胰高血糖素^在进餐之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660525	Blood; Del; Deletions; DJ-1; Document; Finding; Findings; Genetics; HEL-S-67p; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Parkinson disease; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660525	PARK7 gene Del Bld/T	4180186
36660525	PARK7 基因 缺失:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36660529	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Heme; notes; Point in time; Random; Telemedicine; Visit note	4180186
36660529	记录:发现:时间点:远程医疗:文档型:血液学	4182948
36660537	Asn40Asp; Blood; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; OPRM1 c.118A&gt;G; PCR; Point in time; Random; rs1799971; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660537	OPRM1 基因.c.118A>G:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36660537	OPRM1 c.118A>G Geno Bld/T	4180186
36660542	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660543	Orthotics prosthetics D/C sum	4180186
36660543	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36660543	出院摘要记录:发现:时间点:{环境}:文档型:矫形学和修复术	4182948
36660544	Adrenalin; Adrenaline; Adreneline; Agg; Aggr; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Hematology; Heme; i; Left; Levo; PA; PA Epineph; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
36660544	PA Epineph 1 umol/L PRP	4180186
36660544	血小板聚集.肾上腺素诱导型^1 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
36660546	1 month; 1 month (30 days); 30 days; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660547	C6S; Chemistry; Chondroitin sulfate C; Chondrotin; CR; Crea; Creat; Genetics; Heredity; Heritable; Inherited; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SO4; SO4-2; Sulf; UA; UCr; UR; Urn	4180186
36660547	软骨素-6-硫酸酯/肌酐:比率:时间点:尿液:定量型	4182948
36660547	C6S/Creat Ur-Rto	4180186
36660549	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; M synoviae; MEIA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
36660549	M synoviae Ab/Pos cntrl Ser IA	4180186
36660549	鸡滑膜支原体 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
36660551	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B burg; B burgdor; B burgdorferi; B burgdorferi oppA2; Bb; Blood; Burgdorf; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Lyme disease; Lymes; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36660551	B burgdorferi oppA2 Bld Ql NAA+non-probe	4180186
36660551	伯氏疏螺旋体 oppA2 基因:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36660553	2; Dynamic; FC; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class II; HLA class II Ab.IgG low risk; HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Inherited; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660553	HLA class II Ab.IgG low risk SerPl FC	4180186
36660553	HLA-DP 与 DQ 与 DR (II 类) 抗体.IgG 低度风险:存在与否或特征标识:时间点:血清/血浆:名义型:流式细胞测量术	4182948
36660554	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV1; HSV1+2; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36660554	HSV1+2 DNA Amn NAA+probe-Log#	4180186
36660554	单纯疱疹病毒 1+2 型 DNA:对数型数量或计数浓度:时间点:羊水:定量型:探针法.基因扩增.靶向	4182948
36660555	CV2 IgG Titr CSF IF	4180186
36660555	CV2 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
36660555	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Collapsin response mediator protein 5; Collapsin response mediator protein 5 Ab; Collapsin response mediator protein 5 Ab.IgG; CRMP5; CRMP-5; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Point in time; POP66; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; ULIP	4180186
36660561	ADL; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey; Up	4180186
36660562	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36660564	5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660564	Glucose 5h p meal SerPl-mCnc	4180186
36660564	葡萄糖^在进餐之后5小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660566	瞳距.双眼远用:长度:时间点:眼睛:定量型:自动验光仪.自动	4182948
36660566	Eye PD binoc far AR.auto	4180186
36660566	AR.auto; Eye; EYE.REFRACTION; Eyeball; Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; PD binoc; PD binoc far; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
36660569	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Marijuana; Nabilone; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; THC; UA; UR; Urn	4180186
36660569	Cannabidiol/THC Ur Cfm-Rto	4180186
36660569	大麻二酚/四氢大麻酚:比率:时间点:尿液:定量型:毒理学确认试验	4182948
36660570	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36660570	Navigator Eval note	4180186
36660570	评价记录:发现:时间点:{环境}:文档型:医疗保健服务导航员	4182948
36660572	Amplification; AR-JP; Blood; Del; Del+Dup; Deletions; Document; Dp; Finding; Findings; Genetics; Heredity; Heritable; Inherited; LPRS2; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELDUP; PARKIN; parkin RBR E3 ubiquitin protein ligase; Parkinson disease (autosomal recessive, juvenile) 2; PCR; PDJ; Point in time; PRKN; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660572	PARK2 gene Del+Dup Bld/T	4180186
36660572	PARK2 基因 缺失+重复:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36660577	Chromogenic assay; DRUG/TOXICOLOGY; Drugs; ENZY; Enzymatic assay; Level; Lixiana; Mass concentration; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Savaysa	4180186
36660577	Edoxaban PPP Chro-mCnc	4180186
36660577	依度沙班:质量浓度:时间点:贫血小板血浆:定量型:凝血因子酶学测定法	4182948
36660579	TTR-assoc familial amyloidosis Pnl Bld	4180186
36660579	Assoc; Blood; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; TTR; TTR-assoc familial amyloidosis Pnl; WB; Whole blood	4180186
36660579	甲状腺素视黄质运载蛋白相关家族性淀粉样变性组套:-:时间点:全血:-	4182948
36660580	垂直棱镜.下射:长度倒数:时间点:矫正镜片.左侧:定量型:透镜屈光度计法	4182948
36660580	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; L; L corr lens; Lensometer; LM; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; V prism-down	4180186
36660580	L corr lens V prism-down by LM	4180186
36660583	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660584	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Patient Telephone; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660586	Finding; Findings; Mental health; MentalHealth; Ordinal; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Screen; Survey	4180186
36660590	Dermatology D/C sum	4180186
36660590	D/C sum; Derm; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36660590	出院摘要记录:发现:时间点:{环境}:文档型:皮肤病学	4182948
36660591	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CHEMISTRY.CHALLENGE TESTING; FCN; Fl; Fld; FLU; Fluid; Func; Funct; Pan; Panc exo fnc Pnl; Pancr; Pancreatc; PANEL.CHALLENGE; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660591	Panc exo fnc Pnl Fld	4180186
36660591	胰腺外分泌功能组套:-:时间点:体液:定量型	4182948
36660592	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
36660593	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M meleagridis; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660593	M meleagridis DNA Ct Spec Qn NAA+probe	4180186
36660593	火鸡支原体 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660594	270 min; 4 1/2 hours; 4.5h p meal; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
36660594	Insulin 4.5h p meal SerPl-aCnc	4180186
36660594	胰岛素^在进餐之后4.5小时:任意型浓度:时间点:血清/血浆:定量型	4182948
36660595	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Lensometer; LM; Number fraction; Ophthalmology; Ophtho; Ophthy; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Ultraviolet Ray; UVT	4180186
36660595	Corr lens UVT by LM	4180186
36660595	紫外线透射率:计数型分数:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36660596	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Canine; Dog (rCan f) 6; e230; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36660596	Dog (rCan f) 6 IgE Qn	4180186
36660596	狗 重组 (rCan f) 6 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36660602	Cerebral spinal fluid; Cerebrospinal Fl; Encephalopathy autoimmune Ab pnl; Neuro; Neurology; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36660602	Encephalopathy autoimmune Ab pnl CSF	4180186
36660602	脑病自身免疫抗体组套:-:时间点:脑脊液:-	4182948
36660603	2D p control ID; After; Dermatologic; Diameter; Epidermis; Identifier; Integument; Intradermal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; React; Rx wheal; Rx^2D p control ID; Rxn; Skin test; SKIN TESTS; Skn	4180186
36660603	Rx wheal 2D p control ID Diam	4180186
36660603	反应风团^在皮内注射对照之后2天:直径:时间点:皮肤:定量型	4182948
36660604	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660606	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; breast cancer; Cerebral spinal fluid; Cerebrospinal Fl; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Oncology; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stiff Man Syndrome	4180186
36660606	Amphiphysin IgG CSF Ql Line blot	4180186
36660606	双载蛋白 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36660607	白蛋白:存在情况或阈值:时间点:尿液:序数型:检测极限 <= 20 mg/L 试纸条法	4182948
36660607	Microalbumin Ur Test Str	4180186
36660607	Alb; Chemistry; Dip stick; Dipstick; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Micro albumin; Microalbumin; Nephrology; Point in time; PR; Protein.albumin; Random; Renal; SmQn; UA; UR; Urn	4180186
36660608	水通道蛋白 4 受体 抗体.IgG:滴定度:时间点:血清:定量型:CBA IFA	4182948
36660608	AQP4 H2O channel IgG Titr Ser CBA IFA	4180186
36660608	ABS; Aby; Antby; Anti; Antibodies; Antibody; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Devic's disease; Dilution factor; Dilution Factor (Titer); Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuro; Neurology; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Water channel aquaporin-4	4180186
36660609	by KM; DIA; Diam; EYE; EYE.REFRACTION; L; L pupil; Length; LT; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660609	L pupil Diam by KM	4180186
36660609	直径:长度:时间点:瞳孔.左侧:定量型:角膜曲率测量法	4182948
36660612	Antigen; Antigens; BDV; Beef; Bovine viral diarrhea; BVD; BVDV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Mucosal disease; Other; Pestivirus; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Spec; SUDS; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36660612	牛病毒性腹泻病毒 抗原/阳性对照:相对比率:时间点:XXX:定量型:免疫测定法	4182948
36660612	BVDV Ag/Pos cntrl Spec IA	4180186
36660613	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; SDOH	4180186
36660615	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey	4180186
36660617	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M synoviae; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660617	M synoviae DNA Ct Spec Qn NAA+probe	4180186
36660617	鸡滑膜支原体 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660626	EYE; EYE.LENSOMETRY; Focimeter; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Typ	4180186
36660626	棱镜模式:类型:时间点:透镜屈光度计:序数型	4182948
36660627	Blood; Cationic trypsinogen; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Hereditary pancreatitis; Heredity; Heritable; high-throughput sequencing; HPC; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; PCTT; Point in time; protease, serine, 1 (trypsin 1); Random; sequencing of entire coding region; Tissue; Tissue, unspecified; TRP1; TRY1; TRY4; TRYP1; Trypsin 1 precursor; Trypsinogen 1; WB; Whole blood; Whole blood or Tissue	4180186
36660627	PRSS1 gene Full Mut Anl Bld/T Seq	4180186
36660627	PRSS1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660628	Rec therapy Telehealth Note	4180186
36660628	记录:发现:时间点:远程医疗:文档型:娱乐疗法	4182948
36660628	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Rec therapy; Telemedicine; Visit note	4180186
36660629	Genitourinary; GU; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; URO; Urology	4180186
36660629	肉芽肿性前列腺炎:存在情况或阈值:时间点:标本:序数型:显微镜检查类实验室方法	4182948
36660629	Granulomatous prostatitis Spec Ql Micro	4180186
36660630	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660630	DNM2 gene Full Mut Anl Bld/T Seq	4180186
36660630	DNM2 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660633	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mental health; MentalHealth; notes; Point in time; Psych; Psychiatry; Random; Telemedicine; Visit note	4180186
36660633	Psych Telehealth Note	4180186
36660633	记录:发现:时间点:远程医疗:文档型:心理学	4182948
36660638	Abortus blauw; Blue-eared pig disease; high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Lelystad virus; Microbiology; Mystery swine disease; Next generation sequencing; NGS; Number fraction; Percent; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PRRS; PRRSV; PRRSV ORF5 gene; PRRSV ORF5 seq; PRRSV Prevacent Hmlgy; QNT; Quan; Quant; Quantitative; Random; Seuchenhafter spatabort der schweine; SIRSV; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Vet; Veterinary	4180186
36660638	猪生殖与呼吸综合征病毒 ORF5 基因序列 Prevacent 同源物:计数型分数:时间点:分离株:定量型:序列测定	4182948
36660638	PRRSV Prevacent Hmlgy Islt Seq-NFr	4180186
36660639	Glial nuc type 1 IgG Titr CSF IF	4180186
36660639	神经胶质细胞核 1 型 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
36660639	ABS; Aby; ACIF; AGNA; AGNA-1; ANA IgG; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Glial nuc type 1; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Lambert-Eaton myasthenic syndrome; Neuro; Neurology; Nuc; Paraneoplastic Antibody; Paraneoplastic syndrome; Point in time; Random; Serology; SmQn; Sox1; Sox1 nuclear antigen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660640	CYL; EYE; EYE.REFRACTION; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; RM; Screen; Typ	4180186
36660640	Type of Cylinder mode	4180186
36660640	柱镜模式:类型:时间点:屈光计:序数型	4182948
36660641	Chemistry; CR; Crea; Creat; Esoteric; N-crotonylglycine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
36660641	Crotonylglycine/Creat Ur-sRto	4180186
36660641	巴豆酰基甘氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
36660642	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
36660643	CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Lying; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660643	DOPamine sup Plas-mCnc	4180186
36660643	多巴胺^仰卧位:质量浓度:时间点:血浆:定量型	4182948
36660645	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; S prime; Screen; Survey	4180186
36660647	Infectious disease D/C sum	4180186
36660647	D/C sum; Dis; Disch; Discharge summary; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; ID; Infectious Disease; InfectiousDisease; notes; Point in time; Random; Visit note	4180186
36660647	出院摘要记录:发现:时间点:{环境}:文档型:感染性疾病	4182948
36660648	浦肯雅细胞胞浆 2 型 抗体:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36660648	PCA-2 Ab Titr Ser IF	4180186
36660648	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Oncology; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36660649	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Insulin-Dependent Diabetes Mellitus; Level; MEIA; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; SUDS	4180186
36660649	GAD65 IgG+IgM CSF IA-sCnc	4180186
36660649	谷氨酸脱羧酶-65 抗体.IgG+IgM:物质的量浓度:时间点:脑脊液:定量型:免疫测定法	4182948
36660650	100WBC; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Leuc; Leuk; Leukocyte; Lkcs; Manl; Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem prod; WBC; WBCs; White blood cell; White blood cells	4180186
36660650	Metamyelocytes/leuk NFr Stem prod Manual	4180186
36660650	晚幼粒细胞/100 个白细胞:计数型分数:时间点:^干细胞产品:定量型:手工计数方法	4182948
36660651	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enterobacter aerogenes; ID; Infectious Disease; InfectiousDisease; K. aerogenes; K. aerogenes DNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660651	K. aerogenes DNA Lower resp Ql NAA+probe	4180186
36660651	产气克雷伯菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36660652	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Beef; BLV; EIA; ELFA; ELISA; Enzootic bovine leukosis; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Retrovirus; Serum; SR; SUDS; Vet; Veterinary	4180186
36660652	BLV Ab Ser IA-aCnc	4180186
36660652	牛白血病病毒 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36660654	Cardio+Pulm disease; Cardiology; cards; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Pulmonary; Random; Respirology; Telemedicine; Visit note	4180186
36660654	Cardio+Pulm disease Telehealth Note	4180186
36660654	记录:发现:时间点:远程医疗:文档型:心血管疾病+肺病	4182948
36660657	Blood; CF gene; coagulation factor VII (serum prothrombin conversion accelerator); Coagulation factor VII gene; Document; Factor 7; Factor VII; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Serum prothrombin conversion accelerator; SPCA; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660657	F7 gene Full Mut Anl Bld/T Seq	4180186
36660657	F7 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660662	1 month; 1 month (30 days); 30 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36660664	Desmogelin; Desmoglein 1+3 IgG Pnl; Desmoglein 3 IgG; DSG; DSG1; DSG3; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; III; Immune globulin G; Immunoglobulin G; MEIA; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
36660664	Desmoglein 1+3 IgG Pnl Ser IA	4180186
36660664	桥粒芯蛋白 1 与桥粒芯蛋白 3 抗体.IgG 组套:-:时间点:血清:定量型:免疫测定法	4182948
36660665	Cerebral spinal fluid; Cerebrospinal Fl; Epilepsy autoimmune Ab pnl; Neuro; Neurology; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36660665	Epilepsy autoimmune Ab pnl CSF	4180186
36660665	癫痫自身免疫抗体组套:-:时间点:脑脊液:-	4182948
36660666	ABS; Aby; ANA IgG; ANNA 1; ANNA-1; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Hu; Hu1; i; Immune globulin G; Immunoglobulin G; Neuronal nuclear type I; Nuc; Oncology; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36660666	Hu1 IgG CSF Ql Line blot	4180186
36660666	神经元细胞核 1 型 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36660670	过去4个星期内接受过癌症化学疗法:发现:4星期:^患者:序数型	4182948
36660670	Chemotherapy rcvd past 4W	4180186
36660670	4 weeks; Cancer; Chemo; Chemotherapy rcvd past 4W; Finding; Findings; Last; ONCOLOGY; Ordinal; QL; Qual; Qualitative; Screen	4180186
36660671	270 min; 4 1/2 hours; 4.5h p meal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Endocrine; Endocrinology; Level; Mass concentration; p meal; PC; Pept; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660671	C peptide 4.5h p meal SerPl-mCnc	4180186
36660671	C 肽^在进餐之后4.5小时:质量浓度:时间点:血清/血浆:定量型	4182948
36660673	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36660673	Encephalitozoon 18S rRNA Spec Ql NAA+prb	4180186
36660673	脑胞内原虫属 18S rRNA 基因:存在情况或阈值:时间点:XXX:序数型:非探针法.基因扩增.靶向	4182948
36660675	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Pharmacy; Point in time; Random; Telemedicine; Visit note	4180186
36660675	记录:发现:时间点:远程医疗:文档型:药理学	4182948
36660676	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660677	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; AvORT; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; ORT; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660677	ORT RNA Ct Spec Qn NAA+probe	4180186
36660677	鼻气管炎鸟杆菌 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660680	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660681	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36660681	HSV1 DNA Spec Ql NAA+non-probe	4180186
36660681	单纯疱疹病毒 1 型 DNA:存在情况或阈值:时间点:XXX:序数型:非探针法.基因扩增.靶向	4182948
36660685	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Cymbalta; DRUG/TOXICOLOGY; Drugs; GCMS; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Screen; Yentreve	4180186
36660685	DULoxetine Sal Ql Cfm	4180186
36660685	度洛西汀:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
36660686	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660686	YARS gene Full Mut Anl Bld/T Seq	4180186
36660686	YARS 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660688	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; EHV; EHV3; Equin; Herpes virus; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660688	EHV3 RNA Spec Ql NAA+probe	4180186
36660688	马疱疹病毒 3 型 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36660690	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36660691	Ear Nose Throat; ENT; Finding; Findings; Lung; Ordinal; Oto; Otolaryngology; Point in time; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
36660691	是否插管困难:发现:时间点:^患者:序数型	4182948
36660692	C auris; Cand; Candidiasis; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36660692	耳道假丝酵母菌:存在情况或阈值:时间点:分离株:序数型:MS.MALDI-TOF	4182948
36660692	C auris Islt Ql MS.MALDI-TOF	4180186
36660693	beta-factor XIIa part 1; Blood; coagulation factor XII; coagulation factor XII (Hageman factor); coagulation factor XIIa heavy chain; coagulation factor XIIa light chain; Document; EC 3.4.21.38; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; HAE3; HAEX; HAF; Hageman factor; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660693	F12 gene Full Mut Anl Bld/T Seq	4180186
36660693	F12 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660694	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH	4180186
36660695	#; ABS; absolute; absolutes; Blood; CD8 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; Esoteric; FC; HLA-B35 CMV CD8 Cells; Human Leukocyte Antigen; Leu2; Leu-2; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; Tsuppressor; WB; Whole blood	4180186
36660695	HLA-B35 CMV CD8 Cells # Bld FC	4180186
36660695	细胞.CD8.HLA-B35 CMV 特异性:计数型浓度:时间点:全血:定量型:流式细胞测量术	4182948
36660698	by KM; Corneal; DIA; Diam; EYE; EYE.REFRACTION; Horiz diam; Length; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT	4180186
36660698	R cornea Horiz diam by KM	4180186
36660698	水平直径:长度:时间点:角膜.右侧:定量型:角膜曲率测量法	4182948
36660699	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; metabolism of cobalamin associated C; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660699	MMACHC Full Mut Anl Bld/T Seq	4180186
36660699	MMACHC 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36660700	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36660701	Rx wheal 1D p control ID Diam	4180186
36660701	反应风团^在皮内注射对照之后1天:直径:时间点:皮肤:定量型	4182948
36660701	1D p control ID; After; Dermatologic; Diameter; Epidermis; Identifier; Integument; Intradermal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; React; Rx wheal; Rx^1D p control ID; Rxn; Skin test; SKIN TESTS; Skn	4180186
36660703	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; EIAV; ELFA; ELISA; Enzyme immunoassay; Equin; Equine infectious anemia; IAA; ID; Infectious Disease; InfectiousDisease; Lentivirus; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; Swamp fever; Vet; Veterinary	4180186
36660703	EIAV Ab Ser IA-aCnc	4180186
36660703	马传染性贫血病毒 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36660704	Encephalopathy autoimmune Ab pnl; Neuro; Neurology; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660704	Encephalopathy autoimmune Ab pnl SerPl	4180186
36660704	脑病自身免疫抗体组套:-:时间点:血清/血浆:-	4182948
36660705	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36660706	Antigen; Antigens; Contagious agalactia; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; M bovis; Microbiology; Mp bovis; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; Vet; Veterinary	4180186
36660706	Mp bovis Ag Tiss Ql ImStn	4180186
36660706	牛型支原体 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
36660707	Vit B6 + metabolites Pnl SerPl	4180186
36660707	Chemistry; Metabolite; Metb; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vit B6 + metabolites Pnl	4180186
36660707	维生素 B6 与代谢产物组套:-:时间点:血清/血浆:定量型	4182948
36660710	Assessment; Cancer; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gyn Onc; Gynecology; H&P; History and physical; notes; OB; ObGyn; Obstetrics; Oncology; Point in time; Random; Visit note	4180186
36660710	Gyn Onc Eval note	4180186
36660710	评价记录:发现:时间点:{环境}:文档型:妇科肿瘤学	4182948
36660714	100 CD19 cells; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD21low38- Cells; Cell; CELL MARKERS; Cellularity; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36660714	CD21low38- Cells/100 CD19 cells NFr Bld	4180186
36660714	细胞.CD21lowCD38-/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
36660716	ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; i; Immune globulin G; Immunoglobulin G; Neuro; Neurology; Oncology; Ordinal; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Yo Ab	4180186
36660716	PCA-1 IgG CSF Ql Line blot	4180186
36660716	浦肯雅细胞胞浆 1 型 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36660717	anti-HBsAg; HBs; HBsAB; HBV; HBV surface; HBV surface Ab Pnl; Hep; Hep B; Hep Bs; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Surf	4180186
36660717	HBV surface Ab Pnl SerPl	4180186
36660717	乙型肝炎病毒表面抗体组套:-:时间点:血清/血浆:-	4182948
36660718	Navigator Note	4180186
36660718	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36660718	记录:发现:时间点:{环境}:文档型:医疗保健服务导航员	4182948
36660720	垂直棱镜.上射:长度倒数:时间点:矫正镜片.左侧:定量型:透镜屈光度计法	4182948
36660720	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; L; L corr lens; Lensometer; LM; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; V prism-up	4180186
36660720	L corr lens V prism-up by LM	4180186
36660721	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; H prism-in; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660721	水平棱镜.入射:长度倒数:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36660721	Corr lens H prism-in by LM	4180186
36660722	ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR; WNV; WNV IgG+IgM Pnl	4180186
36660722	WNV IgG+IgM Pnl Ser	4180186
36660722	西尼罗河病毒抗体.IgG 与 IgM 组套:-:时间点:血清:序数型	4182948
36660723	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
36660728	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes virus; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Malignant catarrhal fever; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; OvHV2; OvHV-2; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36660728	绵羊疱疹病毒 2 型 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36660728	OvHV2 DNA Ct Spec Qn NAA+probe	4180186
36660731	Coll; Collect; Collected; Dt of 1st pos specimen collection; Point in time; Pos; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36660731	Dt of 1st pos specimen collection	4180186
36660731	首次采集标本阳性的日期:日期:时间点:^患者:定量型	4182948
36660732	Deoxyribonucleic acid; HBV; HBV DNA Pnl; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Liver; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36660732	HBV DNA Pnl SerPl	4180186
36660732	乙型肝炎病毒 DNA 组套:-:时间点:血清/血浆:-	4182948
36660733	1 month; 1 month (30 days); 30 days; ADL; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Up	4180186
36660734	Blood; Chromosom; Chromosomes; Finding; Findings; Genetics; Heredity; Heritable; Inherited; MISC; Miscellaneous molecular pathology; Molecular genetics; Molecular pathology; MOLPATH; Narrative; PCR; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36660734	Chromosome aneup Bld/T	4180186
36660734	染色体非整倍体性详情:发现:时间点:全血/组织:叙述型:分子遗传学类实验室方法	4182948
36660738	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bhanja virus serocomplex; DNA NUCLEIC ACID PROBE; DNA probe; Heartland virus; HRTV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; lone star tick; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Phleboviruses; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36660738	HRTV RNA Spec Ql NAA+probe	4180186
36660738	心地班阳病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36660739	Blood; CD14 substypes; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; LeuM3; Leu-M3; Level; LPS receptor; LPS-R; Mass concentration; MEIA; Mo2; Mo-2; My4; My-4; Pl; PlasBld; Plasma; Plsm; Point in time; Presepsin; QNT; Quan; Quant; Quantitative; Random; sCD14 subtype; sCD14-ST; Sepsis Syndromes; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; SUDS; WB; Whole blood	4180186
36660739	sCD14-ST SerPlBld IA-mCnc	4180186
36660739	可溶性 CD14 亚型:质量浓度:时间点:血清/血浆/全血:定量型:免疫测定法	4182948
36660742	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K oxytoca; K oxytoca DNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36660742	K oxytoca DNA Lower resp Ql NAA+probe	4180186
36660742	产酸克雷伯菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36660745	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; H prism-out; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660745	Corr lens H prism-out by LM	4180186
36660745	水平棱镜.出射:长度倒数:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36660747	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
36660748	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36660749	ABS; Aby; ANA IgG; ANNA 2; ANNA-2; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Hu; Hu2; II; Immune globulin G; Immunoglobulin G; Neuronal nuclear type II; Nuc; Oncology; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RI; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36660749	Hu2 IgG CSF Ql Line blot	4180186
36660749	神经元细胞核 2 型 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
36660750	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36660750	Corr lens Prism by LM	4180186
36660750	棱镜:长度倒数:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36660783	H&P.HX	4180186
36660916	EYE.LENSOMETRY	4180186
36661369	SARS 冠状病毒 2 抗体:存在情况或阈值:时间点:血清/血浆/全血:序数型:免疫测定法.快速	4182948
36661369	SARS-CoV-2 Ab SerPlBld Ql IA.rapid	4180186
36661369	2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Severe Acute Respiratory Syndrome; SR; SUDS; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus	4180186
36661371	SARS-CoV-2 N gene Resp NAA+probe-Log#	4180186
36661371	SARS 冠状病毒 2 N 基因:对数型数量或计数浓度:时间点:呼吸道:定量型:探针法.基因扩增.靶向	4182948
36661371	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; PH; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; QNT; Quan; Quant; Quantitative; Random; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 N gene; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; Viral Pneumonias; Wuhan coronavirus	4180186
36661373	SARS-CoV-2 IgM Titr SerPl IF	4180186
36661373	SARS 冠状病毒 2 抗体.IgM:滴定度:时间点:血清/血浆:定量型:免疫荧光法	4182948
36661373	2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; II; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; PH; Pl; Plasma; Plsm; Point in time; Public Health; PublicHealth; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Viral Pneumonias; Wuhan coronavirus	4180186
36661377	SARS-CoV-2 RNA Resp Ql Seq	4180186
36661377	SARS 冠状病毒 2 RNA:存在情况或阈值:时间点:呼吸道:序数型:序列测定	4182948
36661377	2019 Novel Coronavirus; 2019-nCoV; Breathing; Corona virus; COVID19; COVID-19; high-throughput sequencing; HTS; ID; II; Infectious Disease; InfectiousDisease; Lungs; Microbiology; Next generation sequencing; NGS; Ordinal; PH; Point in time; PR; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; Ribonucleic acid; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; Severe Acute Respiratory Syndrome; Spec; Viral Pneumonias; Wuhan coronavirus	4180186
36661378	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Oral fluid; Ordinal; PCR; PH; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; QL; Qual; Qualitative; Random; Sal; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 N gene; Screen; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36661378	SARS-CoV-2 N gene Sal Ql NAA+probe	4180186
36661378	SARS 冠状病毒 2 N 基因:存在情况或阈值:时间点:唾液:序数型:探针法.基因扩增.靶向	4182948
36661380	就职于健康医疗服务场所:发现:时间点:^患者:序数型	4182948
36661380	AOEObservation; Employed in healthcare setting; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; PH; Point in time; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; Screen	4180186
36661380	Employed in healthcare setting	4180186
36661381	AOEObservation; Disease; Disorder; Finding; Findings; H+P; H+P.HX; Has symptoms for condition; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Sx; Virus	4180186
36661381	是否存在与所关注的情况相关的症状:发现:时间点:^患者:序数型	4182948
36661381	Has symptoms for condition	4180186
36661383	居住在聚居式照护服务场所:发现:时间点:^患者:序数型	4182948
36661383	AOEObservation; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36661383	Resides in a congregate care setting	4180186
36661384	流感病毒 A & 流感病毒 B & SARS 冠状病毒 2 & SARS-相关冠状病毒 RNA 组套:-:时间点:呼吸道:-:探针法.基因扩增.靶向	4182948
36661384	FluAB+SARS-CoV-2+SARSr-CoV Resp NAA+prb	4180186
36661384	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Breathing; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUABV + SARS-CoV-2; FLUABV+SARS-CoV-2+SARSr-CoV RNA pnl; FLUAV; FLUB; FLUBV; FLUV; Fowl plague; ID; II; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2+SARSr-CoV; SARS-CoV-2+SARSr-CoV RNA; SARS-CoV-2+SARSr-CoV RNA pnl; SARSr-CoV; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplifi...	4180186
36661391	Chair &or bed-to-chair transfer - most dependent performance during the past Mo	4180186
36661395	Carries something in both hands - most dependent performance during the past Mo	4180186
36661399	Go up and down a curb &or step - most dependent performance during the past Mo	4180186
36661408	Toileting hygiene - most dependent performance during the past Mo	4180186
36661412	Used or needed assistive devices in the past Mo	4180186
36661422	24r-Hydroxycalcidiol+24r-Hydroxyercalcidiol	4180186
36661430	ADRA2A gene.c.-1252G>C	4180186
36661454	Glutamate decarboxylase 65 Ab.IgG+IgM	4180186
36661470	Walks for 15M - most dependent performance during the past Mo	4180186
36661471	In the last 12Mo, did you ever cut the size of your meals or skip meals because there wasn't enough money for food	4180186
36661472	Cells.CD8.HLA-B35 CMV specific	4180186
36661476	PTEN gene deletion+duplication & full mutation analysis	4180186
36661494	Wheel 50 feet with two turns - most dependent performance during the past Mo	4180186
36661496	Paid caregiver's ability and willingness to provide medical procedure &or treatment assistance	4180186
36661504	Cells.CD8.HLA-B8 CMV specific	4180186
36661506	COVID-19+Progress note	4180186
36661507	SARS coronavirus 2 RNA	4180186
36661511	Cat recombinant (rFel d) 7 Ab.IgE	4180186
36661520	SARS coronavirus+SARS coronavirus 2 Ag	4180186
36661522	SARS coronavirus 2 RNA panel	4180186
36661543	CYP21A2 gene deletion+duplication & full mutation analysis	4180186
36661545	Walks indoors - most dependent performance during the past Mo	4180186
36661546	Borrelia burgdorferi G39_40 Ab.IgG bands	4180186
36661548	Dermatan sulfate & heparan sulfate & chondroitin-6-sulfate & keratan sulfate panel	4180186
36661550	Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to Prevacent	4180186
36661553	Cells.CD8.PMA+ionomycin stimulated CD107a+b expressing/100 cells.CD3+CD8+	4180186
36661560	Cells.CD8.HLA-B35 CMV specific.CMV antigen stimulated CD107a+b expressing	4180186
36661575	Candida albicans+dubliniensis+parapsilosis+tropicalis	4180186
36661576	VEGFA gene.c.-1154A>G	4180186
36661577	Hepatitis B virus surface Ag & little e Ab & Ag panel	4180186
36661578	PKLR gene deletion+duplication & full mutation analysis	4180186
36661582	Cells.CD8.HLA-B7 CMV specific.CMV antigen stimulated gamma interferon producing	4180186
36661599	Vertical prism.down	4180186
36661602	COVID-19	4180186
36661616	Upper body dressing - most dependent performance during the past Mo	4180186
36661620	Staphylococcus aureus & Staphylococcus aureus.methicillin resistant identified	4180186
36661630	UGT2B15 gene.c.253G>T	4180186
36661639	Go up and down a curb &or step - usual functional ability	4180186
36661643	Glasses.lens.left	4180186
36661644	OxyMORphone & Noroxymorphone panel	4180186
36661655	COVID-19+Consultation note	4180186
36661659	Hepatitis A virus Ab.IgM & total panel	4180186
36661664	Exposure source in 30D prior to onset of illness	4180186
36661665	Biliary tract neoplasm chromosome aneuploidy & cytology analysis	4180186
36661668	Lactobacillus crispatus+gasseri+jensenii+Gardnerella vaginalis+Atopobium vaginae rRNA	4180186
36661693	Makes a light hot meal - most dependent performance during the past Mo	4180186
36661695	HLA-DP & DQ & DR (class II) Ab.IgG with prozone effect	4180186
36661697	Simple financial management - most dependent performance during the past Mo	4180186
36661702	Has a partner threatened, shoved, hit or kicked you or hurt you physically in any way in the past 3Mo	4180186
36661705	In the last 12Mo, how often did you not eat for a whole day because there wasn't enough money for food	4180186
36661712	Car transfer - most dependent performance during the past Mo	4180186
36661721	Eating - most dependent performance during the past Mo	4180186
36661729	CD11a & CD11b & CD18 phenotyping panel	4180186
36661734	HLA-DRB3 & HLA-DRB4 & HLA DRB5	4180186
36661737	Altered level of consciousness in last 3D	4180186
36661739	Hepatitis A virus Ab.IgM panel	4180186
36661741	Need for and availability of a shower &or commode chair	4180186
36661746	COVID-19+Intubation+Consultation note	4180186
36661750	Toilet transfer - most dependent performance during the past Mo	4180186
36661751	GRIK4 gene.c.83-10039T>C	4180186
36661762	Walking 10 feet on uneven surfaces - most dependent performance during the past Mo	4180186
36661793	Wheel 150 feet - most dependent performance during the past Mo	4180186
36661795	BRCA1+BRCA2 gene deletion+duplication & full mutation analysis	4180186
36661797	MTHFR gene.c.677C>T & c.1298A>C	4180186
36661801	SARS coronavirus 2 RdRp gene	4180186
36661803	Need for and availability of a walk or wheel-in shower	4180186
36661804	Light daily housework - most dependent performance during the past Mo	4180186
36661805	Level of paid caregiver assistance in the past Mo	4180186
36661809	VEGFA gene.c.-1498C>G & c.-1498C>T	4180186
36661813	RptPeriod^max	4180186
36661818	COVID-19+Intubation+Progress note	4180186
36661822	HLA-DQA1 & HLA-DQB1 typing panel	4180186
36661828	COVID-19+Intubation+Procedure note	4180186
36661829	Celiac disease IgA & HLA typing & serology panel	4180186
36661832	PRKAR1A gene deletion+duplication & full mutation analysis	4180186
36661848	MLYCD gene deletion+duplication & full mutation analysis	4180186
36661870	Cells.CD8.HLA-A1 CMV specific.CMV antigen stimulated CD107a+b expressing	4180186
36661872	Vitamin B6 & metabolites panel	4180186
36661877	Cells.CD8.HLA-B8 CMV specific.CMV antigen stimulated CD107a+b expressing	4180186
36661882	Roll left and right - most dependent performance during the past Mo	4180186
36661903	RHD gene allele & RHCE gene allele	4180186
36661919	VEGFA gene.c.-634C>G	4180186
36661934	Intensive care unit discharge date	4180186
36661935	Putting on and taking off footwear - most dependent performance during the past Mo	4180186
36661937	In the last 12Mo, did any of the children ever skip meals because there wasn't enough money for food	4180186
36661939	Curvature radius.flat	4180186
36661942	Wound, Ostomy, and Continence Care.team	4180186
36661944	Cells.CD8.HLA-A1 CMV specific	4180186
36661958	CHRNA3 gene.c.645C>T	4180186
36661968	Shower &or bathe self - usual functional ability	4180186
36661969	In the last 12Mo, we couldn't afford to eat balanced meals	4180186
36661973	Hepatitis D virus Ab.IgM panel	4180186
36661975	SARS coronavirus 2 Ab.IgM	4180186
36661979	Views GE 6^W R-bending + W L-bending	4180186
36661982	Glasses.lens.right	4180186
36661991	Chromosome 1q & 9 & 11 & 15 aneuploidy & chromosome region 13q deletion	4180186
36662000	Picking up object - most dependent performance during the past Mo	4180186
36662005	Sulfocysteine, Hypoxanthine, Xanthine, Urate & Creatinine panel	4180186
36662007	Answering telephone call - most dependent performance during the past Mo	4180186
36662012	UGT1A1 gene.TA repeats	4180186
36662034	Wheels across a street - most dependent performance during the past Mo	4180186
36662040	Desmoglein 1 & Desmoglein 3 Ab.IgG panel	4180186
36662042	TP53 gene deletion+duplication & full mutation analysis	4180186
36662043	Walks for 15M - usual functional ability	4180186
36662047	In the last 12Mo, were the children ever hungry but you just couldn't afford more food	4180186
36662048	In the last 12Mo, I relied on only a few kinds of low-cost food to feed my children because I was running out of money to buy food	4180186
36662060	Hepatitis B virus core Ab.IgM panel	4180186
36662072	Probe.amp.tar.CDC primer-probe set N2	4180186
36662074	Cells.CD8.HLA-A1 CMV specific.CMV antigen stimulated gamma interferon producing	4180186
36662089	In the last 12Mo, how often did you cut the size of your meals or skip meals because there wasn't enough money for food	4180186
36662098	Self-care priorities for the next 6Mo	4180186
36662099	Placing telephone call - most dependent performance during the past Mo	4180186
36662100	SLC25A15 gene.c.562_564delTTC	4180186
36662103	FASI v1.0 - Motorized wheelchair &or scooter - most dependent performance	4180186
36662106	Lower body dressing - most dependent performance during the past Mo	4180186
36662109	SARS coronavirus 2 Ab.IgA	4180186
36662114	SEEK	4180186
36662117	Aldosterone & sodium panel	4180186
36662123	Borrelia burgdorferi 49736 Ab.IgG bands	4180186
36662126	COVID-19+Initial evaluation form	4180186
36662133	STK11 gene deletion+duplication & full mutation analysis	4180186
36662135	Coagulation factor VIII activity & inhibitor panel	4180186
36662147	Voltage-gated calcium channel N type binding Ab.IgG+IgM	4180186
36662148	Medical aid in dying.patient	4180186
36662157	Walk 10 feet - most dependent performance during the past Mo	4180186
36662159	In the last 12Mo, did you ever eat less than you felt you should because there wasn't enough money for food	4180186
36662165	HLA-DP & DQ & DR (class II) Ab.IgG low risk	4180186
36662169	Living arrangement during the past 1Mo	4180186
36662171	GRHPR gene deletion+duplication & full mutation analysis	4180186
36662173	pVNT	4180186
36662184	Calculated.ExoDx	4180186
36662203	Apis mellifera dipeptidyl peptidase recombinant (rApi m) 5	4180186
36662211	Cells.CD8.HLA-B35 CMV specific.CMV antigen stimulated gamma interferon producing	4180186
36662213	Cells.CD8.PMA+ionomycin stimulated gamma interferon producing	4180186
36662221	Medication management.oral medications - most dependent performance during the past Mo	4180186
36662223	Go up and down 4 steps - most dependent performance during the past Mo	4180186
36662226	VEGFA gene.c.-2578A>C & c.-2578A>T	4180186
36662245	PAM.Revised	4180186
36662267	HLA-A & B & C (class I) Ab.IgG high risk	4180186
36662269	Cells.CD8.HLA-B8 CMV specific.CMV antigen stimulated gamma interferon producing	4180186
36662275	In the last 12Mo, how often did any of the children skip meals because there wasn't enough money for food	4180186
36662277	Medication management.inhalant &or mist medications - most dependent performance during the past Mo	4180186
36662278	Medication management.inhalant &or mist medications - usual functional ability	4180186
36662596	This parent group contains a single group of LOINC terms for detection of SARS-CoV-2 antibodies.	4180186
36674184	Assessment using Goal Attainment Scaling-Light	4180186
36674184	Assessment using Goal Attainment Scaling-Light (procedure)	4180186
36674185	Burn of eye proper (disorder)	4180186
36674187	Second diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus immunization	4180186
36674187	Second diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus immunisation	4180186
36674187	Second diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus vaccination	4180186
36674187	Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)	4180186
36674187	Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens	4180186
36674188	Seen in diabetes preconception counseling clinic (finding)	4180186
36674188	Seen in diabetes preconception counselling clinic	4180186
36674189	GPCOG - General Practitioner Assessment of Cognition	4180186
36674189	General Practitioner Assessment of Cognition (assessment scale)	4180186
36674190	2p21 microdeletion syndrome without cystinuria (disorder)	4180186
36674192	2p13.2 microdeletion syndrome (disorder)	4180186
36674194	New-onset refractory status epilepticus (disorder)	4180186
36674194	NORSE - new-onset refractory status epilepticus	4180186
36674195	Autosomal dominant intermediate Charcot-Marie-Tooth disease type F (disorder)	4180186
36674196	16q24.1 microdeletion syndrome (disorder)	4180186
36674196	Monosomy 16q24.1	4180186
36674198	External drainage of lymph node abscess (procedure)	4180186
36674199	Proliferative diabetic retinopathy of right eye	4180186
36674199	Proliferative retinopathy of right eye due to diabetes mellitus (disorder)	4180186
36674199	Proliferative retinopathy of right eye due to diabetes mellitus	4180186
36674201	Product containing semaglutide in parenteral dose form (medicinal product form)	4180186
36674206	Superficial burn of skin of upper and lower lip	4180186
36674206	Epidermal burn of skin of upper and lower lip (disorder)	4180186
36674206	First degree burn of skin of upper and lower lip	4180186
36674206	Burn erythema of skin of upper and lower lip	4180186
36674207	Third degree burn of skin and subcutaneous tissue of upper and lower lip	4180186
36674207	Full thickness burn of skin and subcutaneous tissue of upper and lower lip (disorder)	4180186
36674210	Extension Namespace {1000219} (namespace concept)	4180186
36674210	Extension Namespace {1000219}	4180186
36674211	Medication review invitation (procedure)	4180186
36674215	Product containing ceftaroline in parenteral dose form (medicinal product form)	4180186
36674219	Product containing atropine and edrophonium (medicinal product)	4180186
36674220	Product containing caffeine and isometheptene and paracetamol (medicinal product)	4180186
36674220	Caffeine- and isometheptene- and paracetamol-containing product	4180186
36674225	Adverse reaction caused by coagulation factor	4180186
36674225	Adverse reaction caused by clotting factor	4180186
36674225	Adverse reaction caused by coagulation protein (disorder)	4180186
36674229	Superficial bite wound (morphologic abnormality)	4180186
36674231	Hyoscine- and papaveretum-containing product	4180186
36674231	Product containing papaveretum and scopolamine (medicinal product)	4180186
36674232	Product containing pyridoxal (medicinal product)	4180186
36674233	Product containing hydrocortisone and neomycin and polymyxin B (medicinal product)	4180186
36674234	Bite of seal (event)	4180186
36674244	Injection of left facet joint of cervical spine using fluoroscopic guidance	4180186
36674244	Injection of left facet joint of cervical spine using fluoroscopic guidance (procedure)	4180186
36674246	Injection of left facet joint of thoracic spine using fluoroscopic guidance (procedure)	4180186
36674246	Injection of left facet joint of thoracic spine using fluoroscopic guidance	4180186
36674251	Deep third degree burn of head and/or neck (disorder)	4180186
36674252	Infection caused by Coccidia co-occurrent with acquired immunodeficiency syndrome (disorder)	4180186
36674252	Coccidiosis co-occurrent with AIDS	4180186
36674253	Infection caused by Toxoplasma gondii co-occurrent with AIDS	4180186
36674253	Infection caused by Toxoplasma gondii co-occurrent with acquired immunodeficiency syndrome (disorder)	4180186
36674254	Infection caused by Isospora co-occurrent with acquired immunodeficiency syndrome (disorder)	4180186
36674254	Infection caused by Isospora co-occurrent with AIDS	4180186
36674255	Injection of right facet joint of lumbar spine using fluoroscopic guidance (procedure)	4180186
36674255	Injection of right facet joint of lumbar spine using fluoroscopic guidance	4180186
36674259	Leucoencephalopathy, palmoplantar keratoderma syndrome	4180186
36674259	Leukoencephalopathy, palmoplantar keratoderma syndrome (disorder)	4180186
36674262	CACP syndrome	4180186
36674262	Arthropathy camptodactyly syndrome	4180186
36674262	CACP (camptodactyly, arthropathy, coxa-vara, pericarditis) syndrome	4180186
36674262	Camptodactyly, arthropathy, coxa-vara, pericarditis syndrome (disorder)	4180186
36674262	Jacobs syndrome	4180186
36674262	Pericarditis, arthropathy, camptodactyly syndrome	4180186
36674267	Partial thickness burn of head and/or neck (disorder)	4180186
36674267	Second degree burn of head and/or neck	4180186
36674268	First degree burn of head and/or neck	4180186
36674268	Burn erythema of head and/or neck	4180186
36674268	Superficial burn of head and/or neck	4180186
36674268	Epidermal burn of head and/or neck (disorder)	4180186
36674269	Infantile epileptic dyskinetic encephalopathy (disorder)	4180186
36674273	Epithelial keratitis caused by infection (disorder)	4180186
36674273	Epithelial keratitis caused by infection	4180186
36674274	Inflammatory myofibroblastic tumour	4180186
36674274	Inflammatory myofibroblastic tumor (disorder)	4180186
36674275	Isolated bilateral hemispheric cerebellar hypoplasia (disorder)	4180186
36674277	Visceral calciphylaxis (disorder)	4180186
36674280	Distal arthrogryposis type 8	4180186
36674280	Autosomal dominant multiple pterygium syndrome (disorder)	4180186
36674281	Radioisotope labeled flumazenil (substance)	4180186
36674281	Radioisotope labelled flumazenil	4180186
36674282	Hashimoto encephalitis	4180186
36674282	SREAT - steroid-responsive encephalopathy associated with autoimmune thyroiditis	4180186
36674282	Steroid-responsive encephalopathy associated with autoimmune thyroiditis (disorder)	4180186
36674283	Congenital muscular dystrophy due to lamin A/C mutation (disorder)	4180186
36674283	Congenital muscular dystrophy due to lamin A/C mutation	4180186
36674283	LMNA-related congenital muscular dystrophy	4180186
36674283	Congenital muscular dystrophy due to LMNA (lamin A/C) mutation	4180186
36674284	Ferriman-Gallwey scale (assessment scale)	4180186
36674285	Product containing halcinonide in cutaneous dose form (medicinal product form)	4180186
36674287	Product containing clobetasol in cutaneous dose form (medicinal product form)	4180186
36674289	Product containing triazine derivative (product)	4180186
36674294	Food lodged in esophagus (disorder)	4180186
36674294	Food lodged in oesophagus	4180186
36674297	Substance with cellular transport inhibitor mechanism of action (substance)	4180186
36674302	Delirium following surgical procedure	4180186
36674302	Delirium following surgical procedure (disorder)	4180186
36674303	Hyperactive delirium following surgical procedure	4180186
36674303	Hyperactive delirium following surgical procedure (disorder)	4180186
36674304	Drupe of genus Prunus	4180186
36674304	Stone fruit of genus Prunus (substance)	4180186
36674306	Fiberoptic endoscopic mucosal resection of lesion of colon	4180186
36674306	Fibreoptic endoscopic mucosal resection of lesion of colon	4180186
36674306	Fiberoptic endoscopic excision of lesion of colonic mucous membrane (procedure)	4180186
36674306	Fibreoptic endoscopic excision of lesion of colonic mucous membrane	4180186
36674308	Laparoscopic repair of epigastric hernia using biological mesh (procedure)	4180186
36674308	Laparoscopic epigastric hernioplasty using biological mesh	4180186
36674309	Product containing tetracaine in cutaneous dose form (medicinal product form)	4180186
36674310	Injection of radioactive isotope into synovial membrane using imaging guidance (procedure)	4180186
36674310	Imaging guided injection of radioactive isotope into synovial membrane	4180186
36674311	Nail regrowth due to and following chemical destruction of nail bed (disorder)	4180186
36674312	Genus Pseudoglutamicibacter (organism)	4180186
36674312	Genus Pseudoglutamicibacter	4180186
36674316	Product containing coagulation factor Xa in parenteral dose form (medicinal product form)	4180186
36674317	Burosumab (substance)	4180186
36674318	Laparoscopic incisional hernioplasty using synthetic mesh	4180186
36674318	Laparoscopic repair of incisional hernia using synthetic mesh (procedure)	4180186
36674319	Laparoscopic repair of incisional hernia using biological mesh (procedure)	4180186
36674319	Laparoscopic incisional hernioplasty using biological mesh	4180186
36674322	NUDT15 intermediate metaboliser	4180186
36674322	Nudix hydrolase 15 intermediate metabolizer (finding)	4180186
36674322	Nudix hydrolase 15 intermediate metabolizer	4180186
36674322	Nudix hydrolase 15 intermediate metaboliser	4180186
36674331	Bictegravir (substance)	4180186
36674332	Bictegravir sodium (substance)	4180186
36674335	Product containing only abacavir and lamivudine and zidovudine (medicinal product)	4180186
36674337	Mitogen-activated protein kinase kinase 2 inhibitor (disposition)	4180186
36674339	Encorafenib (substance)	4180186
36674341	Product containing antidiuretic hormone (medicinal product)	4180186
36674343	Obstruction co-occurrent and due to paraesophageal hernia (disorder)	4180186
36674343	Obstruction co-occurrent and due to paraoesophageal hernia	4180186
36674344	Type 2 diabetes mellitus risk assessment declined (situation)	4180186
36674344	Type II diabetes mellitus risk assessment declined	4180186
36674345	Organ donor card (record artifact)	4180186
36674346	Sarcopenia (disorder)	4180186
36674346	Age-related loss of skeletal muscle mass	4180186
36674346	Loss of skeletal muscle mass	4180186
36674350	Product containing nicotine in oromucosal dose form (medicinal product form)	4180186
36674352	Buccal dose form (dose form)	4180186
36674353	Influenza A virus subtype H3N8 (organism)	4180186
36674354	Intoxication caused by recreational drug misuse (disorder)	4180186
36674356	Amidotrizoic acid (substance)	4180186
36674357	Laparoscopic augmentation of lower esophageal sphincter using magnetic titanium ring (procedure)	4180186
36674357	Laparoscopic augmentation of lower oesophageal sphincter using magnetic titanium ring	4180186
36674358	Endoscopic snare resection of lesion of colon using full thickness resection device (procedure)	4180186
36674364	Product containing ivosidenib (medicinal product)	4180186
36674367	Heel sliding pad exerciser (physical object)	4180186
36674368	Paediatric dorsiflexion slant board	4180186
36674368	Pediatric dorsiflexion slant board (physical object)	4180186
36674371	Product containing only morphine (medicinal product)	4180186
36674372	Allergy to triclofos (finding)	4180186
36674372	Triclofos allergy	4180186
36674373	Unable to initiate gait (finding)	4180186
36674374	Able to initiate gait (finding)	4180186
36674375	Emergency medicine (qualifier value)	4180186
36674376	Sting by wasp (event)	4180186
36674377	Sting by ant (event)	4180186
36674378	Sting by hornet (event)	4180186
36674380	Proliferative hyperkeratosis (morphologic abnormality)	4180186
36674381	Acanthoma of nail matrix	4180186
36674381	Onychocytic matricoma (disorder)	4180186
36674382	Painful orbital and systemic neurofibroma, marfanoid habitus syndrome (disorder)	4180186
36674383	MCAHS (multiple congenital anomalies, hypotonia, seizures syndrome) type 2	4180186
36674383	Multiple congenital anomalies, hypotonia, seizures syndrome type 2 (disorder)	4180186
36674385	Hereditary infantile gigantism	4180186
36674385	Familial infantile gigantism (disorder)	4180186
36674385	Infantile gigantism due to pituitary hyperplasia	4180186
36674387	Nasoduodenal feeding tube (physical object)	4180186
36674388	Hypercholesterolaemia due to cholesterol 7alpha-hydroxylase deficiency	4180186
36674388	Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency (disorder)	4180186
36674389	Autosomal dominant rhegmatogenous retinal detachment (disorder)	4180186
36674391	XMPMA - X-linked myopathy with postural muscle atrophy	4180186
36674391	X-linked myopathy with postural muscle atrophy (disorder)	4180186
36674394	Humero-radio-ulnar fusion	4180186
36674394	Humeroradioulnar synostosis (disorder)	4180186
36674394	Humero-radio-ulnar synostosis	4180186
36674396	Deafness with onychodystrophy syndrome (disorder)	4180186
36674400	Gardner Silengo Wachtel syndrome	4180186
36674400	Genitopalatocardiac syndrome (disorder)	4180186
36674401	Simosa craniofacial syndrome	4180186
36674401	Flat face, microstomia, ear anomaly syndrome (disorder)	4180186
36674401	Blepharophimosis, telecanthus, microstomia syndrome	4180186
36674401	Simosa Penchaszadeh Bustos syndrome	4180186
36674402	Shiga toxin-producing E. coli serotype O123:H2	4180186
36674402	STEC (Shiga toxin-producing Escherichia coli) Serotype O123:H2	4180186
36674402	Shiga toxin-producing Escherichia coli serotype O123:H2 (organism)	4180186
36674403	Cyphellophora laciniata (organism)	4180186
36674404	Cyphellophora pluriseptata (organism)	4180186
36674405	Ant venom (substance)	4180186
36674406	Mollusk venom (substance)	4180186
36674406	Mollusc venom	4180186
36674411	Hand and foot deformity, flat facies syndrome	4180186
36674411	Emery Nelson syndrome (disorder)	4180186
36674412	Ataxia, photosensitivity, short stature syndrome (disorder)	4180186
36674412	Fenton Wilkinson Toselano syndrome	4180186
36674415	Product containing antisense oligonucleotide (product)	4180186
36674417	Amputation of left forefoot (procedure)	4180186
36674418	Consumer product (product)	4180186
36674420	Ceruminolytic therapeutic role (role)	4180186
36674422	Stool softener therapeutic role (role)	4180186
36674427	Anesthetic therapeutic role (role)	4180186
36674427	Anaesthetic therapeutic role	4180186
36674428	Antacid therapeutic role (role)	4180186
36674431	Medicinal product acting as antimigraine agent (product)	4180186
36674435	Aquaretic therapeutic role (role)	4180186
36674438	Contraceptive therapeutic role (role)	4180186
36674439	Diuretic therapeutic role (role)	4180186
36674441	Emollient therapeutic role (role)	4180186
36674442	Expectorant therapeutic role (role)	4180186
36674443	Gallstone solubilizer therapeutic role (role)	4180186
36674446	Irritant therapeutic role (role)	4180186
36674447	Keratolytic therapeutic role (role)	4180186
36674448	Product containing nerve growth factor agonist (product)	4180186
36674450	Bursitis of left hip (disorder)	4180186
36674452	Extension Namespace {1000224}	4180186
36674452	Extension Namespace {1000224} (namespace concept)	4180186
36674453	Dermatology care plan (record artifact)	4180186
36674455	Endocrinology care plan (record artifact)	4180186
36674456	Prosthetic care plan (record artifact)	4180186
36674457	Orthotic care plan (record artifact)	4180186
36674458	Palliative care plan (record artifact)	4180186
36674460	ENT (ear, nose, throat) care plan	4180186
36674460	Ear, nose and throat care plan (record artifact)	4180186
36674462	Peripheral dysostosis (disorder)	4180186
36674465	Medicinal product acting as bowel cleanser (product)	4180186
36674467	High intensity focused ultrasound ablation of lesion of breast using magnetic resonance imaging guidance	4180186
36674467	High intensity focused ultrasound ablation of lesion of breast using magnetic resonance imaging guidance (procedure)	4180186
36674468	High intensity focused ultrasound ablation of lesion of bone using magnetic resonance imaging guidance (procedure)	4180186
36674468	High intensity focused ultrasound ablation of lesion of bone using magnetic resonance imaging guidance	4180186
36674469	Leukonychia totalis, trichilemmal cysts, ciliary dystrophy syndrome (disorder)	4180186
36674469	Leukonychia totalis, trichilemmal cysts, ciliary dystrophy syndrome	4180186
36674470	Familial angiolipomatosis (disorder)	4180186
36674472	Protein kinase cAMP-dependent type I regulatory subunit beta-related neurodegenerative dementia with intermediate filaments (disorder)	4180186
36674472	Protein kinase cAMP-dependent type I regulatory subunit beta-related neurodegenerative dementia with intermediate filaments	4180186
36674474	Pancytopenia with developmental delay syndrome (disorder)	4180186
36674474	Trilineage bone marrow failure with developmental delay syndrome	4180186
36674475	Neonatal scleroderma (disorder)	4180186
36674476	Proper part of (attribute)	4180186
36674477	Neonatal dermatomyositis (disorder)	4180186
36674479	Neonatal antiphospholipid syndrome (disorder)	4180186
36674479	Neonatal Hughes syndrome	4180186
36674479	Neonatal antiphospholipid antibody syndrome	4180186
36674482	Assessment using Age, Blood pressure, Clinical features, Duration, Diabetes 2 score (procedure)	4180186
36674482	Assessment using ABCD2 (Age, Blood pressure, Clinical features, Duration, Diabetes) stroke risk score	4180186
36674482	Assessment using ABCD2 (Age, Blood pressure, Clinical features, Duration, Diabetes) score	4180186
36674485	Assessment using AUDIT-PC (Alcohol Use Disorders Identification Test for Primary Care)	4180186
36674485	Assessment using Alcohol Use Disorders Identification Test Piccinelli Consumption	4180186
36674485	Assessment using Alcohol Use Disorders Identification Test for Primary Care (procedure)	4180186
36674487	Alcohol Dependence Scale total score (observable entity)	4180186
36674487	Alcohol Dependence Scale total score	4180186
36674488	Global Deterioration Scale (assessment scale)	4180186
36674488	GDS - Global Deterioration Scale	4180186
36674493	Helium and/or helium compound (substance)	4180186
36674493	Helium and/or helium compound	4180186
36674493	Helium and helium compound (substance)	4180186
36674496	Radon and/or radon compound (substance)	4180186
36674496	Radon and/or radon compound	4180186
36674496	Radon and radon compound (substance)	4180186
36674497	Eravacycline (substance)	4180186
36674498	Product containing eravacycline (medicinal product)	4180186
36674499	Product containing eravacycline in parenteral dose form (medicinal product form)	4180186
36674500	Product containing castor oil (medicinal product)	4180186
36674502	Product containing only amorolfine (medicinal product)	4180186
36674510	Securing of catheter (procedure)	4180186
36674511	Neonatal clicking hip (finding)	4180186
36674515	Syndromic multisystem autoimmune disease due to itchy E3 ubiquitin protein ligase deficiency	4180186
36674515	Syndromic multisystem autoimmune disease due to itchy E3 ubiquitin protein ligase deficiency (disorder)	4180186
36674516	Monocytopenia and mycobacterial infection syndrome	4180186
36674516	Monocyte-B natural killer dendritic cell deficiency syndrome	4180186
36674516	Dendritic cell, monocyte, B and NK lymphoid deficiency	4180186
36674516	Monocytopenia with susceptibility to infections (disorder)	4180186
36674516	MonoMAC	4180186
36674516	Combined immunodeficiency with susceptibility to mycobacterial, viral and fungal infection	4180186
36674518	Lethal polymalformative syndrome Boissel type (disorder)	4180186
36674519	Primary CD59 deficiency (disorder)	4180186
36674520	Product containing only everolimus (medicinal product)	4180186
36674521	Tissue engineered blood vessel (substance)	4180186
36674521	TEBV - tissue engineered blood vessel	4180186
36674524	Harvest of bone graft from tibia and fibula (procedure)	4180186
36674526	Harvest of bone graft from patella (procedure)	4180186
36674527	Harvesting of bone graft from femur (procedure)	4180186
36674527	Harvest of bone graft from femur	4180186
36674529	Genus Emmonsia (organism)	4180186
36674529	Emmonsia	4180186
36674532	Cladophialophora arxii (organism)	4180186
36674538	Perenniporia	4180186
36674538	Genus Perenniporia (organism)	4180186
36674541	Product containing nonacog alfa (medicinal product)	4180186
36674542	Product containing only nonacog alfa (medicinal product)	4180186
36674544	Product containing only elbasvir and grazoprevir in oral dose form (medicinal product form)	4180186
36674549	Arctictis	4180186
36674549	Genus Arctictis (organism)	4180186
36674553	Product containing only omadacycline in oral dose form (medicinal product form)	4180186
36674554	Product containing omadacycline in parenteral dose form (medicinal product form)	4180186
36674555	Hyperemia of eye (finding)	4180186
36674555	Ocular hyperemia	4180186
36674555	Bloodshot eye	4180186
36674555	Ocular hyperaemia	4180186
36674555	Hyperaemia of eye	4180186
36674557	Metoserpate (substance)	4180186
36674558	Grandiniella sordida	4180186
36674558	Corticium sordidum	4180186
36674558	Peniophora sordida	4180186
36674558	Peniophora sordidella	4180186
36674558	Hypochnus sordidellus	4180186
36674558	Terana sordida	4180186
36674558	Phanerochaete sordida (organism)	4180186
36674560	Shiga toxin-producing Escherichia coli serogroup O130 (organism)	4180186
36674560	STEC (Shiga toxin-producing Escherichia coli) serogroup O130	4180186
36674560	Shiga toxin-producing E. coli serogroup O130	4180186
36674561	Intolerance to lactose due to nonpersistence of intestinal lactase (finding)	4180186
36674562	MSG (monosodium glutamate) intolerance	4180186
36674562	E621 intolerance	4180186
36674562	Monosodium glutamate intolerance	4180186
36674562	Sodium hydrogen L-glutamate intolerance	4180186
36674562	Intolerance to monosodium glutamate (finding)	4180186
36674563	Sucrose intolerance due to sucrase-isomaltase deficiency (finding)	4180186
36674564	Acquired intolerance to fructose (finding)	4180186
36674565	STEC (Shiga toxin-producing Escherichia coli) serotype O103:H25	4180186
36674565	Shiga toxin-producing E. coli serotype O103:H25	4180186
36674565	Shiga toxin-producing Escherichia coli serotype O103:H25 (organism)	4180186
36674568	Nodule of subcutaneous tissue of foot (finding)	4180186
36674569	Petriella guttulata (organism)	4180186
36674569	Microascus guttulatus	4180186
36674570	Pestalotiopsis uvicola (organism)	4180186
36674570	Pestalotia uvicola	4180186
36674571	Pestalotiopsis monochaeta (organism)	4180186
36674572	Pestalotia disseminata	4180186
36674572	Pestalotiopsis disseminata (organism)	4180186
36674575	Shewanella fodinae (organism)	4180186
36674576	Intolerance to glycerol (finding)	4180186
36674577	Intolerance to lactose (finding)	4180186
36674578	Microvirga vignae (organism)	4180186
36674579	Product containing galcanezumab (medicinal product)	4180186
36674582	Product containing only amikacin liposome in pulmonary dose form (medicinal product form)	4180186
36674583	Product containing galcanezumab in parenteral dose form (medicinal product form)	4180186
36674584	N,N-dimethylformamide (substance)	4180186
36674585	Product containing only galcanezumab in parenteral dose form (medicinal product form)	4180186
36674589	Product containing only levofolinic acid in parenteral dose form (medicinal product form)	4180186
36674589	Levofolinic acid only product in parenteral dose form	4180186
36674591	Bothriocephalidea	4180186
36674591	Order Bothriocephalidea (organism)	4180186
36674592	Disease caused by cestode of order Bothriocephalidea	4180186
36674592	Disease caused by cestode of order Bothriocephalidea (disorder)	4180186
36674594	Allergy to dihydroergocristine and dihydroergocornine and dihydroergocryptine (finding)	4180186
36674596	Substance with arachidonate 5-lipoxygenase inhibitor mechanism of action (substance)	4180186
36674605	Test of problem solving (assessment scale)	4180186
36674606	Assessment using test of problem solving (procedure)	4180186
36674608	Examination for sexual abuse done (situation)	4180186
36674609	Metastatic HER2 positive neoplasm of gastroesophageal junction	4180186
36674609	Metastatic HER2 positive neoplasm of gastroesophageal junction (disorder)	4180186
36674613	Flexion deformity of finger of left hand (finding)	4180186
36674616	Bone quality assessment using in vivo microindentation (procedure)	4180186
36674618	Decision support system	4180186
36674618	Decision support tool (physical object)	4180186
36674620	Parentcraft education (procedure)	4180186
36674621	Alkindi (product)	4180186
36674625	Generic Tearmos eye drops (product)	4180186
36674628	Esketamine (substance)	4180186
36674629	Formaldehyde 0.75% gel (product)	4180186
36674630	Methadone 2mg/5ml linctus (product)	4180186
36674631	Bladder irrigation (qualifier value)	4180186
36674632	Resolution Chemicals Ltd (qualifier value)	4180186
36674635	Hydroquinone 5% cream 1 gram (product)	4180186
36674636	Brigatinib (product)	4180186
36674641	Mobilisation of shoulder girdle	4180186
36674641	Mobilization of shoulder girdle (regime/therapy)	4180186
36674642	Viral sepsis	4180186
36674642	Sepsis caused by virus (disorder)	4180186
36674643	Aeromicrobium choanae (organism)	4180186
36674644	Deep third degree burn of buttock (disorder)	4180186
36674646	Deep third degree burns of multiple sites of trunk (disorder)	4180186
36674646	Deep full thickness burns of multiple sites of trunk	4180186
36674648	Paenibacillus ginsengihumi (organism)	4180186
36674649	Deep third degree burn of upper and lower lip (disorder)	4180186
36674650	Ethyl glucuronide (substance)	4180186
36674653	2-hydroxybutyrate dehydrogenase (substance)	4180186
36674657	Product containing phosphoinositide 3 kinase inhibitor (product)	4180186
36674659	Product containing polyadenosine 5'-diphosphoribose polymerase inhibitor (product)	4180186
36674660	Product containing vasopressin receptor antagonist (product)	4180186
36674663	Product containing 5-alpha reductase inhibitor (product)	4180186
36674665	Product containing acaricide (product)	4180186
36674667	Order Eggerthellales (organism)	4180186
36674667	Eggerthellales	4180186
36674668	Family Eggerthellaceae (organism)	4180186
36674668	Eggerthellaceae	4180186
36674669	Genus Raoultibacter (organism)	4180186
36674669	Raoultibacter	4180186
36674671	Product containing antischistosomal (product)	4180186
36674672	Medicinal product containing aminoglycoside and acting as antibacterial agent (product)	4180186
36674674	Product containing coagulation factor inhibitor (product)	4180186
36674676	Product containing non-specific protein-tyrosine kinase inhibitor (product)	4180186
36674677	Carbapenemase-producing Raoultella (organism)	4180186
36674678	Product containing nucleotide (product)	4180186
36674681	Product containing pyrazine (product)	4180186
36674682	Fourth degree burn of finger	4180186
36674682	Deep full thickness burn of finger (disorder)	4180186
36674687	Aleukaemic mast cell leukaemia	4180186
36674687	Aleukemic mast cell leukemia (disorder)	4180186
36674693	Crossed polysyndactyly (disorder)	4180186
36674695	Distal monosomy 19p13.3 (disorder)	4180186
36674698	Alport syndrome (disorder)	4180186
36674699	Product containing amoxicillin and clavulanic acid in oral dose form (medicinal product form)	4180186
36674700	Product containing amoxicillin and clavulanic acid in parenteral dose form (medicinal product form)	4180186
36674701	Product containing trimethadione in oral dose form (medicinal product form)	4180186
36674703	Product containing loprazolam in oral dose form (medicinal product form)	4180186
36674704	Product containing lormetazepam in oral dose form (medicinal product form)	4180186
36674706	Product containing treosulfan in parenteral dose form (medicinal product form)	4180186
36674708	Product containing trilostane in oral dose form (medicinal product form)	4180186
36674709	Product containing trientine in oral dose form (medicinal product form)	4180186
36674712	Early-onset epileptic encephalopathy and intellectual disability due to glutamate receptor, ionotropic, N-methyl-D-aspartate, subunit 2A mutation (disorder)	4180186
36674712	Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A (glutamate receptor, ionotropic, N-methyl-D-aspartate, subunit 2A) mutation	4180186
36674712	Early-onset epileptic encephalopathy and intellectual disability due to glutamate receptor, ionotropic, N-methyl-D-aspartate, subunit 2A mutation	4180186
36674715	Familial benign flecked retina (disorder)	4180186
36674716	Familial BAV (bicuspid aortic valve)	4180186
36674716	Familial bicuspid aortic valve (disorder)	4180186
36674720	TSQ (Trauma Screening Questionnaire) score	4180186
36674720	Trauma Screening Questionnaire score (observable entity)	4180186
36674721	Trauma Screening Questionnaire (assessment scale)	4180186
36674721	TSQ - Trauma Screening Questionnaire	4180186
36674722	Assessment using Trauma Screening Questionnaire (procedure)	4180186
36674722	Assessment using TSQ (Trauma Screening Questionnaire)	4180186
36674723	Isochromosomy Yq (disorder)	4180186
36674724	Congenital hypoplasia of part of upper limb (disorder)	4180186
36674726	Allergic contact dermatitis caused by iodine (disorder)	4180186
36674727	Mortality Prediction Model II score (observable entity)	4180186
36674727	Mortality Prediction Model II score	4180186
36674727	Mortality Probability Model II score	4180186
36674729	ZASP related myofibrillar myopathy	4180186
36674729	Late-onset distal myopathy Markesbery Griggs type (disorder)	4180186
36674729	ZASP (Z-band alternatively spliced PDZ motif protein) related myofibrillar myopathy	4180186
36674730	Leiomyosarcoma of body of uterus	4180186
36674730	Leiomyosarcoma of corpus uteri (disorder)	4180186
36674731	PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1) related lissencephaly	4180186
36674731	Lissencephaly due to LIS1 mutation (disorder)	4180186
36674731	PAFAH1B1-related lissencephaly	4180186
36674733	Maternal uniparental disomy of chromosome 1 (disorder)	4180186
36674734	Maternal uniparental disomy of chromosome 13 (disorder)	4180186
36674735	Microcephalic primordial dwarfism Alazami type (disorder)	4180186
36674735	Alazami syndrome	4180186
36674736	Microcephalic primordial dwarfism Dauber type (disorder)	4180186
36674739	Biopsy of right breast using digital tomosynthesis guidance (procedure)	4180186
36674739	Biopsy of right breast using digital tomosynthesis guidance	4180186
36674743	Endoscopic ultrasound report (record artifact)	4180186
36674744	Airway endoscopy report (record artifact)	4180186
36674746	Endobronchial ultrasound report (record artifact)	4180186
36674749	Ultrasound scan of soft tissue of lumbar region of back	4180186
36674749	Ultrasound of soft tissue of lumbar region of back	4180186
36674749	Ultrasonography of soft tissue of lumbar region of back (procedure)	4180186
36674751	High intensity focused ultrasound ablation of lesion of breast (procedure)	4180186
36674752	Retinal microaneurysm of right eye with diabetes mellitus	4180186
36674752	Diabetic retinal microaneurysm of right eye	4180186
36674752	Microaneurysm of right retinal artery due to diabetes mellitus (disorder)	4180186
36674753	Diabetic retinal microaneurysm of left eye	4180186
36674753	Retinal microaneurysm of left eye with diabetes mellitus	4180186
36674753	Microaneurysm of left retinal artery due to diabetes mellitus (disorder)	4180186
36674754	Ultrasound guided localization of lesion with dye	4180186
36674754	Localization of lesion with diagnostic dye using ultrasonographic guidance (procedure)	4180186
36674754	Localization of lesion with diagnostic dye using ultrasonographic guidance	4180186
36674754	Localisation of lesion with diagnostic dye using ultrasonographic guidance	4180186
36674754	Ultrasonography guided localisation of lesion with diagnostic dye	4180186
36674754	Ultrasound guided localisation of lesion with dye	4180186
36674755	Cryoablation of lesion using ultrasonography guidance	4180186
36674755	Ultrasound guided cryoablation of lesion	4180186
36674755	Cryoablation of lesion using ultrasonography guidance (procedure)	4180186
36674759	Pseudounicornuate uterus (disorder)	4180186
36674759	Incomplete unilateral aplasia of Mullerian ducts	4180186
36674759	Incomplete unilateral Mullerian aplasia	4180186
36674759	Unicornuate uterus with rudimentary horn	4180186
36674760	Proton pump inhibitor responsive eosinophilic esophagitis (disorder)	4180186
36674760	Proton pump inhibitor responsive eosinophilic oesophagitis	4180186
36674760	PPI-REE - proton pump inhibitor responsive eosinophilic oesophagitis	4180186
36674760	PPI-REE - proton pump inhibitor responsive eosinophilic esophagitis	4180186
36674761	Refractory sprue	4180186
36674761	Refractory coeliac disease	4180186
36674761	Refractory celiac disease (disorder)	4180186
36674763	Ring chromosome 12 syndrome (disorder)	4180186
36674763	Ring chromosome 12	4180186
36674764	Immune-mediated rippling muscle disease	4180186
36674764	Acquired rippling muscle disease	4180186
36674764	Rippling muscle disease with myasthenia gravis (disorder)	4180186
36674768	Exocrine pancreatic squamous cell carcinoma	4180186
36674768	Squamous cell carcinoma of exocrine pancreas (disorder)	4180186
36674771	Total replacement of left hip joint (procedure)	4180186
36674771	Prosthetic total arthroplasty of left hip	4180186
36674772	Diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus immunisation	4180186
36674772	Diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus immunization	4180186
36674772	Diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus vaccination	4180186
36674772	Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens	4180186
36674772	Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)	4180186
36674773	Burn injury of skin of finger (disorder)	4180186
36674779	Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens	4180186
36674779	Third diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus immunization	4180186
36674779	Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (procedure)	4180186
36674779	Third diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus immunisation	4180186
36674779	Third diphtheria and Haemophilus influenzae type B and hepatitis B and pertussis and tetanus vaccination	4180186
36674782	Product containing interleukin 5 receptor antagonist (product)	4180186
36674783	BIMSE - benign infantile focal epilepsy with midline spikes and waves during sleep	4180186
36674783	Benign infantile focal epilepsy with midline spikes and waves during sleep (disorder)	4180186
36674784	Benign occipital epilepsy	4180186
36674784	Benign occipital lobe epilepsy (disorder)	4180186
36674785	Benign partial epilepsy of infancy with complex partial seizures (disorder)	4180186
36674786	Meripilus	4180186
36674786	Genus Meripilus (organism)	4180186
36674788	Congenital Claude Bernard Horner syndrome	4180186
36674788	Congenital Horner syndrome (disorder)	4180186
36674791	Distal 17p13.1 microdeletion syndrome (disorder)	4180186
36674795	EuroQol Five Dimension (Youth) instrument (assessment scale)	4180186
36674795	EuroQol Five Dimension (Youth) instrument	4180186
36674797	Assessment using Nottingham Prognostic Index (procedure)	4180186
36674800	Magnetic resonance venography of jugular vein (procedure)	4180186
36674800	MR venography of jugular vein	4180186
36674800	Magnetic resonance venogram of jugular vein	4180186
36674802	Magnetic resonance imaging of external auditory canal with contrast	4180186
36674802	Magnetic resonance imaging of external auditory meatus with contrast (procedure)	4180186
36674802	Magnetic resonance imaging of external auditory meatus with contrast	4180186
36674804	MTLE-HS - mesial temporal lobe epilepsy with hippocampal sclerosis	4180186
36674804	Mesial temporal lobe epilepsy with hippocampal sclerosis (disorder)	4180186
36674805	Stenosis of external auditory canal due to and after radiation therapy (disorder)	4180186
36674808	Franek Bocker Kahlen syndrome	4180186
36674808	Microcephalus, brain defect, spasticity, hypernatremia syndrome (disorder)	4180186
36674808	Microcephalus, brain defect, spasticity, hypernatraemia syndrome	4180186
36674810	Standardized Assessment of Concussion total score (observable entity)	4180186
36674810	SAC (Standardized Assessment of Concussion) total score	4180186
36674811	Assessment using SAC (Standardized Assessment of Concussion)	4180186
36674811	Assessment using Standardized Assessment of Concussion (procedure)	4180186
36674812	Kiteboarding (qualifier value)	4180186
36674813	Tetrasomy 11q24.1 (disorder)	4180186
36674813	Microtriplication 11q24.1	4180186
36674816	Non-telomeric trisomy 10q	4180186
36674816	Non-distal duplication 10q	4180186
36674816	Non-distal trisomy 10q (disorder)	4180186
36674818	Paternal uniparental disomy of chromosome 13 (disorder)	4180186
36674820	Paternal uniparental disomy of chromosome 6 (disorder)	4180186
36674827	Prader-Willi-like syndrome (disorder)	4180186
36674830	Secondary syringomyelia (disorder)	4180186
36674834	Vasculitis due to ADA2 deficiency	4180186
36674834	Vasculitis due to adenosine deaminase 2 deficiency (disorder)	4180186
36674834	Vasculitis due to ADA2 (adenosine deaminase 2) deficiency	4180186
36674838	Christensenella species	4180186
36674838	Genus Christensenella (organism)	4180186
36674838	Christensenella	4180186
36674839	Mycobacterium arabiense (organism)	4180186
36674841	Referral to spinal surgery service (procedure)	4180186
36674846	Insert of stent into esophagus using fluoroscopic guidance	4180186
36674846	Insert of stent into esophagus using fluoroscopic guidance (procedure)	4180186
36674846	Insert of stent into oesophagus using fluoroscopic guidance	4180186
36674846	Fluoroscopy guided insertion of stent into oesophagus	4180186
36674847	Activated factor VII adverse reaction (disorder)	4180186
36674852	Factor VII adverse reaction (disorder)	4180186
36674853	Factor XI adverse reaction (disorder)	4180186
36674855	Von Willebrand factor adverse reaction (disorder)	4180186
36674857	Allergy to coagulation factor VIIa (finding)	4180186
36674857	Activated factor VII allergy	4180186
36674858	Allergy to coagulation factor V (finding)	4180186
36674858	Factor V allergy	4180186
36674859	Allergy to coagulation factor VII (finding)	4180186
36674859	Allergy to factor VII	4180186
36674859	Factor VII allergy	4180186
36674860	Allergy to coagulation factor XI (finding)	4180186
36674860	Factor XI allergy	4180186
36674864	Autosomal recessive spastic paraplegia type 58 (disorder)	4180186
36674864	Autosomal recessive spastic ataxia type 2	4180186
36674867	Bosch Boonstra Schaaf optic atrophy syndrome	4180186
36674867	Optic atrophy, intellectual disability syndrome (disorder)	4180186
36674867	BBSOAS - Bosch Boonstra Schaaf optic atrophy syndrome	4180186
36674868	Autosomal recessive spastic paraplegia type 70 (disorder)	4180186
36674872	Traboulsi syndrome	4180186
36674872	Facial dysmorphism, lens dislocation, anterior segment abnormalities, nontraumatic conjunctive cyst syndrome	4180186
36674872	FDLAB (facial dysmorphism, lens dislocation, anterior segment abnormalities, spontaneous filtering bleb) syndrome	4180186
36674872	Facial dysmorphism, lens dislocation, anterior segment abnormalities, spontaneous filtering bleb syndrome (disorder)	4180186
36674873	Referral for brief intervention for smoking cessation (procedure)	4180186
36674874	Ambulatory posturograph (physical object)	4180186
36674878	Implantable electrical stimulation system interoperative test lead (physical object)	4180186
36674881	Intraoperative tumour margin analysis probe	4180186
36674881	Intraoperative tumor margin analysis probe (physical object)	4180186
36674882	Gluteal implant (physical object)	4180186
36674883	Wearable musculoskeletal infrared phototherapy unit (physical object)	4180186
36674885	Visible-light neurological phototherapy unit (physical object)	4180186
36674886	Transcutaneous electrical nerve stimulation wristband (physical object)	4180186
36674886	Transcutaneous electrical nerve stimulation wristband	4180186
36674887	Insulin infusion patch pump cartridge filling device (physical object)	4180186
36674889	Cone beam computed tomography of bilateral ankles (procedure)	4180186
36674889	Cone beam computed tomography of bilateral ankles	4180186
36674889	Cone beam computed tomography of left and right ankle	4180186
36674890	Localization of lesion with diagnostic dye using cone beam computed tomography	4180186
36674890	Localization of lesion with diagnostic dye using cone beam computed tomography (procedure)	4180186
36674890	Localisation of lesion with diagnostic dye using cone beam computed tomography	4180186
36674890	Cone beam CT guided localisation of lesion with diagnostic dye	4180186
36674891	ENT (ear, nose and throat) surgical snare wire	4180186
36674891	Ear, nose and throat surgical snare wire (physical object)	4180186
36674892	Referral for combined healthy eating and physical education program (procedure)	4180186
36674892	Referral for combined healthy eating and physical education programme	4180186
36674893	Intellectual disability, seizures, macrocephaly, obesity syndrome (disorder)	4180186
36674894	Severe motor and intellectual disabilities, sensorineural deafness, dystonia syndrome (disorder)	4180186
36674895	Deep second degree burn of skin of upper and lower lip	4180186
36674895	Deep partial thickness burn of skin of upper and lower lip (disorder)	4180186
36674896	Superficial partial thickness burn of skin of upper and lower lip (disorder)	4180186
36674896	Superficial second degree burn of skin of upper and lower lip	4180186
36674902	Referral to community diabetes antenatal clinic (procedure)	4180186
36674904	Autosomal dominant neovascular inflammatory vitreoretinopathy (disorder)	4180186
36674905	Adult-onset distal myopathy due to valosin containing protein mutation (disorder)	4180186
36674905	Adult-onset distal myopathy due to VCP (valosin containing protein) mutation	4180186
36674905	Adult-onset distal myopathy due to VCP mutation	4180186
36674906	5p13 microduplication syndrome (disorder)	4180186
36674906	Trisomy 5p13	4180186
36674907	11p15.4 microduplication syndrome (disorder)	4180186
36674907	Trisomy 11p15.4	4180186
36674908	Single photon emission computed tomography with computed tomography of entire bony skeleton (procedure)	4180186
36674908	SPECT CT of entire bony skeleton	4180186
36674910	Extracorporeal shockwave lithotripsy of calculus of right ureter using fluoroscopic guidance (procedure)	4180186
36674910	Fluoroscopy guided ESWL (extracorporeal shockwave lithotripsy) of calculus of right ureter	4180186
36674910	Extracorporeal shockwave lithotripsy of calculus of right ureter using fluoroscopic guidance	4180186
36674912	Fluoroscopy guided ESWL (extracorporeal shockwave lithotripsy) of calculus of both ureters	4180186
36674912	Extracorporeal shockwave lithotripsy of calculus of bilateral ureters using fluoroscopic guidance (procedure)	4180186
36674912	Extracorporeal shockwave lithotripsy of calculus of both ureters using fluoroscopic guidance	4180186
36674912	Extracorporeal shockwave lithotripsy of calculus of bilateral ureters using fluoroscopic guidance	4180186
36674912	Extracorporeal shockwave lithotripsy of calculus of left and right ureter using fluoroscopic guidance	4180186
36674916	Distal monosomy 12p (disorder)	4180186
36674916	12p13.33 microdeletion syndrome	4180186
36674916	Distal deletion 12p	4180186
36674917	Postorgasmic illness syndrome (disorder)	4180186
36674920	Jerk test of knee (procedure)	4180186
36674922	49,XXXYY syndrome (disorder)	4180186
36674924	Magnetic resonance imaging of wall of blood vessel (procedure)	4180186
36674924	Magnetic resonance imaging of wall of blood vessel	4180186
36674926	Dry needling of verruca plantaris (procedure)	4180186
36674928	Application of homoeopathic topical agent to verruca plantaris	4180186
36674928	Application of homeopathic topical agent to verruca plantaris (procedure)	4180186
36674931	Deep bite wound (morphologic abnormality)	4180186
36674932	Product containing bepotastine (medicinal product)	4180186
36674934	Product containing clobetasone and neomycin (medicinal product)	4180186
36674940	Product containing fluocinolone and hydroquinone and tretinoin (medicinal product)	4180186
36674941	Product containing enoxolone and hyaluronic acid and povidone (medicinal product)	4180186
36674941	Enoxolone- and hyaluronic acid- and povidone-containing product	4180186
36674943	Congenital panfollicular nevus (disorder)	4180186
36674943	Congenital panfollicular naevus	4180186
36674949	Postaxial tetramelic oligodactyly (disorder)	4180186
36674952	Pyrazole and/or pyrazole derivative (substance)	4180186
36674952	Pyrazole and/or pyrazole derivative	4180186
36674952	Pyrazole and pyrazole derivative (substance)	4180186
36674954	Mucor velutinosus (organism)	4180186
36674957	Monascus pilosus (organism)	4180186
36674958	Microascus cirrosus (organism)	4180186
36674962	Flabellopilus giganteus	4180186
36674962	Polyporus giganteus	4180186
36674962	Cladomeris giganteus	4180186
36674962	Grifola gigantea	4180186
36674962	Polypilus giganteus	4180186
36674962	Merisma giganteum	4180186
36674962	Meripilus giganteus (organism)	4180186
36674962	Boletus giganteus	4180186
36674965	Bite of arthropod (event)	4180186
36674966	Product containing gadofosveset (medicinal product)	4180186
36674967	Product containing citric acid and nalidixic acid (medicinal product)	4180186
36674968	Pilotto syndrome (disorder)	4180186
36674969	Monosomy 9p (disorder)	4180186
36674969	Alfi syndrome	4180186
36674969	9p deletion syndrome	4180186
36674970	Lymphoproliferative disorder caused by methotrexate (disorder)	4180186
36674970	Methotrexate-associated lymphoproliferative disorder	4180186
36674971	Microcephaly, short stature, intellectual disability, facial dysmorphism syndrome (disorder)	4180186
36674973	Leptomyelolipoma (disorder)	4180186
36674974	Intellectual disability, short stature, hypertelorism syndrome (disorder)	4180186
36674974	Stoll Geraudel Chauvin syndrome	4180186
36674975	Immunodeficiency due to mannan binding lectin serine peptidase 2 deficiency	4180186
36674975	Immunodeficiency due to mannan binding lectin serine peptidase 2 deficiency (disorder)	4180186
36674975	Immunodeficiency due to MASP-2 (mannan binding lectin serine peptidase 2) deficiency	4180186
36674977	Distal spinal muscular atrophy with vocal cord paralysis	4180186
36674977	Distal hereditary motor neuropathy type 7 (disorder)	4180186
36674978	Acute medicine care plan (record artifact)	4180186
36674979	Pain in upper arm (finding)	4180186
36674980	Selective salpingography using fluoroscopic guidance (procedure)	4180186
36674980	Selective salpingography using fluoroscopic guidance	4180186
36674981	Gated positron emission tomography with computed tomography of heart using sodium fluoride (18-F) (procedure)	4180186
36674981	Gated cardiac PET CT using sodium fluoride (18-F)	4180186
36674981	Gated PET CT of heart using sodium fluoride (18-F)	4180186
36674982	Biopsy of breast using digital tomosynthesis guidance	4180186
36674982	Biopsy of breast using digital tomosynthesis guidance (procedure)	4180186
36674983	Localisation of lesion with diagnostic dye using fluoroscopic guidance	4180186
36674983	Localization of lesion with diagnostic dye using fluoroscopic guidance (procedure)	4180186
36674983	Fluoroscopy guided localisation of lesion with diagnostic dye	4180186
36674983	Localization of lesion with diagnostic dye using fluoroscopic guidance	4180186
36674985	Injection of right facet joint of cervical spine using fluoroscopic guidance	4180186
36674985	Injection of right facet joint of cervical spine using fluoroscopic guidance (procedure)	4180186
36674986	Injection of right facet joint using fluoroscopic guidance (procedure)	4180186
36674986	Injection of right facet joint using fluoroscopic guidance	4180186
36674987	Injection of left and right facet joint using fluoroscopic guidance	4180186
36674987	Injection of bilateral facet joints using fluoroscopic guidance (procedure)	4180186
36674987	Injection of both facet joints using fluoroscopic guidance	4180186
36674987	Injection of bilateral facet joints using fluoroscopic guidance	4180186
36674988	Benign partial epilepsy with secondarily generalised seizures in infancy	4180186
36674988	Benign partial epilepsy with secondarily generalized seizures in infancy (disorder)	4180186
36674990	Hereditary sensory-motor neuropathy type V	4180186
36674990	Hereditary motor and sensory neuropathy type 5 (disorder)	4180186
36674990	Charcot-Marie-Tooth disease, pyramidal features syndrome	4180186
36674991	Autosomal recessive axonal Charcot-Marie-Tooth disease with acrodystrophy	4180186
36674991	Hereditary motor and sensory neuropathy with acrodystrophy (disorder)	4180186
36674991	Autosomal recessive Charcot-Marie-Tooth type 2 with acrodystrophy	4180186
36674992	Herpetiform pemphigus (disorder)	4180186
36674998	Vessel receiving coronary graft (observable entity)	4180186
36674999	Brief intervention for smoking cessation (procedure)	4180186
36675001	M-BESS - Modified Balance Error Scoring System	4180186
36675001	Modified Balance Error Scoring System (assessment scale)	4180186
36675001	mBESS - modified Balance Error Scoring System	4180186
36675002	Assessment using M-BESS (Modified Balance Error Scoring System)	4180186
36675002	Assessment using mBESS (modified Balance Error Scoring System)	4180186
36675002	Assessment using Modified Balance Error Scoring System (procedure)	4180186
36675003	Ectrodactyly polydactyly syndrome (disorder)	4180186
36675004	Typus Edinburgensis	4180186
36675004	Edinburgh malformation syndrome (disorder)	4180186
36675005	Extrasystoles, short stature, hyperpigmentation, microcephaly syndrome (disorder)	4180186
36675005	Char Douglas Dungan syndrome	4180186
36675006	Hallux varus, preaxial polysyndactyly syndrome (disorder)	4180186
36675006	Kleiner Holmes syndrome	4180186
36675008	Sparse hair, short stature, skin anomalies syndrome	4180186
36675008	Thumb deformity, alopecia, pigmentation anomaly syndrome (disorder)	4180186
36675009	Genus Vanrija (organism)	4180186
36675009	Vanrija	4180186
36675012	Pilodental dysplasia, refractive errors syndrome (disorder)	4180186
36675012	Euhidrotic ectodermal dysplasia	4180186
36675012	Kopysc Barczyk Krol syndrome	4180186
36675013	Ultrasound of placenta	4180186
36675013	Ultrasonography of placenta (procedure)	4180186
36675013	Ultrasound scan of placenta	4180186
36675016	Fourth degree burn involving joint	4180186
36675016	Deep full thickness burn involving joint (disorder)	4180186
36675017	Fourth degree burn involving bone	4180186
36675017	Deep full thickness burn involving bone (disorder)	4180186
36675021	Bite of tick (event)	4180186
36675022	Product containing tetracycline structure (product)	4180186
36675023	Organic acid and/or organic acid derivative-containing product	4180186
36675023	Product containing organic acid and/or organic acid derivative (product)	4180186
36675023	Product containing organic acid and organic acid derivative (product)	4180186
36675024	Congenital aplasia of extensor muscle of finger and thumb associated with generalised polyneuropathy	4180186
36675024	Digital extensor muscle aplasia with polyneuropathy (disorder)	4180186
36675024	Congenital aplasia of extensor muscle of finger and thumb associated with generalized polyneuropathy	4180186
36675024	Polyneuropathy, hand defect syndrome	4180186
36675024	Hamanishi Ueba Tsuji syndrome	4180186
36675025	Patterson pseudoleprechaunism syndrome	4180186
36675025	Patterson syndrome	4180186
36675025	Pseudoleprechaunism syndrome Patterson type (disorder)	4180186
36675027	Absent radius, anogenital anomalies syndrome (disorder)	4180186
36675028	Teebi Shaltout syndrome (disorder)	4180186
36675029	Torticollis, keloids, cryptorchidism, renal dysplasia syndrome (disorder)	4180186
36675030	Congenital muscular dystrophy with ITGA7 (integrin alpha-7) deficiency	4180186
36675030	Congenital muscular dystrophy with ITGA7 deficiency	4180186
36675030	Congenital muscular dystrophy with integrin alpha-7 deficiency (disorder)	4180186
36675032	Rose bengal stain technique (qualifier value)	4180186
36675033	Pentetic acid and/or pentetic acid derivative (substance)	4180186
36675033	Pentetic acid and/or pentetic acid derivative	4180186
36675033	Pentetic acid and pentetic acid derivative (substance)	4180186
36675035	Prematurity of infant (disorder)	4180186
36675036	Hereditary progressive mucinous histiocytosis (disorder)	4180186
36675037	Axial spondylometaphyseal dysplasia (disorder)	4180186
36675038	Distal spinal muscular atrophy type 4	4180186
36675038	Autosomal recessive distal spinal muscular atrophy type 4	4180186
36675038	Autosomal recessive lower motor neuron disease with childhood onset (disorder)	4180186
36675041	Progressive polyneuropathy with bilateral striatal necrosis (disorder)	4180186
36675042	POIKTMP (poikiloderma, tendon contractures, myopathy, pulmonary fibrosis) syndrome	4180186
36675042	POIKTMP syndrome	4180186
36675042	Hereditary fibrosing poikiloderma, tendon contractures, myopathy, pulmonary fibrosis syndrome (disorder)	4180186
36675044	Non-acquired combined pituitary hormone deficiency, deafness, rigid cervical spine syndrome	4180186
36675044	Non-acquired combined pituitary hormone deficiency, sensorineural hearing loss, spine abnormalities syndrome (disorder)	4180186
36675045	Autosomal recessive lymphoproliferative disease (disorder)	4180186
36675046	Tooth furcation involvement index for assessment of periodontal disease (observable entity)	4180186
36675046	Furcation involvement index	4180186
36675050	Tarantula venom (substance)	4180186
36675052	Antigen of Neisseria meningitidis 29E	4180186
36675052	Antigen of Neisseria meningitidis E	4180186
36675052	Antigen of Neisseria meningitidis E (substance)	4180186
36675052	Antigen of Neisseria meningitidis Z'	4180186
36675052	Neisseria meningitidis E antigen	4180186
36675054	Procedure on body region (procedure)	4180186
36675055	Procedure on uvula (procedure)	4180186
36675057	IL10 (interleukin 10) related early-onset inflammatory bowel disease	4180186
36675057	Interleukin 10 related early-onset inflammatory bowel disease	4180186
36675057	IL10-related early-onset inflammatory bowel disease	4180186
36675057	Immune dysregulation, inflammatory bowel disease, arthritis, recurrent infection syndrome (disorder)	4180186
36675058	Autosomal dominant limb-girdle muscular dystrophy type 1H (disorder)	4180186
36675059	Ectodermal dysplasia syndactyly syndrome (disorder)	4180186
36675060	Polymicrogyria with optic nerve hypoplasia (disorder)	4180186
36675061	1q21.1 microduplication syndrome (disorder)	4180186
36675061	Trisomy 1q21.1	4180186
36675062	Parietal foramina with clavicular hypoplasia (disorder)	4180186
36675062	Parietal foramina with cleidocranial dysplasia	4180186
36675067	Measurement of periodontal pocket depth-six areas per tooth exam (procedure)	4180186
36675068	Paraben and/or paraben derivative-containing product	4180186
36675068	Product containing paraben and/or paraben derivative (product)	4180186
36675068	Product containing paraben and paraben derivative (product)	4180186
36675070	Substance with enzyme reactivator mechanism of action (substance)	4180186
36675074	Noradrenaline uptake inhibitor	4180186
36675074	Substance with norepinephrine uptake inhibitor mechanism of action (substance)	4180186
36675076	Substance with phosphodiesterase mechanism of action (substance)	4180186
36675078	Corynebacterium amycolatum or Corynebacterium xerosis (finding)	4180186
36675079	Substance with prostacyclin receptor agonist mechanism of action (substance)	4180186
36675080	Substance with receptor activator mechanism of action (substance)	4180186
36675081	Substance with receptor agonist mechanism of action (substance)	4180186
36675082	Corynebacterium timonense (organism)	4180186
36675084	Substance with synaptic vesicular amine transporter inhibitor mechanism of action (substance)	4180186
36675087	Substance with effector mechanism of action (substance)	4180186
36675090	Brettanomyces bruxellensis (organism)	4180186
36675091	Stability of joint structure of pelvic girdle (observable entity)	4180186
36675092	Stability of patellofemoral joint (observable entity)	4180186
36675092	Stability of femoropatellar joint	4180186
36675097	Stability of intercarpal joint (observable entity)	4180186
36675103	Stability of atlantoaxial joint (observable entity)	4180186
36675107	Product containing flavonoid (product)	4180186
36675108	Stability of lateral collateral ligament (observable entity)	4180186
36675109	Stability of medial collateral ligament (observable entity)	4180186
36675110	Cognitive dysfunction following surgical procedure	4180186
36675110	Cognitive dysfunction following surgical procedure (disorder)	4180186
36675110	POCD - postoperative cognitive dysfunction	4180186
36675112	Mixed hyperactive hypoactive delirium following surgical procedure (disorder)	4180186
36675112	Mixed hyperactive hypoactive delirium following surgical procedure	4180186
36675113	Monosomy 14q22q23	4180186
36675113	Monosomy 14q22-q23	4180186
36675113	14q22q23 microdeletion syndrome (disorder)	4180186
36675113	14q22-q23 microdeletion syndrome	4180186
36675115	Hyperbiliverdinaemia	4180186
36675115	Hyperbiliverdinemia (disorder)	4180186
36675122	Autism epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency (disorder)	4180186
36675123	Frostbite with tissue necrosis of upper limb (disorder)	4180186
36675125	Platelet aggregation inhibitor (disposition)	4180186
36675127	Repair of abdominal aortic aneurysm with insertion of stent (procedure)	4180186
36675128	Caldibacillus	4180186
36675128	Genus Caldibacillus (organism)	4180186
36675130	Piperazine and/or piperazine derivative (substance)	4180186
36675130	Piperazine and/or piperazine derivative	4180186
36675130	Piperazine and piperazine derivative (substance)	4180186
36675132	New sexual contact (finding)	4180186
36675135	Product containing amiloride and hydrochlorothiazide (medicinal product)	4180186
36675137	Product containing ciprofloxacin and hydrocortisone (medicinal product)	4180186
36675138	Genus Aeribacillus (organism)	4180186
36675138	Aeribacillus	4180186
36675139	Metakosakonia	4180186
36675139	Genus Metakosakonia (organism)	4180186
36675142	Jawad syndrome (disorder)	4180186
36675146	Gastric adenocarcinoma and proximal polyposis of stomach (disorder)	4180186
36675146	GAPPS - gastric adenocarcinoma and proximal polyposis of stomach	4180186
36675146	Familial fundic gland polyposis with gastric cancer	4180186
36675147	Autosomal recessive distal spinal muscular atrophy type 5	4180186
36675147	Young adult-onset distal hereditary motor neuropathy (disorder)	4180186
36675148	Autosomal recessive leukoencephalopathy, ischemic stroke, retinitis pigmentosa syndrome (disorder)	4180186
36675148	Autosomal recessive leukoencephalopathy, ischaemic stroke, retinitis pigmentosa syndrome	4180186
36675152	Cystourethroscopy with ureteral catheterisation and brush biopsy of lower urinary tract	4180186
36675152	Cystourethroscopy with ureteral catheterization and brush biopsy of lower urinary tract (procedure)	4180186
36675154	Leiotrametes lactinea (organism)	4180186
36675154	Trametes lactinea	4180186
36675154	Coriolus lactineus	4180186
36675154	Polyporus lactineus	4180186
36675156	Closed fracture of multiple bones (morphologic abnormality)	4180186
36675158	Closed and compound fracture of multiple bones (morphologic abnormality)	4180186
36675158	Closed and open fracture of multiple bones	4180186
36675162	Closed fractures involving multiple regions of right upper limb (disorder)	4180186
36675164	Fractures involving multiple regions of right upper limb (disorder)	4180186
36675166	Open fractures involving multiple regions of right upper limb (disorder)	4180186
36675167	Product containing beclometasone in pulmonary dose form (medicinal product form)	4180186
36675167	Beclometasone-containing product in pulmonary dose form	4180186
36675168	Product containing fluticasone in pulmonary dose form (medicinal product form)	4180186
36675169	Product containing mometasone in pulmonary dose form (medicinal product form)	4180186
36675172	Product containing glucose and potassium chloride and sodium chloride in parenteral dose form (medicinal product form)	4180186
36675173	Moderate to late prematurity of infant (disorder)	4180186
36675175	IGSF1 (immunoglobulin superfamily member 1) deficiency syndrome	4180186
36675175	X-linked central congenital hypothyroidism with late-onset testicular enlargement (disorder)	4180186
36675175	X-linked central congenital hypothyroidism with late-onset macroorchidism	4180186
36675176	Hereditary thrombocytosis with transverse limb defect	4180186
36675176	Thrombocythemia with distal limb defect (disorder)	4180186
36675176	Familial thrombocytosis with transverse limb defect	4180186
36675176	Thrombocythaemia with distal limb defect	4180186
36675177	AUTS2 syndrome	4180186
36675177	Autism spectrum disorder due to AUTS2 activator of transcription and developmental regulator deficiency	4180186
36675177	Autism spectrum disorder due to AUTS2 activator of transcription and developmental regulator deficiency (disorder)	4180186
36675180	Facial dysmorphism, immunodeficiency, livedo, short stature syndrome (disorder)	4180186
36675180	FILS (facial dysmorphism, immunodeficiency, livedo, short stature) syndrome	4180186
36675180	FILS syndrome	4180186
36675182	Severe combined immunodeficiency due to caspase recruitment domain family member 11 deficiency (disorder)	4180186
36675182	Severe combined immunodeficiency due to caspase recruitment domain family member 11 deficiency	4180186
36675182	Severe combined immunodeficiency due to CARD11 (caspase recruitment domain family member 11) deficiency	4180186
36675183	Non-immunoglobulin E-mediated allergic contact hypersensitivity process (qualifier value)	4180186
36675186	Product containing lissamine green B stain in ocular dose form (medicinal product form)	4180186
36675193	Abscess at puncture site due to and following peripheral nerve block (disorder)	4180186
36675194	Meningitis due to and following central neuraxial nerve block (disorder)	4180186
36675194	Meningitis due to and following central neuraxial nerve block	4180186
36675195	Cold extremity (finding)	4180186
36675195	Cold limb	4180186
36675198	Painful and cold leg	4180186
36675198	Painful and cold lower limb (finding)	4180186
36675201	Jeotgalicoccus aerolatus (organism)	4180186
36675204	Brevibacterium pityocampae (organism)	4180186
36675205	Mucor lanceolatus (organism)	4180186
36675208	Monitoring of continuous bladder irrigation (regime/therapy)	4180186
36675209	Fluoroscopy for colonic transit study (procedure)	4180186
36675214	Index for level of dental plaque on tooth (observable entity)	4180186
36675217	Polyethylene terephthalate (substance)	4180186
36675217	Dacron	4180186
36675217	Poly(ethylene terephthalate) polymer	4180186
36675218	Fiberoptic endoscopic mucosal resection of lesion of upper gastrointestinal tract	4180186
36675218	Fibreoptic endoscopic mucosal resection of lesion of upper gastrointestinal tract	4180186
36675218	Fiberoptic endoscopic excision of lesion of mucous membrane of upper gastrointestinal tract (procedure)	4180186
36675218	Fibreoptic endoscopic excision of lesion of mucous membrane of upper gastrointestinal tract	4180186
36675220	Product containing avatrombopag (medicinal product)	4180186
36675222	Product containing pegvaliase (medicinal product)	4180186
36675223	Product containing pegvaliase in parenteral dose form (medicinal product form)	4180186
36675227	Excision of lesion of mucous membrane of lower bowel using fibreoptic sigmoidoscope	4180186
36675227	Endoscopic mucosal resection of lesion of lower bowel using fiberoptic sigmoidoscope	4180186
36675227	Excision of lesion of mucous membrane of lower bowel using fiberoptic sigmoidoscope (procedure)	4180186
36675227	Endoscopic mucosal resection of lesion of lower bowel using fibreoptic sigmoidoscope	4180186
36675232	Product containing heparinoid and lauromacrogol 400 (medicinal product)	4180186
36675234	Product containing colfosceril in pulmonary dose form (medicinal product form)	4180186
36675235	Product containing cromoglicic acid in pulmonary dose form (medicinal product form)	4180186
36675235	Cromoglicic acid-containing product in pulmonary dose form	4180186
36675236	Product containing formoterol in pulmonary dose form (medicinal product form)	4180186
36675238	Tildrakizumab (substance)	4180186
36675239	Substance with interleukin 23 receptor antagonist mechanism of action (substance)	4180186
36675241	CGPR antagonist	4180186
36675241	Calcitonin gene-related peptide receptor antagonist (disposition)	4180186
36675242	Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance)	4180186
36675242	CGPR antagonist	4180186
36675244	Product containing technetium (99m-Tc) sulfur colloid in parenteral dose form (medicinal product form)	4180186
36675246	Product containing technetium (99m-Tc) mebrofenin in parenteral dose form (medicinal product form)	4180186
36675248	Product containing technetium (99m-Tc) mertiatide in parenteral dose form (medicinal product form)	4180186
36675250	Product containing technetium (99m-Tc) oxidronate in parenteral dose form (medicinal product form)	4180186
36675252	Product containing technetium (99m-Tc) sestamibi in parenteral dose form (medicinal product form)	4180186
36675253	Product containing technetium (99m-Tc) macrosalb in parenteral dose form (medicinal product form)	4180186
36675255	Product containing enflurane in pulmonary dose form (medicinal product form)	4180186
36675256	Product containing halothane in pulmonary dose form (medicinal product form)	4180186
36675257	Product containing isoflurane in pulmonary dose form (medicinal product form)	4180186
36675258	Product containing sevoflurane in pulmonary dose form (medicinal product form)	4180186
36675259	Fiberoptic endoscopic coagulation of hemorrhage of esophagus (procedure)	4180186
36675259	Fibreoptic endoscopic coagulation of haemorrhage of oesophagus	4180186
36675264	Open femoral hernioplasty using synthetic mesh	4180186
36675264	Open repair of femoral hernia using synthetic mesh (procedure)	4180186
36675265	Open repair of lumbar hernia using sutures (procedure)	4180186
36675266	Open repair of lumbar hernia using synthetic mesh (procedure)	4180186
36675266	Open lumbar hernioplasty using synthetic mesh	4180186
36675267	Open lumbar hernioplasty using biological mesh	4180186
36675267	Open repair of lumbar hernia using biological mesh (procedure)	4180186
36675269	Open hernioplasty using biological mesh for recurrent lumbar hernia	4180186
36675269	Open repair of recurrent lumbar hernia using biological mesh (procedure)	4180186
36675270	Hook wire localisation and excision of lesion of breast using radionuclide guidance with radioactive isotope	4180186
36675270	Hook wire localization and excision of lesion of breast using radionuclide guidance with radioactive isotope (procedure)	4180186
36675276	Product containing benzhydrocodone and paracetamol in oral dose form (medicinal product form)	4180186
36675276	Benzhydrocodone- and paracetamol-containing product in oral dose form	4180186
36675278	Open umbilical hernioplasty using biological mesh	4180186
36675278	Open repair of umbilical hernia using biological mesh (procedure)	4180186
36675280	Open hernioplasty using biological mesh for recurrent umbilical hernia	4180186
36675280	Open repair of recurrent umbilical hernia using biological mesh (procedure)	4180186
36675281	Product containing ivacaftor and tezacaftor in oral dose form (medicinal product form)	4180186
36675282	Open repair of recurrent umbilical hernia using synthetic mesh (procedure)	4180186
36675282	Open hernioplasty using synthetic mesh for recurrent umbilical hernia	4180186
36675283	Product containing erenumab (medicinal product)	4180186
36675284	Product containing erenumab in parenteral dose form (medicinal product form)	4180186
36675285	Product containing calcitonin gene-related peptide receptor antagonist (product)	4180186
36675287	Product containing technetium (99m-Tc) arcitumomab in parenteral dose form (medicinal product form)	4180186
36675289	Product containing technetium (99m-Tc) depreotide in parenteral dose form (medicinal product form)	4180186
36675290	Open repair of spigelian hernia using synthetic mesh (procedure)	4180186
36675290	Open spigelian hernioplasty using synthetic mesh	4180186
36675291	Open repair of spigelian hernia using biological mesh (procedure)	4180186
36675291	Open spigelian hernioplasty using biological mesh	4180186
36675294	Product containing technetium (99m-Tc) disofenin in parenteral dose form (medicinal product form)	4180186
36675297	Product containing technetium (99m-Tc) exametazime in parenteral dose form (medicinal product form)	4180186
36675298	Product containing technetium (99m-Tc) fanolesomab in parenteral dose form (medicinal product form)	4180186
36675299	Product containing technetium (99m-Tc) sodium glucoheptonate in parenteral dose form (medicinal product form)	4180186
36675302	Product containing etonogestrel in subcutaneous dose form (medicinal product form)	4180186
36675309	Genus Myrmecridium (organism)	4180186
36675309	Myrmecridium	4180186
36675311	Oxyporus	4180186
36675311	Genus Oxyporus (organism)	4180186
36675312	Laparoscopic repair of umbilical hernia using sutures (procedure)	4180186
36675315	Laparoscopic repair of umbilical hernia using biological mesh (procedure)	4180186
36675315	Laparoscopic umbilical hernioplasty using biological mesh	4180186
36675316	Laparoscopic repair of recurrent umbilical hernia using sutures (procedure)	4180186
36675319	Open repair of inguinal hernia using sutures (procedure)	4180186
36675322	Open hernioplasty using synthetic mesh for recurrent inguinal hernia	4180186
36675322	Open repair of recurrent inguinal hernia using synthetic mesh (procedure)	4180186
36675324	Open repair of epigastric hernia using synthetic mesh (procedure)	4180186
36675324	Open epigastric hernioplasty using synthetic mesh	4180186
36675326	Open epigastric hernioplasty using biological mesh	4180186
36675326	Open repair of epigastric hernia using biological mesh (procedure)	4180186
36675327	Open repair of recurrent epigastric hernia using synthetic mesh (procedure)	4180186
36675327	Open hernioplasty using synthetic mesh for recurrent epigastric hernia	4180186
36675330	Laparoscopic repair of epigastric hernia (procedure)	4180186
36675331	Laparoscopic hernioplasty using biological mesh for recurrent epigastric hernia	4180186
36675331	Laparoscopic repair of recurrent epigastric hernia using biological mesh (procedure)	4180186
36675333	Product containing haloprogin in cutaneous dose form (medicinal product form)	4180186
36675334	Product containing clindamycin in cutaneous dose form (medicinal product form)	4180186
36675336	Product containing menthol in pulmonary dose form (medicinal product form)	4180186
36675338	Product containing terbinafine in cutaneous dose form (medicinal product form)	4180186
36675339	Product containing olopatadine in ocular dose form (medicinal product form)	4180186
36675344	Product containing betamethasone in cutaneous dose form (medicinal product form)	4180186
36675345	Product containing budesonide in cutaneous dose form (medicinal product form)	4180186
36675347	Product containing aciclovir in cutaneous dose form (medicinal product form)	4180186
36675347	Aciclovir-containing product in cutaneous dose form	4180186
36675355	Product containing miconazole in ocular dose form (medicinal product form)	4180186
36675356	Product containing bovine thrombin in cutaneous dose form (medicinal product form)	4180186
36675361	Product containing fluocinolone in ocular dose form (medicinal product form)	4180186
36675362	Product containing timolol in ocular dose form (medicinal product form)	4180186
36675363	Product containing calcitriol in cutaneous dose form (medicinal product form)	4180186
36675364	Product containing tyloxapol in ocular dose form (medicinal product form)	4180186
36675365	Product containing sulfacetamide in cutaneous dose form (medicinal product form)	4180186
36675370	Product containing mupirocin in cutaneous dose form (medicinal product form)	4180186
36675371	Product containing griseofulvin in cutaneous dose form (medicinal product form)	4180186
36675373	Product containing acetylcysteine in pulmonary dose form (medicinal product form)	4180186
36675377	Open repair of incisional hernia using sutures (procedure)	4180186
36675381	Product containing benzalkonium in cutaneous dose form (medicinal product form)	4180186
36675382	Product containing gramicidin in cutaneous dose form (medicinal product form)	4180186
36675383	Product containing oxymetazoline in ocular dose form (medicinal product form)	4180186
36675389	Product containing glutaraldehyde in cutaneous dose form (medicinal product form)	4180186
36675390	Product containing eflornithine in cutaneous dose form (medicinal product form)	4180186
36675392	Product containing polymyxin B in ocular dose form (medicinal product form)	4180186
36675393	Product containing mometasone in cutaneous dose form (medicinal product form)	4180186
36675394	Product containing nicotine in cutaneous dose form (medicinal product form)	4180186
36675397	Product containing potassium permanganate in cutaneous dose form (medicinal product form)	4180186
36675400	Product containing fluorescein stain in ocular dose form (medicinal product form)	4180186
36675401	Mercaptamine-containing product in ocular dose form	4180186
36675401	Product containing mercaptamine in ocular dose form (medicinal product form)	4180186
36675402	Product containing homatropine in ocular dose form (medicinal product form)	4180186
36675404	Product containing erythromycin in ocular dose form (medicinal product form)	4180186
36675407	Product containing tetracycline in ocular dose form (medicinal product form)	4180186
36675408	Product containing ethacridine in cutaneous dose form (medicinal product form)	4180186
36675409	Product containing hydrogen peroxide in cutaneous dose form (medicinal product form)	4180186
36675410	Product containing trimethoprim in ocular dose form (medicinal product form)	4180186
36675411	Product containing vidarabine in ocular dose form (medicinal product form)	4180186
36675412	Phenoxymethylpenicillin-containing product in ocular dose form	4180186
36675412	Product containing phenoxymethylpenicillin in ocular dose form (medicinal product form)	4180186
36675414	Product containing urea in cutaneous dose form (medicinal product form)	4180186
36675416	Product containing colistimethate in pulmonary dose form (medicinal product form)	4180186
36675420	Product containing fusidic acid in ocular dose form (medicinal product form)	4180186
36675421	Product containing boric acid in ocular dose form (medicinal product form)	4180186
36675422	Product containing buprenorphine in cutaneous dose form (medicinal product form)	4180186
36675427	Product containing povidone in ocular dose form (medicinal product form)	4180186
36675429	Product containing exalamide in cutaneous dose form (medicinal product form)	4180186
36675431	Product containing methylprednisolone in cutaneous dose form (medicinal product form)	4180186
36675432	Product containing povidone iodine in cutaneous dose form (medicinal product form)	4180186
36675433	Product containing isopropyl alcohol in cutaneous dose form (medicinal product form)	4180186
36675437	Product containing cinchocaine in cutaneous dose form (medicinal product form)	4180186
36675437	Cinchocaine-containing product in cutaneous dose form	4180186
36675441	Product containing scopolamine in ocular dose form (medicinal product form)	4180186
36675441	Hyoscine-containing product in ocular dose form	4180186
36675446	Product containing olodaterol in pulmonary dose form (medicinal product form)	4180186
36675447	Product containing zinc in ocular dose form (medicinal product form)	4180186
36675448	Product containing miconazole in cutaneous dose form (medicinal product form)	4180186
36675451	Product containing cocaine in ocular dose form (medicinal product form)	4180186
36675452	Product containing dibrompropamidine in ocular dose form (medicinal product form)	4180186
36675452	Dibrompropamidine-containing product in ocular dose form	4180186
36675454	Product containing potassium in cutaneous dose form (medicinal product form)	4180186
36675456	Product containing dexamethasone in cutaneous dose form (medicinal product form)	4180186
36675457	Repair of incisional hernia using surgical mesh (procedure)	4180186
36675458	Product containing tiotropium in pulmonary dose form (medicinal product form)	4180186
36675459	Product containing human insulin in pulmonary dose form (medicinal product form)	4180186
36675462	Product containing nicotine in pulmonary dose form (medicinal product form)	4180186
36675467	Product containing ascorbic acid in cutaneous dose form (medicinal product form)	4180186
36675472	Product containing oxiconazole in cutaneous dose form (medicinal product form)	4180186
36675474	Product containing gramicidin in ocular dose form (medicinal product form)	4180186
36675475	Product containing fusidic acid in cutaneous dose form (medicinal product form)	4180186
36675477	Product containing desoximetasone in cutaneous dose form (medicinal product form)	4180186
36675478	Product containing tretinoin in cutaneous dose form (medicinal product form)	4180186
36675480	Product containing ganciclovir in ocular dose form (medicinal product form)	4180186
36675482	Product containing meclocycline in cutaneous dose form (medicinal product form)	4180186
36675487	Product containing cod liver oil in cutaneous dose form (medicinal product form)	4180186
36675488	Product containing umeclidinium in pulmonary dose form (medicinal product form)	4180186
36675489	Product containing zinc in cutaneous dose form (medicinal product form)	4180186
36675494	Product containing levofloxacin in ocular dose form (medicinal product form)	4180186
36675495	Product containing ketoprofen in cutaneous dose form (medicinal product form)	4180186
36675496	Product containing promestriene in cutaneous dose form (medicinal product form)	4180186
36675497	Adrenaline-containing product in ocular dose form	4180186
36675497	Product containing epinephrine in ocular dose form (medicinal product form)	4180186
36675498	Product containing dexamethasone in pulmonary dose form (medicinal product form)	4180186
36675500	Product containing salicylic acid in cutaneous dose form (medicinal product form)	4180186
36675502	Product containing methacholine in ocular dose form (medicinal product form)	4180186
36675503	Product containing chlortetracycline in cutaneous dose form (medicinal product form)	4180186
36675504	Product containing sulconazole in cutaneous dose form (medicinal product form)	4180186
36675506	Product containing benzocaine in cutaneous dose form (medicinal product form)	4180186
36675507	Product containing lomefloxacin in ocular dose form (medicinal product form)	4180186
36675508	Product containing piroxicam in cutaneous dose form (medicinal product form)	4180186
36675513	Product containing phenylephrine in cutaneous dose form (medicinal product form)	4180186
36675514	Product containing ipratropium in pulmonary dose form (medicinal product form)	4180186
36675515	Product containing amcinonide in cutaneous dose form (medicinal product form)	4180186
36675516	Product containing fluocortolone in cutaneous dose form (medicinal product form)	4180186
36675517	Product containing dichloroxylenol in cutaneous dose form (medicinal product form)	4180186
36675520	Product containing methylphenidate in cutaneous dose form (medicinal product form)	4180186
36675523	Product containing epinephrine in cutaneous dose form (medicinal product form)	4180186
36675523	Adrenaline-containing product in cutaneous dose form	4180186
36675524	Product containing dibrompropamidine in cutaneous dose form (medicinal product form)	4180186
36675524	Dibrompropamidine-containing product in cutaneous dose form	4180186
36675527	Product containing bacitracin in cutaneous dose form (medicinal product form)	4180186
36675528	Product containing atropine in ocular dose form (medicinal product form)	4180186
36675529	Product containing nystatin in cutaneous dose form (medicinal product form)	4180186
36675532	Product containing sodium bicarbonate in cutaneous dose form (medicinal product form)	4180186
36675533	Orciprenaline-containing product in pulmonary dose form	4180186
36675533	Product containing orciprenaline in pulmonary dose form (medicinal product form)	4180186
36675534	Product containing ciclesonide in pulmonary dose form (medicinal product form)	4180186
36675537	Product containing ketoconazole in cutaneous dose form (medicinal product form)	4180186
36675538	Product containing methylcellulose in ocular dose form (medicinal product form)	4180186
36675541	Product containing boric acid in cutaneous dose form (medicinal product form)	4180186
36675542	Product containing dextran in ocular dose form (medicinal product form)	4180186
36675543	Product containing econazole in ocular dose form (medicinal product form)	4180186
36675544	Product containing fluorouracil in cutaneous dose form (medicinal product form)	4180186
36675546	Product containing xylometazoline in ocular dose form (medicinal product form)	4180186
36675550	Product containing bexarotene in cutaneous dose form (medicinal product form)	4180186
36675551	Open repair of recurrent incisional hernia using biological mesh (procedure)	4180186
36675551	Open hernioplasty using biological mesh for recurrent incisional hernia	4180186
36675552	Product containing levonorgestrel in cutaneous dose form (medicinal product form)	4180186
36675557	Product containing pilocarpine in ocular dose form (medicinal product form)	4180186
36675559	Product containing tacrolimus in cutaneous dose form (medicinal product form)	4180186
36675560	Product containing bifonazole in cutaneous dose form (medicinal product form)	4180186
36675561	Product containing methoxsalen in cutaneous dose form (medicinal product form)	4180186
36675562	Product containing neomycin in cutaneous dose form (medicinal product form)	4180186
36675563	Product containing moxifloxacin in ocular dose form (medicinal product form)	4180186
36675564	Product containing ethanol in cutaneous dose form (medicinal product form)	4180186
36675565	Nitrofural-containing product in cutaneous dose form	4180186
36675565	Product containing nitrofural in cutaneous dose form (medicinal product form)	4180186
36675567	Product containing fluticasone and vilanterol in pulmonary dose form (medicinal product form)	4180186
36675568	Product containing glycerol in cutaneous dose form (medicinal product form)	4180186
36675568	Glycerol-containing product in cutaneous dose form	4180186
36675570	Product containing iloprost in pulmonary dose form (medicinal product form)	4180186
36675571	Product containing clioquinol in cutaneous dose form (medicinal product form)	4180186
36675574	Product containing diphenhydramine in cutaneous dose form (medicinal product form)	4180186
36675575	Product containing triamcinolone in pulmonary dose form (medicinal product form)	4180186
36675582	At risk of emotional abuse (finding)	4180186
36675582	At risk for emotional abuse	4180186
36675583	Product containing technetium (99m-Tc) human immunoglobulin G in parenteral dose form (medicinal product form)	4180186
36675585	DALK - deep anterior lamellar keratoplasty	4180186
36675585	Deep anterior lamellar keratoplasty (procedure)	4180186
36675586	History of deep anterior lamellar keratoplasty (situation)	4180186
36675587	History of deep lamellar endothelial keratoplasty (situation)	4180186
36675592	Ultrasonography guided injection of glue to varicose vein of lower limb	4180186
36675592	Injection of adhesive agent to varicose vein of lower limb using ultrasonographic guidance (procedure)	4180186
36675592	Ultrasound guided injection of glue to varicose vein of lower limb	4180186
36675592	Injection of adhesive agent to varicose vein of lower limb using ultrasonographic guidance	4180186
36675593	Non-binary gender (finding)	4180186
36675594	Failed delivery by vacuum extraction	4180186
36675594	Failed ventouse delivery (situation)	4180186
36675595	Failed instrumental delivery (situation)	4180186
36675596	Invasive silicone sheet dressing (physical object)	4180186
36675600	Fontanometer	4180186
36675600	Neonatal transcutaneous intracranial pressure sensor (physical object)	4180186
36675602	Percutaneous pressure probe (physical object)	4180186
36675604	Radiofrequency ablation of rectal hemorrhoid (procedure)	4180186
36675604	Radiofrequency ablation of rectal haemorrhoid	4180186
36675610	Product containing hydrolase (product)	4180186
36675613	Product containing fostamatinib (medicinal product)	4180186
36675614	Product containing fostamatinib in oral dose form (medicinal product form)	4180186
36675615	Product containing burosumab (medicinal product)	4180186
36675616	Product containing burosumab in parenteral dose form (medicinal product form)	4180186
36675617	Technetium (99m-Tc) rhenium sulfide colloid (substance)	4180186
36675618	Hemipelvectomy	4180186
36675618	Amputation of entire lower limb and ipsilateral hemipelvis (procedure)	4180186
36675618	Jaboulay's amputation	4180186
36675618	Hindquarter amputation	4180186
36675619	Limb sparing pelvic resection	4180186
36675619	Resection of innominate bone (procedure)	4180186
36675619	Internal hemipelvectomy	4180186
36675620	Mycobacterium paraense (organism)	4180186
36675623	Product containing monoclonal immunoglobulin (product)	4180186
36675624	Amputation of entire left lower limb and ipsilateral hemipelvis (procedure)	4180186
36675626	Arsenic acid (substance)	4180186
36675629	Pseudomonas aeruginosa Liverpool epidemic strain (organism)	4180186
36675629	Pseudomonas aeruginosa LES (Liverpool epidemic strain)	4180186
36675632	CYP2B6 rapid metaboliser	4180186
36675632	Cytochrome P450 family 2 subfamily B member 6 rapid metaboliser	4180186
36675632	Cytochrome P450 family 2 subfamily B member 6 rapid metabolizer	4180186
36675632	Cytochrome P450 family 2 subfamily B member 6 rapid metabolizer (finding)	4180186
36675634	Laparoscopic repair of recurrent lumbar hernia using synthetic mesh (procedure)	4180186
36675634	Laparoscopic hernioplasty using synthetic mesh for recurrent lumbar hernia	4180186
36675635	Laparoscopic lumbar hernioplasty using biological mesh	4180186
36675635	Laparoscopic repair of lumbar hernia using biological mesh (procedure)	4180186
36675636	Laparoscopic repair of lumbar hernia using synthetic mesh (procedure)	4180186
36675636	Laparoscopic lumbar hernioplasty using synthetic mesh	4180186
36675637	Repair of recurrent lumbar hernia (procedure)	4180186
36675638	Laparoscopic repair of lumbar hernia (procedure)	4180186
36675639	Laparoscopic repair of recurrent lumbar hernia using biological mesh (procedure)	4180186
36675639	Laparoscopic hernioplasty using biological mesh for recurrent lumbar hernia	4180186
36675640	Proportionate short stature (disorder)	4180186
36675640	PSS - proportionate short stature	4180186
36675641	DSS - disproportionate short stature	4180186
36675641	Disproportionate short stature (disorder)	4180186
36675642	Stool buoyancy (observable entity)	4180186
36675645	Product containing bictegravir and emtricitabine and tenofovir (medicinal product)	4180186
36675646	Product containing bictegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)	4180186
36675647	Product containing binimetinib (medicinal product)	4180186
36675651	Repair of recurrent incisional hernia of abdominal wall (procedure)	4180186
36675652	Product containing technetium (99m-Tc) rhenium sulfide colloid (medicinal product)	4180186
36675653	Product containing technetium (99m-Tc) rhenium sulfide colloid in parenteral dose form (medicinal product form)	4180186
36675655	Laparoscopic spigelian hernioplasty using biological mesh	4180186
36675655	Laparoscopic repair of spigelian hernia using biological mesh (procedure)	4180186
36675657	Laparoscopic repair of recurrent spigelian hernia using biological mesh (procedure)	4180186
36675657	Laparoscopic hernioplasty using biological mesh for recurrent spigelian hernia	4180186
36675658	Laparoscopic repair of recurrent spigelian hernia using synthetic mesh (procedure)	4180186
36675658	Laparoscopic hernioplasty using synthetic mesh for recurrent spigelian hernia	4180186
36675660	Doxorubicin hydrochloride pegylated liposome (substance)	4180186
36675661	Requires HEV (hepatitis E virus) negative blood component	4180186
36675661	Requires hepatitis E virus negative blood component (finding)	4180186
36675662	Requires irradiated blood component (finding)	4180186
36675669	Autosomal dominant childhood-onset proximal spinal muscular atrophy	4180186
36675669	SMALED - spinal muscular atrophy, lower extremity, dominant	4180186
36675669	Lower extremity-predominant autosomal dominant proximal spinal muscular atrophy	4180186
36675669	Autosomal dominant childhood-onset proximal spinal muscular atrophy (disorder)	4180186
36675673	Recreational drug misuse withdrawal (disorder)	4180186
36675675	Obstruction co-occurrent and due to right femoral hernia (disorder)	4180186
36675676	Obstruction co-occurrent and due to recurrent right inguinal hernia (disorder)	4180186
36675678	Obstruction co-occurrent and due to left inguinal hernia (disorder)	4180186
36675680	Mumps suspected (situation)	4180186
36675681	Suspected whooping cough	4180186
36675681	Pertussis suspected (situation)	4180186
36675682	Botulism suspected (situation)	4180186
36675683	Suspected Hansen disease	4180186
36675683	Leprosy suspected (situation)	4180186
36675684	Obstruction co-occurrent and due to bilateral recurrent inguinal hernia (disorder)	4180186
36675684	Bilateral obstructed recurrent inguinal hernia	4180186
36675685	Diphtheria suspected (situation)	4180186
36675688	Tetanus suspected (situation)	4180186
36675690	Acute poliomyelitis suspected (situation)	4180186
36675692	Scarlet fever suspected (situation)	4180186
36675694	Smallpox suspected (situation)	4180186
36675699	Paratyphoid fever suspected (situation)	4180186
36675701	Legionella pneumonia suspected (situation)	4180186
36675701	Suspected Legionnaires disease	4180186
36675702	Malaria suspected (situation)	4180186
36675705	Ability to balance when standing with both feet apart (observable entity)	4180186
36675706	Application of below elbow back slab (procedure)	4180186
36675706	Application of dorsal slab	4180186
36675708	Rubella suspected (situation)	4180186
36675708	Suspected German measles	4180186
36675709	Collagenase (substance)	4180186
36675712	Mobile intraoperative three-dimensional computed tomography of cervical spine (procedure)	4180186
36675712	Mobile intraoperative three-dimensional computed tomography of cervical spine	4180186
36675713	Mobile intraoperative three-dimensional computed tomography of head (procedure)	4180186
36675713	Mobile intraoperative three-dimensional computed tomography of head	4180186
36675715	RAB18, member RAS oncogene family deficiency (disorder)	4180186
36675715	RAB18, member RAS oncogene family deficiency	4180186
36675717	Ability to balance when standing with both feet in tandem stance (observable entity)	4180186
36675719	Ability to balance when standing with both feet in semi tandem stance (observable entity)	4180186
36675721	Able to balance when standing with both feet in tandem stance (finding)	4180186
36675722	Able to balance when standing with both feet together (finding)	4180186
36675724	Unable to balance when standing with both feet apart (finding)	4180186
36675725	Unable to balance when standing with both feet in tandem stance (finding)	4180186
36675726	Unable to balance when standing with both feet in semi tandem stance (finding)	4180186
36675727	Unable to balance when standing with both feet together (finding)	4180186
36675732	Lauromacrogol (substance)	4180186
36675733	Computed tomography venography of vein of lower limb with contrast	4180186
36675733	CT venography of vein of lower extremity with contrast	4180186
36675733	CT venogram of vein of lower limb with contrast	4180186
36675733	Computed tomography venography of vein of lower limb with contrast (procedure)	4180186
36675734	Product containing only abacavir in oral dose form (medicinal product form)	4180186
36675735	Product containing only abacavir and lamivudine in oral dose form (medicinal product form)	4180186
36675738	High-grade glioma	4180186
36675738	High grade glioma (morphologic abnormality)	4180186
36675739	Product containing retinol and vitamin D in oral dose form (medicinal product form)	4180186
36675739	Retinol- and vitamin D-containing product in oral dose form	4180186
36675742	Product containing abciximab in parenteral dose form (medicinal product form)	4180186
36675743	Product containing adalimumab in parenteral dose form (medicinal product form)	4180186
36675747	Product containing agalsidase beta in parenteral dose form (medicinal product form)	4180186
36675748	Product containing alfentanil in parenteral dose form (medicinal product form)	4180186
36675749	Product containing allantoin and coal tar extract in cutaneous dose form (medicinal product form)	4180186
36675752	Aluminium oxide-containing product in cutaneous dose form	4180186
36675752	Product containing aluminium oxide in cutaneous dose form (medicinal product form)	4180186
36675754	Product containing amifostine in parenteral dose form (medicinal product form)	4180186
36675755	Product containing amobarbital in parenteral dose form (medicinal product form)	4180186
36675757	Ampicillin- and flucloxacillin-containing product in parenteral dose form	4180186
36675757	Product containing ampicillin and flucloxacillin in parenteral dose form (medicinal product form)	4180186
36675759	Product containing apraclonidine in ocular dose form (medicinal product form)	4180186
36675760	Product containing argatroban in parenteral dose form (medicinal product form)	4180186
36675761	Product containing aspirin and codeine in oral dose form (medicinal product form)	4180186
36675767	Product containing azelaic acid in cutaneous dose form (medicinal product form)	4180186
36675769	Product containing basiliximab in parenteral dose form (medicinal product form)	4180186
36675770	Product containing becaplermin in cutaneous dose form (medicinal product form)	4180186
36675771	Extension Namespace {1000223}	4180186
36675771	Extension Namespace {1000223} (namespace concept)	4180186
36675772	Product containing bendroflumethiazide and potassium chloride in oral dose form (medicinal product form)	4180186
36675775	Product containing benzalkonium and tolnaftate in cutaneous dose form (medicinal product form)	4180186
36675777	Product containing benzalkonium in oromucosal dose form (medicinal product form)	4180186
36675779	Mertiatide (substance)	4180186
36675780	Product containing benzocaine and dequalinium in oromucosal dose form (medicinal product form)	4180186
36675784	Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form)	4180186
36675787	Product containing benzoyl peroxide and potassium hydroxyquinoline sulfate in cutaneous dose form (medicinal product form)	4180186
36675788	Product containing benzoyl peroxide and clindamycin in cutaneous dose form (medicinal product form)	4180186
36675789	Metopimazine (substance)	4180186
36675790	Product containing benzydamine in oromucosal dose form (medicinal product form)	4180186
36675791	Product containing benzydamine in cutaneous dose form (medicinal product form)	4180186
36675792	Product containing betamethasone and salicylic acid in cutaneous dose form (medicinal product form)	4180186
36675795	Product containing betamethasone and neomycin in cutaneous dose form (medicinal product form)	4180186
36675797	Product containing betamethasone and neomycin in ocular dose form (medicinal product form)	4180186
36675798	Product containing betaxolol in ocular dose form (medicinal product form)	4180186
36675799	Product containing botulinum toxin type A in parenteral dose form (medicinal product form)	4180186
36675801	Product containing brimonidine in ocular dose form (medicinal product form)	4180186
36675803	Product containing budesonide and formoterol in pulmonary dose form (medicinal product form)	4180186
36675804	Product containing bumetanide and potassium chloride in oral dose form (medicinal product form)	4180186
36675806	Product containing butalbital and paracetamol in oral dose form (medicinal product form)	4180186
36675806	Butalbital- and paracetamol-containing product in oral dose form	4180186
36675807	Product containing caffeine and ergotamine in rectal dose form (medicinal product form)	4180186
36675811	Product containing calcium carbonate and light kaolin in oral dose form (medicinal product form)	4180186
36675812	Product containing calcium glubionate and calcium lactobionate in oral dose form (medicinal product form)	4180186
36675816	Product containing carbaryl in cutaneous dose form (medicinal product form)	4180186
36675817	Product containing carbocisteine in oral dose form (medicinal product form)	4180186
36675817	Carbocisteine-containing product in oral dose form	4180186
36675818	Product containing carbomer-980 in ocular dose form (medicinal product form)	4180186
36675820	Product containing carmustine in parenteral dose form (medicinal product form)	4180186
36675825	Product containing cetylpyridinium and lidocaine in dental dose form (medicinal product form)	4180186
36675826	Product containing chlorhexidine and chlorobutanol in oromucosal dose form (medicinal product form)	4180186
36675829	Product containing chlorhexidine and nystatin in cutaneous dose form (medicinal product form)	4180186
36675830	Product containing chlorhexidine and tolnaftate in cutaneous dose form (medicinal product form)	4180186
36675833	Product containing cisatracurium in parenteral dose form (medicinal product form)	4180186
36675834	Product containing cladribine in parenteral dose form (medicinal product form)	4180186
36675835	Product containing clavulanic acid and ticarcillin in parenteral dose form (medicinal product form)	4180186
36675837	Product containing clioquinol and hydrocortisone in cutaneous dose form (medicinal product form)	4180186
36675839	Product containing clobetasone in cutaneous dose form (medicinal product form)	4180186
36675842	Product containing clotrimazole and hydrocortisone in cutaneous dose form (medicinal product form)	4180186
36675844	Coal tar- and dithranol- and salicylic acid-containing product in cutaneous dose form	4180186
36675844	Product containing coal tar and dithranol and salicylic acid in cutaneous dose form (medicinal product form)	4180186
36675845	Product containing cod liver oil and zinc in cutaneous dose form (medicinal product form)	4180186
36675847	Product containing cromoglicic acid and xylometazoline in nasal dose form (medicinal product form)	4180186
36675847	Cromoglicic acid- and xylometazoline-containing product in nasal dose form	4180186
36675848	Product containing crotamiton and hydrocortisone in cutaneous dose form (medicinal product form)	4180186
36675849	Product containing crotamiton in cutaneous dose form (medicinal product form)	4180186
36675850	Product containing dalfopristin and quinupristin in parenteral dose form (medicinal product form)	4180186
36675851	Product containing danaparoid in parenteral dose form (medicinal product form)	4180186
36675852	Product containing darbepoetin alfa in parenteral dose form (medicinal product form)	4180186
36675853	Product containing desmopressin in parenteral dose form (medicinal product form)	4180186
36675855	Product containing dextran 70 and hypromellose in ocular dose form (medicinal product form)	4180186
36675856	Dextropropoxyphene- and paracetamol-containing product in oral dose form	4180186
36675856	Product containing dextropropoxyphene and paracetamol in oral dose form (medicinal product form)	4180186
36675859	Product containing diazoxide in parenteral dose form (medicinal product form)	4180186
36675860	Dichloralphenazone- and isometheptene- and paracetamol-containing product in oral dose form	4180186
36675860	Product containing dichloralphenazone and isometheptene and paracetamol in oral dose form (medicinal product form)	4180186
36675861	Product containing diflucortolone in cutaneous dose form (medicinal product form)	4180186
36675862	Product containing dihydrocodeine and paracetamol in oral dose form (medicinal product form)	4180186
36675862	Dihydrocodeine- and paracetamol-containing product in oral dose form	4180186
36675863	Product containing dihydrocodeine in parenteral dose form (medicinal product form)	4180186
36675864	Product containing diphenhydramine and paracetamol in oral dose form (medicinal product form)	4180186
36675864	Diphenhydramine- and paracetamol-containing product in oral dose form	4180186
36675865	Product containing dipyridamole in parenteral dose form (medicinal product form)	4180186
36675866	Product containing pamidronic acid in parenteral dose form (medicinal product form)	4180186
36675867	Product containing dithranol and salicylic acid in cutaneous dose form (medicinal product form)	4180186
36675867	Dithranol- and salicylic acid-containing product in cutaneous dose form	4180186
36675869	Product containing domperidone and paracetamol in oral dose form (medicinal product form)	4180186
36675869	Domperidone- and paracetamol-containing product in oral dose form	4180186
36675872	Product containing dorzolamide and timolol in ocular dose form (medicinal product form)	4180186
36675873	Product containing dorzolamide in ocular dose form (medicinal product form)	4180186
36675877	Product containing econazole and hydrocortisone in cutaneous dose form (medicinal product form)	4180186
36675878	Product containing eculizumab in parenteral dose form (medicinal product form)	4180186
36675879	Product containing edrophonium in parenteral dose form (medicinal product form)	4180186
36675880	Product containing emedastine in ocular dose form (medicinal product form)	4180186
36675882	Product containing epinephrine and guanethidine in ocular dose form (medicinal product form)	4180186
36675882	Adrenaline- and guanethidine-containing product in ocular dose form	4180186
36675884	Product containing epoetin alfa in parenteral dose form (medicinal product form)	4180186
36675886	Product containing epoprostenol in parenteral dose form (medicinal product form)	4180186
36675889	Product containing erythromycin and isotretinoin in cutaneous dose form (medicinal product form)	4180186
36675890	Product containing erythromycin and tretinoin in cutaneous dose form (medicinal product form)	4180186
36675895	Estradiol- and norethisterone-containing product in oral dose form	4180186
36675895	Product containing estradiol and norethisterone in oral dose form (medicinal product form)	4180186
36675899	Product containing ethinylestradiol and ferrous fumarate and norgestrel in oral dose form (medicinal product form)	4180186
36675899	Ethinylestradiol- and ferrous fumarate- and norgestrel-containing product in oral dose form	4180186
36675901	Product containing fentanyl in parenteral dose form (medicinal product form)	4180186
36675902	Product containing ferric ammonium citrate and folic acid in oral dose form (medicinal product form)	4180186
36675904	Product containing ferrous sulfate and folic acid in oral dose form (medicinal product form)	4180186
36675906	Product containing fish derived omega 3 fatty acid in oral dose form (medicinal product form)	4180186
36675907	Product containing flumazenil in parenteral dose form (medicinal product form)	4180186
36675909	Product containing fluoxetine and olanzapine in oral dose form (medicinal product form)	4180186
36675910	Product containing fluprednidene and miconazole in cutaneous dose form (medicinal product form)	4180186
36675911	Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)	4180186
36675913	Product containing fosaprepitant in parenteral dose form (medicinal product form)	4180186
36675914	Product containing foscarnet in parenteral dose form (medicinal product form)	4180186
36675915	Product containing diethylstilbestrol in oral dose form (medicinal product form)	4180186
36675917	Product containing fulvestrant in parenteral dose form (medicinal product form)	4180186
36675919	Product containing fusidic acid and hydrocortisone in cutaneous dose form (medicinal product form)	4180186
36675921	Product containing galactose and palmitic acid in parenteral dose form (medicinal product form)	4180186
36675922	Product containing gallamine in parenteral dose form (medicinal product form)	4180186
36675923	Product containing galsulfase in parenteral dose form (medicinal product form)	4180186
36675924	Product containing gamolenic acid in oral dose form (medicinal product form)	4180186
36675926	Product containing gentamicin and hydrocortisone in otic dose form (medicinal product form)	4180186
36675928	Glyceryl trinitrate-containing product in cutaneous dose form	4180186
36675928	Product containing glyceryl trinitrate in cutaneous dose form (medicinal product form)	4180186
36675930	Product containing glycopyrronium in parenteral dose form (medicinal product form)	4180186
36675931	Product containing glycopyrronium and neostigmine in parenteral dose form (medicinal product form)	4180186
36675932	Product containing gonadorelin in parenteral dose form (medicinal product form)	4180186
36675933	Product containing hemin in parenteral dose form (medicinal product form)	4180186
36675933	Haemin-containing product in parenteral dose form	4180186
36675934	Product containing heparinoid and salicylic acid in cutaneous dose form (medicinal product form)	4180186
36675935	Product containing heparinoid in cutaneous dose form (medicinal product form)	4180186
36675936	Product containing surface antigen of Hepatitis B virus in parenteral dose form (medicinal product form)	4180186
36675938	Product containing hexobarbital in oral dose form (medicinal product form)	4180186
36675939	Product containing human insulin zinc suspension crystalline in parenteral dose form (medicinal product form)	4180186
36675940	Product containing isophane insulin in parenteral dose form (medicinal product form)	4180186
36675946	Product containing hydrochlorothiazide and olmesartan in oral dose form (medicinal product form)	4180186
36675948	Product containing hydrochlorothiazide and spironolactone in oral dose form (medicinal product form)	4180186
36675951	Product containing hydrochlorothiazide and methyldopa in oral dose form (medicinal product form)	4180186
36675952	Product containing hydrochlorothiazide and reserpine in oral dose form (medicinal product form)	4180186
36675954	Product containing hydrocortisone and urea in cutaneous dose form (medicinal product form)	4180186
36675956	Product containing hydrocortisone and neomycin in cutaneous dose form (medicinal product form)	4180186
36675957	Product containing hydroquinone in cutaneous dose form (medicinal product form)	4180186
36675958	Product containing calcium phosphate in oral dose form (medicinal product form)	4180186
36675961	Product containing idarubicin in parenteral dose form (medicinal product form)	4180186
36675963	Product containing iloperidone in oral dose form (medicinal product form)	4180186
36675964	Product containing imiglucerase in parenteral dose form (medicinal product form)	4180186
36675971	Product containing iopanoic acid in oral dose form (medicinal product form)	4180186
36675972	Product containing irbesartan in oral dose form (medicinal product form)	4180186
36675974	Product containing iron sorbitol in parenteral dose form (medicinal product form)	4180186
36675976	Isometheptene- and paracetamol-containing product in oral dose form	4180186
36675976	Product containing isometheptene and paracetamol in oral dose form (medicinal product form)	4180186
36675981	Product containing labetalol in oral dose form (medicinal product form)	4180186
36675985	Product containing lactic acid and salicylic acid in cutaneous dose form (medicinal product form)	4180186
36675986	Product containing lactic acid and urea in cutaneous dose form (medicinal product form)	4180186
36675993	Product containing lauromacrogol and urea in cutaneous dose form (medicinal product form)	4180186
36675994	Product containing leflunomide in oral dose form (medicinal product form)	4180186
36675995	Product containing lenalidomide in oral dose form (medicinal product form)	4180186
36675996	Product containing lenograstim in parenteral dose form (medicinal product form)	4180186
36675998	Product containing letrozole in oral dose form (medicinal product form)	4180186
36675999	Product containing levobunolol in ocular dose form (medicinal product form)	4180186
36676000	Product containing levobupivacaine in parenteral dose form (medicinal product form)	4180186
36676001	Product containing levocabastine in ocular dose form (medicinal product form)	4180186
36676002	Product containing levodopa in oral dose form (medicinal product form)	4180186
36676003	Levomepromazine-containing product in parenteral dose form	4180186
36676003	Product containing levomepromazine in parenteral dose form (medicinal product form)	4180186
36676005	Product containing lidocaine in oromucosal dose form (medicinal product form)	4180186
36676007	Product containing lidocaine and tetracaine in cutaneous dose form (medicinal product form)	4180186
36676008	Product containing lidocaine and methylprednisolone in parenteral dose form (medicinal product form)	4180186
36676009	Product containing lidocaine in gingival dose form (medicinal product form)	4180186
36676011	Product containing lithium citrate in oral dose form (medicinal product form)	4180186
36676012	Product containing lodoxamide in ocular dose form (medicinal product form)	4180186
36676013	Lovastatin- and nicotinic acid-containing product in oral dose form	4180186
36676013	Product containing lovastatin and nicotinic acid in oral dose form (medicinal product form)	4180186
36676014	Product containing lovastatin in oral dose form (medicinal product form)	4180186
36676015	Product containing loxapine in oral dose form (medicinal product form)	4180186
36676017	Product containing magnesium alginate and sodium alginate in oral dose form (medicinal product form)	4180186
36676019	Product containing malathion in cutaneous dose form (medicinal product form)	4180186
36676021	Product containing mazindol in oral dose form (medicinal product form)	4180186
36676024	Meclozine-containing product in oral dose form	4180186
36676024	Product containing meclozine in oral dose form (medicinal product form)	4180186
36676026	Product containing melphalan in oral dose form (medicinal product form)	4180186
36676027	Product containing memantine in oral dose form (medicinal product form)	4180186
36676030	Product containing mepenzolate in oral dose form (medicinal product form)	4180186
36676033	Product containing meptazinol in oral dose form (medicinal product form)	4180186
36676036	Product containing metaxalone in oral dose form (medicinal product form)	4180186
36676037	Product containing metamfetamine in oral dose form (medicinal product form)	4180186
36676037	Metamfetamine-containing product in oral dose form	4180186
36676038	Product containing methazolamide in oral dose form (medicinal product form)	4180186
36676042	Methionine-containing product in oral dose form	4180186
36676042	Product containing methionine in oral dose form (medicinal product form)	4180186
36676045	Product containing methscopolamine and pseudoephedrine in oral dose form (medicinal product form)	4180186
36676047	Product containing methyclothiazide in oral dose form (medicinal product form)	4180186
36676048	Product containing 5-aminolevulinic acid in cutaneous dose form (medicinal product form)	4180186
36676051	Methylene blue-containing product in oral dose form	4180186
36676051	Product containing methylthioninium chloride in oral dose form (medicinal product form)	4180186
36676051	Product containing methylene blue stain in oral dose form (medicinal product form)	4180186
36676051	Methylthioninium chloride-containing product in oral dose form	4180186
36676052	Product containing methylergometrine in oral dose form (medicinal product form)	4180186
36676052	Methylergometrine-containing product in oral dose form	4180186
36676060	Mineral oil- and white soft paraffin-containing product in cutaneous dose form	4180186
36676060	Product containing mineral oil and white petrolatum in cutaneous dose form (medicinal product form)	4180186
36676062	Product containing mitobronitol in oral dose form (medicinal product form)	4180186
36676064	Product containing mitotane in oral dose form (medicinal product form)	4180186
36676065	Product containing mivacurium in parenteral dose form (medicinal product form)	4180186
36676066	Mizoribine (substance)	4180186
36676067	Product containing modafinil in oral dose form (medicinal product form)	4180186
36676068	Product containing molgramostim in parenteral dose form (medicinal product form)	4180186
36676070	Product containing monobasic sodium phosphate in oral dose form (medicinal product form)	4180186
36676071	Moracizine-containing product in oral dose form	4180186
36676071	Product containing moracizine in oral dose form (medicinal product form)	4180186
36676072	Product containing moxonidine in oral dose form (medicinal product form)	4180186
36676078	Product containing netilmicin in parenteral dose form (medicinal product form)	4180186
36676079	Nicotinic acid-containing product in cutaneous dose form	4180186
36676079	Product containing nicotinic acid in cutaneous dose form (medicinal product form)	4180186
36676080	Product containing nilotinib in oral dose form (medicinal product form)	4180186
36676087	Product containing norepinephrine in parenteral dose form (medicinal product form)	4180186
36676087	Noradrenaline-containing product in parenteral dose form	4180186
36676089	Product containing norgestrel in oral dose form (medicinal product form)	4180186
36676091	Product containing octreotide in parenteral dose form (medicinal product form)	4180186
36676094	Product containing oxcarbazepine in oral dose form (medicinal product form)	4180186
36676098	Product containing oxypertine in oral dose form (medicinal product form)	4180186
36676101	Product containing palivizumab in parenteral dose form (medicinal product form)	4180186
36676102	Product containing palonosetron in parenteral dose form (medicinal product form)	4180186
36676103	Product containing pancuronium in parenteral dose form (medicinal product form)	4180186
36676105	Product containing pantoprazole in parenteral dose form (medicinal product form)	4180186
36676106	Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)	4180186
36676106	Hyoscine- and papaveretum-containing product in parenteral dose form	4180186
36676107	Product containing paracetamol and salicylamide in oral dose form (medicinal product form)	4180186
36676107	Paracetamol- and salicylamide-containing product in oral dose form	4180186
36676109	Product containing pegaspargase in parenteral dose form (medicinal product form)	4180186
36676112	Product containing pentosan polysulfate in oral dose form (medicinal product form)	4180186
36676113	Product containing pentostatin in parenteral dose form (medicinal product form)	4180186
36676115	Product containing permethrin stain in cutaneous dose form (medicinal product form)	4180186
36676116	Product containing pethidine in oral dose form (medicinal product form)	4180186
36676116	Pethidine-containing product in oral dose form	4180186
36676118	Pethidine-containing product in parenteral dose form	4180186
36676118	Product containing pethidine in parenteral dose form (medicinal product form)	4180186
36676120	Product containing phenazopyridine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form)	4180186
36676121	Product containing phenindione in oral dose form (medicinal product form)	4180186
36676125	Product containing beractant in pulmonary dose form (medicinal product form)	4180186
36676126	Product containing poractant alfa in pulmonary dose form (medicinal product form)	4180186
36676127	Product containing piperacillin and tazobactam in parenteral dose form (medicinal product form)	4180186
36676128	Product containing pipotiazine in parenteral dose form (medicinal product form)	4180186
36676128	Pipotiazine-containing product in parenteral dose form	4180186
36676129	Product containing podophyllotoxin in cutaneous dose form (medicinal product form)	4180186
36676130	Product containing polynoxylin in cutaneous dose form (medicinal product form)	4180186
36676131	Product containing polyvinyl alcohol in ocular dose form (medicinal product form)	4180186
36676133	Product containing posaconazole in oral dose form (medicinal product form)	4180186
36676135	Product containing potassium chloride and sodium chloride in parenteral dose form (medicinal product form)	4180186
36676136	Product containing pralidoxime in parenteral dose form (medicinal product form)	4180186
36676137	Product containing prilocaine in parenteral dose form (medicinal product form)	4180186
36676139	Product containing probenecid in oral dose form (medicinal product form)	4180186
36676141	Product containing propantheline in oral dose form (medicinal product form)	4180186
36676142	Product containing propiverine in oral dose form (medicinal product form)	4180186
36676144	Product containing pseudoephedrine and terfenadine in oral dose form (medicinal product form)	4180186
36676146	Product containing rasburicase in parenteral dose form (medicinal product form)	4180186
36676149	Product containing reteplase in parenteral dose form (medicinal product form)	4180186
36676151	Product containing roflumilast in oral dose form (medicinal product form)	4180186
36676152	Product containing romiplostim in parenteral dose form (medicinal product form)	4180186
36676154	Product containing salicylic acid and white petrolatum in cutaneous dose form (medicinal product form)	4180186
36676154	Salicylic acid- and white soft paraffin-containing product in cutaneous dose form	4180186
36676157	Product containing salsalate in oral dose form (medicinal product form)	4180186
36676158	Product containing sapropterin in oral dose form (medicinal product form)	4180186
36676159	Product containing sargramostim in parenteral dose form (medicinal product form)	4180186
36676160	Product containing secbutabarbital in oral dose form (medicinal product form)	4180186
36676160	Secbutabarbital-containing product in oral dose form	4180186
36676162	Product containing sennoside in oral dose form (medicinal product form)	4180186
36676163	Product containing sertraline in oral dose form (medicinal product form)	4180186
36676165	Product containing silodosin in oral dose form (medicinal product form)	4180186
36676166	Product containing sitagliptin in oral dose form (medicinal product form)	4180186
36676167	Product containing sodium citrate in oral dose form (medicinal product form)	4180186
36676168	Product containing sodium feredetate in oral dose form (medicinal product form)	4180186
36676168	Sodium feredetate-containing product in oral dose form	4180186
36676169	Product containing sodium fluoride in oromucosal dose form (medicinal product form)	4180186
36676170	Product containing sodium glycerophosphate in parenteral dose form (medicinal product form)	4180186
36676171	Product containing nitroprusside in parenteral dose form (medicinal product form)	4180186
36676172	Product containing sodium oxybate in oral dose form (medicinal product form)	4180186
36676174	Product containing somatropin(epr) in parenteral dose form (medicinal product form)	4180186
36676175	Product containing somatropin(rbe) in parenteral dose form (medicinal product form)	4180186
36676176	Product containing somatropin(rmc) in parenteral dose form (medicinal product form)	4180186
36676177	Product containing sorafenib in oral dose form (medicinal product form)	4180186
36676181	Product containing sulfamethizole in oral dose form (medicinal product form)	4180186
36676182	Product containing sulfamethoxazole in oral dose form (medicinal product form)	4180186
36676183	Product containing sulfinpyrazone in oral dose form (medicinal product form)	4180186
36676184	Product containing sulindac in oral dose form (medicinal product form)	4180186
36676185	Product containing tacalcitol in cutaneous dose form (medicinal product form)	4180186
36676186	Product containing tafamidis in oral dose form (medicinal product form)	4180186
36676187	Product containing tafluprost in ocular dose form (medicinal product form)	4180186
36676188	Product containing tapentadol in oral dose form (medicinal product form)	4180186
36676189	Product containing tazarotene in cutaneous dose form (medicinal product form)	4180186
36676191	Product containing tenoxicam in parenteral dose form (medicinal product form)	4180186
36676192	Product containing teriparatide in parenteral dose form (medicinal product form)	4180186
36676197	Product containing triamcinolone in oromucosal dose form (medicinal product form)	4180186
36676199	Product containing trifluridine in ocular dose form (medicinal product form)	4180186
36676200	Trimetaphan-containing product in parenteral dose form	4180186
36676200	Product containing trimetaphan in parenteral dose form (medicinal product form)	4180186
36676201	Product containing triptorelin in parenteral dose form (medicinal product form)	4180186
36676202	Product containing undecylenic acid in cutaneous dose form (medicinal product form)	4180186
36676204	Product containing vindesine in parenteral dose form (medicinal product form)	4180186
36676209	Laparoscopic hernioplasty using biological mesh with fascial closure for recurrent lumbar hernia	4180186
36676209	Laparoscopic repair of recurrent lumbar hernia using biological mesh with fascial closure (procedure)	4180186
36676210	Laparoscopic hernioplasty using synthetic mesh with fascial closure for recurrent lumbar hernia	4180186
36676210	Laparoscopic repair of recurrent lumbar hernia using synthetic mesh with fascial closure (procedure)	4180186
36676211	Pimethixene (substance)	4180186
36676216	Obstruction co-occurrent and due to left recurrent femoral hernia (disorder)	4180186
36676219	Assessment of risk of type II diabetes mellitus	4180186
36676219	Assessment of risk of type 2 diabetes mellitus (procedure)	4180186
36676224	Non-Alcoholic Fatty Liver Disease fibrosis score (observable entity)	4180186
36676224	Non-Alcoholic Fatty Liver Disease fibrosis score	4180186
36676225	4-methylaminophenol	4180186
36676225	p-methylaminophenol (substance)	4180186
36676226	Product containing p-methylaminophenol (medicinal product)	4180186
36676229	IPS - Individual Placement and Support	4180186
36676229	Individual Placement and Support (regime/therapy)	4180186
36676231	Anti-cyclic citrullinated peptide antibody positive arthralgia (finding)	4180186
36676231	Anti-CCP (anti-cyclic citrullinated peptide) antibody positive arthralgia	4180186
36676232	Influenza A virus subtype H5N1 (organism)	4180186
36676233	Influenza caused by Influenza A virus subtype H5N1 (disorder)	4180186
36676235	Detection of Influenza A virus using polymerase chain reaction technique	4180186
36676235	Detection of Influenza A virus using polymerase chain reaction technique (procedure)	4180186
36676237	Oxomemazine (substance)	4180186
36676240	Aspirin- and caffeine- and dextropropoxyphene-containing product	4180186
36676240	Product containing aspirin and caffeine and dextropropoxyphene (medicinal product)	4180186
36676241	Product containing bendroflumethiazide and potassium chloride (medicinal product)	4180186
36676242	Product containing bovine thrombin (medicinal product)	4180186
36676243	Product containing bumetanide and potassium chloride (medicinal product)	4180186
36676246	Product containing carbocisteine (medicinal product)	4180186
36676246	Carbocisteine-containing product	4180186
36676247	Product containing cetrimide and dimeticone 1000 (medicinal product)	4180186
36676248	Product containing clobetasol and neomycin and nystatin (medicinal product)	4180186
36676249	Coal tar- and dithranol- and salicylic acid-containing product	4180186
36676249	Product containing coal tar and dithranol and salicylic acid (medicinal product)	4180186
36676252	Product containing cromoglicic acid and xylometazoline (medicinal product)	4180186
36676252	Cromoglicic acid- and xylometazoline-containing product	4180186
36676254	Dihydrocodeine- and paracetamol-containing product	4180186
36676254	Product containing dihydrocodeine and paracetamol (medicinal product)	4180186
36676255	Product containing domperidone and paracetamol (medicinal product)	4180186
36676255	Domperidone- and paracetamol-containing product	4180186
36676256	Product containing dried aluminium hydroxide gel and magnesium hydroxide (medicinal product)	4180186
36676256	Dried aluminium hydroxide gel- and magnesium hydroxide-containing product	4180186
36676260	Product containing glycopyrronium and neostigmine (medicinal product)	4180186
36676266	Product containing hydralazine and hydrochlorothiazide and reserpine (medicinal product)	4180186
36676267	Product containing hydrochlorothiazide and timolol (medicinal product)	4180186
36676269	Product containing methscopolamine and pseudoephedrine (medicinal product)	4180186
36676271	Mineral oil- and white soft paraffin-containing product	4180186
36676271	Product containing mineral oil and white petrolatum (medicinal product)	4180186
36676273	Product containing oxytetracycline and phenazopyridine and sulfamethizole (medicinal product)	4180186
36676274	Product containing permethrin stain (medicinal product)	4180186
36676275	Product containing phenazopyridine and sulfamethoxazole and trimethoprim (medicinal product)	4180186
36676276	Product containing buprenorphine in oromucosal dose form (medicinal product form)	4180186
36676278	Product containing human insulin zinc suspension mixed in parenteral dose form (medicinal product form)	4180186
36676281	Product containing retinol and vitamin D (medicinal product)	4180186
36676281	Retinol- and vitamin D-containing product	4180186
36676285	Product containing somatropin(epr) (medicinal product)	4180186
36676287	Product containing somatropin(rmc) (medicinal product)	4180186
36676288	GLP-1 receptor agonist	4180186
36676288	Glucagon-like peptide 1 receptor agonist (disposition)	4180186
36676288	Incretin mimetic	4180186
36676290	Tecovirimat (substance)	4180186
36676291	DTC - differentiated thyroid cancer	4180186
36676291	Differentiated thyroid cancer	4180186
36676291	Primary differentiated carcinoma of thyroid gland (disorder)	4180186
36676295	Fast field-cycling magnetic resonance imaging	4180186
36676295	Fast field-cycling magnetic resonance imaging (procedure)	4180186
36676295	Fast field-cycling MRI	4180186
36676295	Rapid field-cycling MRI	4180186
36676296	Harmful use of hypnotic (disorder)	4180186
36676299	Metal nail (physical object)	4180186
36676300	Emergency department encounter summary	4180186
36676300	Emergency department report	4180186
36676300	Emergency department encounter report (record artifact)	4180186
36676304	Acute hepatitis caused by infection (disorder)	4180186
36676304	Acute hepatitis caused by infection	4180186
36676305	Acute hepatitis caused by infection suspected (situation)	4180186
36676305	Acute hepatitis caused by infection suspected	4180186
36676306	Haemorrhagic gastroenteritis suspected	4180186
36676306	Hemorrhagic gastroenteritis suspected (situation)	4180186
36676308	Laryngeal stridor (finding)	4180186
36676309	Cystoisospora oocyst	4180186
36676309	Genus Cystoisospora oocyst	4180186
36676309	Oocyst of genus Cystoisospora (organism)	4180186
36676311	Reconstruction of anterior abdominal wall (procedure)	4180186
36676315	Product containing ivosidenib in oral dose form (medicinal product form)	4180186
36676316	Congenital abnormality of cardiac ventricle (disorder)	4180186
36676317	Foreign body in lower urinary tract (disorder)	4180186
36676320	Magnetic resonance imaging of left orbit (procedure)	4180186
36676320	Magnetic resonance imaging of left orbit	4180186
36676321	Magnetic resonance imaging of right orbit	4180186
36676321	Magnetic resonance imaging of right orbit (procedure)	4180186
36676324	Laparoscopic hernioplasty using biological mesh with fascial closure for recurrent umbilical hernia	4180186
36676324	Laparoscopic repair of recurrent umbilical hernia using biological mesh with fascial closure (procedure)	4180186
36676325	Laparoscopic repair of recurrent umbilical hernia using sutures with fascial closure (procedure)	4180186
36676325	Laparoscopic herniorrhaphy with fascial closure for recurrent umbilical hernia	4180186
36676331	Laparoscopic repair of recurrent incisional hernia using biological mesh with fascial closure (procedure)	4180186
36676331	Laparoscopic hernioplasty using biological mesh with fascial closure for recurrent incisional hernia	4180186
36676332	Laparoscopic epigastric hernioplasty using biological mesh with fascial closure	4180186
36676332	Laparoscopic repair of epigastric hernia using biological mesh with fascial closure (procedure)	4180186
36676333	Laparoscopic repair of recurrent epigastric hernia using biological mesh with fascial closure (procedure)	4180186
36676333	Laparoscopic hernioplasty using biological mesh with fascial closure for recurrent epigastric hernia	4180186
36676335	Laparoscopic TEP (totally extraperitoneal) femoral hernioplasty using synthetic mesh	4180186
36676335	Laparoscopic TEP (totally extraperitoneal) repair of femoral hernia using synthetic mesh	4180186
36676335	Laparoscopic totally extraperitoneal repair of femoral hernia using synthetic mesh (procedure)	4180186
36676337	Laparoscopic totally extraperitoneal repair of recurrent femoral hernia using synthetic mesh (procedure)	4180186
36676337	Laparoscopic TEP (totally extraperitoneal) hernioplasty using synthetic mesh for recurrent femoral hernia	4180186
36676337	Laparoscopic TEP (totally extraperitoneal) repair of recurrent femoral hernia using synthetic mesh	4180186
36676338	Laparoscopic TEP (totally extraperitoneal) hernioplasty using synthetic mesh for recurrent inguinal hernia	4180186
36676338	Laparoscopic totally extraperitoneal repair of recurrent inguinal hernia using synthetic mesh (procedure)	4180186
36676338	Laparoscopic TEP (totally extraperitoneal) repair of recurrent inguinal hernia using synthetic mesh	4180186
36676339	Product containing amfetamine in oral dose form (medicinal product form)	4180186
36676339	Amfetamine-containing product in oral dose form	4180186
36676340	Product containing ipodate in oral dose form (medicinal product form)	4180186
36676342	Product containing ipodate (medicinal product)	4180186
36676343	Local excision of lesion of thorax (procedure)	4180186
36676345	Local excision of lesion of sternum (procedure)	4180186
36676354	Bioabsorbable synthetic polymer urinary tract reconstructive material (physical object)	4180186
36676356	Cardiac low intensity collimated ultrasound ablation system catheter (physical object)	4180186
36676359	Electronic pressure algometer (physical object)	4180186
36676360	Mechanical pressure algometer (physical object)	4180186
36676362	Laparoscopic repair of inguinal hernia using surgical mesh (procedure)	4180186
36676364	Laparoscopic TAPP (transabdominal preperitoneal) femoral hernioplasty using synthetic mesh	4180186
36676364	Laparoscopic transabdominal preperitoneal repair of femoral hernia using synthetic mesh (procedure)	4180186
36676364	Laparoscopic TAPP (transabdominal preperitoneal) repair of femoral hernia using synthetic mesh	4180186
36676367	Cyclin-dependent kinase-like 5 deficiency (disorder)	4180186
36676367	CDKL5 deficiency disorder	4180186
36676367	CDKL5 (cyclin-dependent kinase-like 5) deficiency	4180186
36676367	CDKL5-related epileptic encephalopathy	4180186
36676370	Substance with isocitrate dehydrogenase-1 inhibitor mechanism of action (substance)	4180186
36676372	Elagolix sodium (substance)	4180186
36676373	Tafenoquine (substance)	4180186
36676375	Product containing only doxazosin (medicinal product)	4180186
36676376	Product containing only doxazosin in oral dose form (medicinal product form)	4180186
36676377	Product containing only disopyramide (medicinal product)	4180186
36676378	Product containing only disopyramide in parenteral dose form (medicinal product form)	4180186
36676379	Product containing only disopyramide in oral dose form (medicinal product form)	4180186
36676383	Diagnostic laparoscopy and biopsy of lesion of liver (procedure)	4180186
36676384	Distal trisomy 7q11.23	4180186
36676384	Distal 7q11.23 microduplication syndrome (disorder)	4180186
36676385	Laparoscopic repair of incisional hernia of anterior abdominal wall using biological mesh with anterior component separation (procedure)	4180186
36676387	Laparoscopic repair of incisional hernia of anterior abdominal wall using synthetic mesh with anterior component separation (procedure)	4180186
36676389	Product containing isocitrate dehydrogenase-1 inhibitor (product)	4180186
36676390	Procedure related to reproduction (procedure)	4180186
36676393	Product containing lusutrombopag in oral dose form (medicinal product form)	4180186
36676396	Gangrene co-occurrent and due to perineal hernia (disorder)	4180186
36676398	Irreducible perineal hernia (disorder)	4180186
36676399	Insertion of temporary dental crown on tooth (procedure)	4180186
36676399	Insertion of temporary dental crown	4180186
36676402	Ehlers-Danlos syndrome spondylocheirodysplastic type (disorder)	4180186
36676403	Familial osteodysplasia Anderson type (disorder)	4180186
36676405	Hydrocephalus, blue sclera, nephropathy syndrome (disorder)	4180186
36676405	Daentl Townsend Siegel syndrome	4180186
36676408	Cervical malignant germ cell tumor	4180186
36676408	Malignant germ cell neoplasm of cervix uteri (disorder)	4180186
36676408	Cervical malignant germ cell tumour	4180186
36676409	Malignant germ cell tumor of corpus uteri	4180186
36676409	Malignant germ cell neoplasm of corpus uteri (disorder)	4180186
36676409	Malignant germ cell tumour of corpus uteri	4180186
36676410	Open repair of incisional hernia of anterior abdominal wall using synthetic mesh with anterior component separation (procedure)	4180186
36676411	Open repair of incisional hernia of anterior abdominal wall using biological mesh with anterior component separation (procedure)	4180186
36676414	Product containing tecovirimat (medicinal product)	4180186
36676415	Product containing tecovirimat in oral dose form (medicinal product form)	4180186
36676416	Biopsy of abdomen using fluoroscopic guidance (procedure)	4180186
36676416	Biopsy of abdomen using fluoroscopic guidance	4180186
36676417	Insertion of stent into trachea using fluoroscopic guidance (procedure)	4180186
36676417	Insertion of stent into trachea using fluoroscopic guidance	4180186
36676418	Paronychia of toe of left foot due to ingrown toenail (disorder)	4180186
36676418	Ingrown toenail of left foot with infection	4180186
36676418	Infection of periungual skin of toenail of left foot due to ingrown toenail	4180186
36676419	Paronychia of toe of right foot due to ingrown toenail (disorder)	4180186
36676419	Infection of periungual skin of toenail of right foot due to ingrown toenail	4180186
36676419	Ingrown toenail of right foot with infection	4180186
36676420	Ingrowing nail with infection	4180186
36676420	Paronychia due to ingrown nail (disorder)	4180186
36676420	Infection of periungual skin due to ingrown nail	4180186
36676427	Spondylometaphyseal dysplasia Golden type (disorder)	4180186
36676427	X-linked spondylometaphyseal dysplasia	4180186
36676429	Congenital lethal myopathy Compton North type (disorder)	4180186
36676431	RI-CMT type A - autosomal recessive intermediate Charcot-Marie-Tooth disease type A	4180186
36676431	Autosomal recessive intermediate Charcot-Marie-Tooth disease type A (disorder)	4180186
36676432	Open repair of incisional hernia of anterior abdominal wall using synthetic mesh with posterior component separation (procedure)	4180186
36676434	Open repair of incisional hernia of anterior abdominal wall using biological mesh with posterior component separation (procedure)	4180186
36676435	Open repair of recurrent incisional hernia of anterior abdominal wall using biological mesh with posterior component separation (procedure)	4180186
36676436	Sweet smelling urine (finding)	4180186
36676436	Sweet urine odour	4180186
36676436	Sweet urine odor	4180186
36676436	Urine smells sweet	4180186
36676437	Monosomy 7q31	4180186
36676437	7q31 microdeletion syndrome (disorder)	4180186
36676438	Female rectocele co-occurrent with enterocele (disorder)	4180186
36676438	Female rectocoele co-occurrent with enterocele	4180186
36676439	Infantile onset panniculitis with uveitis and systemic granulomatosis (disorder)	4180186
36676441	RI-CMT type B - autosomal recessive intermediate Charcot-Marie-Tooth disease type B	4180186
36676441	Autosomal recessive intermediate Charcot-Marie-Tooth disease type B (disorder)	4180186
36676442	NGPS - Nestor Guillermo progeria syndrome	4180186
36676442	Nestor Guillermo progeria syndrome (disorder)	4180186
36676443	Craniosynostosis and dental anomalies syndrome (disorder)	4180186
36676443	Kreiborg Pakistani syndrome	4180186
36676447	Monosomy 20p13	4180186
36676447	20p subtelomeric deletion syndrome	4180186
36676447	20p13 microdeletion syndrome (disorder)	4180186
36676448	Change in Gibbs energy	4180186
36676448	Delta G (qualifier value)	4180186
36676448	Change of Gibbs free energy	4180186
36676450	Product containing only vincristine liposome (medicinal product)	4180186
36676453	Product containing only irinotecan (medicinal product)	4180186
36676454	Product containing only irinotecan liposome (medicinal product)	4180186
36676456	Product containing only irinotecan liposome in parenteral dose form (medicinal product form)	4180186
36676457	Product containing only daunorubicin (medicinal product)	4180186
36676460	Product containing only daunorubicin liposome in parenteral dose form (medicinal product form)	4180186
36676461	Product containing only cisplatin (medicinal product)	4180186
36676462	Product containing only cisplatin liposome (medicinal product)	4180186
36676465	Product containing only doxorubicin (medicinal product)	4180186
36676466	Product containing only doxorubicin liposome (medicinal product)	4180186
36676468	Product containing only doxorubicin liposome in parenteral dose form (medicinal product form)	4180186
36676473	Product containing only morphine liposome (medicinal product)	4180186
36676474	Product containing only morphine in oral dose form (medicinal product form)	4180186
36676475	Product containing only morphine in rectal dose form (medicinal product form)	4180186
36676476	Product containing only morphine in parenteral dose form (medicinal product form)	4180186
36676481	Product containing only amphotericin B phospholipid complex (medicinal product)	4180186
36676483	Product containing only amphotericin B in parenteral dose form (medicinal product form)	4180186
36676484	Product containing only amphotericin B liposome in parenteral dose form (medicinal product form)	4180186
36676486	Product containing only amphotericin B phospholipid complex in parenteral dose form (medicinal product form)	4180186
36676490	Product containing only axitinib (medicinal product)	4180186
36676492	Product containing only axitinib in oral dose form (medicinal product form)	4180186
36676497	Non-hypoproteinemic hypertrophic gastropathy (disorder)	4180186
36676497	Non-hypoproteinaemic hypertrophic gastropathy	4180186
36676497	Hypertrophic gastropathy without hypoproteinemia	4180186
36676497	Hypertrophic gastropathy without hypoproteinaemia	4180186
36676499	Acetylcholine allergy	4180186
36676499	Allergy to acetylcholine (finding)	4180186
36676507	Computed tomography of cisterna magna (procedure)	4180186
36676507	Computed tomography of cisterna magna	4180186
36676508	Fluoroscopic cisternography with contrast (procedure)	4180186
36676511	Autosomal recessive intermediate Charcot-Marie-Tooth disease type C (disorder)	4180186
36676511	RI-CMT type C - autosomal recessive intermediate Charcot-Marie-Tooth disease type C	4180186
36676513	Intellectual disability, facial dysmorphism, hand anomalies syndrome (disorder)	4180186
36676514	Allergy to etynodiol	4180186
36676514	Ethynodiol allergy	4180186
36676514	Allergy to etynodiol (finding)	4180186
36676514	Etynodiol allergy	4180186
36676516	Severe intellectual disability, short stature, behavioral abnormalities, facial dysmorphism syndrome (disorder)	4180186
36676516	Severe intellectual disability, short stature, behavioural abnormalities, facial dysmorphism syndrome	4180186
36676517	Bamethan allergy	4180186
36676517	Allergy to bamethan (finding)	4180186
36676519	East Texas bleeding disorder (disorder)	4180186
36676524	Allergy to danaparoid (finding)	4180186
36676524	Danaparoid allergy	4180186
36676525	Isosorbide allergy	4180186
36676525	Allergy to isosorbide (finding)	4180186
36676526	Obstetric care plan (record artifact)	4180186
36676532	Plastic surgery care plan (record artifact)	4180186
36676533	Trauma surgery care plan (record artifact)	4180186
36676535	Hepatobiliary surgical care plan (record artifact)	4180186
36676536	Dermatological surgery care plan (record artifact)	4180186
36676538	Podiatric surgery care plan (record artifact)	4180186
36676539	Ophthalmic surgery care plan (record artifact)	4180186
36676541	Gastrointestinal surgery care plan (record artifact)	4180186
36676543	Forensic psychiatry care plan (record artifact)	4180186
36676544	Psychiatric intensive care plan (record artifact)	4180186
36676548	Psychology care plan (record artifact)	4180186
36676549	Dextrothyroxine allergy	4180186
36676549	Allergy to dextrothyroxine (finding)	4180186
36676550	Bird respirator therapy	4180186
36676550	Bird respiratory therapy (procedure)	4180186
36676554	Product containing only amlodipine and atorvastatin in oral dose form (medicinal product form)	4180186
36676555	Product containing only dextromethorphan (medicinal product)	4180186
36676556	Product containing only dextromethorphan in oral dose form (medicinal product form)	4180186
36676558	Product containing only guaifenesin in oral dose form (medicinal product form)	4180186
36676559	Product containing only guaifenesin and pseudoephedrine (medicinal product)	4180186
36676561	Product containing guaifenesin and pseudoephedrine in oral dose form (medicinal product form)	4180186
36676563	Product containing cytochrome P450 2D6 inhibitor (product)	4180186
36676565	Product containing nadroparin in parenteral dose form (medicinal product form)	4180186
36676566	Product containing only nadroparin (medicinal product)	4180186
36676568	Product containing cytochrome P450 17A1 inhibitor (product)	4180186
36676569	Product containing only zofenopril (medicinal product)	4180186
36676572	Allergy to clodronic acid (finding)	4180186
36676572	Clodronic acid allergy	4180186
36676573	Hyaluronic acid allergy	4180186
36676573	Allergy to hyaluronic acid (finding)	4180186
36676576	Dextromethorphan allergy	4180186
36676576	Allergy to dextromethorphan (finding)	4180186
36676577	Allergy to dibrompropamidine	4180186
36676577	Allergy to dibrompropamidine (finding)	4180186
36676577	Dibrompropamidine allergy	4180186
36676578	Combined immunodeficiency due to mucosa-associated lymphoid tissue lymphoma translocation gene 1 deficiency	4180186
36676578	Combined immunodeficiency due to mucosa-associated lymphoid tissue lymphoma translocation gene 1 deficiency (disorder)	4180186
36676581	Pamidronic acid allergy	4180186
36676581	Allergy to pamidronic acid (finding)	4180186
36676584	14q24.1q24.3 microdeletion syndrome (disorder)	4180186
36676584	Monosomy 14q24.1q24.3	4180186
36676585	Episodic ataxia type 8	4180186
36676585	Episodic ataxia with slurred speech (disorder)	4180186
36676589	Allergy to etidronic acid (finding)	4180186
36676589	Etidronic acid allergy	4180186
36676590	Emepronium allergy	4180186
36676590	Allergy to emepronium (finding)	4180186
36676592	Allergy to meclozine hydrochloride	4180186
36676592	Allergy to meclozine hydrochloride (finding)	4180186
36676592	Meclozine allergy	4180186
36676594	Ozone therapy (regime/therapy)	4180186
36676596	Gynecology care plan (record artifact)	4180186
36676596	Gynaecology care plan	4180186
36676598	Interventional radiology care plan (record artifact)	4180186
36676599	Ophthalmology care plan (record artifact)	4180186
36676604	Speech and language therapy care plan (record artifact)	4180186
36676605	Allergy to estropipate (finding)	4180186
36676605	Estropipate allergy	4180186
36676606	Head injury rehabilitation care plan (record artifact)	4180186
36676608	Phenylpropanolamine allergy	4180186
36676608	Allergy to phenylpropanolamine (finding)	4180186
36676611	Product containing mogamulizumab in parenteral dose form (medicinal product form)	4180186
36676613	Nail clippings sent for organism evaluation (situation)	4180186
36676614	Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukaemia	4180186
36676614	Retinoic acid syndrome	4180186
36676614	Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder)	4180186
36676617	Product containing ethinylestradiol and segesterone in vaginal dose form (medicinal product form)	4180186
36676617	Ethinylestradiol- and segesterone-containing product in vaginal dose form	4180186
36676619	Product containing migalastat in oral dose form (medicinal product form)	4180186
36676620	13q12.3 microdeletion syndrome (disorder)	4180186
36676620	Monosomy 13q12.3	4180186
36676623	Frederiksenia	4180186
36676623	Genus Frederiksenia (organism)	4180186
36676624	Severe intellectual disability, poor language, strabismus, grimacing face, long fingers syndrome (disorder)	4180186
36676626	Shaheen syndrome	4180186
36676626	Hypohidrosis, enamel hypoplasia, palmoplantar keratoderma, intellectual disability syndrome (disorder)	4180186
36676627	Beaulieu Boycott Innes syndrome	4180186
36676627	THO complex 6-related developmental delay, microcephaly, facial dysmorphism syndrome	4180186
36676627	THO complex 6-related developmental delay, microcephaly, facial dysmorphism syndrome (disorder)	4180186
36676627	BBIS - Beaulieu Boycott Innes syndrome	4180186
36676631	Physical medicine service (qualifier value)	4180186
36676632	Progressive retinal dystrophy due to retinol transport defect (disorder)	4180186
36676632	Retinol dystrophy, iris coloboma, comedogenic acne syndrome	4180186
36676637	Intellectual disability, craniofacial dysmorphism, cryptorchidism syndrome (disorder)	4180186
36676638	Infection caused by Hendra virus	4180186
36676638	Infection caused by Hendra virus (disorder)	4180186
36676646	Podiatry care plan (record artifact)	4180186
36676649	Orthodontic care plan (record artifact)	4180186
36676651	Care of elderly care plan (record artifact)	4180186
36676655	Sting by hymenoptera (event)	4180186
36676661	Sting by plant (event)	4180186
36676665	Chudley McCullough syndrome (disorder)	4180186
36676667	Product containing ribonucleic acid, double stranded (product)	4180186
36676669	Intellectual disability, hypotonia, brachycephaly, pyloric stenosis, cryptorchidism syndrome (disorder)	4180186
36676670	Craniofacial dysplasia osteopenia syndrome (disorder)	4180186
36676670	Hamamy syndrome	4180186
36676671	Spigelian hernia with cryptorchidism syndrome (disorder)	4180186
36676673	SOFT (short stature, onychodysplasia, facial dysmorphism, hypotrichosis) syndrome	4180186
36676673	SOFT syndrome	4180186
36676673	Short stature, onychodysplasia, facial dysmorphism, hypotrichosis syndrome (disorder)	4180186
36676675	Porencephaly, microcephaly, bilateral congenital cataract syndrome (disorder)	4180186
36676676	Frontonasal dysplasia, severe microphthalmia, severe facial clefting syndrome (disorder)	4180186
36676676	ALX1-related frontonasal dysplasia	4180186
36676676	ALX1 (aristaless-like homeobox 1) related frontonasal dysplasia	4180186
36676676	Frontonasal dysplasia type 3	4180186
36676679	Urinary catheter submitted as specimen (specimen)	4180186
36676680	Familial cold urticaria with common variable immunodeficiency	4180186
36676680	PLCG2 (phospholipase C gamma 2) associated antibody deficiency and immune dysregulation	4180186
36676680	FACU - familial atypical cold urticaria	4180186
36676680	Phospholipase C gamma 2 associated antibody deficiency and immune dysregulation	4180186
36676680	Phospholipase C gamma 2 associated antibody deficiency and immune dysregulation (disorder)	4180186
36676681	Nephrotic syndrome, deafness, pretibial epidermolysis bullosa syndrome (disorder)	4180186
36676681	Nephrotic syndrome, hearing loss, pretibial epidermolysis bullosa syndrome	4180186
36676682	Congenital cataract, deafness, severe developmental delay syndrome	4180186
36676682	Congenital cataract, hearing loss, severe developmental delay syndrome (disorder)	4180186
36676682	Lethal neurodegenerative disorder due to copper transport defect	4180186
36676683	Transient infantile hypertriglyceridaemia and fatty liver	4180186
36676683	Transient infantile hypertriglyceridaemia and hepatosteatosis	4180186
36676683	Transient infantile hypertriglyceridemia and hepatosteatosis (disorder)	4180186
36676683	Transient infantile hypertriglyceridemia and fatty liver	4180186
36676685	Product containing lenvatinib in oral dose form (medicinal product form)	4180186
36676690	DAVID (deficiency in anterior pituitary function, variable immunodeficiency) syndrome	4180186
36676690	Deficiency in anterior pituitary function, variable immunodeficiency syndrome (disorder)	4180186
36676692	Hypoinsulinemic hypoglycaemia and body hemihypertrophy	4180186
36676692	Hypoinsulinemic hypoglycemia and body hemihypertrophy (disorder)	4180186
36676695	Paced Auditory Serial Addition Test score (observable entity)	4180186
36676695	Paced Auditory Stimulation Test score	4180186
36676695	PASAT-Paced Auditory Serial Addition Test score	4180186
36676696	Distal Xq28 microduplication syndrome (disorder)	4180186
36676696	Distal trisomy Xq28	4180186
36676698	Lethal occipital encephalocele, skeletal dysplasia syndrome (disorder)	4180186
36676701	Hepatitis A virus genotype II (organism)	4180186
36676704	Hepatitis A virus genotype V (organism)	4180186
36676705	Hepatitis A virus genotype VI (organism)	4180186
36676708	Hepatitis A virus genotype IB (organism)	4180186
36676709	Hepatitis A virus genotype IIB (organism)	4180186
36676711	Hepatitis A virus genotype IIIA (organism)	4180186
36676713	Microcornea, posterior megalolenticonus, persistent foetal vasculature, coloboma syndrome	4180186
36676713	Microcornea, posterior megalolenticonus, persistent fetal vasculature, coloboma syndrome (disorder)	4180186
36676713	MPPC (microcornea, posterior megalolenticonus, persistent foetal vasculature, coloboma) syndrome	4180186
36676713	MPPC (microcornea, posterior megalolenticonus, persistent fetal vasculature, coloboma) syndrome	4180186
36676721	OMPP - sterile osteomyelitis, multifocal with periostitis and pustulosis	4180186
36676721	Sterile multifocal osteomyelitis with periostitis and pustulosis (disorder)	4180186
36676721	Autoinflammatory disease due to interleukin-1 receptor antagonist deficiency	4180186
36676721	Interleukin-1 receptor antagonist deficiency	4180186
36676722	Nasojejunal feeding tube (physical object)	4180186
36676723	Assessment using Oxford Shoulder Score (procedure)	4180186
36676723	Assessment using OSS (Oxford Shoulder Score)	4180186
36676724	Discussed with psychiatrist (situation)	4180186
36676726	Rare non-syndromic intellectual disability (disorder)	4180186
36676728	High-grade neuroendocrine carcinoma of corpus uteri (disorder)	4180186
36676728	Poorly differentiated neuroendocrine carcinoma of corpus uteri	4180186
36676731	Antidepressant therapeutic role (role)	4180186
36676734	Analeptic therapeutic role (role)	4180186
36676735	Anorexiant therapeutic role (role)	4180186
36676736	Antianaemic therapeutic role	4180186
36676736	Antianemic therapeutic role (role)	4180186
36676737	Antidiarrhoeal therapeutic role	4180186
36676737	Antidiarrheal therapeutic role (role)	4180186
36676738	Antidote therapeutic role (role)	4180186
36676740	Antigout therapeutic role (role)	4180186
36676743	Antineoplastic therapeutic role (role)	4180186
36676744	Antiparasitic therapeutic role (role)	4180186
36676745	Antiparkinson therapeutic role (role)	4180186
36676746	Antipsychotic therapeutic role (role)	4180186
36676747	Antiplatelet therapeutic role (role)	4180186
36676753	Anxiolytic therapeutic role (role)	4180186
36676755	Lubricant therapeutic role (role)	4180186
36676759	Vasodilator therapeutic role (role)	4180186
36676760	Vasoconstrictor therapeutic role (role)	4180186
36676761	Mucolytic therapeutic role (role)	4180186
36676764	Oxytocic therapeutic role (role)	4180186
36676768	Sedative therapeutic role (role)	4180186
36676770	Tocolytic therapeutic role (role)	4180186
36676775	Decongestant therapeutic role (role)	4180186
36676776	Medicinal product acting as antiacne agent (product)	4180186
36676778	Family Capnodiaceae (organism)	4180186
36676778	Capnodiaceae	4180186
36676779	Genus Sagrahamala (organism)	4180186
36676779	Sagrahamala	4180186
36676780	Genus Polyscytalum (organism)	4180186
36676780	Polyscytalum	4180186
36676782	Genus Dactylella (organism)	4180186
36676782	Dactylella	4180186
36676789	Necrotizing otitis externa of left external auditory canal (disorder)	4180186
36676789	Necrotising otitis externa of left external auditory canal	4180186
36676790	Lanadelumab (substance)	4180186
36676791	Product containing cenegermin (medicinal product)	4180186
36676792	Product containing cenegermin in ocular dose form (medicinal product form)	4180186
36676793	Product containing lanadelumab (medicinal product)	4180186
36676796	Transient neonatal hypothyroidism due to neonatal iodine exposure (disorder)	4180186
36676796	Transient neonatal hypothyroidism due to neonatal iodine exposure	4180186
36676797	Product containing only L-ornithine L-aspartate (medicinal product)	4180186
36676802	Visible and exudative idiopathic juxtafoveolar retinal telangiectasis	4180186
36676802	Idiopathic macular telangiectasia type 1 (disorder)	4180186
36676803	Idiopathic linear interstitial keratitis (disorder)	4180186
36676804	pcALCL - primary cutaneous anaplastic large cell lymphoma	4180186
36676804	Primary cutaneous anaplastic large cell lymphoma (disorder)	4180186
36676805	Transcatheter aortic valve implantation (procedure)	4180186
36676805	TAVI - transcatheter aortic valve implantation	4180186
36676805	Transcatheter aortic valve replacement	4180186
36676805	TAVR - transcatheter aortic valve replacement	4180186
36676806	Custom-made pressure-management insole	4180186
36676806	Custom-made pressure-management insole (physical object)	4180186
36676807	Non-coated synthetic polymer burn dressing (physical object)	4180186
36676807	Non-coated synthetic polymer burn dressing	4180186
36676809	High-altitude sleep mask (physical object)	4180186
36676810	High intensity focused ultrasound ablation (procedure)	4180186
36676814	Ear, nose and throat drain	4180186
36676814	Ear, nose and throat drain (physical object)	4180186
36676816	Wearable venous compression pump (physical object)	4180186
36676817	High intensity focused ultrasound ablation of uterine fibroid using magnetic resonance imaging guidance (procedure)	4180186
36676817	High intensity focused ultrasound ablation of uterine fibroid using magnetic resonance imaging guidance	4180186
36676820	High intensity focused ultrasound ablation of lesion of prostate using magnetic resonance imaging guidance (procedure)	4180186
36676820	High intensity focused ultrasound ablation of lesion of prostate using magnetic resonance imaging guidance	4180186
36676821	High intensity focused ultrasound ablation of lesion of liver using magnetic resonance imaging guidance	4180186
36676821	High intensity focused ultrasound ablation of lesion of liver using magnetic resonance imaging guidance (procedure)	4180186
36676822	High intensity focused ultrasound ablation of lesion of kidney using magnetic resonance imaging guidance (procedure)	4180186
36676822	High intensity focused ultrasound ablation of lesion of kidney using magnetic resonance imaging guidance	4180186
36676823	High intensity focused ultrasound ablation of hemangioma using magnetic resonance imaging guidance (procedure)	4180186
36676823	High intensity focused ultrasound ablation of haemangioma using magnetic resonance imaging guidance	4180186
36676823	MRI guided high intensity focused ultrasound ablation of haemangioma	4180186
36676823	High intensity focused ultrasound ablation of hemangioma using magnetic resonance imaging guidance	4180186
36676825	Antithyroid therapeutic role (role)	4180186
36676827	Assessment using Global Deterioration Scale (procedure)	4180186
36676827	Assessment using GDS (Global Deterioration Scale)	4180186
36676830	Obstruction of left Eustachian tube (disorder)	4180186
36676831	Obstruction of right Eustachian tube (disorder)	4180186
36676836	Arthropathy of left knee joint (disorder)	4180186
36676836	Disorder of joint of left knee	4180186
36676838	Arthropathy of joint of right hand (disorder)	4180186
36676839	Arthropathy of joint of left hand (disorder)	4180186
36676840	Pain of right forearm (finding)	4180186
36676842	Pain of left shoulder blade (finding)	4180186
36676842	Left scapulalgia	4180186
36676843	Pain of right acromioclavicular joint (finding)	4180186
36676846	Instability of left hip joint (finding)	4180186
36676847	Instability of right shoulder joint (finding)	4180186
36676848	Instability of left shoulder joint (finding)	4180186
36676849	Instability of left elbow joint (finding)	4180186
36676850	Spasm of right piriformis muscle (finding)	4180186
36676854	Severe intellectual disability, progressive postnatal microcephaly, midline stereotypic hand movements syndrome (disorder)	4180186
36676854	IQSEC2 (IQ motif and Sec7 domain 2) related syndromic intellectual disability	4180186
36676854	IQSEC2-related syndromic intellectual disability	4180186
36676859	Periodic paralysis with later-onset distal motor neuropathy (disorder)	4180186
36676860	Short stature, auditory canal atresia, mandibular hypoplasia, skeletal anomalies syndrome (disorder)	4180186
36676860	SAMS syndrome	4180186
36676860	SAMS (short stature, auditory canal atresia, mandibular hypoplasia, skeletal anomalies) syndrome	4180186
36676864	Has pack size (attribute)	4180186
36676867	Product name (product name)	4180186
36676869	Product containing blinatumomab (medicinal product)	4180186
36676870	Product containing blinatumomab in parenteral dose form (medicinal product form)	4180186
36676871	Dysfunction of inferior oblique muscle of right eye (disorder)	4180186
36676877	Product containing dantron in oral dose form (medicinal product form)	4180186
36676877	Dantron-containing product in oral dose form	4180186
36676878	Product containing bran in oral dose form (medicinal product form)	4180186
36676881	Plant fibre-containing product in oral dose form	4180186
36676881	Product containing plant fiber in oral dose form (medicinal product form)	4180186
36676882	Product containing Frangula in oral dose form (medicinal product form)	4180186
36676889	Product containing potassium bicarbonate and potassium bitartrate in rectal dose form (medicinal product form)	4180186
36676894	Assessment using ASEPSIS (Additional treatment, Serous discharge, Erythema, Purulent exudate, Separation of deep tissue, Isolation of bacteria, duration of inpatient Stay) scoring method	4180186
36676894	Assessment using Additional treatment, Serous discharge, Erythema, Purulent exudate, Separation of deep tissue, Isolation of bacteria, duration of inpatient Stay scoring method (procedure)	4180186
36676895	Additional treatment, Serous discharge, Erythema, Purulent exudate, Separation of deep tissue, Isolation of bacteria, duration of inpatient Stay scoring method score (observable entity)	4180186
36676895	ASEPSIS (Additional treatment, Serous discharge, Erythema, Purulent exudate, Separation of deep tissue, Isolation of bacteria, duration of inpatient Stay) scoring method score	4180186
36676897	Intellectual disability, severe speech delay, mild dysmorphism syndrome (disorder)	4180186
36676899	Growth and developmental delay, hypotonia, vision impairment, lactic acidosis syndrome (disorder)	4180186
36676900	Fatal post-viral neurodegenerative disorder (disorder)	4180186
36676901	Acute infantile liver failure with multisystemic involvement syndrome (disorder)	4180186
36676902	Sebaceous naevus, central nervous system malformations, aplasia cutis congenita, limbal dermoid, pigmented naevus syndrome	4180186
36676902	Sebaceous nevus, central nervous system malformations, aplasia cutis congenita, limbal dermoid, pigmented nevus syndrome (disorder)	4180186
36676902	Sebaceous nevus, central nervous system malformations, aplasia cutis congenita, limbal dermoid, pigmented nevus syndrome	4180186
36676903	Aplasia cutis congenita, naevus sebaceous syndrome	4180186
36676903	Didymosis aplasticosebacea (disorder)	4180186
36676903	Aplasia cutis congenita, nevus sebaceous syndrome	4180186
36676905	Congenital erythroderma, hypotrichosis, recurrent infections, multiple food allergies syndrome	4180186
36676905	Severe dermatitis, multiple allergies, metabolic wasting syndrome (disorder)	4180186
36676905	SAM syndrome	4180186
36676906	Microcornea, myopic chorioretinal atrophy, telecanthus syndrome (disorder)	4180186
36676906	MMCAT (microcornea, myopic chorioretinal atrophy, telecanthus) syndrome	4180186
36676906	MMCAT syndrome	4180186
36676912	Product containing magnesium citrate in oral dose form (medicinal product form)	4180186
36676915	MTP inhibitor	4180186
36676915	Substance with microsomal triglyceride transfer protein inhibitor mechanism of action (substance)	4180186
36676916	Product containing sorbitol in oral dose form (medicinal product form)	4180186
36676917	Product containing dapiprazole in ocular dose form (medicinal product form)	4180186
36676921	Sodium/potassium adenosine triphosphatase enzyme inhibitor-containing product	4180186
36676921	Product containing sodium/potassium adenosine triphosphatase enzyme inhibitor (product)	4180186
36676923	Product containing only 1,3,5-tris(2-hydroxyethyl)-hexahydrotriazine (medicinal product)	4180186
36676924	Product containing only 1,4-butanediol diacrylate (medicinal product)	4180186
36676926	Product containing only 1,6-hexanediol diacrylate (medicinal product)	4180186
36676927	Product containing only deoxycortone (medicinal product)	4180186
36676928	Product containing only 2,2,4-trimethyl-1,2-dihydroquinoline (medicinal product)	4180186
36676930	Product containing only 2-bromo-2-nitropropane-1,3-diol (medicinal product)	4180186
36676932	Product containing only 2-ethylhexyl acrylate (medicinal product)	4180186
36676933	Product containing only 2-hydroxyethyl acrylate (medicinal product)	4180186
36676934	Product containing only 2-hydroxyethyl methacrylate (medicinal product)	4180186
36676935	Product containing only 2-hydroxypropyl acrylate (medicinal product)	4180186
36676942	Product containing only 2-tert-butyl-4-methoxyphenol (medicinal product)	4180186
36676945	Product containing only 3-aminophenol (medicinal product)	4180186
36676950	Product containing only 4-tert-Butylbenzoic acid (medicinal product)	4180186
36676951	Product containing only 4-tert-butylphenol formaldehyde resin (medicinal product)	4180186
36676953	Product containing only 5-aminolevulinic acid (medicinal product)	4180186
36676954	Product containing only 5-methoxypsoralen (medicinal product)	4180186
36676955	Product containing only oxyquinoline (medicinal product)	4180186
36676956	Product containing only glacial acetic acid and oxyquinoline (medicinal product)	4180186
36676960	Product containing only Achillea millefolium extract (medicinal product)	4180186
36676965	Product containing only diosmin (medicinal product)	4180186
36676966	Product containing only Enhydrina schistosa antivenom (medicinal product)	4180186
36676969	Product containing only Escherichia coli antiserum (medicinal product)	4180186
36676970	Product containing only Escherichia coli antiserum and Pasteurella multocida antiserum and Salmonella typhimurium antiserum (medicinal product)	4180186
36676971	Product containing only Frangula (medicinal product)	4180186
36676972	Product containing only Frangula and Sterculia gum (medicinal product)	4180186
36676973	Product containing only Fuller's earth (medicinal product)	4180186
36676977	Product containing only Lactobacillus (medicinal product)	4180186
36676979	Product containing only Lactobacillus reuteri (medicinal product)	4180186
36676981	Product containing only Micrurus fulvius antivenom (medicinal product)	4180186
36676982	Product containing only N,N'-Diphenyl paraphenylenediamine (medicinal product)	4180186
36676983	Product containing only N,N-di-beta-naphthyl-4-phenylenediamine (medicinal product)	4180186
36676988	Product containing only N-isopropyl-N'-phenyl paraphenylenediamine (medicinal product)	4180186
36676994	Product containing only Saccharomyces boulardii (medicinal product)	4180186
36676996	Product containing only Staphylococcus toxoid vaccine (medicinal product)	4180186
36676998	Product containing only Streptococcus equisimilis antiserum (medicinal product)	4180186
36676999	Product containing only Streptococcus equisimilis antiserum and Streptococcus suis antiserum (medicinal product)	4180186
36677000	Product containing only Streptococcus suis antiserum (medicinal product)	4180186
36677002	Product containing only Vaccinia human immune globulin (medicinal product)	4180186
36677003	Product containing only abaloparatide (medicinal product)	4180186
36677004	Product containing only abarelix (medicinal product)	4180186
36677005	Product containing only abatacept (medicinal product)	4180186
36677008	Product containing only abietic acid (medicinal product)	4180186
36677009	Product containing only abiraterone (medicinal product)	4180186
36677011	Product containing only acamprosate (medicinal product)	4180186
36677015	Product containing only aceclofenac (medicinal product)	4180186
36677017	Product containing only acenocoumarol (medicinal product)	4180186
36677022	Product containing only acetic acid (medicinal product)	4180186
36677023	Product containing only acetic acid and honey and squill (medicinal product)	4180186
36677024	Product containing only acetic acid and hydrocortisone (medicinal product)	4180186
36677026	Product containing only acetohexamide (medicinal product)	4180186
36677027	Product containing only acetohydroxamic acid (medicinal product)	4180186
36677028	Product containing only acetomenaphthone (medicinal product)	4180186
36677029	Product containing only acetone (medicinal product)	4180186
36677030	Product containing only acetylcarbromal (medicinal product)	4180186
36677032	Product containing only acetylcysteine (medicinal product)	4180186
36677033	Aciclovir only product	4180186
36677033	Product containing only aciclovir (medicinal product)	4180186
36677034	Product containing only acipimox (medicinal product)	4180186
36677036	Product containing only aclarubicin (medicinal product)	4180186
36677041	Product containing only activated attapulgite (medicinal product)	4180186
36677042	Product containing only activated charcoal (medicinal product)	4180186
36677043	Product containing only activated charcoal and magnesium hydroxide (medicinal product)	4180186
36677044	Product containing only adalimumab (medicinal product)	4180186
36677046	Product containing only adapalene and benzoyl peroxide (medicinal product)	4180186
36677047	Product containing only adefovir (medicinal product)	4180186
36677051	Product containing only aflibercept (medicinal product)	4180186
36677054	Product containing only agomelatine (medicinal product)	4180186
36677056	Product containing only albiglutide (medicinal product)	4180186
36677058	Product containing only alclometasone (medicinal product)	4180186
36677059	Alcohol and aluminium chloride only product	4180186
36677059	Product containing only alcohol and aluminium chloride (medicinal product)	4180186
36677060	Product containing only alcuronium (medicinal product)	4180186
36677061	Product containing only aldesleukin (medicinal product)	4180186
36677071	Product containing only alfentanil (medicinal product)	4180186
36677072	Product containing only alfuzosin (medicinal product)	4180186
36677074	Alginic acid and aluminium hydroxide and magnesium trisilicate and sodium bicarbonate only product	4180186
36677074	Product containing only alginic acid and aluminium hydroxide and magnesium trisilicate and sodium bicarbonate (medicinal product)	4180186
36677076	Product containing only alglucosidase alfa (medicinal product)	4180186
36677078	Product containing only aliskiren (medicinal product)	4180186
36677081	Product containing only aliskiren and valsartan (medicinal product)	4180186
36677084	Product containing only alkali-metal soap and camphor and turpentine oil (medicinal product)	4180186
36677086	Product containing only allantoin and coal tar (medicinal product)	4180186
36677087	Product containing only allantoin and coal tar extract (medicinal product)	4180186
36677089	Product containing only allopurinol (medicinal product)	4180186
36677090	Product containing only allopurinol and lesinurad (medicinal product)	4180186
36677091	Product containing only allylestrenol (medicinal product)	4180186
36677092	Product containing only almond oil (medicinal product)	4180186
36677096	Product containing only Aloe and benzoin and Podophyllum resin and Styrax (medicinal product)	4180186
36677098	Product containing only aloin (medicinal product)	4180186
36677099	Product containing only alosetron (medicinal product)	4180186
36677100	Product containing only alpha-amylase (medicinal product)	4180186
36677102	Product containing only alpha-pinene (medicinal product)	4180186
36677103	Product containing only alpha-tocopherol (medicinal product)	4180186
36677105	Product containing only alprazolam (medicinal product)	4180186
36677106	Product containing only alprostadil (medicinal product)	4180186
36677107	Product containing only alteplase (medicinal product)	4180186
36677108	Product containing only altrenogest (medicinal product)	4180186
36677109	Product containing only altretamine (medicinal product)	4180186
36677112	Aluminium chloride only product	4180186
36677112	Product containing only aluminium chloride (medicinal product)	4180186
36677113	Aluminium hydroxide only product	4180186
36677113	Product containing only aluminium hydroxide (medicinal product)	4180186
36677117	Product containing only aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product)	4180186
36677117	Aluminium hydroxide and magnesium hydroxide and simeticone only product	4180186
36677118	Product containing only aluminium hydroxide and magnesium trisilicate (medicinal product)	4180186
36677118	Aluminium hydroxide and magnesium trisilicate only product	4180186
36677122	Aluminium sulfate only product	4180186
36677122	Product containing only aluminium sulfate (medicinal product)	4180186
36677127	Product containing only ambenonium (medicinal product)	4180186
36677128	Product containing only ambrisentan (medicinal product)	4180186
36677129	Product containing only ambroxol (medicinal product)	4180186
36677135	Product containing only amikacin (medicinal product)	4180186
36677136	Product containing only amiloride (medicinal product)	4180186
36677138	Product containing only amiloride and bumetanide (medicinal product)	4180186
36677139	Product containing only amiloride and cyclopenthiazide (medicinal product)	4180186
36677142	Product containing only amiloride and hydrochlorothiazide and timolol (medicinal product)	4180186
36677144	Aminoacridine and lidocaine only product	4180186
36677144	Product containing only aminoacridine and lidocaine (medicinal product)	4180186
36677148	Product containing only para-aminosalicylic acid (medicinal product)	4180186
36677149	Product containing only aminosalicylic sodium (medicinal product)	4180186
36677151	Product containing only amisulpride (medicinal product)	4180186
36677157	Product containing only amlodipine and benazepril (medicinal product)	4180186
36677158	Product containing only amlodipine and hydrochlorothiazide and olmesartan (medicinal product)	4180186
36677160	Product containing only amlodipine and olmesartan (medicinal product)	4180186
36677161	Product containing only amlodipine and telmisartan (medicinal product)	4180186
36677162	Product containing only amlodipine and valsartan (medicinal product)	4180186
36677164	Product containing only ammonia and ammonium bicarbonate (medicinal product)	4180186
36677165	Product containing only ammonia and ipecacuanha (medicinal product)	4180186
36677167	Product containing only ammonium bicarbonate (medicinal product)	4180186
36677168	Product containing only ammonium bicarbonate and ipecacuanha (medicinal product)	4180186
36677170	Product containing only ammonium bicarbonate and potassium iodide (medicinal product)	4180186
36677172	Product containing only ammonium chloride and caffeine (medicinal product)	4180186
36677175	Product containing only ammonium persulfate (medicinal product)	4180186
36677177	Product containing only ammonium thioglycolate (medicinal product)	4180186
36677179	Product containing only amobarbital and secobarbital (medicinal product)	4180186
36677181	Product containing only amodiaquine and artemisinin (medicinal product)	4180186
36677182	Product containing only amodiaquine and artesunate (medicinal product)	4180186
36677183	Product containing only amoxapine (medicinal product)	4180186
36677184	Product containing only amoxicillin (medicinal product)	4180186
36677185	Product containing only amoxicillin and clavulanic acid (medicinal product)	4180186
36677188	Product containing only ampicillin (medicinal product)	4180186
36677190	Ampicillin and flucloxacillin only product	4180186
36677190	Product containing only ampicillin and flucloxacillin (medicinal product)	4180186
36677196	Product containing only amyl nitrite (medicinal product)	4180186
36677197	Product containing only amylase (medicinal product)	4180186
36677200	Product containing only amylin (medicinal product)	4180186
36677201	Product containing only amylmetacresol (medicinal product)	4180186
36677203	Product containing only anakinra (medicinal product)	4180186
36677204	Product containing only anastrozole (medicinal product)	4180186
36677207	Product containing only angiotensin II (medicinal product)	4180186
36677210	Product containing only anisindione (medicinal product)	4180186
36677211	Product containing only anisotropine (medicinal product)	4180186
36677220	Product containing only antithrombin III (medicinal product)	4180186
36677223	Product containing only apomorphine (medicinal product)	4180186
36677224	Product containing only apraclonidine (medicinal product)	4180186
36677234	Product containing only aripiprazole (medicinal product)	4180186
36677238	Product containing only artemether (medicinal product)	4180186
36677239	Product containing only artemether and lumefantrine (medicinal product)	4180186
36677240	Product containing only artesunate (medicinal product)	4180186
36677241	Product containing only artesunate and mefloquine (medicinal product)	4180186
36677242	Product containing only ascorbic acid (medicinal product)	4180186
36677245	Product containing only ascorbic acid and cyanocobalamin and ferrous fumarate (medicinal product)	4180186
36677246	Product containing only ascorbic acid and dimethyl sulfone (medicinal product)	4180186
36677247	Product containing only ascorbic acid and ferrous gluconate and folic acid (medicinal product)	4180186
36677248	Product containing only ascorbic acid and ferrous sulfate (medicinal product)	4180186
36677250	Product containing only asenapine (medicinal product)	4180186
36677254	Product containing only aspirin (medicinal product)	4180186
36677256	Product containing only aspirin and butalbital and caffeine and codeine (medicinal product)	4180186
36677259	Product containing only aspirin and caffeine and dextropropoxyphene (medicinal product)	4180186
36677259	Aspirin and caffeine and dextropropoxyphene only product	4180186
36677260	Product containing only aspirin and caffeine and dihydrocodeine (medicinal product)	4180186
36677261	Product containing only aspirin and caffeine and orphenadrine (medicinal product)	4180186
36677262	Aspirin and caffeine and paracetamol only product	4180186
36677262	Product containing only aspirin and caffeine and paracetamol (medicinal product)	4180186
36677265	Product containing only aspirin and codeine (medicinal product)	4180186
36677266	Product containing only aspirin and cyclizine (medicinal product)	4180186
36677267	Product containing only aspirin and dipyridamole (medicinal product)	4180186
36677268	Product containing only aspirin and glycine (medicinal product)	4180186
36677270	Product containing only aspirin and isosorbide (medicinal product)	4180186
36677273	Product containing only aspirin and metoclopramide (medicinal product)	4180186
36677274	Product containing only aspirin and omeprazole (medicinal product)	4180186
36677275	Product containing only aspirin and oxycodone (medicinal product)	4180186
36677276	Product containing only aspirin and papaveretum (medicinal product)	4180186
36677278	Product containing only aspirin and pentazocine (medicinal product)	4180186
36677279	Product containing only aspirin and pravastatin (medicinal product)	4180186
36677283	Product containing only atenolol (medicinal product)	4180186
36677285	Atenolol and chlortalidone only product	4180186
36677285	Product containing only atenolol and chlortalidone (medicinal product)	4180186
36677290	Product containing only atovaquone (medicinal product)	4180186
36677291	Product containing only atovaquone and proguanil (medicinal product)	4180186
36677293	Product containing only atranorin (medicinal product)	4180186
36677294	Product containing only atropine (medicinal product)	4180186
36677295	Product containing only atropine and difenoxin (medicinal product)	4180186
36677299	Product containing only atropine and pralidoxime (medicinal product)	4180186
36677301	Product containing only auranofin (medicinal product)	4180186
36677302	Product containing only aurothioglucose (medicinal product)	4180186
36677303	Product containing only avanafil (medicinal product)	4180186
36677304	Product containing only avatrombopag (medicinal product)	4180186
36677306	Product containing only aviptadil (medicinal product)	4180186
36677307	Product containing only aviptadil and phentolamine (medicinal product)	4180186
36677309	Product containing only avobenzone and ecamsule and octocrilene (medicinal product)	4180186
36677309	Avobenzone and ecamsule and octocrilene only product	4180186
36677318	Product containing only azelastine (medicinal product)	4180186
36677319	Product containing only azilsartan (medicinal product)	4180186
36677321	Product containing only azlocillin (medicinal product)	4180186
36677322	Product containing only azodiisobutyrodinitrile (medicinal product)	4180186
36677324	Product containing only bacampicillin (medicinal product)	4180186
36677325	Product containing only bacitracin (medicinal product)	4180186
36677326	Product containing only bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product)	4180186
36677329	Product containing only bacitracin and polymyxin B (medicinal product)	4180186
36677330	Product containing only baclofen (medicinal product)	4180186
36677331	Product containing only balsalazide (medicinal product)	4180186
36677334	Product containing only bambuterol (medicinal product)	4180186
36677335	Product containing only bamethan (medicinal product)	4180186
36677342	Product containing only beclamide (medicinal product)	4180186
36677347	Product containing only beef insulin (medicinal product)	4180186
36677350	Product containing only belimumab (medicinal product)	4180186
36677351	Product containing only belinostat (medicinal product)	4180186
36677353	Product containing only belladonna alkaloid and ergotamine and phenobarbital (medicinal product)	4180186
36677356	Product containing only belladonna alkaloid and phenobarbital (medicinal product)	4180186
36677359	Product containing only benazepril (medicinal product)	4180186
36677361	Product containing only bendamustine (medicinal product)	4180186
36677363	Product containing only bendroflumethiazide and nadolol (medicinal product)	4180186
36677364	Product containing only bendroflumethiazide and potassium (medicinal product)	4180186
36677368	Product containing only benethamine penicillin (medicinal product)	4180186
36677369	Product containing only benfotiamine (medicinal product)	4180186
36677371	Product containing only benorilate (medicinal product)	4180186
36677373	Product containing only benproperine (medicinal product)	4180186
36677375	Product containing only benserazide (medicinal product)	4180186
36677377	Product containing only bentoquatam (medicinal product)	4180186
36677379	Product containing only benzalkonium (medicinal product)	4180186
36677383	Product containing only benzalkonium and tolnaftate (medicinal product)	4180186
36677385	Product containing only benzbromarone (medicinal product)	4180186
36677386	Product containing only benzestrol (medicinal product)	4180186
36677387	Product containing only benzethonium (medicinal product)	4180186
36677388	Product containing only benzfetamine (medicinal product)	4180186
36677388	Benzfetamine only product	4180186
36677389	Product containing only benzhydrocodone and paracetamol (medicinal product)	4180186
36677389	Benzhydrocodone and paracetamol only product	4180186
36677390	Product containing only benznidazole (medicinal product)	4180186
36677392	Product containing only benzocaine and cetylpyridinium (medicinal product)	4180186
36677394	Product containing only benzocaine and dequalinium (medicinal product)	4180186
36677396	Benzocaine and mepyramine only product	4180186
36677396	Product containing only benzocaine and mepyramine (medicinal product)	4180186
36677397	Product containing only benzocaine and phenazone (medicinal product)	4180186
36677397	Benzocaine and phenazone only product	4180186
36677398	Product containing only benzocaine and phenazone and phenylephrine (medicinal product)	4180186
36677398	Benzocaine and phenazone and phenylephrine only product	4180186
36677403	Product containing only benzocaine and tyrothricin (medicinal product)	4180186
36677405	Product containing only benzoic acid and salicylic acid (medicinal product)	4180186
36677406	Product containing only benzoin and menthol (medicinal product)	4180186
36677408	Product containing only benzotriazole (medicinal product)	4180186
36677409	Product containing only benzoyl peroxide (medicinal product)	4180186
36677410	Product containing only benzoyl peroxide and clindamycin (medicinal product)	4180186
36677411	Product containing only benzoyl peroxide and erythromycin (medicinal product)	4180186
36677413	Product containing only benzoyl peroxide and potassium hydroxyquinoline sulfate (medicinal product)	4180186
36677414	Product containing only benzoyl peroxide and sulfur (medicinal product)	4180186
36677415	Product containing only benzquinamide (medicinal product)	4180186
36677416	Product containing only benzthiazide (medicinal product)	4180186
36677419	Product containing only benzyl alcohol (medicinal product)	4180186
36677420	Product containing only benzyl benzoate (medicinal product)	4180186
36677422	Product containing only benzyl para-hydroxybenzoate (medicinal product)	4180186
36677423	Product containing only benzyl salicylate (medicinal product)	4180186
36677424	Product containing only benzylpenicillin (medicinal product)	4180186
36677424	Benzylpenicillin only product	4180186
36677427	Product containing only bepotastine (medicinal product)	4180186
36677428	Product containing only bepridil (medicinal product)	4180186
36677429	Product containing only beractant (medicinal product)	4180186
36677432	Product containing only beta tocopherol (medicinal product)	4180186
36677433	Product containing only betacarotene (medicinal product)	4180186
36677434	Product containing only beta-galactosidase (medicinal product)	4180186
36677438	Product containing only betamethasone and calcipotriol (medicinal product)	4180186
36677439	Product containing only betamethasone and clioquinol (medicinal product)	4180186
36677440	Product containing only betamethasone and clotrimazole (medicinal product)	4180186
36677441	Product containing only betamethasone and fusidic acid (medicinal product)	4180186
36677443	Product containing only betamethasone and salicylic acid (medicinal product)	4180186
36677446	Product containing only bethanechol (medicinal product)	4180186
36677447	Product containing only betrixaban (medicinal product)	4180186
36677449	Product containing only bexarotene (medicinal product)	4180186
36677451	Product containing only bezlotoxumab (medicinal product)	4180186
36677452	Product containing only bicalutamide (medicinal product)	4180186
36677453	Product containing only biclotymol (medicinal product)	4180186
36677454	Product containing only bictegravir and emtricitabine and tenofovir (medicinal product)	4180186
36677455	Product containing only bifenthrin (medicinal product)	4180186
36677456	Product containing only bifonazole (medicinal product)	4180186
36677458	Product containing only bimatoprost (medicinal product)	4180186
36677459	Product containing only bimatoprost and timolol (medicinal product)	4180186
36677460	Product containing only binimetinib (medicinal product)	4180186
36677461	Product containing only biotin (medicinal product)	4180186
36677462	Product containing only biperiden (medicinal product)	4180186
36677463	Product containing only biphasic isophane insulin human (medicinal product)	4180186
36677466	Product containing only bis (diethyldithiocarbamato) zinc (medicinal product)	4180186
36677467	Product containing only bisacodyl (medicinal product)	4180186
36677469	Product containing only bismuth (medicinal product)	4180186
36677470	Product containing only bismuth biskalcitrate (medicinal product)	4180186
36677473	Product containing only bismuth subgallate (medicinal product)	4180186
36677478	Product containing only bisoprolol (medicinal product)	4180186
36677480	Product containing only bisphenol A (medicinal product)	4180186
36677481	Product containing only bitolterol (medicinal product)	4180186
36677482	Product containing only bitter orange oil (medicinal product)	4180186
36677485	Product containing only blood group antibody D (medicinal product)	4180186
36677486	Product containing only boceprevir (medicinal product)	4180186
36677487	Product containing only boldenone (medicinal product)	4180186
36677488	Product containing only bortezomib (medicinal product)	4180186
36677493	Product containing only botulinum toxin type B (medicinal product)	4180186
36677495	Product containing only bovine collagen and polymethyl methacrylate (medicinal product)	4180186
36677496	Product containing only bovine insulin protamine zinc (medicinal product)	4180186
36677497	Bovine insulin soluble only product	4180186
36677497	Product containing only bovine regular insulin (medicinal product)	4180186
36677498	Product containing only bovine serum albumin (medicinal product)	4180186
36677499	Product containing only cannabidiol (medicinal product)	4180186
36677501	Product containing only bovine thrombin (medicinal product)	4180186
36677503	Product containing only brentuximab vedotin (medicinal product)	4180186
36677504	Product containing only bretylium (medicinal product)	4180186
36677505	Product containing only brigatinib (medicinal product)	4180186
36677508	Product containing only brimonidine (medicinal product)	4180186
36677509	Product containing only brimonidine and timolol (medicinal product)	4180186
36677512	Product containing only bromazepam (medicinal product)	4180186
36677513	Product containing only bromazine (medicinal product)	4180186
36677513	Bromazine only product	4180186
36677516	Product containing only bromfenac (medicinal product)	4180186
36677517	Product containing only bromocriptine (medicinal product)	4180186
36677518	Product containing only brompheniramine (medicinal product)	4180186
36677523	Product containing only budesonide and formoterol (medicinal product)	4180186
36677524	Product containing only bufexamac (medicinal product)	4180186
36677525	Product containing only buffered aspirin (medicinal product)	4180186
36677526	Product containing only buffered aspirin and caffeine (medicinal product)	4180186
36677530	Product containing only bupivacaine (medicinal product)	4180186
36677533	Product containing only bupivacaine and lidocaine (medicinal product)	4180186
36677534	Product containing only buprenorphine (medicinal product)	4180186
36677536	Product containing only bupropion (medicinal product)	4180186
36677537	Product containing only bupropion and naltrexone (medicinal product)	4180186
36677538	Product containing only burbot liver oil (medicinal product)	4180186
36677539	Product containing only burosumab (medicinal product)	4180186
36677540	Product containing only buserelin (medicinal product)	4180186
36677541	Product containing only buspirone (medicinal product)	4180186
36677544	Product containing only butalbital (medicinal product)	4180186
36677545	Product containing only butalbital and caffeine and codeine and paracetamol (medicinal product)	4180186
36677545	Butalbital and caffeine and codeine and paracetamol only product	4180186
36677546	Product containing only butalbital and caffeine and paracetamol (medicinal product)	4180186
36677546	Butalbital and caffeine and paracetamol only product	4180186
36677547	Butalbital and paracetamol only product	4180186
36677547	Product containing only butalbital and paracetamol (medicinal product)	4180186
36677548	Product containing only butenafine (medicinal product)	4180186
36677550	Product containing only butoconazole (medicinal product)	4180186
36677551	Product containing only butorphanol (medicinal product)	4180186
36677553	Product containing only butyl acrylate (medicinal product)	4180186
36677555	Product containing only butyl para-hydroxybenzoate (medicinal product)	4180186
36677556	Product containing only butylated hydroxyanisole (medicinal product)	4180186
36677558	Product containing only cabazitaxel (medicinal product)	4180186
36677559	Product containing only cabergoline (medicinal product)	4180186
36677560	Product containing only cabozantinib (medicinal product)	4180186
36677562	Product containing only cade oil and coal tar (medicinal product)	4180186
36677563	Product containing only cadexomer iodine (medicinal product)	4180186
36677565	Caffeine and codeine and paracetamol only product	4180186
36677565	Product containing only caffeine and codeine and paracetamol (medicinal product)	4180186
36677566	Caffeine and dihydrocodeine and paracetamol only product	4180186
36677566	Product containing only caffeine and dihydrocodeine and paracetamol (medicinal product)	4180186
36677567	Product containing only caffeine and ergotamine (medicinal product)	4180186
36677568	Product containing only caffeine and glucose (medicinal product)	4180186
36677569	Product containing only caffeine and isometheptene and paracetamol (medicinal product)	4180186
36677569	Caffeine and isometheptene and paracetamol only product	4180186
36677570	Product containing only caffeine and paracetamol (medicinal product)	4180186
36677570	Caffeine and paracetamol only product	4180186
36677572	Product containing only caffeine and sodium benzoate (medicinal product)	4180186
36677573	Product containing only calamine (medicinal product)	4180186
36677574	Product containing only calamine and clioquinol and zinc oxide (medicinal product)	4180186
36677575	Product containing only calamine and dibrompropamidine (medicinal product)	4180186
36677575	Calamine and dibrompropamidine only product	4180186
36677576	Calamine and dimeticone and zinc only product	4180186
36677576	Product containing only calamine and dimeticone and zinc (medicinal product)	4180186
36677578	Product containing only calcifediol (medicinal product)	4180186
36677579	Product containing only calcipotriol (medicinal product)	4180186
36677580	Product containing only calcitonin (medicinal product)	4180186
36677581	Product containing only calcitriol (medicinal product)	4180186
36677582	Product containing only calcium (medicinal product)	4180186
36677585	Product containing only calcium and magnesium (medicinal product)	4180186
36677587	Product containing only calcium carbonate (medicinal product)	4180186
36677588	Product containing only calcium carbonate and colecalciferol (medicinal product)	4180186
36677588	Calcium carbonate and colecalciferol only product	4180186
36677590	Product containing only calcium carbonate and famotidine and magnesium hydroxide (medicinal product)	4180186
36677592	Product containing only calcium carbonate and light kaolin (medicinal product)	4180186
36677593	Product containing only calcium carbonate and magnesium carbonate (medicinal product)	4180186
36677594	Product containing only calcium carbonate and magnesium chloride (medicinal product)	4180186
36677596	Product containing only calcium carbonate and simeticone (medicinal product)	4180186
36677596	Calcium carbonate and simeticone only product	4180186
36677599	Product containing only calcium glubionate and calcium lactobionate (medicinal product)	4180186
36677600	Product containing only calcium gluconate (medicinal product)	4180186
36677602	Product containing only calcium phosphate (medicinal product)	4180186
36677603	Product containing only calcium phosphate and carmellose (medicinal product)	4180186
36677603	Calcium phosphate and carmellose only product	4180186
36677604	Product containing only calcium iodide (medicinal product)	4180186
36677605	Product containing only calcium lactate (medicinal product)	4180186
36677606	Product containing only calcium lactate and calcium phosphate and ergocalciferol (medicinal product)	4180186
36677607	Product containing only calcium lactate and carob (medicinal product)	4180186
36677608	Product containing only calcium leucovorin (medicinal product)	4180186
36677610	Product containing only calcium sulfaloxate (medicinal product)	4180186
36677611	Product containing only calcium sulfate (medicinal product)	4180186
36677613	Product containing only calcium-45 (medicinal product)	4180186
36677614	Product containing only calcium-47 (medicinal product)	4180186
36677616	Product containing only camphene (medicinal product)	4180186
36677617	Product containing only camphor (medicinal product)	4180186
36677620	Product containing only camphor and menthol and methyl salicylate (medicinal product)	4180186
36677621	Product containing only camphor and menthol and phenol (medicinal product)	4180186
36677622	Product containing only camphor and salicylic acid (medicinal product)	4180186
36677624	Product containing only canagliflozin and metformin (medicinal product)	4180186
36677625	Product containing only canakinumab (medicinal product)	4180186
36677628	Product containing only cangrelor (medicinal product)	4180186
36677629	Product containing only cannabinol and delta-9-tetrahydrocannabinol (medicinal product)	4180186
36677630	Product containing only cantharidin (medicinal product)	4180186
36677632	Product containing only capreomycin (medicinal product)	4180186
36677633	Product containing only capsaicin (medicinal product)	4180186
36677634	Product containing only captafol (medicinal product)	4180186
36677636	Product containing only captopril (medicinal product)	4180186
36677637	Product containing only captopril and hydrochlorothiazide (medicinal product)	4180186
36677639	Product containing only carbachol (medicinal product)	4180186
36677643	Product containing only carbazochrome (medicinal product)	4180186
36677645	Product containing only carbenoxolone (medicinal product)	4180186
36677646	Product containing only carbetocin (medicinal product)	4180186
36677648	Product containing only carbidopa and entacapone and levodopa (medicinal product)	4180186
36677649	Product containing only carbidopa and levodopa (medicinal product)	4180186
36677651	Product containing only carbinoxamine (medicinal product)	4180186
36677653	Product containing only carbinoxamine and pseudoephedrine (medicinal product)	4180186
36677654	Product containing only carbocisteine (medicinal product)	4180186
36677654	Carbocisteine only product	4180186
36677656	Product containing only carbomer-940 (medicinal product)	4180186
36677657	Product containing only carbomer-980 (medicinal product)	4180186
36677660	Product containing only carbon-14 (medicinal product)	4180186
36677663	Product containing only carfecillin (medicinal product)	4180186
36677666	Product containing only cariprazine (medicinal product)	4180186
36677667	Product containing only carisoprodol (medicinal product)	4180186
36677669	Product containing only carmustine (medicinal product)	4180186
36677672	Product containing only carteolol (medicinal product)	4180186
36677675	Product containing only cascara (medicinal product)	4180186
36677676	Product containing only cascara and senna (medicinal product)	4180186
36677679	Product containing only castor oil and collodion and colophony (medicinal product)	4180186
36677680	Product containing only castor oil and zinc oxide (medicinal product)	4180186
36677681	Product containing only catechin (medicinal product)	4180186
36677684	Cefalexin only product	4180186
36677684	Product containing only cefalexin (medicinal product)	4180186
36677685	Cefalotin only product	4180186
36677685	Product containing only cefalotin (medicinal product)	4180186
